вêî²îì²Ì ¿
ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñÇ
2008 Ã. ÑáõÉÇëÇ 7-Ç N 11-Ü Ññ³Ù³Ýáí
вڲêî²ÜÆ Ð²Üð²äºîàôÂÚ²Ü ¸ºÔºðÆ äºî²Î²Ü ¶ð²Üò²Ø²îÚ²Ü (é»»ëïñ)
(Éñ³Ùß³Ïí³Í ï³ñµ»ñ³Ï, 31.12.2007 Ã. ¹ñáõÃÛ³Ùµ)
·ñ³ÝóÙ³Ý
ųÙÏ»ïÁ
9
5344
11
¸2
êÉáí»Ýdz
J01M A03
5272
10
07.02.2005
07.02.2010
07.02.2005
07.02.2010
êÉáí³Ïdz
C04A D03
4251
¸
êÉáí³Ïdz
C04A D03
4252
¶»ñÙ³Ýdz
C08C A05
5918
19.06.2003
19.06.2008
19.06.2003
19.06.2008
02.03.2006
02.03.2011
ê³Ý¹á½ öñÇí³ï ÈÇÙÇﻹ
Sandoz Private Limited
Ðݹϳëï³Ý
C02L A01,
C02L A51
1190/4372/1
03.10.2007
10.09.2008
¸
6Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(6)
0.1%,
15· å³ñÏáõ×
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·. ζ
EBEWE Pharma Ges.m.b.H.
Nfg. KG
Þ»ñÇÝ· ê.å.².
Schering
S.p.A.
²íëïñdz
C01E B10
4785
21.06.2004
21.06.2009
¸
Æï³Édz
D07A A01,
D10A A02,
H02A B04
4652
18.08.2004
18.08.2009
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0,18%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
àõÏñ³Çݳ
C01C A24
1129/7086
02.10.2007
08.08.2012
¸
Ëï³ÝÛáõÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
50Ù·/25ÙÉ,
25ÙÉ ëñí³Ï (1)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¸²´àôð ü³ñÙ³ Èï¹ DABUR
Pharma Ltd
Ðݹϳëï³Ý
L01D B01
0549/6515
17.11.2006
17.11.2011
¸
Ëï³ÝÛáõÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
10Ù·/5ÙÉ,
5ÙÉ ëñí³Ï (1)
¸²´àôð ü³ñÙ³ Èï¹ DABUR
Pharma Ltd
Ðݹϳëï³Ý
L01D B01
0548/6516
17.11.2006
17.11.2011
¸
ÉáõÍáõÛÃ
ÛáõÕ³ÛÇÝ,
(100000ØØ+100Ù·
) (10)
²ÉóÛíÇï³ÙÇÝÇ ö´À
Altajvitaminy Closed JSC
èáõë³ëï³Ý
A11JA
1408/7025
03.12.2007
03.12.2012
²¸3
²é¨ïñ³ÛÇÝ
³Ýí³ÝáõÙÁ
ÙÇç³½·³ÛÇÝ
h³ÙÁݹѳÝáõñ
(ç»Ý»ñÇÏ) ϳ٠³ÏïÇí
µ³Õ³¹ñ³ï³ññ»ñÇ
³Ýí³ÝáõÙÝ»ñÁ
¹»Õ³Ó¨Á
¹»Õ³ã³÷Á ¨
ÃáÕ³ñÏÙ³Ý Ó¨Á
(÷³Ã»Ã³íáñáõÙÁ)
³ñï³¹ñáÕÁ
»ñÏÇñÁ
1
1
2
²µ³Ïï³É
Abaktal
²µ³Ïï³É
Abaktal
3
å»ýÉûùë³óÇÝ
pefloxacin
å»ýÉûùë³óÇÝ
pefloxacin
å»ÝïûùëÇýÇÉÇÝ
pentoxifyllin
å»ÝïûùëÇýÇÉÇÝ
pentoxifyllin
ÝÇý»¹ÇåÇÝ
nifedipine
5
400Ù·
(10)
400Ù·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
100Ù·
(60)
400Ù·
(20,50,100)
20Ù·
(30)
6
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
²·³åáõñÇÝ
Agapurin
²·³åáõñÇÝ é»ï³ñ¹
Agapurin retard
²¹³É³ï - êÈ
Adalat SL
4
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Ëï³ÝÛáõà Ý/»
Ý»ñ³ñÏáõÙÝ»ñÇ
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï (¹ñ³Å»)
¹»Õ³Ñ³ï»ñ é»ï³ñ¹
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
(0,1·+10Ù·+10Ù·)
(250)
2
3
4
5
6
7
8
²¹»Éý³Ý-¿½Ç¹ñ»ùë
Adelphan-Esidrex
黽»ñåÇÝ,
¹ÇÑǹñ³É³½ÇÝÇ
ëáõÉý³ï,
ÑǹñáùÉáñáÃdz½Ç¹
reserpine, dihydralazin
sulfate,
hydrochlorothiazide
²¹»Ýá½ÇÝ §¾´ºìº¦
³¹»Ýá½ÇÝ
Adenosin §EBEWE¦
adenosine
²¹í³Ýï³Ý
Advantan
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
1 - ³Ý³ïáÙdzϳÝ, µáõųϳÝ, ùÇÙÇ³Ï³Ý Í³Íϳ·Çñ
2 - ¹»Õ³ïáÙëáí µ³ó ÃáÕÝíáÕ ¹»Õ
9
²¹ñ»Ý³ÉÇÝ¿åÇÝ»ýñÇÝÇ
¼¹áñáíÛ»
ÑǹñáùÉáñǹÇ
Adrenalin-Zdorovye
epinephrine
hydrochloride
10
²¹ñÇÙ
¹ûùëáéáõµÇóÇÝÇ
Adrim
ÑǹñáùÉáñǹ
doxorubicin
hydrochloride
11
²¹ñÇÙ
¹ûùëáéáõµÇóÇÝÇ
Adrim
ÑǹñáùÉáñǹ
doxorubicin
hydrochloride
12
²»íÇï
A, E íÇï³ÙÇÝÝ»ñ
Aevit
(é»ïÇÝáÉ å³ÉÙÇï³ï,
¹»Õ³Ñ³ï»ñ
óճÝóå³ï, é³åǹ
é»ï³ñ¹
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
ùëáõù
µ³óÃáÕÙ³Ý
ϳñ·Á
·ñ³ÝóÙ³Ý
ѳí³ëï³·ñÇ
ѳٳñÁ
7
êÉáí»Ýdz
¹»Õ»ñÇ ATC1
ͳÍϳ·ÇñÁ ¨/ϳÙ
ï»ë³Ï³ÛÇÝ
å³ïϳݻÉáõÃÛáõÝ
Á
8
J01M A03
Ð/Ñ
¸
¸
¸
1
13
²»íÇï
Aevit
³Éý³-ÃáÏáý»ñáÉÇ
³ó»ï³ï)
vitamin A, E (retinol
palmitate, alphatocopherol acetate)
íÇï³ÙÇÝÝ»ñ A, E
vitamins A, E
14
²½³É»åïÇÝ
Azaleptin
²½³É»åïÇÝ
Azaleptinum
²½³ïñÇÉ
Azatril
ÏÉá½³åÇÝ
clozapine
ÏÉá½³åÇÝ
clozapine
³½ÇÃñáÙÇóÇÝ
azithromycin
²½³ïñÇÉ
Azatril
²½³ïñÇÉ
Azatril
³½ÇÃñáÙÇóÇÝ
azithromycin
³½ÇÃñáÙÇóÇÝ
azithromycin
¹»Õ³÷áßÇ ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
²½³ñ³Ý
Azaran
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
15
16
17
18
19
3 - ³é³Ýó ¹»Õ³ïáÙëÇ µ³ó ÃáÕÝíáÕ ¹»Õ
4 - ¹»Õ³ïáÙëáí ÑëÏíáÕ
20
²½³ñ³Ý
ó»ýïñdzùëáÝ
Azaran
ceftriaxone
21
²½Ç
³½ÇÃñáÙÇóÇÝ
Azee
azithromycin
22
²½ÇÃñáÙÇóÇÝ
³½ÇÃñáÙÇóÇÝ
Azithromycin
azithromycin
23
¹»Õ³å³ïÇ×Ý»-ñáõÙ
ÉáõÍáõÛÃ
ÛáõÕ³ÛÇÝ,
¹»Õ³å³ïÇ×Ý»-ñáõÙ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³÷áßÇ ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
²½ÇÙ»¹ ÎØä
Azimed KMP
²½Çïñ³É
Azitral
²Éµ»Ý
Alben
³½ÇÃñáÙÇóÇÝ
azithromycin
³½ÇÃñáÙÇóÇÝ
azithromycin
³Éµ»Ý¹³½áÉ
albendazole
¹»Õ³å³ïÇ×Ý»ñ
26
²Éµ»Ý
Alben
³Éµ»Ý¹³½áÉ
albendazole
·ñ³ÝáõÉÝ»ñ
27
²ÉµáõÙÇÝ 10
%ÉáõÍáõÛÃ
Albumin 10%
³ÉµáõÙÇÝ Ù³ñ¹áõ
human albumin
ÉáõÍáõÛÃ
24
25
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
100000ØØ+0.1·
(10)
ØÇÝëÏÇÝï»ñϳåë
Minskintercaps
´»É³éáõë
A11JA
0632/6647
27.12.2006
27.12.2011
²¸
0.1·
(50)
100Ù·
(8,20,50)
200Ù·/5ÙÉ,
20ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
ßßÇÏáõÙ
250Ù·
(6, 8)
100Ù·/5ÙÉ,
20ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
ßßÇÏáõÙ
1000Ù·,
ëñí³Ï (1,10,50)
úñ·³ÝÇϳ ´´À
Organica
Open JSC
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
èáõë³ëï³Ý
N05A H02
5056
¸\Ð4
г۳ëï³Ý
N05A H02
5116
´áõÉÕ³ñdz
J01F A10
1256/7224
27.08.2004
27.08.2009
24.08.2004
24.08.2009
12.10.2007
12.10.2012
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
´áõÉÕ³ñdz
J01F A10
0382/6410
¸
´áõÉÕ³ñdz
J01F A10
1257/7225
11.09.2006
11.09.2011
12.10.2007
12.10.2012
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
J01D A13
4451
19.11.2003
19.11.2008
¸
250Ù·,
ëñí³Ï (1,10, 50)
250Ù·
(6,60)
0.25·
(6)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
êÇåɳ Èï¹.
Cipla Ltd.
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat OJSC
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï. Èï¹.
Shreya Life Sciences Pvt. Ltd.
²¶Î ²·ñáí»ï½³ßãÇï³ êäÀ
§Agrovetzashita¦ SVC Ltd.
гñ³íëɳ-ídz
J01D A13
4450
¸
Ðݹϳëï³Ý
J01F A10
3989
´»É³éáõë
J01F A10
0796/6790
19.11.2003
19.11.2008
23.04.2003
23.04.2008
20.03.2007
20.03.2012
àõÏñ³Çݳ
J01F A10
4988
¸
Ðݹϳëï³Ý
J01F A10
0347\5398
èáõë³ëï³Ý
4960
²¶Î ²·ñáí»ï½³ßãÇï³ êäÀ
§Agrovetzashita¦ SVC Ltd.
èáõë³ëï³Ý
4961
06.09.2004
06.09.2009
¸
ØÇÏñá·»Ý ¶²Ø
Microgen SIU
èáõë³ëï³Ý
³Ý³ëݳµáõųϳÝ,
P02C A03
³Ý³ëݳµáõųϳÝ,
P02C A03
B05A
14.10.2004
14.10.2009
21.08.2006
21.08.2011
06.09.2004
06.09.2009
5570
05.09.2005
05.09.2010
¸
0.25·,
(6,10)
250Ù·
(6)
360Ù·
(25,100)
20%,
20·, 500·, 1000·
÷³Ã»ÃÝ»ñ
10%,
100ÙÉ ßßÇÏ
¸\Ð
¸
¸
¸
¸
¸
¸
2
solution
28 ²ÉµáõÙÇÝ ´Çáý³ñÙ³
Albumin Biopharma
29 ²ÉµáõÙÇÝ ´Çáý³ñÙ³
Albumin Biopharma
30 ²ÉµáõÙÇÝ Ù³ñ¹áõ
20%
Human Albumin
20%
31
²Éµáõ-ï»ù 20
Albu-Tech 20
Ù³ñ¹áõ ³ÉµáõÙÇÝ
human albumin
Ù³ñ¹áõ ³ÉµáõÙÇÝ
human albumin
Ù³ñ¹áõ ³ÉµáõÙÇÝ
human albumin
àõÏñ³Çݳ
B05A A01
1260/7228
àõÏñ³Çݳ
B05A
1259/7227
²íëïñdz
B05A
5164
15.10.2007
12.10.2012
15.10.2007
12.10.2012
09.11.2004
09.11.2009
¸
¸
¸
20%,
5ÙÉ,10ÙÉ ßßÇÏ
ü³ñÙ³î»ù ö´À
PharmaTech CJSC
г۳ëï³Ý
S01AB04
0996/6621
30.05.2007
30.05.2012
¸
³ÏݳϳÃÇÉÝ»ñ
30%,
5ÙÉ,10ÙÉ ßßÇÏ
ü³ñÙ³î»ù ö´À
PharmaTech CJSC
г۳ëï³Ý
S01AB04
0997/6620
30.05.2007
30.05.2012
¸
û׳é³Ñ»ÕáõÏ
(3.0·+0.5·+
1.0·)/100·,
200· ßßÇÏ
Ø»¹Çϳ ²¸
Medica AD
´áõÉÕ³ñdz
-
4361
14.08.2003
14.08.2008
²¸
³ÏݳϳÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
0.05%,
6ÙÉ ßßÇÏ
¶»ñÙ³Ýdz
R01A C03,
S01GX07
0766/5190/1
28.02.2007
27.01.2010
¸
Ýñµ³ùëáõù
1%,
18· å³ñÏáõ×
1%,
18· å³ñÏáõ×
25Ù·
(20)
20Ù·/ÙÉ
10ÙÉ ßßÇÏ
غ¸² ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
(¹»Õ³Ó¨Ç ³ñï³¹ñáÕÁ`
îáõµÇÉáõùë ü³ñÙ³ ê.å.².,
Æï³Édz)
MEDA Pharma GmbH & Co.
KG (dosage form
manufacturer-Tubilux Pharma
S.p.A., Italy)
êáý³ñÙ³ ´À
Sopharma JSC
êáý³ñÙ³ ´À
Sopharma JSC
êáý³ñÙ³ ´À
Sopharma JSC
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co. KG
ÈÇÉÇ üñ³Ýë ê.².ê.
Lilly France S.A.S.
´áõÉÕ³ñdz
5609
¶»ñÙ³Ýdz
S01G
0354/6338
20.07.2005
20.07.2010
20.07.2005
20.07.2010
11.11.2005
11.11.2010
28.08.2006
28.08.2011
²¸
´áõÉÕ³ñdz
D04A A09,
R06A C03
D04A A09,
R06A C03
R06A C03
üñ³Ýëdz
L01B A04
0757/6660
28.02.2007
28.02.2012
¸
¶»ñÙ³Ýdz
L01A A03
4390
22.07.2003
22.07.2008
¸
´áõÉÕ³ñdz
A02A,
C04B
4436
28.07.2003
28.07.2008
²¸
33
²É·áåÇùë
Algopix
34
²É»ñ·á¹ÇÉ
Allergodil
35
²É»ñ·á½³Ý
Allergosan
²É»ñ·á½³Ý
Allergosan
²É»ñ·á½³Ý
Allergosan
²É»ñ·áùñáÙ
Allergocrom
ùÉáñáåÇñ³ÙÇÝ
chloropyramine
ùÉáñáåÇñ³ÙÇÝ
chloropyramine
ùÉáñáåÇñ³ÙÇÝ
chloropyramine
ùñáÙá·ÉÇϳï
ݳïñÇáõÙÇ
sodium cromoglicate
39
²ÉÇÙï³
Alimta
å»Ù»ïñ»ù뻹
pemetrexed
40
²ÉÏ»ñ³Ý
Alkeran
Ù»Éý³É³Ý
melphalan
41
²ÉÙ³·»É
Almagel
³ÉÛáõÙÇÝÇáõÙÇ ¨
Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹݻñ
aluminium and
magnesium hydroxides
38
´Çáý³ñÙ³ ö´À
Biopharma Closed JSC
´Çáý³ñÙ³ ö´À
Biopharma Closed JSC
´³ùëï»ñ ²¶
Baxter AG
³ÏݳϳÃÇÉÝ»ñ
²Éµáõ-ï»ù 30
Albu-Tech 30
37
10%(100ÙÉ),
100ÙÉ ßßÇÏ
ÉáõÍáõÛÃ
10%(50ÙÉ),
50ÙÉ ßßÇÏ
ÉáõÍáõÛÃ
20%,
ϳÃÇɳݻñ³ñÏ-Ù³Ý 50ÙÉ,100ÙÉ ëñí³Ï
(1)
ëáõÉý³ó»ï³Ùǹ
ݳïñÇáõÙÇ
sulfacetamide natrium
ëáõÉý³ó»ï³Ùǹ
ݳïñÇáõÙÇ
sulfacetamide natrium
ϳݳã
ÙÇÏñáçñÇÙáõéÝ»ñÇ
ëåÇñï³ÛÇÝ Ñ³ÝáõÏ,
·ÇÑáõ ÓÛáõÃ,
ë³ÉÇóÇɳÃÃáõ
green microalgae
ethanol extract+Juniper
tar+salicylic acid
³½»É³ëïÇÝÇ
ÑǹñáùÉáñǹ
azelastine
hydrochloride
32
36
ÉáõÍáõÛÃ
ùëáõù
¹»Õ³Ñ³ï»ñ
óճÝóå³ï (¹ñ³Å»)
³ÏݳϳÃÇÉÝ»ñ
¹»Õ³÷áßÇ
ÉÇáýÇɽ³óí³Í,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·,
ëñí³Ï (1)
¹»Õ³Ï³ËáõÛÃ
4%+1.38%
(436Ù·+150Ù·)/
10ÙÉ,
10ÙÉ ÷³Ã»ÃÝ»ñ
(10,20),
2Ù·,
(25)
лáõÙ³Ý ü³ñÙ³ ¶ÙµÐ
(¶É³ùëáàõ»ÉùáÙ ¶ÙµÐ ¨ øá.-Ç
ѳٳñ)
Heumann Pharma GmbH for
GlaxoWellcome GmbH & Co.
´³ÉϳÝý³ñÙ³ - îñáÛ³Ý ²¸
Balkanpharma - Troyan AD
´áõÉÕ³ñdz
5610
5846
²¸
²¸
¸
3
42
²ÉÙ³·»É ²
Almagel A
43
²ÉÙ³·»É ܺú
Almagel NEO
44
²ÉÙáÉ
Almol
45
µ»Ý½áϳÛÇÝ,
³ÉÛáõÙÇÝÇáõÙÇ ¨
Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹݻñ
benzocaine, aluminium
and magnesium
hydroxides
³ÉÛáõÙÇÝÇáõÙÇ ¨
Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹݻñ,
ëÇÙ»ÃÇÏáÝ
aluminium and
magnesium hydroxides,
simeticon
Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹ,
³ÉÛáõÙÇÝÇáõÙÇ
Ñǹñûùëǹ
magnesium hydroxide,
aluminium hydroxide
-
¹»Õ³Ï³ËáõÛÃ
²Éá» í»ñ³ É»ÙáÝ
ɳÛÙ
Aloe Vera Lemon
Lime
5 - Ï»Ýë³ÏïÇí ëÝݹ³ÛÇÝ Ñ³í»ÉáõÙ
46 ²Éá» í»ñ³ Ëï³ÝÛáõÃ
Aloe Vera
Concentrate
47
²Éá» í»ñ³ ѳµ»ñ
Aloe Vera tablets
¹»Õ³Ï³ËáõÛÃ
170ÙÉ, 200ÙÉ
ßßÇÏ
2%+4%+1.38%
(218Ù·+436Ù·+
150Ù·)/10ÙÉ,
10ÙÉ ÷³Ã»ÃÝ»ñ
(10,20)
170ÙÉ, 200ÙÉ
ßßÇÏ
(340Ù·+395Ù·+
36Ù·)/5ÙÉ,
170ÙÉ, 200ÙÉ
ßßÇÏ,
10ÙÉ ÷³Ã»Ã
(10 ¨ 20)
´³ÉϳÝý³ñÙ³ - îñáÛ³Ý ²¸
Balkanpharma - Troyan AD
´áõÉÕ³ñdz
D04A B04,
C05A D03,
R02A D01,
A02A
4435
28.07.2003
28.07.2008
²¸
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
´áõÉÕ³ñdz
A02A
0223/6296
26.07.2006
26.07.2011
²¸
¹»Õ³Ï³ËáõÛÃ
(200Ù·+225Ù·)/5Ù,
355ÙÉ ßßÇÏ
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
A02A
1156/7208
13.09.2007
13.09.2012
²¸
ÑÛáõÃ
236ÙÉ åɳëïÇÏ
ßßÇÏ
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
²ØÜ
βêÐ5
5905
13.01.2006
13.01.2011
²¸
-
Ñ»ÕáõÏ
236ÙÉ åɳëïÇÏ
ßßÇÏ
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
²ØÜ
βêÐ
5904
13.01.2006
13.01.2011
²¸
-
ѳµ»ñ
г۳ëï³Ý
βêÐ
0156/6253
07.07.2006
07.07.2011
²¸
г۳ëï³Ý
βêÐ
0155/6252
07.07.2006
07.07.2011
²¸
г۳ëï³Ý
βêÐ
0157/6254
07.07.2006
07.07.2011
²¸
èáõë³ëï³Ý
A05A X
1319/7290
30.10.2007
12.10.2012
²¸
48
²Éá» í»ñ³ ÑÛáõÃ
Aloe Vera succus
-
ÑÛáõÃ
49
²Éá» í»ñ³ å³ïÇ×Ý»ñ
Aloe Vera capsules
-
å³ïÇ×Ý»ñ
50
²ÉáËáÉ
Allochol
¹»Õ³Ñ³ï»ñ
51
²ÉáËáÉ
Allochol
52
²ÉáËáÉ
Allochol
»ÕÝçÇ, ëËïáñÇ
ѳÝáõÏÝ»ñ, É»ÕÇ,
³ÏïÇí³óí³Í ³ÍáõË
extracts urticae, allium,
bile, activated charcoal
É»ÕÇ ãáñ, ëËïáñ
ãáñ³óñ³Í, »ÕÝçÇ
ï»ñ¨Ý»ñ, ³ÏïÇí³óí³Í ³ÍáõË
bile dry,
Allium sativum siccum
(garlic dried), Urticae
folia, activated charcoal
É»ÕÇ ãáñ, ëËïáñ
ãáñ³óñ³Í, »ÕÝçÇ
700Ù·
ìÇï³Ù³ùë-º êäÀ
/150Ù· ѳÉí»/
Vitamax-E Ltd
(20,30 /µÉÇëï»ñ/,
100 /ï³ñ³/)
80ÙÉ
ìÇï³Ù³ùë-º êäÀ
(ѳÉí»Ç
Vitamax-E Ltd
ÑÛáõÃ)/100ÙÉ,
30ÙÉ, 60ÙÉ ßßÇÏ
200Ù·,
ìÇï³Ù³ùë-º êäÀ
(20,30 /µÉÇëï»ñ/,
Vitamax-E Ltd
100 /ï³ñ³/)
(5Ù·+40Ù·+80Ù·+ ü³ñÙëï³Ý¹³ñï-îáÙëÏùÇÙý³ñÙ ´´À
25Ù·) (10)
PharmstandardTomskchimpharm OJSC
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(80Ù·+40Ù·+5Ù·+
25Ù·)
(10, 50/5x10/)
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
àõÏñ³Çݳ
A05AX10
7407/7050
19.11.2007
19.11.2012
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(0.08·+0.04·+0.005
·+0.025·)
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
Belmedpreparaty RUP
´»É³éáõë
A05AX
0888/6890
13.04.2007
13.04.2012
²¸
4
53
54
55
ï»ñ¨Ý»ñ, ³ÏïÇí³óñ³Í
³ÍáõË
bile (dried), Allium
sativum siccum (garlic
dried), Urticae folia,
charcoal activated
²Éá×Ç Ñ»ÕáõÏ
³Éá×Ç ëåÇñï³ÛÇÝ
ѳÝáõÏ
ѳÝáõÏ
Crataegi extractum
extractum Crataegi
fluidum
spirituosum
²ÉáåáõñÇÝáÉ
³ÉáåáõñÇÝáÉ
Allopurinol
allopurinol
²Éáõídz
ÉáåÇݳíÇñ, éÇïáݳíÇñ
Aluvia
lopinavir, ritonavir
56
²Éï»
Alte
57
²Éý³ ù»ÙáïñÇåëÇÝ
Ý»ñ³ñÏáõÙ
Alfachymotrypsin
injection
58
²Éý³Ï³ÛÇÝ Ü
Alphacaine N
59
²Éý³-ïáÏáý»ñáÉ
Alpha-tocopherol
60
²Éý³-ïáÏáý»ñáÉ (E
íÇï³ÙÇÝ)
Alpha-tocopherol
(vitamin E)
²ÉýÇÝï»ñÝ
Alphintern
61
62
²ÉýÉáõïáå
Alflutop
63
²ÉýÉáõïáå
Alflutop
ïáõÕïÇ ³ñÙ³ïÝ»ñÇ 5%
ѳÝáõÏ
5% extract ex radix
Althaeae
ù»ÙáïñÇåëÇÝ
chemotrypsin
(10,50/5x10/)
Ñ»ÕáõÏ Ñ³ÝáõÏ
(1:1)
25ÙÉ ßßÇÏ
ê³ÝÇï³ë ²´
Sanitas AB
ÈÇïí³
µáõë³Ï³Ý
5491
29.03.2005
29.03.2010
²¸
¹»Õ³Ñ³ï»ñ
100Ù·
(30)
(200Ù·+50Ù·)
(120)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
²´´àîî ȳµáñ³ïáñdz êäÀ
ABBOTT Laboratories Ltd.
г۳ëï³Ý
M04A A01
1166/7147
¸
J05A E03
1497/7369
ûß³ñ³Ï
34.9·/100·,
125· ßßÇÏ
¶»ÙÇ
Gemi
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
Ȼѳëï³Ý
13.09.2007
13.09.2012
20.12.2007
20.12.2012
µáõë³Ï³Ý
5366
23.03.2005
23.03.2010
²¸
¹»Õ³÷áßÇ 3ÙÉ
ÉáõÍãáí
(ݳïñÇáõÙÇ
ùÉáñǹÇ
ǽáïáÝÇÏ
ÉáõÍáõÛÃ)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
5Ù· (450¿.³.Ù./21
ÙÇÏñáϳï³É),
³ÙåáõÉ/³ÙåáõÉ
(3)
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
º·Çåïáë
B06A A04
0050/5998
24.05.2006
24.05.2011
¸
¸»ÝïëåÉÇ üñ³Ýë ê²ê
Dentsply France SAS
üñ³Ýëdz
N05A A01
1107/7087
08.08.2007
08.08.2012
¸
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
Belmedpreparaty RUP
´»É³éáõë
A11H A03
1071/7011/1
16.07.2007
13.06.2012
¸
ØÇÝëÏÇÝï»ñϳåë
Minskintercaps
´»É³éáõë
A11H A03
1084/7134
09.08.2007
09.08.2012
²¸
300¿.³.Ù./
14 ÙÇÏñáϳï³É/+
300¿.³.Ù.
/5 ÙÇÏñáϳï³É/
(20)
1%,
30· å³ñÏáõ×
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
º·Çåïáë
B06A A04
0049/5997
24.05.2006
24.05.2011
¸
´Çáï»ËÝáë ê.².
Biotehnos S.A.
èáõÙÇÝdz
-
0176/6233
13.07.2006
13.07.2011
²¸
10Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
´Çáï»ËÝáë ê.².
Biotehnos S.A.
èáõÙÇÝdz
-
0177/6234
13.07.2006
13.07.2011
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
³ñïÇϳÛÇÝÇ
(4·+0.6Ù·)/100ÙÉ,
ÑǹñáùÉáñǹ,
1.8ÙÉ
¿åÇÝ»ýñÇÝÇ
÷³Ù÷áõßïÝ»ñ (100)
ÑǹñáùÉáñǹ
articaine hydrochloride,
epinephrine
hydrochloride
³Éý³-ÃáÏáý»ñáÉÇ ³ó»ï³ï
ÛáõÕ³ÛÇÝ
0,2·
alpha-tocopherol
ÉáõÍáõÛÃ (50%)
(10, 30/3x10/,
acetate
¹»Õ³å³ïÇ×Ý»-ñáõÙ
50/5x10/)
³Éý³-ÃáÏáý»ñáÉÇ ³ó»ï³ï
ÉáõÍáõÛÃ
0.2·
alpha-tocopherol
ÛáõÕ³ÛÇÝ (50%) (10, 20, 30, 40, 50)
acetate
¹»Õ³å³ïÇ×Ý»-ñáõÙ
ùÇÙáïñÇåëÇÝ,
ïñÇåëÇÝ
chymotrypsin, trypsin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Íáí³ÛÇÝ
ûñ·³ÝǽÙÝ»ñÇ
(ÓÏÝ»ñ) Ï»Ýë³ÏïÇí
Ëï³ÝÛáõÃ
sea organisms (fish)
bioactive concentrate
Íáí³ÛÇÝ
ûñ·³ÝǽÙÝ»ñÇ
(ÓÏÝ»ñ) Ï»Ýë³ÏïÇí
Ëï³ÝÛáõÃ
sea organisms (fish)
¹áݹáÕ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¸
5
64
²ÍáõË ³ÏïÇí³óí³Í
Charcoal activated
bioactive concentrate
³ÏïÇí³óí³Í ³ÍáõË
activated charcoal
65
²ÏÝ»-ýñÇ ¹áݹáÕ
Acne-Free Gel
66
¹»Õ³Ñ³ï»ñ
0.25·
(10)
ïñ»ïÇÝáÇÝ
tretinoin
¹áݹáÕ
0.025%,
30· å³ñÏáõ×
²ÏÝ»-üñÇ
Ýñµ³ùëáõù
Acne-Free Cream
ïñ»ïÇÝáÇÝ
tretinoin
Ýñµ³ùëáõù
0.05%,
30· å³ñÏáõ×
67
²Ïï³½áÝ ²ëdz
Actazone Asia
¹»Õ³Ñ³ï»ñ
30Ù·
(20)
68
²Ïï³ÉÇåǹ
Actalipid
åÇá·ÉÇï³½áÝÇ
ÑǹñáùÉáñǹ
pioglitazone
hydrochloride
ëÇÙí³ëï³ïÇÝ
simvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(28)
-
390Ù· å³ïÇ×Ý»ñ
(30)
-
380Ù· å³ïÇ×Ý»ñ
(33)
å먹á¿ý»¹ñÇÝ,
ïñÇåñáÉǹÇÝ
pseudoephedrine,
triprolidine
÷먹á¿ý»¹ñÇÝ,
ïñÇåñáÉǹÇÝ
pseudoephedrine,
triprolidine
»ñϳÃÇ (II) ëáõÉý³ï
+¸,È-ë»ñÇÝ
ferrous (II) sulfate+ D,Lserin
åÇá·ÉÇï³½áÝ
pioglitazone
åÇá·ÉÇï³½áÝ
pioglitazone
ÑáñÃÇ ³ñÛ³Ý
ëåÇï³Ïáõó³½»ñÍ
³Í³ÝóÛ³É
deproteinised
haemoderivate of calf
blood
ÑáñÃÇ ³ñÛ³Ý
ëåÇï³Ïáõó³½»ñÍ
³Í³ÝóÛ³É
deproteinised
haemoderivate of calf
blood
ÑáñÃÇ ³ñÛ³Ý
¹»Õ³Ñ³ï»ñ
69 ²ÏïÇíÇï ³ÝïÇûùëǹ³Ýï
Aktivit antioxidant
70
²ÏïÇíÇï ¿Ý»ñçÇ
Aktivit energy
71
²ÏïÇý»¹
Actifed
72
²ÏïÇý»¹
Actifed
73
²ÏïÇý»ñÇÝ
Aktiferrin
74
²Ïïáë
Actos
²Ïïáë
Actos
²Ïïáí»·ÇÝ
Actovegin
75
76
77
²Ïïáí»·ÇÝ
Actovegin
78
²Ïïáí»·ÇÝ
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
Pharmaceutical
èáõë³ëï³Ý
A07BA01
0573/4950/1
24.11.2006
23.07.2009
²¸
º·Çåïáë
-
0043/5868
24.05.2006
24.05.2011
²¸
º·Çåïáë
-
0045/5869
24.05.2006
24.05.2011
²¸
êÇñdz
-
5403
18.02.2005
18.02.2010
¸
Æëɳݹdz
C10A A01
5917
18.01.2006
18.01.2011
¸
èáõë³ëï³Ý
βêÐ
0306/6327
èáõë³ëï³Ý
βêÐ
0305/6326
¶»ñÙ³Ýdz
R01B A52
4119
01.08.2006
01.08.2011
01.08.2006
01.08.2011
24.01.2003
24.01.2008
²¸
60Ù·+2.5Ù·
(12)
²Ïï³íÇë Ñ.ý. (ÉÇó»Ý½Ç³ÛÇ
ï»ñÁ ´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸´áõÉÕ³ñdz)
Actavis h.f (license holder
Balkanpharma-Dupnitza ADBulgaria)
ü³ñÙåñáÛ»Ïï ö´À
Pharmproject CJSC
ü³ñÙåñáÛ»Ïï ö´À
Pharmproject CJSC
¶É³ùëáàõ»ÉùáÙ ¶ÙµÐ ¨ øá.
Glaxo Wellcome GmbH & Co.
¹»Õ³Ñ³ï»ñ
60Ù·+2.5Ù·
(12)
àõ»ÉùáÙ ü³áõݹ»ÛßÁÝ Èï¹
Wellcome Foundation Limited
²Ý·Édz
R01B A52
4060
01.04.2003
01.04.2008
¸\Ð
ϳÃÇÉÝ»ñ
(4.72·+3.56·)/
100ÙÉ,
30ÙÉ ßßÇÏ
Ø»ñÏÉ» ¶ÙµÐ
Merckle GmbH
¶»ñÙ³Ýdz
B03A
5364
02.02.2005
02.02.2010
¸
¹»Õ³Ñ³ï»ñ
¾ÉÇ ÈÇÉÇ ¨ ÁÝÏ»ñáõÃÛáõÝ
Eli Lilly & Company
¾ÉÇ ÈÇÉÇ ¨ ÁÝÏ»ñáõÃÛáõÝ
Eli Lilly & Company
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²ØÜ
-
4257
²ØÜ
-
4256
²íëïñdz
D11AX
0905/6956
25.06.2004
18.04.2008
25.06.2004
18.04.2008
20.04.2007
20.04.2012
¸
¹áݹáÕ ³ñï³ùÇÝ
ÏÇñ³éÙ³Ý
30Ù·
(7,30)
15Ù·
(7,30)
20%,
20· å³ñÏáõ×
ùëáõù ³ñï³ùÇÝ
ÏÇñ³éÙ³Ý
5%,
20· å³ñÏáõ×
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
D11AX
0901/6960
20.04.2007
20.04.2012
²¸
Ýñµ³ùëáõù
5%,
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
²íëïñdz
D11AX
0902/6959
20.04.2007
²¸
¹»Õ³Ñ³ï»ñ
²¸
¸\Ð
¸
²¸
6
Actovegin
79
80
81
82
83
84
85
86
87
88
89
ëåÇï³Ïáõó³½»ñÍ
³Í³ÝóÛ³É
deproteinised
haemoderivate of calf
blood
²Ïïáí»·ÇÝ
ÑáñÃÇ ³ñÛ³Ý
Actovegin
ëåÇï³Ïáõó³½»ñÍ
³Í³ÝóÛ³É
deproteinised
haemoderivate of calf
blood
²Ïïáí»·ÇÝ
ÑáñÃÇ ³ñÛ³Ý
Actovegin
ëåÇï³Ïáõó³½»ñÍ
Ñ»Ùá¹»ñÇí³ï
deproteinised
haemoderivate of calf
blood
²Ïïáí»·ÇÝ
ÑáñÃÇ ³ñÛ³Ý
Actovegin
ëåÇï³Ïáõó³½»ñÍ
Ñ»Ùá¹»ñÇí³ï
deproteinised
haemoderivate of calf
blood
²Ïïáí»·ÇÝ
ÑáñÃÇ ³ñÛ³Ý
¹»ùëïñá½Ç
ëåÇï³Ïáõó³½»ñÍ
ÉáõÍáõÛÃáõÙ
³Í³ÝóÛ³É
Actovegin in
deproteinised
dextrose solution
haemoderivate of calf
blood
²Ïïáí»·ÇÝ
ÑáñÃÇ ³ñÛ³Ý
ݳïñÇáõÙÇ
ëåÇï³Ïáõó³½»ñÍ
ùÉáñǹÇ
³Í³ÝóÛ³É
ÉáõÍáõÛÃáõÙ
deproteinised
Actovegin in natrium haemoderivate of calf
chloride solution
blood
²Ïïáí»·ÇÝ
ÑáñÃÇ ³ñÛ³Ý
ݳïñÇáõÙÇ
ëåÇï³Ïáõó³½»ñÍ
ùÉáñǹÇ
³Í³ÝóÛ³É
ÉáõÍáõÛÃáõÙ
deproteinised
Actovegin in natrium haemoderivate of calf
chloride solution
blood
²Ïïáí»·ÇÝ
ÑáñÃÇ ³ñÛ³Ý
Actovegin
ëåÇï³Ïáõó³½»ñÍ
³Í³ÝóÛ³É
deproteinised
haemoderivate of calf
blood
²Ïïñ³åǹ-ÐØ
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
Actrapid HM
¸Ü ÇÝëáõÉÇÝ
Human rDNA Insulin
²ÏñÇå³Ùǹ
Çݹ³å³Ùǹ
Akripamide
indapamide
²Ù³ñÇÉ
·ÉÇÙ»åÇñǹ
Amaryl
glimepiride
²Ùµ»Ý»
³).ý»ÝÇɵáõï³½áÝ,
³ñï³ùÇÝ ÏÇñ³éÙ³Ý
20· å³ñÏáõ×
Nycomed Austria GmbH
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
80Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(25)
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
D11AX
0903/6958
20.04.2007
20.04.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
200Ù·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5,25)
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
-
5284
08.12.2004
08.12.2009
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
400Ù·/10ÙÉ,
10ÙÉ ³ÙåáõÉÝ»ñ
(5,25)
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
-
5285
08.12.2004
08.12.2009
¸
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
10%,
250ÙÉ ëñí³Ï
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
D11AX
0906/6955
20.04.2007
20.04.2012
¸
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
20%,
250ÙÉ ëñí³Ï
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
D11AX
0908/6953
20.04.2007
20.04.2012
¸
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
10%,
250ÙÉ ëñí³Ï
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
D11AX
0907/6954
20.04.2007
20.04.2012
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(50)
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
D11AX
0904/6957
20.04.2007
20.04.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100ØØ/ÙÉ
10ÙÉ ëñí³Ï (1)
Üáíá-Üáñ¹ÇëÏ ²/ê
Novo-Nordisk A/S
¸³Ýdz
A10A
5182
03.11.2004
03.11.2009
¸
èáõë³ëï³Ý
C03B A11
4916
¸
Æï³Édz
A10B B12
1222/7138
¶»ñÙ³Ýdz
M01B A01
5293
12.08.2004
12.08.2009
19.10.2007
13.10.2012
02.02.2005
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
0.0025·
²ÏñÇËÇÝ ´´À
Akrikhin
(30)
Open JSC
1Ù·
ê³ÝáýÇ ²í»ÝïÇë ê.å.².
(30)
Sanofi-Aventis S.p.A.
{³).(375Ù·+150Ù·+
Ø»ñÏÉ» ¶ÙµÐ
20.04.2012
¸
¸
7
Ambene
ë³ÉÇóÇɳÙǹ -û ³ó»ï³ï
ݳïñÇáõÙÇ,
ÉǹáϳÛÇÝ,
ݳïñÇáõÙÇ
Ñǹñûùëǹ,
¹»ùë³Ù»Ã³½áÝ;
µ).ÉǹáϳÛÇÝ,
ódzÝáÏᵳɳÙÇÝ
a).phenylbutazon,
salicylamid-o-acetate
natrium, lidocaine,
sodium hydroxide,
dexamethasone;
b).lidocaine,
cyanocobalamine
³).ý»ÝÇɵáõï³½áÝ,
ë³ÉÇóÇɳÙǹ -û ³ó»ï³ï
ݳïñÇáõÙÇ,
ÉǹáϳÛÇÝ,
ݳïñÇáõÙÇ
Ñǹñûùëǹ,
¹»ùë³Ù»Ã³½áÝ,
µ).ÉǹáϳÛÇÝ,
ódzÝáÏᵳɳÙÇÝ
a).phenylbutazon,
salicylamid-o-acetate
natrium, lidocaine,
sodium hydroxide,
dexamethasone;
b).lidocaine,
cyanocobalamine
³ÙµñoùëáÉÇ
ÑǹñáùÉáñǹ
ambroxol hydrochloride
Ý»ñ³ñÏÙ³Ý,
³ÙåáõÉÝ»ñáõÙ
4Ù·+49,08Ù·+3,32
Ù·)/2ÙÉ
µ).(2Ù·+2,5Ù·)/1ÙÉ
} ³ÙåáõÉ/³ÙåáõÉ
(3)
Merckle GmbH
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
»ñÏËáõó
Ý»ñ³ñÏÇãÝ»ñ
{³).(375Ù·+ 150Ù·+
4Ù·+49,08Ù·+
3,32Ù·)/2ÙÉ
µ).(2Ù·+2,5Ù·)/
1ÙÉ}
(»ñÏËáõó
Ý»ñ³ñÏÇãÝ»ñ (3))
Ø»ñÏÉ» ¶ÙµÐ
Merckle GmbH
¶»ñÙ³Ýdz
M01B A01
5292
02.02.2005
02.02.2010
¸
¹»Õ³Ñ³ï»ñ
30Ù·
(20)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
äðà. غ¸. êÇ ¿ë äñ³Ñ³ ³.ë.
PRO.MED.CS Praha a.s.
¶»ñÙ³Ýdz
R05C B06
5370
25.01.2005
25.01.2010
²¸
¶»ñÙ³Ýdz
R05C B06
5594
15.06.2005
15.06.2010
²¸
â»Ëdz
R05C B06
0367/6284
31.08.2006
31.08.2011
²¸
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
àõÏñ³Çݳ
R05C B06
0771/6699
07.03.2007
07.03.2012
²¸
àõÏñ³Çݳ
R05C B06
3909
²¸
´»É³éáõë
R05C B06
5124
12.02.2003
12.02.2008
13.12.2004
13.12.2009
èáõÙÇÝdz
R05C B06
1108/6980
18.09.2007
18.09.2012
²¸
90
²Ùµ»Ý»
Ambene
91
²ÙµñáÑ»ùë³É
Ambrohexal
92
²ÙµñáÑ»ùë³É
Ambrohexal
³ÙµñoùëáÉÇ
ÑǹñáùÉáñǹ
ambroxol hydrochloride
ûß³ñ³Ï
3Ù·/ÙÉ,
100ÙÉ ßßÇÏ
93
²Ùµñáë³Ý
Ambrosan
¹»Õ³Ñ³ï»ñ
30Ù·
(20)
94
²Ùµñáï³ñ¹ 75
Ambrotard 75
³ÙµñoùëáÉÇ
ÑǹñáùÉáñǹ
ambroxol hydrochloride
³ÙµñûùëáÉ
ambroxol
¹»Õ³å³ïÇ×Ý»ñ
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
75Ù·
(10)
95
²ÙµñáùëáÉ - ÎØä
Ambroxol - KMP
²ÙµñûùëáÉ
Ambroxol
³ÙµñoùëáÉ
ambroxol
³ÙµñûùëáÉ
ambroxol
¹»Õ³Ñ³ï»ñ
0.03·
(10,20,30,50)
0.3%,
50ÙÉ,100ÙÉ ßßÇÏ
²ÙµñûùëáÉ
Ambroxol
³ÙµñûùëáÉÇ
ÑǹñáùÉáñǹ
ambroxol hydrochloride
96
97
ÉáõÍáõÛÃ
(¹»Õ³Ë³éÝáõñ¹)
ûß³ñ³Ï
15Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
02.02.2010
²¸
8
98
²ÙµñûùëáÉ
Ambroxol
³ÙµñûùëáÉÇ
ÑǹñáùÉáñǹ
ambroxol hydrochloride
¹»Õ³Ñ³ï»ñ
0.03·
(20)
99
²ÙµñûùëáÉ 15
Ambroxol 15
³ÙµñûùëáÉ
ambroxol
ûß³ñ³Ï
15Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
100
²ÙµñûùëáÉ 30
Ambroxol 30
³ÙµñûùëáÉ
ambroxol
ûß³ñ³Ï
30Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
101
²ÙµñûùëáÉ
ÑǹñáùÉáñǹ
Ambroxol
hydrochloride
³ÙµñûùëáÉ
ambroxol
¹»Õ³Ñ³ï»ñ
0,03·
(20)
³ÙµñûùëáÉ
ambroxol
³ÙµñûùëáÉ
ambroxol
ûß³ñ³Ï
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
15Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
30Ù·
(20)
³ÙµñûùëáÉ
ambroxol
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
60Ù·
(10)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
³ÙµñûùëáÉ
ambroxol
ûß³ñ³Ï
15Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
ÏÉáïñÇÙ³½áÉ
clotrimazole
ùÉáñåñáÙ³½ÇÝ
chlorpromazine
Ýñµ³ùëáõù
ùÉáñåñáÙ³½ÇÝ
chlorpromazine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1%,
20· å³ñÏáõ×
2.5%(2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
25Ù·
(20)
³ÙÇÝáϳåñáݳÃÃáõ
aminocaproic acid
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
³ÙÇÝáϳåñáݳÃÃáõ
aminocaproic acid
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
³ÙÇݳÃÃáõÝ»ñ
aminoacids
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
102 ²ÙµñûùëáÉ êáý³ñÙ³
Ambroxol Sopharma
103
²ÙµñûùëáÉÑ»Ùáý³ñÙ
AmbroxolHemofarm
104
²ÙµñûùëáÉÑ»Ùáý³ñÙ
AmbroxolHemofarm
105
²ÙµñûùëáÉÑ»Ùáý³ñÙ
AmbroxolHemofarm
106
²ÙÇÏÉáÝ
Amyclon
107
²ÙÇݳ½ÇÝ
Aminazin
108
109
²ÙÇݳ½Çݼ¹áñáíÛ»
Aminazin-Zdorovye
²ÙÇÝáϳåñáݳÃÃáõ 5%
Acidum
aminocapronicum
5%
110
²ÙÇÝáϳåñáݳÃÃáõ-5% ÉáõÍáõÛÃ
Aminocaproic acid
5% solution
111 ²ÙÇÝáåɳ½Ù³É º
Aminoplasmal E
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
5%,
200ÙÉ ëñí³Ï,
100ÙÉ, 200ÙÉ,
250ÙÉ åɳëïÇÏ
÷³Ã»Ã
5%,
100ÙÉ, 200ÙÉ,
250ÙÉ åɳëïÇÏ
÷³Ã»Ã
10%,
500ÙÉ, 1000ÙÉ
ëñí³Ï
´áñÇëáíÛ³Ý
´»É³éáõë
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
´áñßã³·áíÛ³Ý
àõÏñ³Çݳ
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´áñßã³·áíÛ³Ý
àõÏñ³Çݳ
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À Borshchahivskiy
Chemical-Pharmaceutical Plant
CJSC
´áñßã³·áíÛ³Ý
àõÏñ³Çݳ
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À Borshchahivskiy
Chemical-Pharmaceutical Plant
CJSC
êáý³ñÙ³ ´À
´áõÉÕ³ñdz
Sopharma JSC
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
ê»ñµÇ³ ¨
Hemofarm koncern A.D.
â»éÝá·áñdz
R05C B06
0794/6792
20.03.2007
20.03.2012
²¸
R05C B06
0502/6281
25.10.2006
25.10.2011
²¸
R05C B06
5839
27.12.2005
27.12.2010
²¸
R05C B06
5841
27.12.2005
27.12.2010
²¸
R05C B06
5943
²¸
R05C B06
4452
20.01.2006
20.01.2011
26.09.2005
26.09.2010
ê»ñµÇ³ ¨
â»éÝá·áñdz
R05C B06
4453
26.09.2005
26.09.2010
²¸
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
R05C B06
4454
26.09.2005
26.09.2010
²¸
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
§¼¹áñáíÛ» ܳñá¹áõ Êä¸Ò¦
§Zdorovye narodu KhSPE¦
èáõë³ëï³Ý
5530
16.05.2005
16.05.2010
23.12.2004
23.12.2009
²¸
àõÏñ³Çݳ
D01A C01,
G01A F02
N05A A01
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
àõÏñ³Çݳ
N05A A01
1130/7088
02.10.2007
08.08.2012
¸\Ð
г۳ëï³Ý
B02A A01
5925
18.01.2006
18.01.2011
¸
ü³ñÙ³ î»ù ö´À PharmaTech
CJSC
г۳ëï³Ý
B02A A01
5643
09.11.2005
09.11.2010
¸
´.´ñ³áõÝ Ø»É½áõÝ·»Ý ²¶
B.Braun Melsungen AG
¶»ñÙ³Ýdz
B05B A01
4719
02.06.2004
02.06.2009
¸
5205
²¸
¸\Ð
9
112
²ÙÇÝáëáÉ-Ü»á
Aminosol-Neo
113
²ÙÇÝáëáÉ-Ü»á
Aminosol-Neo
114
²ÙÇÝáëáÉ-Ü»á-º
Aminosol-Neo-E
115
²ÙÇáÏáñ¹ÇÝ
Amiokordin
116
²ÙÇáÏáñ¹ÇÝ
Amiokordin
²ÙÇïñÇåïÇÉÇÝ
Amitriptylinum
²ÙÇïñÇåïÇÉÇÝ
Amitriptylinum
²ÙÇïñÇåïÇÉÇÝ
Amitriptylin
117
118
119
120
121
122
123
124
125
126
127
128
129
130
²ÙÇïñÇåïÇÉÇÝ
Amitriptyline
²ÙÇïñÇåïÇÉÇÝêÉáí³Ïáý³ñÙ³
Amitriptylin
Slovakofarma
²ÙÉá¹ÇåÇÝ
Amlodipine
²ÙÉá¹ÇåÇÝ
Amlodipine
²ÙÉá¹ÇåÇݼ¹áñáíÛ»
AmlodipineZdorovye
²ÙÉá¹ÇåÇݼ¹áñáíÛ»
AmlodipineZdorovye
²ÙÉáåñ»ë - L
Amlopres L
²ÙÉáåñ»ë - ²î
Amlopres AT
²ÙÉáåñ»ë ²î 25
Amlopres AT 25
²ÙÉáí³ëÏ
Amlovask
²ÙáÏÉ³Ý 1,2·
Amoclan 1,2g
³ÙÇݳÃÃáõÝ»ñÇ
ÉáõÍáõÛÃ
˳éÝáõñ¹
ϳÃÇɳݻñ³ñÏ-Ù³Ý
mixture of amino acids
³ÙÇݳÃÃáõÝ»ñÇ
ÉáõÍáõÛÃ
˳éÝáõñ¹
ϳÃÇɳݻñ³ñÏ-Ù³Ý
mixture of amino acids
³ÙÇݳÃÃáõÝ»ñÇ
ÉáõÍáõÛÃ
˳éÝáõñ¹
ϳÃÇɳݻñ³ñÏ-Ù³Ý
mixture of amino acids
³ÙÇá¹³ñáÝ
ÉáõÍáõÛÃ
amiodarone
Ý»ñ³ñÏÙ³Ý
³ÙÇá¹³ñáÝ
amiodarone
³ÙÇïñÇåïÇÉÇÝ
amitriptylinum
³ÙÇïñÇåïÇÉÇÝ
amitriptylinum
³ÙÇïñÇåïÇÉÇÝÇ
ÑǹñáùÉáñǹ
amitriptyline
hydrochloride
³ÙÇïñÇåïÇÉÇÝ
amitriptyline
³ÙÇïñÇåïÇÉÇÝ
amitriptylin
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
³ÙÉá¹ÇåÇÝ
amlodipine
³ÙÉá¹ÇåÇÝÇ µ»½Çɳï
amlodipine besilate
³ÙÉá¹ÇåÇÝÇ µ»ëÇɳï
amlodipine besilate
¹»Õ³Ñ³ï»ñ
³ÙÉá¹ÇåÇÝÇ µ»ëÇɳï
amlodipine besilate
¹»Õ³Ñ³ï»ñ
³ÙÉá¹ÇåÇÝ,
ÉǽÇÝáåñÇÉ
amlodipine, lisinopril
³ÙÉá¹ÇåÇÝ, ³ï»ÝáÉáÉ
amlodipine, atenolol
³ÙÉá¹ÇåÇÝ, ³ï»ÝáÉáÉ
amlodipine, atenolol
³ÙÉá¹ÇåÇÝ
amlodipine
³ÙûùëÇóÇÉÇÝ,
ϳÉÇáõٳϳÝ
ùɳíáõɳݳï
amoxicilline, potassium
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³÷áßÇ Ý/»
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
150·/1000ÙÉ
(500ÙÉ), 500ÙÉ
³å³Ï» ëñí³Ï (1)
100·/1000ÙÉ
(500ÙÉ), 500ÙÉ
³å³Ï» ëñí³Ï (1)
100·/1000ÙÉ
(500ÙÉ), 500ÙÉ
³å³Ï» ëñí³Ï (1)
150Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
200Ù·
(30,60)
10Ù·
(60/2x30/)
25Ù·
(60/2x30/)
0.025·
(20,50,100)
лÙáý³ñÙ ÏáÝó»éÝ ².¸.
Hemofarm concern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
B05BA01
1442/7418
20.12.2007
20.12.2012
¸
лÙáý³ñÙ ÏáÝó»éÝ ².¸.
Hemofarm concern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
B05BA01
1441/7417
20.12.2007
20.12.2012
¸
лÙáý³ñÙ ÏáÝó»éÝ ².¸.
Hemofarm concern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
B05BA01
1443/7419
20.12.2007
20.12.2012
¸
Îèβ ¹.¹.Üáíá Ù»ëïá
KRKA d.d.Novo mesto
êÉáí»Ýdz
C01B D01
4605
24.03.2005
24.03.2010
¸
Îèβ ¹.¹.,Üáíá Ù»ëïá
KRKA d.d.Novo mesto
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
ICN Polfa Rzeszow S.A.
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
ICN Polfa Rzeszow S.A.
¼»ÝïÇí³ ³.ë.
Zentiva a.s.
êÉáí»Ýdz
C01B D01
5985
¸
Ȼѳëï³Ý
N06A A09
0453/6320
Ȼѳëï³Ý
N06A A09
0458/6319
êÉáí³Ïdz
N06A A09
1185/7175
22.02.2006
22.02.2011
29.09.2006
29.09.2011
29.09.2006
29.09.2011
24.09.2007
13.09.2012
г۳ëï³Ý
N06A A09
5107
¸
êÉáí³Ïdz
N06A A09
4250
17.09.2004
17.09.2009
19.06.2003
19.06.2008
г۳ëï³Ý
C08C A01
4688
¸
г۳ëï³Ý
C08C A01
5871
àõÏñ³Çݳ
C08C A01
1241/7062
16.02.2004
16.02.2009
11.01.2006
11.01.2011
15.10.2007
15.10.2012
àõÏñ³Çݳ
C08C A01
1242/7063
15.10.2007
15.10.2012
¸
Ðݹϳëï³Ý
C08C,
C09B A03
4063
13.03.2003
13.03.2008
¸
Ðݹϳëï³Ý
4097
0361/6294
êÇñdz
C08C A01
5266
Ðáñ¹³Ý³Ý
J01C R02
5385
25.03.2003
25.03.2008
28.08.2006
28.08.2011
09.02.2005
09.02.2010
11.01.2006
11.01.2011
¸
Ðݹϳëï³Ý
C08C,
C07F B03
C08C A01
25Ù·
²ðöÆغ¸ ÐÒ ö´À ARPIMED
(24,48,100)
J.V. CJ-S Co.
25Ù·,
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
0.0283·
Slovakofarma a.s., Hlohovec
³ÙÇïñÇåïÇÉÇÝÇ
ÑǹñáùÉáñǹ
(20,50,100)
10Ù·
²ðöÆغ¸ ÐÒ ö´À
(10,24,30)
ARPIMED J.V. CJ-S Co.
5Ù·
²ðöÆغ¸ ÐÒ ö´À
ARPIMED
(10,20,30)
J.V. CJ-S Co.
5Ù·
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
(10, 30, 30/3x10/)
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
10Ù·
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
(10, 30, 30/3x10/)
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
5Ù·+5Ù·
êÇåɳ Èï¹
(10x5x10)
Cipla Ltd
5Ù·+50Ù·
(10,30)
5Ù·+25Ù·
(10)
50Ù·
(30)
(1000Ù·+200Ù·)
ëñí³Ï (1)
êÇåɳ Èï¹
Cipla Ltd.
êÇåɳ Èï¹
Cipla Ltd.
è³Ù½Ç Þ³µ³ÝÇ (è³ß³) ɳµë.
Ramzi Chabani (Racha) Labs.
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇù³Éë
Hikma Pharmaceuticals
¸
¸
¸
¸
¸
¸
¸
¸
¸
10
131
132
133
134
135
136
137
clavulanate
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ Ý/»
(500Ù·+100Ù·)
ϳÉÇáõٳϳÝ
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
ùɳíáõɳݳï
ÉáõÍáõÛÃÇ
amoxicilline, potassium
clavulanate
²ÙáÏÉ³Ý ´Æ¸
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ
200Ù·+28.5Ù·
Amoclan BID
ùɳíáõɳݳÃÃáõ
¹»Õ³Ï³ËáõÛÃÇ
(¹»Õ³÷áßÇ 70ÙÉ
amoxicillin, clavulanic
¹»Õ³Ï³ËáõÛÃÇ
acid
ѳٳñ)
²ÙáÏÉ³Ý ´Æ¸
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ
400Ù·+57Ù·
Amoclan BID
ùɳíáõɳݳÃÃáõ
¹»Õ³Ï³ËáõÛÃÇ
(¹»Õ³÷áßÇ 70ÙÉ
amoxicillin, clavulanic
¹»Õ³Ï³ËáõÛÃÇ
acid
ѳٳñ)
²ÙáÏÉ³Ý ´Æ¸
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
(875Ù·+125Ù·)
Amoclan BID
ϳÉÇáõٳϳÝ
(10)
ùɳíáõɳݳï
amoxicilline, potassium
clavulanate
²ÙáÏÉ³Ý ýáñï»
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
500Ù·+125Ù·
Amoclan Forte
ϳÉÇáõٳϳÝ
(10)
ùɳíáõɳݳï
amoxicilline, potassium
clavulanate
²ÙáÝdzÏÇ ÉáõÍáõÛÃ
³ÙáÝdzÏ
ÉáõÍáõÛÃ
10%,
10%
ammonia
10ÙÉ, 30ÙÉ 40ÙÉ
Ammonia solution
ßßÇÏ
10%
²ÙáïñÇÉ
ÏÉáݳ½»å³Ù
¹»Õ³Ñ³ï»ñ
2Ù·
Amotril
clonazepam
(30)
²ÙáÏÉ³Ý 600Ù·
Amoclan 600mg
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇù³Éë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
J01C R02
5386
11.01.2006
11.01.2011
¸
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
J01C R02
5140
14.12.2004
14.12.2009
¸
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
J01C R02
5141
14.12.2004
14.12.2009
¸
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇù³Éë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
J01C R02
5388
11.01.2006
11.01.2011
¸
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
J01C R02
0171/5387
13.07.2006
13.07.2011
¸
¾ëÏáõɳå êäÀ
Esculap Ltd.
г۳ëï³Ý
-
4879
17.08.2004
17.08.2009
²¸
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
º·Çåïáë
N03A E01
0114/6158
15.06.2006
15.06.2011
¸\Ð
º·Çåïáë
N03A E01
0115/6159
15.06.2006
15.06.2011
¸\Ð
êÇñdz
J01C A51
3986
05.05.2003
05.05.2008
¸
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
àõÏñ³Çݳ
J01C G01
4990
27.08.2004
27.08.2009
¸
1·,
ëñí³Ï (10)
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
´áõÉÕ³ñdz
J01C A01
6065
24.03.2006
24.03.2011
¸
250Ù·/5ÙÉ,
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ ³å³Ï»
ßßÇÏáõÙ
500Ù·
(16/2x8/,
100/10x10/, 1000)
ڲβ-80
JAKA-80
سϻ¹áÝdz
J01CA04
0865/6477
30.03.2007
30.03.2012
¸
ڲβ-80
JAKA-80
سϻ¹áÝdz
J01C A04
1101/6476
07.09.2007
07.09.2012
¸
138
²ÙáïñÇÉ
Amotril
ÏÉáݳ½»å³Ù
clonazepam
¹»Õ³Ñ³ï»ñ
0.5Ù·
(30)
139
²ÙåÇÏÉûùëÇÝ 250
Ampicloxin 250
³ÙåÇóÇÉÇÝ,
ÏÉûùë³óÇÉÇÝ
ampicillin, cloxacillin
¹»Õ³Ï³ËáõÛÃ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
(125Ù·+125Ù·)/
5ÙÉ,
60ÙÉ,100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
0.5·+1·,
ëñí³Ï (1)
140 ²ÙåÇëáõɵÇÝ - ÎØä
Ampisulbin - KMP
141
²ÙåÇóÇÉÇÝ
Ampicillin
142
²ÙåÇóÇÉÇÝ
Ampicilin
ëáõɵ³Ïï³Ù,
³ÙåÇóÇÉÇÝ
sulbactam, ampicillin
³ÙåÇóÇÉÇÝ
ݳïñÇáõÙÇ
ampicillin sodium
³ÙåÇóÇÉÇÝ
ampicillin
143
²ÙåÇóÇÉÇÝ
Ampicilin
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
11
144
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(1000(10x100))
145 ²ÙåÇóÇÉÇÝ 250Ù·
Ampicillin 250mg
³ÙåÇóÇÉÇÝÇ
»éñÇÑǹñ³ï
ampicillin trihydrate
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(20)
146 ²ÙåÇóÇÉÇÝ ´Ç-öÇ
Ampicillin BP
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(16/2x8/,
100/10x10/)
147 ²ÙåÇóÇÉÇÝ ´Ç-öÇ
Ampicillin BP
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(16/2x8/,
100/10x10/)
148
²ÙåÇóÇÉÇÝ
ÆÝÝáï»ù
Ampicillin Innotech
149
²ÙåÇóÇÉÇÝ
ïñÇÑǹñ³ï
Ampicillin trihydrate
150 ²ÙåÇóÇÉÇÝ-²Îàê
Ampicillin-AKOS
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
1·,
ëñí³Ï (1)
³ÙåÇóÇÉÇÝ
ampicilline
¹»Õ³Ñ³ï»ñ
0.25·
(6,10)
³ÙåÇóÇÉÇÝ
ampicillin
0,5·
ëñí³Ï (50)
151
²ÙåÇóÇÉÇÝ-²Îàê
Ampicillin-AKOS
³ÙåÇóÇÉÇÝ
ampicilin
1· (10ÙÉ),
ëñí³Ï (1, 50)
152
²ÙåÇóÇÉÇݲëï»ñdz
Ampicillin-Asteria
²ÙåÇóÇÉÇݲëï»ñdz
Ampicillin-Asteria
²ÙåÇóÇÉÇÝ-ÎØä
Ampicillin-KMP
³ÙåÇóÇÉÇÝ
ampicilin
ÉÇáýÇÉǽ³ï Ù/Ù
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
ÆÝáï»ù ÆÝï»ñݳëÇáݳÉ
ȳµáñ³ïáñdz
Laboratoires Innotech
International
ºíñáý³ñÙ ê.².(¶É³ùëáêÙÇÃÎɳÛÝÇ Ñ³Ù³ñ)
Europharm S.A.for
GlaxoSmithKline
Âñáç Ø»¹ÇÏ³É /Âñáç Ø»¹ÇϳÉ,
/¶»ñÙ³Ýdz/-Ç Ñ³Ù³ñ
Troge Medical /for Troge
Medical, Germany/
Âñáç Ø»¹ÇÏ³É /Âñáç Ø»¹ÇϳÉ,
/¶»ñÙ³Ýdz/-Ç Ñ³Ù³ñ
Troge Medical /for Troge
Medical, Germany/
ȳµáñ³ïáñdz ÆÝÝáï»ù
ÆÝï»ñݳëÇáÝ³É Laboratoires
Innotech International
´áñÇëáíÛ³Ý ´ä¶
Borisovski Pharmaceutical
Work
êÇÝû½ ´´À
Sintez Open JSC
²ÙåÇóÇÉÇÝ-ÎØä
Ampicillin-KMP
³ÙåÇóÇÉÇÝ
ampicillin
153
154
155
156
²ÙåÇóÇÉÇÝ ÇÝáï»ù
Ampicillin Innotech
²ÙåÇóÇÉÇÝݳïñÇáõÙ
Ampicillin-natrium
157
²ÙåÇóÇÉÇÝûùë³óÇÉÇÝ-ÎØä
Ampicilin-OxacillinKMP
158 ²ÙåÇûùë-ݳïñÇáõÙ
Ampiox-sodium
üñ³Ýëdz
J01C A01
S01A A19
4304
27.06.2003
27.06.2008
¸
èáõÙÇÝdz
J01C A01
5492
08.04.2005
08.04.2010
¸
Ðݹϳëï³Ý
J01C A01
0489/6481
16.10.2006
16.10.2011
¸
Ðݹϳëï³Ý
J01C A01
0488/6480
16.10.2006
16.10.2011
¸
üñ³Ýëdz
J01C A01
4636
05.02.2004
05.02.2009
¸
´»É³éáõë
J01C A01
4586
15.12.2003
15.12.2008
¸
èáõë³ëï³Ý
J01CA01
1125/7130
19.11.2007
08.08.2012
¸
êÇÝû½ êäÀ
Sintez Co.Ltd
èáõë³ëï³Ý
J01CA01
1403/7365
19.11.2007
05.11.2012
¸
250Ù·
(100/10x10/)
гÝÏáõÏ Îáñáõë ü³ñÙ øá. Èï¹
Hankook Korus Pharm Co., Ltd
Îáñ»³
J01CA04
0325/6330
08.08.2006
08.08.2011
¸
³ÙåÇóÇÉÇÝ
ampicilin
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(100/10x10/)
гÝÏáõÏ Îáñáõë ü³ñÙ øá. Èï¹
Hankook Korus Pharm Co., Ltd
Îáñ»³
J01CA04
0324/6331
08.08.2006
08.08.2011
¸
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³÷áßÇ Ù/Ù, Ý/»
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ Ù/Ù, Ý/»
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
1000Ù·
ëñí³Ï (40)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
àõÏñ³Çݳ
J01DA06
0336/6341
21.08.2006
21.08.2011
¸
500Ù·,
ëñí³Ï (40)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
àõÏñ³Çݳ
J01CA01
0335/6342
11.08.2006
11.08.2011
¸
0.5·,
ëñí³Ï (1)
´»É³éáõë
J01C A01
S01A A19
4336
18.07.2003
18.07.2008
¸
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý
0.5·
(0.3335·+ 0.1665·)
(40)
´áñÇëáíÛ³Ý ´ä¶
Borisovski Pharmaceutical
Work
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
àõÏñ³Çݳ
J01C A51
0396/6417
19.09.2006
19.09.2011
¸
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
J01C A51
4584
29.10.2003
29.10.2008
¸
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
J01C A51
4585
29.10.2003
29.10.2008
¸
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
0644/6680
12.01.2007
12.01.2012
¸
³ÙåÇóÇÉÇÝ
ampicillin
³ÙåÇóÇÉÇÝ,
ûùë³óÇÉÇÝ
ampicilin, oxacillin
³ÙåÇóÇÉÇÝ,
ûùë³óÇÉÇÝ
ampicillin, oxacillin
159 ²ÙåÇûùë-ݳïñÇáõÙ
³ÙåÇóÇÉÇÝ,
Ampiox-sodium
ûùë³óÇÉÇÝ ampicillin,
oxacillin
160 ²ÙûÏëÇÏɳí ùíÇùï³µ
³ÙûùëÇóÇÉÇÝ,
1000
ùɳíáõɳݳÃÃáõ
¹»Õ³÷áßÇ Ý/»
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
0.5·
(0.3335·+0.1665·)
ëñí³Ï (1)
0.5·
(0.3335·+ 0.1665·)
ëñí³Ï (1)
(850Ù·+125Ù·)
(10/2x5/, 14/2x7/)
12
Amoksiklav
Quicktab 1000
²ÙûÏëÇÏɳí ùíÇùï³µ
625
Amoksiklav
Quicktab 625
²ÙûÏëÇóÇÉÇÝ
Amoksicilin
amoxicilline, clavulanic
acid
³ÙûùëÇóÇÉÇÝ,
ùɳíáõɳݳÃÃáõ
amoxicilline, clavulanic
acid
³ÙûùëÇóÇÉÇÝ
amoxsicillin
163
²ÙûÏëÇóÇÉÇÝ
Amoksicilin
³ÙûùëÇóÇÉÇÝ
amoxicillin
¹»Õ³÷áßÇ
¹»Õ³Ï³ËáõÛÃÇ
164
²ÙûÏëÇóÇÉÇÝ
Amoksicillin
²ÙûÏëÇóÇÉÇÝ
Amoksicillin
²ÙûÏëÇóÇÉÇÝ
Amoksicillin
³ÙûùëÇóÇÉÇÝ
amoxicilline
³ÙûùëÇóÇÉÇÝ
amoxicilline
³ÙûùëÇóÇÉÇÝ
amoxicilline
¹»Õ³å³ïÇ×Ý»ñ
161
162
165
166
167
168
169
170
171
172
173
174
²ÙûùëÇÉ - ÎØä
Amoxyl - KMP
²ÙûùëÇÉ - ÎØä
Amoxyl - KMP
²ÙûùëÇÏɳí
Amoksiklav
¹»Õ³Ñ³ï»ñ
(500Ù·+125Ù·)
(10/2x5/, 14/2x7/)
È»Ï ý³ñÙ³ëÛáõïÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
0645/6679
12.01.2007
12.01.2012
¸
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(16/2x8/,
100/10x10/, 1000)
250Ù·/5ÙÉ,
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ ³å³Ï»
ßßÇÏáõÙ
250Ù·
(16)
500Ù·
(16)
250Ù·/5ÙÉ
(40· ·ñ³ÝáõÉÝ»ñ
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ)
0.25·
(20)
0.5·
(20)
600Ù·,
ëñí³Ï (5)
ÚAKA-80
JAKA-80
سϻ¹áÝdz
J01C A04
1102/6473
07.09.2007
07.09.2012
¸
ڲβ-80
JAKA-80
سϻ¹áÝdz
J01CA04
0864/6472
30.03.2007
30.03.2012
¸
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
ê»ñµÇ³ ¨
â»éÝá·áñdz
ê»ñµÇ³ ¨
â»éÝá·áñdz
J01C A04
5220
¸
J01C A04
5221
J01C A04
5222
02.11.2004
02.11.2009
02.11.2004
02.11.2009
02.11.2004
02.11.2009
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
àõÏñ³Çݳ
J01C A04
3907
¸
àõÏñ³Çݳ
J01C A04
3908
êÉáí»Ýdz
J01C R02
5427
12.02.2003
12.02.2008
12.02.2003
12.02.2008
21.03.2005
21.03.2010
1.2·,
ëñí³Ï (5)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5428
21.03.2005
21.03.2010
¸
156,25Ù·/5ÙÉ
(100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5429
21.03.2005
21.03.2010
¸
625Ù·
(15)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5431
21.03.2005
21.03.2010
¸
375Ù·
(15)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5432
21.03.2005
21.03.2010
¸
(875Ù·+125Ù·)
(10,14)
ȺΠü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
LEK Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5083
14.09.2004
14.09.2009
¸
¹»Õ³å³ïÇ×Ý»ñ
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ
³ÙûùëÇóÇÉÇÝ
¹»Õ³Ñ³ï»ñ
amoxycillin
³ÙûùëÇóÇÉÇÝ
¹»Õ³Ñ³ï»ñ
amoxycillin
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ
ϳÉÇáõٳϳÝ
Ý»ñ³ñÏÙ³Ý
ùɳíáõɳݳï
ÉáõÍáõÛÃÇ
amoxicillin, potassium
clavulanate
²ÙûùëÇÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ
Amoksiklav
ϳÉÇáõٳϳÝ
Ý»ñ³ñÏÙ³Ý
ùɳíáõɳݳï
ÉáõÍáõÛÃÇ
amoxicillin, potassium
clavulanate
²ÙûùëÇÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ
Amoksiklav
ϳÉÇáõٳϳÝ
¹»Õ³Ï³ËáõÛÃÇ
ùɳíáõɳݳï
amoxicillin, potassium
clavulanate
²ÙûùëÇÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
Amoksiklav
ϳÉÇáõٳϳÝ
óճÝóå³ï
ùɳíáõɳݳï
amoxicillin, potassium
clavulanate
²ÙûùëÇÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
Amoksiklav
ϳÉÇáõٳϳÝ
óճÝóå³ï
ùɳíáõɳݳï
amoxicillin, potassium
clavulanate
²ÙûùëÇÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
2x1000Ù· ¹»Õ³Ñ³ï»ñ
ùɳíáõɳݳÃÃáõ
óճÝóå³ï
Amoksiklav
amoxicilline, clavulanic
¸
¸
¸
¸
13
2x1000mg tablets
acid
²ÙûùëÇÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ
(400Ù·+57Ù·)
2x457Ù·/5ÙÉ
ùɳíáõɳݳÃÃáõ
¹»Õ³Ï³ËáõÛÃÇ
(¹»Õ³÷áßÇ 35ÙÉ
ËÙ»Éáõ
amoxicilline, clavulanic
ϳ٠70ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
acid
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
ѳٳñ)
Amoksiklav
2x457mg/5ml
powder for oral
suspension
176
²ÙûùëÇÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
(500Ù·+125Ù·)
2x625 Ù· ¹»Õ³Ñ³ï»ñ
ùɳíáõɳݳÃÃáõ
óճÝóå³ï
(10,14)
Amoksiklav 2x625 amoxicilline, clavulanic
mg tablets
acid
177 ²ÙûùëÇÏɳí ýáñï»
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ
312,5Ù·/5ÙÉ
Amoksiklav forte
ϳÉÇáõٳϳÝ
¹»Õ³Ï³ËáõÛÃÇ
(100ÙÉ
ùɳíáõɳݳï
¹»Õ³Ï³ËáõÛÃÇ
amoxicillin, potassium
¹»Õ³÷áßÇ)
clavulanate
178
²ÙûùëÇóÇÉÇÝ
³ÙûùëÇóÇÉÇÝ
¹»Õ³Ñ³ï»ñ
500Ù·
Amoxicillin
amoxicillin
(100x10)
175
179
²ÙûùëÇóÇÉÇÝ
Amoxicilin
³ÙûùëÇóÇÉÇÝ
amoxicillin
180
²ÙûùëÇóÇÉÇÝ
Amoxicillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
181
²ÙûùëÇóÇÉÇÝ
Amoxicillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
182
²ÙûùëÇóÇÉÇÝ
Amoxicillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
183
²ÙûùëÇóÇÉÇÝ
Amoxycillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
184
²ÙûùëÇóÇÉÇÝ
250Ù· Amoxicillin
250mg
³ÙûùëÇóÇÉÇÝÇ
»éÑǹñ³ï
amoxicillin trihydrate
185
²ÙûùëÇóÇÉÇÝ ´ÇöÇ
Amoxicillin BP
³ÙûùëÇóÇÉÇÝ
amoxicillin
186
²ÙûùëÇóÇÉÇÝ ´ÇöÇ
³ÙûùëÇóÇÉÇÝ
amoxicillin
ȺΠü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
LEK Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5084
14.09.2004
14.09.2009
¸
ȺΠü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
LEK Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5082
14.09.2004
14.09.2009
¸
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01C R02
5430
21.03.2005
21.03.2010
¸
¶»ñÙ³Ýdz
J01C A04
4500
23.12.2003
23.12.2008
¸
г۳ëï³Ý
J01C A04
0371/6287
11.09.2006
11.09.2011
¸
г۳ëï³Ý
J01C A04
0191/6271
13.07.2006
13.07.2011
¸
г۳ëï³Ý
J01C A04
4694
16.02.2004
16.02.2009
¸
г۳ëï³Ý
J01C A04
5076
11.03.2005
11.03.2010
¸
г۳ëï³Ý
J01C A04
5879
12.01.2006
12.01.2011
¸
èáõÙÇÝdz
J01C A04
5493
08.04.2005
08.04.2010
¸
Ðݹϳëï³Ý
J01C A04
0491/6484
16.10.2006
16.10.2011
¸
Ðݹϳëï³Ý
J01C A04
0472/6483
16.10.2006
16.10.2011
¸
ê³Ý³íÇï³ ²Ïïǻݷ»½»Éß³ýï ¨ øá.
Sanavita Aktiengesellschaft &
Co.
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
¾ëÏáõɳå êäÀ
(10,16, 20 µÉÇëï»ñ
Esculap Ltd
¨ åɳëïÇÏ ï³ñ³)
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
¾ëÏáõɳå êäÀ
(10,16, 20
Esculap Ltd
/µÉÇëï»ñ ¨ åɳëïÇÏ
ï³ñ³/)
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
§ÜúÎƦ ѳ۳ٻñÇϳ·»ñٳݳϳÝ
(10,20)
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ êäÀ
§NOKI¦ Armenian-AmericanGerman Pharmac. J.V.Co.Ltd.
¹»Õ³÷áßÇ ËÙ»Éáõ
250Ù·/5ÙÉ
êäÀ §ÜúÎƦ
¹»Õ³Ï³ËáõÛÃÇ
(5· ¹»Õ³÷áßÇ
ѳ۳ٻñÇϳ·»ñٳݳϳÝ
100ÙÉ
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
¹»Õ³Ï³ËáõÛÃÇ
Ó»éݳñÏáõÃÛáõÝ
ѳٳñ)
§NOKI¦ Armenian-AmericanGerman Pharmac. J.V. Co.Ltd.
·ñ³ÝáõÉÝ»ñ
250Ù·/5ÙÉ,
¾ëÏáõɳå êäÀ
Ý»ñùÇÝ
100ÙÉ
Esculap Ltd.
ÁݹáõÝÙ³Ý,
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³Ï³ËáõÛÃÇ
å³ïñ³ëïÙ³Ý Ñ³Ù³ñ
·ñ³ÝáõÉÝ»ñ
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
ºíñáý³ñÙ ê.².(¶É³ùëáêÙÇÃ(12)
ÎɳÛÝÇ Ñ³Ù³ñ)
Europharm S.A.for
GlaxoSmithKline
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
Âñáç Ø»¹ÇÏ³É /Âñáç Ø»¹ÇϳÉ,
(100/10x10/)
/¶»ñÙ³Ýdz/-Ç Ñ³Ù³ñ
Troge Medical /for Troge
Medical, Germany/
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
Âñáç Ø»¹ÇÏ³É /Âñáç Ø»¹ÇϳÉ,
(16/2x8/,
/¶»ñÙ³Ýdz/-Ç Ñ³Ù³ñ
14
Amoxicillin BP
187
188
189
²ÙûùëÇóÇÉÇݲëï»ñdz
Amoxicillin-Asteria
²ÙûùëÇóÇÉÇݲëï»ñdz
Amoxicillin-Asteria
²ÛÏñáÉ
Eyecrol
100/10x10/)
³ÙûùëÇóÇÉÇÝ
amoxicillin
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(100/10x10/)
Troge Medical /for Troge
Medical, Germany/
гÝÏáõÏ Îáñáõë ü³ñÙ øá. Èï¹
Hankook Korus Pharm Co., Ltd
³ÙûùëÇóÇÉÇÝ
amoxicillin
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(100/10x10/)
ùñáÙá·ÉÇϳï
ݳïñÇáõÙÇ
cromoglicate sodium
³ÏݳϳÃÇÉÝ»ñ
4%,
10ÙÉ ßßÇÏ
190
²Ý³É·ÇÝ
Analgin
Ù»ï³ÙǽáÉ
metamizole
¹»Õ³Ñ³ï»ñ
0.5·
(10)
191
²Ý³É·ÇÝ
Analgin
²Ý³É·ÇÝ
Analgin
²Ý³É·ÇÝ
Analgin
Ù»ï³ÙǽáÉ
metamizole
Ù»ï³ÙǽáÉ
metamizole
Ù»ï³ÙǽáÉ
ݳïñÇáõÙÇ
metamizole sodium
¹»Õ³Ñ³ï»ñ
500Ù·
(20/2x10/)
500Ù·
(10,20,100)
50% (2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
194
²Ý³É·ÇÝ-¸³ñÝÇó³
Analgin-Darnitsa
Ù»ï³ÙǽáÇÉ
ݳïñÇáõÙÇ
metamizole sodium
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
50% (2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
195
²Ý³É·ÇÝ-¼¹áñáíÛ»
Analgin-Zdorovye
Ù»ï³ÙǽáÉ
ݳïñÇáõÙÇ
metamizole sodium
¹»Õ³Ñ³ï»ñ
0,5·
(10)
196
²Ý³åñÇÉÇÝ
Anaprilin
åñáåñ³ÝáÉáÉ
propranolol
¹»Õ³Ñ³ï»ñ
197
²Ý³åñÇÉÇݼ¹áñáíÛ»
Anaprilin-Zdorovye
åñáåñ³ÝáÉáÉ
propranolol
¹»Õ³Ñ³ï»ñ
0.04·
(30/3x10/,
50/5x10/)
40Ù·
(50)
198
²Ý³åñÇÉÇݼ¹áñáíÛ»
Anaprilin-Zdorovye
åñáåñ³ÝáÉáÉ
propranolol
¹»Õ³Ñ³ï»ñ
10Ù·
(50)
ëï³ýÇÉáÏáϳÛÇÝ
ïáùëÇÝ
staphylococcal toxin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1ÙÉ(2¹»Õ³ã³÷),
³ÙåáõÉÝ»ñ (10)
ëï³ýÇÉáÏáϳÛÇÝ
ïáùëÇÝ
staphylococcal toxin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10-14Ø/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
192
193
199
²Ý³ïáùëÇÝ
ëï³ýÇÉáÏáϳÛÇÝ
Ù³ùñí³Í, Ý»ñÏɳÝí³Í,
Ñ»ÕáõÏ
Anatoxin
staphylococcal
purified, adsorbed,
liquid
200
²Ý³ïáùëÇÝ
ëï³ýÇÉáÏáϳÛÇÝ
Ù³ùñí³Í, Ñ»ÕáõÏ
Anatoxin
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
Îáñ»³
J01CA04
0322/6333
08.08.2006
08.08.2011
¸
гÝÏáõÏ Îáñáõë ü³ñÙ øá. Èï¹
Hankook Korus Pharm Co., Ltd
Îáñ»³
J01CA04
0323/6332
08.08.2006
08.08.2011
¸
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ, ²Ý·Édz-Ç Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
England)
§ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³¦ ´´À
§Pharmstandard-Leksredstva¦
OJSC
êáý³ñÙ³ ´À
Sopharma JSC
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
Closed JSC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¶³Ù³É»³ÛÇ ³Ýí. ¾Ø¶ÐÆ äÒ
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
§Medgamal¦ branch of SI
SRIEM after Gamalei
º·Çåïáë
S01G X01
0852/6859
26.03.2007
13.03.2012
¸
èáõë³ëï³Ý
N02B B02
4949
21.06.2005
23.07.2009
²¸
´áõÉÕ³ñdz
N02B B02
0919/6706
²¸
г۳ëï³Ý
N02B B02
5109
´»É³éáõë
N02BB02
6004
26,04.2007
26.04.2012
27.09.2004
27.09.2009
13.03.2006
13.03.2011
àõÏñ³Çݳ
B05XA07
1264/7232
30.10.2007
12.10.2012
¸
àõÏñ³Çݳ
N02B B02
1131/7089
02.10.2007
08.08.2012
²¸
èáõë³ëï³Ý
C07A A05
0467\6489
11.10.2006
11.10.2011
¸
àõÏñ³Çݳ
C07A A05
1240/7059
15.10.2007
15.10.2012
¸
àõÏñ³Çݳ
C07A A05
1239/7058
15.10.2007
15.10.2012
¸
èáõë³ëï³Ý
-
5731
26.08.2005
26.08.2010
¸
èáõë³ëï³Ý
-
5686
26.08.2005
26.08.2010
¸
¶³Ù³É»³ÛÇ ³Ýí. ¾Ø¶ÐÆ äÒ
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
§Medgamal¦ branch of SI
SRIEM after Gamalei
²¸
¸
15
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
staphylococcal
purified, liquid
²Ý¹³Ýï»
Andante
²Ý¹³Ýï»
Andante
²Ý¹ñá·»É
Androgel
²Ý¹ñáÏáõñ
Androcur
²Ý¹ñáÏáõñ-10
Androcur-10
²Ý»ëï³Ý
Anestane
²Ý¿ëû½áÉ
Anaesthesol
½³É»åÉáÝ
zaleplon
½³É»åÉáÝ
zaleplon
ûëïáëï»ñáÝ
testosterone
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹áݹáÕ
5Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
(7,14)
Gedeon Richter Ltd.
10Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
(7,14)
Gedeon Richter Ltd.
1% (50Ù·/5·)
´»½ÇÝë ÆÝï»ñݳëÇáݳÉ
÷³Ã»ÃÝ»ñ (10,30) ɳµáñ³ïáñdzݻñ êáÉí»Ç ѳٳñ
Besins Intarnational
Laboratoires foe Solvay
50Ù·
Þ»ñÇÝ· ²¶
(50)
Schering AG
10Ù·
Þ»ñÇÝ· ²¶
(15)
Schering AG
100%,
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
250ÙÉ ßßÇÏ
Hikma Pharmaceuticals
(0,1·+0,04·+
ÜÇÅý³ñÙ ´´À
0,02·+ 0,004·)
Nizhpharm Open JSC
(10)
óÇåñáï»ñáÝÇ ³ó»ï³ï
¹»Õ³Ñ³ï»ñ
cyproterone acetate
óÇåñáï»ñáÝÇ ³ó»ï³ï
¹»Õ³Ñ³ï»ñ
cyproterone acetate
ѳÉáóÝ
ÉáõÍáõÛÃ
halothane
ßÝã³éÙ³Ý
µ»Ý½áϳÛÇÝ,
ÙáÙÇÏÝ»ñ
µÇëÙáõÃÇ ëáõµ·³É³ï,
óÇÝÏÇ ûùëǹ, Ù»ÝÃáÉ
benzocaine, bismuth
subgallate, zinc oxyde,
menthol
²Ý¿ëï»ñ³Ý
ǽáýÉáõñ³Ý
ÉáõÍáõÛÃ
99.9%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Anesteran
isofluranum
ßÝã³éÙ³Ý
100ÙÉ ßßÇÏ
Rompharm Company SRL
²ÝÃñ³óÇÝ
¾åÇñáõµÇóÇÝ
Ëï³ÝÛáõÃ
50Ù·/25ÙÉ,
¸²´àõð ü³ñÙ³ Èï¹
Anthracin
epirubicin
ϳÃÇɳݻñ³ñÏ-Ù³Ý
25ÙÉ ëñí³Ï (1)
DABUR Pharma Ltd
ÉáõÍáõÛÃÇ
²ÝÃñ³óÇÝ
¾åÇñáõµÇóÇÝ
Ëï³ÝÛáõÃ
10Ù·/5ÙÉ,
¸²´àõð ü³ñÙ³ Èï¹
Anthracin
epirubicin
ϳÃÇɳݻñ³ñÏ-Ù³Ý
5ÙÉ ëñí³Ï (1)
DABUR Pharma Ltd
ÉáõÍáõÛÃÇ
²ÝÏáïÇÉ
ýÉáõóÇïá½ÇÝ
ÉáõÍáõÛÃ
10Ù·/ÙÉ,
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
Ancotil
flucytosine
ϳÃÇɳݻñ³ñÏ-Ù³Ý
250ÙÉ ëñí³Ï (5)
ICN Switzerland AG
²Ýáõ½áÉ
ßÇϳï³ÏÇ Ñ³ÝáõÏ, óÇÝÏÇ
ÙáÙÇÏÝ»ñ
(10)
ÜÇÅý³ñÙ ´´À
Anusol
ëáõÉý³ï, ùë»ñáýáñÙ,
Nizhpharm Open JSC
·ÉÇó»ñÇÝ
belladonnae extract,
zinc sulfate, xeroform,
glycerol
²Ýï³ùëáÝ
ݳÉïñ»ùëáÝ
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
¼³ÙµáÝ ¶ñáõå ê.å.².
Antaxon
naltrexone
(10)
Zambon Group S.p.A.
²ÝïÇ-¶ñÇå
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
¹»Õ³Ñ³ï»ñ
450Ù·+20Ù·+ 20Ù· ²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
Anti-Grip
Ïáý»ÇÝ,
(20)
Pharmaceutical
³ëÏáñµÇݳÃÃáõ
acetylsalicylic acid,
caffeine, ascorbic acid
²ÝïÇÃñáÙµÇÝ III Ù³ñ¹áõ åɳ½Ù³ÛÇ
¹»Õ³÷áßÇ
100ØØ,
´³ùëï»ñ ²¶
ÇÙáõÝá
³ÝïÇÃñáÙµÇÝ ³Í³ÝóÛ³É
Ý»ñ³ñÏÙ³Ý
(ëñí³Ï, 20ÙÉ
Baxter AG
Antithrombin III human plasma-derived
ÉáõÍáõÛÃÇ,
ÉáõÍÇã, Ý»ñ³ñÏÇã,
Immuno
antithrombin
ÉÇáýÇÉǽ³óí³Í,
³ë»ÕÝ»ñ)
ÉáõÍãáí
²ÝïÇÃñáÙµÇÝ III Ù³ñ¹áõ åɳ½Ù³ÛÇ
¹»Õ³÷áßÇ
500ØØ,
´³ùëï»ñ ²¶
ÇÙáõÝá
³ÝïÇÃñáÙµÇÝ ³Í³ÝóÛ³É
Ý»ñ³ñÏÙ³Ý
(ëñí³Ï, 10ÙÉ
Baxter AG
Antithrombin III human plasma-derived
ÉáõÍáõÛÃÇ,
ÉáõÍÇã, Ý»ñ³ñÏÇã,
Immuno
antithrombin
ÉÇáýÇÉǽ³óí³Í,
³ë»ÕÝ»ñ)
ÉáõÍãáí
ÐáõÝ·³ñdz
N05C F03
5251
ÐáõÝ·³ñdz
N05C F03
5252
üñ³Ýëdz
G03BA03
0321/6314
¶»ñÙ³Ýdz
G03H A01
4649
¶»ñÙ³Ýdz
G03H A01
4648
Ðáñ¹³Ý³Ý
N01A B01
5142
èáõë³ëï³Ý
C05A D03
1058/6849
èáõÙÇÝdz
N01A B06
1158/7205
Ðݹϳëï³Ý
L01D B03
0312/6087
Ðݹϳëï³Ý
L01D B03
Þí»Ûó³ñdz
22.02.2006
22.02.2011
22.02.2006
22.02.2011
08.08.2006
08.08.2011
¸\Ð
04.03.2004
04.03.2009
04.03.2004
04.03.2009
14.12.2004
14.12.2009
10.07.2007
10.07.2012
¸
¸\Ð
¸
¸
¸
²¸
13.09.2007
13.09.2012
01.08.2006
01.08.2011
¸
0314/6086
01.08.2006
01.08.2011
¸
J02A X01
5710
¸
èáõë³ëï³Ý
C05A X04
1055/6852
10.02.2006
10.02.2011
10.07.2007
10.07.2012
Æï³Édz
V03A B30
5407
êÇñdz
N02B A71
4074
²íëïñdz
B01A B02
5560
29.08.2005
29.08.2010
¸
²íëïñdz
B01A B02
5559
29.08.2005
29.08.2010
¸
01.04.2005
01.04.2010
05.11.2003
05.11.2008
¸
²¸
¸
²¸
16
217
²ÝïÇɳÛë
Antilice
218
²ÝïÇÏáÉ
Anticol
åÇñ»ÃñÇÝÝ»ñ,
åÇå»ñáÝÇÉ
pyrethrins, piperonyl
¹ÇëáõÉýÇñ³Ù
disulfiram
219
²ÝïÇÙÇÏ-ÝÛáõ
Antimyk-Neu
ÏÉáïñÇÙ³½áÉ
clotrimazole
220
²ÝïÇáùë+
Antiox+
-
221
²ÝïÇëï»Ýáϳñ¹ÇÝ
Antistenocardin
²ÝïÇëïñáõÙÇÝ
Antistrumin
²ÝïÇëïñáõÙÇÝ
Antistrumin
²ÝïÇ-ùáɹ
Anti-cold
222
223
224
225
²ÝïÇ-ùáɹ
Anti-cold
226
²ÝïÇýÉáõ
Antiflu
227
²ÝïÇýÉáõ µ»µÇ
Antiflu Baby
û׳é³Ñ»ÕáõÏ
0.165%+1.65%,
125ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
500Ù·
(30)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
г۳ëï³Ý
_
4146
10.02.2003
10.02.2008
²¸
Ȼѳëï³Ý
P03A A04
V03A A01
5147
22.10.2004
22.10.2009
¸
г۳ëï³Ý
D01A C01
3446
04.02.2005
04.02.2010
²¸
Æéɳݹdz
βêÐ
5827
26.10.2005
26.10.2010
²¸
´áõÉÕ³ñdz
B01A C07
0916/6591
¸
´áõÉÕ³ñdz
V03AB21
0870/5967
´áõÉÕ³ñdz
V03AB21
0869/5966
г۳ëï³Ý
N02B E71
0910/6008
26,04.2007
26.04.2012
30.03.2007
30.03.2012
30.03.2007
30.03.2012
20.04.2007
20.04.2012
²ðöÆغ¸ Ð/Ò ö´À
ARPIMED J.V. CJ-S Co
г۳ëï³Ý
R05X
1013/7001
04.06.2007
22.05.2012
²¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
N02B E71
5992
13.03.2006
13.03.2011
²¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
R05X
0318/5931
08.08.2006
08.08.2011
²¸
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
ê²
Warsaw
Pharmaceutical Works §Polfa¦
SA
Ýñµ³ùëáõù
1%,
êäÀ §ÜúÎƦ
20· å³ñÏáõ×
ѳ۳ٻñÇϳ·»ñٳݳϳÝ
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
§NOKI¦ Armenian-AmericanGerman Pharmac.J.V.Co.Ltd
å³ïÇ×Ý»ñ
390Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
¹ñ³Å»
25Ù·
êáý³ñÙ³ ´À
(60/2x30/)
Sopharma JSC
¹»Õ³Ñ³ï»ñ
1Ù·
êáý³ñÙ³ ´À
óճÝóå³ï (¹ñ³Å»)
(20)
Sopharma JSC
¹»Õ³Ñ³ï»ñ
0.5Ù·
êáý³ñÙ³ ´À
óճÝóå³ï (¹ñ³Å»)
(20)
Sopharma JSC
ûß³ñ³Ï
(160Ù·+1Ù·+5Ù·)/
²ðöÆغ¸ Ð/Ò ö´À
5ÙÉ,
ARPIMED J.V. CJ-S Co
60ÙÉ,120ÙÉ ßßÇÏ
¹ÇåÇñǹ³ÙáÉ
dipyridamole
ϳÉÇáõÙÇ Ûá¹Ç¹
potassium iodide
ϳÉÇáõÙÇ Ûá¹Ç¹
potassium iodide
å³ñ³ó»ï³ÙáÉ,
ùÉáñý»ÝÇñ³ÙÇÝÇ
ٳɻ³ï,
ý»ÝÇÉåñáå³ÝáɳÙÇÝ
Ç ÑǹñáùÉáñǹ
paracetamol,
chlorpheniramine
maleate,
phenylpropanolamine
hydrochloride
å³ñ³ó»ï³ÙáÉ,
¹»Õ³Ñ³ï»ñ
(325Ù·+2Ù·+5Ù·)
ùÉáñý»ÝÇñ³ÙÇÝÇ
(20/2x10/)
ٳɻ³ï, ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ
paracetamol,
chlorpheniramine
maleate, phenylephrine
hydrochloride
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ ËÙ»Éáõ
(650Ù·+10Ù·+
ý»ÝÇÉ¿ýñÇÝÇ
ÉáõÍáõÛÃÇ
4Ù·)/ ÷³Ã»Ã,
ÑǹñáùÉáñǹ,
÷³Ã»ÃÝ»ñ (5)
ùÉáñý»ÝÇñ³ÙÇÝÇ
ٳɻ³ï
paracetamol,
phenylephrine
hydrochloride,
chlorpheniramine
maleate
³ó»ï³ÙÇÝáý»Ý,
ϳÃÇÉÝ»ñ ËÙ»Éáõ (60Ù·+8Ù·)/ 0.8ÙÉ,
³ëÏáñµÇݳÃÃáõ
15ÙÉ ßßÇÏ
acetaminophen,
ascorbic acid
¸
¸
²¸
17
228 ²ÝïÇýÉáõ ¹»Õ³Ñ³ï»ñ
Antiflu tablets
229
²ÝïÇýÉáõ ùǹë
Antiflu Kids
230
²ÝïÇýáõÝ·áÉ
Antifungol
å³ñ³ó»ï³ÙáÉ,
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ,
ùÉáñý»ÝÇñ³ÙÇÝÇ
ٳɻ³ï
paracetamol,
phenylephrine
hydrochloride,
chlorpheniramine
maleate
³ó»ï³ÙÇÝáý»Ý,
³ëÏáñµÇݳÃÃáõ,
ùÉáñý»ÝÇñ³ÙÇÝÇ
ٳɻ³ï
acetaminophen,
ascorbic acid,
chlorpheniramine
maleate
ÏÉáïñÇÙ³½áÉ
clotrimazole
231
²ÝïÇýáõÝ·áÉ
Antifungol
ÏÉáïñÇÙ³½áÉ
clotrimazole
Ýñµ³ùëáõù
1%,
25·, 50· å³ñÏáõ×
232
²Ýïá¹ÇÝ 20Ù·
Antodine 20mg
ý³ÙáïǹÇÝ
famotidine
¹»Õ³Ñ³ï»ñ
20Ù·
(20)
233
²Ýïá¹ÇÝ 40Ù·
Antodine 40mg
ý³ÙáïǹÇÝ
famotidine
¹»Õ³Ñ³ï»ñ
40Ù·
(10)
¹Ç³½»å³Ù
diazepam
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
¹Ç³½»å³Ù
diazepam
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5Ù·
(30/2x15/)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
N05B A01
0937/6877
03.05.2007
03.05.2012
¸\Ð
Ù»ÕíÇ ÃáõÛÝ, ³ÉÇÉ
ǽáÃÇáódzݳï,
Ù»ÃÇÉ ë³ÉÇóÇɳï
apitoxin, allyl
isothiocyanate, methyl
salicylate
Ù»Õí³Ï³Ã
ùëáõù
(0,003·+1,0·+
10,0·)/100·;
(20·,30·,50·, 100·
å³ñÏáõ×)
¾ëå³ñÙ³ ¶ÙµÐ
Esparma GmbH
¶»ñÙ³Ýdz
-
4592
02.12.2003
02.12.2008
²¸
¹»Õ³Ñ³ï»ñ
10Ù·
¶ñÇݹ»ùë ´À
ȳïídz
A13A
0710/6639
25.01.2007
²¸
234 ²å³áõñÇÝ 10Ù·/2ÙÉ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Apaurin 10mg/2ml
solution for injection
235
²å³áõñÇÝ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
Apaurin coated
tablets
236
²åǽ³ñÃñáÝ
Apisarthron
237
²åÇɳÏ
¹»Õ³Ñ³ï»ñ
(325Ù·+5Ù·+
2Ù·)/÷³Ã»Ã,
(12)
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
N02B E71
5991
13.03.2006
13.03.2011
²¸
¹»Õ³÷áßÇ ËÙ»Éáõ
ÉáõÍáõÛÃÇ
(160Ù·+50Ù·+
1Ù·)/÷³Ã»Ã,
÷³Ã»ÃÝ»ñ (5)
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
N02B E51
5947
27.02.2006
27.02.2011
²¸
ÉáõÍáõÛÃ
10Ù·/ÙÉ,
20ÙÉ, 50ÙÉ ßßÇÏ
ê³Éáõï³ë ü³ñÙ³ (È»Ï
ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.,
êÉáí»ÝdzÛÇ Ñ³Ù³ñ)
Salutas Pharma (for Lek
Pharmaceuticals d.d.,
Slovenia)
ê³Éáõï³ë ü³ñÙ³ (È»Ï
ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.,
êÉáí»ÝdzÛÇ Ñ³Ù³ñ)
Salutas Pharma (for Lek
Pharmaceuticals d.d.,
Slovenia)
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É øá.
ê.².º.
Amoun Pharmaceutical Co.
S.A.E.
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É øá.
ê.².º.
Amoun Pharmaceutical Co.
S.A.E.
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
¶»ñÙ³Ýdz
D01A C01
1075/6927
08.08.2007
08.08.2012
²¸
¶»ñÙ³Ýdz
D01A C01
1076/6926
08.08.2007
08.08.2012
²¸
º·Çåïáë
A02BA03
0987/6634
30.05.2007
30.05.2012
¸
º·Çåïáë
A02BA03
0988/6633
30.05.2007
30.05.2012
¸
êÉáí»Ýdz
N05B A01
0938/6876
03.05.2007
03.05.2012
¸\Ð
18
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
Apilac
²åÇɳÏ
Apilac
royal jelly
Ù»Õí³Ï³Ã
royal jelly
²åá-²ÙåÇ
Apo-Ampi
²åá-³ÙåÇ
Apo-ampi
²åá-³ÙûùëÇ
Apo-amoxi
²åá-³ÙûùëÇ
Apo-amoxi
²åá-³ï»ÝáÉáÉ
Apo-atenolol
²åá-¹ÇÉïdz½
Apo-diltiaz
²åá-¹ÇÉïdz½
Apo-diltiaz
²åá-¹ûùëÇ
Apo-doxy
²åá-Éáå»ñ³Ùǹ
Apo-loperamide
²åá-Éáñ³½»å³Ù
Apo-lorazepam
²åá-Éáñ³½»å³Ù
Apo-lorazepam
²åá-ϳåïá
Apo-capto
²åá-ϳåïá
Apo-capto
²åá-ϳñµ³Ù³½»åÇÝ
Apo-carbamazepine
²åá-Ñǹñá
Apo-hydro
²åá-ݳåñûùë»Ý
Apo-naproxen
²åá-ëáõÉý³ïñÇÙ
Apo-sulfatrim
³ÙåÇóÇÉÇÝ
ampicilin
³ÙåÇóÇÉÇÝ
ampicillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
³ï»ÝáÉáÉ
atenolol
¹ÇÉïdz½»Ù
diltiazem
¹ÇÉïdz½»Ù
diltiazem
¹ûùëÇóÇÏÉÇÝ
doxycycline
Éáå»ñ³Ùǹ
loperamide
Éáñ³½»å³Ù
lorazepam
Éáñ³½»å³Ù
lorazepam
ϳåïáåñÇÉ
captopril
ϳåïáåñÇÉ
captopril
ϳñµ³Ù³½»åÇÝ
carbamazepine
ÑǹñáùÉáñáÃdz½Ç¹
hydrochlorothiazide
ݳåñûùë»Ý
naproxen
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
í»ñ³å³ÙÇÉ
verapamil
ïñÇýÉáõáå»ñ³½ÇÝ
trifluoperazine
²åá-í»ñ³å
Apo-verap
²åáïñÇýÉáõáå»ñ³½ÇÝ
Apo-trifluoperazine
²åá-ó»ý³É»ùë
ó»ý³É»ùëÇÝ
Apo-cephalex
cefalexin
²åá-ó»ý³É»ùë
ó»ý³É»ùëÇÝ
Apo-cephalex
cefalexin
²åñ»ë³ 10
³ÙÉá¹ÇåÇÝÇ µ»½Çɳï
Apresa 10
amlodipine besylate
²åñ»ë³ 5
³ÙÉá¹ÇåÇÝÇ µ»½Çɳï
Apresa 5
amlodipine besylate
500Ù·
(20,100)
250Ù·
(100)
500Ù·
(20,100)
250Ù·
(100)
50Ù·
(100)
60Ù·
(30,100)
30Ù·
(100)
100Ù·
(100)
2Ù·
(100)
2Ù·
(100)
1Ù·
(100)
50Ù·
(100)
25Ù·
(100)
200Ù·
(100)
50Ù·
(100)
250Ù·
(100)
400Ù·+80Ù·
(100)
Grindex JSC
î³ÉÇÝÇ ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
´À
Tallinn Pharmaceutical Works
A.S.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
80Ù·
(100)
5Ù·
(100)
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
γݳ¹³
C08D A01
5450
γݳ¹³
N05A B06
5461
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
500Ù·
(100)
250Ù·
(100)
10Ù·
(20,30,60,100)
5Ù·
(20,30,60,100)
²åáï»ùë ÆÝÏ.
Apotex Inc.
²åáï»ùë ÆÝÏ.
Apotex Inc.
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
γݳ¹³
J01D B01
5446
γݳ¹³
J01D B01
5447
êÉáí³Ïdz
C08C A01
4234
êÉáí³Ïdz
C08C A01
4233
ùëáõù
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
(25)
3%,
50· å³ñÏáõ×
¾ëïáÝdz
D11AX
0609/6606
γݳ¹³
J01C A01
0069/5453/1
γݳ¹³
J01C A01
5452
γݳ¹³
J01C A04
5442
γݳ¹³
J01C A04
5441
γݳ¹³
C07A B03
5443
γݳ¹³
C08D B01
5725
γݳ¹³
C08D B01
5458
γݳ¹³
J01A A02
5726
γݳ¹³
A07D A03
5456
γݳ¹³
N05B A06
4747
γݳ¹³
N05B A06
4746
γݳ¹³
C09A A01
5455
γݳ¹³
C09A A01
5454
γݳ¹³
N03A F01
5457
γݳ¹³
C03A A03
5459
γݳ¹³
5448
γݳ¹³
M01A E02,
M02A A12
J01E E01
5445
25.01.2012
14.12.2006
14.12.2011
02.06.2006
11.11.2010
11.11.2005
11.11.2010
18.10.2005
18.10.2010
16.12.2005
16.12.2010
16.12.2005
16.12.2010
10.08.2005
10.08.2010
16.12.2005
16.12.2010
10.08.2005
10.08.2010
18.10.2005
18.10.2010
25.06.2004
25.06.2009
25.06.2004
25.06.2009
11.11.2005
11.11.2010
11.11.2005
11.11.2010
18.10.2005
18.10.2010
18.10.2005
18.10.2010
02.02.2006
02.02.2011
16.12.2005
16.12.2010
²¸
¸
¸
¸
¸
¸
¸
¸
¸
²¸
¸\Ð
¸\Ð
¸
¸
¸
¸
¸
¸
16.12.2005
16.12.2010
11.11.2005
11.11.2010
¸
18.10.2005
18.10.2010
18.10.2005
18.10.2010
19.06.2003
19.06.2008
19.06.2003
19.06.2008
¸
¸
¸
¸
¸
19
262
²åñáí»É
Aprovel
263
²åñáí»É
Aprovel
264 ²ëóÉÇÝ ßÝã³éÙ³Ý
Asthalin inhaler
Çñµ»ë³ñï³Ý
irbesartan
Çñµ»ë³ñï³Ý
irbesartan
ë³Éµáõï³ÙáÉ
salbutamol
¹»Õ³Ñ³ï»ñ
265
²ëÃÙ»ñáÉ
Asthmerol
ë³ÉÙ»ï»ñáÉ
salmeterol
óáÕ³óÇñ
266
²ëdz-ÙÇ·ñ»ÛÝ
Asia Migrain
²ëÏáñµÇݳÃÃáõ
Ascorbic acid
¿ñ·áï³ÙÇÝ, Ïáý»ÇÝ
ergotamine, caffeine
³ëÏáñµÇݳÃÃáõ
ascorbic acid
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
²ëÏáñµÇݳÃÃáõ
Ascorbic acid
³ëÏáñµÇݳÃÃáõ
ascorbic acid
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
267
268
269
²ëÏáñµÇݳÃÃáõ
³ëÏáñµÇݳÃÃáõ,
·ÉÛáõÏá½áí
¹»ùëïñá½
Ascorbic acid with ascorbic acid, dextrose
glucose
270
²ëÏáñµÇݳÃÃáõ
³ëÏáñµÇݳÃÃáõ,
·ÉÛáõÏá½áí
·ÉÛáõÏá½
Ascorbinic acid with ascorbic acid, glucose
glucose
271 ²ëÏáñµÇݳÃÃíÇ 0,1·
³ëÏáñµÇݳÃÃáõ,
¨ ýáɳÃÃíÇ 0,0008·
ýáɳÃÃáõ
¹»Õ³Ñ³ï»ñ
ascorbic acid, folic acid
Ascorbic acid 0,1g
and folic acid
0,0008g tablets
272
²ëÏáñáõïÇÝ
³ëÏáñµÇݳÃÃáõ,
Ascorutin
éáõïá½Ç¹
ascorbic acid, rutoside
273
²ëÏáý»Ý - ²ðöÆ
å³ñ³ó»ï³ÙáÉ,
Ascophen - ARPI ³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
Ïáý»ÇÝ
paracetamol,
acetylsalicylic acid,
caffein
274
²ëÏáý»Ý ä
å³ñ³ó»ï³ÙáÉ,
Ascophen P
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
Ïáý»ÇÝ
paracetamol,
acetylsalicylic acid,
caffeine
275
²ëÏáý»Ý-¸³ñÝÇó³ ³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
Askophen-Darnitsa å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
acetylsalicylic acid,
¹»Õ³Ñ³ï»ñ
óáÕ³óÇñ
ßÝã³éÙ³Ý
¹»Õ³Ñ³ï»ñ
150Ù·
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
(14,28,56,98)
Sanofi Winthrop Industrie
300Ù·
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
(14,28,56,98)
Sanofi Winthrop Industrie
100ÙÏ·/¹»Õ³ã³÷,
êÇåɳ Èï¹.
200 ¹»Õ³ã³÷
Cipla Ltd.
ßÝã³éÙ³Ý ë³ñùáõÙ
25ÙÏ·/¹»Õ³ã³÷,
γëå³ñ Þ³µ³ÝÇ É³µë.
(120 ¹»Õ³ã³÷
Kaspar Chabani Labs
ßÝã³éÙ³Ý
ë³ñùáõÙ)
1Ù·+100Ù·
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
(20)
Pharmaceutical
5%(1ÙÉ),
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
1ÙÉ ³ÙåáõÉÝ»ñ
üÇñÙ³ ´´À
(10)
Yerevan ChemicalPharmaceutical Firm Open J/S
Company
5%(2ÙÉ),
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
2ÙÉ ³ÙåáõÉÝ»ñ
üÇñÙ³ ´´À
(10)
Yerevan ChemicalPharmaceutical Firm Open J/S
Company
(0,1·+0,877·)
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
(10, 40)
Pharmstandard-UfaVITA Open
JSC
üñ³Ýëdz
-
4493
22.04.2004
22.04.2009
29.09.2003
29.09.2008
23.04.2003
23.04.2008
¸
üñ³Ýëdz
-
4494
Ðݹϳëï³Ý
R03A C02
4274
êÇñdz
R03A C12
5261
19.02.2005
19.02.2010
¸
êÇñdz
N02C A72
4986
¸
г۳ëï³Ý
A11G A01
5254
17.09.2004
17.09.2009
25.07.2005
25.07.2010
г۳ëï³Ý
A11G A01
5255
25.07.2005
25.07.2010
¸
èáõë³ëï³Ý
A11G B
1318/7289
30.10.2007
12.10.2012
²¸
¸
¸
¸
¹»Õ³Ñ³ï»ñ
0.1·
(6,10)
´áñÇëáíÛ³Ý ´ä¶
Borisovski Pharmaceutical
Work
´»É³éáõë
A11G
4588
08.01.2004
08.01.2009
²¸
¹»Õ³Ñ³ï»ñ
(0,1· +0,0008·)
(50)
²ÉóÛíÇï³ÙÇÝÇ ö´À
Altajvitaminy Closed JSC
èáõë³ëï³Ý
B03BB51
1127/7090
12.11.2007
08.08.2012
²¸
¹»Õ³Ñ³ï»ñ
ëñí³Ï (50),
µÉÇëï»ñ
(10 ¨ 50/5x10/)
200Ù·+200Ù·+
40Ù·
(10,20,100,200)
î»ËÝáÉá· ´´À
Technolog Open JSC
àõÏñ³Çݳ
C05CA51
0986/6962
30.05.2007
30.05.2012
²¸
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
г۳ëï³Ý
N02B E71
4981
12.07.2004
12.07.2009
²¸
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
(0,2·+0,2·+0,04·)
(10)
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
èáõë³ëï³Ý
N02B A71
1317/7288
30.10.2007
12.10.2012
²¸
¹»Õ³Ñ³ï»ñ
(0,2·+0,2·+0,04·)
(6,10)
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
àõÏñ³Çݳ
N02B A51
0664/6139
12.01.2007
12.01.2012
²¸
20
276
277
278
279
280
281
282
283
paracetamol, caffeine
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
¹»Õ³Ñ³ï»ñ
(200Ù·+20Ù·+40Ù·
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
) (10)
acetylsalicylic acid,
paracetamol, caffeine
²ëå³ñϳÙ
ϳÉÇáõÙÇ ¨
¹»Õ³Ñ³ï»ñ
(350/35x10/)
Asparcam
Ù³·Ý»½ÇáõÙÇ
³ëå³ñ³·ÇݳïÝ»ñ
potassium and
magnesium aspartate
²ëå³ñϳÙ-¼¹áñáíÛ» Ù³·Ý»½ÇáõÙÇ ³ëå³ñï³ï,
¹»Õ³Ñ³ï»ñ
(0,175·+0.175·)
Asparkam-Zdorovye
ϳÉÇáõÙÇ ³ëå³ñï³ï
(50, 50/5x10/-³Ï³Ý)
magnesium aspartate,
potassium aspartate
²ëåÇñÇÝ
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ
¹»Õ³Ñ³ï»ñ
500Ù·
Aspirin
acetylsalicylic acid
(10,100)
²ëåÇñÇÝ Ï³ñ¹Çá
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ
¹»Õ³Ñ³ï»ñ
300Ù·
Aspirin cardio
acetylsalicylic acid
³Õ»ÉáõÛÍ
(20)
²ëåÇñÇÝ Ï³ñ¹Çá
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ
¹»Õ³Ñ³ï»ñ
100Ù·
Aspirin cardio
acetylsalicylic acid
³Õ»ÉáõÛÍ
(20)
²ëåÇñÇÝ-ò
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
¹»Õ³Ñ³ï»ñ
(400Ù·+240Ù·)
Aspirin-C
³ëÏáñµÇݳÃÃáõ
¹Ûáõñ³ÉáõÛÍ
(10)
acetylsalicylic acid,
ascorbic acid
²ëíÇïáÉ
³ëÏáñµÇݳÃÃáõ
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
200Ù·
Asvitol
ascorbic acid
(20)
²ëÏáý»Ý-ä
Ascophen-P
284
²ëïÙáå»Ýï
Astmopent
ûñóÇåñ»Ý³ÉÇÝ
orciprenaline
óáÕ³óÇñ
ßÝã³éÙ³Ý
285
²í³Ý¹³Ù»ï
Avandamet
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
286
²í³ëïÇÝ
Avastin
éáëÇ·ÉÇï³½áÝ,
Ù»ïýáñÙÇÝ
rosiglitazone,
metformine
µ¨³ëǽáõÙ³µ
bevacizumab
287
²í»Éáùë
Avelox
²í»Éûùë
Avelox
²í»ùëáÝ-²í»ñëÇ
Avexon-Aversi
ÙáùëÇýÉûùë³óÇÝ
moxifloxacin
ÙáùëÇýÉûùë³óÇÝ
moxifloxacin
ó»ýïñdzùëáÝ
ceftriaxone
290
²ï³Ïáõñ
Atacure
291
²ï³ÙÇ Ï³ÃÇÉÝ»ñ
Tooth-drops
³ïñ³ÏáõñÇáõÙÇ
µ»½Çɳï
atracurium besilate
åÕå»Õ³ÛÇÝ ³Ý³ÝáõËÇ
ÛáõÕ, ù³÷áõñ, ϳïí³ËáïÇ
á·»ÃáõñÙ
oleum menthe piperite,
camphora, tinctura
valeriane
288
289
750ÙÏ·/¹»Õ³ã³÷
(20ÙÉ/400¹»Õ³ã³÷/ ßÝã³éÙ³Ý
ë³ñùáõÙ)
2Ù·+500Ù·
(14,28,56)
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
100Ù·/4ÙÉ,
ëñí³Ï (1)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
400Ù·
(5,10/2x5/)
400Ù·/250ÙÉ,
250ÙÉ ëñí³Ï
1· ëñí³Ï (1)
ÉáõÍáõÛÃ
50Ù·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
10ÙÉ ßßÇÏ
CJSC
øÇÙý³ñÙ ´À
Chimpharm JSC
Ô³½³Ëëï³Ý
N02B A71
0834/6619
22.03.2007
22.03.2012
²¸
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
èáõë³ëï³Ý
A12CX
0468\6488
11.10.2006
11.10.2011
¸
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
´³Û»ñ ²¶
Bayer AG
´³Û»ñ ²¶
Bayer AG
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
àõÏñ³Çݳ
A12C C05
1417/7044
25.12.2007
25.12.2012
¸
¶»ñÙ³Ýdz
N02B A01
6006
²¸
¶»ñÙ³Ýdz
N02B A01
1086/7092
¶»ñÙ³Ýdz
N02B A01
1085/7091
¶»ñÙ³Ýdz
N02B A51
6005
09.03.2006
09.03.2011
13.08.2007
13.08.2012
13.08.2007
13.08.2012
09.03.2006
09.03.2011
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
¶É³ùëáàõ»ÉùáÙ ê.².
GlaxoWellcome S.A.
èáõë³ëï³Ý
A11G A01
0411/6353
19.09.2006
19.09.2011
²¸
Ȼѳëï³Ý
R03A B03
R03C B03
5036
17.08.2004
17.08.2009
¸
Æëå³Ýdz
A10B A02,
A10B D02,
A10B G02
5984
02.02.2006
02.02.2011
¸
¶»Ý»Ýï»ù ÆÝÏ. (ü.ÐáýÙ³Ý-ȳ
èáß Èï¹-Ç Ñ³Ù³ñ) Genentch
Inc.(for F.Hoffmann-La Roche
Ltd.)
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
²í»ñëÇ è³ÃÇáÝ³É êäÀ
Aversi Rational Ltd
²ØÜ
L01X C07
5732
06.09.2005
06.09.2010
¸
¶»ñÙ³Ýdz
J01M A14
0531/6518
¸
¶»ñÙ³Ýdz
J01M A14
5204
ìñ³ëï³Ý
J01D D04
1496/7370
10.11.2006
10.11.2011
06.12.2005
27.01.2010
21.12.2007
20.12.2012
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
-
0113/5390
15.06.2006
15.06.2011
¸
¾ëÏáõɳå êäÀ
Esculap Ltd.
г۳ëï³Ý
-
4352
01.08.2003
01.08.2008
²¸
¸
¸
²¸
¸
¸
21
292
²ï³ñ³ùë
Atarax
²ï»ÝáÉáÉ
Atenolol
²ï»ÝáÉáÉ
Atenolol
²ï»ÝáÉáÉ
Atenolol
ÑǹñûùëǽÇÝ
hydroxyzine
³ï»ÝáÉáÉ
atenolol
³ï»ÝáÉáÉ
atenolol
³ï»ÝáÉáÉ
atenolol
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
25Ù·
(25)
25Ù·
(30)
50Ù·
(30)
0.05·
(10,20,30,50)
296
²ï»ÝáÉáÉ
Atenolol
³ï»ÝáÉáÉ
atenolol
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
100Ù·
(20/2x10/)
297
²ï»ÝáÉáÉ
Atenolol
³ï»ÝáÉáÉ
atenolol
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(20/2x10/)
298
²ï»ÝáÉáÉ
Atenolol
²ï»ÝáÉáÉ
Atenolol
²ï»ÝáÉáÉ
Atenolol
²ï»ÝáÉáÉ
Atenolol
³ï»ÝáÉáÉ
atenolol
³ï»ÝáÉáÉ
atenolol
³ï»ÝáÉáÉ
atenolol
³ï»ÝáÉáÉ
atenolol
¹»Õ³Ñ³ï»ñ
100Ù·
(14,1000x14)
100Ù·
(14, 28/2x14/)
50Ù·
(30/3x10/)
0.1·
(10,20,30,50)
²ï»ÝáÉáÉ
Atenolol
²ï»ÝáÉáÉ ¹»Õ³Ñ³ï»ñ
´ä 100Ù·
Atenolol Tablets BP
100mg
²ï»ÝáÉáÉ ¸»Õ³Ñ³ï»ñ
´ä 25Ù·
Atenolol Tablets BP
25mg
²ï»ÝáÉáÉ ¹»Õ³Ñ³ï»ñ
´ä 50Ù·
Atenolol Tablets BP
50mg
²ï»ñ»ùë³ 20
Aterexa 20
²ï»ñ»ùë³ 40
Aterexa 40
²ïáñ³½ 20
Atoraz 20
³ï»ÝáÉáÉ
atenolol
³ï»ÝáÉáÉ
atenolol
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
50Ù·
(30)
100Ù·
(28)
Úáõ-êÇ-´Ç ê.².ü³ñÙ³ ê»Ïïáñ
UCB S.A.Pharma Sector
êáý³ñÙ³ ²¸
Sopharma AD
êáý³ñÙ³ ²¸
Sopharma AD
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
꺸ÆÎà ü³ñÙ³ëÛáõÃÇù³É øá.
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²Ý·Édz)
SEDICO Pharmaceutical Co.
(for World Medicine, England)
꺸ÆÎà ü³ñÙ³ëÛáõÃÇù³É øá.
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²Ý·Édz)
SEDICO Pharmaceutical Co.
(for World Medicine, England)
ڲβ-80
JAKA-80
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupniza AD
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹
CP Pharmaceuticals Ltd.
³ï»ÝáÉáÉ
atenolol
¹»Õ³Ñ³ï»ñ
25Ù·
(28)
³ï»ÝáÉáÉ
atenolol
¹»Õ³Ñ³ï»ñ
ëÇÙí³ëï³ïÇÝ
simvastatin
ëÇÙí³ëï³ïÇÝ
simvastatin
³ïáñí³ëï³ïÇÝ
atorvastatin
²ïáñÇë
Atoris
²ïáñÇë
Atoris
²ïñáåÇÝÇ ëáõÉý³ï
³ïáñí³ëï³ïÇÝ
atorvastatin
³ïáñí³ëï³ïÇÝ
atorvastatin
³ïñáåÇÝÇ ëáõÉý³ï
293
294
295
299
300
301
302
303
304
305
306
307
308
309
310
311
07.04.2005
07.04.2010
05.06.2003
05.06.2008
20.05.2003
20.05.2008
13.12.2004
13.12.2009
¸
0674/6717
17.01.2007
17.01.2012
¸
C07A B03
0675/6716
17.01.2007
17.01.2012
¸
سϻ¹áÝdz
C07A B03
5671
¸
Êáñí³Ãdz
C07AB03
1325/7077
Êáñí³Ãdz
C07A B03
0763/6640
´»É³éáõë
C07A B03
4998
19.09.2005
19.09.2010
31.10.2007
31.10.2012
28.02.2007
28.02.2012
13.12.2004
13.12.2009
´áõÉÕ³ñdz
C07A B03
0617/6644
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
C07A B03
1308/7277
18.12.2006
18.12.2011
12.10.2007
12.10.2012
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹
CP Pharmaceuticals Ltd.
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
C07A B03
1309/7276
12.10.2007
12.10.2012
¸
50Ù·
(28)
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹
CP Pharmaceuticals Ltd.
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
C07A B03
1307/7278
12.10.2007
12.10.2012
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·
(30,60)
40Ù·
(30,60)
20Ù·
(30,10)
êÉáí³Ïdz
B04A B01
4235
¸
êÉáí³Ïdz
B04A B01
4236
êÇñdz
C01A A05
0968/6967/1
19.06.2003
19.06.2008
19.06.2003
19.06.2008
14.05.2007
20.04.2012
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
10Ù·
(10,30,90)
20Ù·
(10,30,90)
0.1%(1ÙÉ),
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
²É è³½Ç ü³ñÙ³ëÛáõÃÇù³É
ȳµë
Al Razi Pharmaceutical Labs
Îèβ ¹.¹.,Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹.,Üáíá Ù»ëïá
KRKA d.d. Novo mesto
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
êÉáí»Ýdz
C10A A05
6092
¸
êÉáí»Ýdz
C10A A05
6093
´»É³éáõë
A03B A01
0753/6784
12.04.2006
12.04.2011
12.04.2006
12.04.2011
15.02.2007
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
´»É·Ç³
N05B B01
5564
´áõÉÕ³ñdz
C07A B03
4309
´áõÉÕ³ñdz
C07A B03
4308
´»É³éáõë
C07A B03
4997
º·Çåïáë
C07A B03
º·Çåïáë
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
22
Atropine sulfate
atropine sulfate
Ý»ñ³ñÏÙ³Ý
312
²ïñáåÇÝÇ ëáõÉý³ï
Atropine sulfate
³ïñáåÇÝ
atropine
³ÏݳϳÃÇÉÝ»ñ
313
²ïñáåÇÝÇ ëáõÉý³ï
Atropine sulfate
³ïñáåÇÝÇ ëáõÉý³ï
atropine sulfate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0.1% (1Ù·/ÙÉ),
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
314
²îü-ÉáÝ·
ATPh-Long
¹»Õ³Ñ³ï»ñ
20Ù·
(40)
315
²îü-ÉáÝ·
ATP-LONG
¹»Õ³Ñ³ï»ñ
10Ù·
(40)
316
²ñ·ÇÝÇÝ-ÈÇÏíá
Arginine-Liqvo
³¹»Ýá½ÇÝ-5»éýáëý³ïáÑÇëïǹÇ-ݳï
Ù³·Ý»½ÇáõÙÇ (II)
»éϳÉÇáõÙ³Ï³Ý ³ÕÇ
ûÏï³Ñǹñ³ï ݳïñÇáõÙÇ
ùÉáñǹáí
adenosine-5triphosphatohistidinatomagnesium (II)
tripotassium
octahydrate with
sodium chloride
³¹»Ýá½ÇÝ-5»éýáëý³ïáÑÇëïǹÇ-ݳï
Ù³·Ý»½ÇáõÙÇ (II)
»éϳÉÇáõÙ³Ï³Ý ³ÕÇ
ûÏï³Ñǹñ³ï ݳïñÇáõÙÇ
ùÉáñǹáí
adenosine-5triphosphatohistidinatomagnesium (II)
tripotassium
octahydrate with
sodium chloride
³ñ·ÇÝÇÝ
arginine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
21.07%,
20ÙÉ ëñí³Ï
317
²ñ·áëáõÉý³Ý
Argosulfan
³ñͳÃÇ ëáõÉý³Ãdz½áÉ
silver sulfathiazole
Ýñµ³ùëáõù
318
²ñ¹áõ³Ý
Arduan
åÇå»ÏáõñáÝÇáõÙÇ
µñáÙǹ
pipecuronium bromide
319
²ñÇïÙÇÉ
Aritmil
³ÙÇá¹³ñáÝ
amiodaron
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý,
ÉáõÍãáí
¹»Õ³Ñ³ï»ñ
320
²ñÇýáÝ-é»ï³ñ¹
Arifon-retard
Çݹ³å³Ùǹ
indapamide
321
²ñÙ»ÝÇÏáõÙ
Armenicum
Ûá¹, ϳÉÇáõÙÇ Ûá¹Ç¹,
ÉÇÃÇáõÙÇ ùÉáñǹ
iodine, potassium
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃ
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
1%,
5ÙÉ ëñí³ÏÝ»ñ (5)
Belmedpreparaty RUP
ØáëÏí³ÛÇ ¾Ý¹áÏñÇݳÛÇÝ
·áñͳñ³Ý
Moscowsky endocrinny zavod
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
êäÀ-Ç Ù³ëݳ×ÛáõÕ ù. ʳñÏáí
Branch of LCC §'Experimental
plant GNCLS¦' c. Kharkov
´áñßã³·áíÛ³Ý ø¸¶
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
èáõë³ëï³Ý
S01F A01
2517
03.09.2003
03.09.2008
¸
àõÏñ³Çݳ
A03B A01
0008/6138
02.05.2006
02.05.2011
¸
àõÏñ³Çݳ
C01E B10
0544/6553
17.11.2006
17.11.2011
¸
´áñßã³·áíÛ³Ý ø¸¶
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
àõÏñ³Çݳ
C01E B10
0545/6554
17.11.2006
17.11.2011
¸
г۳ëï³Ý
A05B A01
B05X B01
4900
10.06.2004
10.06.2009
¸
Ȼѳëï³Ý
D06B A02
6077
24.03.2006
24.03.2011
²¸
ÐáõÝ·³ñdz
M03A C06
5419
01.06.2005
01.06.2010
¸
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
ê»ñíÇ» ɳµáñ³ïáñdz
Les
Laboratoires Servier
àõÏñ³Çݳ
-
0506/5907
07.11.2006
07.11.2011
¸
üñ³Ýëdz
C03B A11
4595
26.11.2003
26.11.2008
¸
§²ñÙ»ÝÇÏáõÙ+¦ ö´À
§Armenicum+¦ CJSC
г۳ëï³Ý
D08A
5144
09.09.2004
09.09.2009
¸
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
2%,
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
15·,40· å³ñÏáõ×,
Jelfa S.A.Pharmaceutical
400· ï³ñ³
Works
4Ù·,
¶»¹»áÝ èÇËï»ñ Èï¹.
ëñí³Ï/³ÙåáõÉ (25)
Gedeon Richter Ltd.
200Ù·
(20)
1.5Ù·
(30)
(8·+12·+0.2·)/
1000ÙÉ,
20ÙÉ ëñí³Ï (1)
15.02.2012
23
322
²ñáÙ³½ÇÝ
Aromasin
323
²ñáõïÇÙáÉ
Arutimol
²ñáõïÇÙáÉ
Arutimol
²ñë»ÝÇÏ ÏáÙå (Çáí
¹Ç³µ»ï)
Arsenic comp (Iov
diabet)
²ñï»Ùǹ³
Artemida
324
325
326
327 ²ñïÇýñÇÝ-¼¹áñáíÛ»
Artiphrin-Zdorovye
328 ²ñïÇýñÇÝ-¼¹áñáíÛ»
Artiphrin-Zdorovye
329 ²ñïÇýñÇÝ-¼¹áñáíÛ»
ýáñï»
Artiphrin-Zdorovye
forte
330
²ñïáõÙ
Artum
331
²ñïñáýÉ»ùë
Artroflex
332
²ó»íáñ
Acevor
²ó»ïÇÉë³ÉÇóÇɳÃÃáõ
Acetylsalicylic acid
²ó»ïÇÉë³ÉÇóÇɳ-
333
334
iodide, lithium chloride
¿ùë»Ù»ëï³Ý
exemestane
å³ïñ³ëï»Éáõ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
-
³ÏݳϳÃÇÉÝ»ñ
Æï³Édz
L02B G06
1433/7376
20.12.2007
20.12.2012
¸
¶»ñÙ³Ýdz
S01ED01
1387/7350
¸
¶»ñÙ³Ýdz
S01ED01
1388/7351
èáõë³ëï³Ý
ÑáÙ»áå³Ã³ÛÇÝ
0964/6986
05.11.2007
05.11.2012
05.11.2007
05.11.2012
14.05.2007
14.05.2012
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
(40Ù·+0.006Ù·)/1Ù
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
É, 1.7ÙÉ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
÷³Ù÷áõßïÝ»ñ (50)
Zdorovye Pharmaceutical
Company LLC
Æéɳݹdz
βêÐ
5818
26.10.2005
26.10.2010
²¸
àõÏñ³Çݳ
N01B B58
1106/7094
08.08.2007
08.08.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
(40Ù·+0,006Ù·)/1Ù
É, 1,7ÙÉ
³ÙåáõÉÝ»ñ (10)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
àõÏñ³Çݳ
N01B B58
1132/7095
02.10.2007
08.08.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
(40Ù·+0.01Ù·)/1ÙÉ
, 1.7ÙÉ
÷³Ù÷áõßïÝ»ñ (50)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
àõÏñ³Çݳ
N01B B58
1105/7093
08.08.2007
08.08.2012
¸
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
ê.ò.»ñ³ådz ê.². S.C.Terapia
S.A.
Æéɳݹdz
βêÐ
5817
26.10.2005
26.10.2010
²¸
èáõÙÇÝdz
M01A
βêÐ3
4601
26.04.2004
26.04.2009
²¸
Ðáõݳëï³Ý
J01F A 06
0172/5296
¸
èáõë³ëï³Ý
N02BA01
0576/4948/1
13.07.2006
13.07.2011
24.11.2006
23.07.2009
г۳ëï³Ý
A01A D05
5108
³ÏݳϳÃÇÉÝ»ñ
ϳÃÇÉÝ»ñ
ÑáÙ»áå³Ã³ÛÇÝ
25Ù·
(30)
0,5%,
5ÙÉ ßßÇÏ
0,25%,
5ÙÉ ßßÇÏ
25ÙÉ ßßÇÏ
-
å³ïÇ×Ý»ñ
³ñïÇϳÛÇÝÇ
ÑǹñáùÉáñǹ,
¿åÇÝ»ýñÇÝÇ
ÑǹñáùÉáñǹ
articaine hydrochloride,
epinephrine
hydrochloride
³ñïÇϳÛÇÝÇ
ÑǹñáùÉáñǹ,
¿åÇÝ»ýñÇÝÇ
ÑǹñáùÉáñǹ
articaine hydrochloride,
epinephrine
hydrochloride
³ñïÇϳÛÇÝÇ
ÑǹñáùÉáñǹ,
¿åÇÝ»ýñÇÝÇ
ÑǹñáùÉáñǹ
articaine hydrochloride,
epinephrine
hydrochloride
-
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
å³ïÇ×Ý»ñ
350Ù·
(60)
·ÉÛáõÏá½³ÙÇÝÇ
ÑǹñáùÉáñǹ,
ùáݹñáÇïÇÝ ëáõÉý³ï
ݳïñÇáõÙÇ
glucosamine
hydrochloride, sodium
chondroitin sulfate
éûùëÇÃñáÙÇóÇÝ
roxithromycin
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ
acetylsalicylic acid
ѳµ»ñ
375Ù·+265Ù·
(30)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
150Ù·
(10)
0.5·
(10)
¹»Õ³Ñ³ï»ñ
500Ù·
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ
ü³ñÙ³ódz Æï³Édz ê.å.².
(öý³Û½»ñ ¶ñáõå)
Pharmacia Italia S.p.A. (Pfizer
Group)
ÞáíÇÝ ³ÝÏ»ñý³ñÙ ¶ÙµÐ
Chauvin ankerpharm GmbH
ÞáíÇÝ ³ÝÏ»ñý³ñÙ ¶ÙµÐ
Chauvin ankerpharm GmbH
³ÉÇáÝ-²
Talion-A
400Ù·
(60)
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
²ðöÆغ¸ ÐÒ ö´À ARPIMED
27.09.2004
¸
²¸
²¸
²¸
24
ÃÃáõ
Acetylsalicylic acid
²ó»ïÇÉóÇëï»ÇÝлÙáý³ñÙ
AcetylcysteinHemofarm
²óǹáõÙ ò
Acidum C
²óÇÏ
Acic
acetylsalicylic acid
²óÇÏÉáíÇñ
Aciclovir
²óÇÏÉáíÇñ
Aciclovir
²óÇÏÉáíÇñ
Aciclovir
²óÇÏÉáíÇñ
Aciclovir
²óÇÏÉáíÇñ-²ÏñÇ
Aciclovir-Akri
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
acyclovir
³óÇÏÉáíÇñ
aciclovir
¹»Õ³Ñ³ï»ñ
²óÇÏÉáíÇñ-²ÏñÇ
Aciclovir-Akri
²óÇÏÉáíÇñ-²ÏñÇ
Aciclovir-Akri
²òò 100
ACC 100
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
aciclovir
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
0.2·
(20)
0.4·
(20)
100Ù·
(20,50,100)
346
²òò 100
ACC 100
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³÷áßÇ ËÙ»Éáõ
ÉáõÍáõÛÃÇ
100Ù·,
÷³Ã»ÃÝ»ñ (20)
347
²òò 200
ACC 200
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
200Ù·
(20,50,100)
348
²òò 200
ACC 200
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³÷áßÇ ËÙ»Éáõ
ÉáõÍáõÛÃÇ
200Ù·,
÷³Ã»ÃÝ»ñ (20)
349
²òò 200 ï³ù
ÁÝå»ÉÇù
ACC 200 hot drink
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³÷áßÇ ËÙ»Éáõ
ï³ù ÉáõÍáõÛÃÇ
ѳٳñ
200Ù·,
÷³Ã»ÃÝ»ñ (20)
350
²òò 600 ï³ù
ÁÙå»ÉÇù
ACC 600 hot drink
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³÷áßÇ
ËÙ»Éáõ, ï³ù
ÉáõÍáõÛÃÇ Ñ³Ù³ñ
600Ù·,
÷³Ã»ÃÝ»ñ (6)
351
²òò ÉáÝ·
ACC long
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
600Ù·
(10, 20, 50,100)
335
336
337
338
339
340
341
342
343
344
345
(10,20,100)
J.V. CJ-S Co.
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
600Ù·
(10)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
-
ϳÃÇÉÝ»ñ
ÑáÙ»áå³Ã³ÛÇÝ
Ýñµ³ùëáõù
25ÙÉ ßßÇÏ
³ÉÇáÝ-²
Talion-A
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ú½áÝ êäÀ
Ozon Ltd.
³ÃùÇÙý³ñÙåñ»å³ñ³ïÇ ´´À
Tatchimpharmpreparaty OJSC
³ÃùÇÙý³ñÙåñ»å³ñ³ïÇ ´´À
Tatchimpharmpreparaty OJSC
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
²ÏñÇËÇÝ ´´À
Akrikhin
Open JSC
èáõë³ëï³Ý
³óÇÏÉáíÇñ
aciclovir
¹»Õ³Ñ³ï»ñ
ùëáõù
ùëáõù
ùëáõù
¹»Õ³Ñ³ï»ñ
5%,
2·, 5· å³ñÏáõ×
200Ù·
(20/2x10/)
0.2·
(20)
5%,
10· å³ñÏáõ×
5%,
5· å³ñÏáõ×
5%,
2·, 3·, 5· å³ñÏáõ×
²ÏñÇËÇÝ ´´À
Akrikhin
Open JSC
²ÏñÇËÇÝ ´´À
Akrikhin
Open JSC
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
B01A C06
N02B A01
R05C B01
27.09.2009
0927/4457
26,04.2007
26.04.2012
²¸
ÑáÙ»áå³Ã³ÛÇÝ
D06B B03
S01A D03
0963/6985
14.05.2007
14.05.2012
18.03.2005
18.03.2010
²¸
èáõë³ëï³Ý
J05A B01
5789
¸
èáõë³ëï³Ý
5829
èáõë³ëï³Ý
D06B B03
J05A B01
D06BB03
1407/7071
èáõë³ëï³Ý
D06B B03
0150/6260
èáõë³ëï³Ý
J05A B01
D06B B03
S01A D03
J05A B01
D06B B03
J05A B01
D06B B03
R05C B01
S01X A08
4913
08.12.2005
08.12.2010
17.03.2006
17.03.2011
03.12.2007
03.12.2012
07.07.2006
07.07.2011
12.08.2004
12.08.2009
¶»ñÙ³Ýdz
R05C B01
V03A B23
5373
25.03.2005
25.03.2010
²¸
¶»ñÙ³Ýdz
R05C B01
S01X A08
5131
15.10.2004
15.10.2009
²¸
¶»ñÙ³Ýdz
R05C B01
5580
13.05.2005
13.05.2010
²¸
¶»ñÙ³Ýdz
R05C B01
5372
25.01.2005
25.01.2010
²¸
¶»ñÙ³Ýdz
R05C B01
5579
30.05.2005
30.05.2010
²¸
¶»ñÙ³Ýdz
R05C B01
5374
25.01.2005
25.01.2010
²¸
¶»ñÙ³Ýdz
èáõë³ëï³Ý
èáõë³ëï³Ý
¶»ñÙ³Ýdz
5369
4914
4915
5130
12.08.2004
12.08.2009
12.08.2004
12.08.2009
15.10.2004
15.10.2009
²¸
¸
²¸
²¸
²¸
¸
¸
²¸
25
352
²òò ÛáõÝÇáñ
ACC Junior
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
353
²ùë»ïÇÝ
Axetine
²ùë»ïÇÝ
Axetine
²ùí³ Ù³ñÇë
Aqua Maris
ó»ýáõñûùëÇÙ
cefuroxime
ó»ýáõñûùëÇÙ
cefuroxime
²¹ñdzïÇÏ ÍáíÇ çáõñ
Adriatic Sea water
²ùí³ Ù³ñÇë
Aqua Maris
²¹ñdzïÇÏ ÍáíÇ çáõñ
Adriatic Sea water
354
355
356
357
²ùí³¹»ïñÇÙ
ËáɻϳÉóÇý»ñáÉ
(D3 íÇï³ÙÇÝ)
cholecalciferol
Aquadetrim
(Vitamin D3)
358
²ýÉáõµÇÝ
Aflubin
359
²ýÉáõµÇÝ
Aflubin
360 BCG å³ïí³ëï³ÝÛáõà mycobacterium bovis-Ç
(ãáñ³óñ³Í)
Ãáõɳóí³Í ßï³Ù
BCG vaccine (dried) attenuated strain of
mycobacterium bovis
361
362
363
364
´³É³ë³Ý³ÛÇÝ
Ñ»Õáõϳùëáõù Áëï
ìÇßݨëÏáõ
Liniment balsamic
by Vishnevsky
´³É³ë³Ý³ÛÇÝ
Ñ»Õáõϳùëáõù Áëï
ìÇßݨëÏáõ
Liniment
balzamicum
Vischnevsky
´³Ïï³Ù»¹
Bactamed
´³Ïï³Ù»¹
Bactamed
Hexal AG)
20Ù·/ÙÉ,
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹-Ç
30· ·ñ³ÝáõÉÝ»ñ
ѳٳñ)
75ÙÉ ÉáõÍáõÛÃÇ Salutas Pharma GmbH (for Lek
ѳٳñ
d.d.)
¹»Õ³÷áßÇ
1500Ù·,
Ø»¹áù»ÙÇ Èï¹
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (10, 50,100)
Medochemie Ltd.
¹»Õ³÷áßÇ
750Ù·,
Ø»¹áù»ÙÇ Èï¹
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (10, 50,100)
Medochemie Ltd.
óáÕ³ßÇà ùÃÇ
30%,
Ú³¹ñ³Ý ¶³É»ÝëÏÇ É³µáñ³ïáñdz
30ÙÉ ßßÇÏ
¹.¹.
Jadran Galenski Laboratorij
d.d.
ùóϳÃÇÉÝ»ñ
30%,
Ú³¹ñ³Ý ¶³É»ÝëÏÇ É³µáñ³ïáñdz
10ÙÉ ßßÇÏ
¹.¹.
Jadran Galenski Laboratorij
d.d.
ÉáõÍáõÛÃ çñ³ÛÇÝ
15000ØØ/ÙÉ,
Ø»¹³Ý³ ü³ñÙ³ î»ñåáÉ ¶ñáõå
10ÙÉ ßßÇÏ
MEDANA PHARMA TERPOL
GROUP
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
ÉáõÍáõÛÃÇ
ϳÃÇÉÝ»ñ
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
ÉáõÍáõÛÃ
ÉÇáýÇÉǽ³ï
å³ïñ³ëï»Éáõ
20ÙÉ,
50ÙÉ,100ÙÉ ßßÇÏ
(12, 48)
0.05Ù·/0.1ÙÉ
[0,5Ù· (10¹»Õ³ã³÷)
ϳ٠1Ù· (20¹»Õ³ã³÷)
ÉÇáýÇÉǽ³ï 1ÙÉ
ϳ٠2ÙÉ ÉáõÍãáí
(0,9% ݳïñÇáõÙÇ
ùÉáñǹ)
³ÙåáõÉÝ»ñ] (5)
(3·+3·)/100·,
40· å³ñÏáõ× Ï³Ù
40·,
100· ³å³Ï» ï³ñ³
¶»ñÙ³Ýdz
R05C B01
1254/7273
22.10.2007
12.10.2012
²¸
ÎÇåñáë
J01D A06
1069/5718
¸
ÎÇåñáë
J01D A06
1070/5717
Êáñí³Ãdz
-
0428/6134
16.07.2007
16.07.2012
16.07.2007
16.07.2012
26.09.2006
26.09.2011
Êáñí³Ãdz
-
0429/6133
26.09.2006
26.09.2011
²¸
Ȼѳëï³Ý
A11C
4195
13.03.2003
13.03.2008
¸
²íëïñdz
5540
1412/5892/1
19.09.2005
19.09.2010
03.12.2007
17.02.2011
30.12.2004
30.12.2009
²¸
èáõë³ëï³Ý
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
-
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´»É³éáõë
-
5006
13.12.2004
13.12.2009
²¸
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Richard Bittner AG
èÇ˳ñ¹ ´ÇÃÝ»ñ ¶ÙµÐ
Richard Bittner AG
¶³Ù³É»Ç ³Ýí. ¾Ø¶ÐÆ äÒ
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
§Medgamal¦ branch of SI
SRIEM after Gamalei
²íëïñdz
5343
¸
²¸
²¸
¸
ÓÛáõÃ, ùë»ñáýáñÙ
tar, xeroform
Ñ»Õáõϳùëáõù
ÓÛáõÃ, ùë»ñáýáñÙ,
³¿ñáëÇÉ, ·»ñã³ÏÇ Ï³Ù
ÓÏ³Ý ÛáõÕ
tar, xeroform, areosil,
oleum Ricini or iecoris
ùëáõù
(30Ù·+30Ù·+
50Ù·+890Ù·)/1·,
30,35,40· å³ñÏáõ×
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
èáõë³ëï³Ý
-
4175
25.07.2003
25.07.2008
²¸
³ÙåÇóÇÉÇÝ,
ëáõɵ³Ïï³Ù
ampicilin, sulbactam
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý,
1.8ÙÉ ÉáõÍãáí
(0.5%
ÉǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ)
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý,
3.5ÙÉ ÉáõÍãáí
(0.5%
ÉǹáϳÛÇÝÇ
0.75· (0.5·+0.25·)
ëñí³Ï/³ÙåáõÉ (1)
ȸä ȳµáñ³ïáñdz ÂáñÉ³Ý ê.².
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²ØÜ)
LDP Laboratorios Torlan S.A.
(for World Medicine, USA)
Æëå³Ýdz
J01C R01
0732/6752
15.02.2007
15.02.2012
¸
1.5· (1·+0.5·)
ëñí³Ï/³ÙåáõÉ (1)
ȸä ȳµáñ³ïáñdz ÂáñÉ³Ý ê.².
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²ØÜ)
LDP Laboratorios Torlan S.A.
(for World Medicine, USA)
Æëå³Ýdz
J01C R01
0733/6753
15.02.2007
15.02.2012
¸
³ÙåÇóÇÉÇÝ,
ëáõɵ³Ïï³Ù
ampicilin, sulbactam
26
365
´³ÏïÇëáõµïÇÉ
Bactisubtil
366
´³ÏïñÇÙ èáß ûß³ñ³Ï
Bactrim Roche
syrup
367
´³ÏïñÇÙ ýáñï»
Bactrim forte
368
´³Ïïûùë
Bactox
ë»ñ»áõë IP 5832
Ù³Ýñ¿Ý»ñ
bacillus cereus IP 5832
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
³ÙûùëÇóÇÉÇÝ
amoxicillin
369
´³Ïïûùë
Bactox
³ÙûùëÇóÇÉÇÝ
amoxicillin
370
´³Ïïûùë
Bactox
³ÙûùëÇóÇÉÇÝ
amoxicillin
371
´³Ïïûùë
Bactox
³ÙûùëÇóÇÉÇÝ
amoxicillin
372
´³Ïïûùë
Bactox
³ÙûùëÇóÇÉÇÝ
amoxicillin
373
´³ñ³É·»ï³ë
Baralgetas
374
´³ñ³É·»ï³ë
Baralgetas
Ù»ï³ÙǽáÉÇ
ݳïñÇáõÙ³Ï³Ý ³Õ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole natrium,
pitofenone
hydrochloride,
fenpiverinum bromide
Ù»ï³ÙǽáÉÇ
ݳïñÇáõÙ³Ï³Ý ³Õ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole natrium,
pitofenone
hydrochloride,
fenpiverinum bromide
-
375
´³ñÓñ³Ï³ñ·
ϳÉóÇáõÙÇ
ѳٳÉÇñ
High Grade Calcium
Complex
376
´»-´á 20%
¿ÙáõÉëdz
Be-Bo 20%
emulsion
377
´»Ïɳï Ü
ÑǹñáùÉáñǹ)
¹»Õ³å³ïÇ×Ý»ñ
35Ù·
(20)
سñÇáÝ Ø»ñ»É ɳµáñ³ïáñdz
Laboratoire Marion Merrell
üñ³Ýëdz
-
4616
29.10.2003
29.10.2008
¸
ûß³ñ³Ï
(200Ù·+40Ù·)/5ÙÉ,
100ÙÉ ßßÇÏ
èáß
Roche
üñ³Ýëdz
J01E E01
4186
14.08.2003
14.08.2008
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
800Ù·+160Ù·
(10)
ÐáýÙ³Ý-ȳ èáß Èï¹.
Hoffmann-La Roche Ltd.
Þí»Ûó³ñdz
J01E E01
4185
18.03.2003
18.03.2008
¸
J01C A04
4635
05.02.2004
05.02.2009
¸
J01C A04
4631
15.01.2004
15.01.2009
¸
J01C A04
4633
15.01.2004
15.01.2009
¸
J01C A04
4634
05.02.2004
05.02.2009
¸
J01C A04
4632
15.01.2004
15.01.2009
¸
N02B B72
4559
18.12.2003
18.12.2008
²¸
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý,
ÉáõÍãáí
¹»Õ³å³ïÇ×Ý»ñ
1·,
ȳµáñ³ïáñdz ÆÝÝáï»ù
üñ³Ýëdz
ëñí³Ï ¨ 5ÙÉ ³ÙåáõÉ ÆÝï»ñݳëÇáÝ³É Laboratoires
(1)
Innotech International
500Ù·
ȳµáñ³ïáñdz ÆÝÝáï»ù
üñ³Ýëdz
(12)
ÆÝï»ñݳëÇáÝ³É Laboratoires
Innotech International
¹»Õ³÷áßÇ ËÙ»Éáõ
250Ù·/5ÙÉ,
ȳµáñ³ïáñdz ÆÝÝáï»ù
üñ³Ýëdz
¹»Õ³Ï³ËáõÛÃÇ
36· ¹»Õ³÷áßÇ
ÆÝï»ñݳëÇáÝ³É Laboratoires
ßßÇÏáõÙ
Innotech International
¹»Õ³÷áßÇ Ù/Ù
500Ù·,
ȳµáñ³ïáñdz ÆÝÝáï»ù
üñ³Ýëdz
Ý»ñ³ñÏÙ³Ý,
ëñí³Ï ¨ 5ÙÉ ³ÙåáõÉ ÆÝï»ñݳëÇáÝ³É Laboratoires
ÉáõÍãáí
(1)
Innotech International
¹»Õ³÷áßÇ ËÙ»Éáõ
125Ù·/5ÙÉ,
ȳµáñ³ïáñdz ÆÝÝáï»ù
üñ³Ýëdz
¹»Õ³Ï³ËáõÛÃÇ
36· ¹»Õ³÷áßÇ
ÆÝï»ñݳëÇáÝ³É Laboratoires
ßßÇÏáõÙ
Innotech International
¹»Õ³Ñ³ï»ñ
500Ù·+5Ù·+ 0.1Ù·
Úáõ·áñ»Ù»¹Ç³
гñ³íëɳ-ídz
(100)
Jugoremedija
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
(2500Ù·+10Ù·+
0.1Ù·)/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
Úáõ·áñ»Ù»¹Ç³
Jugoremedija
гñ³íëɳ-ídz
N02B B72
4560
18.12.2003
18.12.2008
¸
å³ïÇ×Ý»ñ
(25,90,180)
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
²ØÜ
βêÐ
5101
20.09.2004
20.09.2009
²¸
µ»Ý½Çɵ»Ý½á³ï
benzyl benzoate
¿ÙáõÉëdz
20%,
100ÙÉ ßßÇÏ
¾ëÏáõɳå êäÀ
Esculap Ltd
г۳ëï³Ý
P03AX01
1126/7096
02.11.2007
08.08.2012
²¸
µ»ÏÉáٻó½áÝ,
Ýñµ³ùëáõù
0.025%+0.5%,
êÇåɳ Èï¹
Ðݹϳëï³Ý
D07C C04
4064
13.03.2003
¸
27
Beclate N
378
´»Ïɳï ò
Beclate C
379
´»ÏÉáÅ»ï
Beclojet
380
´»ÏÉáýáñï»
ßÝã³éÙ³Ý CFC½áõñÏ
Becloforte CFC-free
inhaler
381 ´¨»ÏݳÛÇÝ ùëáõù
Turpentine ointment
Ý»áÙÇóÇÝÇ ëáõÉý³ï
beclomethasone,
neomycin sulfate
µ»ÏÉáٻó½áÝ,
ùÇÝáýáñÙ
beclomethasone,
chinoform
µ»ÏÉáٻó½áÝ
beclomethasone
µ»ÏÉáٻó½áÝ
beclomethasone
ÉáõÍáõÛÃ
ßÝã³éÙ³Ý
µ¨»ÏݳÛáõÕ
oleum terebinthinae
ùëáõù
382
´»Ïáݳ½
Beconaze
µ»ÏÉáٻó½áÝ
beclomethasone
383
´»Ý³Ïáñï
Benacort
µáõ¹»½áÝǹ
budesonide
384
´»Ý³ÙÇÉ-Ø
Benamil-M
385
´»Ý-·»Û ëåáñïë
µ³ÉÙ
Ben-Guy Sports
Balm
´»Ý-·»Û ó³í³½ñÏáÕ
Ù»ñëáõÙ
Ben-Guy Pain
Relieving Rub
´»Ý½ÇÉ µ»Ý½á³ï
Benzyl Benzoate
Ù»ï³ÙǽáÉ, Ïáý»ÇÝ,
ÃdzÙÇÝÇ
ÑǹñáùÉáñǹ
metamizole, caffeine,
thiamine hydrochloride
Ù»ÃÇÉ ë³ÉÇóÇɳï,
Ù»ÝÃáÉ
methyl salicylate,
menthol
Ù»ÃÇÉ ë³ÉÇóÇɳï,
Ù»ÝÃáÉ
methyl salicylate,
menthol
µ»Ý½ÇÉ µ»Ý½á³ï
benzyl benzoate
´»Ý½ÇÉ µ»Ý½á³ï
Benzyl benzoate
´»Ý½ÇÉ µ»Ý½á³ï
Benzyl benzoate
µ»Ý½ÇÉ µ»Ý½á³ï
benzyl benzoate
µ»Ý½ÇÉ µ»Ý½á³ï
benzyl benzoate
386
387
388
389
390 ´»Ý½ÇÉå»ÝÇóÇÉÇ µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
Ý Ý³ïñÇáõÙ
benzylpenicillin
Benzylpenicillin
sodium
391 ´»Ý½ÇÉå»ÝÇóÇÉÇ µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
Ý -ݳïñÇáõÙ
ݳïñÇáõÙÇ
1000000 ØØ
benzylpenicillin sodium
15· å³ñÏáõ×
Cipla Ltd
Ýñµ³ùëáõù
0.025%+3%,
15· å³ñÏáõ×
êÇåɳ Èï¹
Cipla Ltd
Ðݹϳëï³Ý
D07C
R01A
4065
13.03.2003
13.03.2008
¸
¹»Õ³Ï³ËáõÛÃ
ßÝã³éÙ³Ý
250ÙÏ·/¹»Õ³ã³÷
(200¹»Õ³ã³÷
ßÝã³éÙ³Ý
ë³ñùáõÙ)
250ÙÏ·/¹»Õ³ã³÷;
(200 ¹»Õ³ã³÷
ßÝã³éÙ³Ý
ë³ñùáõÙ)
ÞÇ»½Ç ê.².
Chiesi S.A.
üñ³Ýëdz
R01A D01
R03B A01
4320
28.07.2003
28.07.2008
¸
¶É³ùëá àõ»ÉùáÙ öñá¹³ùßÁÝ
Glaxo Wellcome Production
üñ³Ýëdz
R01A D01,
R03B A01
4818
01.04.2004
01.04.2009
¸
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
¶É³ùëáàõ»ÉùáÙ ê.².
GlaxoWellcome S.A.
´»É³éáõë
-
5019
13.12.2004
13.12.2009
²¸
Æëå³Ýdz
R01A D01,
R03B A01
4167
25.02.2003
25.02.2008
¸
äáõÉÙáÙ»¹ ö´À
Pulmomed CJSC
èáõë³ëï³Ý
-
5055
12.08.2005
12.08.2010
¸
ØÇÉí» ü³ñÙ³ëÛáõÃÇù³É
·áñͳñ³ÝÝ»ñ
Milve Pharmaceutical Plants
´áõÉÕ³ñdz
N02B B52
5723
11.11.2005
11.11.2010
²¸
20%,
15·, 25· å³ñÏáõ×
ϳ٠³å³Ï» ï³ñ³
óáÕ³ßÇà çñ³ÛÇÝ,
50ÙÏ·/¹»Õ³ã³÷,
ùÃÇ
100 ¨ 200 ¹»Õ³ã³÷
ßÝã³éÙ³Ý ë³ñùáõÙ
¹»Õ³÷áßÇ
200ÙÏ·/¹»Õ³ã³÷
ßÝã³éÙ³Ý
(200 ¹»Õ³ã³÷
óÇÏÉáѳɻñáõÙ)
¹»Õ³Ñ³ï»ñ
500Ù·+50Ù·+
38.75Ù·
(10,20,50x20)
13.03.2008
Ýñµ³ùëáõù
28%+10%,
(35· å³ñÏáõ×)
öý³Û½»ñ ÆɳÏɳñÇ Èï¹.
Pfizer Ilaclari Ltd.
Âáõñùdz
-
4797
23.04.2004
23.04.2009
²¸
Ýñµ³ùëáõù
15%+10%,
(35· å³ñÏáõ×)
öý³Û½»ñ ÆɳÏɳñÇ Èï¹.
Pfizer Ilaclari Ltd.
Âáõñùdz
-
4798
23.04.2004
23.04.2009
²¸
ùëáõù
20%,
30· å³ñÏáõ×
¾ëïáÝdz
P03A X01
0731/6754
15.02.2007
15.02.2012
²¸
ÉáÃÇáÝ
25%,
120ÙÉ ßßÇÏ
20%,
25·, 30·, 50·
å³ñÏáõ× Ï³Ù ³å³Ï»
ï³ñ³
1000000ØØ
ëñí³Ï (1, 50)
î³ÉÇÝÇ ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
´À
Tallinn Pharmaceutical Works
A.S.
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
г۳ëï³Ý
P03A X01
4199
²¸
èáõë³ëï³Ý
P03A X01
0615/6682
10.02.2003
10.02.2008
18.12.2006
18.12.2011
êÇÝû½ ´´À
Sintez Open JSC
èáõë³ëï³Ý
J01C E09
1110/7131
27.08.2007
27.08.2012
¸
²ÝïǵÇáïÇÏ ê.².
Antibiotice
S.A.
èáõÙÇÝdz
J01C E01
4356
16.07.2003
16.07.2008
¸
ùëáõù
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
1000000ØØ,
ëñí³Ï (1, 50)
²¸
28
392
393
394
395
396
397
398
Benzylpenicillin
sodium 1000000 IU
´»Ý½ÇÉå»ÝÇóÇÉÇ µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
¹»Õ³÷áßÇ
5000000ØØ,
²ÝïǵÇáïÇÏ ê.².
Antibiotice
Ý -ݳïñÇáõÙ
ݳïñÇáõÙÇ
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1, 50)
S.A.
5000000 ØØ
benzylpenicillin sodium
Benzylpenicillin
sodium 5000000 IU
´»Ý½ÇÉå»ÝÇóÇÉÇ µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
¹»Õ³÷áßÇ
1000000ØØ
ÎǨٻ¹åñ»å³ñ³ï ´´À
Ý-ÎØä
benzylpenicillin
Ý»ñ³ñÏÙ³Ý
(10,40)
Kievmedpreparat JSC
BenzylpenicillinÉáõÍáõÛÃÇ
KMP
´»Ý½áݳÉ
µ»Ý½áµ³ñµÇï³É
¹»Õ³Ñ³ï»ñ
100Ù·
²ðöÆغ¸ ÐÒ ö´À ARPIMED
Benzonal
benzobarbital
(20,24,48,100)
J.V. CJ-S Co.
´»Ý½áݳÉ
µ»Ý½áµ³ñµÇï³É
¹»Õ³Ñ³ï»ñ
0.1·
³ÃùÇÙý³ñÙåñ»å³ñ³ïÇ ´´À
Benzonal
benzobarbital
(50)
Tatchimpharmpreparaty OJSC
´»ï³·ÇÝ
åáíǹáÝ Ûá¹ÇÝ
ÉáõÍáõÛà ³ñï³ùÇÝ
10%,
´Çáý³ñÙ ê.².
Betagin
povidone iodine
ÏÇñ³éÙ³Ý
30ÙÉ, 50ÙÉ ßßÇÏ
Biofarm S.A.
´»ï³¹ÇÝ
åáíǹáÝ Ûá¹ÇÝ
ùëáõù
100Ù·/·,
¾·Çë ü³ñÙ³ëÛáõÃÇù³É Èï¹.
Betadine
povidone iodine
20· å³ñÏáõ×
Egis Pharmaceuticals Ltd.
´»ï³¹ÇÝ
Betadine
´»ï³¹ÇÝ
Betadine
´»ï³¹ÇÝ
Betadine
åáíǹáÝ Ûá¹ÇÝ
povidone iodine
åáíǹáÝ Ûá¹ÇÝ
povidone iodine
åáíǹáÝ Ûá¹ÇÝ
povidone iodine
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
ÉáõÍáõÛÃ
401
´»ï³¹ÇÝ
Betadine
åáíǹáÝ Ûá¹ÇÝ
povidone iodine
ÉáõÍáõÛÃ
402
´»ï³¹ÇÝáÏ
Betadinok
åáíǹáÝ Ûá¹
povidone iodine
ÉáõÍáõÛÃ
403
´»ï³É·áÝ
Betalgon
ùëáõù
404
´»ï³Ûá¹ÇÝ
Betaiodine
ÝÇÏáïÇݳÃÃíÇ BµáõÃûùëÇ¿ÃÇÉ »Ã»ñ,
å»É³ñ·áݳÃÃíÇ
í³ÝÇÉÇɳÙǹ
nicotinic acid Bbutoxyethyl ether,
pelargonic acid
vanillylamide
åáíǹáÝ Ûá¹ÇÝ
povidone iodine
405
´»ï³Ûá¹ÇÝ
Betaiodine
406
´»ï³ë³ÉÇÏ - ÎØä
399
400
200Ù·,
¾·Çë ü³ñÙ³ëÛáõÃÇù³É Èï¹.
(7,14)
Egis Pharmaceuticals Ltd.
200Ù·
²ÉϳÉáǹ ²¸-êÏáåÛ»
(14)
Alkaloid AD-Skopje
10%,
²ÉϳÉáǹ ²¸-êÏáåÛ»
100ÙÉ åɳëïÇÏ
Alkaloid AD-Skopje
ßßÇÏ
10%,
¾¶Æê ´´À
30ÙÉ, 120ÙÉ,
EGIS PLC
1000ÙÉ ßßÇÏ
100Ù·/ÙÉ,
ÜúÎÆ Ñ³Û³Ù»ñÇϳ·»ñٳݳϳÝ
20ÙÉ, 30ÙÉ, 75ÙÉ
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
ßßÇÏ ¨ 1000ÙÉ,
Ó»éݳñÏáõÃÛáõÝ êäÀ
5000ÙÉ
NOKI Armenian-AmericanÑÇí³Ý¹³Ýáó³ÛÇÝ German Pharmac.J.V. Co. Ltd
÷³Ã»Ã³íáñáõÙ
(25Ù·+4Ù·)/1·,
ÜÇÅý³ñÙ ´´À
15·, 20· å³ñÏáõ×
Nizhpharm Open JSC
èáõÙÇÝdz
J01C E01
4355
16.07.2003
16.07.2008
¸
àõÏñ³Çݳ
J01C E01
0395/6416
19.09.2006
19.09.2011
¸
г۳ëï³Ý
-
4847
¸
èáõë³ëï³Ý
N03A A
0923/6860
èáõÙÇÝdz
D08A G02
0483/6497
ÐáõÝ·³ñdz
D08A G02,
D09A A09,
D11A C06,
G01A X11,
R02A A15
G01A X11
4288
20.05.2004
20.05.2009
26,04.2007
26.04.2012
16.10.2006
16.10.2011
21.07.2003
21.07.2008
D08A G02,
D09A A09
D08A G02,
D09A A09
0070/6038
ÐáõÝ·³ñdz
D08AG02
г۳ëï³Ý
ÐáõÝ·³ñdz
²¸
²¸
21.07.2003
21.07.2008
02.06.2006
02.06.2011
02.06.2006
02.06.2011
²¸
0849/6867
26.03.2007
26.03.2012
²¸
D08A G02
1054/7082
10.07.2007
10.07.2012
²¸
èáõë³ëï³Ý
M02A X10
0665/6370
12.01.2007
12.01.2012
²¸
4201
10.02.2003
10.02.2008
²¸
1168/7149
13.09.2007
13.09.2012
²¸
3903
12.02.2003
²¸
سϻ¹áÝdz
سϻ¹áÝdz
Ýñµ³ùëáõù
10%,
25· å³ñÏáõ×
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
г۳ëï³Ý
åáíǹáÝ Ûá¹
povidone iodine
ÉáõÍáõÛà ³ñï³ùÇÝ
ÏÇñ³éÙ³Ý
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
г۳ëï³Ý
µ»ï³Ù»Ã³½áÝÇ
ùëáõù
10%,
60ÙÉ ßßÇÏ,
1É, 2É, 3É, 5É
åɳëïÇÏ ï³ñ³
(0.064·+3·)/100·,
D08A G02
D09A A09
D11A C06
G01A X11
D08A G02
ÎǨٻ¹åñ»å³ñ³ï ´´À
àõÏñ³Çݳ
D07B C01
4287
¸
0071/6039
²¸
²¸
29
Betasalic - KMP
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
¹ÇåñáåÇáݳï,
15· å³ñÏáõ×
Kievmedpreparat Open JSC
ë³ÉÇóÇɳÃÃáõ
betamethasone
dipropionate, salicylic
acid
´»ï³ë»ñÏ
µ»ï³ÑÇëïÇÝ
¹»Õ³Ñ³ï»ñ
8Ù·
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì.
Betaserc
betahistine
(30)
Solvay Pharmaceuticals B. V.
´»ï³ë»ñÏ
µ»ï³ÑÇëïÇÝ
¹»Õ³Ñ³ï»ñ
16Ù·
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì.
Betaserc
betahistine
(30)
Solvay Pharmaceuticals B.V.
´»ï³ë»ñÏ
µ»ï³ÑÇëïÇÝ
¹»Õ³Ñ³ï»ñ
24Ù·
êáÉí»É ý³ñÙ³ëÛáõÃÇù³Éë ´.ì.
Betaserc
betahistine
(20,50,100)
Solvay Pharmaceuticals B.V.
´»ï³ùë
µ»ï³ùëáÉáÉ
³ÏݳϳÃÇÉÝ»ñ
0.5%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Betax
betaxolol
(ÉáõÍáõÛÃ)
5ÙÉ ßßÇÏ
Rompharm Company SRL
´»ï³ùëáÉáÉ
µ»ï³ùëáÉáÉÇ
³ÏݳϳÃÇÉÝ»ñ
0.5%,
ü³ñÙ³åɳÝï ´ÇᷳɻÝÇϳ
Betaxolol
ÑǹñáùÉáñǹ
10ÙÉ ßßÇÏ
Pharmaplant Biogalenica
betaxolol hydrochloride
´»ï³ý»ñáÝ
ÇÝï»ñý»ñáÝ-µ»ï³¹»Õ³÷áßÇ
0.25Ù·
Þ»ñÇÝ· ²¶
Betaferon
1-µ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
(8 ÙÇÉÇáÝ
Schering AG
interferon-beta-1-b
ÉáõÍáõÛÃÇ,
ØØ)/ÙÉ,
1,2ÙÉ ÉáõÍãáí
ëñí³Ï/ݳ˳-Éóí³Í
(0,54% ݳïñÇáõÙÇ
Ý»ñ³ñÏÇã (15)
ùÉáñǹ)
´»ï³ýáõóÇÝ
ýáõ½Ç¹³ÃÃáõ,
Ýñµ³ùëáõù
(2%+0.1%)
¸»Éï³ ü³ñÙ³ ê.².º.
Betafucin
µ»ï³Ù»Ã³½áÝ
15· å³ñÏáõ×
Delta Pharma S.A.E.
fusidic acid,
betamethasone
´»ïáåïÇÏ ê
µ»ï³ùëáÉáÉ
¹»Õ³Ï³ËáõÛÃ2.5Ù·/ÙÉ (0.25%),
ê.².²ÉÏáÝ øáõíñ»áõñ Ü.ì.
Betoptic S
betaxolol
³ÏݳϳÃÇÉÝ»ñ
5ÙÉ,10ÙÉ ßßÇÏ
S.A.Alcon-Couvreur N.V.
´»ñµ»ñÇë ÏáÙå (Çáí
·ñ³ÝáõÉÝ»ñ
20· ßßÇÏ
³ÉÇáÝ-²
Ù³ÉÇß)
ÑáÙ»áå³Ã³ÛÇÝ
Talion-A
Berberis comp (Iov
malish)
´»ñÉÇåñÇÉ 10
¿Ý³É³åñÇÉÇ Ù³É»³ï
¹»Õ³Ñ³ï»ñ
10Ù·
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
Berlipril 10
enalapril maleate
(30)
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
´»ñÉÇåñÇÉ 20
¿Ý³É³åñÇÉÇ Ù³É»³ï
¹»Õ³Ñ³ï»ñ
20Ù·
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
Berlipril 20
enalapril maleate
(30)
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
´Ç½áÏáñ 10
µÇëáåñáÉáÉ
¹»Õ³Ñ³ï»ñ
10Ù·
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Bizocor 10
bisoprolol
óճÝóå³ï
(20)
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
´Ç½áÏáñ 5
µÇëáåñáÉáÉ
¹»Õ³Ñ³ï»ñ
5Ù·
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Bizocor 5
bisoprolol
óճÝóå³ï
(20)
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
´ÇÃÝ»ñÇ ûñÇ·ÇÝ³É µáõë³Ï³Ý ѳÝáõÏÝ»ñ ѳÝáõÏ ëåÇñï³ÛÇÝ 50ÙÉ,100ÙÉ,250Ù
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Ù»Í µ³É³ë³Ý
herbal extracts
É ßßÇÏ
Richard Bittner AG
Original Great
Bittner Balsam
´ÇÉáµÇÉ ýáñï»
·ÇÝÏ·á µÇÉáµ³ÛÇ
¹»Õ³å³ïÇ×Ý»ñ
80Ù·
Îèβ ¹.¹., Üáíá Ù»ëïá
Bilobil Forte
ï»ñ¨Ý»ñÇ ãáñ ѳÝáõÏ
(20,60)
KRKA d.d., Novo mesto
Ginkgo biloba leaf dry
extract
´ÇÉïñÇóǹ
åñ³½Çùí³Ýï»É
¹»Õ³Ñ³ï»ñ
600Ù·
´³Û»ñ лÉÃù»ñ ²¶
12.02.2008
Üǹ»éɳݹݻñ
Üǹ»éɳݹݻñ
Üǹ»éɳݹݻñ
èáõÙÇÝdz
N07G A01
1152/7212
13.09.2007
13.09.2012
13.09.2007
13.09.2012
23.05.2003
23.05.2008
13.07.2006
13.07.2011
16.09.2003
16.09.2008
¸
N07G A01
1151/7213
N07C A01
4300
S01E D02
0182/6265
èáõÙÇÝdz
S01E D02
4395
¶»ñÙ³Ýdz
L03A B08
0770/6711
28.02.2007
28.02.2012
¸
º·Çåïáë
D07B C01
1169/7164
13.09.2007
13.09.2012
²¸
´»É·Ç³
S01E D02
4894
¸
èáõë³ëï³Ý
ÑáÙ»áå³Ã³ÛÇÝ
0962/6984
31.05.2004
31.05.2009
14.05.2007
14.05.2012
¶»ñÙ³Ýdz
C09A A02
0977/6983
22.05.2007
22.05.2012
¸
¶»ñÙ³Ýdz
C09AA02
0976/6982
22.05.2007
22.05.2012
¸
êÇñdz
C07A B07
5506
06.06.2005
06.06.2010
¸
êÇñdz
C07A B07
5505
23.08.2005
23.08.2010
¸
²íëïñdz
µáõë³Ï³Ý
5569
19.09.2005
19.09.2010
²¸
êÉáí»Ýdz
N6B X19
0137/6118
29.06.2006
29.06.2011
²¸
¶»ñÙ³Ýdz
P02B A01
5690
05.08.2005
¸
¸
¸
¸
¸
²¸
30
Biltricide
´ÇݳýÇÝ
Binafin
´ÇݳýÇÝ
Binafin
´ÇáÙ»ÏïÇÝ
Biomectin
praziquantel
ï»ñµÇݳýÇÝ
terbinafine
ï»ñµÇݳýÇÝ
terbinafine
Çí»ñÙ»ÏïÇÝ
ivermectin
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
´ÇáÝáñÙ³ÉÇÝ
Bionormalin
´Çáå³ëÇï
Biopassit
µáõë³Ë³éÝáõñ¹
herbal mix
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
÷áßÇ
(6)
250Ù·
(14)
1%,
10· å³ñÏáõ×
1%,
20ÙÉ,50ÙÉ,100ÙÉ
, 250ÙÉ,500ÙÉ
ßßÇÏ
(60)
ûß³ñ³Ï
100ÙÉ ßßÇÏ
428
´Çáå³ñáùë
Bioparox
ýáõ½³ýáõÝ·ÇÝ
fusafungine
429
´¨ÇåÉ»ùë
Beviplex
430
´Çë³Ïá¹ÇÉ
Bisakodil
´Çë³Ïá¹ÇÉ
Bisacodyl
B1, B2, B6, B12
íÇï³ÙÇÝÝ»ñ,
ϳÉóÇáõÙÇ å»Ýïáï»Ý³ï,
ÝÇÏáïÇݳÙǹ
B1, B2, B6, B12 vitamins,
calcium pantotenate,
nicotinamide
µÇë³Ïá¹ÇÉ
bisakodyl
µÇë³Ïá¹ÇÉ
bisacodyl
´Çë³Ïá¹ÇÉ
Bisacodyl
´Çë³Ïá¹ÇÉ
Bisacodyl
µÇë³Ïá¹ÇÉ
bisacodyl
µÇë³Ïá¹ÇÉ
bisacodyl
434
´Çë³Ïá¹ÇÉ
Bisacodyl
µÇë³Ïá¹ÇÉ
bisacodyl
435
´Çë³Ïá¹ÇÉ Ð»Ùáý³ñÙ
Bisacodyl Hemofarm
´Çë³Ïá¹ÇÉ Ð»Ùáý³ñÙ
Bisacodyl Hemofarm
´Çë³Ïá¹ÇÉ ÜÇÅý³ñÙ
Bisacodyl Nizhpharm
´Çë³Ïá¹ÇÉлÙáý³ñÙ
BisacodylHemofarm
µÇë³Ïá¹ÇÉ
bisacodyl
423
424
425
426
427
431
432
433
436
437
438
Ýñµ³ùëáõù
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
óáÕ³óÇñ
ßÝã³éÙ³Ý
0.125Ù·/¹»Õ³ã³÷
(50Ù·/5ÙÉ),
(400¹»Õ³ã³÷ 20ÙÉ
óáÕ³óÇñ ë³ñùáõÙ)
¹»Õ³÷áßÇ
40Ù·+4Ù·+8Ù·+
ÉÇáýÇÉǽ³óí³Í,
0.004Ù·+10Ù·+
Ý/», Ù/Ù
100Ù·,
Ý»ñ³ñÏáõÙÝ»ñÇ, ³ÙåáõÉ/³ÙåáõÉ (5)
2ÙÉ Ý»ñ³ñÏÙ³Ý
çáõñ ÉáõÍãáí
¹ñ³Å»
D01B A02,
D01A E15
D01B A02,
D01A E15
³Ý³ëݳµáõųϳÝ,
P02C F01
5567
àõÏñ³Çݳ
βêÐ
0510/6560
Ðݹϳëï³Ý
µáõë³Ï³Ý
5353
ÐáõÝ·³ñdz
R02A B03
¶³É»ÝÇϳ ³.¹.
Galenika a.d.
ê»ñµÇ³ ¨
â»éÝá·áñdz
äáÉÇý»Ý
Polifen
ØáõÉï³ÝÇ ü³ñÙ³ëÛáõÃÇù³Éë
Èï¹.
Multani Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³É Èï¹
Egis Pharmaceutical Ltd.
Ðݹϳëï³Ý
Ðݹϳëï³Ý
Ȼѳëï³Ý
5568
5843
05.08.2010
06.03.2006
06.03.2011
06.03.2006
06.03.2011
08.11.2005
08.11.2010
¸
²¸
¸
07.11.2006
07.11.2011
14.06.2005
14.06.2010
²¸
5608
23.06.2005
23.06.2010
²¸
A11
5864
02.12.2005
02.12.2010
¸
سϻ¹áÝdz
-
5212
²¸
Ȼѳëï³Ý
A06A G02
0120/6241
19.09.2005
19.09.2010
15.06.2006
15.06.2011
Ȼѳëï³Ý
A06A B02
0452/6334
²¸
ȳïídz
A06A B02,
A06A G02
0073/6212
29.09.2006
29.09.2011
07.06.2006
07.06.2011
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ
ÙáÙÇÏÝ»ñ
5Ù·
(30)
5Ù·
(40/4x10/)
ڲβ-80
JAKA-80
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
ICN Polfa Rzeszow S.A.
¶ñÇݹ»ùë ´À
Grindex JSC
5Ù·
(30)
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupniza AD
´áõÉÕ³ñdz
A06A B02
0616/6643
18.12.2006
18.12.2011
²¸
5Ù·
(6)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
A06A B02,
A06A G02
4459
02.10.2003
02.10.2008
²¸
µÇë³Ïá¹ÇÉ
bisacodyl
ÙáÙÇÏÝ»ñ
10Ù·
(6)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
A06A B02,
A06A G02
4460
02.10.2003
02.10.2008
²¸
µÇë³Ïá¹ÇÉ
bisacodyl
ÙáÙÇÏÝ»ñ
0.01·
(10)
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
èáõë³ëï³Ý
A06A B02,
A06A G02
4517
24.10.2003
24.10.2008
²¸
µÇë³Ïá¹ÇÉ
bisacodyl
¹ñ³Å»
5Ù·
(30)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
A06A B02,
A06A G02
4458
02.10.2003
02.10.2008
²¸
ÙáÙÇÏÝ»ñ
5Ù·
(20,1000)
10Ù·
(10)
Bayer HealthCare AG
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï.Èï¹.
Shreya Life Sciences Pvt.Ltd.
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï.Èï¹.
Shreya Life Sciences Pvt.Ltd.
ì»ïáùíÇÝáÉ ´Çáí»ï Èï¹.
Vetoquinol Biowet Ltd.
²¸
²¸
31
439
´Çë»åïáÉ
Biseptol
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprime
¹»Õ³Ï³ËáõÛÃ
ËÙ»Éáõ
(200Ù·+40Ù·)/5ÙÉ
80ÙÉ ßßÇÏ
440
´Çë»åïáÉ 120
Biseptol 120
¹»Õ³Ñ³ï»ñ
100Ù·+20Ù·
(20)
441
´Çë»åïáÉ 480
Biseptol 480
¹»Õ³Ñ³ï»ñ
400Ù·+80Ù·
(20)
442
´Çë»åïáÉ 480 ³Ùå.
Biseptol 480 amp.
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
(80Ù·+16Ù·)/ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
443
´Çë»åïñÇÙ
Biseptrim
¹»Õ³Ñ³ï»ñ
400Ù·+80Ù·
(20)
444
´ÇëÏ
Beesk
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
-
445
´Çëáϳñ¹
Bisocard
´Çëáϳñ¹
Bisocard
´ÇëáåñáÉáÉ 5Ù·
¹»Õ³Ñ³ï»ñ
Bisoprolol 5mg
tablets
´ÇëáåñáÉáÉ È»Ï
Bisoprolol Lek
446
447
448
449
´ÇëáåñáÉáÉ È»Ï
Bisoprolol Lek
450
´ÇëïñáõÙ·»É
Bystrumgel
´Çí³Éáë
Bivalos
451
452
´ÇóÇÉÇÝ-3 ÎØä
Bicillin-3 KMP
µÇëáåñáÉáÉ
bisoprolol
µÇëáåñáÉáÉ
bisoprolol
µÇëáåñáÉáÉÇ
Ñ»ÙÇýáõÙ³ñ³ï
bisoprolol
hemifumarate
µÇëáåñáÉáÉÇ
ýáõÙ³ñ³ï
bisoprolol fumarate
µÇëáåñáÉáÉÇ
ýáõÙ³ñ³ï
bisoprolol fumarate
Ï»ïáåñáý»Ý
ketoprofen
ëïñáÝóÇáõÙ é³Ý»É³ï
strontium ranelate
µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
µ»Ý½³ÃÇÝÇ,
µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
ݳïñÇáõÙÇ,
åñáϳÛÇÝÇ
µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
benzathine
benzylpenicillin,
benzylpenicillin sodium,
procaine
å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
Ø»¹³Ý³ ü³ñÙ³ î»ñåáÉ ¶ñáõå
ѳٳï»Õ µ³ÅÝ»ïÇñ³Ï³Ý
ÁÝÏ»ñáõÃÛáõÝ MEDANA
PHARMA TERPOL GROUP,
JOINT STOCK COMPANY
䳵dzÝÇó»Ç §äáÉý³¦
¹»Õ·áñͳñ³Ý
Pabianice Pharmaceutical
Works §Polfa¦
䳵dzÝÇó»Ç §äáÉý³¦
¹»Õ·áñͳñ³Ý
Pabianice Pharmaceutical
Works §Polfa¦
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
ê² Pharmaceutical Works
§Polfa¦ SA
ºíñáý³ñÙ ê.².
¶É³ùëáêÙÇÃÎɳÛÝÇ Ñ³Ù³ñ
Europharm S.A. for
GlaxoSmithKline
350Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
5Ù·
²Û-êÇ-¾Ý äáÉý³ Ä»ßáõí ê.².
(30,60)
ICN Polfa Rzeszow S.A.
10Ù·
²Û-êÇ-¾Ý äáÉý³ Ä»ßáõí ê.².
(30,60)
ICN Polfa Rzeszow S.A.
5Ù·
ÜÇã æ»Ý»ñÇÏë Èï¹.
(20, 28, 30, 50, 56,
Niche Generics Limited
60,100)
Ȼѳëï³Ý
J01E E01
5158
18.11.2004
18.11.2009
¸
Ȼѳëï³Ý
J01E E01
4524
21.10.2003
21.10.2008
¸
Ȼѳëï³Ý
J01E E01
4525
21.10.2003
21.10.2008
¸
Ȼѳëï³Ý
J01E E01
4507
27.10.2003
27.10.2008
¸
èáõÙÇÝdz
J01E E01
4794
08.12.2004
08.12.2009
¸
Æéɳݹdz
βêÐ
5815
26.10.2005
26.10.2010
²¸
Ȼѳëï³Ý
C07A B07
5606
¸
Ȼѳëï³Ý
C07A B07
5607
Æéɳݹdz
C07A B07
4611
10.03.2006
10.03.2011
10.03.2006
10.03.2011
21.01.2004
21.01.2009
¸
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(30)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
C07A B07
0348\5283\1
21.08.2006
07.02.2011
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5Ù·
(30)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
C07A B07
0349\5282\1
21.08.2006
07.02.2010
¸
¹áݹáÕ
2.5%,
30· å³ñÏáõ×
2·,
÷³Ã»ÃÝ»ñ (28)
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
ê»ñíÇ» Çݹ³ëïñÇ
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
èáõë³ëï³Ý
5074
11.11.2004
11.11.2009
11.04.2006
11.04.2011
²¸
üñ³Ýëdz
M01A E03
M02A A10
M05B X03
àõÏñ³Çݳ
J01C
0397/6418
19.09.2006
19.09.2011
¸
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ï³ËáõÛÃÇ
600000ØØ
(200000ØØ+
200000ØØ+
200000ØØ),
ëñí³Ï (40)
6098
¸
32
453
´ÇóÇÉÇÝ-5 ÎØä
Bicillin-5 KMP
454
´ÇýǹáÙ³ùë
Bifidomax
455 ´ÇýǹáõÙµ³Ïï»-ñÇÝ
Bifidumbacterin
456
´ÇýÇÏáÉ ãáñ
Bificol siccum
457
´ÇýÇÏáÉÇÝ
å³ïÇ×Ý»ñ
Bificolin capsules
458
´ÇýÇýáñÙ
Bifiform
459
´É»Ù³ñ»Ý
Blemaren
460
´É»Ù³ñ»Ý
Blemaren
461
´É»Ý³Ù³ùë
benzylpenicillin
µ»Ý½³ÃÇÝ
µ»Ý½ÇÉå»ÝÇóÇÉÇÝ,
åñáϳÛÇÝ
µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
benzathine
benzylpenicillin,
procaine
benzylpenicillin
µÇýǹᵳÏï»ñÇáõÙ
µÇýǹáõÙ
bifidobacterium bifidum
µÇýǹᵳÏï»ñÇáõÙ
µÇýǹáõÙ
bifidobacterium bifidum
µÇýǹᵳÏï»ñÇáõÙ
µÇýǹáõÙ, ¿ß»ñÇËdz
ÏáÉÇ Ø-17
bifidobacterium bifidum,
Escherichia coli M-17
µÇýǹᵳÏï»ñÇáõÙ
µÇýǹáõÙ, ¿ß»ñÇËdz
ÏáÉÇ Ø-17
Bifidobacterium
bifidum, Escherichia
coli m-17
µÇýǹᵳÏï»ñÇáõÙ
ÉáÝ·áõÙ, ¿Ýï»ñáÏáÏáõë
ý»óÇáõÙ
Bifidobacterium
longum, Enterococcus
faecium
ϳÉÇáõÙÇ
Ñǹñá·»Ýϳñµáݳï,
ÏÇïñáݳÃÃáõ,
ݳïñÇáõÙÇ óÇïñ³ï
potassium
hydrogencarbonate,
citric acid, sodium
citrate
ϳÉÇáõÙÇ
Ñǹñá·»Ýϳñµáݳï,
ÏÇïñáݳÃÃáõ,
ݳïñÇáõÙÇ óÇïñ³ï
potassium
hydrogencarbonate,
citric acid, sodium
citrate
µÉ»áÙÇóÇÝ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ï³ËáõÛÃÇ
1500000ØØ
(1200000ØØ+
300000ØØ),
ëñí³Ï (40)
àõÏñ³Çݳ
J01C E
0398/6419
19.09.2006
19.09.2011
¸
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd.
г۳ëï³Ý
βêÐ
5881
04.01.2006
04.01.2011
²¸
107³ëïÇ׳ÝÇó áã
å³Ï³ë /100Ù·/
ϻݹ³ÝÇ
µ³Ïï»ñdzݻñÇ
ÉÇáýÇÉǽ³óí³Í
÷áßÇ
å³ïÇ×Ý»ñáõÙ
÷áßÇ
ÉÇáýÇÉǽ³óí³Í
5 ã³÷/ëñí³Ï,
ëñí³Ï (10)
´Çáý³ñÙ³ ö´À
Biopharma Closed JSC
àõÏñ³Çݳ
βêÐ
0698/6741
25.01.2007
25.01.2012
²¸
÷áßÇ
ÉÇáýÇÉǽ³óí³Í
5 ã³÷/ëñí³Ï,
ëñí³Ï (10)
´Çáý³ñÙ³ ö´À
Biopharma Closed JSC
àõÏñ³Çݳ
βêÐ
0697/6742
25.01.2007
25.01.2012
²¸
å³ïÇ×Ý»ñ
107 áã å³Ï³ë
(100Ù·) ϻݹ³ÝÇ
µ³Ïï»ñdzݻñÇ
ÉÇáýÇÉǽ³óí³Í
÷áßÇ
å³ïÇ×Ý»ñáõÙ,
(30 /µÉÇëï»ñ/,
100 /ï³ñ³/)
10.8Ù·+17.2Ù·
(30)
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd
г۳ëï³Ý
βêÐ
0158/6255
07.07.2006
07.07.2011
²¸
ü»ñáë³Ý ²/ê
Ferrosan A/S
¸³Ýdz
-
5318
10.03.2005
10.03.2010
²¸
·ñ³ÝáõÉÝ»ñ
¹Ûáõñ³ÉáõÛÍ
(967.5Ù·+1197Ù·+
835.5Ù·)/¹»Õ³-ã³÷
200·
¾ëå³ñÙ³ ¶ÙµÐ
Esparma GmbH
¶»ñÙ³Ýdz
A12B
4661
10.02.2004
10.02.2009
¸
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
(967.5Ù·+1197Ù·+
835.5Ù·)
(20, 4x20)
¾ëå³ñÙ³ ¶ÙµÐ
Esparma GmbH
¶»ñÙ³Ýdz
A12B
4593
10.02.2004
10.02.2009
¸
¹»Õ³÷áßÇ
15ØØ
ü³ñÙ³ù»ÙÇ ´.ì. (îºì²
Üǹ»éɳݹ-
L01D C01
5314
08.01.2005
¸
¹»Õ³å³ïÇ×Ý»ñ
(30,90)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
33
Blenamax
bleomycin
Ý»ñ³ñÏÙ³Ý,
ÉÇáýÇÉǽ³óí³Í
ëñí³Ï (1,10)
462
´É»áÙÇóÇÝ
Bleomycin
µÉ»áÙÇóÇÝ
bleomycin
15 Ødzíáñ
ëñí³Ï/³ÙåáõÉ (1)
463
´ÛáõÃÇ
Beauty
-
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
5ÙÉ ÉáõÍãáí
(Ý»ñ³ñÏÙ³Ý çáõñ)
å³ïÇ×Ý»ñ
464
´Ý³Ï³Ý ³ñóáõÝù
¹»ùëïñ³Ý-70,
ÉáõÍáõÛÃ
ÈÇÏíá
ÑǹñûùëÇåñáåÇÉٻà (³ÏݳϳÃÇÉÝ»ñ)
Nature Tears Liqvo
ÇÉ-ó»ÉÛáõÉá½
dextran-70,
hydroxypropyl
methylcellulose
465
´áÙ-µ»Ý·»
Ù»ÝÃáÉ Ï³Ù
ùëáõù
Bom-Benge
åÕå»Õ³ÛÇÝ ³Ý³ÝáõËÇ
ÛáõÕ,
Ù»ÃÇÉë³ÉÇóÇɳï
menthol or oleum
Menthae Piperitae,
methylsalicylate
466
´áÙ-´»Ý·» ùëáõù
Ù»ÝÃáÉ Ï³Ù
ùëáõù
Bom-Benge
åÕå»Õ³ÛÇÝ ³Ý³ÝáõËÇ
ointment
ÛáõÕ,
Ù»ÃÇÉë³ÉÇóÇɳï
menthol or oleum
Menthae piperitae,
methylsalicylate
467
´áݹñáݳï
ǵ³Ý¹ñáݳÃÃáõ
Ëï³ÝÛáõÃ
Bondronat
ibandronic acid
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
468
´áݹñáݳï
Bondronat
ǵ³Ý¹ñáݳÃÃáõ
ibandronic acid
469
´áÝíÇí³
Bonviva
ǵ³Ý¹ñáݳÃÃáõ
ibandrûnic acid
470
´áÝíÇí³ 150Ù·
Bonviva 150mg
471
´áëϳñÇ
Boscari
472
´áñ³ÃÃíÇ ùëáõù
Boric acid ointment
ǵ³Ý¹ñáݳÃÃáõ
ibandronic acid
µáñ³ÃÃáõ
boric acid
ü³ñÙ³ëÛáõÃÇù³É-Ç Ñ³Ù³ñ)
Pharmachemie B.V.(for TEVA
Pharmaceutical)
¸²´àõð ü³ñÙ³ Èï¹
DABUR Pharma Ltd
Ý»ñ
08.01.2010
Ðݹϳëï³Ý
L01DC01
0992/6992
30.05.2007
30.05.2012
¸
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
Æéɳݹdz
βêÐ
5816
26.10.2005
26.10.2010
²¸
г۳ëï³Ý
S
5159
13.12.2004
13.12.2009
²¸
(3.9· ϳÙ
7.8·+20.2·/100·)
40· å³ñÏáõ×
ê³ÝÇï³ë ²´
Sanitas AB
ÈÇïí³
-
5490
29.03.2005
29.03.2010
²¸
(3.9· ϳ٠7.8·+
20.2·)/100·,
25·, 30· å³ñÏáõ×
ϳ٠³å³Ï» ï³ñ³
¾ëÏáõɳå êäÀ
Esculap Ltd.
г۳ëï³Ý
-
5186
21.01.2005
21.01.2010
²¸
2Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(1,5)
èáß ¸Ç³·ÝáëïÇÏë ¶ÙµÐ
(¶»ñÙ³Ýdz) ü.ÐáýÙ³Ý-ȳ èáß
Èï¹-Ç (Þí»Ûó³ñdz) ѳٳñ
Roche Diagnostics GmbH
(Germany) for F.Hoffmann-La
Roche Ltd (Switzerland)
èáß ¸Ç³·ÝáëïÇÏë ¶ÙµÐ
Roche Diagnostics GmbH
¶»ñÙ³Ýdz
M05B A06
4561
15.12.2003
15.12.2008
¸
¶»ñÙ³Ýdz
M05B A06
5663
12.07.2005
12.07.2010
¸
¶»ñÙ³Ýdz
M05B A06
0688/6732
17.01.2007
17.01.2012
¸
Þí»Ûó³ñdz
M05B A06
5948
¸
г۳ëï³Ý
βêÐ5
1074/6687
г۳ëï³Ý
S02A A03
4505
06.02.2006
06.02.2011
25.07.2007
25.07.2012
04.09.2003
04.09.2008
500Ù·
(60)
0.1%+0.3%,
10ÙÉ ßßÇÏ
Ëï³ÝÛáõÃ
6Ù·/6ÙÉ,
ϳÃÇɳݻñ³ñÏ-Ù³Ý ëñí³ÏÝ»á (1,5,10)
ÉáõÍáõÛÃÇ
ÉáõÍáõÛÃ
3Ù·/3ÙÉ,
ì»ï»ñ ü³ñÙ³ ü»ñïÇ·áõÝ· ¶ÙµÐ ¨
Ý»ñ³ñÏÙ³Ý
ݳ˳Éóí³Í Ý»ñ³ñÏÇã øá. ζ (ü. ÐáýÙ³Ý-ȳ èáß Èï¹.-Ç
(1)
ѳٳñ, Þí»Ûó³ñdz)
Vetter Pharma-Fertigung
GmbH & Co.KG (for F.
Hoffmann-La Roche Ltd.,
Switzerland)
¹»Õ³Ñ³ï»ñ
150Ù·
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
óճÝóå³ï
(1,3)
F.Hoffmann-La Roche Ltd.
å³ïÇ×Ý»ñ
400Ù·
гÛÏ-94
(20, 30, 100)
Hayk-94
ùëáõù
5%,
¾ëÏáõɳå êäÀ
15·, 25·, 30· ï³ñ³
Esculap Ltd.
²¸
²¸
34
473
474
475
476
477
478
´áõµÇÉ
Bubil
´áõåÇí³Ï³ÛÇÝÇ
ÑǹñáùÉáñǹ
Bupivacaine
hydrochloride
´áõåÇí³Ï³ÛÇÝÇ
ÑǹñáùÉáñǹ
Bupivacaine
hydrochloride
´áõåÇí³Ï³ÛÇÝÇ
ÑǹñáùÉáñǹ
Bupivacaine
hydrochloride
´áõï³¹ÇáÝ
Butadion
´ñ³É³Ý·ÇÝ
Bralangin
479
´ñ³É³Ý·ÇÝ
Bralangine
480
´ñ³íÇÝïáÝ
Bravintone
´ñ³íÇÝïáÝ
Bravintone
481
åÇñ»ÃñÇÝ
û׳é³Ñ»ÕáõÏ
0.18Ù·/60ÙÉ,
pyrethrin
60ÙÉ ßßÇÏ
µáõåÇí³Ï³ÛÇÝÇ
ÉáõÍáõÛÃ
5Ù·/ÙÉ (10ÙÉ),
ÑǹñáùÉáñǹ
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï (5)
bupivacaine
hydrochloride
µáõåÇí³Ï³ÛÇÝÇ
ÉáõÍáõÛÃ
5Ù·/ÙÉ (10ÙÉ),
ÑǹñáùÉáñǹ
Ý»ñ³ñÏÙ³Ý
10ÙÉ ³ÙåáõÉÝ»ñ
bupivacaini
(10)
hydrochloride
µáõåÇí³Ï³ÛÇÝÇ
ÉáõÍáõÛÃ
5Ù·/ÙÉ (20ÙÉ),
ÑǹñáùÉáñǹ
Ý»ñ³ñÏÙ³Ý
20ÙÉ ëñí³Ï (5)
bupivacaine
hydrochloride
ý»ÝÇɵáõï³½áÝ
ùëáõù
5%,
phenylbutazone
20· å³ñÏáõ×
Ù»ï³ÙǽáÉ,
ÉáõÍáõÛÃ
(0.5·+0.002·+
åÇïáý»ÝáÝ,
Ý»ñ³ñÏÙ³Ý
0.02Ù·)/ÙÉ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
5ÙÉ ³ÙåáõÉÝ»ñ
metamizole, pitofenone,
(5,25)
fenpiverinum bromide
Ù»ï³ÙǽáÉ,
¹»Õ³Ñ³ï»ñ
500Ù·+5Ù·+ 0.1Ù·
åÇïáý»ÝáÝ,
(10,20,100)
ý»ÝåÇí»ñÇÝ
metamizole, pitofenon,
fenpiverin
íÇÝåáó»ïÇÝ
¹»Õ³Ñ³ï»ñ
0.005·
vinpocetine
(10,20,25,50)
íÇÝåáó»ïÇÝ
ÉáõÍáõÛÃ
5Ù·/ÙÉ (0.5%),
vinpocetine
ϳÃÇɳݻñ³ñÏ-Ù³Ý 2ÙÉ ³ÙåáõÉÝ»ñ
(10)
å³ïÇ×Ý»ñ
410Ù·
(30)
ڲβ-80
JAKA-80
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý ê²
Warsaw Pharmaceutical Works
''Polfa'' SA
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý ê²
Warsaw Pharmaceutical Works
"Polfa" SA
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý ê²
Warsaw Pharmaceutical Works
''Polfa'' SA
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
سϻ¹áÝdz
PC3A C01
5798
27.02.2006
27.02.2011
13.09.2007
13.09.2012
²¸
Ȼѳëï³Ý
N01B01
1148/7215
Ȼѳëï³Ý
N 01B01
1150/7217
13.09.2007
13.09.2012
¸
Ȼѳëï³Ý
N01B01
1149/7216
13.09.2007
13.09.2012
¸
ÐáõÝ·³ñdz
5660
14.12.2005
14.12.2010
25.08.2003
25.08.2008
²¸
èáõë³ëï³Ý
M01A A01,
M02A A01
N02B B72
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
èáõë³ëï³Ý
N02B B72
5330
15.02.2005
15.02.2010
²¸
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
èáõë³ëï³Ý
N06B X18
5336
¸
èáõë³ëï³Ý
N06B X18
5337
15.02.2005
15.02.2010
03.02.2005
03.02.2010
Æéɳݹdz
βêÐ
5804
26.10.2005
26.10.2010
²¸
300Ù·
(10, 20,30,40,50)
0.05%,
10ÙÉ ßßÇÏ
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
§´ñÇÝó³Éáí-²¦ ö´À
CJSC
§Brinsalov-A¦
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
èáõë³ëï³Ý
-
4582
¸
èáõë³ëï³Ý
4758
09.12.2003
09.12.2008
18.03.2004
18.03.2009
4402
482
´ñ»ÛÝ-û-ýÉ»ùë
Brain-O Flex
483
´ñ»Ýódzɻ ýáñï»
Brenciale forte
´ñǽáÉÇÝ
Brizoline
ýáëýáÉÇåǹݻñ
phospholipids
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
¹»Õ³å³ïÇ×Ý»ñ
485
´ñǽáÉÇÝ
Brizoline
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
0.1%,
10ÙÉ ßßÇÏ
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
èáõë³ëï³Ý
486
´ñǽáñ³É
Brizoral
´ñÇÉǹ
Brilid
´ñÇÉáϳÛÇݳ¹ñ»Ý³ÉÇÝ
Brilocaineadrenaline
´ñÇÉáϳÛÇݳ¹ñ»Ý³ÉÇÝ ýáñï»
Brilocaineadrenaline forte
Ï»ïáÏáݳ½áÉ
ketoconazole
éûùëÇÃñáÙÇóÇÝ
roxithromycin
³ñïÇϳÛÇÝ, ³¹ñ»Ý³ÉÇÝ
articaine, adrenaline
¹»Õ³Ñ³ï»ñ
´ñÇÝó³Éáí-² ö´À
Brinsalov-A CJSC
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
´ñÇÝó³Éáí-² ö´À
Brinsalov-A CJSC
èáõë³ëï³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
èáõë³ëï³Ý
J01F A06
4762
èáõë³ëï³Ý
N01B B58
5949
³ñïÇϳÛÇÝ, ³¹ñ»Ý³ÉÇÝ
articaine, adrenaline
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
200Ù·
(10)
0.15·
(10,20)
(72Ù·+0.009Ù·)/
1.8ÙÉ,
1.8ÙÉ
÷³Ù÷áõßïÝ»ñ (50)
(72Ù·+0.018Ù·)/
1.8ÙÉ,
1.8ÙÉ
÷³Ù÷áõßïÝ»ñ (50)
R01A A07,
R01A B06,
S01G A03
R01A A07,
R01A B06,
S01G A03
J02A B02
´ñÇÝó³Éáí-² ö´À
Brinsalov-A CJSC
èáõë³ëï³Ý
N01B B58
5950
484
487
488
489
ùóϳÃÇÉÝ»ñ
¸
¸
¸
²¸
4759
18.03.2004
18.03.2009
²¸
5951
28.02.2006
28.02.2011
29.03.2004
29.03.2009
28.02.2006
28.02.2011
¸
28.02.2006
28.02.2011
¸
¸
¸
35
490
´ñÇݳý 250
Brinaf 250
491
´ñÇý»ë»åïáÉ
Brifeseptol
492
´ñÇýë»åïáÉ
Brifseptol
493
´ñá½³³ñ
Brozaar
494
´ñá-½»¹»ùë
Bro-zedex
495
496
497
498
499
500
501
502
ï»ñµÇݳýÇÝÇ
ÑǹñáùÉáñǹ
terbinafine
hydrochloride
Ïá-ïñÇÙûùë³½áÉ
(ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ)
co-trimoxasole
(sulfamethoxazole,
trimethoprim)
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ,
sulfamethoxazole,
trimethoprim
Éá½³ñï³Ý
losartan
¹»Õ³Ñ³ï»ñ
250Ù·
(14,28)
ÉáõÍáõÛÃ
(400Ù·+80Ù·)/5ÙÉ
ϳÃÇɳݻñ³ñÏ-Ù³Ý 5ÙÉ ³ÙåáõÉÝ»ñ
(10)
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïdz
D01A E15
D01B A02
4245
19.06.2003
19.06.2008
¸
´ñÇÝó³Éáí-² ö´À
Brinsalov-A CJSC
èáõë³ëï³Ý
J01E E01
5952
28.02.2006
28.02.2011
¸
¹»Õ³Ñ³ï»ñ
480Ù·
(10,20)
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
J01E E01
4403
25.08.2003
25.08.2008
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.05·
(10,14,20,28,30,40,
42,50)
(2.5Ù·+8Ù·+
100Ù·+ 5Ù·)/10ÙÉ,
100ÙÉ ßßÇÏ
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
èáõë³ëï³Ý
C09C A01
4760
29.03.2004
29.03.2009
¸
ìáÏ˳ñ¹ Èï¹
Wockhardt Ltd
Ðݹϳëï³Ý
R05C A10
0608/6686
18.12.2006
18.12.2011
¸
4Ù·/5ÙÉ,
125ÙÉ ßßÇÏ
4Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
êáý³ñÙ³ ²¸
Sopharma AD
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
´áõÉÕ³ñdz
R05C B02
4310
²¸
èáõë³ëï³Ý
R05C B02
0413/6372
17.10.2003
17.10.2008
19.09.2006
19.09.2011
èáõë³ëï³Ý
R05CB02
0839/6665
26.03.2007
26.03.2012
²¸
èáõë³ëï³Ý
R05C B02
5332
15.02.2005
15.02.2010
²¸
¶»ñÙ³Ýdz
R05C B02
4715
20.02.2004
20.02.2009
²¸
¶»ñÙ³Ýdz
R05C B02
4716
20.02.2004
20.02.2009
²¸
ÐáõÝ·³ñdz
G02C B01
N04A H01
5240
01.06.2005
01.06.2010
¸
¶»ñÙ³Ýdz
_
4208
13.02.2003
13.02.2008
²¸
ûß³ñ³Ï
´ñáÙÑ»ùëÇÝ
Bromhexin
´ñáÙÑ»ùëÇÝ
Bromhexine
ûñµáõï³ÉÇÝÇ
ëáõÉý³ï,
µñáÙÑ»ùëÇÝÇ
ÑǹñáùÉáñǹ,
·áõ³Ûý»Ý»½ÇÝ,
Ù»ÝÃáÉ
terbutaline sulphate,
bromhexine
hydrochloride,
guaiphenesin, menthol
µñáÙÑ»ùëÇÝ
bromhexine
µñáÙÑ»ùëÇÝ
bromhexine
´ñáÙÑ»ùëÇÝ
Bromhexine
µñáÙÑ»ùëÇÝ
bromhexine
¹»Õ³Ñ³ï»ñ
ûß³ñ³Ï
ûß³ñ³Ï
0.008·
(10,20)
´ñáÙÑ»ùëÇÝ
µñáÙÑ»ùëÇÝ
ûß³ñ³Ï
4Ù·/5ÙÉ,
ü»ñ»ÛÝ
bromhexine
60ÙÉ,100ÙÉ ßßÇÏ
Bromhexin-Ferein
´ñáÙÑ»ùëÇÝ-4
µñáÙÑ»ùëÇÝ
ÉáõÍáõÛà ËÙ»Éáõ
4Ù·/5ÙÉ,
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
´»éÉÇÝ ø»ÙÇ
bromhexine
60ÙÉ, 100ÙÉ ßßÇÏ
·ñáõå)
Bromhexin-4 BerlinBerlin-Chemie AG (Menarini
Chemie
Group)
´ñáÙÑ»ùëÇÝ-8
µñáÙÑ»ùëÇÝ
¹ñ³Å»
8Ù·
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
´»éÉÇÝ ø»ÙÇ
bromhexine
(20,25,50)
·ñáõå)
Bromhexin-8 BerlinBerlin-Chemie AG (Menarini
Chemie
Group)
´ñáÙáÏñÇåïÇݵñáÙáÏñÇåïÇÝ
¹»Õ³Ñ³ï»ñ
2.5Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
èÇËï»ñ
bromocriptin
(30)
Gedeon Richter Ltd.
Bromocriptin-Richter
´ñáÝËÇÏáõÙ
áõñóÇ, ·ñÇݹ»ÉdzÛÇ
ÉáõÍáõÛÃ
130· ßßÇÏ
².ܳûñÙ³Ý ¨ òÇ» ¶ÙµÐ
¿ÉÇùëÇñ
ËáïÇ, Ïí»µñ³ËáÛÇ
A.Nattermann & Cie GmbH
Bronchicum Elixir
ϻըÇ, ·Ý³ñµáõÏÇ
³ñÙ³ïÇ, ³ÝÇëáÝÇ
á·»ÃáõñÙ»ñ
tinctures of Thyme,
²¸
36
503
´ñáÝËÇÏáõÙ
å³ëïÇÉ»Ý
Bronchicum
Pastillen
504 ´ñáÝËÇÏáõÙ ûß³ñ³Ï
Bronchicum Syrup
Grindelia herb,
Quebracho bark,
Primula root and
Pimpinella root
áõñóÇ Ñ³ÝáõÏ
thyme extract
Éá½³ÝÝ»ñ
100Ù·
(20)
².ܳûñÙ³Ý ¨ òÇ» ¶ÙµÐ
A.Nattermann & Cie GmbH
¶»ñÙ³Ýdz
_
4207
13.02.2003
13.02.2008
²¸
ûß³ñ³Ï
130· ßßÇÏ
².ܳûñÙ³Ý ¨ òÇ» ¶ÙµÐ
A.Nattermann & Cie GmbH
¶»ñÙ³Ýdz
_
4209
13.02.2003
13.02.2008
²¸
ûß³ñ³Ï
(4.6Ù·+5.75Ù·)/5Ù,
125· ßßÇÏ
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
R05F A02
1024/7004
13.06.2007
13.06.2012
²¸
¹»Õ³å³ïÇ×Ý»ñ
7Ù·
(10)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
R07AX
5434
10.05.2005
10.05.2010
¸
¹»Õ³å³ïÇ×Ý»ñ
3.5Ù·
(10)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
R07AX
5433
10.05.2005
10.05.2010
¸
ÉáõÍáõÛÃ
(ϳÃÇÉÝ»ñ)
ûß³ñ³Ï
0.2·/25ÙÉ,
25ÙÉ ßßÇÏ
(5.75Ù·+4.6Ù·+
5.75Ù·)/5ÙÉ,
125· ßßÇÏ
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
êÉáí³Ïdz
R05C B02
4240
²¸
´áõÉÕ³ñdz
A08A A56
0229/6295
29.07.2003
29.07.2008
26.07.2006
26.07.2011
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
Warsaw Pharmaceutical Works
§Polfa¦
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
Warsaw Pharmaceutical Works
§Polfa¦
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
ê.².
Warsaw Pharmaceutical Works
§Polfa¦ S.A.
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
èáõë³ëï³Ý
N02B A03
4765
Ȼѳëï³Ý
R01A A07,
R01A B06
4231
18.03.2004
18.03.2009
26.05.2003
26.05.2008
¸
ÉáõÍáõÛÃ
(ùóϳÃÇÉÝ»ñ)
20%,
10· ßßÇÏ
0.05%,
10ÙÉ ëñí³Ï
Ȼѳëï³Ý
R01A A07,
R01A B06
4232
26.05.2003
26.05.2008
²¸
Ȼѳëï³Ý
R01A A07,
R01A B06
4281
26.05.2003
26.05.2008
²¸
Ȼѳëï³Ý
R01A A07,
4282
26.05.2003
²¸
´ñáïÇÝáõÙ
Brotinum
¶³É³½áÉÇÝ
Galazolin
·ñÇݹ»ÉdzÛÇ
ËáïÇ,³ÝÇëáÝÇ,
·Ý³ñµáõÏÇ ³ñÙ³ïÇ,
Ù³ëñ»Ýáõ ͳÕÇÏÝ»ñÇ,
áõñóÇ á·»ÃáõñÙ»ñ
tinctures of Grindelia
herb, Pimpinella root,
Primula root, Rose
flores and Thyme herb
¿ý»¹ñÇÝÇ
ÑǹñáùÉáñǹ,
·É³áõóÇÝÇ
ÑǹñáµñáÙǹ
ephedrine
hydrochloride, glaucine
hydrobromide
Ù³Ýñ¿Ý»ñÇ
ÉÇáýÇÉǽ³ï
lyophilized bacterial
lysate
Ù³Ýñ¿Ý»ñÇ
ÉÇáýÇÉǽ³ï
lyophilized bacterial
lysate
µñáÙÑ»ùëÇÝ
bromhexin
·É³áõóÇÝÇ
ÑǹñáµñáÙǹ,
¿ý»¹ñÇÝÇ
ÑǹñáùÉáñǹ, é»Ñ³ÝÇ
ÛáõÕ
gluacine hydrobromide,
ephedrine
hydrochloride, basil oil
ËáÉÇÝÇ ë³ÉÇóÇɳï
choline salicylate
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
512
¶³É³½áÉÇÝ
Galazolin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ÉáõÍáõÛÃ
(ùóϳÃÇÉÝ»ñ)
0.1%,
10ÙÉ ëñí³Ï
513
¶³É³½áÉÇÝ
Galazolin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
¹áݹáÕ ùÃÇ
0.05%,
5·,10· å³ñÏáõ×,
10· ßßÇÏ
514
¶³É³½áÉÇÝ
ùëÇÉáٻﳽáÉÇÝ
¹áݹáÕ ùÃÇ
0.1%,
505
´ñáÝËáÉÇïÇÝ
Broncholytin
506
´ñáÝËá-ÙáõݳÉ
Broncho-Munal
507
´ñáÝËá-ÙáõÝ³É ä
Broncho-Munal P
508
´ñáÝËáë³Ý
Bronchosan
´ñáÝËáóÇÝ
Bronchocin
509
510
511
¸
²¸
37
Galazolin
xylometazoline
5·,10· å³ñÏáõ×,
10· ßßÇÏ
515 ¶³Éá½ÇÉáù 0,05%
Galoziloc 0,05%
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
516 ¶³Éá½ÇÉáù 0,05%
Galoziloc 0,05%
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
óáÕ³ßÇà ùÃÇ
517
¶³Éá½ÇÉáù 0,1%
Galoziloc 0,1%
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
518
¶³Éá½ÇÉáù 0,1%
Galoziloc 0,1%
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
óáÕ³ßÇà ùÃÇ
-
ϳÃÇÉÝ»ñ
--
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
¹»Õ³å³ïÇ×Ý»ñ
519
¶³Éëï»Ý³
Galstena
520
¶³Éëï»Ý³
Galstena
521
¶³Éý»ñ ü²
¹»Õ³å³ïÇ×Ý»ñ
Galfer FA capsules
522
¶³Ý·É»ñáÝ
Gangleron
523
¶³Ý·É»ñáÝ
Gangleron
524
¶³ëï³É
Gastal
525
¶³ëï»ñáÉ
Gasterol
¶»Éáýáõ½ÇÝ
Gelofusine
526
527
¶»Ù³½³
Gemase
»ñϳÃÇ ýáõÙ³ñ³ï,
ýáɳÃÃáõ
ferrous fumarate, folic
acid
ǽáµáõïûùëǵ»Ý½áÛ
³-ÃÃíÇ ³Í³ÝóÛ³ÉÝ»ñÇ
˳éÝáõñ¹
mixture of
isobutoxybenzoic acid
derivates
ǽáµáõïûùëǵ»Ý½áÛ
³-ÃÃíÇ ³Í³ÝóÛ³ÉÝ»ñÇ
˳éÝáõñ¹
mixture of
isobutoxybenzoic acid
derivates
³ÉÛáõÙÇÝáõÙÇ
Ñǹñûùëǹ Ù³·Ý»½ÇáõÙÇ Ï³ñµáݳï
¹áݹáÕ, Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹ
aluminum hydroxide magnesium carbonate
gel, magnesium
hydroxide
-
ê.².
Warsaw Pharmaceutical Works
§Polfa¦ S.A.
0.05%,
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
5ÙÉ,10ÙÉ ßßÇÏ
ÙdzíáñáõÙ (²²Ø) êäÀ
Arsemi Agroindustrial Union
(AIU) Ltd
0.05%,
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
10ÙÉ, 15ÙÉ, 30ÙÉ
ÙdzíáñáõÙ (²²Ø) êäÀ
ßßÇÏ
Arsemi Agroindustrial Union
(AIU) Ltd
0.1%,
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
5ÙÉ,10ÙÉ ßßÇÏ
ÙdzíáñáõÙ (²²Ø) êäÀ
Arsemi Agroindustrial Union
(AIU) Ltd
0.1%,
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
10ÙÉ, 15ÙÉ, 30ÙÉ
ÙdzíáñáõÙ (²²Ø) êäÀ
ßßÇÏ
Arsemi Agroindustrial Union
(AIU) Ltd
20ÙÉ, 50ÙÉ,
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
100ÙÉ ßßÇÏ
Richard Bittner AG
(12, 48)
èÇ˳ñ¹ ´ÇÃÝ»ñ ¶ÙµÐ
Richard Bittner AG
(305Ù·+0.35Ù·)
ÂáñÝïáÝ ¨ èáë Èï¹
(28)
Thornton & Ross Ltd.
R01A B06
26.05.2008
г۳ëï³Ý
R01A A07
0718/6689
07.02.2007
07.02.2012
²¸
г۳ëï³Ý
R01A A07
0716/6691
07.02.2007
07.02.2012
²¸
г۳ëï³Ý
R01A A07
0717/6690
07.02.2007
07.02.2012
²¸
г۳ëï³Ý
R01A A07
0719/6688
07.02.2007
07.02.2012
²¸
²íëïñdz
-
0037/6164
²¸
²íëïñdz
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
B03A D02
1412/5894/1
19.05.2006
19.05.2011
03.12.2007
17.02.2011
22.03.2007
22.03.2012
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
0830/6815
²¸
¸
¹»Õ³å³ïÇ×Ý»ñ
40Ù·
(60)
ÐÐ ¶²² Üáõñµ úñ·³Ý³Ï³Ý
øÇÙdzÛÇ ÆÝëïÇïáõï /ÜúøÆ/
NAS RA Institute of Fine
Organic Chemistry /IFOC/
г۳ëï³Ý
--
1448/7440
20.12.2007
20.12.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1,5%,
2ÙÉ, ³ÙåáõÉÝ»ñ
(10)
ÐÐ ¶²² Üáõñµ úñ·³Ý³Ï³Ý
øÇÙdzÛÇ ÆÝëïÇïáõï /ÜúøÆ/
NAS RA Institute of Fine
Organic Chemistry /IFOC/
г۳ëï³Ý
--
1447/7441
20.12.2007
20.12.2012
¸
¹»Õ³Ñ³ï»ñ
450Ù·+300Ù·
(24,30,48,60)
äÉÇí³-Îñ³Ïáí
Pliva-Krakow
Ȼѳëï³Ý
A02A B,
A06A D
4486
21.11.2003
21.11.2008
²¸
ѳµ»ñ
350Ù·
(20,30)
40·/1000ÙÉ (4%),
500ÙÉ åɳëïÇÏ
ßßÇÏ
5000ØØ (1ÙÉ),
1ÙÉ ³ÙåáõÉÝ»ñ
ä³ñ³ý³ñÙ ö´À
Parapharm
CJSC
´.´ñ³áõÝ Ø»É½áõÝ·»Ý ²¶
B.Braun Melsungen AG
èáõë³ëï³Ý
βêÐ
5196
²¸
¶»ñÙ³Ýdz
B05A A06
0891/6745/1
08.12.2004
08.12.2009
20.04.2007
29.12.2011
èáõë³ëï³Ý
B01AD
1366/7327
13.11.2007
05.11.2012
¸
åáÉÇëáõÏóÇݳóí³Í
ÉáõÍáõÛÃ
ŻɳïÇÝ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
gelatin polysuccinylated
é»ÏáÙµÇݳÝï³ÛÇÝ
ÉÇáýÇÉǽ³ï
åñááõñáÏÇݳ½
Ý»ñ³ñÏÙ³Ý
èáõë³ëï³ÝÇ ëñï³µ³Ý³Ï³Ý
·Çï³³ñï³¹ñ³Ï³Ý ѳٳÉÇñÇ
¸
38
prourokinase
recombinant
ÉáõÍáõÛÃÇ
(5)
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ùëáõù
200Ù·,
ëñí³Ï (1)
µÅßϳϻÝë³µ³Ý³Ï³Ý
å³ïñ³ëïáõÏÝ»ñÇ ÷áñÓ³ñ³ñ³Ï³Ý
³ñï³¹ñáõÃÛáõÝ
Russian cardiology research
and production complexexperimental plant for biomedical products
ÈÇÉÉÇ üñ³Ýë ê.².ê.
Lilly France S.A.S.
1000Ù·,
ëñí³Ï (1)
528
¶»Ù½³ñ
Gemzar
·»ÙóÇï³µÇÝ
gemcitabine
529
¶»Ù½³ñ
Gemzar
·»ÙóÇï³µÇÝ
gemcitabine
530
¶ºØÆ ÏáßïáõÏÇ
ùëáõù
GEMI Corn
ointmnet
¶»ÙóÇï³µÇÝ È»Ï
Gemcitabine Lek
ë³ÉÇóÇɳÃÃáõ,
Çß³éíáõÛïÇ ëå»Õ³ÝÇ
Salicylic acid, Meliloti
emplastrum
·»ÙóÇï³µÇÝ
gemcitabine
532
¶»ÙóÇï³µÇÝ È»Ï
Gemcitabine Lek
·»ÙóÇï³µÇÝ
gemcitabine
533
¶»Ýï³ÙÇóÇÝ
Gentamycin
·»Ýï³ÙÇóÇÝ
gentamycin
534
¶»Ýï³ÙÇóÇÝ
Gentamicin
¶»Ýï³ÙÇóÇÝ
Gentamicin
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
gentamicin sulfate
·»Ýï³ÙÇóÇÝ
gentamicin
531
535
536
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
³Ïݳùëáõù
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
üñ³Ýëdz
L01B C05
0436/6367
26.09.2006
26.09.2011
¸
ÈÇÉÉÇ üñ³Ýë ê.².ê.
Lilly France S.A.S.
üñ³Ýëdz
L01B C05
0437/6368
26.09.2006
26.09.2011
¸
(5·+5·)/10·,
10· åɳëïÇÏ ï³ñ³
¶»ÙÇ
Gemi
Ȼѳëï³Ý
D02AF
0543/6457/1
17.11.2006
16.10.2011
²¸
1000Ù·
(1, 5, 10)
È»Ï ¹.¹
Lek d.d.
êÉáí»Ýdz
L01B C05
1276/7244
22.10.2007
12.10.2012
¸
200Ù·
(1, 5, 10)
È»Ï ¹.¹
Lek d.d.
êÉáí»Ýdz
L01B C05
1275/7243
22.10.2007
12.10.2012
¸
80Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
0.3%,
5· å³ñÏáõ×
80Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
80Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10/2x5/)
ê³Ý³íÇï³
Sanavita
¶»ñÙ³Ýdz
J01G B03
4102
13.02.2003
13.02.2008
¸
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
´áõÉÕ³ñdz
S01A A11
1147/7150
¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
J01G B03
5501
13.09.2007
13.09.2012
23.05.2005
23.05.2010
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
J01G B03
0931/6883
03.05.2007
03.05.2012
¸
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá. ζ
Ursapharm Arzneimittel GmbH
& Co. KG
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
¶»ñÙ³Ýdz
S01AA11
0884/6910
06.04.2007
06.04.2012
¸
àõÏñ³Çݳ
JO1G B03
1133/7097
02.10.2007
08.08.2012
¸
´»É³éáõë
D06A X07
J01 G B03
5008
13.12.2004
13.12.2009
¸
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
êÉáí»Ýdz
S01G B03
0819/6824
20.03.2007
20.03.2012
¸
¶»Ýï³ÙÇóÇÝ Î
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
Ý»ñ³ñÏÙ³Ý
gentamicin sulfate
ÉáõÍáõÛÃ
Gentamicin-K
solution for injection
537 ¶»Ýï³ÙÇóÇÝ äúê ·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
Gentamicin-POS
gentamicin sulphate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
³Ïݳùëáõù
5Ù·/·,
2.5· å³ñÏáõ×
538
¶»Ýï³ÙÇóÇÝÇ
ëáõÉý³ï
Gentamicin sulfate
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
gentamicin sulfate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
4%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
539
¶»Ýï³ÙÇóÇÝÇ
ùëáõù
Gentamycin
ointment
¶»Ýï³ÙÇóÇÝ-Î
Gentamicin-K
·»Ýï³ÙÇóÇÝ
gentamicin
ùëáõù
0.1%,
15· å³ñÏáõ× Ï³Ù
15·, 20· ³å³Ï» ï³ñ³
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
gentamicin sulfate
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
40Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10/2x5/)
540
¸
39
541
542
543
¶»Ýïáë
Gentos
¶»Ýïáë
Gentos
¶»Ýý»ñáÝ
Genferon
-
ϳÃÇÉÝ»ñ
--
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
ÙáÙÇÏÝ»ñ
544
¶»Ýý»ñáÝ
Genferon
545
¶»Ýý»ñáÝ
Genferon
546
¶»ñÇï³ÙÇÝ
Geritamin
547
¶ÇݳɷÇÝ
Gynalgin
548
¶ÇÝÇåñ³É
Gynipral
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
ÇÝï»ñý»ñáÝ ³Éý³-2,
ï³áõñÇÝ, µ»Ý½áϳÛÇÝ
interferonum humanum
recombinantum
alpha-2, taurin,
benzocaine
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
ÇÝï»ñý»ñáÝ ³Éý³-2,
ï³áõñÇÝ, µ»Ý½áϳÛÇÝ
interferonum humanum
recombinantum
alpha-2, taurin,
benzocaine
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
ÇÝï»ñý»ñáÝ ³Éý³-2,
ï³áõñÇÝ, µ»Ý½áϳÛÇÝ
interferonum humanum
recombinantum
alpha-2, taurin,
benzocaine
é»ïÇÝáÉ, ïáÏáý»ñáÉ
(A ¨ E íÇï³ÙÇÝÝ»ñ)
retinol, tocopherol
(vitaminsA, E)
ùÉáñùíÇݳɹáÉ,
Ù»ïñáÝǹ³½áÉ
chlorquinaldol,
metronidazol
Ñ»ùëáåñ»Ý³ÉÇÝ
hexoprenaline
549
¶ÇÝÇåñ³É
Gynipral
¶ÇÝÇåñ³É
Gynipral
Ñ»ùëáåñ»Ý³ÉÇÝ
hexoprenaline
Ñ»ùëáåñ»Ý³ÉÇÝ
hexoprenaline
551
¶ÇÝÏáñ ¹áݹáÕ
Ginkor gel
552
¶ÇÝÏáñ ýáñï
Ginkor Fort
553
¶ÇÝÏáý³ñ
Ginkofar
554
¶ÇÝáÙ»ï
Ginomet
·ÇÝÏ·á µÇÉáµ³ÛÇ
ѳÝáõÏ, ïñáùë»ñáõïÇÝ
ginkgo biloba extract,
troxerutin
ïñáùë»ñáõïÇÝ, ·ÇÝÏ·á
µÇÉáµ³, Ñ»åï³ÙÇÝáÉ
troxerutin, ginkgo
biloba, heptaminol
·ÇÝÏ·á µÇÉáµ³ÛÇ
ï»ñ¨Ý»ñÇ ãáñ ѳÝáõÏ
Ginkgo biloba leaves
dry extract
Ù»ïñáÝǹ³½áÉ,
ÙÇÏáݳ½áÉ
550
20ÙÉ,
50ÙÉ,100ÙÉ ßßÇÏ
(20, 40)
(1000000ØØ+
0,01·+ 0,055·)
(10)
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Richard Bittner AG
èÇ˳ñ¹ ´ÇÃÝ»ñ ¶ÙµÐ
Richard Bittner AG
´Çáϳ¹ ö´À
Biokad CJSC
²íëïñdz
1414/5893/1
èáõë³ëï³Ý
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
L03AB04
²íëïñdz
5539
1040/6970
08.08.2005
08.08.2010
03.12.2007
07.12.2011
21.06.2007
21.06.2012
²¸
²¸
¸
ÙáÙÇÏÝ»ñ
(250000ØØ+
0,01·+ 0,055·)
(10)
´Çáϳ¹ ö´À
Biokad CJSC
èáõë³ëï³Ý
L03AB04
1039/6968
21.06.2007
21.06.2012
¸
ÙáÙÇÏÝ»ñ
(500000ØØ+
0,01·+ 0,055·)
(10)
´Çáϳ¹ ö´À
Biokad CJSC
èáõë³ëï³Ý
L03AB04
1038/6969
21.06.2007
21.06.2012
¸
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
30000ØØ+0.07·
(20)
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
´áõÉÕ³ñdz
A11C
A11H
4081
14.01.2003
14.01.2008
²¸
¹»Õ³Ñ³ï»ñ
Ñ»ßïáó³ÛÇÝ
100Ù·+250Ù·
(10)
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
ICN Polfa Rzeszow S.A.
Ȼѳëï³Ý
G01A F01
0451/6335
29.09.2006
29.09.2011
¸
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
10ÙÏ·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
0.5Ù·
(20/2x10/)
25ÙÏ·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
(0.14·+3·)/100·,
40· å³ñÏáõ×
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
R05C C05
0741/6767
15.02.2007
15.02.2012
¸
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
R05C C05
0740/6768
¸
²íëïñdz
R05C C05
0742/6766
15.02.2007
15.02.2012
15.02.2007
15.02.2012
´áýáõñ Æåë»Ý ÆݹáõëïñÇ
Beaufour Ipsen Industrie
üñ³Ýëdz
N06B
5088
06.09.2004
06.09.2009
²¸
¹»Õ³Ñ³ï»ñ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹áݹáÕ
¸
¹»Õ³å³ïÇ×Ý»ñ
300Ù·+14Ù·+
300Ù·
(20,30,40,60)
´áýáõñ Æåë»Ý ÆݹáõëïñÇ
Beaufour Ipsen Industrie
üñ³Ýëdz
C05C
N06B
C01D
4226
06.03.2003
06.03.2008
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
40Ù·
(20, 60)
´Çáý³ñÙ êå, ½.û.û
Biofarm Sp z.o.o.
Ȼѳëï³Ý
µáõë³Ï³Ý
N06BX19
0329/6300
11.08.2006
11.08.2011
²¸
¹»Õ³Ñ³ï»ñ
Ñ»ßïáó³ÛÇÝ
(500Ù·+100Ù·)
(14)
XL ɳµáñ³ïáñdz PVT Èï¹.
XL Laboratories PVT Ltd.
Ðݹϳëï³Ý
G01A F01
0014/6056
12.05.2006
12.05.2011
¸
40
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
¶ÇÝá-ä»í³ñÇÉ
Gyno-Pevaryl
¶ÇÝá-ä»í³ñÇÉ
Gyno-Pevaryl
¶ÇÝáýáñï
Gynofort
metronidazole,
miconazole
¿Ïáݳ½áÉ
econazol
¿Ïáݳ½áÉ
econazol
µáõïáÏáݳ½áÉ
butoconazole
¶Çñ³µÉáÏ
Gyrablock
¶É³áõýáë
Glaufos
¶É³áùë
Glaox
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
Ýñµ³ùëáõù
Ñ»ßïáó³ÛÇÝ
150Ù·
(3)
50Ù·
(15)
2%,
5· Ýñµ³ùëáõù
Ý»ñ¹ñáõÏáõÙ
ÝáñýÉûùë³óÇÝ
norfloxacin
ûýÉûùë³óÇÝ
ofloxacine
µ»ï³ùëáÉáÉ
betaxolol
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
³ÏݳϳÃÇÉÝ»ñ
400Ù·
(14,100)
200Ù·
(10,1000x10)
0,5%,
5ÙÉ ßßÇÏ
¶É³í»ñ³É
Glaveral
¶ÉdzïÇÉÇÝ
Gliatilin
ûÙ»åñ³½áÉ
omeprazole
ËáÉÇÝÇ ³Éýáëó»ñ³ï
choline alfoscerate
¹»Õ³å³ïÇ×Ý»ñ
¶ÉdzïÇÉÇÝ
Gliatilin
¶Éǵ»Ý»½ é»ï³ñ¹
Glibenese Retard
ËáÉÇÝÇ ³Éýáëó»ñ³ï
choline alfoscerate
·ÉÇåǽǹ
glipizide
¶Éǵ»ÝÏɳÙǹ
Glibenclamid
¶Éǵ»ÝÏɳÙǹ¼¹áñáíÛ»
GlibenclamidZdorovye
¶ÉÇÏɳ½Ç¹
Gliclazide
¶ÉÇÏɳ½Ç¹
¹»Õ³Ñ³ï»ñ 80Ù·
Gliclazide Tablets
80mg
¶ÉÇÏá¹ÇÝ
Glycodin
·Éǵ»ÝÏɳÙǹ
glibenclamide
·Éǵ»ÝÏɳÙǹ
glibenclamide
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
20Ù·
(14)
1000Ù·/4ÙÉ,
4ÙÉ ³ÙåáõÉÝ»ñ
(5)
400Ù·
(14)
5Ù·
(30)
¶ÉÇí»Ï
Glivec
¶ÉÇí»Ï
Glivec
¶ÉÇó»ñÇÝ
Glycerin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
5Ù·
(50)
5Ù·
(50, 50/5x10/,
120/6x20/)
Þí»Ûó³ñdz
N02A B03
1153/7211
Þí»Ûó³ñdz
N02A B03
1154/7210
²ØÜ
G01A F15
4219
ÎÇåñáë
J01M A06
0208/6168
سϻ¹áÝdz
J01M A01
5797
г۳ëï³Ý
S01E D02
1281/7249
Ðáõݳëï³Ý
A02B C01
5299
Æï³Édz
N07A X02
1274/7241
Æï³Éý³ñÙ³Ïá ê.å.².
Italfarmaco S.p.A.
öý³Û½»ñ ä¶Ø
Pfizer PGM
Æï³Édz
N07A X02
1273/7242
üñ³Ýëdz
A07B B07
0427/6409
г۳ëï³Ý
A10B B01
5631
àõÏñ³Ýdz
A10B B01
1247/7055
г۳ëï³Ý
A10B B09
4204
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
A01B B09
4417
¾ëÏáõɳå êäÀ
Esculap Ltd.
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë
CP Pharmaceuticals
13.09.2007
13.09.2012
13.09.2007
13.09.2012
06.05.2005
01.09.2008
¸
21.07.2006
21.07.2011
01.11.2005
01.11.2010
15.10.2007
12.10.2012
¸
13.01.2005
13.01.2010
12.10.2007
12.10.2012
¸
12.10.2007
12.10.2012
26.09.2006
26.09.2011
¸
21.10.2005
21.10.2010
15.10.2007
15.10.2012
¸
10.02.2003
10.02.2008
15.07.2003
15.07.2008
¸
¸
¸
¸
¸
¸
¸
¸
·ÉÇÏɳ½Ç¹
gliclazide
·ÉÇÏɳ½Ç¹
gliclazide
¹»Õ³Ñ³ï»ñ
ï»ñåÇÝ Ñǹñ³ï,
¹»ùëïñáÙ»Ãáñý³Ý,
ɨáÙ»ÝÃáÉ
terpin hydrate,
dextromethorphan,
levomenthol
ÇÙ³ïÇÝÇµÇ Ù»½Çɳï
imatinib mesylate
ÇÙ³ïÇÝÇµÇ Ù»½Çɳï
imatinib mesylate
·ÉÇó»ñáÉ
glycerol
ûß³ñ³Ï
(10Ù·+10Ù·+
3.75Ù·)/ 5ÙÉ,
50ÙÉ,100ÙÉ ßßÇÏ
²É»ÙµÇÏ ÈÇÙÇﻹ
Alembic Limited
Ðݹϳëï³Ý
R05D
0062/6148
30.05.2006
30.05.2011
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÙáÙÇÏÝ»ñ
400Ù·
(30)
100Ù·
(60)
2.11·
(10)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
Þí»Ûó³ñdz
L01XX28
4610
¸
Þí»Ûó³ñdz
L01XX28
4609
èáõë³ëï³Ý
A06AG04
0334/6352
02.12.2003
02.12.2008
02.12.2003
02.12.2008
11.08.2006
11.08.2011
¹»Õ³Ñ³ï»ñ
80Ù·
(50)
80Ù·,
(28,30,56,60)
êÇɳ· ²¶
Cilag AG
êÇɳ· ²¶
Cilag AG
Îì ü³ñÙ³ëÛáõÃÇù³É øáÙå³ÝÇ,
²ØÜ (¶»¹»áÝ èÇËï»ñ,
ÐáõÝ·³ñdzÛÇ Ñ³Ù³ñ)
KV Pharmaceutical Company,
USA (for Gedeon Richter,
Hungary)
Ø»¹áù»ÙÇ Èï¹
Medochemie Ltd
ڲβ-80
JAKA-80
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
Æï³Éý³ñÙ³Ïá ê.å.².
Italfarmaco S.p.A.
¸
¸
²¸
41
573
¶ÉÇó»ñÇÝ
ÙáÙÇÏÝ»ñ ´ä
ٻͻñÇ
Glycerin
suppositories BP
adult size
¶ÉÇóÇÝ
Glycine
·ÉÇó»ñáÉ
glycerol
ÙáÙÇÏÝ»ñ
áõÕÇÕ³ÕÇù³ÛÇÝ
4·
(12)
¾ÉêǾ٠êäÀ (ÂáñáÝïáÝ ¨
èáë êäÀ-Ç Ñ³Ù³ñ)
LCM Ltd (forThoronton & Ross
Ltd)
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
A06A X01
1440/7394
20.12.2007
20.12.2012
²¸
·ÉÇóÇÝ
glycine
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
0.1·
(50)
èáõë³ëï³Ý
B05C X03
1026/6963
13.06.2007
13.06.2012
¸
¶ÉÛáõÏáµ³Û
Glucobay
¶ÉÛáõÏáµ³Û
Glucobay
¶ÉÛáõÏá½
Glucose
³Ï³ñµá½
acarbose
³Ï³ñµá½
acarbose
¹»ùëïñá½
dextrose
¹»Õ³Ñ³ï»ñ
¶»ñÙ³Ýdz
A10B F01
5922
¶»ñÙ³Ýdz
A10B F01
5923
г۳ëï³Ý
B05BA03
0709/6650
02.03.2006
02.03.2011
02.03.2006
02.03.2011
25.01.2007
25.01.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
50Ù·
(30)
100Ù·
(30)
40% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
578
¶ÉÛáõÏá½
Glucosa
¹»ùëïñá½
dextrose
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
40% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10,10/2x5/)
´»É³éáõë
B05B A03
0951/6872
03.05.2007
03.05.2012
¸
579
¶ÉÛáõÏá½
Glucose
¹»ùëïñá½
dextrose
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
г۳ëï³Ý
B05C X01
1090/7098
01.10.2007
08.08.2012
¸
580
¶ÉÛáõÏá½Ç 10%
ÉáõÍáõÛÃ
Glucose 10%
solution
¹»ùëïñá½
dextrose
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ü³ñÙ³ï»ù ¸.Ò.
Pharmatech S.E.
г۳ëï³Ý
-
4351
08.04.2005
08.04.2010
¸
581
¶ÉÛáõÏá½Ç 5%
ÉáõÍáõÛÃ
Glucose 5%
solution
¹»ùëïñá½
dextrose
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ü³ñÙ³ï»ù ¸.Ò.
Pharmatech S.E.
г۳ëï³Ý
-
4350
08.04.2005
08.04.2010
¸
582
¶ÉÛáõÏáí³Ýë
Glucovance
Ù»ïýáñÙÇÝ,
·Éǵ»ÝÏɳÙǹ
metformin,
glibenclamide
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5%,
200ÙÉ, 250ÙÉ,
500ÙÉ, 3000ÙÉ
åɳëïÇÏ ï³ñ³
10%,
100ÙÉ, 200ÙÉ,
250ÙÉ, 500ÙÉ,
1000ÙÉ, 2000ÙÉ,
3000ÙÉ åɳëïÇÏ
÷³Ã»Ã
5%,
100ÙÉ, 200ÙÉ,
250ÙÉ, 500ÙÉ,
1000ÙÉ, 2000ÙÉ,
3000ÙÉ åɳëïÇÏ
÷³Ã»Ã
500Ù·+2.5Ù·
(30)
§´ÆàîÆÎƦ µÅßϳϳÝ
·Çï³³ñï³¹ñ³Ï³Ý ÙdzíáñáõÙ êäÀ
Open JSC Medical Scientific
and Production Complex
§BIOTIKI¦
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳϳÝ
ýÇñÙ³ ´´À
Yerevan ChemicalPharmaceutical firm Open J/S
Company
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
üñ³Ýëdz
A10B D02
5914
19.01.2006
19.01.2011
¸
583
¶ÉÛáõÏáí³Ýë
Glucovance
Ù»ïýáñÙÇÝ,
·Éǵ»ÝÏɳÙǹ
metformin,
glibenclamide
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·+5Ù·
(30)
üñ³Ýëdz
A10B D02
5915
19.01.2006
19.01.2011
¸
584
¶ÉÛáõÏáý³Å
Glucophage
Ù»ïýáñÙÇÝ
metformin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(30,60)
Ø»ñÏ ê³Ýï» ë.³.ë., (ÜÇÏáÙ»¹
²íëïñdz ¶ÙµÐ, ²íëïñdzÛÇ
ѳٳñ)
Merck Sante s.a.s., France (for
Nycomed Austria GmbH,
Austria)
Ø»ñÏ ê³Ýï» ë.³.ë., (ÜÇÏáÙ»¹
²íëïñdz ¶ÙµÐ, ²íëïñdzÛÇ
ѳٳñ)
Merck Sante s.a.s., (for
Nycomed Austria GmbH,
Austria)
Ø»ñÏ ê³Ýï» ë.³.ë., (ÜÇÏáÙ»¹
²íëïñdz ¶ÙµÐ, ²íëïñdzÛÇ
üñ³Ýëdz
A10B A02
5911
19.01.2006
19.01.2011
¸
574
575
576
577
¹»Õ³Ñ³ï»ñ
¸
¸
42
585
¶ÉÛáõÏáý³Å
Glucophage
Ù»ïýáñÙÇÝ
metformin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
850Ù·
(30,60)
586
¶ÉÛáõÏáý³Å
Glucophage
Ù»ïýáñÙÇÝ
metformin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1000Ù·
(30,60)
587
¶ÉÛáõý»ñ³É
Gluferal
¹»Õ³Ñ³ï»ñ
25Ù·+70Ù·+5Ù·+
200Ù·
(10,20,30)
588
¶ÉáñÇùëáÝ
Glorixon
ý»Ýáµ³ñµÇï³É,
µñáÙǽáí³É, Ïáý»ÇÝÇ
ݳïñÇáõÙ µ»Ý½á³ï,
ϳÉóÇáõÙÇ ·ÉÛáõÏáݳï
phenobarbital,
bromisoval, caffeine
sodium benzoate,
calcium gluconate
ó»ýáï³ùëÇÙ
cefotaxime
1·,
ëñí³Ï/³ÙåáõÉ (1)
589
¶ÉáñÇùëáÝ
Glorixon
ó»ýáï³ùëÇÙ
cefotaxime
590
¶¨Ï³Ù»Ý ùëáõù
Geucamen ointment
Ù»ÝÃáÉ, ù³÷áõñ,
ÝÇí»Ýáõ ÛáõÕ
menthol, camphora,
eucalypt oil
¹»Õ³÷áßÇ Ý/»
Ý»ñ³ñÏÙ³Ý,
10ÙÉ Ý»ñ³ñÏÙ³Ý
çáõñ ÉáõÍãáí
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý,
3.5ÙÉ
ÉǹáϳÛÇÝÇ 1%
ÉáõÍáõÛÃ ÉáõÍãáí
ùëáõù
591
¶áɹ»Ý
·ÇÝÏ·á/·ÇÝÏ·á
µÇÉáµ³
Golden
Ginkgo/ginkgo
biloba
¶áݳÉ-ü
Gonal-F
-
å³ïÇ×Ý»ñ
ýáÉÇïñáåÇÝ ³Éý³
follitropin alfa
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ, 1ÙÉ
ÉáõÍãáí
75ØØ,
ëñí³Ï/ ݳ˳Éóí³Í
Ý»ñ³ñÏÇã (1)
¶áñ¹áùë
Gordox
³åñáïÇÝÇÝ
aprotinin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100000Ø(ÎÆØ)/
10ÙÉ,
10ÙÉ ³ÙåáõÉÝ»ñ
(25)
592
593
ѳٳñ)
Merck Sante s.a.s., (for
Nycomed Austria GmbH,
Austria)
Ø»ñÏ ê³Ýï» ë.³.ë., (ÜÇÏáÙ»¹
²íëïñdz ¶ÙµÐ, ²íëïñdzÛÇ
ѳٳñ)
Merck Sante s.a.s., (for
Nycomed Austria GmbH,
Austria)
Ø»ñÏ ê³Ýï» ë.³.ë., ÜÇÏáÙ»¹
²íëïñdz ¶ÙµÐ, ²íëïñdzÛÇ
ѳٳñ)
Merck Sante s.a.s., (for
Nycomed Austria GmbH,
Austria)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED
J.V. CJ-S Co.
üñ³Ýëdz
A10B A02
5912
19.01.2006
19.01.2011
¸
üñ³Ýëdz
A10B A02
5913
19.01.2006
19.01.2011
¸
г۳ëï³Ý
N
5303
30.12.2004
30.12.2009
¸\Ð
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
Ðáõݳëï³Ý
J01D D01
0173/5300
13.07.2006
13.07.2011
¸
1·,
ëñí³Ï/³ÙåáõÉ (1)
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
Ðáõݳëï³Ý
J01D D01
0174/5301
13.07.2006
13.07.2011
¸
(18·+10·+10·)/
100·,
15·,20·,25·,40·
å³ñÏáõ× Ï³Ù ³å³Ï»
ï³ñ³
20Ù·
(60)
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´»É³éáõë
-
5009
13.12.2004
13.12.2009
²¸
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
²ØÜ
βêÐ
N06B X19
5395
16.03.2005
16.03.2010
²¸
Æݹáõëïñdz ü³ñÙ³ó¨ïÇϳ
ê»ñáÝá ê.å.². (ê»ñáÝá ºáõñáå
êäÀ, ØdzóÛ³É
³·³íáñáõÃÛáõÝ)
Industria Farmaceutica Serono
S.p.A. (for Serono Europe Ltd,
UK)
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
Æï³Édz
G03GA05
1501/7442
20.12.2007
20.12.2012
¸
ÐáõÝ·³ñdz
B02A B01
5422
30.05.2005
30.05.2010
¸
43
594
¶ñ³Ý¹³ùëÇÝ
Grandaxin
Ãáýǽáå³Ù
tophisopam
¹»Õ³Ñ³ï»ñ
595
¶ñǽ»áýáõÉíÇÝ
Griseofulvin
·ñǽ»áýáõÉíÇÝ
griseofulvin
¹»Õ³Ñ³ï»ñ
596
597
598
599
600
601
602
603
604
605
606
607
50Ù·
(20/2x10/,60/6x
10/)
125Ù·
(40/2x20/)
¾¶Æê ´´À
EGIS LLC
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
¶ñÇÝ Ù»çÇÏ
÷áßÇ
27·,142·, 283.5· ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
Green Magic
New Spirit Naturals Inc.
¶ñÇåáóÇïñáÝå³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ Ý»ñùÇÝ (500Ù·+50Ù·+20Ù·
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
¼¹áñáíÛ»
³ëÏáñµÇݳÃÃáõ,
ÁݹáõÝÙ³Ý
+ 10Ù·),
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Grippocitroný»ÝÇñ³ÙÇÝÇ Ù³É»³ï,
ÉáõÍáõÛÃÇ
2,2· ÷³Ã»ÃÇÏÝ»ñ
Zdorovye Pharmaceutical
Zdorovye
ý»ÝÇÉ¿ýñÇÝÇ
(10)
Company LLC
ÑǹñáùÉáñǹ
paracetamol, ascorbic
acid, pheniramine
maleate, phenylephrine
hydrochloride
¶ñÇåý»ñáÝ
ùóϳÃÇÉÝ»ñ
10000ØØ/ÙÉ,
üÆðÜ-Ø
ÇÝï»ñý»ñáÝ  2-³
Grippferon
5ÙÉ,10ÙÉ ßßÇÏ
FIRN-M
interferone  2-a
¸³É³ñ·ÇÝ
¹³É³ñ·ÇÝ
¹»Õ³÷áßÇ
0.001·,
´ÇáÉ»Ï ö´À
Dalargin
dalargin
ÉÇáýÇÉǽ³óí³Í,
³ÙåáõÉÝ»ñ (10)
Biolek CJSC
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¸³É³óÇÝ
ÏÉÇݹ³ÙÇóÇÝÇ ýáëý³ï
Ýñµ³ùëáõù
2%,
ü³ñÙ³ódz ¨ ²åçáÝ øáÙå³ÝÇ
Dalacin
clindamycine
Ñ»ßïáó³ÛÇÝ
20· å³ñÏáõ×,
Pharmacia & Upjohn Company
phosphate
3 Ý»ñ¹ñáõÏÝ»ñ
¸³Ïï³ñÇÝ óáÕ³ßÇÃáí ÙÇÏáݳ½áÉÇ ÝÇïñ³ï
¹»Õ³÷áßÇ
0.16%,
ü³ñÙ³ëáÉ Èï¹.(ØdzóÛ³É
¹»Õ³÷áßÇ
miconazole nitrate
óáÕ³ßÇÃáí
105· ¹»Õ³÷áßÇ
³·³íáñáõÃÛáõÝ) Ú³Ýë»Ý
Daktarin spray
óáÕ³óÇñ ë³ñùáõÙ ü³ñÙ³ëÛáõÃÇù³ Ü.ì. (´»É·Ç³)-Ç
powder
ѳٳñ
Pharmasol Ltd. (UK) for
Janssen Pharmaceutica N.V.
(Belgium)
¸³Ýáí³É
¹³Ý³½áÉ
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
Danoval
danazol
(100)
KRKA d.d. Novo mesto
¸³åëáÝ
¹³åëáÝ
¹»Õ³Ñ³ï»ñ
100Ù·
²ðöÆغ¸ ÐÒ ö´À
Dapsone
dapsone
(50)
ARPIMED J.V. CJ-S Co
¸³ùëáï»É
¹áó»ï³ùë»É
Ëï³ÝÛáõÃ
80Ù·/2ÙÉ,
¸²´àõð ü³ñÙ³ Èï¹
Daxotel
docetaxel
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï/ëñí³Ï (1)
DABUR Pharma Ltd
ÉáõÍáõÛÃÇ,
6ÙÉ ÉáõÍãáí
¸³ùëáï»É
¹áó»ï³ùë»É
Ëï³ÝÛáõÃ
20Ù·/0,5ÙÉ,
¸²´àõð ü³ñÙ³ Èï¹
Daxotel
docetaxel
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï/ëñí³Ï (1)
DABUR Pharma Ltd
ÉáõÍáõÛÃÇ,
1,5ÙÉ ÉáõÍãáí
¸³ýÝ»çÇÝ
óÇÏÉáåÇñûùë
Ýñµ³ùëáõù
1%,
¸áå»É ü³ñÙ³ëÛáõÃÇóÇ ê.é.È.
Dafnegin
ciclopirox
Ñ»ßïáó³ÛÇÝ
78· å³ñÏáõ×,
(äáÉÇ Æݹáõëïñdz øÇÙÇϳ
6 Ý»ñ¹ñáõÏ)
ê.å.²-Ç Ñ³Ù³ñ)
Doppel Farmaceutici S.r.L. for
Poli Industria Chimica S.p.A.
¸³ýÝ»çÇÝ
óÇÏÉáåÇñûùë
Ñ»ßïáó³ÙáÙÇÏ100Ù·
¸áå»É ü³ñÙ³ëÛáõÃÇóÇ ê.é.È.
Dafnegin
ciclopirox
Ý»ñ
(6)
(äáÉÇ Æݹáõëïñdz øÇÙÇϳ
ê.å.²-Ç Ñ³Ù³ñ)
ÐáõÝ·³ñdz
N05B A23
0925/6941
26,04.2007
26.04.2012
¸\Ð
àõÏñ³Çݳ
D01B A01
0775/6698
07.03.2007
07.03.2012
¸
²ØÜ
βêÐ
5103
²¸
àõÏñ³Çݳ
N02B E51
1350/7311
20.09.2004
20.09.2009
05.11.2007
05.11.2012
èáõë³ëï³Ý
L03A B04
4171
²¸
àõÏñ³Çݳ
A02X
0521/6514
13.02.2003
13.02.2008
10.11.2006
10.11.2011
²ØÜ
D07B C01
5495
22.04.2005
22.04.2010
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
D01A C02,
G01A F04,
J02A B01
4499
08.09.2003
08.09.2008
²¸
êÉáí»Ýdz
G03X A01
0658/6567
¸
г۳ëï³Ý
J04B A02
0682/6735
Ðݹϳëï³Ý
L01C D01
0694/6627
12.01.2007
12.01.2012
17.01.2007
17.01.2012
25.01.2007
25.01.2012
Ðݹϳëï³Ý
L01C D01
0695/6626
25.01.2007
25.01.2012
¸
Æï³Édz
G01A X12
5045
20.08.2004
20.08.2009
¸
Æï³Édz
G01A X12
5046
20.08.2004
20.08.2009
¸
²¸
¸
¸
¸
44
608
¸»Ï³ïÇÉ»Ý
Decatylen
609
¸»Ï³ñÇë
Decaris
¸»Ï³ñÇë
Decaris
¸»Õ³Ñ³ï»ñ ѳ½Ç
¹»Ù
Tablets for cough
610
611
612
613
614
¸»-ÜáÉ
De-Nol
¸»å³ÏÇÝ ¿Ýï»ñÇÏ
300
Depakine enteric
300
¸»åá-Ù»¹ñáÉ
Depo-medrol
¹»ùí³ÉÇÝÇáõÙÇ
ùÉáñǹ, ¹ÇµáõϳÛÇÝÇ
ÑǹñáùÉáñǹ
dequalinium chloride,
dibucaine hydrochloride
ɨ³ÙǽáÉ
levamisole
ɨ³ÙǽáÉ
levamisole
ûñÙáåëÇëÇ Ëáï,
ݳïñÇáõÙÇ
Ñǹñáϳñµáݳï
Thermopsis-herb,
sodium hydrocarbonate
µÇëÙáõÃÇ ëáõµóÇïñ³ï
bismuth subcitrate
í³Éåñá³ï ݳïñÇáõÙÇ
valproate sodium
Éá½³ÝÝ»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0,25Ù·+0,03Ù·
(20)
Doppel Farmaceutici S.r.L. for
Poli Industria Chimica S.p.A.
Ø»ý³ Èï¹.
Mepha Ltd.
50Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
(2)
Gedeon Richter Ltd.
150Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
(1)
Gedeon Richter Ltd.
(0.0067·+0.2500·)
³ÃùÇÙý³ñÙåñ»å³ñ³ïÇ ´´À
(10)
Tatchimpharmpreparaty OJSC
Þí»Ûó³ñdz
R02A A02
0622/6673
27.12.2006
27.12.2011
²¸
ÐáõÝ·³ñdz
P02CE01
5414
¸
ÐáõÝ·³ñdz
P02CE01
5415
èáõë³ëï³Ý
-
5776
14.12.2005
14.12.2010
14.12.2005
14.12.2010
17.03.2006
17.03.2011
120Ù·
(112)
300Ù·
(100)
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
ê³ÝáýÇ ìÇÝïñáå Æݹ³ëïñÇ
Sanofi Winthrop Industrie
Üǹ»éɳݹݻñ
üñ³Ýëdz
A02B X05
5462
N03A G01
5577
öý³Û½»ñ سÝáõý³ÏïáõñÇÝ·
´»É·Ç³ Ü.ì.
Pfizer Manufakturing Belgium
N.V.
´Çáý³ñÙ ´À
Biopharm JSC
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
ê»ñíÇ» ɳµáñ³ïáñdz
Les
Laboratoires Servier
´»É·Ç³
H02A B04
ìñ³ëï³Ý
¸
²¸
23.06.2005
23.06.2010
07.07.2005
07.07.2010
¸
0426/6384
26.09.2006
26.09.2011
¸
H01B A02
4684
¸
Æéɳݹdz
βêÐ
5826
08.01.2004
08.01.2009
26.10.2005
26.10.2010
üñ³Ýëdz
C05C A53
4596
26.11.2003
26.11.2008
¸
¸
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
¹»Õ³Ï³ËáõÛÃ
40Ù·/ÙÉ,
1ÙÉ ëñí³Ï
¸»ëÙáåñ»ëÇÝ
Desmopressin
¸»ïáùë+
Detox+
¹»ëÙáåñ»ëÇÝ
desmopressin
-
ùóϳÃÇÉÝ»ñ
0.1Ù·/ÙÉ,
5ÙÉ ßßÇÏ
387.5Ù·
(60)
617
¸»ïñ³É»ùë
Detralex
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
450Ù·+50Ù·
(30)
618
¸»ñÙ³½ÇÝ
Dermazin
¹ÇáëÙÇÝ,
Ñ»ëå»ñǹÇÝ diosmin,
hesperidin
³ñͳÃÇ ëáõÉý³¹Ç³½ÇÝ
silver sulfadiazine
Ýñµ³ùëáõù
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
D06B A01
5271
07.02.2005
07.02.2010
¸
619
¸»ñÙ³ïñÇÉ
Dermatril
Ýñµ³ùëáõù
²ðöÆغ¸ Ð/Ò ö´À
ARPIMED J.V. CJ-S Co
г۳ëï³Ý
D07CC01
1378/7340
06.11.2007
05.11.2012
¸
620
¸»ñÙáí³ï
Dermovate
µ»ï³Ù»Ã³½áÝ,
ÏÉáïñÇÙ³½áÉ,
·»Ýï³ÙÇóÇÝ
betamethasone,
clotrimazole,
gentamicin
ÏÉᵻﳽáÉ
clobetasole
1%,
50· å³ñÏáõ×,
250· ï³ñ³
(0,5Ù·+10Ù·+1Ù·)/
1g,
15· å³ñÏáõ×
Ýñµ³ùëáõù
0.05%,
25· å³ñÏáõ×
Ȼѳëï³Ý
D07A D01
4331
15.07.2003
15.07.2008
¸
621
¸»ñÙáí³ï
Dermovate
ÏÉᵻﳽáÉ
clobetasole
ùëáõù
0.05%,
25· å³ñÏáõ×
Ȼѳëï³Ý
D07A D01
4330
15.07.2003
15.07.2008
¸
622
¸»ùë³-·»Ýï³ÙÇóÇÝ
Dexa-Gentamicin
¹»ùë³Ù»Ã³½áÝ,
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
dexamethasone,
³Ïݳùëáõù
(0.3Ù·+5Ù·)/1·,
2.5· å³ñÏáõ×
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë
GlaxoSmithKline
Pharmaceuticals
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë
GlaxoSmithKline
Pharmaceuticals
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
¶»ñÙ³Ýdz
D07C B04
5889
07.02.2006
07.02.2011
¸
615
616
å³ïÇ×Ý»ñ
²¸
45
623
¸»ùë³-·»Ýï³ÙÇóÇÝ
Dexa-Gentamicin
624
¸»ùë³½áÝ
Dexason
gentamicin sulfate
¹»ùë³Ù»Ã³½áÝ,
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
dexamethasone,
gentamicin sulfate
¹»ùë³Ù»Ã³½áÝ
dexamethasone
625
¸»ùë³½áÝ
Dexason
626
¸»ùë³ÃáµñáÙ
DexaTobrom
627
¸»ùë³É·ÇÝ
Dexalgin
628
& Co.KG
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶»ñÙ³Ýdz
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co.KG
¶³É»ÝÇϳ ³.¹.
гñ³íëɳ-ídz
Galenika a.d.
³ÏݳϳÃÇÉÝ»ñ
(1Ù·+5Ù·)/1ÙÉ,
5ÙÉ ßßÇÏ)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
4Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(25)
¹»ùë³Ù»Ã³½áÝ
dexamethasone
¹»Õ³Ñ³ï»ñ
0.5Ù·
(50)
¶³É»ÝÇϳ ³.¹.
Galenika a.d.
гñ³íëɳ-ídz
³ÏݳϳÃÇÉÝ»ñ
(¹»Õ³Ï³ËáõÛÃ)
(1Ù·+3Ù·)/ÙÉ,
5ÙÉ ßßÇÏ
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
25Ù·
(10, 30, 50)
¸»ùë³Ïáñï
Dexacort
¹»ùë³Ù»Ã³½áÝ,
Ãáµñ³ÙÇóÇÝ
dexamethasone,
tobramycin
¹»ùëÏ»ïáåñáý»ÝÇ
ÃñáÙ»ï³ÙáÉ
dexketoprofen
trometamol
¹»ùë³Ù»Ã³½áÝ
dexamethasone
³Ïݳ-/
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
0.1%,
5ÙÉ ßßÇÏ
629
¸»ùë³Ù»Ã³½áÝ
Dexamethason
¹»ùë³Ù»Ã³½áÝ
dexamethasone
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
¸³ñáõ ö³Ëß ü³ñÙ³ëÛáõÃÇù³É
Øý·.øá.
Darou Pakhsh Pharmaceutical
Mfg.Co.
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
630
¸»ùë³Ù»Ã³½áÝ
Dexamethason
¹»ùë³Ù»Ã³½áÝ
dexamethason
631
¸»ùë³Ù»Ã³½áÝ
Dexamethason
¸»ùë³Ù»Ã³½áÝ
Dexamethason
¸»ùë³Ù»Ã³½áÝ
Dexamethasone
¹»ùë³Ù»Ã³½áÝ
dexamethason
¹»ùë³Ù»Ã³½áÝ
dexamethasone
¹»ùë³Ù»Ã³½áÝ
dexamethasone
¸»ùë³Ù»Ã³½áÝ
Dexamethason
¸»ùë³Ù»Ã³½áÝÈÇÏíá
DexamethasoneLiqvo
¸»ùë³åáë
Dexapos
¹»ùë³Ù»Ã³½áÝ
dexamethason
¹»ùë³Ù»Ã³½áÝ
dexamethasone
¹»ùë³Ù»Ã³½áÝ
dexamethasone
³ÏݳϳÃÇÉÝ»ñ
0.1%,
5ÙÉ ßßÇÏ
¸»ùëå³ÝûÝáÉлÙáý³ñÙ
DexpanthenolHemofarm
¹»ùëå³ÝûÝáÉ
dexpanthenol
ùëáõù
5%,
30· å³ñÏáõ×
632
633
634
635
636
637
4Ù·/1ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(25/5x5/)
¹»Õ³Ï³ËáõÛÃ
0.1%,
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
(³ÏݳϳÃÇÉÝ»ñ)
10ÙÉ ³å³Ï» ßßÇÏ,
ê²
5ÙÉ åɳëïÇÏ ßßÇÏ Warsaw Pharmaceutical Works
§Polfa¦ SA
³ÏݳϳÃÇÉÝ»ñ
0,1%;
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
(¹»Õ³Ï³ËáõÛÃ)
10ÙÉ ßßÇÏ
Rompharm Company SRL
¹»Õ³Ñ³ï»ñ
0.0005·
²ÏñÇËÇÝ ´´À
Akrikhin
(50)
Open JSC
ÉáõÍáõÛÃ
0.4%,
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
Ý»ñ³ñÏÙ³Ý
1ÙÉ ³ÙåáõÉÝ»ñ
êäÀ-Ç Ù³ëݳ×ÛáõÕ ù.ʳñÏáí
(5)
Branch of LCC §Experimental
plant GNCLS¦ c.Kharkov
¹»Õ³Ñ³ï»ñ
0,5Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(10)
KRKA d.d. Novo mesto
¹»Õ³Ï³ËáõÛà ³ãùÇ
0.1%,
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
10ÙÉ ßßÇÏÝ»ñ
Ó»éݳñÏáõÃÛáõÝ
ϳÃáóÇÏáí
Liqvor Pharmaceuticals
S01C A01,
S02C A06
5890
07.02.2006
07.02.2011
¸
4580
24.11.2003
24.11.2008
¸
4581
24.11.2003
24.11.2008
¸
èáõÙÇÝdz
A01A C02
C05A A09
D07A B19
D10A A03
H02A B02
C05A A09
D07A B19
H02A B02
R01A D03
S01C A01
0184/6263
13.07.2006
13.07.2011
¸
¶»ñÙ³Ýdz
M01AE
0736/6750
15.02.2007
15.02.2012
¸
Æñ³Ý
4591
05.11.2003
05.11.2008
¸
êÉáí»Ýdz
S01B A01
S01C B01
S02B A06
S03B A01
A01A C02
0647/6658
12.01.2007
12.01.2012
¸
Ȼѳëï³Ý
S01 BA
0020/4283/1
12.05.2006
26.05.2008
¸
èáõÙÇÝdz
S01C B01
0185/6262
¸
èáõë³ëï³Ý
-
4921
àõÏñ³Çݳ
C05A A09,
H02A B02
5876
13.07.2006
13.07.2011
12.08.2004
12.08.2009
12.01.2006
12.01.2011
êÉáí»Ýdz
H02A B02
0654/6571
¸
г۳ëï³Ý
S01B A01,
S02B A06,
S03B A01
4705
12.01.2007
12.01.2012
25.02.2004
25.02.2009
S01B A01,
S01C B01,
S02B A06,
S03B A01
D03A X03
5891
07.02.2006
07.02.2011
¸
0928/6601
26,04.2007
26.04.2012
²¸
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶»ñÙ³Ýdz
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co.KG
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
ê»ñµÇ³ ¨
Hemofarm koncern A.D.
â»éÝá·áñdz
¸
¸
²¸
46
638
639
¸Ç³µ»ïáÝ
Diabeton
¸Ç³µ»ïáÝ Øè
Diabeton MR
640
·ÉÇÏɳ½Ç¹
gliclazide
·ÉÇÏɳ½Ç¹
gliclazide
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
¸Ç³½»å³Ù
Diazepam
641
¸Ç³½»å³Ù
Diazepam
642
¸Ç³½»å³Ù
Diazepam
643 ¸Ç³½»å³Ù ³ÉϳÉáǹ
Diazepam Alkaloid
¹Ç³½»å³Ù
diazepam
¹Ç³½»å³Ù
diazepam
¹Ç³½»å³Ù
diazepam
¹Ç³½»å³Ù
diazepam
644 ¸Ç³½»å³Ù ³ÉϳÉáǹ
Diazepam Alkaloid
645
¸Ç³½áÉÇÝ
Diazolin
646
¸Ç³½áÉÇÝ
Diazolin
647
¸Ç³½áÉÇÝ
Diazolin
648
¸Ç³½áÉÇÝ
Diazolin
649
¸Ç³½áÉÇÝ
Diazolin
650
¸Ç³½áÉÇÝü³ñÙëï³Ý¹³ñï
DiazolinPharmstandard
651
¸Ç³½áÉÇÝü³ñÙëï³Ý¹³ñï
DiazolinPharmstandard
652
¸Ç³Ï³ñµ
Diacarb
653
¸Ç³Ï³ñÙáÝ
Diakarmon
¹Ç³½»å³Ù
diazepam
Ù»µÑǹñáÉÇÝ
mebhydrolin
Ù»µÑǹñáÉÇÝ
mebhydrolin
Ù»µÑǹñáÉÇÝ
mebhydrolin
Ù»µÑǹñáÉÇÝ
mebhydrolin
Ù»µÑǹñáÉÇÝ
mebhydrolin
Ù»µÑǹñáÉÇÝ
mebhydrolin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹ñ³Å»
Ù»µÑǹñáÉÇÝ
mebhydrolin
³ó»ï³½áɳÙǹ
acetazolamide
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
gentamicin sulfate
654
¸Ç³Ý»-35
Diane-35
655
656
657
80Ù·
(60)
30Ù·
(60)
üñ³Ýëdz
A10B B09
4178
üñ³Ýëdz
A10B B09
6018
г۳ëï³Ý
N05B A01
4845
г۳ëï³Ý
N05B A01
4846
´áõÉÕ³ñdz
N05B A01
0032/6131
г۳ëï³Ý
N05B A01
0530/6555
г۳ëï³Ý
N05B A01
0529/6556
èáõë³ëï³Ý
R06A X15
5365
àõÏñ³Çݳ
R06A X15
4962
àõÏñ³Çݳ
R06A X15
4963
àõÏñ³Çݳ
R06A X15
4964
èáõë³ëï³Ý
R06A X15
4917
èáõë³ëï³Ý
R06AX15
1030/6925
14.03.2003
14.03.2008
01.03.2006
01.03.2011
¸
20.05.2004
20.05.2009
20.05.2004
20.05.2009
19.05.2006
19.05.2011
10.11.2006
10.11.2011
¸\Ð
10.11.2006
10.11.2011
05.04.2005
05.04.2010
20.08.2004
20.08.2009
20.08.2004
20.08.2009
20.08.2004
20.08.2009
12.08.2004
12.08.2009
21.06.2007
21.06.2012
¸\Ð
¸
5Ù·
(24,48)
10Ù·
(24,48)
10Ù·
(20)
10Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
5Ù·
(30)
0.1·
(10,20,50)
0.1·
(10,20)
0.05·
(10, 20)
0.1·
(10,20)
0.05·
(10)
100Ù·
(10)
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD Skopje
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
ü³ñÙ³Ï êäÀ
Farmak JSC
ü³ñÙ³Ï êäÀ
Farmak JSC
ü³ñÙ³Ï êäÀ
Farmak JSC
²ÏñÇËÇÝ ´´À
Akrikhin
Open JSC
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
Pharmstandard-UfaVITA OJSC
¹ñ³Å»
50Ù·
(10)
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
Pharmstandard-UfaVITA OJSC
èáõë³ëï³Ý
R06AX15
1031/6924
21.06.2007
21.06.2012
²¸
¹»Õ³Ñ³ï»ñ
250Ù·
(24/2x12/)
80Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(50)
35ÙÏ·+2Ù·
(21)
äáÉý³ñÙ³ ê.².
Polpharma S.A.
лÉ÷ ê.².
Help S.A.
Ȼѳëï³Ý
S01E C01
0065/6142
¸
Ðáõݳëï³Ý
J01G B03
4221
02.06.2006
02.06.2011
20.03.2003
20.03.2008
Þ»ñÇÝ· ²¶
Schering AG
¶»ñÙ³Ýdz
G03C,
L02A
4647
04.03.2004
04.03.2009
¸
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
CJSC
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
CJSC
¶ñÇݹ»ùë ´À
Grindex JSC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
àõÏñ³Çݳ
C04AX31
1230/7162
14.11.2007
13.09.2012
¸
àõÏñ³Çݳ
C04AX31
1231/7163
14.11.2007
13.09.2012
¸
ȳïídz
C01A A05
0435/6443
¸
àõÏñ³Çݳ
C01A A05
1134/7099
26.09.2006
26.09.2011
02.10.2007
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹ñ³Å»
¹ñ³Å»
¹»Õ³Ñ³ï»ñ
¹ñ³Å»
¹ñ³Å»
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï (¹ñ³Å»)
¸Çµ³½áÉ-¸³ñÝÇó³
Dibazol-Darnitsa
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ,
óÇåñáï»ñáÝ
ethinylestradiol,
cyproterone
µ»Ý¹³½áÉ
bendazol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
¸Çµ³½áÉ-¸³ñÝÇó³
Dibazol-Darnitsa
µ»Ý¹³½áÉ
bendazol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1% (1ÙÉ),
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
¹Ç·oùëÇÝ
digoxin
¹Ç·oùëÇÝ
¹»Õ³Ñ³ï»ñ
0.25Ù·
(50)
0,25Ù·
¸Ç·oùëÇÝ
Digoxin
658 ¸Ç·oùëÇÝ-¼¹áñáíÛ»
ê»ñíÇ» ɳµáñ³ïáñdz
Les Laboratoires Servier
ê»ñíÇ» Æݹ³ëïñÇ É³µáñ³ïáñdz
Les Laboratoires Servier
Industrie
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD Skopje
¹»Õ³Ñ³ï»ñ
¸\Ð
¸\Ð
¸\Ð
²¸
²¸
²¸
²¸
²¸
²¸
¸
¸
47
Digoxin-Zdorovye
digoxin
659
¸Ç·ûùëÇÝ
Digoxin
¹Ç·ûùëÇÝ
digoxin
¹»Õ³Ñ³ï»ñ
0,25Ù·
(30)
660
¸Ç·ûùëÇÝ
Digoxin
¹Ç·ûùëÇÝ
digoxin
¹»Õ³Ñ³ï»ñ
0.25Ù·
(30)
661
¸ÇÃÇÉÇÝ
Dithylin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
662
¸ÇɳëǹáÙ
Dilasydom
ëáõùë³Ù»ÃáÝÇáõÙÇ
Ûá¹Ç¹
suxamethonium iodide
ÙáÉëǹáÙÇÝ
molsidomine
2%,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
4Ù·
(30)
663
¸ÇɳëǹáÙ
Dilasydom
664
¸Çɳïñ»Ý¹
Dilatrend
¸Çɳïñ»Ý¹
Dilatrend
¸Çɳïñ»Ý¹
Dilatrend
¸ÇÉó»ñ»Ý
Dilceren
¸ÇÏɳÏ
Diclac
665
666
667
668
669
¸ÇÏÉ³Ï 5% ¹áݹáÕ
Diclac 5% gel
670
¸ÇÏÉ³Ï 50
Diclac 50
671
¸ÇÏÉ³Ï Æ¸ 150
Diclac ID 150
672
¸ÇÏÉ³Ï Æ¸ 75
Diclac ID 75
673
¸ÇÏÉáµñÛáõ
Diclobru
674
¸ÇÏÉá·»Ýï³
DicloGenta
(50)
¹»Õ³Ñ³ï»ñ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ü³ñÙëï³Ý¹³ñï-îáÙëÏùÇÙý³ñÙ ´´À
PharmstandardTomskchimpharm OJSC
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
ê.².
Warsaw Pharmaceutical Works
§Polfa¦ S.A.
´ÇáÉ»Ï ö´À
Biolek CJSC
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
Warsaw Pharmaceutical Works
§Polfa¦ SA
ÙáÉëǹáÙÇÝ
¹»Õ³Ñ³ï»ñ
2Ù·
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
molsidomine
(30)
Warsaw Pharmaceutical Works
§Polfa¦ SA
ϳñí»¹ÇÉáÉ
¹»Õ³Ñ³ï»ñ
12.5Ù·
èáß ê.å.².
carvedilol
(30,100)
Roche S.p.A.
ϳñí»¹ÇÉáÉ
¹»Õ³Ñ³ï»ñ
6.25Ù·
èáß ê.å.².
carvedilol
(30,100)
Roche S.p.A.
ϳñí»¹ÇÉáÉ
¹»Õ³Ñ³ï»ñ
25Ù·
èáß ê.å.².
carvedilol
(30,100)
Roche S.p.A.
ÝÇÙá¹ÇåÇÝ
ÉáõÍáõÛÃ
0.02%,
êÉáí³Ïáý³ñÙ³ ³.ë.(ÐÉáÑáí»ó)
nimodipine
ϳÃÇɳݻñ³ñÏ-Ù³Ý
50ÙÉ ëñí³Ï (1)
Slovakofarma a.s. (Hlohovec)
¹ÇÏÉáý»Ý³Ï
ÉáõÍáõÛÃ
75Ù·/3ÙÉ,
ڻݳѻùë³É ü³ñÙ³ ¶ÙµÐ (È»Ï
diclofenac
Ý»ñ³ñÏÙ³Ý
³ÙåáõÉÝ»ñ (5, 10)
¹.¹.-Ç Ñ³Ù³ñ)
Jenahexal Pharma GmbH for
Lek d.d.
¹ÇÏÉáý»Ý³Ï
¹áݹáÕ
5%,
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
ݳïñÇáõÙÇ
50· å³ñÏáõ×
²¶-Ç Ñ³Ù³ñ)
diclofenac sodium
Salutas Pharma GmbH (for
Hexal AG)
¹ÇÏÉáý»Ý³Ï
¹»Õ³Ñ³ï»ñ
50Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
ݳïñÇáõÙÇ
³Õ»ÉáõÛÍ
(20)
²¶-Ç Ñ³Ù³ñ)
diclofenac sodium
Salutas Pharma GmbH (for
Hexal AG)
¹ÇÏÉáý»Ý³Ï
»ñϳñ³ï¨
150Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
ݳïñÇáõÙÇ
Ó»ñµ³½³ïٳٵ
(20,100)
²¶-Ç Ñ³Ù³ñ)
diclofenac sodium
¹»Õ³Ñ³ï»ñ
Salutas Pharma GmbH (for
Hexal AG)
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ ¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
75Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
diclofenac sodium
Ó»ñµ³½³ïٳٵ
(20,100)
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ÉáõÍáõÛÃ
75Ù·/3ÙÉ,
´ñÛáõý³ñÙ¿ùëåáñï ë.å.é.É.
diclofenac sodium
Ý»ñ³ñÏÙ³Ý
3ÙÉ ³ÙåáõÉÝ»ñ
Brupharmexport s.p.r.l.
(5)
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ,
³ÏݳϳÃÇÉÝ»ñ
(0.1Ù·+0.3Ù·)/ÙÉ,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
(ÉáõÍáõÛÃ)
5ÙÉ ßßÇÏ
Rompharm Company SRL
diclofenac sodium,
gentamicine sulfate
08.08.2012
èáõë³ëï³Ý
C01AA05
1371/7333
05.11.2007
05.11.2012
¸
Ȼѳëï³Ý
C01A A05
4285
26.05.2003
26.05.2008
¸
àõÏñ³Çݳ
M03A B01
0524/6511
10.11.2006
10.11.2011
¸
Ȼѳëï³Ý
C01D X12
0597/6605
14.12.2006
14.12.2011
¸
Ȼѳëï³Ý
C01D X12
0600/6604
14.12.2006
14.12.2011
¸
Æï³Édz
C07A G02
4857
¸
Æï³Édz
C07A G02
4856
Æï³Édz
C07A G02
4858
êÉáí³Ïdz
C08C A06
3601
¶»ñÙ³Ýdz
M01A B05
1289/7257
18.05.2004
18.05.2009
18.05.2004
18.05.2009
18.05.2004
18.05.2009
16.09.2003
16.09.2008
22.10.2007
12.10.2012
¶»ñÙ³Ýdz
M01A B05,
M02A A15
5581
13.05.2005
13.05.2010
²¸
¶»ñÙ³Ýdz
M01A B05
M02A A15
5371
25.01.2005
25.01.2010
¸
¶»ñÙ³Ýdz
M01A B05,
M02A A15
5588
19.05.2005
19.05.2010
¸
¶»ñÙ³Ýdz
M01A B05,
M02A A15
5587
19.05.2005
19.05.2010
¸
´»É·Ç³
M01AB05
1344/7304
12.11.2007
05.11.2012
¸
èáõÙÇÝdz
S01C C01
0178/6269
13.07.2006
13.07.2011
¸
¸
¸
¸
¸
48
675
¸ÇÏÉáíÇï
Diclovit
¸ÇÏÉáíÇï
Diclovit
¸ÇÏÉáï³ñ¹
Diclotard
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³Ï
ݳïñÇáõÙÇ
diclofenac sodium
678
¸ÇÏÉáñ³Ý
Dicloran
¹ÇÏÉáý»Ý³Ï
ݳïñÇáõÙÇ
diclofenac sodium
679
¸ÇÏÉáñ³Ý
Dicloran
¹ÇÏÉáý»Ý³ÏÇ
¹Ç¿ÃÇɳÙÇÝ
diclofenac diethylamine
680
¸ÇÏÉáñ³Ý êè
Dicloran SR
¹ÇÏÉáý»Ý³Ï
ݳïñÇáõÙÇ
diclofenac sodium
681
¸ÇÏÉáý»Ý
Diklofen
¹ÇÏÉáý»Ý³Ï
diclofenac
682
¸ÇÏÉáý»Ý³Ï
Diklofenak
683
¸ÇÏÉáý»Ý³Ï
Diklofenak
¸ÇÏÉáý»Ý³Ï
Diklofenak
¸ÇÏÉáý»Ý³Ï
Diklofenak
¸ÇÏÉáý»Ý³Ï
Diklofenak
¸ÇÏÉáý»Ý³Ï
Diclofenac
676
677
684
685
686
687
688
689
¸ÇÏÉáý»Ý³Ï
Diclofenac
¸ÇÏÉáý»Ý³Ï
Diclofenac
ÙáÙÇÏÝ»ñ
¹áݹáÕ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
»ñϳñ³ï¨
³½¹»óáõÃÛ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ, »ñϳñ³ï¨
³½¹»óáõÃÛ³Ý
¹áݹáÕ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
»ñϳñ³ï¨
³½¹»óáõÃÛ³Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹ÇÏÉáý»Ý³Ï
¹áݹáÕ
¹Ç»ÃÇɳÙÇÝ
diklofenac diethylamin
¹ÇÏÉáý»Ý³Ï
ÙáÙÇÏÝ»ñ
diclofenac
¹ÇÏÉáý»Ý³Ï
ÙáÙÇÏÝ»ñ
diclofenac
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ÙáÙÇÏÝ»ñ
diclofenac sodium
¹ÇÏÉáý»Ý³Ï
¹áݹáÕ
diclofenac
¹ÇÏÉáý»Ý³Ï
ÙáÙÇÏÝ»ñ
ݳïñÇáõÙÇ
áõÕÇÕ³ÕÇù³ÛÇÝ
diclofenac sodium
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ÙáÙÇÏÝ»ñ
diclofenac sodium
áõÕÇÕ³ÕÇù³ÛÇÝ
¹ÇÏÉáý»Ý³Ï
¹»Õ³Ñ³ï»ñ
diclofenac
óճÝóå³ï,
³Õ»ÉáõÛÍ
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ÉáõÍáõÛÃ
diclofenac sodium
Ý»ñ³ñÏÙ³Ý
0.05·
(10)
1%,
20·, 30· å³ñÏáõ×
0.1·
(20)
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
ÜÇÅý³ñÙ ´´À
Nizhpharm OJSC
»ñ³ådz ê.².
Terapia S.A.
50Ù·,
(20,100)
ÚáõÝÇù ü³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
ÚáõÝÇù ý³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
ÚáõÝÇù ý³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
¶³É»ÝÇϳ ³.¹.
Galenika a.d.
èáõë³ëï³Ý
èáõë³ëï³Ý
5944
0587/6459
25.01.2006
25.01.2011
05.12.2006
05.12.2011
08.09.2003
08.09.2008
¸
²¸
èáõÙÇÝdz
M01A B05
M02A A15
4497
Ðݹϳëï³Ý
M01A B05
M02A A15
4363
28.07.2003
28.07.2008
¸
Ðݹϳëï³Ý
M01A B05,
M02A A15,
S01B C03
4368
31.03.2004
31.03.2009
²¸
Ðݹϳëï³Ý
M01A B05,
M02A A15,
S01B C03
4370
31.03.2004
31.03.2009
¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
M01A B05
M02A A15
5209
12.11.2004
12.11.2009
¸
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
4279
25.04.2003
25.04.2008
²¸
50Ù·
(10)
25Ù·
(10)
100Ù·
(10)
1%,
60· å³ñÏáõ×
100Ù·
(6, 10)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
ڳϳ-80
JAKA-80
ڲβ-80
JAKA-80
ü³ñÙ³åñÇÙ êèÈ
Farmaprim SRL.
гñ³íëɳ-ídz
4278
1104/6470
سϻ¹áÝdz
M02A A15
1103/6471
Øáɹáí³
M01A B05
1491/7413
19.11.2003
19.11.2008
19.11.2003
19.11.2008
07.09.2007
07.09.2012
07.09.2007
07.09.2012
20.12.2007
20.12.2012
¸
سϻ¹áÝdz
M01A B05
M02A A15
S01B C03
M01A B05
S01B C03
M01A B05
S01B C03
M01A B05
50Ù·
(6,10)
0.05·
(20/2x10/)
ü³ñÙ³åñÇÙ êèÈ
Farmaprim SRL
ú½áÝ êäÀ
Ozon Ltd.
Øáɹáí³
20.12.2007
20.12.2012
08.12.2005
08.12.2010
¸
1%,
20· å³ñÏáõ×
100Ù·
(20,100)
75Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
1%/(1.16·/100·),
40· å³ñÏáõ×
гñ³íëɳ-ídz
4277
1490/7390
¸
¸
¸
¸
¸
èáõë³ëï³Ý
M01A B05,
M02A A15
5792
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
5175
04.10.2004
04.10.2009
¸
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
M01A B05
M02A A15
S01B C03
M01A B05
M02A A15
S01B C03
M01A B05
M02A A15
S01B C03
M01A B05,
M02A A15
M01A B05
5176
04.10.2004
04.10.2009
¸
5177
04.10.2004
04.10.2009
¸
5672
19.09.2005
19.09.2010
16.10.2006
¸
690
¸ÇÏÉáý»Ý³Ï
Diklofenak
691
¸ÇÏÉáý»Ý³Ï
Diklofenak
¹ÇÏÉáý»Ý³Ï
diclofenac
¹»Õ³Ñ³ï»ñ
óճÝóå³ï é»ï³ñ¹
25Ù·/ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
100Ù·
(20)
692
¸ÇÏÉáý»Ý³Ï
Diklofenak
¹ÇÏÉáý»Ý³Ï
diclofenac
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(20)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
693
¸ÇÏÉáý»Ý³Ï
Diklofenak
¸ÇÏÉáý»Ý³Ï ´Ç-öÇ
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
50Ù·
(20,1600x10)
50Ù·
ڲβ-80
JAKA-80
Âñáç Ø»¹ÇÏ³É /Âñáç Ø»¹ÇϳÉ,
سϻ¹áÝdz
694
M01A B05,
M02A A15
M02 A15
Ðݹϳëï³Ý
0487/6479
¸
¸
49
Diclofenac BP
diclofenac sodium
695
¸ÇÏÉáý»Ý³Ï
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ݳïñÇáõÙ ÈÐ
diclofenac sodium
Diclofenac sodium
LH
696
¸ÇÏÉáý»Ý³Ï
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ûýï³ÉÙÇÏ
diclofenac sodium
Diclofenac
ophthalmic
697 ¸ÇÏÉáý»Ý³Ï-²ëï»ñdz ¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
Diclofenac-Asteria
diclofenac sodium
³Õ»ÉáõÛÍ
(1000/100x10/)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2.5%,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
³ÏݳϳÃÇÉÝ»ñ
0.1%,
10ÙÉ ßßÇÏ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
75Ù·/3ÙÉ,
³ÙåáõÉÝ»ñ (5)
698
¸ÇÏÉáý»Ý³Ï¼¹áñáíÛ»
Diclofenac-Zdorovye
¹ÇÏÉáý»Ý³Ï
diclofenac
¹áݹáÕ
1%,
30·, 50· å³ñÏáõ×
699
¸ÇÏÉáý»Ý³ÏݳïñÇáõÙ
Diclofenac natrium
¸ÇÏÉáýɳÙ
Dicloflame
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
diclofenac sodium
ùëáõù
1%,
30· å³ñÏáõ×
¹ÇÏÉáý»Ý³Ï
diclofenac
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
701
¸ÇÙ»¹ñáÉ
Dimedrol
¹Çý»ÝÑǹñ³ÙÇÝ
diphenhydramine
¹»Õ³Ñ³ï»ñ
702
¸ÇÙ»¹ñáÉ
Dimedrol
¹Çý»ÝÑǹñ³ÙÇÝ
diphenhydramine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
75Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(10)
50Ù·
(10,20/2x10/,
30/3x10/)
1% (1ÙÉ)
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
703
¸ÇÙ»¹ñáÉ-¸³ñÝÇó³
Dimedrol-Darnitsa
¹Çý»ÝÑǹñ³ÙÇÝ
diphenhydramine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
704
¸ÇÙ»ùë
Dimex
ûß³ñ³Ï
705
¸ÇݳÙǽ³Ý
Dynamisan
706
¸Çáí³Ý
Diovan
¸Çáí³Ý
Diovan
¸ÇåÇñǹ³ÙáÉ
Dipyridamole
¹Çý»ÝÑǹñ³ÙÇÝ,
³ÙáÝÇáõÙÇ ùÉáñǹ
diphenhydramine,
ammonium chloride
íÇï³ÙÇÝÝ»ñ,
³ÙÇݳÃÃáõÝ»ñ,
ѳÝù³ÝÛáõûñ,
Å»Ýß»ÝÇ Ñ³ÝáõÏ
vitamins, aminoacids,
minerals, extract
ginseng
í³Éë³ñï³Ý
valsartan
í³Éë³ñï³Ý
valsartan
¹ÇåÇñǹ³ÙáÉ
dipyridamole
700
707
708
/¶»ñÙ³Ýdz/-Ç Ñ³Ù³ñ
Troge Medical /for Troge
Medical, Germany/
´ÇáÉ»Ï ö´À
Biolek Closed JSC
àõÏñ³Çݳ
M01A B05
6102
11.04.2006
11.04.2011
¸
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
г۳ëï³Ý
S01B C03
5747
20.09.2005
20.09.2010
¸
гÝÏáõÏ Îáñáõë ü³ñÙ øá.
Èï¹Hankook Korus Pharm Co.,
Ltd
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
ÆÝï³ë ý³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Intas Pharmaceuticals Ltd.
Îáñ»³
M01AB05
1384/7347
26.12.2007
05.11.2012
¸
àõÏñ³Ýdz
M01A A15
1270/7238
15.11.2007
13.09.2012
²¸
´»É³éáõë
M01A B05
M02A A15
5010
13.12.2004
13.12.2009
²¸
Ðݹϳëï³Ý
M01A
0685/6710
17.01.2007
17.01.2012
¸
´»É³éáõë
R06A A02
0470\6466
11.10.2006
11.10.2011
¸
г۳ëï³Ý
R06A A02
0612/6596
18.12.2006
18.12.2011
¸
àõÏñ³Çݳ
R06A A02
1269/7237
30.10.2007
12.10.2012
¸
´áõÉÕ³ñdz
R06A A52
5440
20.07.2005
20.07.2010
¸
Æï³Édz
βêÐ
4501
18.09.2003
18.09.2008
²¸
Þí»Ûó³ñdz
-
4314
¸
Þí»Ûó³ñdz
-
4315
àõÏñ³Çݳ
B01AC07
1343/7303
10.10.2003
10.10.2008
26.06.2003
26.06.2008
13.11.2007
05.11.2012
´»ÉÙ»¹åñ»å³ñ³ïÇ ´àôÒ
Belmedpreparaty RUP
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
ýÇñÙ³ ´´À
Yerevan ChemicalPharmaceutical Firm Open J/S
Company
1% (1ÙÉ),
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
1ÙÉ ³ÙåáõÉÝ»ñ
ö´À
(10)
Darnitsa Pharmaceutical Firm
Closed JSC
(10Ù·+100Ù·)/5ÙÉ
êáý³ñÙ³ ´À
125ÙÉ ßßÇÏ
Sopharma JSC
ѳµ»ñ
(30)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
80Ù·
(14,28)
160Ù·
(14,28)
0,025·
(40)
16.10.2011
ü³Ù³ñ Æï³Édz ê.å.². - Æï³Édz
(Üáí³ñïÇë øáÝëáõÙ»ñ лÉÃÞí»Ûó³ñdz ϳ½Ù³Ï»ñåáõÃÛ³Ý
ѳٳñ)
Famar
Italy S.p.A. Italy for Novartis
Consumer Health
( Switzerland)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À/ ²·ñáý³ñÙ êäÀ
Borshchahivskiy Chemical-
¸
¸
50
709
¸Çåñáë³ÉÇÏ
Diprosalic
710
¸Çåñáë³ÉÇÏ
Diprosalic
711
¸Çåñáëå³Ý
Diprospan
712
¸ÇëÙ»ÝáñÙ
Dysmenorm
713
¸Çëåáñï
Dysport
714
715
716
717
718
719
720
721
722
723
µ»ï³Ù»Ã³½áÝÇ
¹ÇåñáåÇáݳï,
ë³ÉÇóÇɳÃÃáõ
betamethasone
dipropionate, salicylic
acid
µ»ï³Ù»Ã³½áÝÇ
¹ÇåñáåÇáݳï,
ë³ÉÇóÇɳÃÃáõ
betamethasone
dipropionate, salicylic
acid
µ»ï³Ù»Ã³½áÝÇ
¹ÇåñáåÇáݳï,
µ»ï³Ù»Ã³½áÝÇ ýáëý³ï
ݳïñÇáõÙÇ
betamethasone
dipropionate,
betamethasone sodium
phosphate
-
ùëáõù
0.05%+3%,
30· å³ñÏáõ×
Pharmaceutical Plant CJSC /
Agropharm Ltd
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering-Plough Labo N.V.
ÉáÃÇáÝ
(50Ù·+2Ù·)/100ÙÉ
30· ßßÇÏ
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
´»É·Ç³
D07B C01
4839
24.05.2004
24.05.2009
¸
Þ»ñÇÝ· öɳáõ
Schering Plough
üñ³Ýëdz
D07B C01
5475
22.04.2005
22.04.2010
¸
(5Ù·+2Ù·)/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(1,5)
Þ»ñÇÝ· - äɳáõ ȳµá Ü.ì.
Schering - Plough Labo N.V.
´»É·Ç³
C05A A05
H02A B01
R01A D06
5468
30.06.2005
22.04.2010
¸
¹»Õ³Ñ³ï»ñ
(80)
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
5215
13.12.2004
13.12.2009
²¸
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
500Ø,
ëñí³Ï (1)
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
-
5291
11.01.2005
11.01.2010
¸
¸ÇëýɳïÇÉ
Disflatyl
¸ÇíÇ·»É
Divigel
¸ÇñáïáÝ
Diroton
¸ÇñáïáÝ
Diroton
¸ÇñáïáÝ
Diroton
¸ÇñáïáÝ
Diroton
¸ÇóÇÝáÝ
Dicynone
A ïÇåÇ µáïáõÉÇݳÛÇÝ
ïáùëÇÝ Ñ»Ù³·ÉÛáõïÇÝÇÝ
ѳٳÉÇñ
clostridium botulinum
type A toxin haemagglutinin
complex
ëÇÙ»ÃÇÏáÝ
simethicone
¿ëïñ³¹ÇáÉ
estradiol
ÉǽÇÝáåñÇÉ
lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
¿ï³Ù½Çɳï
etamsylate
¶»ñÙ³Ý³Ï³Ý ÐáÙ»áå³Ã³ÛÇÝ
ØÇáõÃÛáõÝ (¶ÐØ)
Deutsche Homoopathie Union
(DHU)
Æåë»Ý ´Çáý³ñÙ ÈÇÙÇﻹ
Ipsen Biopharm Limited
ϳÃÇÉÝ»ñ
Þí»Ûó³ñdz
-
4809
²¸
üÇÝɳݹdz
G03C A03
5253
ÐáõÝ·³ñdz
C09A A03
5657
ÐáõÝ·³ñdz
G09AA03
1409/7016
ÐáõÝ·³ñdz
G09AA03
1411/7018
ÐáõÝ·³ñdz
G09AA03
1410/7017
êÉáí»Ýdz
B02B X01
5346
27.05.2004
27.05.2009
17.01.2005
17.01.2010
08.09.2005
08.09.2010
03.12.2007
03.12.2012
03.12.2007
03.12.2012
03.12.2007
03.12.2012
07.02.2005
07.02.2010
¸ÇóÇÝáÝ
Dicynone
¸ÇóÇÝáÝ
Dicynone
¿ï³Ù½Çɳï
etamsylate
¿ï³Ù½Çɳï
etamsylate
¹»Õ³Ñ³ï»ñ
êÉáí»Ýdz
B02B X01
5345
Þí»Ûó³ñdz
B02B X01
4428
07.02.2005
07.02.2010
15.09.2003
15.09.2008
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¸ÇûùëǹÇÝ
¹ÇûùëǹÇÝ
ÉáõÍáõÛÃ
40Ù·/ÙÉ,
30ÙÉ ßßÇÏ
0.1%,
1· ÷³Ã»ÃÝ»ñ (28)
2.5Ù·
(14,28)
5Ù·
(14, 28)
20Ù·
(14, 28)
10Ù·
(14, 28)
250Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(50)
250Ù·
(100)
250Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(4,100)
1%,
´»É³éáõë
-
5001
13.12.2004
¸
¹áݹáÕ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
úñÇáÝ Îáñåáñ»ÛßÝ
Orion Corporation
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
úØ ü³ñÙ³
OM Pharma
´áñÇëáíÛ³Ý ´ä¶
¸
¸
¸
¸
¸
¸
¸
51
Dioxidin
dioxidine
Ý»ñ³ñÏÙ³Ý
¸Çý»ÝÇÝ
Diphenin
¸Çý»ñ»ÉÇÝ
Diphereline
ý»ÝÇïáÇÝ
phenytoin
ÃñÇåïáñ»ÉÇÝ
triptorelin
¹»Õ³Ñ³ï»ñ
726
¸Çý»ñ»ÉÇÝ
Diphereline
ÃñÇåïáñ»ÉÇÝ
triptorelin
727
¸Çýɳ½áÝ
Diflazon
¸Çýɳ½áÝ
Diflazon
¸Çýɳ½áÝ
Diflazon
¸ÇýÉÛáõ½áÉ
Difluzol
¸ÇýÉáõϳÝ
Diflucan
¸ÇýÉáõϳÝ
Diflucan
¸ÇýÉáõϳÝ
Diflucan
¸ÉdzÝáë
Dlianos
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
735
¸ÉdzÝáë
Dlianos
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
736
¸Ûáõñá·»½ÇÏ
Durogesic
ý»Ýï³ÝÇÉ
fentanyl
ѳٳϳñ· µáõųϳÝ,
Ù³ßϳÛÇÝ
737
¸Ûáõñá·»½ÇÏ
Durogesic
ý»Ýï³ÝÇÉ
fentanyl
ѳٳϳñ· µáõųϳÝ,
Ù³ßϳÛÇÝ
738
¸Ûáõý³É³Ï
Duphalac
ɳÏïáõÉá½
lactulose
ûß³ñ³Ï
739
¸Ûáõý³ëïáÝ
Duphaston
¹Ç¹ñá·»ëï»ñáÝ
dydrogesterone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
724
725
728
729
730
731
732
733
734
¹»Õ³÷áßÇ
»ÝóٳßϳÛÇÝ,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ 1ÙÉ
ÉáõÍãáí
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý,
¹»Õ³Ï³ËáõÛÃÇ
ÉáõÍãáí
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
óáÕ³ßÇà ùÃÇ
5ÙÉ ³ÙåáõÉÝ»ñ
Borisov Medical Preparations
(10)
Plant RUP
117Ù·
²ðöÆغ¸ ÐÒ ö´À
ARPIMED
(10,24,48)
J.V. CJ-S Co.
0.1Ù·, ëñí³Ï/³ÙåáõÉ Æåë»Ý ü³ñÙ³ ´Çáï»Ë (´áýáõñ
(1,7)
Æåë»Ý ÆÝï»ñݳëÇáݳÉ-Ç
ѳٳñ)
Ipsen Pharma Biotech (for
Beaufour Ipsen International)
3.75Ù·,
Æåë»Ý ü³ñÙ³ ´Çáï»Ë /´áýáõñ
ëñí³Ï/³ÙåáõÉ (1),
Æåë»Ý ÆÝï»ñݳëÇáݳÉ-Ç
Ý»ñ³ñÏÇã, 2³ë»Õ
ѳٳñ/
Ipsen Pharma Biotech /for
Beaufour Ipsen International/
150Ù·
Îèβ ¹.¹.Üáíá Ù»ëïá
(1)
KRKA d.d. Novo mesto
2Ù·/ÙÉ,
Îèβ ¹.¹.,Üáíá Ù»ëïá
100ÙÉ ëñí³Ï (1)
KRKA d.d.Novo mesto
50Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(7)
KRKA d.d. Novo mesto
0.15·
ÎǨٻ¹åñ»å³ñ³ï ´´À
(1,7)
Kievmedpreparat OJSC
150Ù·
öý³Û½»ñ ä¶Ø
(1)
Pfizer PGM
50Ù·
öý³Û½»ñ ä¶Ø
(7)
Pfizer PGM
2Ù·/ÙÉ,
öý³Û½»ñ ä¶Ø
50ÙÉ ëñí³Ï (1)
Pfizer PGM
0.1%,
Üáí³ñïÇë ¾Ýï»ñåñ³Û½Çë
10ÙÉ ßßÇÏ
öñÇí³ï, Ðݹϳëï³Ý (Üáí³ñïÇë
øáÝëáõÙ»ñ лÉÃ,
Þí»Ûó³ñdzÛÇ Ñ³Ù³ñ)
Novartis Enterprises Private,
India (for Novartis Consumer
Health, Switzerland)
0.05%,
Üáí³ñïÇë ¾Ýï»ñåñ³Û½Çë
10ÙÉ ßßÇÏ
öñÇí³ï, Ðݹϳëï³Ý (Üáí³ñïÇë
øáÝëáõÙ»ñ лÉÃ,
Þí»Ûó³ñdzÛÇ Ñ³Ù³ñ)
Novartis Enterprises Private,
India (for Novartis Consumer
Health, Switzerland)
25ÙÏ·/ųÙ,
Ú³Ýë»Ý ü³ñÙ³ëÛáõÃÇù³ Ü.ì.
ëå»Õ³ÝÇ
Janssen Pharmaceutica N.V.
(5)
50ÙÏ·/ųÙ,
Ú³Ýë»Ý ü³ñÙ³ëÛáõÃÇù³ Ü.ì.
ëå»Õ³ÝÇ
Janssen Pharmaceutica N.V.
(5)
667Ù·/ÙÉ,
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì.
100ÙÉ, 200ÙÉ,
Solvay Pharmaceuticals B.V.
500ÙÉ ßßÇÏ,
15ÙÉ ÷³Ã»ÃÝ»ñ
(10)
10Ù·
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì.
(20)
Solvay Pharmaceuticals B.V.
13.12.2009
г۳ëï³Ý
N03A B02
5304
30.12.2004
30.12.2009
19.05.2004
19.05.2009
¸
üñ³Ýëdz
L02A E04
4658
üñ³Ýëdz
L02A E04
4659
04.03.2004
04.03.2009
¸
êÉáí»Ýdz
J02A C01
3703
¸
êÉáí»Ýdz
J02A C01
4602
êÉáí»Ýdz
J02A C01
1114/7100
àõÏñ³Çݳ
J02A C01
4991
üñ³Ýëdz
J02A C01
4802
üñ³Ýëdz
J02A C01
4801
üñ³Ýëdz
J02A C01
4800
Ðݹϳëï³Ý
R01A A07
S01G A03
4420
26.03.2003
26.03.2008
22.02.2006
22.02.2011
12.09.2007
08.08.2012
01.02.2005
01.02.2010
23.04.2004
23.04.2009
23.04.2004
23.04.2009
18.06.2004
18.06.2009
19.08.2003
19.08.2008
Ðݹϳëï³Ý
R01A A07
S01G A03
4421
19.08.2003
19.08.2008
²¸
´»É·Ç³
N02A B03
0033/6119
19.05.2006
19.05.2011
¸\Ð
´»É·Ç³
N02A B03
0034/6120
19.05.2006
19.05.2011
¸\Ð
Üǹ»éɳݹݻñ
A06A D11
0380/6402
11.09.2006
11.09.2011
²¸
Üǹ»éɳݹݻñ
G03DB01
0320/6316
08.08.2006
08.08.2011
¸
¸
¸
¸
¸
¸
¸
¸
²¸
52
740 ¸áµáõï³ÙÇÝ §¾´ºìº¦
¹áµáõï³ÙÇÝ
Ëï³ÝÛáõÃ
250Ù·/20ÙÉ,
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð.Üý·. ζ
250Ù·
dobutamin
ϳÃÇɳݻñ³ñÏ-Ù³Ý
20ÙÉ ëñí³Ï (1)
EBEWE Pharma Ges.m.b. H.
Dobutamin
ÉáõÍáõÛÃÇ
Nfg.KG
§EBEWE¦ 250mg
741
¸áÉýÇÝ
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ÙáÙÇÏÝ»ñ
12.5Ù·
¸»Éï³ ü³ñÙ³ ê.².º.
Dolphin
diclofenac sodium
(10)
Delta Pharma S.A.E.
742
¸áÉýÇÝ-Î
¹ÇÏÉáý»Ý³ÏÇ
ϳÃÇÉÝ»ñ
15Ù·/ÙÉ,
¸»Éï³ ü³ñÙ³ ê.².º.
Dolphin-K
ϳÉÇáõÙ³Ï³Ý ³Õ
15ÙÉ ßßÇÏ
Delta Pharma S.A.E.
diclofenac potassium
743
¸áÏïáñ ØúØ
ÝÇí»Ýáõ ÛáõÕ,
ÉáõÍáõÛÃ
(0.5ÙÉ+1.5·+1.5·+
ÚáõÝÇù ý³ñÙ³ëÛáõÃÇù³É
Doctor MOM
Ù»ÝÃáÉ, ù³÷áõñ,
2,5ÙÉ)/10ÙÉ,
ɳµáñ³ïáñdz
Ù»ÃÇÉ ë³ÉÇóÇɳï
10ÙÉ ·Ý¹³Ù³ïÇï
Unique Pharmaceutical
eucalypt oil, menthol,
Laboratories
camphor, methyl
salicylate
744
¸áÏïáñ ØúØ
Ù³ïáõï³Ï, Ïá׳åÕå»Õ,
Éá½³ÝÝ»ñ
15Ù·+10Ù·+10Ù·+
ÚáõÝÇù ü³ñÙ³ëÛáõÃÇù³É
ѳϳѳ½³ÛÇÝ
¿ÙµÉÇϳ, Ù»ÝÃáÉ
ݳñÝçÇ, ÏÇïñáÝÇ,
7Ù·
ɳµáñ³ïáñdz (æÇ.´Ç.øÇÙdzϳÝ
µáõë³Ï³Ý Éá½³ÝÝ»ñ
Glycyrrhiza glabra,
³Ý³Ý³ëÇ, »É³ÏÇ,
(8,12,20)
¨ ¹»Õ³·áñÍ³Ï³Ý Èï¹. Ù³ëݳ×áõÕ)
Doctor MOM herbal
Zingiber officinale,
Ùáñáõ ѳٻñáí
Unique Pharmaceutical
cough lozenges
Emblica officinalis,
Laboratories (A divison of
menthol
J.B.Chemicals &
Pharmaceuticals Ltd)
745
¸áÏïáñ ØúØ
Ù»ÝÃáÉ, ù³÷áõñ,
ùëáõù
(0.61·+1.05·+
ÚáõÝÇù ü³ñÙ³ëÛáõÃÇù³É
Ùñë³ÍáõÃÛáõÝÁ
ÃÇÙáÉ, ÝÇí»Ýáõ
0.02·+0.3ÙÉ+
ɳµáñ³ïáñdz (æÇ.´Ç.øÇÙdzϳÝ
µáõÅáÕ ùëáõù
ÛáõÕ, µ¨»ÏݳÛáõÕ,
1.11ÙÉ+
¨ ¹»Õ³·áñÍ³Ï³Ý Èï¹.
Doctor MOM Cold
Ýß³ÛáõÕ
0.11ÙÉ)/20·,
Ù³ëݳ×ÛáõÕ)
Rub
menthol,
20· åɳëïÇÏ ï³ñ³
Unique Pharmaceutical
camphor,thymol,
Laboratories (A division of
eucalyptus oil,
J.B.Chemicals &
terpentine oil, nutmeg
Pharmaceuticals Ltd.)
oil
746
¸áÙå»ñǹáÝ
¹áÙå»ñǹáÝ
¹»Õ³Ñ³ï»ñ
10Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
лùë³É
domperidone
(20)
²¶-Ç Ñ³Ù³ñ)
Domperidon HEXAL
Salutas Pharma GmbH (for
Hexal AG)
747
¸áÝáñÙÇÉ
¹ûùëÇɳÙÇÝ ëáõÏóÇݳï
¹»Õ³Ñ³ï»ñ
15Ù·
´ñÇëïáÉ-سۻñë êùíǵ
Donormyl
doxylamine succinate
¹Ûáõñ³ÉáõÛÍ
(10,20)
Bristol-Myers Squibb
748
¸áÝáñÙÇÉ
¹ûùëÇɳÙÇÝ ëáõÏóÇݳï
¹»Õ³Ñ³ï»ñ
15Ù·
´ñÇëïáÉ-سۻñë êùíǵ
Donormyl
doxylamine succinate
óճÝóå³ï
(15,30)
Bristol-Myers Squibb
749
¸áå³ÙÇÝ §¾´ºìº¦
¹áå³ÙÇÝ
Ëï³ÝÛáõÃ
200Ù·/5ÙÉ,
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·. ζ
Dopamin §EBEWE¦
dopamin
ϳÃÇɳݻñ³ñÏ-Ù³Ý 5ÙÉ ³ÙåáõÉÝ»ñ
EBEWE Pharma Ges.m.b.H.
ÉáõÍáõÛÃÇ
(5)
Nfg. KG
750 ¸áå³ÙÇÝ êáÉí»Û 50
¹áå³ÙÇÝÇ
Ëï³ÝÛáõÃ
50Ù·/5ÙÉ,
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
Dopamin Solvay 50
ÑǹñáùÉáñǹ
ϳÃÇɳݻñ³ñÏ-Ù³Ý 5ÙÉ ³ÙåáõÉÝ»ñ
¶ÙµÐ
dopamine
ÉáõÍáõÛÃÇ
(5,30)
Solvay Pharmaceuticals GmbH
hydrochloride
751
¸áå»·Çï
Ù»ÃÇɹáå³
¹»Õ³Ñ³ï»ñ
250Ù·
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Dopegyt
methyldopa
(50)
Egis Pharmaceuticals Ltd.
752
¸áåÙÇÝ
¹áå³ÙÇÝ
Ëï³ÝÛáõÃ
40Ù·/ÙÉ,
úñÇáÝ Îáñåáñ»ÛßÝ
Dopmin
dopamine
ϳÃÇɳݻñ³ñÏ-Ù³Ý 5ÙÉ ³ÙåáõÉÝ»ñ
Orion Corporation
ÉáõÍáõÛÃÇ
(5)
753
¸áåñáÏÇÝ
¹áÙå»ñǹáÝ
¹»Õ³Ñ³ï»ñ
10Ù·
꺸ÆÎà ü³ñÙ³ëÛáõÃÇù³É øá.
Doprokin
domperidone
(20 /2x10/)
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²Ý·Édz)
SEDICO Pharmaceutical Co.
²íëïñdz
C01C A07
4305
04.07.2003
04.07.2008
¸
º·Çåïáë
M01A B05
1173/7168
¸
º·Çåïáë
M01A B05
1172/7167
13.09.2007
13.09.2012
13.09.2007
13.09.2012
Ðݹϳëï³Ý
-
4367
31.03.2004
31.03.2009
²¸
Ðݹϳëï³Ý
-
4884
09.07.2004
09.07.2009
²¸
Ðݹϳëï³Ý
-
4885
04.10.2004
04.10.2009
²¸
¶»ñÙ³Ýdz
A03F A03
5854
05.12.2005
05.12.2010
¸
üñ³Ýëdz
R06A A09
4474
¸
üñ³Ýëdz
R06A A09
4475
²íëïñdz
C01C A04
4786
23.01.2006
22.07.2008
23.01.2006
26.07.2008
21.06.2004
21.06.2009
¶»ñÙ³Ýdz
C01C A04
4371
04.07.2003
04.07.2008
¸
ÐáõÝ·³ñdz
C02A B01
6076
¸
üÇÝɳݹdz
C01C A04
4711
23.03.2006
23.03.2011
25.02.2004
25.02.2009
º·Çåïáë
A03FA03
0004/6147
21.04.2006
21.04.2011
¸
¸
¸
¸
¸
53
754
¸áñ³ÙÇóÇÝ
Doramycin
ëåÇñ³ÙÇóÇÝ
spiramycin
755
¸áñ½áåï
Dorzopt
¸áñÙÇÏáõÙ
Dormicum
¹áñ½áɳÙǹ
dorzolamide
Ùǹ³½áɳÙ
midazolam
¸áõáíÇï
Duovit
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
vitamins, minerals
756
757
758
(for World Medicine, England)
ÚáõÝÇý³ñÙ³ àõáɹ Ø»¹ÇëÇÝÇ
ѳٳñ - ²Ý·Édz
Unipharma for World Medicine
- England
³ÏݳϳÃÇÉÝ»ñ
2%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
(ÉáõÍáõÛÃ)
5ÙÉ ßßÇÏ
Rompharm Company SRL
ÉáõÍáõÛÃ Ù/Ù ¨
5Ù·/ÙÉ,
êºÜºøêÆ ê²ê, üñ³Ýëdz
Ý/»
3ÙÉ ³ÙåáõÉÝ»ñ
(ü.ÐáýÙ³Ý-ȳ
Ý»ñ³ñÏáõÙÝ»ñÇ
(5)
èáß,Þí»Ûó³ñdzÛÇ
ÉÇó»Ý½Ç³Ûáí)
CENEXI SAS, France (under
license from F.Hoffmann-La
Roche, Switzerland)
¹ñ³Å»Ý»ñ
40/4x10 (5 ϳñÙÇñ
Îèβ ¹.¹. Üáíá Ù»ëïá
(óճÝóå³ï
¹ñ³Å» KRKA d.d. Novo mesto
¹»Õ³Ñ³ï»ñ)
íÇï³ÙÇÝÝ»ñ ¨ 5
»ñÏݳ·áõÛÝ
¹ñ³Å» ѳÝù³ÝÛáõûñ)/
ѳµ»ñ óճÝóå³ï
1.88·
Îèβ ¹.¹.,Üáíá Ù»ëïá
(30)
KRKA d.d. Novo mesto
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¸áõáíÇï ϳݳÝó
íÇï³ÙÇÝÝ»ñ ¨
ѳٳñ
ѳÝù³ÝÛáõûñ
Duovit for Women vitamins and minerals
759
¸áõáíÇï Ù»Ùá
É»óÇïÇÝ, íÇï³ÙÇÝÝ»ñ
å³ëï»ÕÝ»ñ
Duovit Memo
lecithin, vitamins
760 ¸áõáíÇï ïÕ³Ù³ñ¹Ï³Ýó
íÇï³ÙÇÝÝ»ñ ¨
ѳµ»ñ óճÝóå³ï
ѳٳñ
ѳÝù³ÝÛáõûñ
Duovit for Men
vitamins and minerals
761
¸áõëå³ï³ÉÇÝ
Ù»µ»í»ñÇÝÇ
¹»Õ³å³ïÇ×Ý»ñ
Duspatalin
ÑǹñáùÉáñǹ
mebeverine
hydrochloride
762 ¸áý³ÙÇÝ ü»ñ»ÛÝ
¹áå³ÙÇÝ
ÉáõÍáõÛÃ
Dofamin - Ferein
dopamine
Ý»ñ³ñÏÙ³Ý
763
¸áý³ÙÇÝ ü»ñ»ÛÝ
Dofamin - Ferein
¹áå³ÙÇÝ
dopamine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
764
¸ñ³ÙÇݳ
Dramina
¹ÇÙ»ÝÑǹñÇݳï
dimenhydrinate
¹»Õ³Ñ³ï»ñ
765
¸ñ³ëåÇñ
Draspir
³ó»ïÇÉë³ÉÇóÇɳïÇ
ÉǽÇÝ
lysine acetylsalicylate
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
766
¸ûùëÇ-Ñ»Ù
ϳÉóÇáõÙÇ ¹áµ»½Çɳï
Doxi-Hem
calcium dobesilate
767 ¸ûùëÇåñáÏï åÉÛáõë
ϳÉóÇáõÙÇ
ùëáõù
¹áµ»½ÇɳïÇ
Doxiproct Plus
ÙáÝáÑǹñ³ï,
ointment
ÉǹáϳÛÇÝ,
¹»ùë³Ù»Ã³½áÝ
calcium dobesilate
monohydrate, lidocaine,
¹»Õ³å³ïÇ×Ý»ñ
ùëáõù
3000000ØØ
(10/2x5/)
º·Çåïáë
J01F A02
1020/7008
13.06.2007
13.06.2012
¸
èáõÙÇÝdz
S01E C03
0179/6268
¸
üñ³Ýëdz
N05C D08
5578
13.07.2006
13.07.2011
12.05.2005
12.05.2010
êÉáí»Ýdz
A11A
0936/6878
03.05.2007
03.05.2012
²¸
êÉáí»Ýdz
βêÐ
6051
31.03.2006
31.03.2011
²¸
31.03.2006
31.03.2011
31.03.2006
31.03.2011
²¸
¸
1.14·
(40)
1.06·
(30)
Îèβ ¹.¹.,Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹.,Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
βêÐ
6050
êÉáí»Ýdz
βêÐ
6052
200Ù·
(20,30)
êáÉí»Û ý³ñÙ³ëÛáõÃÇù³Éë
Solvay Pharmaceuticals
Üǹ»éɳݹݻñ
A03A A04
4275
08.05.2003
08.05.2008
¸
0.5% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
4% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
50Ù·
(5,10)
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
èáõë³ëï³Ý
C01C A04
5325
03.02.2005
03.02.2010
¸
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
èáõë³ëï³Ý
C01C A04
5326
03.02.2005
03.02.2010
¸
Ú³¹ñ³Ý ¶³É»ÝëÏÇ É³µáñ³ïáñdz
¹.¹.
Jadran Galenski Laboratorij
d.d.
ü³ñ³Ý ȳµáñ³ïáñdz ê.². Faran
Laboratories S.A.
Êáñí³Ãdz
-
0430/6132
26.09.2006
26.09.2011
²¸
Ðáõݳëï³Ý
B05X
4697
23.03.2004
23.03.2009
¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
äáñïáõ·³-Édz
C05B X01
5174
¸
C05A,
C01B,
C05B
4430
04.10.2004
04.10.2009
29.07.2003
29.07.2008
0,9·(0,5·
³ó»ïÇÉë³ÉÇóÇɳÃÃíÇÝ Ñ³Ù³ñÅ»ù,
ëñí³Ï (6)
500Ù·
(30)
(4·+2·+0.025·)/
100·,
20· å³ñÏáõ×
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
úØ äáñïáõ·»ë
OM Portugues
²¸
²¸
54
768
¸ûùëÇåñáÏï ùëáõù
Doxiproct ointment
769
¸ûùëÇóÇÏÉÇÝ
Doxycycline
¸ûùëÇóÇÏÉÇÝ
Doxycyclin
770
771
772
773
774
775
776
777
778
dexamethasone
ϳÉóÇáõÙÇ
¹áµ»½ÇɳïÇ
ÙáÝáÑǹñ³ï,
ÉǹáϳÛÇÝ
calcium dobesilate
monohydrate, lidocaine
¹ûùëÇóÇÏÉÇÝ
doxycycline
¹ûùëÇóÇÏÉÇÝ
doxycycline
ùëáõù
(4·+2·)/100·,
30· å³ñÏáõ×
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
(10)
100Ù·
(100x10)
¹»Õ³Ñ³ï»ñ
¸ûùëÇóÇÏÉÇÝ
¹ûùëÇóÇÏÉÇÝÇ Ñǹñ³ï
¹»Õ³å³ïÇ×Ý»ñ
Doxycyclin
doxycycline hydrate
¸ûùëÇóÇÏÉÇݹûùëÇóÇÏÉÇÝÇ ÑÇÏɳï
¹»Õ³å³ïÇ×Ý»ñ
²ëï»ñdz
doxycycline hyclate
Doxycycline-Asteria
¸ûùëÇóÇÏÉÇÝÇ
¹ûùëÇóÇÏÉÇÝ
¹»Õ³å³ïÇ×Ý»ñ
ÑǹñáùÉáñǹ
doxycycline
Doxycycline
hydrochloride
¸ûùëáéáõµÇóÇݹûùëáéáõµÇóÇÝ
ÉáõÍáõÛÃ
¾µ»í»
doxorubicin
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Doxorubicin-Ebewe
¸ûùëáéáõµÇóÇݹûùëáéáõµÇóÇÝ
ÉáõÍáõÛÃ
¾µ»í»
doxorubicin
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Doxorubicin-Ebewe
¸ûùëáñáõµÇóÇÝ
¹ûùëáñáõµÇóÇÝ
¹»Õ³÷áßÇ
ÎØä
doxorubicin
Ý»ñ³ñÏÙ³Ý
Doxorubicin KMP
ÉÇáýÇÉǽ³óí³Í
ºíñáåñÇÉ
ϳåïáåñÇÉ
¹»Õ³å³ïÇ×Ý»ñ
Europril
captopril
¼³É³ÛÇÝ
ë»ñï³Ïáݳ½áÉ
Ýñµ³ùëáõù
Zalain
sertaconazole
äáñïáõ·³-Édz
C05B X01,
N01B B52
4429
15.09.2003
15.09.2008
²¸
Europharm
S.A.
ê³Ý³íÇï³ ²Ïïǻݷ»ë»Éß³ýï ¨ øá.
Sanavita Aktiengesellschaft &
Co.
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
ÐáõáÝë øá. Èï¹.
Huons Co.Ltd
èáõÙÇÝdz
J01A A02
4534
¸
¶»ñÙ³Ýdz
J01A A02
4947
04.11.2003
04.11.2008
11.04.2005
11.04.2010
´áõÉÕ³ñdz
G01A A02
6114
¸
Îáñ»³
J01A A02
5483
11.04.2006
11.04.2011
26.05.2005
26.05.2010
0.1·
(6,10)
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´»É³éáõë
J01A A02
5002
13.12.2004
13.12.2009
¸
10Ù·/5ÙÉ,
ëñí³Ï (1)
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·.ζ
EBEWE Pharma Ges.m.b.H.
Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·.ζ
EBEWE Pharma Ges.m.b.H.
Nfg.KG
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
²íëïñdz
L01D B01
5179
03.02.2005
03.02.2010
¸
²íëïñdz
L01D B01
5180
03.02.2005
03.02.2010
¸
àõÏñ³Çݳ
L01D B01
4293
03.07.2003
03.07.2008
¸
èáõÙÇÝdz
C09A A01
4536
¸
Æëå³Ýdz
D01A C14
0464\6339
04.11.2003
04.11.2008
11.10.2006
11.10.2011
Æëå³Ýdz
D01A C14
0465\6340
11.10.2006
11.10.2011
¸
Ȼѳëï³Ý
A02B A02
4537
15.10.2003
15.10.2008
¸
Ȼѳëï³Ý
A02B A02
4538
15.10.2003
15.10.2008
¸
100Ù·
(6)
100Ù·
(100)
50Ù·/25ÙÉ,
ëñí³Ï (1)
0.01·,
ëñí³Ï (1,40)
25Ù·
(30)
2%,
20· å³ñÏáõ×
779
¼³É³ÛÇÝ
Zalain
ë»ñï³Ïáݳ½áÉ
sertaconazole
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
300Ù·
(1)
780
¼³Ýï³Ï
Zantac
é³ÝÇïǹÇÝ
ranitidine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
150Ù·
(20)
781
¼³Ýï³Ï
Zantac
é³ÝÇïǹÇÝ
ranitidine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
300Ù·
(10)
úØ äáñïáõ·»ë
OM Portugues
ºíñáý³ñÙ ê.².
ºíñáý³ñÙ ê.².
Europharm
S.A.
ü»ñ»ñ ÆÝï»ñݳëÇáÝ³É ê.².
(¾¶Æê ´´À, ÐáõÝ·³ñdzÇ
ѳٳñ)
Ferrer Internacional S.A. (for
EGIS PLC, Hungary)
ü»ñ»ñ ÆÝï»ñݳëÇáÝ³É ê.².
(¾¶Æê ´´À, ÐáõÝ·³ñdzÇ
ѳٳñ)
Ferrer Internacional S.A. (for
EGIS PLC, Hungary)
¶É³ùëá ú÷»ñ»ÛßÝë, ØdzóÛ³É
³·³íáñáõÃÛáõÝ
(÷³Ã»Ã³íáñáõÙÁ
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².)
Glaxo Operations, UK (packed
by GlaxoSmithKline
Pharmaceuticals S.A.)
¶É³ùëá ú÷»ñ»ÛßÝë, ØdzóÛ³É
³·³íáñáõÃÛáõÝ
(÷³Ã»Ã³íáñáõÙÁ
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².)
¸
¸
²¸
55
782
¼»¹»ùë
Zedex
783
¼»ÛÉ î
Zeel T
784
µñáÙÑ»ùëÇÝÇ
ÑǹñáùÉáñǹ,
¹»ùëïñáÙ»Ãáñý³Ý,
³ÙáÝÇáõÙÇ ùÉáñǹ,
Ù»ÝÃáÉ
bromhexine
hydrochloride,
dextromethorphane,
ammonium chloride,
menthol
-
ùëáõù
50·, 100· å³ñÏáõ×
¼»ÛÉ î
Zeel T
-
¹»Õ³Ñ³ï»ñ
(50,250)
785
¼»ï³Ù³ùë
Zetamax
³½ÇÃñáÙÇóÇÝ
azithromycin
2·,
60ÙÉ ßßÇÏ
786
¼»ñáÏáɹ-ä
Zerocold-P
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ,
»ñϳñ³ï¨
³½¹»óáõÃÛ³Ý
¹»Õ³Ñ³ï»ñ
787
¼»ýÇùë
Zeffix
¼Çµ³Ý
Zyban
788
789
790
¼ÇÙáùë
Zimox
¼Çݳï
Zinnat
791
¼Çݳó»ý
Zinacef
792
¼ÇÝ»ñÇï
Zineryt
793
¼Çåñ»ùë³
Zyprexa
ûß³ñ³Ï
Glaxo Operations, UK (packed
by GlaxoSmithKline
Pharmaceuticals S.A.)
(8Ù·+10Ù·+100Ù·+
ìáÏѳñ¹ Èï¹
5Ù·)/10ÙÉ,
Wockhardt Ltd
100ÙÉ ßßÇÏ
å³ñ³ó»ï³ÙáÉ,
500Ù·+2Ù·+5Ù·+
ùÉáñý»ÝÇñ³ÙÇÝ,
30Ù·
ý»ÝÇÉ¿ýñÇÝ, Ïáý»ÇÝ
(10, /10x10/,
paracetamol,
/10x20/, /4x50/)
chlorpheniramine,
phenylephrine, caffeine
ɳÙÇíáõ¹ÇÝ
ÉáõÍáõÛà ËÙ»Éáõ
5Ù·/ÙÉ,
lamivudine
240ÙÉ ßßÇÏ
µáõåñáåÇáÝÇ
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
150Ù·
ÑǹñáùÉáñǹ
Ó»ñµ³½³ïÙ³Ý
(30,60)
bupropion
hydrochloride
ɨá¹áå³,ϳñµÇ¹áå³
¹»Õ³Ñ³ï»ñ
250Ù·+25Ù·
levodopa,carbidopa
(30)
ó»ýáõñoùëÇÙ
¹»Õ³Ñ³ï»ñ
250Ù·
cefuroxime
óճÝóå³ï
(10)
ó»ýáõñûùëÇÙ
cefuroxime
¹»Õ³÷áßÇ
750Ù·,
Ý»ñ³ñÏÙ³Ý Ï³Ù
ëñí³Ï (1)
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÝ»ñÇ
¿ñÇÃñáÙÇóÇÝ, óÇÝÏÇ ¹»Õ³÷áßÇ ÉáõÍãáí (40Ù·+12Ù·)/ÙÉ,
³ó»ï³ï
30ÙÉ ÉáõÍáõÛÃÇ
erythromycin, zinc
ѳٳñ ¹»Õ³÷áßÇ ¨
acetate
ÉáõÍÇã ßßÇÏ/ßßÇÏ
(1) ¨ ÉáÃÇáÝÇ
³åÉÇϳïáñ
ûɳݽ³åÇÝ
¹»Õ³÷áßÇ
10Ù·,
olanzapine
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
ÉáõÍáõÛÃÇ
Ðݹϳëï³Ý
R05C A10
0646/6685
12.01.2007
12.01.2012
²¸
´ÇáÉá·Çß Ð³ÛÉÙÇÃ»É Ð»ÛÉ
¶ÙµÐ
Biologische
Heilmittel Heel GmbH
´ÇáÉá·Çß Ð³ÛÉÙÇÃ»É Ð»ÛÉ
¶ÙµÐ
Biologische
Heilmittel Heel GmbH
öý³Û½»ñ ü³ñÙ³ëÛáõÃÇù³Éë
êäÀ
Pfizer Pharmaceuticals Llc
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ
5307
04.02.2005
04.02.2010
²¸
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ
5306
04.02.2005
04.02.2010
²¸
²ØÜ
J01FA10
1399/7362
05.11.2007
05.11.2012
¸
´ÇáÙ»¹Çϳñ Biomedicare
Ðݹϳëï³Ý
N02B E71
5289
11.04.2005
11.04.2010
²¸
¶É³ùëáêÙÇÃÎɳÛÝ ÆÝÏ.
GlaxoSmithKline Inc.
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
ü³ñ³Ý ȳµáñ³ïáñdz ê.². Faran
Laboratories S.A.
¶É³ùëá ú÷»ñ»ÛßÝë Èï¹
Glaxo Operations UK Limited
γݳ¹³
J05A B10
4263
¸
Ȼѳëï³Ý
_
4036
03.06.2003
03.06.2008
01.04.2003
01.04.2008
Ðáõݳëï³Ý
N04B A02
4698
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
Æï³Édz
J01DA06
1340/7305
23.03.2004
23.03.2009
05.11.2007
05.11.2012
J01D A06
5117
27.09.2004
27.09.2009
¸
¶É³ùëáêÙÇÃÎɳÛÝ ê.å.².
GlaxoSmithKline S.p.A.
¸
¸
²ëï»É³ë ü³ñÙ³ ºáõñáå ´.ì.
Astellas Pharma Europe B.V.
Üǹ»éɳݹݻñ
D10A F52
1174/7137
13.09.2007
13.09.2012
²¸
ÈÇÉÇ ü³ñÙ³ ü»ñïÇ·áõÝ· ¨
¸ÇëïñǵáõïÇáÝ ¶ÙµÐ ¨ øá.ζ
Lilly Pharma Fertigung und
Distribution GmbH 7 Co. KG
¶»ñÙ³Ýdz
-
4959
14.07.2004
14.07.2009
¸
56
794
¼Çåñ»ùë³
Zyprexa
ûɳݽ³åÇÝ
olanzapine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(28)
¾ÉÇ ÈÇÉÇ ¨ øáÙå³ÝÇ Èï¹
Eli Lilly & Company Ltd
795
¼Çåñ»ùë³
Zyprexa
ûɳݽ³åÇÝ
olanzapine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5Ù·
(28)
¾ÉÇ ÈÇÉÇ ¨ øáÙå³ÝÇ Èï¹
Eli Lilly & Company Ltd
796
¼Çï³½áÝÇáõÙ
Zitazonium
¼Çñï»Ï
Zyrtec
¼Çñï»Ï
Zyrtec
¼á¹³Ï
Zodac
¹»Õ³Ñ³ï»ñ
10Ù·
(30/3x10/)
10Ù·
(7,10,20)
10Ù·/ÙÉ (1%),
10ÙÉ ßßÇÏ
10Ù·
(10,30,60)
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
Úáõ-êÇ-´Ç ü³ñËÇÙ ê²
UCB Farchim S.A.
Úáõ-êÇ-´Ç ü³ñÙ³ ê.å. ².
UCB Pharma S.p.A.
È»ãÇí³ ³.ë.
Lechiva a.s.
¹»Õ³Ñ³ï»ñ
0.25Ù·
(10)
800
¼áɳÙ
Zolam
ï³ÙûùëÇý»Ý
tamoxifen
ó»ïÇñǽÇÝ
cetirizine
ó»ïÇñǽÇÝ
cetirizine
ó»ïÇñǽÇÝÇ
ÑǹñáùÉáñǹ
cetirizini hydrochloride
³Éåñ³½áɳÙ
alprazolam
801
¼áɳÙ
Zolam
³Éåñ³½áɳÙ
alprazolam
¹»Õ³Ñ³ï»ñ
0.5Ù·
(10)
802
¼áÉ»ï
Zolet
µñÇíáõ¹ÇÝ
brivudin
¹»Õ³Ñ³ï»ñ
125Ù·
(7)
803
¼áÉáýï
Zoloft
¼áÙ³ùë 500
Zomax 500
¼áÙ»ï³
Zometa
ë»ñïñ³ÉÇÝ
sertraline
³½ÇÃñáÙÇóÇÝ
azithromycin
½áÉ»¹ñáݳÃÃáõ
zoledronic acid
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
50Ù·
(28)
500Ù·
(3)
4Ù·,
ëñí³Ï/³ÙåáõÉ (1)
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
öý³Û½»ñ Æï³Édz ê.é.É.
Pfizer Italia S.r.l.
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇù³Éë
Hikma Pharmaceuticals
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
806
¼áÙ»ï³
Zometa
4Ù·/5ÙÉ,
ëñí³Ï (1)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
807
¼áíÇñ³ùë
Zovirax
½áÉ»¹ñáݳï
ݳïñÇáõÙÇ
zoledronat sodium
³óÇÏÉáíÇñ
acyclovir
808
¼áíÇñ³ùë
Zovirax
³óÇÏÉáíÇñ
aciclovir
Ýñµ³ùëáõù
5%,
2· å³ñÏáõ×
809
¼áíÇñ³ùë
Zovirax
³óÇÏÉáíÇñ
aciclovir
³Ïݳùëáõù
3%,
4,5· å³ñÏáõ×
797
798
799
804
805
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³÷áßÇ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ,
5ÙÉ ÉáõÍÇãáí
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
200Ù·
(25)
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
ÐáõÝ·³ñdz
N05A H03
5536
23.05.2005
23.05.2010
¸
N05A N03
5537
23.05.2005
23.05.2010
¸
L02B A01
6106
¸
Þí»Ûó³ñdz
R06A E07
5178
Æï³Édz
R06A E07
5600
â»Ëdz
R06A E07
4104
13.04.2006
13.04.2011
04.11.2004
04.11.2009
12.12.2005
12.12.2010
10.04.2003
10.04.2008
º·Çåïáë
N05B A12
0047/5996
24.05.2006
24.05.2011
¸/Ð
º·Çåïáë
N05B A12
0048/5995
24.05.2006
24.05.2011
¸/Ð
¶»ñÙ³Ýdz
-
4644
15.06.2004
15.06.2009
¸
Æï³Édz
N06A B06
0681/6657
¸
Ðáñ¹³Ý³Ý
J01F A10
5391
Þí»Ûó³ñdz
-
5260
17.01.2007
17.01.2012
11.01.2006
11.01.2011
21.12.2004
21.12.2009
Þí»Ûó³ñdz
-
4401
01.09.2003
01.09.2008
¸
D06B B03,
J05A B01,
S01A D03
4795
26.04.2004
26.04.2009
¸
D06B B03
5624
06.07.2005
06.07.2010
²¸
J05A B01,
S01A D03
4521
26.09.2003
26.09.2008
¸
¶É³ùëáàõ»ÉùáÙ ê.².
Æëå³Ýdz
(Æëå³Ýdz) /÷³Ã»Ã³íáñáõÙÁª
¶É³ùëá êÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².,
Ȼѳëï³Ý/
Glaxo Wellcome S.A., Spain
(paked by GlaxoSmithKline
Pharmaceuticals S.A., Poland)
¶É³ùëá àõ»ÉùáÙ úå»ñ»ÛßÝë Ø»Í ´ñÇï³Ýdz
(¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ)
Glaxo Wellcome Operations for
GlaxoSmithKline Consumer
Healthcare
¸ñ³ùëÇë ü³ñÙ³ ÆÝÏ. γݳ¹³
γݳ¹³
(¶É³ùëáêÙÇÃÎɳÛÝ, γݳ¹³ÛÇ
ѳٳñ)
²¸
²¸
²¸
¸
¸
57
810
¼áýñ³Ý
Zofran
ûݹ³Ýë»ïñáÝ
ondansetron
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
8Ù·
(10)
811
¼áýñ³Ý
Zofran
ûݹ³Ýë»ïñáÝ
ondansetron
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
4Ù·
(10)
812
¼áýñ³Ý
Zofran
ûݹ³Ýë»ïñáÝ
ondansetron
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
813
¼áýñ³Ý
Zofran
ûݹ³Ýë»ïñáÝ
ondansetron
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
814
¾·ÇÉáÏ
Egilok
¾·ÇÉáÏ
Egilok
¾·ÇÉáÏ
Egilok
¾·ÇÉáÏ é»ï³ñ¹
Egilok Retard
¾·ÇÉáÏ é»ï³ñ¹
Egilok Retard
¾·ÇÉáÏ é»ï³ñ¹
Egilok retard
¾·ÇÉáÏ é»ï³ñ¹
Egilok retard
¾·ÉáÝÇÉ
Eglonyl
¾·ÉáÝÇÉ
Eglonyl
¾·ÉáÝÇÉ
Eglonyl
Ù»ïáåñáÉáÉ
metoprolol
Ù»ïáåñáÉáÉ
metoprolol
Ù»ïáåñáÉáÉ
metoprolol
Ù»ïáåñáÉáÉ
metoprolol
Ù»ïáåñáÉáÉ
metoprolol
Ù»ïáåñáÉáÉÇ ï³ñïñ³ï
metoprolol tartrate
Ù»ïáåñáÉáÉÇ ï³ñïñ³ï
metoprolol tartrate
ëáõÉåÇñǹ
sulpiride
ëáõÉåÇñǹ
sulpiride
ëáõÉåÇñǹ
sulpiride
¹»Õ³Ñ³ï»ñ
824
¾¹ÇóÇÝ
Edicin
í³ÝÏáÙÇóÇÝ
vancomycin
8Ù·/4ÙÉ,
4ÙÉ ³ÙåáõÉÝ»ñ
(5)
4Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
25Ù·
(30,60)
50Ù·
(30,60)
100Ù·
(30,60)
50Ù·,
(30)
100Ù·,
(30)
50Ù·
(30)
100Ù·
(30)
50Ù·
(30)
200Ù·
(12)
100Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(6)
0.5·,
ëñí³Ï (1)
825
¾¹ÇóÇÝ
Edicin
í³ÝÏáÙÇóÇÝ
vancomycin
826
¾¹ÝÇï
Ednyt
¾¹ÝÇï
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
815
816
817
818
819
820
821
822
823
827
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
Draxis Pharma Inc. Canada
(for GlaxoSmithKline, Canada)
¶É³ùëáàõ»ÉùáÙ ú÷»ñ»ÛßÁÝë
(ØdzóÛ³É Â³·³íáñáõÃÛáõÝ)
¶É³ùëáêÙÇÃÎɳÛÝ
ý³ñÙ³ëÛáõÃÇù³ÉëÇ ê.². ѳٳñ
GlaxoWellcome Operations
(United Kingdom) for
GlaxoSmithKline
Pharmaceuticals S.A.
¶É³ùëáàõ»ÉùáÙ ú÷»ñ»ÛßÁÝë
(ØdzóÛ³É Â³·³íáñáõÃÛáõÝ)
¶É³ùëáêÙÇÃÎɳÛÝ
ý³ñÙ³ëÛáõÃÇù³ÉëÇ ê.². ѳٳñ
GlaxoWellcome Operations
(United Kingdom) for
GlaxoSmithKline
Pharmaceuticals S.A.
¶É³ùëáêÙÇÃÎɳÛÝ ê.å.².
GlaxoSmithKline S.p.A.
Ȼѳëï³Ý
A04A A01
4118
12.02.2003
12.02.2008
¸
Ȼѳëï³Ý
A04A A01
4117
12.02.2003
12.02.2008
¸
Æï³Édz
A04A A01
4523
26.09.2003
26.09.2008
¸
¶É³ùëáêÙÇÃÎɳÛÝ ê.å.².
GlaxoSmithKline S.p.A.
Æï³Édz
A04A A01
4522
26.09.2003
26.09.2008
¸
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³É Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³É Èï¹.
Egis Pharmaceuticals Ltd.
¾¶Æê ´´À
EGIS PLC
¾¶Æê ´´À
EGIS PLC
ê³ÝáýÇ àõÇÝÃñáå Æݹ³ëïñÇ
Sanofi Winthrop Industrie
ê³ÝáýÇ àõÇÝÃñáå Æݹ³ëïñÇ
Sanofi Winthrop Industrie
ê³ÝáýÇ àõÇÝÃñáå Æݹ³ëïñÇ
Sanofi Winthrop Industrie
ÐáõÝ·³ñdz
C07 B02
5051
¸
ÐáõÝ·³ñdz
C07 B02
5052
ÐáõÝ·³ñdz
C07 B02
5053
ÐáõÝ·³ñdz
C07A B02
4392
ÐáõÝ·³ñdz
C07A B02
4393
ÐáõÝ·³ñdz
C07A B02
1177/7176
ÐáõÝ·³ñdz
C07A B02
1178/7177
üñ³Ýëdz
N05A L01
5908
üñ³Ýëdz
N05A L01
5910
üñ³Ýëdz
N05A L01
5909
31.07.2004
31.07.2009
31.07.2004
31.07.2009
31.07.2004
31.07.2009
21.07.2003
21.07.2008
21.07.2003
21.07.2008
18.09.2007
13.09.2012
18.09.2007
13.09.2012
24.03.2006
24.03.2011
24.03.2006
24.03.2011
24.03.2006
24.03.2011
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01X A01
0393/6396
19.09.2006
19.09.2011
¸
1·,
ëñí³Ï (1)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
J01X A01
0394/6395
19.09.2006
19.09.2011
¸
20Ù·
(20)
2.5Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
ÐáõÝ·³ñdz
C09A A02
5545
¸
ÐáõÝ·³ñdz
C09A A02
5542
30.05.2005
30.05.2010
30.05.2005
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
58
Ednyt
¾¹ÝÇï
Ednyt
¾¹ÝÇï
Ednyt
¾É»ÝÇáõÙ
Elenium
enalapril
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
enalapril
ùÉáñ¹Ç³½»åûùëǹ
chlordiazepoxide
831
¾Éǹ»É
Elidel
÷ÇÙ»ÏñáÉÇÙáõë
pimecrolimus
Ýñµ³ùëáõù
832
¾ÉáÏáÙ
Elocom
¾ÉáÏáÙ
Elocom
¾ÉáÏáÙ
Elocom
¾ÉáÏáÙ
Elocom
¾ÉáÏáÙ-ê
Elocom-S
ùëáõù
828
829
830
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(20)
5Ù·
(20)
10Ù·
(20)
10Ù·
(50)
1%,
15·,30·,100·
å³ñÏáõ×
0.1%,
15· å³ñÏáõ×
0.1%,
15· å³ñÏáõ×
0.1%,
20ÙÉ ßßÇÏ
0,1%,
20ÙÉ ßßÇÏ
(1Ù·+50Ù·)/·,
15·,45· å³ñÏáõ×
837
¾Éáõ¹ñÇÉ
Eludril
838
¾Éûùë³ïÇÝ
Eloxatin
ÙáٻﳽáÝÇ ýáõñá³ï
mometasone furoate
ÙáٻﳽáÝÇ ýáõñá³ï
mometasone furoate
ÙáٻﳽáÝÇ ýáõñá³ï
mometasone furoate
ÙáٻﳽáÝÇ ýáõñá³ï
mometasone furoate
ÙáٻﳽáÝÇ ýáõñá³ï,
ë³ÉÇóÇɳÃÃáõ
mometasone furoate,
salicylic acid
ùÉáñÑ»ùëǹÇÝ,
ùÉáñáµáõï³ÝáÉ
chlorhexidine,
chlorobutanol
ûùë³ÉÇåɳïÇÝ
oxaliplatin
839
¾Éûùë³ïÇÝ
Eloxatin
ûùë³ÉÇåɳïÇÝ
oxaliplatin
840
¾Ï³ÉÇÝ
Ekalin
¾Ï³ÉÇÝ
Ekalin
¾Ï³ÉÇÝ
Ekalin
¾ùáñ³É
Equoral
¿Ïáݳ½áÉÇ ÝÇïñ³ï
econazole nitrate
¿Ïáݳ½áÉÇ ÝÇïñ³ï
econazole nitrate
¿Ïáݳ½áÉÇ ÝÇïñ³ï
econazole nitrate
óÇÏÉáëåáñÇÝ
ciclosporin
844
¾ùáñ³É
Equoral
óÇÏÉáëåáñÇÝ
ciclosporin
¹»Õ³å³ïÇ×Ý»ñ
25Ù·
(50)
845
¾ùáñ³É
Equoral
óÇÏÉáëåáñÇÝ
ciclosporin
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(50)
846
¾ùáñ³É
Equoral
óÇÏÉáëåáñÇÝ
ciclosporin
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
(50)
847
¾Ïí³ïáñ
Ekvator
³ÙÉá¹ÇåÇÝ,
ÉǽÇÝáåñÇÉ
¹»Õ³Ñ³ï»ñ
5Ù·+10Ù·
(20(10x2),
833
834
835
836
841
842
843
Ýñµ³ùëáõù
ÉáÃÇáÝ
ÉáÃÇáÝ
ùëáõù
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
î³ñËáÙÇÝÇ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý §äáÉý³¦ ê.².
Tarchomin Pharmaceutical
Work §Polfa¦ S.A.
Üáí³ñïÇë ü³ñÙ³ ¶ÙµÐ
Novartis Pharma GmbH
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering-Plough Labo N.V.
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering-Plough Labo N.V.
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering-Plough Labo N.V.
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering Plough Labo N. V.
Þ»ñÇÝ·-öɳáõ ü³ñÙ³ ȹ³
Schering-Plough Farma Lda
30.05.2010
25.05.2005
25.05.2010
25.05.2005
25.05.2010
12.04.2006
12.04.2011
ÐáõÝ·³ñdz
C09A A02
5543
¸
ÐáõÝ·³ñdz
C09A A02
5544
Ȼѳëï³Ý
N05B A02
6096
¶»ñÙ³Ýdz
-
4050
23.07.2003
23.07.2008
²¸
´»É·Ç³
D07A C13
5471
¸
´»É·Ç³
D07A C13
5470
´»É·Ç³
D07A C13
5469
Æï³Édz
R01AD09
1418/6948
äáñïáõ·³-Édz
D07A
5960
22.04.2005
22.04.2010
22.04.2005
22.04.2010
22.04.2005
22.04.2010
25.12.2007
25.12.2012
10.02.2006
10.02.2011
üñ³Ýëdz
D08A C52
4754
18.03.2005
18.03.2010
²¸
üñ³Ýëdz
-
3808
29.09.2003
29.09.2008
¸
¸
¸/Ð
¸
¸
¸
¸
ÉáõÍáõÛÃ
(0.5ÙÉ+0.5·)/
100ÙÉ,
90ÙÉ ßßÇÏ
¹»Õ³÷áßÇ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
óáÕ³ßÇÃ
100Ù·(5Ù·/ÙÉ),
ëñí³Ï (1)
äÇ»é ü³µñ» Ø»¹ÇϳٻÝï
öñá¹³ÏëÇáÝ
Pierre Fabre Medicament
Production
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Sanofi Winthrop Industrie
50Ù·(5Ù·/ÙÉ),
ëñí³Ï (1)
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Sanofi Winthrop Industrie
üñ³Ýëdz
-
3807
29.09.2003
29.09.2008
¸
ڲβ-80
JAKA-80
ڲβ-80
JAKA-80
ڲβ-80
JAKA-80
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
سϻ¹áÝdz
D01A C03
0129/5795
¸
سϻ¹áÝdz
D01A C03
0130/5794
سϻ¹áÝdz
G01A F05
0131/5796
â»Ëdz
L04A A01
4640
21.06.2006
21.06.2011
21.06.2006
21.06.2011
21.06.2006
21.06.2011
14.04.2004
14.04.2009
â»Ëdz
L04A A01
4641
14.04.2004
14.04.2009
¸
â»Ëdz
L04A A01
4642
14.04.2004
14.04.2009
¸
â»Ëdz
L04A A01
4643
14.04.2004
14.04.2009
¸
ÐáõÝ·³ñdz
C08C
5426
14.12.2005
14.12.2010
¸
1%,
50· ëñí³Ï
Ýñµ³ùëáõù
1%,
30· å³ñÏáõ×
Ñ»ßïáó³ÙáÙÇÏ150Ù·
Ý»ñ
(3)
ÉáõÍáõÛà ËÙ»Éáõ 100Ù·/ÙÉ (10%),
50ÙÉ ßßÇÏ
¸
¸
¸
59
amlodipine, lisinopril
848
¾ÏïÇíÇ
Aktivy
849
¾ÏïáóǹáÉ 600
Ectocidol 600
¾Ù³¹ÇÝ
Emadine
¾Ø´-ü³ïáÉ 400Ù·
EMB-Fatol 400mg
850
851
852
¾Ù»ë»ï
Emeset
853
¾Ù»ë»ï
Emeset
854
¾Ù»ë»ï
Emeset
855
¾Ù»ïñáÝ
Emetron
856
¾Ù»ïñáÝ
Emetron
857
¾Ù»ïñáÝ
Emetron
858
¾Ù»ïñáÝ
Emetron
859
¾Ù-Ûáõ ÃÇÝ
M-U Tene
¾ÙûùëÇåÇÝ
Emoxypine
860
861
¾ÙûùëÇåÇÝ
Emoxypine
862
¾Ý³É³åñÇÉ
Enalapril
863
¾Ý³É³åñÇÉ
Enalapril
-
å³ïÇ×Ý»ñ
10(10x1),
30(10x3))
400Ù·
(60)
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
¹Ç³½ÇÝáÝ
ÉáõÍáõÛà ݻñùÇÝ
600Ù·/ÙÉ,
ÆÝí»ë³
diazinon
ÁݹáõÝÙ³Ý
1É åɳëïÇÏ ï³ñ³
Invesa
¿Ù»¹³ëïÇÝ
ÉáõÍáõÛÃ0.05%,
ê.².²ÉÏáÝ øáõíñ»áõñ Ü.ì.
emedastine
³ÏݳϳÃÇÉÝ»ñ
5ÙÉ ßßÇÏ
S.A.Alcon-Couvreur N.V.
¿Ã³ÙµáõïáɹÇÑǹñṻճѳï»ñ
400Ù·
ü³ïáÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ
ùÉáñǹ
óճÝóå³ï
[100(10x10), 1000]
Fatol Arzneimittel GmbH
ethambutoldihydrochloride
ûݹ³Ýë»ïñáÝÇ
ÉáõÍáõÛÃ
2Ù·/ÙÉ,
êÇåɳ Èï¹
ÑǹñáùÉáñǹ
Ý»ñ³ñÏÙ³Ý
4ÙÉ ³ÙåáõÉÝ»ñ
Cipla Ltd.
ondansetron
(5)
hydrochloride
ûݹ³Ýë»ïñáÝÇ
¹»Õ³Ñ³ï»ñ
8Ù·
êÇåɳ êäÀ
ÑǹñáùÉáñǹ
(10, 200 /20x10/)
Cipla Ltd.
ondansetron
hydrochloride
ûݹ³Ýë»ïñáÝÇ
¹»Õ³Ñ³ï»ñ
4Ù·
êÇåɳ êäÀ
ÑǹñáùÉáñǹ
(10, 500/10x5x10/)
Cipla Ltd.
ondansetron
hydrochloride
ûݹ³Ýë»ïñáÝ
ÉáõÍáõÛÃ
4Ù·/2ÙÉ,
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
ondansetrone
Ý»ñ³ñÏÙ³Ý
2ÙÉ ³ÙåáõÉÝ»ñ
·áñͳñ³Ý ö´À
(5)
Chemical Works Gedeon
Richter Ltd.
ûݹ³Ýë»ïñáÝ
¹»Õ³Ñ³ï»ñ
4Ù·
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
ondansetrone
óճÝóå³ï
(10)
·áñͳñ³Ý ö´À
Chemical Works Gedeon
Richter Ltd.
ûݹ³Ýë»ïñáÝ
¹»Õ³Ñ³ï»ñ
8Ù·
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
ondansetrone
óճÝóå³ï
(10)
·áñͳñ³Ý ö´À
Chemical Works Gedeon
Richter Ltd.
ûݹ³Ýë»ïñáÝ
ÉáõÍáõÛÃ
8Ù·/4ÙÉ,
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
ondansetrone
Ý»ñ³ñÏÙ³Ý
4ÙÉ ³ÙåáõÉÝ»ñ
·áñͳñ³Ý ö´À
(5)
Chemical Works Gedeon
Richter Ltd.
µ»ï³Ï³ñáïÇÝ
å³ïÇ×Ý»ñ
(30,60,80,120)
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
Beta carotene
New Spirit Naturals Inc.
¿ÙûùëÇåÇÝ
ÉáõÍáõÛÃ
1%,
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
emoxypine
Ý»ñ³ñÏÙ³Ý
1ÙÉ ³ÙåáõÉÝ»ñ
Belmedpreparaty RUP
(10)
¿ÙûùëÇåÇÝ
ÉáõÍáõÛÃ
3%,
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
emoxypine
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
Belmedpreparaty RUP
(5)
¿Ý³É³åñÇÉ
¹»Õ³Ñ³ï»ñ
0.005· (10, 20,
´áñÇëáíÛ³Ý ´ä¶
enalapril
25, 30, 40, 50)
Borisov Medical Preparations
Plant RUP
¿Ý³É³åñÇÉ
¹»Õ³Ñ³ï»ñ
0.01· (10, 20, 25,
´áñÇëáíÛ³Ý ´ä¶
enalapril
30, 40, 50)
Borisov Medical Preparations
Æéɳݹdz
βêÐ
5819
26.10.2005
26.10.2010
²¸
Æëå³Ýdz
0309/6306
¶»ñÙ³Ýdz
J04A K02
4935
01.08.2006
01.08.2011
31.05.2004
31.05.2009
03.07.2004
03.07.2009
¸
´»É·Ç³
³Ý³ëݳµáõųϳÝ
-
Ðݹϳëï³Ý
A04A A01
0359/6198
28.08.2006
28.08.2011
¸
Ðݹϳëï³Ý
A04A A01
1438/7398
20.12.2007
20.12.2012
¸
Ðݹϳëï³Ý
A04A A01
1437/7397
20.12.2007
20.12.2012
¸
ÐáõÝ·³ñdz
A04A A01
4732
24.02.2004
24.02.2009
¸
ÐáõÝ·³ñdz
A04A A01
4730
24.02.2004
24.02.2009
¸
ÐáõÝ·³ñdz
A04A A01
4731
24.02.2004
24.02.2009
¸
ÐáõÝ·³ñdz
A04A A01
4733
24.02.2004
24.02.2009
¸
²ØÜ
βêÐ
5104
²¸
´»É³éáõë
V03AX
0701/6730
20.09.2004
20.09.2009
25.01.2007
25.01.2012
´»É³éáõë
V03AX
0702/6729
25.01.2007
25.01.2012
¸
´»É³éáõë
C09A A02
5026
13.12.2004
13.12.2009
¸
´»É³éáõë
C09A A02
5027
13.12.2004
13.12.2009
¸
4892
¸
¸
¸
60
864
865
866
867
868
869
870
871
872
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ
Enalapril
¾Ý³É³åñÇÉ - Ð
Enalapril - H
873
¾Ý³É³åñÇɼ¹áñáíÛ»
Enalapril-Zdorovye
874
¾Ý³É³åñÇÉ-м¹áñáíÛ»
Enalapril-HZdorovye
¾Ý³É³åñÇÉ-Ðȼ¹áñáíÛ»
Enalapril-HLZdorovye
¾Ý³Éá½Ç¹
Enalozid
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï,
ÑǹñáùÉáñáÃdz½Ç¹
enalapril maleate,
hydrochlorothiazide
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
10Ù·
(20, 30)
¹»Õ³Ñ³ï»ñ
(10Ù·+25Ù·)
(20, 30, 40/2x20/,
60/2x30/)
¹»Õ³Ñ³ï»ñ
(10Ù·+12,5Ù·)
(20, 30, 40, 60)
¹»Õ³Ñ³ï»ñ
10Ù·+25Ù·
(20)
¹»Õ³Ñ³ï»ñ
5Ù·
(30)
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
20Ù·
(20,1600x10)
0.005·
(20/2x10/)
10Ù·
(20)
10Ù·
(20,1600x10)
0.01·
(20/2x10/)
0.02·
(20/2x10/)
20Ù·
(20)
5Ù·
(20)
10Ù·+25Ù·
(10, 20, 30)
877
¾Ý³Ñ»ùë³É
Enahexal
¿Ý³É³åñÇÉÇ Ù³É»³ï,
ÑǹñáùÉáñáÃdz½Ç¹
enalapril maleate,
hydrochlorothiazide
¿Ý³É³åñÇÉÇ Ù³É»³ï,
ÑǹñáùÉáñáÃdz½Ç¹
enalapril maleate,
hydrochlorothiazide
¿Ý³É³åñÇÉÇÇ Ù³É»³ï,
ÑǹñáùÉáñáÃdz½Ç¹
enalapril maleate,
hydrochlorothiazide
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
878
¾Ý³Ñ»ùë³É
Enahexal
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¹»Õ³Ñ³ï»ñ
20Ù·
(30)
879
¾Ý³Ñ»ùë³É
Enahexal
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¹»Õ³Ñ³ï»ñ
10Ù·
(30)
880
¾Ý³å
Enap
¾Ý³å ¹»Õ³Ñ³ï»ñ
Enap tablets
¾Ý³å ¹»Õ³Ñ³ï»ñ
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
¹»Õ³Ñ³ï»ñ
2.5Ù·
(20)
5Ù·
(20/2x10/)
10Ù·
875
876
881
882
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
Plant RUP
ڲβ-80
JAKA-80
ú½áÝ êäÀ
Ozon Ltd.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ڲβ-80
JAKA-80
ú½áÝ êäÀ
Ozon Ltd.
ú½áÝ êäÀ
Ozon Ltd.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
سϻ¹áÝdz
C09A A02
5669
19.09.2005
19.09.2010
08.12.2005
08.12.2010
24.03.2006
24.03.2011
19.09.2005
19.09.2010
08.12.2005
08.12.2010
08.12.2005
08.12.2010
24.03.2006
24.03.2011
24.03.2006
24.03.2011
12.11.2004
12.11.2009
¸
èáõë³ëï³Ý
C09A A02
5786
ê»ñµÇ³ ¨
â»éÝá·áñdz
سϻ¹áÝdz
C09B A02
6027
C09A A02
5668
èáõë³ëï³Ý
C09A A02
5787
èáõë³ëï³Ý
C09A A02
5788
ê»ñµÇ³ ¨
â»éÝá·áñdz
ê»ñµÇ³ ¨
â»éÝá·áñdz
г۳ëï³Ý
C09B A02
6028
C09B A02
6026
C09B A02
5153
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ü³ñÙ³Ï ´´À
Farmak JSC
àõÏñ³Çݳ
C09A A02
1252/7065
15.10.2007
15.10.2012
¸
àõÏñ³Çݳ
C09A A02
1251/7064
15.10.2007
15.10.2012
¸
àõÏñ³Çݳ
C09BA02
1234/7171
15.11.2007
13.09.2012
¸
àõÏñ³Çݳ
C09B A02
5697
17.10.2005
17.10.2010
¸
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d., Novo mesto
Îèβ ¹.¹., Üáíá Ù»ëïá
¶»ñÙ³Ýdz
C09A A02
5584
19.05.2005
19.05.2010
¸
¶»ñÙ³Ýdz
C09A A02
5586
19.05.2005
19.05.2010
¸
¶»ñÙ³Ýdz
C09A A02
5585
19.05.2005
19.05.2010
¸
êÉáí»Ýdz
C09A A02
4439
¸
êÉáí»Ýdz
C05A A02
1011/6930
êÉáí»Ýdz
C09A A02
0823/6820
16.07.2003
16.07.2008
04.06.2007
04.06.2012
20.03.2007
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
61
883
884
Enap tablets
¾Ý³å ¹»Õ³Ñ³ï»ñ
Enap tablets
¾Ý³å Ð ¹»Õ³Ñ³ï»ñ
Enap H tablets
885 ¾Ý³å ÐÈ ¹»Õ³Ñ³ï»ñ
Enap-HL tablets
enalapril
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉÇ Ù³É»³ï,
ÑǹñáùÉáñáÃdz½Ç¹
enalapril maleate,
hydrochlorothiazide
¿Ý³É³åñÇÉÇ Ù³É»³ï,
ÑǹñáùÉáñáÃdz½Ç¹
enalapril maleate,
hydrochlorothiazide
¿Ý³É³åñÇÉÇ Ù³É»³ï,
ÑǹñáùÉáñáÃdz½Ç¹
enalapril maleate,
hydrochlorothiazide
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
886
¾Ý³å-ÐÈ 20
Enap-HL 20
887
¾Ý³å-è
Enap-R
¿Ý³É³åñÇɳï
enalaprilat
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
888
¾Ý³ñ»Ý³É
Enarenal
¾Ý³ñ»Ý³É
Enarenal
¾Ý³ñ»Ý³É
Enarenal
¾Ý»Ù³ùë ¾Ý»Ù³
Enemax Enema
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
enalapril
¿Ý³É³åñÇÉ
enalapril
ݳïñÇáõÙÇ ýáëý³ï,
»ñÏݳïñÇáõÙÇ ýáëý³ï
monosodium
phosphate, disodium
phosphate
ëáõɵáõÃdzÙÇÝ
sulbutiamine
¹»Õ³Ñ³ï»ñ
889
890
891
892
¾Ý»ñÇáÝ
Enerion
893
¾Ý½Çùë
Enzix
I-¿Ý³É³åñÇÉÇ Ù³É»³ï,
II-Çݹ³å³Ùǹ
I-enalapril maleate,
II-indapamide
894
¾Ý½Çùë ¹áõá
I-¿Ý³É³åñÇÉÇ Ù³É»³ï,
Enzix Duo
II-Çݹ³å³Ùǹ
I-enalapril maleate,
II-indapamide
895 ¾Ý½Çùë ¹áõá ýáñï» I-¿Ý³É³åñÇÉÇ Ù³É»³ï,
Enzix Duo Forte
II-Çݹ³å³Ùǹ
I-enalapril maleate,
II-indapamide
896
¾Ýç»ñÇùë ´
é»ÏáÙµÇݳÝï ¸ÜÂEngerix B
å³ïí³ëï³ÝÛáõÃ
rDNA vaccine
897
¾Ýï»ñáÉ
Enterol
ë³Ï˳ñáÙÇó»ë
µáõɳñ¹Ç
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ñá·Ý³ÛÇ
(20/2x10/)
20Ù·
(20/2x10/)
10Ù·+25Ù·
(20/2x10/)
KRKA d.d., Novo mesto
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
10Ù·+12,5Ù·
(20/2x10/)
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
20Ù·+12.5Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(20/2x10/,
KRKA d.d. Novo mesto
30/3x10/, 60/6x10/,
90/9x10/,
100/10x10/)
1,25Ù·/1ÙÉ,
Îèβ ¹.¹. Üáíá Ù»ëïá
1ÙÉ ³ÙåáõÉÝ»ñ
KRKA d.d. Novo mesto
(5)
10Ù·
äáÉý³ñÙ³ ê.².
Polpharma
(20, 30, 60)
S.A.
20Ù·
äáÉý³ñÙ³ ê.².
Polpharma
(20, 30, 60)
S.A.
5Ù·
äáÉý³ñÙ³ ê.².
Polpharma
(20, 30, 60)
S.A.
(16·+6·)/100ÙÉ,
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
120ÙÉ ßßÇÏ
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
20.03.2012
20.03.2007
20.03.2012
20.03.2007
20.03.2012
êÉáí»Ýdz
C09A A02
0822/6821
êÉáí»Ýdz
C09B A02
0821/6822
êÉáí»Ýdz
C09B A02
0820/6823
20.03.2007
20.03.2012
¸
êÉáí»Ýdz
C09B A02
0565/6529
24.11.2006
24.11.2011
¸
êÉáí»Ýdz
C05AA02
1215/7184
04.12.2007
13.09.2012
¸
Ȼѳëï³Ý
C09A A02
4726
¸
Ȼѳëï³Ý
C09A A02
4727
Ȼѳëï³Ý
C09A A02
4725
º·Çåïáë
-
0118/6042
19.08.2004
19.08.2009
19.08.2004
19.08.2009
19.08.2004
19.08.2009
15.06.2006
15.06.2011
A11DA02
0333/6369
11.08.2006
11.08.2011
¸
C09B A02
6031
24.03.2006
24.03.2011
¸
¸
¸
¸
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(20)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
I-10Ù·,
II-2.5Ù·,
(15+15)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
I-10Ù·,
II-2.5Ù·,
(30+15)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
C09B A02
6030
24.03.2006
24.03.2011
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
I-20Ù·,
II-2.5Ù·,
(30+15)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
C09B A02
6029
24.03.2006
24.03.2011
¸
¶É³ùëáêÙÇÃÎɳÛÝ
´ÇáÉáçÇϳÉë ë.³.
GlaxoSmithKline Biologicals
s.a.
´»É·Ç³
-
5057
03.08.2004
03.08.2009
¸
´ÇáÏá¹»ùë
Biocodex
üñ³Ýëdz
A07FA02
1446/7416
20.12.2007
20.12.2012
²¸
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
HBsAg 20ÙÏ·/1ÙÉ
(ٻͳѳë³ÏÝ»ñÇ
ѳٳñ),
(1¹»Õ³ã³÷ Éóí³Í
Ý»ñ³ñÏãáõÙ)
¹»Õ³÷áßÇ ËÙ»Éáõ 250Ù·, ÷³Ã»ÃÝ»ñ
¹»Õ³Ï³ËáõÛÃÇ
(10)
ê»ñíÇ» Çݹ³ëïñÇ É³µáñ³ïáñdz
üñ³Ýëdz
(ê»ñíÇ» ɳµáñ³ïáñdzÛÇ Ñ³Ù³ñ,
üñ³Ýëdz)
Les Laboratoires Servier
Industrie for Les Laboratoires
Servier
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
ê»ñµÇ³ ¨
Hemofarm koncern A.D.
â»éÝá·áñdz
¸
62
ÉÇáýÇÉǽ³óí³Í
µçÇçÝ»ñ
lyophilized cells of
saccharomyces
boulardii
ë³Ï˳ñáÙÇó»ë
µáõɳñ¹Ç
ÉÇáýÇÉǽ³óí³Í
µçÇçÝ»ñ
lyophilized cells of
saccharomyces
boulardii
¿ÝñáýÉûùë³óÇÝ
enrofloxacin
898
¾Ýï»ñáÉ
Enterol
899
¾ÝñáµÇáýÉûùë
10%
Enrobioflox 10%
900
¾Ýñáí»ï 10%
Enrovet 10%
¿ÝñáýÉûùë³óÇÝ
enrofloxacin
ÉáõÍáõÛà ËÙ»Éáõ
¾ÝñáýÉûùë 10%
Enroflox 10%
¿ÝñáýÉûùë³óÇÝ
enrofloxacin
ËÙ»Éáõ ÉáõÍáõÛÃ
902 ¾áõÃÇñûùë 100ÙÏ·
Euthyrox 100mcg
903 ¾áõÃÇñûùë 125 ÙÏ·
Euthyrox 125 mcg
904 ¾áõÃÇñûùë 150 ÙÏ·
Euthyrox 150 mcg
905 ¾áõÃÇñûùë 25 ÙÏ·
Euthyrox 25 mcg
906 ¾áõÃÇñûùë 50 ÙÏ·
Euthyrox 50 mcg
907 ¾áõÃÇñûùë 75 ÙÏ·
Euthyrox 75 mcg
908
¾áõýÇÉÇÝ
Euphyllin
909
¾áõýÇÉÇÝ
Euphyllin
ɨáÃÇñûùëÇÝ
levothyroxine
ɨáÃÇñûùëÇÝ
levothyroxine
ɨáÃÇñûùëÇÝ
levothyroxine
ɨáÃÇñûùëÇÝ
levothyroxine
ɨáÃÇñûùëÇÝ
levothyroxine
ɨáÃÇñûùëÇÝ
levothyroxine
³ÙÇÝáýÇÉÇÝ
aminophylline
³ÙÇÝáýÇÉÇÝ
aminophylline
¹»Õ³Ñ³ï»ñ
910
¾áõýÇÉÇÝ
Euphyllin
³ÙÇÝáýÇÉÇÝ
aminophylline
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
911
¾áõýÇÉÇݼ¹áñáíÛ»
Euphyllin-Zdorovye
ûáýÇÉÇÝ
theophylline
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
912
¾åÇϳÛÇÝ
Epicaine
µáõåÇí³Ï³ÛÇÝ
bupivacaine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
913
¾åÇñ³Ù³ï
Epiramat
ïáåÇñ³Ù³ï
topiramate
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
901
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(10)
´ÇáÏá¹»ùë
Biocodex
üñ³Ýëdz
A07FA02
1445/7415
20.12.2007
20.12.2012
²¸
Ñ»ÕáõÏ ËÙ»Éáõ
10%, 25ÙÉ,
50ÙÉ, 100ÙÉ,
250ÙÉ, 500ÙÉ,
1000ÙÉ ßßÇÏ
100Ù·/ÙÉ,
1É, 20É ï³ñ³
ì»ïáùíÇÝáÉ ´Çáí»ï Èï¹.
Vetoquinol Biowet Ltd.
Ȼѳëï³Ý
³Ý³ëݳµáõųϳÝ,
J01M
5844
08.11.2005
08.11.2010
¸
Ðݹϳëï³Ý
0147/6277
07.07.2006
07.07.2011
¸
0205/6258
21.07.2006
21.07.2011
¸
¶»ñÙ³Ýdz
³Ý³ëݳµáõųϳÝ,
J01M A
³Ý³ëݳµáõųϳÝ,
J01M A
H03A A01
5356
¸
¶»ñÙ³Ýdz
H03A A01
4790
¶»ñÙ³Ýdz
H03A A01
4791
¶»ñÙ³Ýdz
H03A A01
4787
¶»ñÙ³Ýdz
H03A A01
4788
¶»ñÙ³Ýdz
H03A A01
4789
èáõë³ëï³Ý
R03D A05
5093
´»É³éáõë
R03D A05
0944/6901
04.02.2005
04.02.2010
22.04.2004
22.04.2009
22.04.2004
22.04.2009
22.04.2004
22.04.2009
22.04.2004
22.04.2009
22.04.2004
22.04.2009
20.08.2004
20.08.2009
03.05.2007
03.05.2012
´»É³éáõë
R03D A05
5029
13.12.2004
13.12.2009
¸
àõÏñ³Çݳ
R003DA04
1348/7309
05.11.2007
05.11.2012
¸
г۳ëï³Ý
N01B B01
0896/6973
20.04.2007
20.04.2012
¸
Êáñí³Ãdz
N03A X11
1323/7079
31.10.2007
31.10.2012
¸
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
100Ù·/ÙÉ,
1É åɳëïÇÏ ï³ñ³
êÇåɳ Èï¹.
Cipla
Ltd.
ÆÝí»ë³
Invesa
100ÙÏ·
Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
(50,100)
Merck KGaA (for Nycomed)
125ÙÏ· (20, 25, 28, Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
50, 60, 84, 90, 100) Merck KGaA (for Nycomed)
150ÙÏ· (20, 25, 28, Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
50, 60, 84, 90, 100) Merck KGaA (for Nycomed)
25ÙÏ· (20, 25, 28, Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
50, 60, 84, 90, 100) Merck KGaA (for Nycomed)
50ÙÏ· (20, 25, 28, Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
50, 60, 84, 90, 100) Merck KGaA (for Nycomed)
75ÙÏ· (20, 25, 28, Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
50, 60, 84, 90, 100) Merck KGaA (for Nycomed)
0.15·
²Û-êÇ-¾Ý È»Ïëñ»¹ëïí³
ICN
(10,30)
Leksredstva
0.15·
´áñÇëáíÛ³Ý
(30)
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
2.4%,
´áñÇëáíÛ³Ý ´ä¶
5ÙÉ ³ÙåáõÉÝ»ñ
Borisov Medical Preparations
(10)
Plant RUP
2% (5ÙÉ),
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
5ÙÉ ³ÙåáõÉÝ»ñ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
(10)
Zdorovye Pharmaceutical
Company LLC
0.5%,
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
20ÙÉ ßßÇÏ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
50Ù·
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
(28/2x14/,
Pliva Hrvatska d.o.o.
60/6x10/)
Æëå³Ýdz
¸
¸
¸
¸
¸
¸
¸
63
914
¾åÇñ³Ù³ï
Epiramat
¾åÇñ³Ù³ï
Epiramat
ïáåÇñ³Ù³ï
topiramate
ïáåÇñ³Ù³ï
topiramate
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
916
¾åÇñ³Ù³ï
Epiramat
ïáåÇñ³Ù³ï
topiramate
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
917
¾åÇñáõµÇóÇÝ
¾´ºìº
Epirubicin EBEWE
¾åñ»ùë
Eprex
¿åÇñáõµÇóÇÝ
epirubicin
915
918
919
920
921
922
923
924
925
926
¿åá»ïÇÝ ³Éý³
epoetin alfa
¾ë»Ý XL ÉÇí»ñ
¿ë»ÝódzÉ
ýáñï» ¹»Õ³å³ïÇ×Ý»ñ
ýáëýáÉÇåǹݻñ,
Essen XL Liver
íÇï³ÙÇÝÝ»ñ
Forte Capsules
essential phospholipids,
vitamins
¾ë»Ýódzɻ Ü
ýáëýáÉÇåǹݻñ
Essentiale N
(¿ë»ÝódzÉ)-¾üÈ
phospholipids
(essential)-EPL
¾ë»Ýódzɻ ýáñï» Ü
ýáëýáÉÇåǹݻñ
Essentiale Forte N
(¿ë»ÝódzÉ)-¾üÈ
phospholipids
(essential)-EPL
¾ëϳå»É
ɨáÝáñ·»ëïñ»É
Escapelle
levonorgestrel
¾ëÏáõ½³Ý
ÓdzϳëÏÇ åïáõÕÝ»ñÇ
Aescusan
ѳÝáõÏ, ÃdzÙÇÝÇ
ÑǹñáùÉáñǹ
dry extract of horse
chestnut seeds,
thiamine hydrochloride
¾ëÏáõ½³Ý 20
ÓdzϳëÏÇ åïáõÕÝ»ñÇ
Aescusan 20
ãáñ ѳÝáõÏ
dry extract from horse
aesculus chestnut
¾ëåáÉ
ï³ù¹»ÕÇ Ñ³ÝáõÏ,
Espol
¹ÇÙ»ùëǹ, ݳñ¹áëÇ,
·ÇÝÓÇ »Ã»ñ³ÛáõÕ»ñ,
ùÉáñáýáñÙ
extract capsici, dimexid,
etheraoleum lavande,
etheraoleum coriander,
chlorophorm
¾ëïÇý³Ý
³ëïճͳÕÇÏ
Estifan
µáëáñ³·áõÛÝ (ãáñ
ѳÝáõÏ)
Echinacea purpurea
(dry extract)
200Ù·
(28/4x7/, 60)
100Ù·
(28/2x14/,
60/6x10/)
25Ù·
(28/2x14/,
60/6x10/)
10Ù·/5ÙÉ,
ëñí³Ï (1)
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
Êáñí³Ãdz
N03A X11
1326/7081
Êáñí³Ãdz
N03A X11
1324/7080
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
Êáñí³Ãdz
N03A X11
²íëïñdz
Ëï³ÝÛáõÃ
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·. ζ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
EBEWE Pharma Ges.m.b.H.
ÉáõÍáõÛÃÇ
Nfg. KG
ÉáõÍáõÛÃ
2000 ØØ/0.5ÙÉ, ì»ï»ñ ü³ñÙ³ ü»ñïÇ·áõÝ· ¶ÙµÐ ¨
Ý»ñ³ñÏÙ³Ý,
ݳ˳Éóí³Í Ý»ñ³ñÏÇã øá. ζ (ÉÇó»Ý½Ç³ÛÇ ï»ñÁ`
ݳ˳Éóí³Í
(6)
êÇɳ· ²¶, Þí»Ûó³ñdz)
Ý»ñ³ñÏÇãáõÙ
Vetter Pharma Fertigung
GmbH & Co.KG (license holder
Cilag AG, Switzerland)
¹»Õ³å³ïÇ×Ý»ñ
(30)
XL ɳµáñ³ïáñdz PVT Èï¹.
XL Laboratories PVT Ltd.
31.10.2007
31.10.2012
31.10.2007
31.10.2012
¸
1322/7078
31.10.2007
31.10.2012
¸
L01D B03
4113
27.03.2003
27.03.2008
¸
¶»ñÙ³Ýdz
-
0159/6001
07.07.2006
07.07.2011
¸
Ðݹϳëï³Ý
-
0012/6059
12.05.2006
12.05.2011
¸
¸
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
50Ù·/ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
². ܳûñÙ³Ý ¨ òÇ» ¶ÙµÐA.
Nattermann & CIE GmbH
¶»ñÙ³Ýdz
A05C
0604/6590
14.12.2006
14.12.2011
¸
¹»Õ³å³ïÇ×Ý»ñ
300Ù·
(30)
². ܳûñÙ³Ý ¨ òÇ» ¶ÙµÐA.
Nattermann & CIE GmbH
¶»ñÙ³Ýdz
A05C
0605/6589
14.12.2006
14.12.2011
¸
¹»Õ³Ñ³ï»ñ
1.5Ù·
(1)
(5,00·6,25·+0,5·)/100·,
20ÙÉ ßßÇÏ
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ü³ñÙ³ ì»ñÝÇ·»ñá¹» ¶ÙµÐ
Pharma Wernigerode GmbH
ÐáõÝ·³ñdz
G03A C03
5425
¸
¶»ñÙ³Ýdz
C05C X
1320/7292
01.06.2005
01.06.2010
23.10.2007
12.10.2012
250Ù· ѳÝáõÏ`
ѳٳñÅ»ù 20Ù·
¿ëóÇÝÇ
(40)
(10·+3·+0.25·+
0.25·+2.5·)/100·,
15·, 20·, 25·, 30·,
35·, 40· å³ñÏáõ×
ڻݳý³ñÙ ¶ÙµÐ ¨ øá. ζ,
Þ»ñÇÝ· ·ñáõå ùáÙå³ÝÇ
Jenapharm GmbH & Co. KG,
Schering Group Company
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
¶»ñÙ³Ýdz
C05CX
1060/6715
10.07.2007
28.02.2012
²¸
èáõë³ëï³Ý
-
4173
23.09.2003
23.09.2008
²¸
0.2·
(10, 20, 30, 50)
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´»É³éáõë
-
5028
13.12.2004
13.12.2009
²¸
ÉáõÍáõÛÃ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ùëáõù
¹»Õ³Ñ³ï»ñ
²¸
64
927
¾ï³Ù½Çɳï 12,5%
Etamsylat 12,5%
¿ï³Ù½Çɳï
etamsylate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
928
¾ï³óǹ
Etacid
ÙáٻﳽáÝÇ ýáõñá³ï
mometasone furoate
ùëáõù
929
¾ïáåá½Ç¹ - ¾µ»í»
Etoposid - Ebewe
¿ïáåá½Ç¹
etoposide
930
¾ñ³½áÝ
Erazon
¾ñ³½áÝ
Erazon
¾ñ³½áÝ
Erazon
¾ñ»Ùý³ï 300
Eremfat 300
¾ñ»Ùý³ï Ý./». 300Ù·
Eremfat i.v. 300mg
åÇñûùëÇϳÙ
piroxicam
åÇñûùëÇϳÙ
piroxicam
åÇñûùëÇϳÙ
piroxicam
éÇý³ÙåÇóÇÝ
rifampicin
éÇý³ÙåÇóÇÝ
rifampicin
935
¾ñ»ëå³É
Eurespal
ý»ÝëåÇñǹ
fenspiride
936
¾ñ»ëå³É
Eurespal
ý»ÝëåÇñǹ
fenspiride
937
¾ñÇÃñáÙÇóÇÝ
Erythromycin
¿ñÇÃñáÙÇóÇÝ
erythromycin
938
¾ñÇÃñáÙÇóÇÝ
Erythromycin
¾ñÇÃñáÙÇóÇÝ
Erythromycin
¾ñÇÃñáÙÇóÇÝ
Erythromycin
¿ñÇÃñáÙÇóÇÝ
erythromycin
¿ñÇÃñáÙÇóÇÝ
erythromycin
¿ñÇÃñáÙÇóÇÝ
erythromycin
941
¾ñÇÃñáÙÇóÇÝ
Erythromycin
¿ñÇÃñáÙÇóÇÝ
erythromycin
942
¾ñÇÃñáÙÇóÇÝ
Erythromycin
¿ñÇÃñáÙÇóÇÝ
erythromycin
943
¾ñÇÃñáÙÇóÇÝÇ
¿ñÇÃñáÙÇóÇÝ
931
932
933
934
939
940
12.5%(2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
0.1%,
15·, 30· å³ñÏáõ×
γÉó»Ïë ´À
Kalceks AS
êƶز ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ (àõáñɹ Ø»¹ÇëÇÝ,
²Ý·ÉdzÛÇ Ñ³Ù³ñ)
SIGMA Pharmaceutical
Industries (for World Medicine,
England)
Ëï³ÝÛáõÃ
100Ù·/5ÙÉ,
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·.ζ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
5ÙÉ ëñí³Ï
EBEWE Pharma Ges.m.b.H.
ÉáõÍáõÛÃÇ
Nfg.KG
Ýñµ³ùëáõù
10Ù·/1·,
Îèβ ¹.¹. Üáíá Ù»ëïá
35· å³ñÏáõ×
KRKA d.d. Novo mesto
¹áݹáÕ
10Ù·/1·,
Îèβ ¹.¹. Üáíá Ù»ëïá
35· å³ñÏáõ×
KRKA d.d. Novo mesto
¹»Õ³å³ïÇ×Ý»ñ
10Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(20/2x10/)
KRKA d.d. Novo mesto
¹»Õ³Ñ³ï»ñ
300Ù·
ü³ïáÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ
óճÝóå³ï
[100(10x10), 1000]
Fatol Arzneimittel GmbH
¹»Õ³÷áßÇ
300Ù·,
ü³ïáÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ
Ý»ñ³ñÏÙ³Ý
ëñí³Ï/³ÙåáõÉ (1)
Fatol Arzneimittel GmbH
ÉáõÍáõÛÃÇ,
ÉáõÍãáí
¹»Õ³Ñ³ï»ñ
80Ù·
ê»ñíÇ» Æݹ³ëïñÇ
óճÝóå³ï
(30)
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
ûß³ñ³Ï
200Ù·/100ÙÉ,
ê»ñíÇ» Æݹ³ëïñÇ
150ÙÉ ßßÇÏ
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
¹»Õ³å³ïÇ×Ý»ñ
250Ù·,
¾ëÏáõɳå êäÀ
µÉÇëï»ñ ¨ åɳëïÇÏ
Esculap Ltd
ï³ñ³
(10, 16, 20)
¹»Õ³Ñ³ï»ñ
200Ù·
²ðöÆغ¸ ÐÒ ö´À
(10)
ARPIMED J.V. CJ-S Co.
ùëáõù
1%,
²ðöÆغ¸ ÐÒ ö´À ARPIMED
25·, 50· å³ñÏáõ×
J.V. CJ-S Co.
¹»Õ³Ñ³ï»ñ
200Ù·
ºíñáý³ñÙ ê.².
(20)
¶É³ùëáêÙÇÃÎɳÛÝÇ Ñ³Ù³ñ
Europharm S.A. for
GlaxoSmithKline
·ñ³ÝáõÉÝ»ñ
200Ù·/5ÙÉ
²ðöÆغ¸ ÐÒ ö´À ARPIMED
ËÙ»Éáõ
(·ñ³ÝáõÉÝ»ñ
J.V. CJ-S Co.
¹»Õ³Ï³ËáõÛÃÇ
ßßÇÏáõÙ 120ÙÉ,
250ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ)
¹»Õ³Ñ³ï»ñ
200Ù·
î³ñËáÙÇÝÇ ¹»Õ³·áñͳϳÝ
óճÝóå³ï
(16)
·áñͳñ³Ý §äáÉý³¦ ê.².
Tarchomin Pharmaceutical
Work §Polfa¦ S.A.
³Ïݳùëáõù
10000ØØ/·,
³ÃùÇÙý³ñÙåñ»å³ñ³ïÇ ´´À
ȳïídz
B02B X01
3611
17.02.2003
17.02.2008
¸
º·Çåïáë
R01A D09
0041/6181
24.05.2006
24.05.2011
¸
êíëïñdz
L01C B01
5527
14.04.2005
14.04.2010
¸
êÉáí»Ýdz
M02A A07
0661/6564
²¸
êÉáí»Ýdz
M02A A047
0660/6565
êÉáí»Ýdz
M01A C01
0662/6563
¶»ñÙ³Ýdz
J04A B02
4934
¶»ñÙ³Ýdz
J04A B02
4933
12.01.2007
12.01.2012
12.01.2007
12.01.2012
12.01.2007
12.01.2012
03.07.2004
03.07.2009
03.07.2004
03.07.2009
üñ³Ýëdz
R03D X03
0514/6557
07.11.2006
07.11.2011
¸
üñ³Ýëdz
R03D X03
0513/6558
07.11.2006
07.11.2011
¸
г۳ëï³Ý
J01F A01
0038/5957
24.05.2006
24.05.2011
¸
г۳ëï³Ý
J01F A01
1167/7148
¸
г۳ëï³Ý
D10A F02
5154
èáõÙÇÝdz
J01F A01
4793
13.09.2007
13.09.2012
12.11.2004
12.11.2009
08.12.2004
08.12.2009
г۳ëï³Ý
J01F A01
5155
12.11.2004
12.11.2009
¸
Ȼѳëï³Ý
J01F A01
5623
01.12.2005
01.12.2010
¸
èáõë³ëï³Ý
S01A A17
5188
19.11.2004
¸
²¸
¸
¸
¸
¸
¸
65
944
945
946
947
948
949
ùëáõù
Erythromycin
ointment
¾ñÇÏñ»³ï 500Ù·
Erycreat 500mg
¾ñÇáõë
Aerius
¾ñÇáõë
Aerius
¾ñáÉÇÝ
Erolin
¾ñáÉÇÝ
Erolin
¾ùëå»Ïïáñ³Ýï
Expectorant
950
¾ý»Ïï üÉÛáõ
Ephact Flu
951
¾ý»ñ³É·³Ý
Efferalgan
¾ý»ñ³É·³Ý
Efferalgan
¾ý»ñ³É·³Ý
Efferalgan
¾ý»ñ³É·³Ý
Efferalgan
¾ýÇÏáñ¹
Ephicord
¾ýÇóÇÉÇÝ 500Ù·
Ephicilin 500mg
952
953
954
955
956
957
¾ýÉáñ³Ý
500Ù·/100ÙÉ
ϳÃÇɳݻñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Efloran
500mg/100ml
solution for infusion
958 ¾ýÉáñ³Ý ¹»Õ³Ñ³ï»ñ
Efloran tablets
959
³ÙÇýÉáõ
Tamiflu
960
³ÙÇýÉáõ
erythromycin
3·,7·,10· å³ñÏáõ×
Tatchimpharmpreparaty OJSC
¿ñÇÃñáÙÇóÇÝ
¹»Õ³Ñ³ï»ñ
500Ù·
Îðº²î ɳµáñ³ïáñdz Laboratoires
erythromycine
óճÝóå³ï
(100x10)
CREAT
¹»ëÉáñ³ï³¹ÇÝ
ûß³ñ³Ï
0.5Ù·/ÙÉ,
Þ»ñÇÝ· - äɳáõ ȳµá Ü.ì.
desloratadine
60ÙÉ,120ÙÉ ßßÇÏ Schering - Plough Labo N.V.
¹»ëÉáñ³ï³¹ÇÝ
¹»Õ³Ñ³ï»ñ
5Ù·
Þ»ñÇÝ· - äɳáõ ȳµá Ü.ì.
desloratadine
óճÝóå³ï
(7,10)
Schering - Plough Labo N.V.
Éáñ³ï³¹ÇÝ
ûß³ñ³Ï
1Ù·/ÙÉ,
¾¶Æê ´´À
loratadine
120ÙÉ ßßÇÏ
EGIS PLC
Éáñ³ï³¹ÇÝ
¹»Õ³Ñ³ï»ñ
10Ù·
¾¶Æê ´´À
loratadine
(10, 30/3x10/)
EGIS PLC
·áõ³Ûý»Ý»½ÇÝ,
ûß³ñ³Ï
(100Ù·+2Ù·+
²ðöÆغ¸ ÐÒ ö´À
ùÉáñý»ÝÇñ³ÙÇÝÇ
5Ù·)/5ÙÉ,
ARPIMED J.V. CJ-S Co
ٳɻ³ï,
60ÙÉ ßßÇÏ
ý»ÝÇÉåñáå³ÝáɳÙÇÝ
Ç ÑǹñáùÉáñǹ
guaifenesin,
chlorpheniramine
maleate,
phenylpropanolamine
hydrochloride
å³ñ³ó»ï³ÙáÉ,
¹»Õ³å³ïÇ×Ý»ñ
(500Ù·+10Ù·+2Ù·)
²í»ñëÇ-è³ÃÇáÝ³É êäÀ
ý»ÝÇÉ¿ýñÇÝ,
(10)
Aversi-Rational Ltd
ùÉáñý»ÝÇñ³ÙÇÝ
paracetamol,
phenylephrine,
chlorpheniramine
å³ñ³ó»ï³ÙáÉ
ÙáÙÇÏÝ»ñ
80Ù·
´ñÇëïáÉ-سۻñë êùíǵ
paracetamol
(10)
Bristol-Myers Squibb
å³ñ³ó»ï³ÙáÉ
ÙáÙÇÏÝ»ñ
150Ù·
´ñÇëïáÉ-سۻñë êùíǵ
paracetamol
(10)
Bristol-Myers Squibb
å³ñ³ó»ï³ÙáÉ
ÙáÙÇÏÝ»ñ
300Ù·
´ñÇëïáÉ-سۻñë êùíǵ
paracetamol
(10)
Bristol-Myers Squibb
å³ñ³ó»ï³ÙáÉ
ûß³ñ³Ï
30Ù·/ÙÉ,
´ñÇëïáÉ-سۻñë êùíǵ
paracetamol
90ÙÉ ßßÇÏ
Bristol-Myers Squibb
¿Ý³É³åñÇÉ
¹»Õ³å³ïÇ×Ý»ñ
10Ù·
ºíñáý³ñÙ ê.².
Europharm
enalapril
(20)
S.A.
³ÙåÇóÇÉÇÝÇ
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
ºíñáý³ñÙ ê.².(¶É³ùëáêÙÇûéÇÑǹñ³ï
(12)
ÎɳÛÝÇ Ñ³Ù³ñ) Europharm
ampicillin trihydrate
S.A.for GlaxoSmithKline
Ù»ïñáÝǹ³½áÉ
ÉáõÍáõÛÃ
500Ù·/100ÙÉ,
Îèβ ¹.¹. Üáíá Ù»ëïá
metronidazole
ϳÃÇɳݻñ³ñÏ-Ù³Ý
100ÙÉ ëñí³Ï
KRKA d.d. Novo mesto
Ù»ïñáÝǹ³½áÉ
metronidazole
û½»Éï³ÙÇíÇñ
oseltamivir
û½»Éï³ÙÇíÇñ
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³÷áßÇ ËÙ»Éáõ
400Ù·
(10)
75Ù·
(10)
12Ù·/ÙÉ,
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
F.Hoffmann-La Roche Ltd.
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
19.11.2009
üñ³Ýëdz
J01F A01
4259
12.06.2003
12.06.2008
30.06.2005
22.04.2010
30.06.2005
22.04.2010
06.04.2007
06.04.2012
06.04.2007
06.04.2012
25.10.2006
25.10.2011
¸
´»É·Ç³
R06A
5466
´»É·Ç³
R06A
5467
ÐáõÝ·³ñdz
R06AX13
0878/6906
ÐáõÝ·³ñdz
R06AX13
0877/6907
г۳ëï³Ý
R05C
0499/6311
ìñ³ëï³Ý
N02B E51
1227/7143
25.09.2007
13.09.2012
²¸
üñ³Ýëdz
N02B E01
4191
²¸
üñ³Ýëdz
N02B E01
4192
üñ³Ýëdz
N02B E01
4193
üñ³Ýëdz
N02B E01
4353
èáõÙÇÝdz
C09A A02
4533
èáõÙÇÝdz
J01C A01
5494
23.01.2006
11.02.2008
23.01.2006
11.02.2008
23.01.2006
11.02.2008
23.01.2006
06.06.2008
04.11.2003
04.11.2008
08.04.2005
08.04.2010
êÉáí»Ýdz
J01X D01
0559/6535
24.11.2006
24.11.2011
¸
êÉáí»Ýdz
J01X D01
0560/6534
¸
Þí»Ûó³ñdz
-
5848
Þí»Ûó³ñdz
-
5849
24.11.2006
24.11.2011
07.11.2005
07.11.2010
07.11.2005
¸
¸
²¸
²¸
²¸
²¸
²¸
²¸
¸
¸
¸
¸
66
Tamiflu
oseltamivir
¹»Õ³Ï³ËáõÛÃÇ
961
ÂÇÛñë ݳïáõñ³É-II
Tears naturale II
ÉáõÍáõÛóÏݳϳÃÇÉÝ»ñ
962
»µ³ÝïÇÝ
Tebantin
»µ³ÝïÇÝ
Tebantin
»µ³ÝïÇÝ
Tebantin
»ÉáñÙÇÝ
Telormin
»ÉáñÙÇÝ
Telormin
»Éý³ëï
Telfast
¹»ùëïñ³Ý,
ÑǹñûùëÇåñáåÇÉ
Ù»ÃÇÉó»ÉÛáõÉá½
dextran, hydroxypropyl
methylcellulose
·³µ³å»ÝïÇÝ
gabapentin
·³µ³å»ÝïÇÝ
gabapentin
·³µ³å»ÝïÇÝ
gabapentin
³ï»ÝáÉáÉ
atenolol
³ï»ÝáÉáÉ
atenolol
ý»ùëáý»Ý³¹ÇÝ
fexofenadine
963
964
965
966
967
968
»Éý³ëï
Telfast
969
»Éý³ëï
Telfast
970
»۳ͳéÇ ÛáõÕ
Tea Tree Oil
ý»ùëáý»Ý³¹ÇÝÇ
ÑǹñáùÉáñǹ
fexofenadine
hydrochloride
ý»ùëáý»Ý³¹ÇÝÇ
ÑǹñáùÉáñǹ
fexofenadine
hydrochloride
-
971 »ÛÙáõñáíÇ Ù³ÍáõÏ µáñ³ÃÃáõ, ݳïñÇáõÙÇ
Pasta Teimurovi
ï»ïñ³µáñ³ï,
ë³ÉÇóÇɳÃÃáõ, óÇÝÏÇ
ûùëǹ,
Ñ»ùë³Ù»ÃÇÉ»Ýï»ïñ³ÙÇÝ, ýáñٳɹ»ÑǹÇ
ÉáõÍáõÛÃ, ϳå³ñÇ ³ó»ï³ï
boric acid, sodium
tetraborate, salicylic
acid, zinc oxide,
hexamethylenetetramine, formald
972
»áï³ñ¹
ûáýÇÉÇÝ
Teotard
theophylline
973
»áï³ñ¹
Teotard
ûáýÇÉÇÝ
theophylline
974
»ñ³åÇÝ
Therapin
»ñ³íÇï ³ÝïÇëïñ»ë
Teravit Antistress
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ
acetylsalicylic acid
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
975
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
[30· ¹»Õ³÷áßÇ
ëñí³ÏáõÙ (1,182·
û½»Éï³ÙÇíÇñ)]
(0.1%+0.3%),
5ÙÉ,10ÙÉ,15ÙÉ
ßßÇÏ
F.Hoffmann-La Roche Ltd.
07.11.2010
ê.².²ÉÏáÝ øáõíñ»áõñ Ü.ì.
S.A.Alcon-Couvreur N.V.
´»É·Ç³
B05A
4888
31.05.2004
31.05.2009
²¸
100Ù·
(50, 100)
300Ù·
(50, 100)
400Ù·
(50, 100)
50Ù·
(30)
100Ù·
(30)
30Ù·
(10)
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V.CJ-S Co.
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V.CJ-S Co.
²í»ÝïÇë ü³ñÙ³ëÛáõÃÇù³Éë
ÆÝÏ.
Aventis Pharmaceuticals Inc.
ê³ÝáýÇ-²í»ÝïÇë ¸áÛãɳݹ
¶ÙµÐ
Sanofi-Aventis Deutchland
GmbH
ê³ÝáýÇ-²í»ÝïÇë ¸áÛãɻݹ
¶ÙµÐ
Sanofi-Aventis Deutchland
GmbH
Ø»ÛÝ ø³Ùå ÂÇ ÂñÇ úÛÉ
ÈÇÙÇﻹ §ìÇï³Ù³ùë º¦-Ç Ñ³Ù³ñ
Main Camp Tea Tree Oil
Limited for Vitamax-E
¾ëÏáõɳå êäÀ
Esculap Ltd.
ÐáõÝ·³ñdz
N03A X12
5649
¸
ÐáõÝ·³ñdz
N03A X12
5650
ÐáõÝ·³ñdz
N03A X12
5651
г۳ëï³Ý
C07A B03
5968
г۳ëï³Ý
C07A B03
5969
²ØÜ
R06A X26
4706
14.12.2005
14.12.2010
14.12.2005
14.12.2010
14.12.2005
14.12.2010
13.03.2006
13.03.2011
13.03.2006
13.03.2011
10.03.2004
10.03.2009
¶»ñÙ³Ýdz
R06A X21
1238/7274
29.10.2007
12.10.2012
²¸
¶»ñÙ³Ýdz
R06AX21
1367/7329
26.12.2007
05.11.2012
²¸
²íëïñ³Édz
βêÐ
5106
20.09.2004
20.09.2009
²¸
г۳ëï³Ý
_
4255
11.04.2003
11.04.2008
²¸
¸
¸
¸
¸
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
120Ù·
(10)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
180Ù·
(10)
ÉáõÍáõÛÃ
1.5ÙÉ, 10ÙÉ,
25ÙÉ ßßÇÏ
Ù³ÍáõÏ
25· å³ñÏáõ× ¨ 25·,
60·, 450·,
800·,1000· ï³ñ³
¹»Õ³å³ïÇ×Ý»ñ
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹»Õ³å³ïÇ×Ý»ñ
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(40/4x10/)
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
êÉáí»Ýdz
R03D A04
0806/6777
20.03.2007
20.03.2012
¸
350Ù·
(40/4x10/)
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
êÉáí»Ýdz
R03D A04
0805/6778
20.03.2007
20.03.2012
¸
325Ù·
(100)
(30,60)
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
N02B A01
5160
²¸
²ØÜ
A11JB
5713
25.11.2004
25.11.2009
10.10.2005
08.08.2010
²¸
67
976
977
978
979
980
981
982
983
984
985
986
vitamins, minerals
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30)
ѳÝù³ÝÛáõûñ
óճÝóå³ï
vitamins, minerals
»ñ³íÇï åñ»·Ý³
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30,60)
Theravit Pregna
ѳÝù³ÝÛáõûñ
óճÝóå³ï
vitamins, minerals
»ñ³íÇï ïáÝÇÏ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30, 60)
Theravit Tonic
ѳÝù³ÝÛáõûñ
óճÝóå³ï
vitamins, minerals
»ñ³ýÉ»ùë
·ÉÛáõÏá½³ÙÇÝÇ
¹»Õ³å³ïÇ×Ý»ñ
500Ù·+400Ù·
Theraflex
ÑǹñáùÉáñǹ,
(30, 60, 120)
ùáݹñáÇïÇÝ ëáõÉý³ï
ݳïñÇáõÙÇ
glucosamine
hydrochloride, sodium
chondroitin sulfate
»ñ³ýÉ»ùë ³¹í³Ýë
·ÉÛáõÏá½³ÙÇÝÇ
¹»Õ³å³ïÇ×Ý»ñ
(250Ù·+200Ù·+
Theraflex Advance ëáõÉý³ï, ùáݹñáÇïÇÝÇ
100Ù·)
ëáõÉý³ï, ǵáõåñáý»Ý
(60, 120)
glucosamine sulfate,
chondroitin sulfate,
ibuprofen
»ñ³ýÉ»ùë Ø
·ÉÛáõÏá½³ÙÇÝÇ
Ýñµ³ùëáõù
(3Ù·+8Ù·+32Ù·+
Theraflex M
ÑǹñáùÉáñǹ,
9Ù·)/·
ùáݹñáÇïÇÝÇ ëáõÉý³ï,
28.4· ϳ٠56.7·
ù³÷áõñ, åÕå»Õ³ÛÇÝ
å³ñÏáõ×
³Ý³ÝáõËÇ ÛáõÕ
glucosamine
hydrochloride,
chondroitin sulfate,
camphor, peppermint
oil
»ñ³ýÉÛáõ
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ Ý»ñùÇÝ
(325Ù·+20Ù·+
Theraflu
ý»ÝÇñ³ÙÇÝÇ Ù³É»³ï,
ÁݹáõÝÙ³Ý
10Ù·) (÷³Ã»ÃÝ»ñ
ý»ÝÇÉ¿ýñÇÝÇ
ÉáõÍáõÛÃÇ, í³ÛñÇ
10)
ÑǹñáùÉáñǹ
(³Ýï³é³ÛÇÝ)
paracetamol,
ѳï³åïáõÕÝ»ñÇ
pheniramine maleate,
ѳÙáí
phenylephrine
hydrochloride
»ñ³ýÉÛáõ
å³ñ³ó»ï³ÙáÉ,
¹»Õ³Ñ³ï»ñ
650Ù·+10Ù·+4Ù·
¿ùëïñ³ï³µ
ý»ÝÇÉ¿ýñÇÝ,
óճÝóå³ï
(10)
Theraflu Extratab
ùÉáñý»ÝÇñ³ÙÇÝ
paracetamol,
phenylephrine,
chlorpheniramine
Âǵ»ñ³É
ûñÝǹ³½áÉ
¹»Õ³Ñ³ï»ñ
500Ù·
Tiberal
ornidazole
óճÝóå³ï
(10)
Âǻݳ٠Ù/Ù
ÇÙÇå»Ý»Ù,
¹»Õ³÷áßÇ Ù/Ù
500Ù·+500Ù·
Tienam I.M.
ëÇɳëï³ïÇÝ imipenem,
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
cilastatin
ÉáõÍáõÛÃÇ
Âǻݳ٠Ý/»
ÇÙÇå»Ý»Ù,
¹»Õ³÷áßÇ Ý/»
500Ù·+500Ù·
Tienam I.V.
ëÇɳëï³ïÇÝ imipenem, ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (5)
cilastatin
ÉáõÍáõÛÃÇ
»ñ³íÇï ¹»Õ³Ñ³ï»ñ
Theravit tablets
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
A11JB
5711
08.08.2005
08.08.2010
²¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
A11JB
5712
08.08.2005
08.08.2010
²¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
A11AA04
0704/6737
25.01.2007
25.01.2012
²¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
M01A
0883/5161/1
06.04.2007
25.11.2009
²¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
M09AX
0882/6887
06.04.2007
06.04.2012
²¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
M01A
5757
11.10.2005
11.10.2010
²¸
ä³Ã»áÝ ìÇïµÇ ÆÝÏ. (Üáí³ñïÇë
øáÝëÛáõÙ»ñ лÉà ê.².
Þí»Ûó³ñdzÛÇ Ñ³Ù³ñ)
Patheon Whitby Inc. for
Novartis Consumer Health S.
A. Switzerland
γݳ¹³
N02BE51
1059/7003
10.07.2007
13.06.2012
²¸
Üáí³ñïÇë àõñáõÝÉ»ñÇ
Novartis URUNLERI
Âáõñùdz
-
5938
24.03.2006
24.03.2011
²¸
ÐáýÙ³Ý-ȳ èáß Èï¹.
Hoffmann-La Roche Ltd.
Ø»ñÏ Þ³ñå ¨ ¸áÑÙ ´.ì.
Merck Sharp & Dohme B.V.
Þí»Ûó³ñdz
4187
18.03.2003
18.03.2008
31.01.2003
31.01.2008
¸
Üǹ»éɳݹݻñ
J01X D03
P01A B03
J01D H51
Ø»ñÏ Þ³ñå ¨ ¸áÑÙ ´.ì.
Merck Sharp & Dohme B.V.
Üǹ»éɳݹݻñ
J01D H51
4100
31.01.2003
31.01.2008
¸
4099
¸
68
987
Âǽ»ñóÇÝ
Tisercin
ɨáÙ»åñáÙ³½ÇÝ
levomepromazine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
988
ÂÇÉá½ÇÝ 200
Tylosin 200
ÃÇÉá½ÇÝ
tylosin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
989
ÂÇÉá½ÇÝ 50
Tylosin 50
ÃÇÉá½ÇÝ
tylosin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
990
ÂÇÙá-·³É
Timo-Gal
ÂÇÙáÉáÉ
Timolol
ÂÇÙáÉáÉ
Timolol
ÂÇÙáÉáÉ Ù³É»³ï
Timolol maleate
ÂÇÙáÉáÉ-äúê
Timolol-POS
ÃÇÙáÉáÉ
timolol
ÃÇÙáÉáÉ
timolol
ÃÇÙáÉáÉ
timolol
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
³ÏݳϳÃÇÉÝ»ñ
995
ÂÇÙáÉáÉ-äúê
Timolol-POS
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
³ÏݳϳÃÇÉÝ»ñ
0.5%,
5ÙÉ ßßÇÏ
996
ÂÇá·³ÙÙ³
Thiogamma
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
600Ù·
(30/3x10/,
60/6x10/)
997
ÂÇá·³ÙÙ³
Thiogamma
998
ÂÇáÏï³óǹ
600 Ðè
Thioctacid 600 HR
ÃÇáÏï³ÃÃáõ (³Éý³
ÉÇåáÛ³ÃÃáõ)
thioctic acid (alpha
lipoic acid)
ÃÇáÏï³ÃÃáõ (³Éý³
ÉÇåáÛ³ÃÃáõ)
thioctic acid (alpha
lipoic acid)
³Éý³-ÉÇåá³ÃÃáõ
alfa-lipoic acid
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
600Ù·
(30)
999
ÂÇáÏï³óǹ 600 î
Thioctacid 600 T
ÃÇáÏï³ÃÃáõ
thioctic acid
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
600Ù·/24ÙÉ,
³ÙåáõÉÝ»ñ (5)
1000
ÂÇáå»Ýï³É-ÎØä
Thiopental-KMP
ÃÇáå»Ýï³É ݳïñÇáõÙÇ
thiopental sodium
1001
ÂÇáå»Ýï³É-ÎØä
Thiopental-KMP
ÃÇáå»Ýï³É
thiopental
1002
ÂÇáëáõÉý³ï
ݳïñÇáõÙÇ
ÃÇáëáõÉý³ï
ݳïñÇáõÙÇ
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
991
992
993
994
³ÏݳϳÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
³ÏݳϳÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
³ÏݳϳÃÇÉÝ»ñ
³ÏݳϳÃÇÉÝ»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
25Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
200Ù·/ÙÉ,
20ÙÉ, 50ÙÉ,
100ÙÉ ëñí³Ï
50Ù·/ÙÉ,
20ÙÉ,
50ÙÉ,100ÙÉ ëñí³Ï
0.5%,
10ÙÉ ßßÇÏ
0.25%,
5ÙÉ ßßÇÏ
0.5%,
5ÙÉ ßßÇÏ
0.5%,
5ÙÉ, 10ÙÉ ßßÇÏ
0.25%,
5ÙÉ ßßÇÏ
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
ÐáõÝ·³ñdz
N05A A02
6109
13.04.2006
13.04.2011
¸\Ð
ÜÇï³-ü³ñÙ ö´À
Nita-Farm Closed JSC
èáõë³ëï³Ý
³Ý³ëݳµáõųϳÝ
0749/6724
15.02.2007
15.02.2012
¸
ÜÇï³-ü³ñÙ ö´À
Nita-Farm Closed JSC
èáõë³ëï³Ý
³Ý³ëݳµáõųϳÝ
0750/6723
15.02.2007
15.02.2012
¸
ü³ñÙ³åɳÝï ´ÇᷳɻÝÇϳ
Pharmaplant Biogalenica
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
ü³ñÙ³Ï ´´À
Farmak JSC
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co.KG
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co.KG
ìá»ñí³· ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
Woerwag Pharma GmbH & Co.
KG
èáõÙÇÝdz
S01E D01
4399
¸
èáõÙÇÝdz
S01E D01
0180/6267
èáõÙÇÝdz
S01E D01
0181/6266
àõÏñ³Çݳ
S01E D01
5698
¶»ñÙ³Ýdz
S01E D01
5887
16.09.2003
16.09.2008
13.07.2006
13.07.2011
13.07.2006
13.07.2011
17.10.2005
17.10.2010
07.02.2006
07.02.2011
¶»ñÙ³Ýdz
S01E D01
5888
07.02.2006
07.02.2011
¸
¶»ñÙ³Ýdz
N07X B01
0691/6663
25.01.2007
25.01.2012
¸
600Ù·/20ÙÉ,
ìá»ñí³· ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
20ÙÉ ³ÙåáõÉÝ»ñ Woerwag Pharma GmbH & Co.
(5, 20)
KG
¶»ñÙ³Ýdz
N07X B01
0692/6664
25.01.2007
25.01.2012
¸
¶»ñÙ³Ýdz
A16AX01
0767/5528/1
28.02.2007
28.04.2010
¸
¶»ñÙ³Ýdz
A16AX01
1370/7332
05.11.2007
05.11.2012
¸
0.5·,
ëñí³Ï (40)
غ¸² ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
(¹»Õ³Ó¨Ç ³ñï³¹ñáÕÁ` ²ì¸ ü³ñÙ³
¶ÙµÐ ¨ øá.ζ, ¶»ñÙ³Ýdz)
MEDA Pharma GmbH & Co.
KG (dosage form
manufacturer-AWD pharma
GmbH & Co.KG, Germany)
´³ùëï»ñ úÝÏáÉáçÇ ¶ÙµÐ
(ìdzïñÇë ¶ÙµÐ ¨ øá. ζ-Ç
ѳٳñ)
Baxter Oncology GmbH (for
Viatris GmbH & Co. KG)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
àõÏñ³Çݳ
N01A F03
0403/6424
19.09.2006
19.09.2011
¸\Ð
1·,
ëñí³Ï (40)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
àõÏñ³Çݳ
N01A F03
0404/6425
19.09.2006
19.09.2011
¸\Ð
30% (5ÙÉ)
5ÙÉ ³ÙåáõÉÝ»ñ
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
ýÇñÙ³ ´´À
г۳ëï³Ý
V03A B06
0613/6595
18.12.2006
18.12.2011
¸
¸
¸
¸
¸
69
Thiosulfat sodium
thiosulfat sodium
ÂÇñá½áÉ
Thyrozol
ÂÇñá½áÉ
Thyrozol
ÂÇñáï³ùë
Tirotax
Ãdzٳ½áÉ
thiamazole
Ãdzٳ½áÉ
thiamazole
ó»ýáï³ùëÇÙ
cefotaxime
1006
ÂÇñáï³ùë
Tirotax
ó»ýáï³ùëÇÙ
cefotaxime
1007
ÂÇñáï³ùë
Tirotax
ó»ýáï³ùëÇÙ
cefotaxime
1008
Âáµñ»ùë
Tobrex
ÂáµñÇÙ»¹
Tobrimed
Ãáµñ³ÙÇóÇÝ
tobramycin
Ãáµñ³ÙÇóÇÝ
tobramycin
ÂáµñÇÙ»¹
Tobrimed
Ãáµñ³ÙÇóÇÝ
tobramycin
1003
1004
1005
1009
1010
1011
ÂáµñáÙ
Ãáµñ³ÙÇóÇÝ
Tobrom
tobramycin
1012 Âñ³ËÇë³Ý µáñµáùí³Í
ÉǹáϳÛÇÝ,
ÏáÏáñ¹Ç
ùÉáñÑ»ùëǹÇÝÇ
áÕáÕáõÙÝ»ñÇ
·ÉÛáõÏáݳï
Trachisan Sore
lidocain, chlorhexidine
Throat Gargle
gluconate
1013
Âñ³ËÇë³Ý
ÉǹáϳÛÇÝ,
Éá½³ÝÝ»ñ
ùÉáñÑ»ùëǹÇÝÇ
Trachisan Lozenges
·ÉÛáõÏáݳï,
ÃÇñáÃñÇóÇÝ
lidocain, chlorhexidine
gluconate, tyrothricin
1014
Âñ³áõÙ»ÛÉ ê
Traumeel S
1015
1016
Âñ³áõÙ»ÛÉ ê
Traumeel S
Âñ³í³ï³Ý
Travatan
1017 Âñ³íÇëÇÉ Ù»ÕñÇ
ѳÙáí
Travisil Honey
Flavour
1018
Âñǵ»ëï³Ý
Tribestan
(10)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³÷áßÇ Ù/Ù, Ý/»
Ý»ñ³ñÏáõÙÝ»ñÇ
ÉáõÍáõÛÃÝ»ñÇ
¹»Õ³÷áßÇ Ý/», Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
ÉáõÍáõÛÃÝ»ñÇ
¹»Õ³÷áßÇ Ý/», Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
ÉáõÍáõÛÃÝ»ñÇ
ÉáõÍáõÛóÏݳϳÃÇÉÝ»ñ
³ÏݳϳÃÇÉÝ»ñ
³Ïݳùëáõù
³ÏݳϳÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
ÉáõÍáõÛÃ
10Ù·
(20, 40, 50, 100)
5Ù·
(50, 100)
1·,
ëñí³Ï (1)
Yerevan ChemicalPharmaceutical Firm Open J/S
Company
Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
Merck KGaA (for Nycomed)
Ø»ñÏ Î¶³² ÜÇÏáÙ»¹Ç ѳٳñ
Merck KGaA for Nycomed
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
0.5·,
ëñí³Ï (1)
2·,
ëñí³Ï (1)
¶»ñÙ³Ýdz
H03B B02
5228
¶»ñÙ³Ýdz
H03B B02
5664
²íëïñdz
J01DD01
0841/6841
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
²íëïñdz
J01DD01
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
²íëïñdz
´»É·Ç³
0.3%,
5ÙÉ ßßÇÏ
0.3% (3Ù·/ÙÉ),
5ÙÉ ßßÇÏ
ê.².²ÉÏáÝ øáõíñ»áõñ Ü.ì.
S.A.Alcon-Couvreur N.V.
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ, ²Ý·Édz-Ç Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
England)
0.3%,
º.Æ.ä.Æ.øá (àõáñɹ
5· å³ñÏáõ×
Ø»¹ÇëÇÝ, ²Ý·ÉdzÛÇ Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
England)
0.3%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
5ÙÉ ßßÇÏ
Rompharm Company SRL
(0.1·+0.2·)/ 100ÙÉ,
¾Ý·»Éѳñ¹ ²ñóݳÛÙÇûÉ
200ÙÉ ßßÇÏ
¶ÙµÐ ¨ øá. ζ
Engelhard Arzneimittel GmbH
& Co.KG
30.11.2004
30.11.2009
08.07.2005
08.07.2010
26.03.2007
26.03.2012
¸
0842/6840
26.03.2007
26.03.2012
¸
J01DD01
0840/6842
26.03.2007
26.03.2012
¸
4891
0787/6855
31.05.2004
31.05.2009
13.03.2007
13.03.2012
¸
º·Çåïáë
J01G B01
S01A A12
S01A A12
º·Çåïáë
S01A A12
0786/6856
13.03.2007
13.03.2012
¸
èáõÙÇÝdz
S01A A12
0186/6261
¸
¶»ñÙ³Ýdz
N01B B52
5618
13.07.2006
13.07.2011
09.08.2005
09.08.2010
¸
¸
¸
²¸
Éá½³ÝÝ»ñ
(1Ù·+1Ù·+0.5Ù·)
(20)
¾Ý·»Éѳñ¹ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ øá. ζ
Engelhard Arzneimittel GmbH
& Co.KG
¶»ñÙ³Ýdz
N01B B52
5619
09.08.2005
09.08.2010
²¸
¹»Õ³Ñ³ï»ñ
(50,250)
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ
5310
04.02.2005
04.02.2010
²¸
-
Ùëáõù
50·,100· å³ñÏáõ×
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ
5311
04.02.2005
04.02.2010
²¸
Ãñ³íáåñáëï
travoprost
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
ÉáõÍáõÛóÏݳϳÃÇÉÝ»ñ
Éá½³ÝÝ»ñ
40ÙÏ·/ÙÉ,
2.5ÙÉ ßßÇÏ
(16)
´ÇáÉá·Çß Ð³ÛÉÙÇÃ»É Ð»ÛÉ
¶ÙµÐ
Biologische Heilmittel Heel
GmbH
´ÇáÉá·Çß Ð³ÛÉÙÇÃ»É Ð»ÛÉ
¶ÙµÐ
Biologische Heilmittel Heel
GmbH
ê.².²ÉÏáÝ-øáõíñ»áõñ Ü.ì.
S.A.Alcon-Couvreur N.V.
öÉ»ÃÇùá ü³ñÙ³ëÛáõÃÇù³Éë
Èï¹
Plethico Pharmaceuticals Ltd.
´»É·Ç³
-
4893
¸
Ðݹϳëï³Ý
-
4303
04.06.2004
04.06.2009
22.12.2004
22.12.2009
Ãñǵ»ëï³Ý
tribestan
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(60)
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
-
5439
20.07.2005
20.07.2010
²¸
¸
70
1019
Âñǹ»ñÙ
Triderm
µ»ï³Ù»Ã³½áÝÇ
¹ÇåñáåÇáݳï,
ÏÉáïñÇÙ³½áÉ,
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
betamethasone
dipropionate,
clotrimazole,
gentamicine sulfate
1020
Âñǹ»ñÙ
µ»ï³Ù»Ã³½áÝÇ
Triderm
¹ÇåñáåÇáݳï,
ÏÉáïñÇÙ³½áÉ,
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
betamethasone
dipropionate,
clotrimazole,
gentamicine sulfate
1021
Âñáٵɻë
Ñ»å³ñÇÝ
Thrombless
heparin
1022 Âñáç Ƶáõåñáý»Ý
ǵáõåñáý»Ý
Troge Ibuprofen
ibuprofen
1023 Âñáç èÇý³ÙåÇóÇÝ
Troge Rifampicin
Ýñµ³ùëáõù
0.05%+1%+0.1%
15·, 30· å³ñÏáõ×
Þ»ñÇÝ·-öɳáõ ȳµá Ü.ì.
Schering Plough Labo N.V.
´»É·Ç³
D07C C01
S01C A05
4994
04.08.2004
04.08.2009
¸
Ùëáõù
0.05%+1%+0.1%
15·, 30· å³ñÏáõ×
Þ»ñÇÝ·-öɳáõ ü³ñÙ³ Èï¹.
Schering Plough Farma Ltd.
äáñïáõ·³-Édz
D07C C01
S01C A05
4995
04.08.2004
04.08.2009
²¸
¹áݹáÕ
1000ØØ/·,
30· å³ñÏáõ×
400Ù·
(100/10x10/)
ÜÇÅý³ñÙ ´´À
èáõë³ëï³Ý
Nizhpharm Open JSC
Âñáç Ø»¹ÇÏ³É ¶ÙµÐ (Âñáç
¶»ñÙ³Ýdz
Ø»¹ÇϳÉÇ Ñ³Ù³ñ, ¶»ñÙ³Ýdz)
Troge Medical GmbH for Troge
Medical, Germany
Âñáç Ø»¹ÇÏ³É ¶ÙµÐ (Âñáç
¶»ñÙ³Ýdz
Ø»¹ÇϳÉÇ Ñ³Ù³ñ, ¶»ñÙ³Ýdz)
Troge Medical GmbH for Troge
Medical, Germany
ڻݳý³ñÙ ¶ÙµÐ ¨ øá.ζ
¶»ñÙ³Ýdz
ùáÙå³ÝÇ Þ»ñÇÝ· ·ñáõå
Jenapharm GmbH & Co.KG
company Schering Group
êäÀ §ÜúÎƦ
г۳ëï³Ý
ѳ۳ٻñÇϳ·»ñٳݳϳÝ
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
§NOKI¦ Armenian-AmericanGerman Pharmac. J.V. Co.Ltd.
´áñßã³·áíÛ³Ý
àõÏñ³Çݳ
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´áñÇëáíÛ³Ý
´»É³éáõë
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ¶áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
ê»ñµÇ³ ¨
Hemofarm koncern A.D.
â»éÝá·áñdz
B01A B01
1299/7294
²¸
M01A E01
1271/7239
15.10.2007
12.10.2012
12.10.2007
12.10.2012
J04A M02
1272/7240
12.10.2007
12.10.2012
¸
G03C A01
L02A A03
5380
06.04.2005
06.04.2010
¸
M01A E01
M02A A13
5075
11.03.2005
11.03.2010
²¸
M01A E01
0501/6243
25.10.2006
25.10.2011
¸
M01A E01
1372/7334
29.11.2007
05.11.2012
²¸
M01A E01
0537/6431
10.11.2006
10.11.2011
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
éÇý³ÙåÇóÇÝ
rifampicin
¹»Õ³å³ïÇ×Ý»ñ
300Ù·
(100/10x10/)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï (¹ñ³Å»)
0.03Ù·+2Ù·
(21)
Ýñµ³ùëáõù
5%,
50· å³ñÏáõ×
²¸
1024
ijÝÇÝ
Jeanine
1025
ƵáõÝáÏ
Ibunok
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ,
¹Ç»Ýá·»ëï³É
ethinylestradiol,
dienogestal
ǵáõåñáý»Ý
ibuprofen
1026
Ƶáõåñáý»Ý
Ibuprofen
ǵáõåñáý»Ý
ibuprofen
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(50)
1027
Ƶáõåñáý»Ý
Ibuprofen
ǵáõåñáý»Ý
ibuprofen
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0,2·
(10, 50)
1028
Ƶáõåñáý»Ý лÙáý³ñÙ
Ibuprofen Hemofarm
Ƶáõåñáý»Ý лÙáý³ñÙ
Ibuprofen Hemofarm
Ƶáõåñáý»Ý -
ǵáõåñáý»Ý
ibuprofen
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
400Ù·
(10, 20, 30, 50)
ǵáõåñáý»Ý
ibuprofen
¹»Õ³Ï³ËáõÛÃ
100Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
M01A E01
0535/6433
10.11.2006
10.11.2011
²¸
ǵáõåñáý»Ý
¹»Õ³Ñ³ï»ñ
200Ù·
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
ê»ñµÇ³ ¨
M01A E01
0536/6432
10.11.2006
²¸
1029
1030
71
1031
1032
1033
1034
1035
1036
1037
1038
1039
лÙáý³ñÙ
Ibuprofen Hemofarm
ƽá¹ÇÝÇï
Isodinit
ƽá¹ÇÝÇï
Isodinit
ƽá½Ç¹ ùáÙå.
300Ù· Ü
Izosid comp.
300mg N
ibuprofen
¹Ûáõñ³ÉáõÛÍ
(10, 20, 30, 50)
ǽáëáñµÇ¹Ç »ñÏÝÇïñ³ï ¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
20Ù·
isosorbide dinitrate
Ó»ñµ³½³ïٳٵ
(60/6x10/)
ǽáëáñµÇ¹Ç »ñÏÝÇïñ³ï
¹»Õ³Ñ³ï»ñ
10Ù·
isosorbide dinitrate
(60/2x30/)
ǽáÝdz½Ç¹,
¹»Õ³Ñ³ï»ñ
300Ù·+60Ù·
åÇñǹûùëÇÝÇ
óճÝóå³ï
[100(10x10), 1000]
ÑǹñáùÉáñǹ
isoniazid, pyridoxine
hydrochloride
ƽá-¾ñ»Ùý³ï 300
éÇý³ÙåÇóÇÝ,
¹»Õ³Ñ³ï»ñ
300Ù·+150Ù·;
Iso-Eremfat 300mg
ǽáÝdz½Ç¹
óճÝóå³ï
[N100(10x10);
rifampicin, isoniazid
N1000]
ƽá-Ù³Ï é»ï³ñ¹ ǽáëáñµÇ¹Ç »ñÏÝÇïñ³ï
¹»Õ³å³ïÇ×Ý»ñ
20Ù·
20Ù·
isosorbide dinitrate
(30)
Iso-Mack Retard
20 mg
ƽá-Ù³Ï é»ï³ñ¹ ǽáëáñµÇ¹Ç »ñÏÝÇïñ³ï
¹»Õ³å³ïÇ×Ý»ñ
40Ù·
40Ù·
isosorbide dinitrate
(30)
Iso-Mack Retard
40 mg
ƽá-Ù³Ï é»ï³ñ¹ ǽáëáñµÇ¹Ç »ñÏÝÇïñ³ï
¹»Õ³å³ïÇ×Ý»ñ
60Ù·
60Ù·
isosorbide dinitrate
(20)
Iso-Mack Retard
60 mg
ƽáåïÇÝ êè
í»ñ³å³ÙÇÉ
¹»Õ³Ñ³ï»ñ
240Ù·
Isoptin SR
verapamil
óճÝóå³ï
(30/3x10, 2x15/)
ƽáýÉáõñ³Ý
ǽáýÉáõñ³Ý
Ñ»ÕáõÏ ßÝã³éÙ³Ý
100%,
Isoflurane
isoflurane
100ÙÉ ßßÇÏ
â»éÝá·áñdz
10.11.2011
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
ü³ïáÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ
Fatol Arzneimittel GmbH
´áõÉÕ³ñdz
C01DA08
0874/6918
´áõÉÕ³ñdz
C01D A08
0897/6947
¶»ñÙ³Ýdz
J04A C51
4936
ü³ïáÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ
Fatol Arzneimittel GmbH
¶»ñÙ³Ýdz
J04A M02
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïdz
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
06.04.2007
06.04.2012
20.04.2007
20.04.2012
03.07.2004
03.07.2009
¸
4938
03.07.2004
03.07.2009
¸
C01D A08
4237
11.07.2003
11.07.2008
¸
êÉáí³Ïdz
C01D A08
4238
11.07.2003
11.07.2008
¸
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïdz
C01D A08
4239
11.07.2003
11.07.2008
¸
²´´úîî ¶ÙµÐ ¨ øá. ζ
ABBOTT GmbH & Co.KG
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
´áõß³ñ³ è»Ïáñ¹³ïÇ Bouchara
Recordati
¶»ñÙ³Ýdz
C08D A01
0055/5733
¸
êÇñdz
N01A B06
3971
25.05.2006
25.05.2011
05.05.2003
05.05.2008
üñ³Ýëdz
S01A A07
5210
31.05.2005
31.05.2010
¸
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
èáõë³ëï³Ý
-
4172
30.05.2003
30.05.2008
²¸
¸
¸
¸
1040
ƽáýñ³
Isofra
ýñ³ÙÇó»ïÇÝÇ ëáõÉý³ï
framycetin sulfate
óáÕ³ßÇà ùÃÇ
(ÉáõÍáõÛÃ)
1041
ÆËÃÇáÉáí
ÙáÙÇÏÝ»ñ
Suppositoria with
Ichthyol
ÆٻݽÇÙ
Immenzym
ÇËÃÇáÉ
ichthyol
ÙáÙÇÏÝ»ñ
å³ÝÏñ»³ïÇÝ, å³å³ÛÇÝ,
µñáٻɳÛÝ, ÉÇå³½,
³ÙÇɳ½,ïñÇåëÇÝ,
ùÇÙáïñÇåëÇÝ, éáõïÇÝ
pancreatin, papain,
bromelain, lipase,
amylase, trypsin,
chymotrypsin, rutin
ëáõÙ³ïñÇåï³Ý
sumatriptan
ëáõÙ³ïñÇåï³Ý
sumatriptan
Éáå»ñ³Ùǹ
loperamide
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ
100Ù·+60Ù·+
45Ù·+10Ù·+10Ù·+
24Ù·+1Ù·+50Ù·
(40, 200, 800)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V.CJ-S Co.
г۳ëï³Ý
-
5535
17.10.2005
17.10.2010
²¸
¹»Õ³Ñ³ï»ñ
50Ù·
(2,6)
100Ù·
(2,6)
2Ù·
(20)
¶É³ùëáêÙÇÃÎɳÛÝ ê²
GlaxoSmithKline SA
¶É³ùëáêÙÇÃÎɳÛÝ ê²
GlaxoSmithKline SA
Ú³Ýë»Ý êÇɳ· ê.².
Janssen-Cilag S.A.
Ȼѳëï³Ý
N02C X04
4478
¸
Ȼѳëï³Ý
N02C X04
4479
üñ³Ýëdz
A07D A03
4897
28.07.2003
28.07.2008
28.07.2003
28.07.2008
22.03.2005
22.03.2010
1042
1043
1044
1045
ÆÙÇ·ñ³Ý
Imigran
ÆÙÇ·ñ³Ý
Imigran
ÆÙá¹ÇáõÙ
Imodium
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
1.25·
(800ØØ)/100ÙÉ 1.25%,
15ÙÉ ßßÇÏ
0.2·
(10)
Hemofarm koncern A.D.
¸
²¸
72
1046 ÆÙá¹ÇáõÙ åÉÛáõë
Imodium plus
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
Éáå»ñ³ÙǹÇ
¹»Õ³Ñ³ï»ñ
2Ù·+125Ù·
Ú³Ýë»Ý êÇɳ· ê.å.². (Æï³Édz)
ÑǹñáùÉáñǹ,
ͳٻÉáõ
(4, 6,12)
Ú³Ýë»Ý ü³ñÙ³ëÛáõÃÇù³ Ü.ì.
ëÇÙ»ÃÇÏáÝ
(´»É·Ç³)-Ç Ñ³Ù³ñ
loperamide
Janssen Cilag S.p.A. Italy for
hydrochloride,
Janssen Pharmaceutica N.V.
simethicone
(Belgium)
ÆÙáå»ñ
ɳÏïáõÉá½
ûß³ñ³Ï
667Ù·/ÙÉ,
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Imoper
lactulose
200ÙÉ ßßÇÏ
Balkanpharma-Troyan AD
ÆÙáõݳÉ
µáëáñ³·áõÛÝ
¹»Õ³Ñ³ï»ñ
80Ù·
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Immunal
¿ËÇݳó»³
(20/2x10/)
Lek Pharmaceuticals d.d.
echinacea purpurea
ÆÙáõݳÉ
µáëáñ³·áõÛÝ
ϳÃÇÉÝ»ñ ËÙ»Éáõ
0.8ÙÉ/1ÙÉ,
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Immunal
¿ËÇݳó»³ÛÇ ÑÛáõÃ
50ÙÉ ßßÇÏ
Lek Pharmaceuticals d.d.
echinacea purpurea
succus
ÆÙáõݳï
Ù³ñ¹áõ ³ñÛ³Ý Ù³Ï³ñ¹Ù³Ý
¹»Õ³÷áßÇ
1000ØØ
´³ùëï»ñ ²¶
Immunate
VIII ·áñÍáÝ
ÉÇáýÇÉǽ³óí³Í,
(¹»Õ³÷áßÇ
Baxter AG
Human Blood
ÉáõÍãáí
ëñí³ÏáõÙ, 10ÙÉ
Coagulation Factor VIII
ÉáõÍÇã ëñí³ÏáõÙ,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ѳٳϳñ· (1)
ÆÙáõݳï
Ù³ñ¹áõ ³ñÛ³Ý Ù³Ï³ñ¹Ù³Ý
¹»Õ³÷áßÇ
250ØØ
´³ùëï»ñ ²¶
Immunate
VIII ·áñÍáÝ
ÉÇáýÇÉǽ³óí³Í,
(¹»Õ³÷áßÇ
Baxter AG
Human Blood
ÉáõÍãáí
ëñí³ÏáõÙ, 5ÙÉ
Coagulation Factor VIII
ÉáõÍÇã ëñí³ÏáõÙ,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ѳٳϳñ· (1)
ÆÙáõݳï
Ù³ñ¹áõ ³ñÛ³Ý Ù³Ï³ñ¹Ù³Ý
¹»Õ³÷áßÇ
500ØØ (¹»Õ³÷áßÇ
´³ùëï»ñ ²¶
Immunate
VIII ·áñÍáÝ
ÉÇáýÇÉǽ³óí³Í,
ëñí³ÏáõÙ, 5ÙÉ
Baxter AG
Human Blood
ÉáõÍãáí
ÉáõÍÇã ëñí³ÏáõÙ,
Coagulation Factor VIII
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ѳٳϳñ· (1)
ÆÙáõÝá·ÉáµáõÉÇ
ÇÙáõÝá·ÉáµÇÝ
ÉáõÍáõÛÃ
100ØØ/¹»Õ³ã³÷
´Çáý³ñÙ³
Ý Ù³ñ¹áõ,
Ù³ñ¹áõ,
Ý»ñ³ñÏÙ³Ý
³ÙåáõÉáõÙ,
Biopharma
ѳϳëï³ýÇÉáÏá-ϳÛÇÝ Ñ³Ï³ëï³ýÇÉáÏáϳ-ÛÇÝ
³ÙåáõÉÝ»ñ (3, 5,
Immunoglobulin
immunoglobulin human
10)
human
antistaphylococcus
antistaphylococcus
ÆÙáõÝá·ÉáµáõÉÇ
Ù³ñ¹áõ
ÉáõÍáõÛÃ
100ØØ/¹»Õ³ã³÷
ØÇÏñá·»Ý ¶²Ø
Ý Ù³ñ¹áõ,
ÇÙáõÝá·ÉáµáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
³ÙåáõÉáõÙ,
Microgen SIU
ѳϳëï³ýÇÉáÏáѳϳëï³ýÇÉáÏáϳ-ÛÇÝ
³ÙåáõÉÝ»ñ (3, 5,
ϳÛÇÝ, Ñ»ÕáõÏ
immunoglobulin human
10)
Immunoglobulin
antistaphylococcus
human
antistaphylococcus,
liquid
ÆÙáõÝáÙ³ùë
å»åïǹá·ÉÇϳÝ
¹»Õ³÷áßÇ
200²Ø,
ÆÙ³ý³ñÙ³ êäÀ Immapharma
Immunomax
peptidoglycan
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (3)
Ltd
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
ÆÙáõñ³Ý
³½³ÃÇáåñÇÝ
¹»Õ³Ñ³ï»ñ
50Ù·
лáõÙ³Ý ü³ñÙ³ ¶ÙµÐ ¶É³ùëá
Imuran
azathioprine
óճÝóå³ï
(100)
àõ»ÉùáÙ ¶ÙµÐ ¨ øá.-Ç Ñ³Ù³ñ
Heumann Pharma GmbH for
GlaxoWellcome GmbH & Co.
ÆÙáõñáÝ
BCG å³ïí³ëï³ÝÛáõÃ
ÉÇáýÇÉǽ³ï
25Ù·,
¶³Ù³É»³ÛÇ ³Ýí. ¾Ø¶ÐÆ äÒ
Æï³Édz
A07D A03
4498
08.09.2003
08.09.2008
²¸
´áõÉÕ³ñdz
A06A D11
0680/6733
²¸
êÉáí»Ýdz
-
0085/6193
17.01.2007
17.01.2012
07.06.2006
07.06.2011
êÉáí»Ýdz
-
0086/6194
07.06.2006
07.06.2011
²¸
²íëïñdz
-
4619
07.11.2003
07.11.2008
¸
²íëïñdz
-
4617
07.11.2003
07.11.2008
¸
²íëïñdz
-
4618
07.11.2003
07.11.2008
¸
àõÏñ³Çݳ
J06B
0595/6397
05.12.2006
05.12.2011
¸
èáõë³ëï³Ý
J06B
0594/6562
05.12.2006
05.12.2011
¸
èáõë³ëï³Ý
-
5729
09.11.2005
09.11.2010
¸
¶»ñÙ³Ýdz
L04A X01
4767
25.05.2004
25.05.2009
¸
èáõë³ëï³Ý
-
5685
26.08.2005
¸
²¸
73
å³ïí³ëï³ÝÛáõÃ
Imuron vaccine
BCG vaccine
Æݹ³å
Indap
ÆݹÇå³Ù
Indipam
ÆݹáÙ»ï³óÇÝ
Indometacin
Çݹ³å³Ùǹ
indapamide
Çݹ³å³Ùǹ
indapamide
ÇݹáÙ»ï³óÇÝ
indometacin
ÆݹáÙ»ï³óÇÝ
Indometacin
ÆݹáÙ»ï³óÇÝ
êáý³ñÙ³
Indometacin
Sopharma
ÆݹáÙ»ï³óÇÝ
Indometacin
ÆݹáÙ»ï³óÇÝÇ
ùëáõù
Indometacin
ointment
ÆݹáÙ»ï³óÇÝêáý³ñÙ³
IndometacinSopharma
ÆݹáÙ»ï³óÇÝêáý³ñÙ³
IndometacinSopharma
Æݹáåñ»ë
Indopres
ÇݹáÙ»ï³óÇÝ
indometacin
ÇݹáÙ»ï³óÇÝ
indometacin
1068
Æݹáí³½ÇÝ
Indovasin
1069
Æݹáí»ÝáÉ
Indovenol
1070
ÆÝѳɳÝï
Inhalant
1071
ÆÝÑǵ³ó»
Inhibace
ÆÝÑǵ³ó»
Inhibace
ÆÝëáõɳï³ñ¹-ÐØ
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1072
1073
Ý»ñËáéáã³ÛÇÝ
Ý»ñ³ñÏáõÙÝ»ñÇ
ÉáõÍáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ
ÙáÙÇÏÝ»ñ
áõÕÇÕ³ÕÇù³ÛÇÝ
ùëáõù
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
2.5Ù·
(30)
2.5Ù·
(30/3x10/)
25Ù·
(30)
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
§Medgamal¦ branch of SI
SRIEM after Gamalei
äñá. غ¸. êÇ ¾ë äñ³Ñ³ ³.ë.
Pro.MED. CS Praha a.s.
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
26.08.2010
100Ù·
(6, 10)
10%,
40· å³ñÏáõ×
ü³ñÙ³åñÇÙ êèÈ
Farmaprim SRL.
êáý³ñÙ³ ²¸
Sopharma AD
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´áõÉÕ³ñdz
´»É³éáõë
M01A B01
M02A A23
5011
â»Ëdz
L01CD01
0720/6628
´áõÉÕ³ñdz
C03B A11
1018/7012
´áõÉÕ³ñdz
M01A B01
0984/6945/1
Øáɹáí³
M01A B01
1489/7389
´áõÉÕ³ñdz
C01E B03,
M01A B01,
M02A A23,
S01B C01
N01B B02
4312
ÇݹáÙ»ï³óÇÝ
indometacin
ÇݹáÙ»ï³óÇÝ
indometacin
ùëáõù
ùëáõù
10%,
40· å³ñÏáõ×
10%,
40· å³ñÏáõ× Ï³Ù
³å³Ï» ï³ñ³
ÇݹáÙ»ï³óÇÝ
indometacin
¹»Õ³Ñ³ï»ñ
³Õ»ÉáõÛÍ
25Ù·
(30)
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
M01A B01
ÇݹáÙ»ï³óÇÝ
indometacin
ÙáÙÇÏÝ»ñ
50Ù·
(6)
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
Çݹ³å³Ùǹ
indapamide
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2.5Ù·
(30/3x10/)
ÇݹáÙ»ï³óÇÝ,
ïñáùë»éáõïÇÝ
indometacin, troxerutin
í»ÝáñáõïÇÝáÉ,
ÇݹáÙ»ï³óÇÝ
venorutinol,
indometacin
¹áݹáÕ
(3%+2%)
45· å³ñÏáõ×
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
¹áݹáÕ
(2·+3·)/100·,
40· å³ñÏáõ×
»Õ¨Ýáõ, ³Ý³ÝáõËÇ,
ÝÇí»Ýáõ ¨ ݳñ¹áëÇ
ÛáõÕ»ñ, ï»ñåÇÝ»áÉ
Abietis, Menthae,
Eucalypti and
Lavandulae olei,
terpineol
ëÇɳ½³åñÇÉ
cilazapril
ëÇɳ½³åñÇÉ
cilazapril
Ù³ñ¹áõ ǽáý³Ý
ÉáõÍáõÛÃ
ëåÇñï³ÛÇÝ,
ßÝã³éÙ³Ý
10ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ï³ËáõÛÃ
5Ù·
(28)
2.5Ù·
(28)
100ØØ/ÙÉ
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´Çáý³ñÙ ê.².
Biofarm S.A.
ÐáýÙ³Ý-ȳ èáß Èï¹.
Hoffmann-La Roche Ltd.
ÐáýÙ³Ý-ȳ èáß Èï¹.
Hoffmann-La Roche Ltd.
Üáíá-Üáñ¹ÇëÏ ²/ê
1077/7101
07.02.2007
07.02.2012
13.06.2007
13.06.2012
22.05.2007
20.04.2012
¸
20.12.2007
20.12.2012
17.10.2003
17.10.2008
¸
¸
¸
²¸
08.08.2007
08.08.2012
13.12.2004
13.12.2009
²¸
0917/6708
26,04.2007
26.04.2012
¸
M01AB01
1035/6922
21.06.2007
21.06.2012
¸
àõÏñ³Çݳ
C03B A11
0092/6070
09.06.2006
09.06.2011
¸
´áõÉÕ³ñdz
C05CA04
0876/6895
06.04.2007
06.04.2012
²¸
àõÏñ³Çݳ
M01A B51
0094/6105
09.06.2006
09.06.2011
²¸
èáõÙÇÝdz
-
0440/6444
26.09.2006
26.09.2011
²¸
Þí»Ûó³ñdz
C09A A08
4184
¸
Þí»Ûó³ñdz
C09A A08
4183
¸³Ýdz
A10A
5183
18.03.2003
18.03.2008
05.05.2003
05.05.2008
03.11.2004
¸
¸
¸
74
Insulatard HM
1074
ÆÝëåñ³
Inspra
ÇÝëáõÉÇÝ
(é»ÏáÙµÇݳÝï)
Human Isophane
Insulin (recombinant)
¿åÉ»ñ»ÝáÝ
eplerenone
1075
ÆÝëåñ³
Inspra
¿åÉ»ñ»ÝáÝ
eplerenone
1076
ÆÝëï»ÝáÝ
Instenon
1077
ÆÝëï»ÝáÝ
Instenon
1078
ÆÝëï»ÝáÝ ýáñï»
Instenon forte
1079
ÆÝï³ùë»É
Intaxel
1080
ÆÝï³ùë»É
Intaxel
1081
ÆÝï³ùë»É
Intaxel
1082
ÆÝï»ñý»ñáÝ
Ù³ñ¹áõ, ãáñ,
É»ÛÏáóÇï³ÛÇÝ
Interferon
Leucocytal human
dried
1083
ÆÝïñ³ï³ùëÇÙ
Intrataxime
1084
ÆÝïñáÝ ²
Intron - A
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï (1)
Novo-Nordisk A/S
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
25Ù·
(28)
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
C03D A04
0356/6361
28.08.2006
28.08.2011
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(28)
ü³ñÙ³ódz ÈÇÙÇﻹ öý³Û½»ñ
ÈÇÙÇï»¹Ç Ñ³Ù³ñ
Pharmacia Limited for Pfizer
Limited
ü³ñÙ³ódz ÈÇÙÇﻹ öý³Û½»ñ
ÈÇÙÇï»¹Ç Ñ³Ù³ñ
Pharmacia Limited for Pfizer
Limited
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
C03D A04
0357/6362
28.08.2006
28.08.2011
¸
²íëïñdz
C01EX
0739/6769
15.02.2007
15.02.2012
¸
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
C01EX
0738/6770
15.02.2007
15.02.2012
¸
ÜÇÏáÙ»¹ ²íëïñdz ¶ÙµÐ
Nycomed Austria GmbH
²íëïñdz
C01EX
0737/6771
15.02.2007
15.02.2012
¸
¸²´àôð ü³ñÙ³ Èï¹.
DABUR Pharma Ltd.
Ðݹϳëï³Ý
L01C D01
6060
28.03.2006
28.03.2011
¸
¸²´àôð ü³ñÙ³ Èï¹.
DABUR Pharma Ltd.
Ðݹϳëï³Ý
L01C D01
6062
28.03.2006
28.03.2011
¸
¸²´àôð ü³ñÙ³ Èï¹.
DABUR Pharma Ltd.
Ðݹϳëï³Ý
L01C D01
6061
28.03.2006
28.03.2011
¸
ØÇÏñá·»Ý ¶²Ø
Microgen SIU
èáõë³ëï³Ý
S01A,
L03A
5571
05.09.2005
05.09.2010
¸
îáñÉ³Ý ê.².
Torlan S.A.
Þ»ñÇÝ· öɳáõ (´ñÇÝÝÇ)
øáÙ÷³ÝÇ ø³áõÝÃÇ øáÏ
Schering - Plough (Brinny)
Company Country Cork
Þ»ñÇÝ· öɳáõ (´ñÇÝÝÇ)
øáÙ÷³ÝÇ ø³áõÝÃÇ øáÏ
Schering - Plough (Brinny)
Company Country Cork
¶É³ùëáêÙÇÃÎɳÛÝ
´ÇáÉáçÇϳÉë ë.³.
GlaxoSmithKline Biologicals
Æëå³Ýdz
J01D A10
5146
¸
Æéɳݹdz
L03A A04
4325
14.10.2004
14.10.2009
26.06.2003
26.06.2008
Æéɳݹdz
L03A A04
4326
26.06.2003
26.06.2008
¸
´»É·Ç³
å³ïí³ëï³-ÝÛáõÃ
5487
08.12.2005
08.12.2010
¸
¿ï³ÙÇí³Ý,
ÉáõÍáõÛÃ
(50Ù·+10Ù·+
Ñ»ùëᵻݹÇÝ,
Ý»ñ³ñÏÙ³Ý
100Ù·)/2ÙÉ,
¿ïáýÇÉÇÝ
2ÙÉ ³ÙåáõÉÝ»ñ
etamivan, hexobendine,
(5)
etofylline
¿ï³ÙÇí³Ý,
¹»Õ³Ñ³ï»ñ
(50Ù·+20Ù·+ 60Ù·)
Ñ»ùëᵻݹÇÝ,
óճÝóå³ï
(30/3x10/)
¿ïáýÇÉÇÝ
etamivan, hexobendine,
etofylline
¿ï³ÙÇí³Ý,
¹»Õ³Ñ³ï»ñ
(100Ù·+60Ù·+
Ñ»ùëᵻݹÇÝ,
óճÝóå³ï
60Ù·) (30/3x10/)
¿ïáýÇÉÇÝ
etamivan, hexobendine,
etofylline
å³ÏÉÇï³ùë»É
Ëï³ÝÛáõÃ
30Ù·/5ÙÉ,
paclitaxel
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (1)
ÉáõÍáõÛÃÇ
å³ÏÉÇï³ùë»É
Ëï³ÝÛáõÃ
260Ù·/43.4ÙÉ,
paclitaxel
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (1)
ÉáõÍáõÛÃÇ
å³ÏÉÇï³ùë»É
Ëï³ÝÛáõÃ
100Ù·/17ÙÉ,
paclitaxel
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (1)
ÉáõÍáõÛÃÇ
ÇÝï»ñý»ñáÝ
¹»Õ³÷áßÇ
1000ØØ,
interferon
³ÙåáõÉÝ»ñ (10)
ó»ýáï³ùëÇÙ
cefotaxime
ÇÝï»ñý»ñáÝ -2µ
interferon -2b
¹»Õ³÷áßÇ Ù/Ù, Ý/»
1·,
Ý»ñ³ñÏáõÙÝ»ñÇ
ëñí³Ï (1)
ÉáõÍáõÛÃ
18 ÙÇÉÇáÝ
Ý»ñ³ñÏÙ³Ý
ØØ/3ÙÉ, ëñí³Ï (1)
1085
ÆÝïñáÝ ²
Intron - A
ÇÝï»ñý»ñáÝ -2µ
interferon -2b
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
25 ÙÇÉÇáÝ
ØØ/2.5ÙÉ,
ëñí³Ï (1)
1086
ÆÝý³ÝñÇùë
Infanrix
¹ÇýûñdzÛÇ,
÷³Ûï³óÙ³Ý, ϳåáõÛï
ѳ½Ç áã µçç³ÛÇÝ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1¹»Õ³ã³÷ (0.5ÙÉ),
ݳ˳Éóí³Í
Ý»ñ³ñÏÇãÝ»ñ
03.11.2009
¸
75
1087
ÆÝý»½áÉ 40
Infesol 40
1088
ÆÝýÉáõí³Ï
Influvac
1089
ÆÝýÉáõóǹ
Influcid
1090
ÆáÝá-ï»ù
Iono-Tech
1091
Æáí í»ÝáõÙ
Iov-Venum
Æå»ñïñáý³Ý
Ipertrofan
1092
1093
Æí»ñÙ»Ï
Ivermec
1094
Æí»ñí»ïá-1
Iverveto-1
Æïñ³ÏáÝ
Itracon
Æñ³ý»Ý-ò
Iraphen-C
1095
1096
1097
ÆñÇϳñ
Iricar
1098
ÆñÇÝáï»É
Irinotel
1099
Æùë»É
Ixel
å³ïí³ëï³ÝÛáõÃ
acellular diphtheria,
tetanus, pertussis
vaccine
L-³ÙÇݳÃÃáõÝ»ñ
L-aminoacids
(1,10)
s.a.
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
100ÙÉ, 250ÙÉ,
500ÙÉ ëñí³Ï
·ñÇåÇ ³ÏïÇí³½»ñÍ
¹»Õ³Ï³ËáõÛà Ý\Ù
å³ïí³ëï³ÝÛáõà (³é³Ýó ϳ٠»ÝóٳßϳÛÇÝ
ÃÇáÙ»ñë³ÉÇ)
Ý»ñ³ñÏÙ³Ý
inactivated influenza
vaccine (without
thiomersal)
¹»Õ³Ñ³ï»ñ
15ÙÏ·/0.5ÙÉ,
0.5ÙÉ Ý³Ë³Éóí³Í
Ý»ñ³ñÏÇã (1,10)
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì.
Solvay Pharmaceuticals B.V.
(60)
¶»ñÙ³Ý³Ï³Ý ÐáÙ»áå³Ã³ÛÇÝ
ØÇáõÃÛáõÝ (¶ÐØ)
Deutsche Homoopathie Union
(DHU)
ݳïñÇáõÙÇ ³ó»ï³ï,
ÉáõÍáõÛÃ
(5·+5.85·+ 0.302·+ ü³ñÙ³î»ù ö´À PharmaTech
ݳïñÇáõÙÇ ùÉáñǹ, ϳÃÇɳݻñ³ñÏ-Ù³Ý
0.36·+0.25·)/
CJSC
ϳÉÇáõÙÇ ùÉáñǹ,
1000ÙÉ,
ϳÉóÇáõÙÇ ùÉáñǹ,
100ÙÉ, 250ÙÉ,
Ù³·Ý»½ÇáõÙÇ ùÉáñǹ
500ÙÉ,1000ÙÉ
sodium acetate, sodium
åɳëïÇÏ ÷³Ã»Ã
chloride, potassium
chloride, calcium
chloride, magnesium
chloride
ϳÃÇÉÝ»ñ
25ÙÉ ßßÇÏ
³ÉÇáÝ-²
ÑáÙ»áå³Ã³ÛÇÝ
Talion-A
Ù»å³ñïñÇóÇÝ
¹»Õ³Ñ³ï»ñ
40Ù·
êáëÇ»ï³ öñá¹áïÇ ²ÝïǵÇáïÇóÇ
mepartricin
óճÝóå³ï,
(10, 20, 30)
ê.å.².
³Õ»ÉáõÛÍ
Societa Prodotti Antibiotici
S.p.A./
Çí»ñÙ»ÏïÇÝ,
ÉáõÍáõÛÃ
(10Ù·+40Ù·)/ÙÉ,
ÜÇï³-ü³ñÙ ö´À
ÃáÏáý»ñáɳó»ï³ï
Ý»ñ³ñÏÙ³Ý
1ÙÉ ëñí³Ï (4),
Nita-Farm Closed JSC
ivermectin,
10ÙÉ ëñí³Ï (120),
tocopherolacetat
20ÙÉ ëñí³Ï (60),
Çí»ñÙ»ÏïÇÝ
ÉáõÍáõÛÃ
10Ù·/ÙÉ,
ì.Ø.¸. ²ÝÇÙ³ÉлÉà Èï¹.
ivermectin
Ý»ñ³ñÏÙ³Ý
100ÙÉ ßßÇÏ
V.M.D. Animal Health Ltd.
Çïñ³Ïáݳ½áÉ
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
ü³ñÙ³Ï ´´À
itraconazole
(5, 15 /3x5/)
Farmak JSC
³ó»ï³ÙÇÝáý»Ý,
¹»Õ³Ñ³ï»ñ
300Ù·+20Ù·
¸³ñááõ ö³Ëß ü³ñÙ³ëÛáõÃÇϳÉ
Ïá¹»ÇÝÇ ýáëý³ï
µ³Å³Ý»ÉÇ
(100)
Øý·.øá.
acetaminophen,
Darou Pakhsh Pharmaceutical
codeine phosphate
Mfg.Co.
Ýñµ³ùëáõù
50· å³ñÏáõ×
¶»ñÙ³Ý³Ï³Ý ÐáÙ»áå³Ã³ÛÇÝ
ØÇáõÃÛáõÝ (¶ÐØ)
Deutsche Homoopathie Union
(DHU)
ÇñÇÝáï»Ï³ÝÇ
ÉáõÍáõÛÃ
40Ù·/2ÙÉ,
¸²´àôð ü³ñÙ³ Èï¹
ÑǹñáùÉáñǹ
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
DABUR Pharma Ltd
irinotecan hydrochloride
ÙÇÉݳóÇåñ³Ý
¹»Õ³å³ïÇ×Ý»ñ
25Ù·
äÇ»é ü³µñ» Ø»¹ÇϳٻÝï
milnacipran
(56)
Pierre Fabre Medicament
¶»ñÙ³Ýdz
-
5085
06.10.2004
06.10.2009
¸
Üǹ»éɳݹݻñ
-
4983
15.10.2004
15.10.2009
¸
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
5216
13.12.2004
13.12.2009
²¸
г۳ëï³Ý
B05X
5636
03.06.2005
03.06.2010
¸
èáõë³ëï³Ý
ÑáÙ»áå³Ã³ÛÇÝ
A01A B16
0967/6989
14.05.2007
14.05.2012
11.08.2003
11.08.2008
²¸
èáõë³ëï³Ý
³Ý³ëݳµáõųϳÝ,
P02C F01
5774
27.10.2005
27.10.2010
¸
ÐáõÝ·³ñdz
0913/6920
Æñ³Ý
N02A A59
5181
26,04.2007
26.04.2012
13.02.2007
13.02.2012
02.12.2004
02.12.2009
¸
àõÏñ³Çݳ
³Ý³ëݳµáõųϳÝ
J02A C02
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
5218
13.12.2004
13.12.2009
²¸
Ðݹϳëï³Ý
R01X X19
1164/7161
13.09.2007
13.09.2012
¸
üñ³Ýëdz
N06A X17
1302/7269
18.10.2007
12.10.2012
¸
Æï³Édz
4327
0721/6245
¸
¸
¸
76
1100
1101
1102
1103
1104
Æùë»É
Ixel
È-ÃÇñûùëÇÝ 50
´»éÉÇÝ ø»ÙÇ
L-Thyroxin 50
Berlin- Chemie
È-ÃÇñûùëÇÝ 100
´»éÉÇÝ-ø»ÙÇ
L-Thyroxin 100
Berlin-Chemie
ȳ½Çùë
Lasix
ȳ½Çùë
Lasix
1105 ȳÏïáµ³Ïï»ñÇÝ ãáñ
Lactobacterinum
siccum
1106
1107
1108
1109
1110
1111
ÙÇÉݳóÇåñ³Ý
milnacipran
ɨáÃÇñûùëÇÝ
levothyroxine
¹»Õ³å³ïÇ×Ý»ñ
ɨáÃÇñûùëÇÝ
ݳïñÇáõÙ
levothyroxine sodium
¹»Õ³Ñ³ï»ñ
100ÙÏ·
(25, 50, 100)
ýáõñáë»Ùǹ
furosemide
ýáõñáë»Ùǹ
furosemide
¹»Õ³Ñ³ï»ñ
40Ù·
(50/5x10/)
20Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
2x109 áã å³Ï³ë
ϻݹ³ÝÇ
µ³Ïï»ñdzݻñÇ
ÉÇáýÇÉǽ³óí³Í
÷áßÇ ëñí³ÏáõÙ,
ëñí³Ï (10)
66Ù·/100ÙÉ,
200ÙÉ ßßÇÏ
1%,
15· å³ñÏáõ×
1%,
15ÙÉ, 30ÙÉ
1%,
15ÙÉ, 30ÙÉ ßßÇÏ
1%,
15·, 30· å³ñÏáõ×
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
äÇ»é ü³µñ» Ø»¹ÇϳٻÝï
Pierre Fabre Medicament
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
²í»ÝïÇë ü³ñÙ³ Èï¹
Aventis Pharma Ltd.
²í»ÝïÇë ü³ñÙ³ Èï¹
Aventis Pharma Ltd.
18.10.2007
12.10.2012
20.02.2004
20.02.2009
¸
0438/6446
26.09.2006
26.09.2011
¸
C03C A01
0389/6349
¸
Ðݹϳëï³Ý
C03C A01
0390/6350
12.09.2006
12.09.2011
12.09.2006
12.09.2011
àõÏñ³Çݳ
βêÐ
0699/6740
25.01.2007
25.01.2012
²¸
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
èáõÙÇÝdz
Rompharm Company SRL
Üáí³ñïÇë ü³ñÙ³ ²¶
Þí»Ûó³ñdz
Novartis Pharma AG
Üáí³ñïÇë ý³ñÙ³ ê.².ê.
üñ³Ýëdz
Novartis Pharma S.A.S
Üáí³ñïÇë ü³ñÙ³ ²¶
Þí»Ûó³ñdz
Novartis Pharma AG
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
Þí»Ûó³ñdz
ê²
Novartis Consumer Health S.A.
Üáí³ñïÇë ý³ñÙ³ëÛáõÃÇù³É ØÂ Ø»Í ´ñÇï³Ýdz
Èï¹ (Üáí³ñïÇë ü³ñÙ³ ²¶,
Þí»ó³ñdzÛÇ Ñ³Ù³ñ)
Novartis Pharmaceutcals UK
Ltd (for Novartis Pharma AG,
Switzerland)
Üáí³ñïÇë øáÝëáõÙ»ñ лÉÃ ê² Þí»Ûó³ñdz
Novartis Consumer Health SA
A06A D11
0671/6714
²¸
D01A E15
D01B A02
C01A E15
4860
17.01.2007
17.01.2012
15.06.2004
15.06.2009
15.06.2006
15.06.2011
15.06.2004
15.06.2009
17.01.2007
17.01.2012
÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
ëñí³ÏáõÙ
ȳÏïáõɳÏ
Lactulac
ȳÙǽÇÉ
Lamisil
ȳÙǽÇÉ
Lamisil
ȳÙǽÇÉ
Lamisil
ȳÙǽÇÉ
Lamisil
ɳÏïáµ³Ïï»ñÇÝ
åɳÝï³ñáõ٠ϳÙ
ý»ñÙ»ÝïáõÙ
lactobactertin
plantarum or
fermentum
ɳÏïáõÉá½
lactulose
ï»ñµÇݳýÇÝ
terbinafine
ï»ñµÇݳýÇÝ
terbinafine
ï»ñµÇݳýÇÝ
terbinafine
ï»ñµÇݳýÇÝ
terbinafine
ȳÙǽÇÉ
Lamisil
ï»ñµÇݳýÇÝ
terbinafine
¹»Õ³Ñ³ï»ñ
250Ù·
(14)
ï»ñµÇݳýÇÝ
terbinafine
¹áݹáÕ
1%,
15· å³ñÏáõ×
ï»ñµÇݳýÇÝ
terbinafine
ÉáõÍáõÛÃ
óճÝó·áÛ³óÝáÕ ³ñï³ùÇÝ
ÏÇñ³éÙ³Ý
¹»Õ³÷áßÇ Ý»ñùÇÝ
ÁݹáõÝÙ³Ý
1%,
4· å³ñÏáõ×
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis Consumer Health S.A.
100·, 200·, 400·,
800· åɳëïÇÏ ï³ñ³
¹»Õ³Ñ³ï»ñ
0,15·
(1)
¹»Õ³Ñ³ï»ñ
0,25·
(14, 14/2x7/,
28/4x7/, 28/2x14/)
1112
ȳÙǽÇÉ 1%
¹»ñÙ·»É
Lamisil 1% Dermgel
1113 ȳÙǽÇÉ àõÜú
Lamisil UNO
1114
Ȩ³ÙǽáÉ 8%
Levamisol 8%
ɨ³ÙǽáÉ
levamisole
1115
Ȩ³ÙǽáÉÇ
ÑǹñáùÉáñǹ
Levamisol
hydrochloride
ȳÙÇÏáÝ
Lamicon
ɨ³ÙǽáÉÇ
ÑǹñáùÉáñǹ
levamisol
hydrochloride
ï»ñµÇݳýÇÝ
terbinafine
1116
¹»Õ³Ñ³ï»ñ
50Ù·
(56)
50ÙÏ·
(50, 100)
ûß³ñ³Ï
Ýñµ³ùëáõù
óáÕ³ßÇÃ
óáÕ³ßÇÃ
Ýñµ³ùëáõù
´Çáý³ñÙ³ ö´À
Biopharma Closed JSC
üñ³Ýëdz
N06A X17
1303/7270
¶»ñÙ³Ýdz
H03A A01
4714
¶»ñÙ³Ýdz
H03A A01
Ðݹϳëï³Ý
0119/6226
4859
¸
¸
²¸
²¸
D01A E15
D01B A02
D01A E15
²¸
0686/6582
D01BA02
0858/6810
30.03.2007
30.03.2012
¸
D01A E15
D01B A02
4444
19.08.2003
19.08.2008
²¸
Þí»Ûó³ñdz
D01A E15
1015/6583
13.06.2007
13.06.2012
²¸
ì»ïáùíÇÝáÉ ´Çáí»ï Èï¹
Vetoquinol Biowet Ltd
Ȼѳëï³Ý
0010/5946
12.05.2006
12.05.2011
¸
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ü³ñÙ³Ï ´´À
Farmak Open JSC
àõÏñ³Çݳ
³Ý³ëݳµáõųϳÝ,
P02C E01
P02CE01
1233/7170
15.11.2007
13.09.2012
¸
àõÏñ³Çݳ
D01A E15
1063/6709
16.07.2007
16.07.2012
¸
²¸
77
1117
1118
1119
1120
ȳÙÇÏáÝ
Lamicon
ȳÙÇÝ íÇÅÇáÝ
Lamin vision
ï»ñµÇݳýÇÝ
terbinafine
-
Ýñµ³ùëáõù
ȳÙÇݳñdz
Laminaria
ȳÙÇï»ñ
Lamiter
-
ѳµ»ñ
óáÕ³ßÇÃ
1121
ȳÙáÉ»å
Lamolep
ï»ñµÇݳýÇÝÇ
ùÉáñÑǹñ³ï
terbinafine chlorhydrate
ɳÙáïñÇçÇÝ
lamotrigine
1122
ȳÙáÉ»å
Lamolep
1123
å³ïÇ×Ý»ñ
1%,
15· å³ñÏáõ×
375Ù·
(60)
350Ù·
(20,30)
1%
20ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
50Ù·
(30)
ɳÙáïñÇçÇÝ
lamotrigine
¹»Õ³Ñ³ï»ñ
25Ù·
(30)
ȳÙáÉ»å
Lamolep
ɳÙáïñÇçÇÝ
lamotrigine
¹»Õ³Ñ³ï»ñ
100Ù·
(30)
1124
ȳÙáïñÇùë
Lamotrix
ɳÙáïñÇçÇÝ
lamotrigine
¹»Õ³Ñ³ï»ñ
1125
ȳÙáïñÇùë
Lamotrix
ȳÙáïñÇùë
Lamotrix
ɳÙáïñÇçÇÝ
lamotrigine
ɳÙáïñÇçÇÝ
lamotrigine
¹»Õ³Ñ³ï»ñ
1127 ȳÛýå³Ï ÛáõÝÇáñ+
Lifepac junior+
-
å³ïÇ×Ý»ñ
1128
ȳÛýå³Ï ë»ÝÛáñ
Lifepac senior
-
å³ïÇ×Ý»ñ
1129
ȳÝûùëÇÝ
Lanoxin
ȳïÇÏáñï
Laticort
¹Ç·ûùëÇÝ
digoxin
ÑǹñáÏáñïǽáÝÇ
µáõïÇñ³ï
hydrocortisone butyrate
¹»Õ³Ñ³ï»ñ
1131
ȳïÇÏáñï
Laticort
ÑǹñáÏáñïǽáÝÇ
µáõïÇñ³ï
hydrocortisone butyrate
ùëáõù
1132
ȳïÇÏáñï
Laticort
ÑǹñáÏáñïǽáÝÇ
µáõïÇñ³ï
hydrocortisone butyrate
Ýñµ³ùëáõù
1133
È»ÏáÏɳñ
ÏɳñÇÃñáÙÇóÇÝ
·ñ³ÝáõÉÝ»ñ
1126
1130
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
ü³ñÙ³Ï ´´À
Farmak JSC
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
ä³ñ³ý³ñÙ ö´À
Parapharm
CJSC
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
·áñͳñ³Ý ö´À
Chemical Works Gedeon
Richter Ltd.
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
·áñͳñ³Ý ö´À
Chemical Works Gedeon
Richter Ltd.
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
·áñͳñ³Ý ö´À
Chemical Works Gedeon
Richter Ltd.
Ø»¹áù»ÙÇ Èï¹
Medochemie Ltd.
25Ù·
(20/2x10/,
30/3x10/, 50/5x10/)
100Ù·
Ø»¹áù»ÙÇ Èï¹
(30/3x10/)
Medochemie Ltd.
50Ù·
Ø»¹áù»ÙÇ Èï¹
(20/2x10/,
Medochemie Ltd.
30/3x10/, 50/5x10/,
100/10x10/)
740Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
500Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
0.25Ù·
¶É³ùëáàõ»ÉùáÙ ¶ÙµÐ ¨ øá.
(100)
GlaxoWellcome GmbH & Co.
0.1%,
Ú»Éý³ ê.². ¹»Õ³·áñͳϳÝ
20ÙÉ ßßÇÏ
·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
0.1%,
Ú»Éý³ ê.². ¹»Õ³·áñͳϳÝ
15· å³ñÏáõ×
·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
0.1%,
Ú»Éý³ ê.². ¹»Õ³·áñͳϳÝ
15· å³ñÏáõ×
·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
125Ù·/5ÙÉ,
ê³Ý¹á½ ê.è.È (È»Ï ¹.¹.-Ç Ñ³Ù³ñ,
àõÏñ³Çݳ
D1A E15
0722/6244
13.02.2007
13.02.2012
26.10.2005
26.10.2010
²¸
Æéɳݹdz
βêÐ
5812
èáõë³ëï³Ý
βêÐ
5199
08.12.2004
08.12.2009
21.06.2007
21.06.2012
²¸
èáõÙÇÝdz
D01AE15
1036/6979
ÐáõÝ·³ñdz
N03A X09
4841
13.05.2004
13.05.2009
¸
ÐáõÝ·³ñdz
N03A X09
4840
13.05.2004
13.05.2009
¸
ÐáõÝ·³ñdz
N03A X09
4842
13.05.2004
13.05.2009
¸
ÎÇåñáë
N03A X09
1068/6772
16.07.2007
16.07.2012
¸
ÎÇåñáë
N03A X09
1066/6774
¸
ÎÇåñáë
N03A X09
1067/6773
16.07.2007
16.07.2012
16.07.2007
16.07.2012
Æéɳݹdz
βêÐ
5825
26.10.2005
26.10.2010
²¸
Æéɳݹdz
βêÐ
5824
26.10.2005
26.10.2010
²¸
¶»ñÙ³Ýdz
C01A A05
4329
¸
Ȼѳëï³Ý
D07A B02
6111
01.07.2003
01.07.2008
12.04.2006
12.04.2011
Ȼѳëï³Ý
D07A B02
6112
12.04.2006
12.04.2011
¸
Ȼѳëï³Ý
D07A B02
6113
12.04.2006
12.04.2011
¸
èáõÙÇÝdz
L01X A01
1279/7247
22.10.2007
¸
²¸
²¸
¸
¸
78
Lekoklar
clarithromycin
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
60ÙÉ ßßÇÏ
1134
È»ÏáÏɳñ
Lekoklar
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
250Ù·/5ÙÉ,
60ÙÉ ßßÇÏ
1135
È»ÏáÏɳñ
Lekoklar
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(14)
1136
È»ÏáÏɳñ
Lekoklar
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(14)
1137
È»ÏñáÉÇÝ
Lecrolyn
³ÏݳϳÃÇÉÝ»ñ
2% (20Ù·/ÙÉ),
10ÙÉ ëñí³Ï
êÉáí»Ýdz)
Sandoz S.R.L for Lek d.d.,
Slovenia
ê³Ý¹á½ ê.è.È. (È»Ï ¹.¹.-Ç
ѳٳñ, êÉáí»Ýdz)
Sandoz S.R.L. for Lekd.d,
Slovenia
ê³Ý¹á½ ê.è.È (È»Ï ¹.¹.-Ç Ñ³Ù³ñ,
/êÉáí»Ýdz/)
Sandoz S.R.L (for Lek d.d., /
Slovenia/)
ê³Ý¹á½ ê.è.È (È»Ï ¹.¹.-Ç Ñ³Ù³ñ,
/êÉáí»Ýdz/)
Sandoz S.R.L (for Lek d.d., /
Slovenia/)
ê³Ýï»Ý ´À
§Santen Oy¦
1138
Ȩ»ÙÇñ ä»ÝýÇÉ
Levemir Penfill
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100²Ø/ÙÉ (3ÙÉ),
ù³ñÃñÇç (5)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100²Ø/ÙÉ (3ÙÉ),
100²Ø/ÙÉ, 3ÙÉ
ݳ˳Éóí³Í ·ñÇã (5)
¹»Õ³Ñ³ï»ñ
2Ù·
(25, 50)
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1140
È»ÛÏ»ñ³Ý
Leukeran
ùñáÙá·ÉÇϳï
ݳïñÇáõÙÇ
cromoglicate sodium
ÇÝëáõÉÇÝ ¹»ï»ÙÇñ
(é»ÏáÙµÇݳÝï)
insulin detemir
(recombinant)
ÇÝëáõÉÇÝ ³ëå³ñï
(é»ÏáÙµÇݳÝï)
insulin aspart
(recombinant)
ùÉáñ³ÙµáõóÇÉ
chlorambucil
1141
Ȼݹ³óÇÝ
Lendacine
ó»ýïñdzùëáÝ
ceftriaxone
1142
È»íÇïñ³
Levitra
í³ñ¹»Ý³ýÇÉ
vardenafil
1143
È»íáëÇÝ
Levosin
1144
È»ïǽ»Ý
Letizen
È»ñϳٻÝ
Lerkamen
ùÉáñ³Ùý»ÝÇÏáÉ,
ëáõÉý³¹ÇÙ»ÃûùëÇÝ,
Ù»ÃÇÉáõñ³óÇÉ,
ïñÇٻϳÛÇÝ
chloramphenicol,
sulfadimethoxine,
methyluracil, trimecaine
ó»ïÇñǽÇÝ
cetirizine
É»ñϳÝǹÇåÇÝÇ
ÑǹñáùÉáñǹ
lercanidipine
hydrochloride
É»ñϳÝǹÇåÇÝÇ
ÑǹñáùÉáñǹ
lerkanidipine
hydrochloride
1139 Ȩ»ÙÇñ üÉ»ùëä»Ý
Levemir FlexPen
1145
1146
È»ñϳٻÝ-10
Lerkamen-10
èáõÙÇÝdz
J01F A09
1280/7248
22.10.2007
12.10.2012
¸
èáõÙÇÝdz
J01FA09
1352/7313
08.11.200705
.11.2012
¸
èáõÙÇÝdz
J01FA09
1351/7312
08.11.2007
05.11.2012
¸
üÇÝɳݹdz
S01G X01
4269
15.07.2003
15.07.2008
²¸
Üáíá Üáñ¹ÇëÏ ²/ê
Novo Nordisk A/S
¸³Ýdz
A10AE
1361/7322
29.11.2007
05.11.2012
¸
Üáíá Üáñ¹ÇëÏ ²/ê
Novo Nordisk A/S
¸³Ýdz
A10AE
1363/7324
29.11.2007
05.11.2012
¸
¶»ñÙ³Ýdz
L01A A02
4480
28.07.2003
28.07.2008
¸
êÉáí»Ýdz
J01D D04
5269
07.02.2005
07.02.2010
¸
´³Û»ñ ²¶ (¶É³ùëáêÙÇÃÎɳÛÝÇ
ѳٳñ)
Bayer AG (for
GlaxoSmithKline)
ÜÇÅý³ñÙ ´´À
Nizhpharm
Open JSC
¶»ñÙ³Ýdz
-
5227
25.01.2005
25.01.2010
¸
èáõë³ëï³Ý
D06A
D10A
G01A
J01B
S01A
S02A
4843
29.09.2004
29.09.2009
²¸
Îèβ ¹.¹.Üáíá Ù»ëïá
KRKA d.d.Novo mesto
´»éÉÇÝ ø»ÙÇ ²¶ (ػݳñÇÝÇ
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
êÉáí»Ýdz
R06A E07
4662
²¸
¶»ñÙ³Ýdz
C03C A13
4094
24.03.2005
24.03.2010
12.03.2003
12.03.2008
¶»ñÙ³Ýdz
C08C A13
5945
07.02.2006
07.02.2011
¸
лáõÙ³Ý ý³ñÙ³ ¶ÙµÐ
¶É³ùëáàõ»ÉùáÙ ¶ÙµÐ ¨ øá.-Ç
ѳٳñ
Heumann Pharma GmbH for
GlaxoWellcome GmbH & Co.
1·,
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
ëñí³Ï (1, 5, 10, 50)
Lek Pharmaceuticals d.d.
5Ù·
(2, 4, 10, 20)
ùëáõù
(1·+4·+4·+3·)/
100·,
40· å³ñÏáõ×,
50·,100·,1000· ï³ñ³
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(10,20)
10Ù·
(7, 14, 28)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(7, 14, 28/2x14/)
12.10.2012
¸
79
1147
1148
È»óÇÃÇÝ
Lecithin
Èǵ»ùëÇÝ
Libexin
-
·ñ³ÝáõÉÝ»ñ
142·, 285·
åñ»Ýûùë¹Ç³½ÇÝ
prenoxdiazine
¹»Õ³Ñ³ï»ñ
100Ù·
(20)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2%+1:80000
1.8ÙÉ
÷³Ù÷áõßïÝ»ñ (50)
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý,
ÉÇáýÇÉǽ³óí³Í
¹áݹáÕ
64Ø (å³ÛٳݳϳÝ),
³ÙåáõÉÝ»ñ (10)
64ØØ,
ëñí³Ï (5)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1149
ÈÇ·Ýáëå³Ý 2%,
ѳïáõÏ
Lignospan 2%
special
1150
Èǹ³½³
Lydasa
Èǹ³½³
Lydaza
ÉǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ,
³¹ñ»Ý³ÉÇÝÇ ï³ñïñ³ï
lidocaine hydrochloride,
adrenaline tartrate
ÑdzÉáõñáÝǹ³½
hyaluronidase
ÑdzÉáõñáÝǹ³½
hyaluronidase
1152
Èǹ³½³
Lydasa
ÑdzÉáõñáÝǹ³½
hyaluronidase
1153
ÈǹáϳÛÇÝ
Lidocaine
ÉǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ
lidocaine hydrochloride
1154
ÈǹáϳÛÇÝ ÈÇÏíá
Lidocain Liqvo
ÉǹáϳÛÇÝ
lidocaine
1151
1155
ÈǹáϳÛÇÝ ÈÇÏíá
ÉǹáϳÛÇÝ,
¿åÇÝ»ýñÇÝáí
¿åÇÝ»ýñÇÝ lidocaine,
Lidocain Liqvo with
epinephrine
epinephrine
1156
ÈǹáϳÛÇÝ
ÉǹáϳÛÇÝ
Lidocain
lidocain
1157
ÈǹáϳÛÇÝÇ
ÉǹáϳÛÇÝ
ÑǹñáùÉáñǹ
lidocain
Lidocaine
hydrochloride
1158
ÈǹáϳÛÇÝÇ
ÉǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ
ÑǹñáùÉáñǹ
Lidocaine
lidocain hydrochloride
hydrochloride
1159
1160
1161
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
óáÕ³óÇñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
²ØÜ
βêÐ
5102
20.09.2004
20.09.2009
19.10.2007
13.10.2012
²¸
ÐáõÝ·³ñdz
R05D B18
1216/7183
üñ³Ýëdz
N01B B52
4852
14.05.2004
14.05.2009
¸
ØÇÏñá·»Ý ¶²Ø
Microgen SIU
´»ÉÙ»¹åñ»å³ñ³ïÇ ´´À
Belmedpreparaty Open JSC
èáõë³ëï³Ý
B06A A03
5572
¸
´»É³éáõë
D06A A03
5236
05.09.2005
05.09.2010
18.11.2004
18.11.2009
64Ø (å³ÛٳݳϳÝ)
³ÙåáõÉÝ»ñ (10)
´ÇáÉ»Ï ö´À
Biolek Closed JSC
àõÏñ³Çݳ
B06A A03
0061/6101
30.05.2006
30.05.2011
¸
5%,
15·, 30· å³ñÏáõ×
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
г۳ëï³Ý
4979
12.07.2004
12.07.2009
²¸
2%,
20ÙÉ, 200ÙÉ
ëñí³ÏÝ»ñ,
100ÙÉ, 200ÙÉ
åɳëïÇÏ ÷³Ã»ÃÝ»ñ
2%+1:100000,
20ÙÉ ëñí³Ï
ÈÇÏíáñ ¸»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
г۳ëï³Ý
C01B B01
D04A B01
N01B B02
R02A D02
C01B B01
C05A D01
N01B B02
4211
07.03.2003
07.03.2008
¸
ÈÇÏíáñ ¸»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
г۳ëï³Ý
N01B B52
4212
07.03.2003
07.03.2008
¸
10%,
38· ßßÇÏ
2%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë êäÀ
Egis Pharmaceuticals Ltd
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
üÇñÙ³ ´´À
Yerevan ChemicalPharmaceutical Firm Open J/S
Company
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
ÐáõÝ·³ñdz
D04A B01
1081/7102
¸
àõÏñ³Çݳ
N01B B02
1135/7103
08.08.2007
08.08.2012
02.10.2007
08.08.2012
г۳ëï³Ý
N01B B02,
C01B B01
0614/6594
18.12.2006
18.12.2011
¸
àõÏñ³Çݳ
C01B B01
1136/7104
02.10.2007
08.08.2012
¸
¶»ñÙ³Ýdz
C09A A03
0641/6180
29.12.2006
29.12.2011
¸
¶»ñÙ³Ýdz
C09A A03
0642/6179
29.12.2006
29.12.2011
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2% (2ÙÉ)
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
ÈǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ
Lidocaine
hydrochloride
ÈǽÇÑ»ùë³É
LisiHEXAL
ÉǹáϳÛÇÝ
lidocain
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
ÉǽÇÝáåñÇÉ
lisinopril
¹»Õ³Ñ³ï»ñ
20Ù·
(30)
ÈǽÇÑ»ùë³É
LisiHEXAL
ÉǽÇÝáåñÇÉ
lisinopril
¹»Õ³Ñ³ï»ñ
5Ù·
(30)
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
ÊÇÝáÇÝ ¹»Õ³·áñÍ³Ï³Ý ¨
ùÇÙÇ³Ï³Ý ·áñͳñ³Ý øá. Èï¹
Chinoin Pharmaceutical and
Chemical Works Co.Ltd.
ê»åïá¹áÝï
Septodont
²¸
¸
¸
80
1162
ÈǽÇÑ»ùë³É
LisiHEXAL
ÉǽÇÝáåñÇÉ
lisinopril
¹»Õ³Ñ³ï»ñ
10Ù·
(30)
1163
ÈǽÇÝáåñÇÉ
Lisinopril
ÈǽÇÝáåñÇÉ
Lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
¹»Õ³Ñ³ï»ñ
10Ù·
(12, 24, 30)
10Ù·
(20)
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
´ñÇëïáÉ È³µáñ³ïáñdz Èï¹
Bristol Laboratories Ltd
1165
ÈǽÇÝáåñÇÉ
Lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
¹»Õ³Ñ³ï»ñ
20Ù·
(28)
´ñÇëïáÉ È³µáñ³ïáñdz Èï¹
Bristol Laboratories Ltd
1166
ÈǽÇÝáåñÇÉ
Lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
¹»Õ³Ñ³ï»ñ
2.5Ù·
(28)
´ñÇëïáÉ È³µáñ³ïáñdz Èï¹
Bristol Laboratories Ltd
1167
ÈǽÇÝáåñÇÉ
Lisinopril
ÉǽÇÝáåñÇÉ
lisinopril
¹»Õ³Ñ³ï»ñ
5Ù·
(28)
´ñÇëïáÉ È³µáñ³ïáñdz Èï¹
Bristol Laboratories Ltd
1168
ÈǽÇÝáïáÝ
Lisinoton
ÈÇÏáåǹ
Licopid
ÉǽÇÝáåñÇÉ
lisinopril
·ÉÛáõÏá½³ÙÇÝÇÉÙáõ
ñ-³ÙÇɹÇå»åïǹ
glucosaminilmuramyldipeptid
·ÉÛáõÏá½³ÙÇÝÇÉÙáõ
ñ-³ÙÇɹÇå»åïǹ
glucosaminilmuramyldipeptid
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ,
·»ëïá¹»Ý
ethinylestradiol,
gestodene
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ,
·»ëïá¹»Ý
ethinylestradiol,
gestodene
ÉÇáýÇÉǽ³óí³Í
ϳÃݳÃÃí³ÛÇÝ Ï»Ý¹³ÝÇ
Ù³Ýñ¿Ý»ñ
lyophilized viable lactic
acid bacteria
ÉÇÝÏáÙÇóÇÝ
lincomycin
¹»Õ³Ñ³ï»ñ
10Ù·
(28, 30)
10Ù·
(10, 20)
²Ïï³íÇë Ñ.ý.
Actavis h.f.
ä»åï»Ï ö´À
Peptek CJSC
¹»Õ³Ñ³ï»ñ
1Ù·
(10, 20)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1164
1169
1170
ÈÇÏáåǹ
Licopid
1171
ÈÇݹÇÝ»ï 20
Lindynette 20
1172
ÈÇݹÇÝ»ï 30
Lindynette 30
1173
ÈÇÝ»ùë
Linex
1174
ÈÇÝÏáÙÇóÇÝ
500Ù· Îñ»³ï
Lincomycin 500mg
Creat
1175 ÈÇÝÏáÙÇóÇÝ ÎØä
Lincomycin KMP
1176 ÈÇÝÏáó»É ùëáõù
Lincocel ointment
1177
ÈÇáïáÝ 1000
Lioton 1000
¶»ñÙ³Ýdz
C09A A03
5856
05.12.2005
05.12.2010
¸
г۳ëï³Ý
C09A A03
4686
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
Æëɳݹdz
C09A A03
1160/7155
26.02.2004
26.02.2009
13.09.2007
13.09.2012
C09A A03
1161/7156
13.09.2007
13.09.2012
¸
C09A A03
1162/7157
13.09.2007
13.09.2012
¸
C09A A03
1163/7158
13.09.2007
13.09.2012
¸
C09A A03
5720
¸
èáõë³ëï³Ý
L03A
1208/7192
07.09.2005
07.09.2010
28.09.2007
13.09.2012
ä»åï»Ï ö´À
Peptek CJSC
èáõë³ëï³Ý
L03A
1209/7193
28.09.2007
13.09.2012
¸
0.02Ù·+0.075Ù·
(21,(3x21))
¶»¹»áÝ èÇËï»ñ ö´À
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
G03C A01
L02A A03
4568
28.10.2003
28.10.2008
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.03Ù·+0.075Ù·
(21,(3x21))
¶»¹»áÝ èÇËï»ñ ö´À
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
G03C A01
L02A A03
4569
28.10.2003
28.10.2008
¸
¹»Õ³å³ïÇ×Ý»ñ
(16)
(µÉÇëï»ñÝ»ñáí ϳÙ
ßßÇÏáí)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
A07FA01
5553
10.05.2005
10.05.2010
²¸
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(100x10)
Îðº²î ɳµáñ³ïáñdz Laboratoires
CREAT
üñ³Ýëdz
J01F F02
4262
12.06.2003
12.06.2008
¸
0.25·
ÎǨٻ¹åñ»å³ñ³ï ´´À
(10, 30)
Kievmedpreparat Open JSC
3.5%,
´áñÇëáíÛ³Ý ´ä¶
15·,25· å³ñÏáõ× Ï³Ù Borisov Medical Preparations
³å³Ï» ï³ñ³
Plant RUP
1000ØØ/1·,
². ػݳñÇÝÇ Ø³Ýáõý³ÏïáõñÇÝ·
30·, 50·, 100·
ÈáçÇëïÇÏ Áݹ ë»ñíǽ
å³ñÏáõ×
êèÈ/µ³ßËáÕ ´»éÉÇÝ-ø»ÙÇ ²¶
ػݳñÇÝÇ ¶ñáõå
àõÏñ³Çݳ
J01F F02
4291
¸
´»É³éáõë
J01F F02
5013
03.07.2003
03.07.2008
13.12.2004
13.12.2009
Æï³Édz
C05BA03
0833/6301/1
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ÉÇÝÏáÙÇóÇÝ
lincomycine
ÉÇÝÏáÙÇóÇÝ
lincomycin
¹»Õ³å³ïÇ×Ý»ñ
Ñ»å³ñÇÝ
heparin
¹áݹáÕ
ùëáõù
22.03.2007
08.08.2011
¸
¸
²¸
²¸
81
1178
ÈÇå³ñï
Lipart
ëÇÙí³ëï³ïÇÝ
simvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·,
(30, 50, 100)
1179
ÈÇå³ñï
Lipart
ëÇÙí³ëï³ïÇÝ
simvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
40Ù·
(30, 50, 100)
1180
ÈÇå³ñï
Lipart
ëÇÙí³ëï³ïÇÝ
simvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·
(30, 50, 100)
1181
ÈÇå³ñï
Lipart
ëÇÙí³ëï³ïÇÝ
simvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
80Ù·
(30, 50, 100)
1182
ÈÇåáëï³ï
Lipostat
ÈÇåñ³½Ç¹ 10
Liprazid 10
åñ³í³ëï³ïÇÝ pravastatin
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
20Ù·,
(10,14,20,28)
10Ù·+12,5Ù·
(30)
¹»Õ³Ñ³ï»ñ
20Ù·+12.5Ù·
(30/3x10/)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·
(30)
1183
1184
ÈÇåñ³½Ç¹ 20
Liprazid 20
1185
ÈÇåñÇÙ³ñ
Liprimar
ÉǽÇÝáåñÇÉ,
ÑǹñáùÉáñáÃdz½Ç¹
lisinopril,
hydrochlorothiazide
ÉǽÇÝáåñÇÉÇ
¹ÇÑǹñ³ï,
ÑǹñáùÉáñáÃdz½Ç¹
lisinopril dihydrate,
hydrochlorothiazide
³ïáñí³ëï³ïÇÝ
atorvastatin
1186
ÈÇåñÇÙ³ñ
Liprimar
³ïáñí³ëï³ïÇÝ
atorvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(30)
1187
ÈÇí-52
Liv-52
ÈÇí³ñáÉ
Livarole
ÈÇïáÉǽÇÝ
Litolizin
ȨÇïñ³
Levitra
ÈáÏñ»Ý
Lokren
ÈáÙ³Ï - 20
Lomac - 20
ȨáÙ»ÏáÉ ùëáõù
Levomecol ointment
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
Ï»ïáÏáݳ½áÉ
ketoconazole
--
¹»Õ³Ñ³ï»ñ
275Ù·
(100)
0.4·
(5)
(60)
1188
1189
1190
1191
1192
1193
í³ñ¹»Ý³ýÇÉ
vardenafil
µ»ï³ùëáÉáÉ
betaxolol
ûÙ»åñ³½áÉ
omeprazole
ùÉáñ³Ùý»ÝÇÏáÉ,
Ù»ÃÇÉáõñ³óÇÉ
chloramphenicol,
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
0.65· ѳµ»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
ùëáõù
10Ù·
(1,2,4, 8,12)
20Ù·
(28)
20Ù·
(10)
(0,75·+4·)/100·,
40· å³ñÏáõ×
A. Menarini Manufacturing
Logistics and Services SRL/
Distributor Berlin-Chemie AG
(Menarini Group)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.Ç Ñ³Ù³ñ)
Salutas Pharma GmbH for Lek
d.d.
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.Ç Ñ³Ù³ñ)
Salutas Pharma GmbH for Lek
d.d.
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.Ç Ñ³Ù³ñ)
Salutas Pharma GmbH for Lek
d.d.
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.Ç Ñ³Ù³ñ)
Salutas Pharma GmbH for Lek
d.d.
´ñÇëïáÉ-سۻñë êùíǵ
Bristol-Myers Squibb
´áñßã³·áíÛ³Ý ø¸¶
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
¶á¹»Ï» ¶ÙµÐ (öý³Û½»ñÇ
ѳٳñ)
Godecke GmbH (for Pfizer)
¶á¹»Ï» ¶ÙµÐ, (¹»Õ³Ñ³ï»ñÇ
³ñï³¹ñáõÃÛáõÝÁª öý³Û½»ñ
Æéɳݹdz ü³ñÙ³ëÛáõÃÇù³Éë)
Godecke GmbH, Germany,
bulk tablets manufacturer
Pfizer Ireland Pharmaceuticals
ÐÇÙ³É³Û ¸ñ³· øá.
Himalaya Drug Co
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
üÇïáëáñµ êäÀ
Phytosorb Ltd.
´³Û»ñ лÉÃù»ñ ²¶
Bayer Healthcare AG
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Sanofi Winthrop Industrie
êÇåɳ Èï¹.
Cipla Ltd.
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
¶»ñÙ³Ýdz
C10A A1
1391/7354
08.11.2007
05.11.2012
¸
¶»ñÙ³Ýdz
C10A A1
1393/7356
08.11.2007
05.11.2012
¸
¶»ñÙ³Ýdz
C10A A1
1392/7355
08.11.2007
05.11.2012
¸
¶»ñÙ³Ýdz
C10A A1
1394/7357
08.11.2007
05.11.2012
¸
üñ³Ýëdz
B04A B03
4477
¸
àõÏñ³Çݳ
C09B A03
0546/6504
22.07.2003
22.07.2008
17.11.2006
17.11.2011
àõÏñ³Çݳ
C09B A03
0095/6104
09.06.2006
09.06.2011
¸
¶»ñÙ³Ýdz
C10A A05
5648
09.02.2006
09.02.2011
¸
¶»ñÙ³Ýdz
C10A A05
5611
22.06.2005
22.06.2010
¸
Ðݹϳëï³Ý
---
1175/7189
¸
èáõë³ëï³Ý
5531
èáõë³ëï³Ý
C01A F11,
J02A B02
βêÐ
0511/6559
¶»ñÙ³Ýdz
G04B E09
0532/4833/2
üñ³Ýëdz
C07A B05
4491
Ðݹϳëï³Ý
A02B C01
5599
èáõë³ëï³Ý
D06C
1297/7265
13.09.2007
13.09.2012
12.08.2005
12.08.2010
07.11.2006
07.11.2011
10.11.2006
30.04.2009
29.09.2003
29.09.2008
24.08.2005
24.08.2010
15.10.2007
12.10.2012
¸
¸
²¸
¸
¸
¸
²¸
82
1194
ȨáÙ»ÏáÉ ùëáõù
Laevomecol
ointment
1195
ȨáÙ»ÏáÉ ùëáõù
Levomecol ointment
1196
ÈáÙÇɳÝ
Lomilan
1197
ÈáÙÇɳÝ
Lomilan
1198
ȨáÙÇó»ïÇÝ
Levomicetin
1199 ȨáÙÇó»ïÇÝ -ÎØä
Laevomycetin-KMP
1200
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
methyluracil
ùÉáñ³Ùý»ÝÇÏáÉ,
Ù»ÃÇÉáõñ³óÇÉ
chloramphenicol,
methyluracil
ùÉáñ³Ùý»ÝÇÏáÉ,
Ù»ÃÇÉáõñ³óÇÉ
chloramphenicol,
methyluracil
Éáñ³ï³¹ÇÝ
loratadine
Éáñ³ï³¹ÇÝ
loratadine
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
ȨáÙÇó»ïÇݸ³ñÝÇó³
LevomicetinDarnitsa
ȨáÙÇó»ïÇݸ³ñÝÇó³
LevomicetinDarnitsa
ȨáÙÇó»ïÇÝ-ÎØä
Laevomycetin-KMP
ȨáÙÇó»ïÇÝ-ÎØä
Laevomycetin-KMP
ȨáÙÇó»ïÇÝ-ÎØä
Laevomycetin-KMP
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
Èáßï³Ï
Loshtak
Èá廹ÇáõÙ
Lopedium
Éáßï³ÏÇ Ñ³ÝáõÏ
Bryonia alba extract
Éáå»ñ³ÙǹÇ
ÑǹñáùÉáñǹ
loperamide
hydrochloride
Éáå»ñ³Ùǹ
loperamide
Éáå»ñ³Ùǹ
loperamide
Èáå»ñ³Ùǹ
Loperamid
Èáå»ñ³Ùǹ
Loperamide
Èáå»ñ³Ùǹ
Loperamide
Èáå»ñ³Ùǹ - ÎØä
Loperamid - KMP
Èáå»ñ³Ùǹ¼¹áñáíÛ»
LoperamideZdorovye
Èáñ³½»å³Ù
Lorazepam
ùëáõù
(7.5Ù·+40Ù·)/1·,
40·,100· å³ñÏáõ×
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
èáõë³ëï³Ý
D06A X02
D10A F03
J01B A01
5073
11.11.2004
11.11.2009
²¸
ùëáõù
(0.75·+4·)/100·,
40· å³ñÏáõ×
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´»É³éáõë
D06A X02
D10A F03
5012
13.12.2004
13.12.2009
²¸
¹»Õ³Ñ³ï»ñ
10Ù·
(10)
5Ù·/5ÙÉ,
120ÙÉ ßßÇÏ
0.25%
5ÙÉ, 10ÙÉ ßßÇÏ
1·,
ëñí³Ï (40)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
ü³ñÙ³î»ù ö´À
PharmaTech CJSC
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
êÉáí»Ýdz
R06A X13
1048/7015
²¸
êÉáí»Ýdz
R06A X13
0912/6928
г۳ëï³Ý
S01AA01
0995/6623
àõÏñ³Çݳ
J01B A01
0953/6917
02.07.2007
02.07.2012
26,04.2007
26.04.2012
30.05.2007
30.05.2012
03.05.2007
03.05.2012
500Ù·
(20/2x10/)
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
Closed JSC
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
Closed JSC
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
àõÏñ³Çݳ
J01B A01
1469/7374
20.12.2007
20.12.2012
¸
àõÏñ³Çݳ
J01B A01
1468/7373
20.12.2007
20.12.2012
¸
àõÏñ³Çݳ
J01B A01
0399/6420
¸
àõÏñ³Çݳ
J01B A01
0400/6421
àõÏñ³Çݳ
J01B A01
0401/6422
19.09.2006
19.09.2011
19.09.2006
19.09.2011
19.09.2006
19.09.2011
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
¶ñÇݹ»ùë ´À
Grindex JSC
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
ú½áÝ êäÀ
Ozon Ltd.
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V.CJ-S Co.
г۳ëï³Ý
A13
0332/6364
²¸
¶»ñÙ³Ýdz
A07D A03
5133
11.08.2006
11.08.2011
15.10.2004
15.10.2009
ȳïídz
A07D A03
0730/6781
²¸
´»É³éáõë
A07D A03
5007
15.02.2007
15.02.2012
13.12.2004
13.12.2009
èáõë³ëï³Ý
A07D A03
5785
²¸
àõÏñ³Çݳ
A07D A03
4031
àõÏñ³Çݳ
A07DA03
1235/7172
08.12.2005
08.12.2010
12.02.2003
12.02.2008
15.11.2007
13.09.2012
г۳ëï³Ý
N05B A06
4432
19.09.2003
19.09.2008
¸/Ð
¹»Õ³Ï³ËáõÛÃ
³ÏݳϳÃÇÉÝ»ñ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
¹»Õ³Ñ³ï»ñ
250Ù·
(20/2x10/)
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
¹»Õ³Ñ³ï»ñ
0.25·
(10)
0.5·
(10)
0.5·,
ëñí³Ï (40)
¹»Õ³Ñ³ï»ñ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
Éáå»ñ³Ùǹ
loperamide
Éáå»ñ³Ùǹ
loperamid
Éáå»ñ³Ùǹ
loperamide
¹»Õ³Ñ³ï»ñ
Éáñ³½»å³Ù
lorazepam
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
7Ù·
(48/2x24/)
2Ù·
(10,20,30,50)
2Ù·
(10)
0.002·
(10,20,30,50)
2Ù·
(10,20/2x10/)
0.002·
(10,20)
2Ù·
(10, 20)
1Ù·,
(10,24,48)
²¸
¸
¸
¸
¸
²¸
²¸
²¸
²¸
83
1213
Èáñ³Ýë 2
Lorans 2
1214
Èáñ³ï³¹ÇÝ
Loratadine
1215 Èáñ³ï³¹ÇÝ-¼¹áñáíÛ»
Loratadin-Zdorovye
1216
1217
1218
1219
Èáñ³ï³¹ÇÝлÙáý³ñÙ
Loratadin-Hemofarm
Èáñ³ï³¹ÇÝлÙáý³ñÙ
Loratadin-Hemofarm
Èáñ³ï³¹ÇÝлÙáý³ñÙ
Loratadin-Hemofarm
Èáñǽ³Ý
Lorizan
ÈáñÇݹ»Ý ²
Lorinden A
Éáñ³½»å³Ù
lorazepam
Éáñ³ï³¹ÇÝ
loratadine
Éáñ³ï³¹ÇÝ
loratadine
¹»Õ³Ñ³ï»ñ
10Ù·
(10)
Ø»¹áù»ÙÇ Èï¹
Medochemie Ltd
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ÎÇåñáë
N05BA06
7408/6683
г۳ëï³Ý
R06A X13
4198
àõÏñ³Çݳ
R06AX13
1349/7310
Éáñ³ï³¹ÇÝ
loratadine
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
ê»ñµÇ³ ¨
â»éÝá·áñdz
R06A X13
Éáñ³ï³¹ÇÝ
loratadine
¹»Õ³Ñ³ï»ñ
10Ù·
(10)
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
Éáñ³ï³¹ÇÝ
loratadine
ûß³ñ³Ï
5Ù·/5ÙÉ,
120ÙÉ ßßÇÏ
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
¹»Õ³Ñ³ï»ñ
0.01·
(10)
(0.2Ù·+30Ù·)/1·,
15· å³ñÏáõ×
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A.Pharmaceutical
Works
ùëáõù
(0.2Ù·+30Ù·)/1·,
15· å³ñÏáõ×
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
3·/15ÙÉ,
15ÙÉ ³ÙåáõÉÝ»ñ
(4,20)
1200Ù·
(20)
1·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
800Ù·
(30)
15Ù·
(10)
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
1221
ÈáñÇݹ»Ý ò
Lorinden C
1222
Èáõó»ï³Ù
Lucetam
Éáñ³ï³¹ÇÝ
loratadine
ýÉáõٻﳽáÝÇ
åÇí³É³ï,
ë³ÉÇóÇɳÃÃáõ
flumetasone pivalate,
salicylic acid
ýÉáõٻﳽáÝÇ
åÇí³É³ï,
Ûá¹ùÉáñûùëÇùÇÝáÉÇ
Ý (ùÉÇáùíÇÝáÉ)
flumetasone pivalate,
iodchloroxichinolin
(clioquinol)
åÇñ³ó»ï³Ù
piracetam
1223
Èáõó»ï³Ù
Lucetam
Èáõó»ï³Ù
Lucetam
åÇñ³ó»ï³Ù
piracetam
åÇñ³ó»ï³Ù
piracetam
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
Èáõó»ï³Ù
Lucetam
ÈûùëǹáÉ
Loxidol
åÇñ³ó»ï³Ù
piracetam
Ù»ÉûùëÇϳÙ
meloxicam
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÊÇïá½³Ý
Chitozan
Êáɳ·áÉ
Cholagol
-
ѳµ»ñ
ùñùáõÙÇ ³ñÙ³ïÝ»ñÇ
Ý»ñϳÝÛáõÃ, ¹ÅÝÇÏÇ
¿Ùá¹ÇÝ,
Ù³·Ý»½ÇáõÙÇ
ë³ÉÇóÇɳï,
»Ã»ñ³ÛáõÕ»ñ
curcumae radicis
pigmenta,
ÉáõÍáõÛÃ
1220
1224
1225
1226
1227
1228
ùëáõù
2Ù·
(50)
10Ù·
(10)
0,01·
(10, 20/2x10/)
500Ù·
(30)
10ÙÉ ßßÇÏ
19.11.2007
13.09.2012
10.02.2003
10.02.2008
05.11.2007
05.11.2012
¸/Ð
0930/6599
26,04.2007
26.04.2012
²¸
R06A X13
0538/6430
10.11.2006
10.11.2011
²¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
R06A X13
0929/6600
26,04.2007
26.04.2012
²¸
àõÏñ³Çݳ
R06A X13
0112/6182
²¸
Ȼѳëï³Ý
D07B B01
6080
15.06.2006
15.06.2011
24.03.2006
24.03.2011
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
Ȼѳëï³Ý
D07B B01
5979
14.02.2006
14.02.2011
¸
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
ÐáõÝ·³ñdz
N06B X03
4527
11.11.2003
11.11.2008
¸
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
ÐáõÝ·³ñdz
N06B X03
4528
¸
ÐáõÝ·³ñdz
N06B X03
4526
11.11.2003
11.11.2008
11.11.2003
11.11.2008
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
ÚáõÝÇý³ñÙ³ (àõáñɹ
Ø»¹ÇëÇÝ (²Ý·ÉÇ³Ç Ñ³Ù³ñ)
Unipharma (for World
Medicine, England)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
¶³É»Ý³ ³.ë.
Galena a.s.
ÐáõÝ·³ñdz
N06B X03
4529
¸
º·Çåïáë
M01AC06
1049/7074
11.11.2003
11.11.2008
02.07.2007
02.07.2012
г۳ëï³Ý
βêÐ
4154
²¸
â»Ëdz
_
4159
06.03.2003
06.03.2008
26.02.2003
26.02.2008
²¸
²¸
¸
¸
¸
²¸
84
1229
ÊáÉÇë³É
Cholisal
1230
ÊáÉáõ¹»ùë³Ý
Choludexan
1231
ÊáýÇïáÉ
Chophytol
1232 ÌÍÙµÇ å³ñ½ ùëáõù
Sulfur ointment
simple
1233 ÌÍÙµÇ å³ñ½ ùëáõù
33%
Sulfur ointment
simple 33%
1234 γɳÝËá»Ç ÑÛáõÃ
Succus Kalanchoes
1235
γɻïñ³
Kaletra
1236
γɻïñ³
Kaletra
1237
1238
1239
1240
1241
1242
frangulaemodinum,
magnesii salicylas,
etherolea mixture
ËáÉÇÝÇ ë³ÉÇóÇɳï,
ó»ï³ÉÏáÝÇáõÙÇ
ùÉáñǹ
choline salycilate,
cetalkonium chloride
áõñëá¹»ûùëÇËáɳÃÃá
õ
ursodeoxycholic acid
¹áݹáÕ
(87.1Ù·+0.1Ù·)/·
10· å³ñÏáõ×
¹»Õ³å³ïÇ×Ý»ñ
300Ù·
(20)
ϳÝϳéÇ Ñ³ÝáõÏ
extractum Cynarae
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÍÍáõÙµ
sulfur
ùëáõù
ÍÍáõÙµ
sulfur
ùëáõù
ϳɳÝËá»Ç óñÙ
ÁÝÓÛáõÕÝ»ñÇ
Ù½í³ÍùÇ ù³ÙáõÏ
filtrate of pressed fresh
sprouts of Kalanchoe
ÉáåÇݳíÇñ, éÇïáݳíÇñ
lopinavir, ritonavir
ÑÛáõÃ
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ
Ú»Éý³ ê.². ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
êƶز ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇë (àõáñɹ Ø»¹ÇëÇÝ
(²Ý·Édz)-Ç Ñ³Ù³ñ
SIGMA Pharmaceutical
Industries (for World Medicine,
England)
200Ù·(0,2·)
èá½³ ýÇïáý³ñÙ³ ɳµáñ³ïáñdz
(60/6x10/,
Laboratoires Rosa60/5x12/, 60,180)
Phytopharma
33%,
´áñÇëáíÛ³Ý ´ä¶
15·, 25· å³ñÏáõ×
Borisov Medical Preparations
ϳ٠ï³ñ³
Plant RUP
33%,
¾ëÏáõɳå êäÀ Esculap Ltd.
25·, 40·, 60· ï³ñ³
10ÙÉ,15ÙÉ,25ÙÉ,
ÐÐ ¶²² Ýáõñµ ûñ·³Ý³Ï³Ý
30ÙÉ,50ÙÉ,100ÙÉ ùÇÙdzÛÇ ÇÝëïÇïáõï /ÜúøÆ/
ßßÇÏ
Institute of Fine Organic
Chemistry NAS RA /IFOC/
133.3Ù·+33.3Ù·
(2x90)
²´´úîî ȳµáñ³ïáñdz
ABBOTT Laboratories
ÉáåÇݳíÇñ, éÇïáݳíÇñ ÉáõÍáõÛà ËÙ»Éáõ (80Ù·+20Ù·)/ÙÉ,
²´´úîî ȳµáñ³ïáñdz
lopinavir, ritonavir
60ÙÉ ßßÇÏ
ABBOTT Laboratories
(5)
γÉÇÙÇÝ 60 Ü
åÇñǹáëïÇ·ÙÇÝÇ
¹»Õ³Ñ³ï»ñ
60Ù·,
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
Kalymin 60 N
µñáÙǹ
(100 ëñí³ÏáõÙ)
AWD Pharma GmbH & Co. KG
pyridostigmine bromide
γÉÇáõÙÇ ùÉáñǹ
ϳÉÇáõÙÇ ùÉáñǹ
ÉáõÍáõÛÃ
4%,
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Potassium chloride
potassium chloride
ϳÃÇɳݻñ³ñÏ-Ù³Ý
200ÙÉ ßßÇÏ,
Ó»éݳñÏáõÃÛáõÝ ö´À
100ÙÉ, 200ÙÉ
Liqvor Pharmaceuticals CJSC
åɳëïÇÏ ÷³Ã»Ã
γÉÇáõÙÇ ûñáï³ï
ϳÉÇáõÙÇ ûñáï³ï
¹»Õ³Ñ³ï»ñ
0.5·
²ÏñÇËÇÝ ´´À
Kalii orotat
potassium orotat
(10)
Akrikhin Open JSC
γÉÇáõÙ-ÝáñÙÇÝ
ϳÉÇáõÙÇ ùÉáñǹ
¹»Õ³Ñ³ï»ñ
1000Ù·
²Û-êÇ-¾Ý ÐáõÝ·³ñdz øáÙå³ÝÇ
Kalium-Normin
potassium chloride
(30)
ÈÇÙÇﻹ
ICN Hungary Company Limited
γÉÇåëáÉ
Ï»ï³ÙÇÝ
ÉáõÍáõÛÃ
500Ù·/10ÙÉ,
¶»¹»áÝ èÇËï»ñ Èï¹.
Calypsol
ketamine
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï (5)
Gedeon Richter Ltd.
γÉó»ÙÇÝ
ϳÉóÇáõÙ,íÇï³ÙÇÝ D3,
¹»Õ³Ñ³ï»ñ
(250Ù·+50ØØ+
ê³·Ù»É ÆÝÏ.
Calcemin
óÇÝÏ, ÏáõåñáõÙ,
óճÝóå³ï
2Ù·+ 0.5Ù·+0.5Ù·+
Sagmel Inc.
ٳݷ³Ý, µáñ
50ÙÏ·)
calcium, vitamin D3,
(30,60,120)
zinc, copper,
manganese, boron
Ȼѳëï³Ý
A01A D11
0474/6460
16.10.2006
16.10.2011
²¸
º·Çåïáë
A05A A02
0081/6189
07.06.2006
07.06.2011
¸
üñ³Ýëdz
A05AX
1027/7048
21.06.2007
21.06.2012
²¸
´»É³éáõë
D10A B02
5126
13.12.2004
13.12.2009
²¸
г۳ëï³Ý
D10A B02
4880
17.08.2004
17.08.2009
²¸
г۳ëï³Ý
-
4996
14.12.2004
14.12.2009
²¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
¶»ñÙ³Ýdz
-
0056/5737
25.05.2006
25.05.2011
¸
-
0057/5738
25.05.2006
25.05.2011
¸
N07A A02
0101/6145
09.06.2006
09.06.2011
¸
г۳ëï³Ý
B05X A01
6017
03.03.2006
03.03.2011
¸
èáõë³ëï³Ý
-
5071
¸
ÐáõÝ·³ñdz
A12B A01
B05X A01
5134
11.11.2004
11.11.2009
24.11.2004
24.11.2009
ÐáõÝ·³ñdz
N01A X03
5232
¸/Ð
²ØÜ
A11
5714
30.05.2005
30.05.2010
08.08.2005
08.08.2010
¸
²¸
85
1243
1244
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
γÉó»ÙÇÝ-³¹í³Ýë ϳÉóÇáõÙ, D3 íÇï³ÙÇÝ,
¹»Õ³Ñ³ï»ñ
500Ù·+200ØØ+40
ê³·Ù»É ÆÝÏ.
Calcemin-Advance
Ù³·Ý»½ÇáõÙ, óÇÝÏ,
óճÝóå³ï
Ù·+
Sagmel Inc.
åÕÇÝÓ, ٳݷ³Ý, µáñ
7.5Ù·+1Ù·+1.8Ù·+
calcium, vitamin D3,
250ÙÏ·
magnesium,
(30,60,120)
zinc,copper,
manganese, boron
γÉóÇÝáí³
ϳÉóÇáõÙ, ýáëýáñ,
¹»Õ³Ñ³ï»ñ
(100Ù·+77Ù·+1000
Îèβ ¹.¹. Üáíá Ù»ëïá
Kalcinova
íÇï³ÙÇÝÝ»ñ A, D3, C,
ØØ+100ØØ+15Ù·+
KRKA d.d., Novo mesto
B6
0.4Ù·) (27)
calcium, phosphore, A,
D3, C, B6 vitamins
γÉóÇÝáí³ ûëï»á
ϳÉóÇáõÙ, C,B6,K,D2
ѳµ»ñ ͳٻÉáõ
40Ù·+30Ù·+1Ù·+
Îèβ ¹.¹.,Üáíá Ù»ëïá
Kalcinova Osteo
íÇï³ÙÇÝÝ»ñ
32.5ÙÏ·+2.5ÙÏ·
KRKA d.d. Novo mesto
calcium, vitamins
(30)
C,B6,K,D2
γÉóÇáõÙ D3
ϳÉóÇáõÙÇ Ï³ñµáݳï,
¹»Õ³Ñ³ï»ñ
(1250Ù·/500Ù·
ÜÇÏáÙ»¹ ý³ñÙ³ ¾Û-êÇ
ÜÇÏáÙ»¹ ýáñï»
D3 íÇï³ÙÇÝ
ͳٻÉáõ,
ϳÉóÇáõÙ/+
Nycomed Pharma AC
Calcium D3
calcii carbonate,
ÏÇïñáÝÇ Ñ³Ùáí
400ØØ/10ÙÏ·/)
Nycomed Forte
vitamin D3
(30, 60, 120)
γÉóÇáõÙ D3
ϳÉóÇáõÙÇ Ï³ñµáݳï,
¹»Õ³Ñ³ï»ñ
(1250Ù·/500Ù·
ÜÇÏáÙ»¹ ü³ñÙ³ ¾Û-êÇ
ÜÇÏáÙ»¹
D3 íÇï³ÙÇÝ
ͳٻÉáõ, ݳñÝçÇ
ϳÉóÇáõÙ/+
Nycomed Pharma AC
CalciumD3 Nycomed
calcii carbonate,
ѳÙáí
200ØØ)
vitamine D3
(20,50,100)
γÉóÇáõÙ ¸3 ѳµ»ñ
(50, 100)
ìÇï³Ù³ùë-º êäÀ
ìÇï³Ù³ùë-º
Vitamax-E Ltd.
Calcium D3-VitamaxE
γÉóÇáõÙÇ
ϳÉóÇáõÙÇ ·ÉÛáõÏáݳï
ÉáõÍáõÛÃ
10%(10ÙÉ),
γÉó»Ïë ´À
·ÉÛáõÏáݳï
calcium gluconate
Ý»ñ³ñÏÙ³Ý
³ÙåáõÉÝ»ñ (10)
Kalceks AS
Calcium gluconate
γÉóÇáõÙÇ
ϳÉóÇáõÙÇ ·ÉÛáõÏáݳï
ÉáõÍáõÛÃ
100Ù·/ÙÉ (10ÙÉ),
ü³ñÙ³Ï ´´À
·ÉÛáõÏáݳï
calcium gluconate
Ý»ñ³ñÏÙ³Ý
10ÙÉ ³ÙåáõÉÝ»ñ
FarmakOpen JSC
ϳÛáõݳóí³Í
(5,10)
Calcium gluconate
stabilisate
γÉóÇáõÙÇ
ϳÉóÇáõÙÇ ·ÉÛáõÏáݳï
ÉáõÍáõÛÃ
100Ù·/ÙÉ (5ÙÉ),
ü³ñÙ³Ï ´´À
·ÉÛáõÏáݳï
calcium gluconate
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
Farmak Open JSC
ϳÛáõݳóí³Í
(5,10)
Calcium gluconate
stabilisate
γÉóÇáõÙÇ
ϳÉóÇáõÙÇ ·ÉáõÏáݳï
ÉáõÍáõÛÃ
10% (5ÙÉ),
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
·ÉáõÏáݳï-¸³ñÝÇó³
calcium gluconate
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
ö´À
Calcium gluconate(10)
Darnitsa Pharmaceutical Firm
Darnitsa
Closed JSC
γÉóÇáõÙÇ
ϳÉóÇáõÙÇ ·ÉáõÏáݳï
ÉáõÍáõÛÃ
10% (10ÙÉ),
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
·ÉáõÏáݳï-¸³ñÝÇó³
calcium gluconate
Ý»ñ³ñÏÙ³Ý
10ÙÉ ³ÙåáõÉÝ»ñ
ö´À
Calcium gluconate(10)
Darnitsa Pharmaceutical Firm
Darnitsa
Closed JSC
γÉóÇáõÙÇ ùÉáñǹ ϳÉóÇáõÙÇ ùÉáñǹ
ÉáõÍáõÛÃ
10% (10ÙÉ),
¶³ÉÇãý³ñÙ ´À
Calcium chloride
calcium chloride
Ý»ñ³ñÏÙ³Ý
10ÙÉ ³ÙåáõÉÝ»ñ
Galichpharm JSC
(10)
γÉóÇáõÙÇ ùÉáñǹ ϳÉóÇáõÙÇ ùÉáñǹ
ÉáõÍáõÛÃ
10% (5ÙÉ)
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
Calcium chloride
calcium chloride
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
ýÇñÙ³ ´´À
(10)
Yerevan Chemical-
²ØÜ
-
5628
27.07.2005
27.07.2010
²¸
êÉáí»Ýdz
A11A A03
1007/6934
04.06.2007
04.06.2012
²¸
êÉáí»Ýdz
βêÐ
6049
31.03.2006
31.03.2011
²¸
Üáñí»·Ç³
A12AX
0508/6552
07.11.2006
07.11.2011
²¸
Üáñí»·Ç³
A02A, A11C
0471\6429
11.10.2006
11.10.2011
²¸
г۳ëï³Ý
βêÐ5
0735/6780
15.02.2007
15.02.2012
²¸
ȳïídz
A12A A03
4038
17.02.2003
17.02.2008
¸
àõÏñ³Çݳ
A12A A03
1463/7396
20.12.2007
20.12.2012
¸
àõÏñ³Çݳ
A12A A03
1458/7395
20.12.2007
20.12.2012
¸
àõÏñ³Çݳ
A12AA03
1267/7235
30.10.2007
12.10.2012
¸
àõÏñ³Çݳ
A12AA03
1268/7236
30.10.2007
12.10.2012
¸
àõÏñ³Çݳ
B05X A07
1119/7020
01.10.2007
01.10.2012
¸
г۳ëï³Ý
B05X A07
0611/6597
18.12.2006
18.12.2011
¸
86
1256 γÉóÇáõÙÇ ùÉáñǹ
Calcium chloride
ϳÉóÇáõÙÇ ùÉáñǹ
calcium chloride
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1257 γÉóÇáõÙÇ ùÉáñǹ
Calcium chloride
1258 γÉóÇáõÙÇ ùÉáñǹ
Calcium chloride
1259 γÉóÇáõÙÇ ùÉáñǹ¸³ñÝÇó³
Calcium chlorideDarnitsa
1260 γÉóÇáõÙÇ ùÉáñǹ¸³ñÝÇó³
Calcium chlorideDarnitsa
1261
γÙÇñ»Ý
Kamiren
1262
γÙÇñ»Ý
Kamiren
1263
γݳÙÇóÇÝ
Kanamycin
ϳÉóÇáõÙÇ ùÉáñǹ
calcium chloride
ϳÉóÇáõÙÇ ùÉáñǹ
calcium chloride
ϳÉóÇáõÙÇ ùÉáñǹ
calcium chloride
ÉáõÍáõÛÃ
ËÙ»Éáõ
ÉáõÍáõÛÃ
ËÙ»Éáõ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ϳÉóÇáõÙÇ ùÉáñǹ
calcium chloride
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
¹ûùë³½á½ÇÝ
doxazosin
¹ûùë³½á½ÇÝ
doxazosin
ϳݳÙÇóÇÝ
kanamycin
¹»Õ³Ñ³ï»ñ
1Ù·
(20,30)
4Ù·
(20,30)
1· (10ÙÉ),
ëñí³Ï (1, 50)
¹»Õ³Ñ³ï»ñ
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
³Ïݳùëáõù
1264
γݳÙÇóÇÝ äúê
Kanamycin-POS
ϳݳÙÇóÇÝÇ ëáõÉý³ï
kanamycin sulphate
1265
γݳÙÇóÇÝ äúê
Kanamycin-POS
ϳݳÙÇóÇÝÇ ëáõÉý³ï
kanamycin sulphate
³ÏݳϳÃÇÉÝ»ñ
1266
γݳÙÇóÇÝ-ÎØä
Kanamycin-KMP
βܸºðØ-´¶
Üð´²øêàôø
CANDERM-BG
CREAM
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
Ýñµ³ùëáõù
γݹÇëï³Ý
Candistan
γݹÇëï³Ý
Candistan
ϳݳÙÇóÇÝ
kanamycin
ÏÉáïñÇÙ³½áÉ,
µ»ÏÉáٻó½áÝÇ
¹ÇåñáåÇáݳï,
·»Ýï³ÙÇóÇÝ
clotrimazole,
beclomethasone
dipropionate,
gentamicin
ÏÉáïñÇÙ³½áÉ
clotrimazole
ÏÉáïñÇÙ³½áÉ
clotrimazole
1270
γå³ëï³ï
Capastat
ϳåñ»áÙÇóÇÝ
capreomycin
1271
γåá½Ç¹
Capozide
ϳåïáåñÇÉ,
ÑǹñáùÉáñáÃdz½Ç¹
captopril,
hydrochlorothiazide
1267
1268
1269
¹»Õ³Ñ³ï»ñ
Ñ»ßïáó³ÛÇÝ
Ýñµ³ùëáõù
Ñ»ßïáó³ÛÇÝ
10% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
10%,
100ÙÉ ßßÇÏ
5%,
100ÙÉ ßßÇÏ
10% (10ÙÉ),
10ÙÉ ³ÙåáõÉÝ»ñ
(10)
Pharmaceutical Firm Open J/S
Company
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
àõÏñ³Çݳ
B05X A07
1118/7019
01.10.2007
01.10.2012
¸
г۳ëï³Ý
A12A A07
0215/6129
²¸
г۳ëï³Ý
A12A A07
0216/6128
àõÏñ³Çݳ
B05XA07
1266/7234
26.07.2006
26.07.2011
26.07.2006
26.07.2011
30.10.2007
12.10.2012
àõÏñ³Çݳ
B05XA07
1265/7233
30.10.2007
12.10.2012
¸
êÉáí»Ýdz
C02C A04
3943
¸
êÉáí»Ýdz
C02C A04
3944
èáõë³ëï³Ý
J01GB04
1402/7366
20.11.2003
20.11.2008
20.11.2003
20.11.2008
19.11.2007
05.11.2012
¶»ñÙ³Ýdz
S01AA24
0885/6911
06.04.2007
06.04.2012
¸
¶»ñÙ³Ýdz
S01AA24
0886/6912
06.04.2007
06.04.2012
¸
àõÏñ³Çݳ
J01G B04
5627
¸
Ðݹϳëï³Ý
D01A C01
5940
02.08.2005
02.08.2010
17.02.2006
17.02.2011
²ñ³µ ¸ñ³· øáÙå³ÝÇ
The Arab Drug Company
²ñ³µ ¸ñ³· øáÙå³ÝÇ
The Arab Drug Company
º·Çåïáë
D01A C01
G01A F02
D01A C01
G01A F02
4721
19.10.2004
19.10.2009
19.10.2004
19.10.2009
¸
¾ÉÇ ÈÇÉÇ
Eli Lilly
¶»ñÙ³Ýdz
G04A B30
0982/6971
22.05.2007
22.05.2012
¸
´ñÇëïáÉ Ø³Û»ñë êùíǵµ
Bristol-Myers Squibb
²íëïñ³Édz
C09B A01
4318
14.04.2003
14.04.2008
¸
¾ëÏáõɳå êäÀ
Esculap Ltd
¾ëÏáõɳå êäÀ
Esculap Ltd
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
Closed JSC
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
Closed JSC
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÇÝû½ êäÀ
Sintez Co.Ltd
6.2Ù·/·,
2.5· å³ñÏáõ×
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ øá. ζ
Ursapharm Arzneimittel GmbH
& Co. KG
6.2Ù·/·,
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
5ÙÉ åɳëïÇÏ» ßßÇÏ
¶ÙµÐ ¨ øá. ζ
Ursapharm Arzneimittel GmbH
& Co. KG
1·,
ÎǨٻ¹åñ»å³ñ³ï ´´À
ëñí³Ï (40)
Kievmedpreparat Open JSC
0.1%+0.025%+
ì³Ûß³ÉÇ ü³ñÙ³ëÛáõÃÇù³Éë
0.1%,
Vaishali Pharmaceuticals
5·,10· å³ñÏáõ×
100Ù·
(6)
2%,
20· å³ñÏáõ× ¨
3 Ý»ñ¹ñáõÏ
1·,
ëñí³Ï (1)
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
50Ù·+25Ù· (10, 15,
20, 30, 40, 45)
º·Çåïáë
4722
²¸
¸
¸
¸
¸
¸
87
1272
γåáï»Ý
Capoten
γåáïñÇÉ
Capotril
γåáïñÇÉ
Capotril
ϳåïáåñÇÉ
captopril
ϳåïáåñÇÉ
captopril
ϳåïáåñÇÉ
captopril
1275
γåëÇϳÙ
Capsicam
1276
γåëÇåɳëï ºØβ
Capsiplast EMKA
¹ÇÙ»ÃÇÉëáõÉýûùëǹ,
ù³÷áõñ, µ¨»ÏݳÛáõÕ,
µ»Ý½ÇÉÝÇÏáïÇݳï,
í³ÝÇÉÇÉÝáݳÙǹ
dimethylsulfoxide,
camphor, turpentine oil,
benzylnicotinat,
vanillylnonamide
ßÇϳï³ÏÇ ¨ ï³ù¹»ÕÇ
ѳÝáõÏÝ»ñ
extract Belladonne,
extract Capsici
1277
γåïáåñÇÉ
Kaptopril
γåïáåñÇÉ
Captopril
ϳåïáåñÇÉ
captopril
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
γåïáåñÇÉ
Kaptopril
γåïáåñÇÉ
Captopril
ϳåïáåñÇÉ
captopril
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
1281
γåïáåñÇÉ
Captopril
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
1282
γåïáåñÇÉ
Captopril
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
1283
γåïáåñÇÉ
Captopril
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
1284
γåïáåñÇÉ
Captopril
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
1273
1274
1278
1279
1280
1285 γåïáåñÇÉ- ü»ñ»ÛÝ
Captopril-Ferein
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ùëáõù
ëå»Õ³ÝÇ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
25Ù·
(30)
25Ù·
(24, 30/10x3/)
50Ù·
(24/12x2/,
30/10x3/)
(50Ù·+30Ù·+
30Ù·+
20Ù·+2Ù·)/1·,
30·, 50· å³ñÏáõ×
´ñÇëïáÉ-سۻñë êùíǵ
Bristol-Myers Squibb
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V.CJ-S Co.
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V.CJ-S Co.
²íëïñ³Édz
C09A A01
4194
г۳ëï³Ý
C09A A01
5986
г۳ëï³Ý
C09A A01
5987
î³ÉÇÝÇ ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
´À
Tallinn Pharmaceutical Works
A.S.
¾ëïáÝdz
M02A
´áõÉÕ³ñdz
(1.36·/Ù2 -1.49·/Ù2)
Ø»¹Çϳ ²¸
+ (11.27·/Ù2 Medica AD
12.33·/Ù2)
6ëÙx10ëÙ,10ëÙx
18ëÙ,
12ëÙx12,5ëÙ,
12ëÙx25ëÙ
(1,3,5) ¨
15ëÙx12.5ëÙ,
15ëÙx25ëÙ,
15ëÙx50ëÙ (10,
25, 50)
50Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(20/2x10/)
KRKA d.d. Novo mesto
25Ù·
꺸ÆÎà ü³ñÙ³ëÛáõÃÇù³É øá.
(20)
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²Ý·Édz)
SEDICO (for World Medicine,
England)
12.5Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(20/2x10/)
KRKA d.d., Novo mesto
50Ù·
꺸ÆÎà ü³ñÙ³ëÛáõÃÇù³É øá.
(20)
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²Ý·Édz)
SEDICO Pharmaceutical Co.,
(for World Medicine, England)
12.5Ù·
Ú»Éý³ ê.².¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
(30)
Jelfa S.A.Pharmaceutical
Works
25Ù·
Ú»Éý³ ê.².¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
(30,40)
Jelfa S.A.Pharmaceutical
Works
50Ù·
Ú»Éý³ ê.².¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
(20,30)
Jelfa S.A.Pharmaceutical
Works
25Ù·
ú½áÝ êäÀ
(20/2x10/,40/4x
Ozon Ltd.
10/)
0.025·,
§´ñÇÝó³Éáí - ²¦ ö´À
(10,20,30,40,50)
CJSC §Brinsalov - A¦
11.02.2003
11.02.2008
13.03.2006
13.03.2011
13.03.2006
13.03.2011
¸
0099/6214
09.06.2006
09.06.2011
²¸
_
4169
27.03.2003
27.03.2008
²¸
êÉáí»Ýdz
C09A A01
1002/6997
¸
º·Çåïáë
C09A A01
0432/6438
04.06.2007
04.06.2012
26.09.2006
26.09.2011
êÉáí»Ýdz
C09A A01
1003/6998
¸
º·Çåïáë
C09A A01
0676/6718
04.06.2007
04.06.2012
17.01.2007
17.01.2012
Ȼѳëï³Ý
C09A A01
5375
23.03.2005
23.03.2010
¸
Ȼѳëï³Ý
C09A A01
5376
23.03.2005
23.03.2010
¸
Ȼѳëï³Ý
C09A A01
5377
23.03.2005
23.03.2010
¸
èáõë³ëï³Ý
C09A A01
5793
08.12.2005
08.12.2010
¸
èáõë³ëï³Ý
C09A A01
5331
15.02.2005
15.02.2010
¸
¸
¸
¸
¸
88
1286
1287
γåïáåñÇÉ-ÎØä
Captopril-KMP
γíÇÝïáÝ
Cavinton
ϳåïáåñÇÉ
captopril
íÇÝåáó»ïÇÝ
vinpocetine
1288
γíÇÝïáÝ
íÇÝåáó»ïÇÝ
Cavinton
vinpocetine
1289
γíÇÝïáÝ ýáñï»
íÇÝåáó»ïÇÝ
Cavinton forte
vinpocetine
1290
γï³ÕáõÃÛ³Ý
ÇÙáõÝá·ÉáµáõÉÇÝÝ»
ÇÙáõÝá·ÉáµáõÉÇÝ ñ å³ñáõݳÏáÕ Ñ»ÕáõÏ
Ý»ñ ÓÇáõ ³ñÛ³Ý
å³ïñ³ëïáõÏ
ßÇ×áõÏÇó
immunoglobulins
Rabies
containing liquid
Immunoglobulins
preparation
from Horse serum
1291
1292
γï³ñ³ùë
Katarax
γïí³ËáïÇ Ñ³ÝáõÏÇ
¹»Õ³Ñ³ï»ñ
Valerian extract
tablets
1293 γïí³ËáïÇ á·»ÃáõñÙ
Valeriane tincture
1294 γïí³ËáïÇ á·»ÃáõñÙ
Tinctura Valerianae
1295 γïí³ËáïÇ á·»ÃáõñÙ
Valerian tincture
1296
1297
1298
1299
1300
1301
1302
1303
γñµ³Ù³½»åÇÝ
Carbamazepin
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
Ñ»ÕáõÏ
0.025·
ÎǨٻ¹åñ»å³ñ³ï ´À
(20)
Kievmedpreparat JSC
10Ù·/2ÙÉ,
¶»¹»áÝ èÇËï»ñ Èï¹.
2ÙÉ ³ÙåáõÉÝ»ñ
Gedeon Richter Ltd.
(10)
5Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
(50)
Gedeon Richter Ltd.
10Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
(30)
Gedeon Richter Ltd.
ïÇïñ > 150ØØ/ÙÉ,
´ÇáÉ»Ï ö´À
(ÇÙáõÝá·ÉáµáõÉ
Biolek CJSC
ÇÝÇ 5ÙÉ Ï³Ù
10ÙÉ ³ÙåáõÉÝ»ñ ¨
Ýáëñ³óí³Í (1:100)
ÇÙáõÝá·ÉáµáõÉÇ
ÝÇ 1ÙÉ
³ÙåáõÉÝ»ñ (5)
0.015%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
15ÙÉ ßßÇÏ
Rompharm Company SRL
20Ù·
´áñÇëáíÛ³Ý
(50)
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
25ÙÉ ßßÇÏ
¾ëÏáõɳå êäÀ Esculap Ltd.
³½³å»Ýï³ó»Ý
azapentacene
ϳïí³ËáïÇ Ñ³ÝáõÏ
extractum valerianae
³ÏݳϳÃÇÉÝ»ñ
ϳïí³ËáïÇ á·»ÃáõñÙ
Valerian tincture
ϳïí³ËáïÇ á·»ÃáõñÙ
valerian tincture
ϳïí³ËáïÇ á·»ÃáõñÙ
tinctura valerianae
ÉáõÍáõÛÃ
ëåÇñï³ÛÇÝ
ÉáõÍáõÛÃ
ëåÇñï³ÛÇÝ
á·»ÃáõñÙ
ϳñµ³Ù³½»åÇÝ
carbamazepin
¹»Õ³Ñ³ï»ñ
0,2·
(20)
¹»Õ³Ñ³ï»ñ
200Ù·
(50/5x10/)
200Ù·
(24,30,50,100)
450Ù·/45ÙÉ,
ëñí³Ï (1)
γñµ³Ù³½»åÇÝ
ϳñµ³Ù³½»åÇÝ
Carbamazepin
carbamazepine
γñµ³Ù³½»åÇÝ
ϳñµ³Ù³½»åÇÝ
Carbamazepine
carbamazepine
γñµáåɳïÇÝ §¾´ºìº¦
ϳñµáåɳïÇÝ
Carboplatine
carboplatin
§EBEWE¦
γñµáóÇëï»ÇÝ
ϳñµáóÇëï»ÇÝ
Carbocisteine
carbocisteine
γñµáóÇëï»ÇÝ
ϳñµáóÇëï»ÇÝ
Carbocisteine
carbocisteine
γñ¹Ç³ÏáÉ ëñï³ÛÇÝ Ñáíï³ßáõß³ÝÇ, ³Éá×Ç,
ϳÃÇÉÝ»ñ
ϳïí³ËáïÇ Ñ³ÝáõÏÝ»ñ
CARDIACOL Guttae Convallariae, Crategi,
Cardiacae
Valerianae tincture
γñ¹ÇÉ
¹ÇÉïdz½»Ù
Cardil
diltiazem
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
ûß³ñ³Ï
ûß³ñ³Ï
ϳÃÇÉÝ»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
25ÙÉ ßßÇÏ
30ÙÉ ßßÇÏ
5%,
120ÙÉ ßßÇÏ
2%,
120ÙÉ ßßÇÏ
(500Ù·+250Ù·+
250Ù·)/·,
30· ßßÇÏ
30Ù·
(30,100)
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·. ζ
EBEWE Pharma Ges.m.b.H.
Nfg. KG
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
¶»ÙÇ
Gemi
úñÇáÝ Îáñåáñ»ÛßÝ
Orion Corporation
àõÏñ³Çݳ
C09A A01
5857
ÐáõÝ·³ñdz
N06B X18
5417
ÐáõÝ·³ñdz
N06B X18
5418
ÐáõÝ·³ñdz
J02A C01
5863
àõÏñ³Çݳ
-
5340
èáõÙÇÝdz
S01XA
0512/6507
´»É³éáõë
N05C M09
0954/6951
г۳ëï³Ý
N05C M09
5632
àõÏñ³Çݳ
N05C M09
0792/6794
´»É³éáõë
N05C M09
0955/6950
àõÏñ³Çݳ
N03A F01
´áõÉÕ³ñdz
09.12.2005
09.12.2010
14.12.2005
14.12.2010
¸
14.12.2005
14.12.2010
22.02.2006
22.02.2011
07.02.2005
07.02.2010
¸
07.11.2006
07.11.2011
03.05.2007
03.05.2012
¸
¸
¸
¸
²¸
12.01.2006
12.01.2011
13.03.2007
13.03.2012
03.05.2007
03.05.2012
²¸
1137/7105
02.10.2007
08.08.2012
¸
N03A F01
0082/6199
¸
г۳ëï³Ý
N03A F01
4980
²íëïñdz
L01X A02
4864
07.06.2006
07.06.2011
12.07.2004
12.07.2009
21.06.2004
21.06.2009
г۳ëï³Ý
R05C B03
4202
²¸
г۳ëï³Ý
R05C B03
4203
Ȼѳëï³Ý
-
0542/6445/1
10.02.2003
10.02.2008
10.02.2003
10.02.2008
17.11.2006
11.10.2011
üÇÝɳݹdz
C08D B01
4710
25.02.2004
25.02.2009
¸
²¸
²¸
¸
¸
²¸
²¸
89
1304
1305
1306
1307
γñ¹ÇÉáåÇÝ
Cardilopin
γñ¹ÇÉáåÇÝ
Cardilopin
γñ¹ÇÉáåÇÝ
Cardilopin
γñ¹ÇÏ»ï
Kardiket
1308
γñ¹ÇÏ»ï
Kardiket
1309
γñ¹Çá·»ñµ
CardioGerb
γñ¹ÇáÙ³·ÝÇÉ
Cardiomagnyl
1310
³ÙÉá¹ÇåÇÝ
¹»Õ³Ñ³ï»ñ
amlodipine
³ÙÉá¹ÇåÇÝ
¹»Õ³Ñ³ï»ñ
amlodipine
³ÙÉá¹ÇåÇÝ
¹»Õ³Ñ³ï»ñ
amlodipine
ǽáëáñµÇ¹Ç »ñÏÝÇïñ³ï ¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
isosorbide dinitrate
³½¹»óáõÃÛ³Ý
ǽáëáñµÇ¹Ç
»ñÏÇÝÇïñ³ï
isosorbide dinitrate
-
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
³½¹»óáõÃÛ³Ý
20Ù·
(20, 50)
ѳµ»ñ
350Ù·
(30,40)
75Ù·+15,2Ù·
(10,30,100)
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
Þí³ñó ü³ñÙ³ öñá¹³ùßÝë-¶ÙµÐ
Schwarz Pharma ProduktionsGmbH
Þí³ñó ü³ñÙ³ öñá¹³ùßÝë-¶ÙµÐ
Schwarz Pharma ProduktionsGmbH
ä³ñ³ý³ñÙ ö´À
Parapharm
CJSC
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
Nycomed Danmark A/S
150Ù·+30,39Ù·
(10,30,100)
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
Nycomed Danmark A/S
¸³Ýdz
N02B A71,
A02A
4376
27.06.2003
27.06.2008
¸
4Ù·
(30)
лÛÝñÇË Ø³ù.ܳãý.¶ÙµÐ ¨
øá. ζ
Heinrich Mack Nachf GmbH &
Co.KG
лÛÝñÇË Ø³ù.ܳãý.¶ÙµÐ ¨
øá.ζ
Heinrich Mack Nachf.GmbH &
Co. KG
êáý³ñÙ³ ´À
Sopharma JSC
¶ñÇݹ»ùë ´À
Grindex JSC
¶ñÇݹ»ùë ´À
Grindex JSC
¶ñÇݹ»ùë ´À
Grindex JSC
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD-Skopje
¶»ñÙ³Ýdz
C02C A04
5801
25.01.2006
25.01.2011
¸
¶»ñÙ³Ýdz
C02C A04
5802
29.03.2006
29.03.2011
¸
´áõÉÕ³ñdz
A05B A03
1025/7005
¸
ȳïídz
C07A G02
0161/6275
ȳïídz
C07A G02
0162/6274
ȳïídz
C07A G02
0163/6273
´áõÉÕ³ñdz
C07A G 02
1041/7083
´áõÉÕ³ñdz
C07A G 02
1042/7084
´áõÉÕ³ñdz
C07A G 02
1043/7085
سϻ¹áÝdz
N02B E71
0072/6040
13.06.2007
13.06.2012
07.07.2006
07.07.2011
07.07.2006
07.07.2011
07.07.2006
07.07.2011
02.07.2007
02.07.2012
02.07.2007
02.07.2012
02.07.2007
02.07.2012
02.06.2006
02.06.2011
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
¹»Õ³Ñ³ï»ñ
Ù³·Ý»½ÇáõÙÇ
óճÝóå³ï
Ñǹñûùëǹ
acetylsalicylic acid,
magnesium hydroxide
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
¹»Õ³Ñ³ï»ñ
Ù³·Ý»½ÇáõÙÇ
óճÝóå³ï (ýáñï»)
Ñǹñûùëǹ
acetylsalicylic acid,
magnesium hydroxide
¹ûùë³½áëÇÝÇ
¹»Õ³Ñ³ï»ñ
Ù»½Çɳï
ϳñ·³íáñíáÕ
doxazosin mesilate
Ó»ñµ³½³ïٳٵ
2.5Ù·
(30)
5Ù·
(30)
10Ù·
(30)
40Ù·
(20, 50)
1311
γñ¹ÇáÙ³·ÝÇÉ
Cardiomagnyl
1312
γñ¹áõñ³ XL
Cardura XL
1313
γñ¹áõñ³ XL
Cardura XL
¹ûùë³½áëÇÝÇ
Ù»½Çɳï
doxazosin mesilate
¹»Õ³Ñ³ï»ñ
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
8Ù·
(30)
1314
γñëÇÉ
Carsil
γñíǹÇÉ
Carvidil
γñíǹÇÉ
Carvidil
γñíǹÇÉ
Carvidil
γñíÇÉ»ùë
Carvilex
γñíÇÉ»ùë
Carvilex
γñíÇÉ»ùë
Carvilex
γý»ïÇÝ
Caffetin
ëÇÉÇÙ³ñÇÝ
silymarin
ϳñí»¹ÇÉáÉ
carvedilol
ϳñí»¹ÇÉáÉ
carvedilol
ϳñí»¹ÇÉáÉ
carvedilol
ϳñí»¹ÇÉáÉ
carvedilol
ϳñí»¹ÇÉáÉ
carvedilol
ϳñí»¹ÇÉáÉ
carvedilol
å³ñ³ó»ï³ÙáÉ,
åñáåÇý»Ý³½áÝ,
Ïáý»ÇÝ, Ïá¹»ÇÝÇ
ýáëý³ïÇ ë»ëùíÇÑǹñ³ï
paracetamol,
propyphenazone,
caffeine, codeine
phosphate
¹ñ³Å»
35Ù·
(80/8x10/)
25Ù·
(28/2x14/)
12.5Ù·
(28/2x14/)
6.25Ù·
(28/2x14/)
25Ù·
(30/3x10/)
12,5Ù·
(30/3x10/)
6,25Ù·
(30/3x10/)
(250Ù·+210Ù·+
50Ù·+10Ù·)
(6,10,12)
1315
1316
1317
1318
1319
1320
1321
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ÐáõÝ·³ñdz
C08C A01
4054
23.01.2003
23.01.2008
23.01.2003
23.01.2008
23.01.2003
23.01.2008
02.11.2007
12.10.2012
¸
ÐáõÝ·³ñdz
C08C A01
4055
ÐáõÝ·³ñdz
C08C A01
4056
¶»ñÙ³Ýdz
C01DA08
1300/7268
¶»ñÙ³Ýdz
C01DA08
1301/7267
02.11.2007
12.10.2012
¸
èáõë³ëï³Ý
βêÐ
5197
²¸
¸³Ýdz
N02B A71,
A02A
4375
08.12.2004
08.12.2009
27.06.2003
27.06.2008
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
²¸
90
λ½áÉ
Kezole
λÙáϳñµ
Kemocarb
sesquihydrate
Ï»ïáÏáݳ½áÉ
ketoconazole
ϳñµáåɳïÇÝ
carboplatin
1324
λÙáϳñµ
Kemocarb
ϳñµáåɳïÇÝ
carboplatin
1325
λݳÉá· 40
Kenalog 40
ïñdzÙóÇÝáÉáÝ
triamcinolone
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
1326
λݳÉá· 40
Kenalog 40
ïñdzÙóÇÝáÉáÝ
triamcinolone
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
1327
λݳÉá·
Kenalog
λëïÇÝ
Kestin
ïñdzÙóÇÝáÉáÝ
triamcinolone
¿µ³ëïÇÝ
ebastine
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1329
λëïÇÝ
Kestin
¿µ³ëïÇÝ
ebastine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1330
λëïÇÝ
Kestin
¿µ³ëïÇÝ
ebastine
ûß³ñ³Ï
1331
λïá½áÉ
Ketozole
Ï»ïáÏáݳ½áÉ
ketokonazole
¹»Õ³Ñ³ï»ñ
1332
λïáÏáݳ½áÉ
Ketokonazole
Ï»ïáÏáݳ½áÉ
ketokonazole
û׳é³Ñ»ÕáõÏ
1333
λïáÏáݳ½áÉ
Ketokonazole
λïáݳÉ
Ketonal
λïáݳÉ
Ketonal
λïáݳÉ
Ketonal
λïáݳÉ
Ketonal
Ï»ïáÏáݳ½áÉ
ketokonazole
Ï»ïáåñáý»Ý
ketoprofen
Ï»ïáåñáý»Ý
ketoprofen
Ï»ïáåñáý»Ý
ketoprofen
Ï»ïáåñáý»Ý
ketoprofen
Ýñµ³ùëáõù
1322
1323
1328
1334
1335
1336
1337
¹»Õ³Ñ³ï»ñ
ÙáÙÇÏÝ»ñ
Ýñµ³ùëáõù
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
200Ù·
(30/3x10/)
450Ù·/45ÙÉ,
45ÙÉ ëñí³Ï (1)
ÆÝï³ë ý³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Intas Pharmaceuticals Ltd.
¸²´àôð ü³ñÙ³ Èï¹
DABUR Pharma Ltd
Ðݹϳëï³Ý
G01A F11
0443/6454
Ðݹϳëï³Ý
L01X A02
0310/6089
150Ù·/15ÙÉ,
15ÙÉ ëñí³Ï (1)
¸²´àôð ü³ñÙ³ Èï¹
DABUR Pharma Ltd
Ðݹϳëï³Ý
L01X A02
40Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
40Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
4Ù·
(50)
10Ù·
(5,10)
´ñÇëïáÉ Ø³Û»ñë êùíǵµ
Bristol-Myers Squibb
Æï³Édz
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Æݹ³ëïñÇ ü³ñÙ³ëÛáõÃÇù³ë
²ÉÙÇñ³É öñá¹»ëý³ñÙ³ ê.².,
(ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê,¸³ÝdzÛÇ
ѳٳñ)
Industries Farmaceuticas
Almirall Prodesfarma S.A.,
Spain (for Nycomed Danmark
A/S, Denmark)
20Ù·
²ÉÙÇñ³É äñá¹»ëý³ñÙ³ ê.È.
(10, 20)
(ÜÇÏáÙ»¹Ç ѳٳñ)
Almirall Prodespharma S.L. (for
Nycomed)
1Ù·/ÙÉ,
²ÉÙÇñ³É äñá¹»ëý³ñÙ³
60ÙÉ,120ÙÉ ßßÇÏ Æݹ³ëïñÇë ü³ñÙ³ëÛáõÃÇù³Éë
ê.È.Æëå³Ýdz (ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ
²/ê, ¸³ÝdzÛÇ Ñ³Ù³ñ)
Almirall Prodesfarma
Industrias Pharmaceuticals
S.L.,Spain (for Nycomed
Danmark A/S, Denmark)
200Ù·
Ø»ÙýÇë øá. ü³ñÙ ¨ ø»ÙÇϳÉ
(10)
Æݹ-Ç Ñ³Ù³ñ
Memphis Co. For Pharm &
Chemical Ind.
2%,
²ðöÆغ¸ ÐÒ ö´À
100ÙÉ,125ÙÉ
ARPIMED J.V. CJ-S Co.
ßßÇÏ
2%,
²ðöÆغ¸ ÐÒ ö´À ARPIMED
15·, 25· å³ñÏáõ×
J.V. CJ-S Co.
100Ù·
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
(12)
Lek Pharmaceuticals d.d.
5%,
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
30·, 50· å³ñÏáõ×
Lek Pharmaceuticals d.d.
50Ù·
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
(25)
Lek Pharmaceuticals d.d.
100Ù·/2ÙÉ,
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
2ÙÉ ³ÙåáõÉÝ»ñ
Lek Pharmaceuticals d.d.
(10,50)
29.09.2006
29.09.2011
01.08.2006
01.08.2011
¸
0311/6088
01.08.2006
01.08.2011
¸
R01A D11,
S01B A05
4319
14.04.2003
14.04.2008
¸
êÉáí»Ýdz
H02A
0568/6526
24.11.2006
24.11.2011
¸
êÉáí»Ýdz
H02A B08
0567/6527
¸
Æëå³Ýdz
R06A X22
4909
24.11.2006
24.11.2011
03.05.2004
03.05.2009
Æëå³Ýdz
R06A X22
0689/6646
17.01.2007
17.01.2012
²¸
Æëå³Ýdz
R06A X22
5764
07.09.2005
07.09.2010
²¸
º·Çåïáë
D01A C08
G01A F11
J02A B02
4828
19.10.2004
19.10.2009
¸
г۳ëï³Ý
D01A C08,
G01A F11,
J02A B02
D01A C08
4691
26.02.2004
26.02.2009
²¸
5151
²¸
M01A E03
M02A A10
M01A E03
M02A A10
M01A E03
M02A A10
M01A E03
M02A A10
5279
12.11.2004
12.11.2009
07.02.2005
07.02.2010
07.02.2005
07.02.2010
07.02.2005
07.02.2010
07.02.2005
07.02.2010
г۳ëï³Ý
êÉáí»Ýdz
êÉáí»Ýdz
êÉáí»Ýdz
êÉáí»Ýdz
5278
5277
5276
¸
²¸
¸
²¸
¸
¸
91
1338
λïáÝ³É ¸àôà
Ketonal DUO
λïáÝ³É é»ï³ñ¹
Ketonal retard
λïáÝ³É ýáñï»
Ketonal forte
λïáåñáý»Ý
Ketoprofen
Ï»ïáåñáý»Ý
ketoprofen
Ï»ïáåñáý»Ý
ketoprofen
Ï»ïáåñáý»Ý
ketoprofen
Ï»ïáåñáý»Ý
ketoprofen
¹»Õ³å³ïÇ×Ý»ñ
λïáïÇý»Ý
Ketotifen
λïáïÇý»Ý
Ketotifen
Ï»ïáïÇý»Ý
ketotifen
Ï»ïáïÇý»Ý
ketotifen
¹»Õ³Ñ³ï»ñ
1344
λïáïÇý»Ý
Ketotifen
Ï»ïáïÇý»Ý
ketotifen
¹»Õ³Ñ³ï»ñ
1Ù·
(30)
1345
λïáïÇý»Ý/лÉ÷
Ketotifen/Help
λïáñáɳÏ
Ketorolac
Ï»ïáïÇý»ÝÇ ýáõÙ³ñ³ï
ketotifen fumarate
Ï»ïáñáɳÏ
ketorolac
¹»Õ³Ñ³ï»ñ
1Ù·
(30)
10Ù·
(10, 20)
1347
λïáó»ý
Ketocef
ó»ýáõñûùëÇÙ
cefuroxim
1348
λñ³ïáë³É
Keratosal
ë³ÉÇóÇɳÃÃáõ
salicylic acid
1349
λý½áÉ
Kefzol
ó»ý³½áÉÇÝ
cefazolin
1350
ÎÇåý»ñáÝ
Kipferon
1351
ÎɳñÇÃñáÙÇóÇÝ
äñáï»ù
Clarithromycin
Protech
ÎɳñÇë»Ýë
Clarisens
ÎɳñÇïÇÝ
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
ÇÝï»ñý»ñáÝ ³Éý³-2,
ÇÙáõݳ·ÉáµáõÉÇݳÛÇ
Ý Ñ³Ù³ÉÇñ å³ïñ³ëïáõÏ
interferonum humanum
recombinantum alpha2, immunoglobulin
complex preparation
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
1339
1340
1341
1342
1343
1346
1352
1353
Éáñ³ï³¹ÇÝ
loratadine
Éáñ³ï³¹ÇÝ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹áݹáÕ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ëå»Õ³ÝÇ
150Ù·
(20,30)
150Ù·
(20)
100Ù·
(20)
2.5%,
30· å³ñÏáõ×
1Ù·
(30)
0.001·,
(10,30)
750Ù·,
ëñí³Ï (5)
30% (70·/Ù2)
2ëÙx4ëÙ,
3ëÙx6ëÙ (2, 6,12),
6ëÙx10ëÙ (3, 5, 10,12),
15ëÙx12,5
1·,
ëñí³Ï (1)
¹»Õ³÷áßÇ Ý/», Ù/Ù
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ÙáÙÇÏÝ»ñ
(500000ØØ+60Ù·)
(10)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
êáý³ñÙ³ ´À
Sopharma JSC
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
ê.².
Warsaw Pharmaceutical Works
§Polfa¦ S.A.
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
äÉÇí³ ¹.¹.
Pliva d.d.
êÉáí»Ýdz
´»É³éáõë
M01A E03,
M02A A10
M01A E03
M02A A10
M01A E03
M02A A10
M02A A10
0795/6791
´áõÉÕ³ñdz
R06A X17
0922/6427
´»É³éáõë
R06A X17
5003
Ȼѳëï³Ý
R06A X17
4284
26.05.2003
26.05.2008
¸
Ðáõݳëï³Ý
R06A X17
4973
¸
´»É³éáõë
M01A B15
0797/6789
11.10.2004
11.10.2009
20.03.2007
20.03.2012
Êáñí³Ãdz
J01D C02
5322
26.06.2005
26.06.2010
¸
Ø»¹Çϳ ²¸
Medica AD
´áõÉÕ³ñdz
D01A E12
S01B C08
4112
27.03.2003
27.03.2008
²¸
¾ÉÇ ÈÇÉÇ Æï³Édz ê.å.².
Eli Lilly Italia S.p.A.
Æï³Édz
J01D A04
4467
17.09.2003
17.09.2008
¸
²Éý³ñÙ êäÀ
Alfarm Ltd.
èáõë³ëï³Ý
L03A A04
1237/7293
12.10.2007
03.11.2008
¸
êÉáí»Ýdz
êÉáí»Ýdz
5939
5274
5275
06.02.2006
06.02.2011
07.02.2005
07.02.2010
07.02.2005
07.02.2010
20.03.2007
20.03.2012
26,04.2007
26.04.2012
13.12.2004
13.12.2009
¸
¸
¸
²¸
¸
²¸
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(10)
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
Ðݹϳëï³Ý
J01F A05
1192/7203
25.09.2007
13.09.2012
¸
¹»Õ³Ñ³ï»ñ
0.01·
(10, 20, 30, 40, 60)
1Ù·/ÙÉ
²Û êÇ ¾Ý äáÉÇý³ñÙ ´´À
ICN Polipharm Open JSC
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
èáõë³ëï³Ý
R06A X13
4332
²¸
´»É·Ç³
R06A X13
4835
24.12.2003
24.12.2008
16.06.2004
ûß³ñ³Ï
²¸
92
1354
1355
1356
1357
1358
1359
1360
1361
1362
1363
Claritine
ÎɳñÇïÇÝ
Claritine
ÎɳñÇý»ñ
Klarifer
ÎɳñÇý»ñ
Klarifer
Îɳóǹ
Klacid
ÎɳýáµñÇÝ
Clafobrin
Îɳýáñ³Ý
Claforan
ÎÉ»ñÇÙ»¹
Klerimed
ÎÉ»ñÇÙ»¹
Klerimed
ÎÉÇÙ³¹ÇÝáÝ
Klimadynon
ÎÉÇÙ³¹ÇÝáÝ
Klimadynon
1364
ÎÉÇÙ³ÏïáåÉ³Ý Ü
Klimaktoplan N
1365
ÎÉÇÙ»Ý
Climen
1366
ÎÉÇÙá¹Ç»Ý
Climodien
1367
ÎÉÇÙáÝáñÙ
Klimonorm
1368
ÎÉÇݹ³ÙÇóÇÝ
Klindamicin
ÎÉÇáÝ - ¸ 100
Klion - D 100
1369
1370
ÎÉá¹Çý»Ý
Clodifen
loratadine
Éáñ³ï³¹ÇÝ
loratadine
Éáñ³ï³¹ÇÝ
loratadine
Éáñ³ï³¹ÇÝ
loratadine
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
ó»ýáï³ùëÇÙ
cefotaxime
ó»ýáï³ùëÇÙ
cefotaxime
60ÙÉ, 120ÙÉ ßßÇÏ Schering-Plough Labo N.V.
10Ù·
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
(7,10)
Schering-Plough Labo N.V.
¹»Õ³Ñ³ï»ñ
10Ù·
§´ñÇÝó³Éáí-²¦ ö´À
(10)
CJSC §Brinsalov-A¦
ûß³ñ³Ï
0.1%,
§´ñÇÝó³Éáí-²¦ ö´À
100ÙÉ ßßÇÏ
CJSC §Brinsalov-A¦
¹»Õ³Ñ³ï»ñ
250Ù·
²´´úîî ê.å.².
(10)
ABBOTT S.p.A.
¹»Õ³÷áßÇ Ù/Ù, Ý/»
1·,
§´ñÇÝó³Éáí-²¦ ö´À
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
§Brinsalov-A¦ CJSC
¹»Õ³÷áßÇ
1·,
ä³Ã»áÝ Ø ÈÇÙÇﻹ ²í»ÝïÇë
Ý»ñ³ñÏÙ³Ý,
ëñí³Ï/³ÙåáõÉ (1)
ɳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
4ÙÉ Ý»ñ³ñÏÙ³Ý
Patheon UK Limited for
çáõñ ÉáõÍãáí
Laboratoire Aventis
ÏɳñÇÃñáÙÇóÇÝ
¹»Õ³Ñ³ï»ñ
250Ù·
Ø»¹áù»ÙÇ Èï¹
clarithromycin
óճÝóå³ï
(14,16,20)
Medochemie Ltd
ÏɳñÇÃñáÙÇóÇÝ
¹»Õ³Ñ³ï»ñ
500Ù·
Ø»¹áù»ÙÇ Èï¹
clarithromycin
óճÝóå³ï
(14,16,20)
Medochemie Ltd
ÙÉϳݳËáïÇ ãáñ ѳÝáõÏ
¹»Õ³Ñ³ï»ñ
20Ù·
´ÇáÝáñÇϳ ²¶
Cimicifugae dry extract
óճÝóå³ï
(60)
Bionorica AG
ÙÉϳݳËáïÇ Ñ»ÕáõÏ
ϳÃÇÉÝ»ñ
12·/100·,
´ÇáÝáñÇϳ ²¶
ѳÝáõÏ
50ÙÉ ßßÇÏ
Bionorica AG
Cimicifugae fluid extract
¹»Õ³Ñ³ï»ñ
(100)
¶»ñÙ³Ý³Ï³Ý ÐáÙ»áå³Ã³ÛÇÝ
ØÇáõÃÛáõÝ (¶ÐØ)
Deutsche Homoopathie Union
(DHU)
I-¿ëïñ³¹ÇáÉí³É»ñ³ï,
¹»Õ³Ñ³ï»ñ
I-2Ù·,
Þ»ñÇÝ· ê.².
II-¿ëïñ³¹ÇáÉí³É»ñ³ï, óճÝóå³ï (¹ñ³Å»)
II-(2Ù·+1Ù·),
Schering S.A.
óÇåñáï»ñáÝÇ ³ó»ï³ï
(21(I-11, II-10) (21)
I-estradiol valerate,
II-estradiol valerate,
cyproterone acetate
¿ëïñ³¹ÇáÉ í³É»ñ³ï,
¹»Õ³Ñ³ï»ñ
2Ù·+2Ù·
Þ»ñÇÝ· ²¶
¹Ç»Ýá·»ëï
óճÝóå³ï
(28)
Schering AG
estradiol valerate,
dienogest
(I-¿ëïñ³¹ÇáÉ-í³É»ñ³ï,
¹»Õ³Ñ³ï»ñ
(I-2Ù·,IIڻݳý³ñÙ ¶ÙµÐ ¨ øá. ζ,
II-¿ëïñ³¹ÇáÉóճÝóå³ï
2Ù·+0,15Ù·),
Þ»ñÇÝ· ·ñáõå ùáÙå³ÝÇ
í³É»ñ³ï,
(21/9+12/)
Jenapharm GmbH & Co. KG,
ɨáÝáñ·»ëïñ»É)
Schering Group Company
(I-estradiol valerate,
II-estradiol valerate,
levonorgestrel)
ÏÉÇݹ³ÙÇóÇÝ
¹»Õ³å³ïÇ×Ý»ñ
150Ù·
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
clindamycin
(16)
Hemofarm koncern A.D.
Ù»ïñáÝǹ³½áÉ,
¹»Õ³Ñ³ï»ñ
100Ù·+100Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
ÙÇÏáݳ½áÉÇ ÝÇïñ³ï
Ñ»ßïáó³ÛÇÝ
(10)
Gedeon Richter Ltd.
metronidazole,
miconazole nitrate
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
³ÏݳϳÃÇÉÝ»ñ
0.1%,
º.Æ.ä.Æ.øá (àõáñɹ
diclofenac sodium
5ÙÉ ßßÇÏ
Ø»¹ÇëÇÝ/²ØÜ/-Ç Ñ³Ù³ñ
ϳÃáóÇÏáí
E.I.P.I.Co (for World Medicine,
¹»Õ³Ñ³ï»ñ
16.06.2009
16.06.2004
16.06.2009
29.10.2003
29.10.2008
29.10.2003
29.10.2008
25.05.2006
25.05.2011
18.03.2004
18.03.2009
06.12.2005
06.12.2010
´»É·Ç³
R06A X13
4834
èáõë³ëï³Ý
R06A X13
4556
èáõë³ëï³Ý
R06A X13
4557
Æï³Édz
J01F A09
0054/5736
èáõë³ëï³Ý
J01D A10
4764
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
J01D D01
5770
ÎÇåñáë
J01F A09
0206/6166
ÎÇåñáë
J01F A09
0207/6167
¶»ñÙ³Ýdz
G02CX
0554/6501
¶»ñÙ³Ýdz
G02CX
0555/6500
¶»ñÙ³Ýdz
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
5258
21.12.2004
21.12.2009
²¸
üñ³Ýëdz
G03C
4653
04.03.2004
04.03.2009
¸
¶»ñÙ³Ýdz
G03C A53
5230
03.02.2005
03.02.2010
¸
¶»ñÙ³Ýdz
G03F B09
0756/6756
28.02.2007
28.02.2012
¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
ÐáõÝ·³ñdz
J01F F01
5170
¸
G01A F20
5246
02.11.2004
02.11.2009
30.05.2005
30.05.2010
º·Çåïáë
S01B C03
5975
09.02.2006
09.02.2011
¸
21.07.2006
21.07.2011
21.07.2006
21.07.2011
17.11.2006
17.11.2011
17.11.2006
17.11.2011
²¸
²¸
²¸
¸
¸
¸
¸
¸
²¸
²¸
¸
93
1371
ÎÉá¹Çý»Ý
Clodifen
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
diclofenac sodium
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1372
ÎÉáÙǹÇÝ
Clomidine
ÏÉáÙÇý»Ý óÇïñ³ï
clomiphene citrate
¹»Õ³Ñ³ï»ñ
ÏÉáÙÇý»Ý
clomifene
¹»Õ³Ñ³ï»ñ
50Ù·
(10,20,30,100)
ÏÉáݳ½»å³Ù
clonazepam
¹»Õ³Ñ³ï»ñ
2Ù·
(30)
1373
ÎÉáÙÇý»Ý
¹»Õ³Ñ³ï»ñ ´ä 50Ù·
Clomifene Tablets
BP 50mg
1374
ÎÉáݳ½»å³Ù
Clonazepam
75Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
50Ù·
(20)
1375
ÎÉáåǹá·ñ»É
Clopidogrel
ÏÉáåǹá·ñ»É
clopidogrel
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.075·
(10, 20)
1376
ÎÉáëïÇɵ»·Çï
Clostilbegyt
ÎÉáïñÇÙ³½áÉ
Clotrimazol
ÎÉáïñÇÙ³½áÉ
Clotrimazol
ÎÉáïñÇÙ³½áÉ
Clotrimazol
ÎÉáïñÇÙ³½áÉ
Clotrimazole
ÏÉáÙÇý»Ý óÇïñ³ï
clomifene citrate
ÏÉáïñÇÙ³½áÉ
clotrimazole
ÏÉáïñÇÙ³½áÉ
clotrimazol
ÏÉáïñÇÙ³½áÉ
clotrimazole
ÏÉáïñÇÙ³½áÉ
clotrimazole
¹»Õ³Ñ³ï»ñ
50Ù·
(10)
1%,
20ÙÉ ßßÇÏ
1%,
15· å³ñÏáõ×
100Ù·
(6)
1%,
20· å³ñÏáõ×
ÎÉáïñÇÙ³½áÉ
Clotrimazole
ÎÉáïñÇÙ³½áÉ
Clotrimazole
ÏÉáïñÇÙ³½áÉ
clotrimazole
ÏÉáïñÇÙ³½áÉ
clotrimazole
1383
ÎÉáïñÇë³É ÎØä
Clotrisal KMP
1384
Îá³ùëÇÉ
Coaxil
Îá¹»É³Ï ýÇïá
Codelac Phyto
ÏÉáïñÇÙ³½áÉ,
ë³ÉÇóÇɳÃÃáõ
clotrimazole, salicylic
acid
ÃdzݻåïÇÝ
tianeptine
Ïá¹»ÇÝÇ ýáëý³ï,
ûñÙáåëÇëÇ, áõñóÇ,
Ù³ïáõï³ÏÇ ³ñÙ³ïÝ»ñÇ
ѳÝáõÏÝ»ñ
codeine phosphate,
thermopsis dry extract,
thymi extract,
glycyrrhiza radix extract
í³Éë³ñï³Ý,
ÑǹñáùÉáñáÃdz½Ç¹
valsartan,
hydrochlorothiazide
1377
1378
1379
1380
1381
1382
1385
1386
Îá-¹Çáí³Ý
Co-Diovan
óáÕ³ßÇÃ
Ýñµ³ùëáõù
¹»Õ³Ñ³ï»ñ
Ñ»ßïáó³ÛÇÝ
Ýñµ³ùëáõù
Ýñµ³ùëáõù
¹»Õ³Ñ³ï»ñ
Ñ»ßïáó³ÛÇÝ
1%,
15·,35· å³ñÏáõ×
100Ù·
(6)
USA)
ºÆäÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
ѳٳñ)
E.I.P.I.Co. (for World Medicine)
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹
CP Pharmaceuticals Ltd.
î³ñËáÙÇÝÇ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý §äáÉý³¦ ê.².
Tarchomin Pharmaceutical
Work §Polfa¦ S.A.
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
êäÀ-Ç Ù³ëݳ×ÛáõÕ ù. ʳñÏáí
Branch of LCC §Experimental
plant GNCLS¦ c. Kharkov
¾¶Æê ´´À
EGIS PLC
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
¾ëÏáõɳå êäÀ
Esculap Ltd.
ú½áÝ êäÀ
Ozon Ltd.
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
²ÝïǵÇáïÇÏ ê.².
Antibiotice S.A.
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
ùëáõù
(1·+1·)/100·,
15·,30· å³ñÏáõ×
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ûß³ñ³Ï
12.5Ù·
(30)
(4.5Ù·+10Ù·+
1000Ù·+200Ù·)/
5ÙÉ,
100ÙÉ ßßÇÏ
ê»ñíÇ» ɳµáñ³ïáñdz
Les
Laboratoires Servier
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
160Ù·/12.5Ù·
(14)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
º·Çåïáë
M01A B05,
M02A A15
5677
22.09.2005
22.09.2010
¸
êÇñdz
G03G B02
5512
23.08.2005
23.08.2010
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
G03G B02
4572
11.11.2003
11.11.2008
¸
Ȼѳëï³Ý
N03A E01
6095
12.04.2006
12.04.2011
¸/Ð
àõÏñ³Çݳ
B01A C04
0743/6757
15.02.2007
15.02.2012
¸
ÐáõÝ·³ñdz
G03GB02
0845/6871
¸
èáõÙÇÝdz
D01A C01
0960/6937
г۳ëï³Ý
D01A C01
5880
èáõë³ëï³Ý
G01A F02
5784
Ȼѳëï³Ý
D01A C01
5224
26.03.2007
26.03.2012
14.05.2007
14.05.2012
12.01.2006
12.01.2011
08.12.2005
08.12.2010
08.12.2004
08.12.2009
èáõÙÇÝdz
D01A C01
5751
Ȼѳëï³Ý
G01AF02
5598
àõÏñ³Çݳ
D01A C01
G01A F02
üñ³Ýëdz
²¸
²¸
¸
²¸
23.12.2005
23.12.2010
09.06.2005
09.06.2010
²¸
4028
23.09.2003
23.09.2008
²¸
-
4598
¸
èáõë³ëï³Ý
R05FA
0412/6371
26.11.2003
26.11.2008
19.09.2006
19.09.2011
Þí»Ûó³ñdz
-
4339
26.06.2003
26.06.2008
¸
¸
¸
94
1387
Îá-¹Çáí³Ý
Co-Diovan
1388
Îá-¹Çáí³Ý
Co-Diovan
1389 ÎáÉǵ³Ïï»ñÇÝ ãáñ
Colibacterinum
siccum
1390
ÎáÉǵ³Ïï»ñáÝ
Colibacteron
í³Éë³ñï³Ý,
ÑǹñáùÉáñáÃdz½Ç¹
valsartan,
hydrochlorothiazide
í³Éë³ñï³Ý,
ÑǹñáùÉáñáÃdz½Ç¹
valsartan,
hydrochlorothiazide
¿ß»ñÇËdz ÎáÉÇ Ø-17
escherichia coli M-17
¿ß»ñÇËdz ÏáÉÇ Ø-17
Escherichia coli M-17
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
160Ù·/25Ù·
(14)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
Þí»Ûó³ñdz
-
4340
26.06.2003
26.06.2008
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
80Ù·/12,5Ù·
(14)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
Þí»Ûó³ñdz
-
4338
26.06.2003
26.06.2008
¸
´Çáý³ñÙ³ ö´À
Biopharma Closed JSC
àõÏñ³Çݳ
A07F A10
1461/7426
20.12.2007
20.12.2012
²¸
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd.
г۳ëï³Ý
βêÐ
6045
14.03.2006
14.03.2011
²¸
M04A C01
0527/6517
10.11.2006
10.11.2011
¸
M04AC01
0331/6360
¸
M04A C01
1306/7275
11.08.2006
11.08.2011
15.10.2007
12.10.2012
èáõÙÇÝdz
M04A C01
0484/6496
¸
Ȼѳëï³Ý
C
5982
16.10.2006
16.10.2011
14.02.2006
14.02.2011
èáõë³ëï³Ý
C01E B
1220/7222
30.10.2007
13.09.2012
¸
´»É³éáõë
-
5259
08.12.2004
08.12.2009
¸
èáõë³ëï³Ý
-
5110
07.09.2004
07.09.2009
¸
º·Çåïáë
A11H,
B03B,
C01E
5679
22.09.2005
22.09.2010
¸
6x109-Çó áã å³Ï³ë
ϻݹ³ÝÇ
µ³Ïï»ñdzݻñ/
¹»Õ³ã³÷ (5
¹»Õ³ã³÷), ³å³Ï» ëñí³Ï
(10)
ãáñ ÷áßÇ
1.5x109 áã å³Ï³ë
ÉÇáýÇÉǽ³óí³Í,
(150Ù·) ϻݹ³ÝÇ
å³ïÇ×Ý»ñáõÙ
Ù³Ýñ¿Ý»ñÇ
ÉÇáýÇÉǽ³óí³Í
ãáñ ÷áßÇ
å³ïÇ×Ý»ñáõÙ,
µÉÇëï»ñÝ»ñ (20,
30) ¨ åɳëïÇÏ ï³ñ³
(90)
¹»Õ³Ñ³ï»ñ
0.5Ù·
óճÝóå³ï
(20, 50/2x25/)
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í
1391 ÎáÉËÇÏáõÙ ¹Çëå»ñï
Colchicum-Dispert
ÏáÉËÇóÇÝ
colchicine
1392
ÏáÉËÇóÇÝ
colchicine
ÏáÉËÇóÇÝ
colchicine
¹»Õ³Ñ³ï»ñ
ÏáÉËÇóÇÝ
colchicine
ÏáϳñµûùëÇɳ½
cocarboxylase
¹»Õ³Ñ³ï»ñ
ÎáÉËÇóÇÝ
Colchicine
1393
ÎáÉËÇóÇÝ
¹»Õ³Ñ³ï»ñ ´ä 500ÙÏ·
Colchicine Tablets
BP 500mcg
1394
ÎáÉËÇóÇݳ
Colchicina
1395 ÎáϳñµûùëÇɳ½³
Cocarboxylase
1396
ÎáϳñµûùëÇɳ½Ç
ÑǹñáùÉáñǹ
Cocarboxylase
hydrochloride
ÏáϳñµûùëÇɳ½
cocarboxylase
1397
ÎáϳñµûùëÇɳ½Ç
ÑǹñáùÉáñǹ
Cocarboxilase
hydrochloride
ÎáϳñµûùëÇɳ½Ç
ÑǹñáùÉáñǹ
Cocarboxylase
hydrochloride
ÎáϳñÝÇï
Cocarnit
ÏáϳñµûùëÇɳ½
cocarboxilase
1398
1399
ÏáϳñµûùëÇɳ½Ç
ÑǹñáùÉáñǹ
cocarboxylase
hydrochloride
»ñÏݳïñÇáõÙ
³¹»Ýá½ÇÝ »éýáëý³ïÇ
»éÑǹñ³ï,
ÏáϳñµûùëÇɳ½,
ódzÝáÏᵳɳÙÇÝ,
¹»Õ³Ñ³ï»ñ
1Ù·
(24,96)
500ÙÏ·
(100)
1Ù·
(40/2x20/)
50Ù·
[(3+3),(5+5)]
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶»ñÙ³Ýdz
¶ÙµÐ
Solvay Pharmaceuticals GmbH
²ðöÆغ¸ ÐÒ ö´À
г۳ëï³Ý
ARPIMED J.V. CJ-S Co
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹ Ø»Í ´ñÇï³Ýdz
CP Pharmaceuticals Ltd.
´Çáý³ñÙ ê.².
Biofarm S.A.
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
0,05·,
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
³ÙåáõÉ/³ÙåáõÉ (5) Pharmstandard-UfaVITA OJSC
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý,
2ÙÉ ÉáõÍãáí
ÉÇáýÇÉǽ³ï
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ÉáõÍÇãáí (2ÙÉ
Ý»ñ³ñÏÙ³Ý çáõñ)
¹»Õ³÷áßÇ
0.05·,
´»ÉÙ»¹åñ»å³ñ³ïÇ ´´À
Ý»ñ³ñÏÙ³Ý
³ÙåáõÉÝ»ñ (5)
Belmedpreparaty Open JSC
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
¹»Õ³÷áßÇ
0.05·,
§ØÇÏñ᷻ݦ ¶²Ø
Ý»ñ³ñÏÙ³Ý 2ÙÉ ³ÙåáõÉ/³ÙåáõÉ (5)
Mikrogen SIU
Ý»ñ³ñÏÙ³Ý çáõñ
ÉáõÍÇãáí
¹»Õ³÷áßÇ
(10Ù·+50Ù·+
ºÆäÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
Ý»ñ³ñÏÙ³Ý
0.5Ù·+ 20Ù·)
ѳٳñ)
ÉáõÍáõÛÃÇ,
³ÙåáõÉ/³ÙåáõÉ (3) E.I.P.I.Co. (for World Medicine)
2ÙÉ ÉǹáϳÛÇÝÇ
0.5% ÉáõÍáõÛÃ
¸
¸
95
ÝÇÏáïÇݳÙǹ
ÉáõÍÇãáí
disodium Adenosine
Triphosphate trihydrate,
cocarboxylase,
cyanocobalamin,
nicotinamide
1400
ÎáٵǷ»É
íáõßÇ ÛáõÕ,
¹áݹáÕ
(3%+1%+10%+
êÇåɳ Èï¹.
Combigel
¹ÇÏÉáý»Ý³Ï,Ù»ÃÇÉ
5%),
Cipla Ltd.
ë³ÉÇóÇɳï, Ù»ÝÃáÉ
30· å³ñÏáõ×
linseed oil,
diclofenac,methyl
salicylate, menthol
1401
ÎàØ´Æܺøê
å³ñ³ó»ï³ÙáÉ,
¹»Õ³å³ïÇ×Ý»ñ
(325Ù·+10Ù·+
ì³Ûß³ÉÇ ü³ñÙ³ëÛáõÃÇù³Éë
COMBINEX
¹»ùëïñáÙ»Ãáñý³ÝÇ
5Ù·+ 2Ù·+50Ù·),
Vaishali Pharmaceuticals
ÑǹñáµñáÙǹ,
(10,100)
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ,
ùÉáñý»ÝÇñ³ÙÇÝÇ
ٳɻ³ï, Ïáý»ÇÝ
paracetamol,
dextrometho
1402 ÎàØ´Æܺøê-ä ûß³ñ³Ï
å³ñ³ó»ï³ÙáÉ,
ûß³ñ³Ï
(500Ù·+10Ù·+
ì³Ûß³ÉÇ ü³ñÙ³ëÛáõÃÇù³Éë
COMBINEX-P syrup ¹»ùëïñáÙ»Ãáñý³ÝÇ
5Ù·+
Vaishali Pharmaceuticals
ÑǹñáµñáÙǹ,
2Ù·+50Ù·)/15ÙÉ,
ý»ÝÇÉ¿ýñÇÝÇ
50ÙÉ,100ÙÉ ßßÇÏ
ÑǹñáùÉáñǹ,
ùÉáñý»ÝÇñ³ÙÇÝÇ
ٳɻ³ï, Ïáý»ÇÝ
paracetamol, dextr
1403 ÎáÙåÉÇíÇï-³ÏïÇí
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30)
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
Complivit-Active
ѳÝù³ÝÛáõûñ
óճÝóå³ï
Pharmstandard-UfaVITA OJSC
vitamins, minerals
1404 ÎáÙåÉÇíÇï-ٳٳ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30)
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
Complivit-Mama
ѳÝù³ÝÛáõûñ
óճÝóå³ï
Pharmstandard-UfaVITA OJSC
vitamins, minerals
1405
ÎáÝÏáñ
µÇëáåñáÉáÉ
¹»Õ³Ñ³ï»ñ
5Ù·
Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
Concor
bisoprolol
óճÝóå³ï
(30,50)
Merck KGaA (for Nycomed)
1406
ÎáÝÏáñ
µÇëáåñáÉáÉ
¹»Õ³Ñ³ï»ñ
10Ù·
Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
Concor
bisoprolol
óճÝóå³ï
(30,50,100)
Merck KGaA (for Nycomed)
1407
ÎáÝÏáñ Îàð
µÇëáåñáÉáÉ
¹»Õ³Ñ³ï»ñ
2.5Ù·
Ø»ñÏ Î¶³² (ÜÇÏáÙ»¹Ç ѳٳñ)
Concor COR
bisoprolol
óճÝóå³ï
(30)
Merck KGaA (for Nycomed)
1408
ÎáÝíáõÉëáýÇÝ
í³Éåñá³ÃÃáõ
¹»Õ³Ñ³ï»ñ
300Ù·
²ì¸ ý³ñÙ³ ¶ÙµÐ ¨ øá. ζ
Convulsofin
valproic acid
(100)
AWD pharma GmbH & Co. KG
1409 ÎáÝïñÇÏ³É 10000
³åñáïÇÝÇÝ
¹»Õ³÷áßÇ
10000ÐîñØ,
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
Contrykal 10000
aprotinine
ÉÇáýÇÉǽ³óí³Í, ëñí³Ï/³ÙåáõÉ (10) AWD Pharma GmbH & Co. KG
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ, 2ÙÉ
ݳïñÇáõÙÇ
ùÉáñǹÇ
ǽáïáÝÇÏ
ÉáõÍáõÛÃ ÉáõÍãáí
1410
Îáå»·áõë
éǵ³íÇñÇÝ
¹»Õ³Ñ³ï»ñ
200Ù·
ü.ÐáýÙ³Ý-ȳ èáß Èï¹
Copegus
ribavirin
óճÝóå³ï
(42,112
F. Hoffmann-La Roche Ltd.
168,180,1000)
1411
Îáí»ñ»ùë
å»ñÇݹáåñÇÉ
¹»Õ³Ñ³ï»ñ
4Ù·,
¾·Çë ü³ñÙ³ëÛáõÃÇù³É Èï¹.
Ðݹϳëï³Ý
M01A B55
4437
08.08.2003
08.08.2008
²¸
Ðݹϳëï³Ý
N02B E71
5941
17.02.2006
17.02.2011
²¸
Ðݹϳëï³Ý
N02B E71
5953
17.02.2006
17.02.2011
²¸
èáõë³ëï³Ý
A11A A04
1219/7220
30.10.2007
13.09.2012
²¸
èáõë³ëï³Ý
A11A A04
1221/7221
30.10.2007
13.09.2012
²¸
¶»ñÙ³Ýdz
C07A B07
5357
¸
¶»ñÙ³Ýdz
C07A B07
4875
¶»ñÙ³Ýdz
C07A B07
5229
¶»ñÙ³Ýdz
N03A G01
0148/6206
¶»ñÙ³Ýdz
B02A B01
0102/6144
04.02.2005
04.02.2010
08.06.2004
08.06.2009
30.11.2004
30.11.2009
07.07.2006
07.07.2011
09.06.2006
09.06.2011
Þí»Ûó³ñdz
J05A B04
0762/6448
28,02.2007
27.01.2009
¸
ÐáõÝ·³ñdz
C09A A04
4394
21.07.2003
¸
¸
¸
¸
¸
96
1413
Îá-ïñÇÙûùë³½áÉ
Co-trimoxazol
1414
Îá-ïñÇÙûùë³½áÉ
Co-trimoxazol
1415
Îáñ³ùë³Ý 5Ù·
Coraxan 5mg
perindopril
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
Çí³µñ³¹ÇÝ
ivabradine
1416
Îáñ³ùë³Ý 7.5Ù·
Coraxan 7.5mg
Çí³µñ³¹ÇÝ
ivabradine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
7.5Ù·
(28,56)
1417
Îáñ·ÉÇÏáÝ
Corglycon
Ïáñ·ÉÇÏáÝ
corglyconum
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0.06%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
1418
Îáñ·ÉÇÏáÝ
Corglycon
Ïáñ·ÉÇÏáÝ
corglycon
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1419
Îáñ¹³ý»Ý
Cordafen
Îáñ¹Ç³ÙÇÝ
Cordiamin
ÝÇý»¹ÇåÇÝ
nifedipine
ÝÇϻóÙǹ
nikethamide
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
Îáñ¹ÇåÇÝ
Cordipin
Îáñ¹ÇåÇÝ XL
Cordipin XL
ÝÇý»¹ÇåÇÝ
nifedipine
ÝÇý»¹ÇåÇÝ
nifedipine
Îáñ¹ÇåÇÝ é»ï³ñ¹
Cordipin retard
Îáñ¹Çó»åë ³ñù³
Cordyceps King
Îáñ¹Çó»åë µ³ñ¹
µ³Õ³¹ñáõÃÛáõÝ
Cordyceps Complex
Formula
Îáñ¹Çó»åë ÉÇÝçÇ
å³ïÇ×Ý»ñ
Cordyceps Linji
Capsules
ÎáñÇÝý³ñ
Corinfar
ÎáñÇÝý³ñ áõÝá
ÝÇý»¹ÇåÇÝ
nifedipine
-
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
ÉáõÍáõÛà ËÙ»Éáõ
0,06%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
10Ù·
(50)
25%(2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
10Ù·
(50/5x10/)
40Ù·
(20)
-
ÉáõÍáõÛà ËÙ»Éáõ
28ÙÉ ßßÇÏ
(6)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
ÈÇÏ» êäÀ
League Ltd
ÈÇÏ» êäÀ
League Ltd
-
å³ïÇ×Ý»ñ
140Ù·
(2x12)
ÈÇÏ» êäÀ
League Ltd
âÇݳëï³Ý
βêÐ
0337\6375
21.08.2006
21.08.2011
²¸
ÝÇý»¹ÇåÇÝ
nifedipine
ÝÇý»¹ÇåÇÝ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
10Ù·
(30,50,100)
40Ù·
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
AWD pharma GmbH & Co.KG
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
¶»ñÙ³Ýdz
C08C A05
5077
¸
¶»ñÙ³Ýdz
C08C A05
5999
12.10.2004
12.10.2009
20.03.2006
1412
1420
1421
1422
1423
1424
1425
1426
1427
1428
Coverex
Îá-ïñÇÙûùë³½áÉ
Co-trimoxazole
(30)
400Ù·+80Ù·
(100x10)
Egis Pharmaceuticals Ltd.
ê³Ý³íÇï³ ²Ïïǻݷ»ë»Éß³ýï ¨ øá.
Sanavita Aktiengesellschaft &
Co.
¹»Õ³Ñ³ï»ñ
400Ù·+80Ù·
(10,20)
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
21.07.2008
11.04.2005
11.04.2010
¶»ñÙ³Ýdz
J01E E01
5290
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´»É³éáõë
J01E E01
5005
13.12.2004
13.12.2009
¸
0.48·
(10, 20)
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
èáõë³ëï³Ý
J01EE01
0581/4952/1
24.11.2006
23.07.2009
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5Ù·
(28,56)
ê»ñíÇ» Çݹ³ëïñÇ
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
ê»ñíÇ» Çݹ³ëïñÇ
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
êäÀ-Ç Ù³ëݳ×ÛáõÕ ù. ʳñÏáí
Branch of LCC §Experimental
plant GNCLS¦ c. Kharkov
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
üñ³Ýëdz
-
0326/6322
08.08.2006
08.08.2011
¸
üñ³Ýëdz
-
0327/6321
08.08.2006
08.08.2011
¸
àõÏñ³Ýdz
C01A X04
0586/6467
05.12.2006
05.12.2011
¸
àõÏñ³Çݳ
C01A X04
1120/7021
01.10.2007
01.10.2012
¸
äáÉý³ñÙ³ ê.².
Polpharma S.A.
¼¹áñáíÛ»
Zdorovye
Ȼѳëï³Ý
C08C A05
5349
¸
àõÏñ³Çݳ
R07A B02
4176
31.10.2005
31.10.2010
20.06.2003
20.06.2008
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d., Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
C08C
1012/6929
¸
êÉáí»Ýdz
C08 A05
5576
04.06.2007
04.06.2012
10.06.2005
10.06.2010
êÉáí»Ýdz
C08C
0804/6779
¸
âÇݳëï³Ý
βêÐ
0339\6377
âÇݳëï³Ý
βêÐ
0338\6376
20.03.2007
20.03.2012
21.08.2006
21.08.2011
21.08.2006
21.08.2011
20Ù·
(30/2x15/)
30ÙÉ ßßÇÏ
¸
¸
¸
²¸
²¸
¸
97
Corinfar Uno
1429
1430
1431
1432
1433
ÎáñÇÝý³ñ é»ï³ñ¹
Corinfar retard
ÎáñÇáÉ
Coryol
ÎáñÇáÉ
Coryol
ÎáñÇáÉ
Coryol
Îáñí³É¹ÇÝ-ü³ñÙ³Ï
Corvaldin-Farmak
1434
Îáñí³ÉáÉý³ñÙëï³Ý¹³ñï
CorvalolPharmstandard
1435
Îáñí³ÉáÉ-ü³ñÙ³Ï
Corvalol-Farmak
1436
ÎáñíÇïÇÝ
Corvitin
1437
ÎáñïáÙÇó»ïÇÝ
Cortomycetin
1438
Îàôβ
KUKA
1439
Îáõñ³ÝïÇÉ N25
Curantyl N25
nifedipine
óճÝóå³ï,
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ ¹³Ý¹³Õ
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
(20,50,100)
AWD pharma GmbH & Co.KG
ÝÇý»¹ÇåÇÝ
20Ù·
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
nifedipine
(30,50,100)
AWD pharma GmbH & Co.KG
ϳñí»¹ÇÉáÉ
12.5Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
carvedilol
(28,30)
KRKA d.d. Novo mesto
ϳñí»¹ÇÉáÉ
¹»Õ³Ñ³ï»ñ
6.25Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
carvedilol
(28,30)
KRKA d.d.Novo mesto
ϳñí»¹ÇÉáÉ
¹»Õ³Ñ³ï»ñ
25Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
carvedilol
(28,30)
KRKA d.d.Novo mesto
³Éý³Ï³ÃÇÉÝ»ñ
(20Ù·+18Ù·+
ü³ñÙ³Ï ´´À
µñáÙǽáí³É»ñ³ÃÃíÇ
1,4Ù·+ 0,2Ù·)/1ÙÉ,
Farmak Open JSC
¿ÃÇÉ ¿ëûñ,
25ÙÉ ßßÇÏ
ý»Ýáµ³ñµÇï³É,
³Ý³ÝáõËÇ ÛáõÕ,
·³ÛÉáõÏÇ ÛáõÕ
ethyl ester of alphabromisovaleric acid,
phenobarbital, oleum
Menthae piperitae,
oleum Humuli
ϳÃÇÉÝ»ñ
(2·+1.826·+79ÙÉ)/ ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
µñáÙǽáí³É»ñdz100ÙÉ,
Pharmstandard-Leksredstva
ݳÃÃíÇ ¿ÃÇÉ ¿ëûñ,
25ÙÉ ßßÇÏ
OJSC
ý»Ýáµ³ñµÇï³É, 95%
¿ÃÇÉ ëåÇñï
-bromisovaleriana
ethyl ester,
phenobarbital, 95%
ethyl alcohol
³Éý³Ï³ÃÇÉÝ»ñ
(20Ù·+18.26Ù·+
ü³ñÙ³Ï ´´À
µñáÙǽáí³É»ñ³ÃÃíÇ
1.42Ù·)/1ÙÉ,
Farmak JSC
¿ÃÇÉ ¿ëûñ,
25ÙÉ ßßÇÏ
ý»Ýáµ³ñµÇï³É,
³Ý³ÝáõËÇ ÛáõÕ
ethyl ester of alphabromisovaleric acid,
phenobarbital, oleum
menthae piperitae
ùí»ñó»ïÇÝ
¹»Õ³÷áßÇ
0.5·,
´áñßã³·áíÛ³Ý
åáÉÇíÇÝÇÉåÇñáÉÇÉÇáýÇÉǽ³óí³Í
ëñí³Ï (5)
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
¹áÝáí
ö´À
quercetine with
Borshchahivskiy Chemicalpolyvinylpyrrolidone
Pharmaceutical Plant CJSC
ÑǹñáÏáñïǽáÝÇ
ùëáõù
(0.005·+0.002·)/ 1·,
ÜÇÅý³ñÙ ´´À
³ó»ï³ï, ùÉáñ³Ùý»ÝÇÏáÉ
15· å³ñÏáõ×
Nizhpharm Open JSC
hydrocortisone acetate,
chloramphenicol
µáõë³Ï³Ý ѳÝáõÏÝ»ñ ûß³ñ³Ï ѳ½³Ù³ñÇã
100ÙÉ ßßÇÏ
ØáõÉï³ÝÇ ü³ñÙ³ëÛáõÃÇù³Éë
herbal extracts
Èï¹.
Multani Pharmaceuticals Ltd.
¹ÇåÇñǹ³ÙáÉ
¹»Õ³Ñ³ï»ñ
25Ù·
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
dipyridamole
óճÝóå³ï
(120)
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
20.03.2011
¶»ñÙ³Ýdz
C08C A05
5078
12.10.2004
12.10.2009
03.11.2003
03.11.2008
26.08.2005
26.08.2010
26.08.2005
26.08.2010
25.07.2007
25.07.2012
¸
êÉáí»Ýdz
C07A G02
4531
êÉáí»Ýdz
C07A G02
4530
êÉáí»Ýdz
C07A G02
4532
àõÏñ³Çݳ
N05C B02
1073/7038
èáõë³ëï³Ý
(ÎáõñëÏ)
N03A
0145/6236
29.06.2006
29.06.2011
²¸
àõÏñ³Çݳ
N05C B02
1100/7039/1
01.10.2007
16.07.2012
²¸
àõÏñ³Çݳ
C05C X10
0505/5842
07.11.2006
07.11.2011
¸
èáõë³ëï³Ý
D07C A01
5989
05.04.2006
05.04.2011
¸
Ðݹϳëï³Ý
µáõë³Ï³Ý
5352
14.06.2005
14.06.2010
²¸
¶»ñÙ³Ýdz
B01A C07
4488
29.09.2003
29.09.2008
¸
¸
¸
¸
²¸
98
1440
1442
Îñ³ï³É
Cratal
1443
Îñ»³å»Ý 500Ù·
Creapen 500mg
Îñ»³óÇÉ 500Ù·
Creacil 500mg
Îñ»áÝ 10000
Kreon 10000
óÇÝÏÇ ÑdzÉáõñáݳï
zinc hyaluronate
åñáåÇý»Ý³½áÝ,
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
propyphenazone,
paracetamol, caffeine
óáõñÇÝ, ³Éá×Ç
åïáõÕÝ»ñÇ Ñ³ÝáõÏ,
³éÛáõͳ·áõ ËáïÇ
ѳÝáõÏ
taurin, extractum
fructum Crataegi,
extractum herbae
Leonuri
³ÙåÇóÇÉÇÝ
ampicillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
å³ÝÏñ»³ïÇÝ
pancreatin
1446
Îñ»áÝ 25000
Kreon 25000
å³ÝÏñ»³ïÇÝ
pancreatin
¹»Õ³å³ïÇ×Ý»ñ
1447
Îñ»áÝ 40000
Kreon 40000
å³ÝÏñ»³ïÇÝ
pancreatin
¹»Õ³å³ïÇ×Ý»ñ
1448
ÎñÇëï»åÇÝ
Crystepin
1449
гÉǹáñ
Halidor
гÉǹáñ
Halidor
1441
1444
1445
1450
1451
1452
1453
1454
1455
1456
ÎáõñÇá½ÇÝ
Curiosin
Îáý»¹áÝ
Coffedon
гÉÇùëáÉ
Halixol
гÉÇùëáÉ
Halixol
гÉáóÝ
Halothane
гÉáå»ñǹáÉ
Haloperidol
гÉáå»ñǹáÉ
Haloperidol
гÉáå»ñǹáÉ
Haloperidol
¹áݹáÕ
15.4Ù·/15·,
15· å³ñÏáõ×
(210Ù·+250Ù·+
50Ù·)
(10,1000, 90x10)
¶»¹»áÝ èÇËï»ñ ö´À
Gedeon Richter Ltd.
ڲβ-80
JAKA-80
ÐáõÝ·³ñdz
-
4438
سϻ¹áÝdz
-
5214
¹»Õ³Ñ³ï»ñ
(867Ù·+43Ù·+
87Ù·)
(20/2x10/,
60/6x10/)
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
àõÏñ³Çݳ
-
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(100x10)
500Ù·
(100x10)
150Ù·
(20)
Îðº²î ɳµáñ³ïáñdz Laboratoires
CREAT
Îðº²î ɳµáñ³ïáñdz Laboratoires
CREAT
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶ÙµÐ
Solvay Pharmaceuticals GmbH
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶ÙµÐ
Solvay Pharmaceuticals GmbH
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶ÙµÐ
Solvay Pharmaceuticals GmbH
üñ³Ýëdz
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
300Ù·
(20)
400Ù·
/25000ØØ
³ÙÇɳ½,
40000ØØ ÉÇå³½,
1600ØØ åñáﻳ½/
(20, 50, 100)
¹ÇÑǹñá¿ñ·áÏñÇëïÇÝ,
¹»Õ³Ñ³ï»ñ
0.58Ù·+0.1Ù·+ 5Ù·
黽»ñåÇÝ, ÏÉáå³Ùǹ óճÝóå³ï (¹ñ³Å»)
(30)
dihydroergocristin,
reserpine, clopamide
µ»ÝóÇÏɳÝÇ ýáõÙ³ñ³ï
¹»Õ³Ñ³ï»ñ
100Ù·
bencyclane fumarate
(50)
µ»ÝóÇÏɳÝÇ ýáõÙ³ñ³ï
ÉáõÍáõÛÃ
50Ù·/2ÙÉ,
bencyclane fumarate
Ý»ñ³ñÏÙ³Ý
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
³ÙµñûùëáÉ
ûß³ñ³Ï
3Ù·/ÙÉ,
ambroxol
100ÙÉ ßßÇÏ
³ÙµñûùëáÉ
¹»Õ³Ñ³ï»ñ
30Ù·
ambroxol
(20)
ѳÉáóÝ
Ñ»ÕáõÏ ßÝã³éÙ³Ý
100%,
halothane
250ÙÉ ßßÇÏ
ѳÉáå»ñǹáÉ
haloperidol
ѳÉáå»ñǹáÉ
haloperidol
ѳÉáå»ñǹáÉ
haloperidol
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
5Ù·
(48)
1.5Ù·
(12, 24, 48)
5Ù·/1ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
01.09.2003
01.09.2008
19.09.2005
19.09.2010
²¸
0503/6318
25.10.2006
25.10.2011
²¸
J01C A01
4261
¸
üñ³Ýëdz
J01C A04
4260
¶»ñÙ³Ýdz
-
5865
12.06.2003
12.06.2008
12.06.2003
12.06.2008
12.12.2005
12.12.2010
¶»ñÙ³Ýdz
-
5866
12.12.2005
12.12.2010
²¸
¶»ñÙ³Ýdz
A09A A02
0528/6548
10.11.2006
10.11.2011
²¸
È»ãÇí³ ³.ë.
Lechiva a.s.
â»Ëdz
C04A E54
4411
05.08.2003
05.08.2008
¸
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
ÐáõÝ·³ñdz
C04A X11
6074
¸
ÐáõÝ·³ñdz
C04A X11
6108
23.03.2006
23.03.2011
13.04.2006
13.04.2011
¾¶Æê ´´À
EGIS PLC
¾¶Æê ´´À
EGIS PLC
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
R05CB06
0850/6866
²¸
ÐáõÝ·³ñdz
R05CB06
0851/6865
êÇñdz
N01B B01
3984
26.03.2007
26.03.2012
26.03.2007
26.03.2012
05.05.2003
05.05.2008
г۳ëï³Ý
N05A D01
4129
¸\Ð
г۳ëï³Ý
N05A D01
4690
ÐáõÝ·³ñdz
N05A D01
5420
11.07.2003
11.07.2008
26.02.2004
26.02.2009
24.05.2005
24.05.2010
²¸
¸
²¸
¸
²¸
¸
¸\Ð
¸\Ð
99
1457
гÉáå»ñǹáÉ
ѳÉáå»ñǹáÉ ¹»Ï³Ýá³ï
¹»Ï³Ýá³ï
haloperidol decanoate
Haloperidol
decanoate
1458 гÉáå»ñǹáÉ ýáñï»
ѳÉáå»ñǹáÉ
Haloperidol forte
haloperidol
1459
гÉáåñÇÉ
ѳÉáå»ñǹáÉ
Halopril
haloperidol
1460
1461
1462
гÉí»-Éáé³Ùñ·Ç
Ëï³ÝÛáõÃ
Aloe Cranberry
Concentrate
гÛóǹ-20
Hycid-20
гÛ-øñáÙ
Hi-Chrome
1463
гݷëï³óÝáÕ
ϳÃÇÉÝ»ñ
Sedative drops
1464
гñïÇÉ
Hartil
гñïÇÉ
Hartil
гñïÇÉ
Hartil
гñïÇÉ
Hartil
гñïÇÉ ¸
Hartil D
1465
1466
1467
1468
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
-
Ëï³ÝÛáõà ѻÕáõÏ
ûÙ»åñ³½áÉ
omeprazole
ùñáÙ (åÇÏáÉÇݳïÇ
Ó¨áí)
chromium (as
picolinate)
ϳïí³ËáïÇ ³ñÙ³ïÝ»ñ,
å³ïñÇÝçÇ Ëáï, µáËÝÇÇ
³ñÙ³ïÝ»ñ, ·³ÛÉáõÏÇ
ÏáÝ»ñ, ݳñ¹áëÇ
ͳÕÇÏÝ»ñ, ¿Ã³ÝáÉ
valerianae radix,
Melissae herba,
Angelica radix, Lupuli
strobili, Lavandulae
flos, ethanol
é³ÙÇåñÇÉ
ramipril
é³ÙÇåñÇÉ
ramipril
é³ÙÇåñÇÉ
ramipril
é³ÙÇåñÇÉ
ramipril
é³ÙÇåñÇÉ,
ÑǹñáùÉáñáÃdz½Ç¹
ramipril,
hydrocÑlorothiazide
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
70.52Ù·/ÙÉ
(ѳÉáå»ñǹáÉ
50Ù·/ÙÉ),
1ÙÉ ³ÙåáõÉ (5)
5Ù·
(50)
0.5% (1ÙÉ),
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
236ÙÉ ßßÇÏ
20Ù·
(30)
200ÙÏ·
(30)
ϳÃÇÉÝ»ñ
(25:25:20:15:15:
100) 35· ßßÇÏ
¹»Õ³Ñ³ï»ñ
2.5Ù·
(14, 28)
10Ù·
(14, 28)
1.25Ù·
(14, 28)
5Ù·
(14, 28)
(5Ù·+25Ù·)
(28/2x14/)
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
1469
гñïÇÉ ¸
Hartil D
é³ÙÇåñÇÉ,
ÑǹñáùÉáñáÃdz½Ç¹
ramipril,
hydrocÑlorothiazide
¹»Õ³Ñ³ï»ñ
(2,5Ù·+12,5Ù·),
(28/2x14/)
1470
л¹»ÉÇùë
ѳ½³Ù³ñÇã ûß³ñ³Ï
µ³Õ»ÕÇ ï»ñ¨Ý»ñÇ
ѳÝáõÏ
ûß³ñ³Ï
0.8· µ³Õ»ÕÇ
ï»ñ¨Ý»ñÇ Ñ³ÝáõÏ
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
N05A D01
5656
14.12.2005
14.12.2010
¸\Ð
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¼¹áñáíÛ» ܳñá¹áõ
Zdorovya narodu
ÐáõÝ·³ñdz
N05A D01
5242
¸\Ð
àõÏñ³Çݳ
N05A D01
4216
06.05.2005
06.05.2010
31.03.2003
31.03.2008
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
²ØÜ
βêÐ
5098
20.09.2004
20.09.2009
²¸
XL ɳµáñ³ïáñdz PVT Èï¹.
XL Laboratories PVT Ltd.
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
¶ºØÆ
GEMI
Ðݹϳëï³Ý
A02B C01
0013/6057
¸
º·Çåïáë
V09C
0197/6219
12.05.2006
12.05.2011
13.07.2006
13.07.2011
Ȼѳëï³Ý
HN02CZ
0477/6455
16.10.2006
16.10.2011
²¸
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾¶Æê ´´À, ¹»Õ³Ó¨Ç
³ñï³¹ñáõÃÛáõÝÁ ²Éý³Ù»¹
ü³ñµÇÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ,
¶»ñÙ³Ýdz
EGIS PLC, dosage form
manufacturer Allphamed
Pharbil Arzneimittel GmbH,
Germany
¾¶Æê ´´À, ¹»Õ³Ó¨Ç
³ñï³¹ñáõÃÛáõÝÁ ²Éý³Ù»¹
ü³ñµÇÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ,
¶»ñÙ³Ýdz
EGIS PLC, dosage form
manufacturer Allphamed
Pharbil Arzneimittel GmbH,
Germany
Îñ»í»É ØáÛ½»Éµ³Ë ¶ÙµÐ
Krewel Meuselbach GmbH
ÐáõÝ·³ñdz
C09A A05
5615
¸
ÐáõÝ·³ñdz
C09A A05
5617
ÐáõÝ·³ñdz
C09A A05
5614
ÐáõÝ·³ñdz
C09A A05
5616
ÐáõÝ·³ñdz
C09BA05
1034/6776/1
10.08.2005
10.08.2010
16.08.2005
16.08.2010
10.08.2005
10.08.2010
10.08.2005
10.08.2010
21.06.2007
26.03.2012
ÐáõÝ·³ñdz
C09BA05
1033/6775/1
21.06.2007
26.03.2012
¸
¶»ñÙ³Ýdz
-
5930
25.01.2006
25.01.2011
²¸
¸\Ð
²¸
¸
¸
¸
¸
100
Hedelix cough syrup extract Hedera helicise
1471
л¹»ÉÇùë ë.³.
Hedelix s.a.
1472
лɳñÇáõÙ
ÑÇå»ñÇÏáõÙ
Helarium Hypericum
1473
лÉÇáïáÝ
Helioton
лÉÙ³¹áÉ
Helmadol
-
Ëï³ÝÛáõà óÝÓñ
³Éµ»Ý¹³½áÉ
albendazole
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
255-285Ù· ãáñ
ѳÝáõÏ (900ÙÏ·
ÑÇå»ñÇóÇÝ)
(30, 60)
100ÙÉ, 200ÙÉ
ßßÇÏ
200Ù·
(2)
лÉÙÇÝïáùë
Helmintox
åÇñ³Ýï»É
pyrantel
¹»Õ³Ï³ËáõÛÃ
ËÙ»Éáõ
125Ù·/2.5ÙÉ,
15ÙÉ ßßÇÏ
1476 лÉÙÇÝïáùë 125Ù·
Helmintox 125mg
åÇñ³Ýï»É
pyrantel
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
125Ù·
(6)
1477 лÉÙÇÝïáùë 250Ù·
Helmintox 250mg
åÇñ³Ýï»É
pyrantel
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(3)
1474
1475
µ³Õ»ÕÇ ï»ñ¨Ý»ñÇ
ѳÝáõÏ
ivy (Hedera) leaf
extract
ëñáÑáõÝ¹Ç ãáñ ѳÝáõÏ
Hypericum dry extract
ϳÃÇÉÝ»ñ
DAC(2.22.9:1)/100ÙÉ,
100ÙÉ ßßÇÏ
0.1· ѳÝáõÏ
(1:1)/ÙÉ,
50ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(¹ñ³Å»)
1478
лٳ-ϳåë
Haema-Caps
íÇï³ÙÇÝÝ»ñ
vitamins
¹»Õ³å³ïÇ×Ý»ñ
(14)
1479
лÙá¹»½
Haemodesum
åáÉÇíǹáÝ
polyvidone
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
6%,
200ÙÉ,400ÙÉ
ëñí³Ï,
250ÙÉ,500ÙÉ
åɳëïÇÏ ÷³Ã»Ã
(60·+5.5·+0.42·+
0.56·+0.005·+
0.23·)/1000ÙÉ,
100ÙÉ, 200ÙÉ,
250ÙÉ, 400ÙÉ,
500ÙÉ åɳëïÇÏ
÷³Ã»Ã
1480 лÙá¹»½-ü³ñÙ³ï»ù åáÉÇíÇÝÇÉåÇñáÉǹá
ÉáõÍáõÛÃ
HaemodesumÝ, ݳïñÇáõÙÇ ùÉáñǹ, ϳÃÇɳݻñ³ñÏ-Ù³Ý
PharmaTech
ϳÉÇáõÙÇ ùÉáñǹ,
ϳÉóÇáõÙÇ ùÉáñǹ,
Ù³·Ý»½ÇáõÙÇ
ùÉáñǹ, ݳïñÇáõÙÇ
Ñǹñáϳñµáݳï
polyvinylpyrolidone,
sodium chloride,
potassium chloride,
calcium chloride,
magnesium chloride,
sodium hydrocarbonas
1481
лÙáÙÇóÇÝ
³½ÇÃñáÙÇóÇÝ
¹»Õ³å³ïÇ×Ý»ñ
Hemomycin
azithromycin
1482
лÙáÙÇóÇÝ
³½ÇÃñáÙÇóÇÝ
¹»Õ³÷áßÇ Ý»ñùÇÝ
Hemomycin
azithromycin
ÁݹáõÝÙ³Ý
¹»Õ³Ï³ËáõÛÃÇ
1483
лå³ÃñáÙµÇÝ
Ñ»å³ñÇÝ
¹áݹáÕ
250Ù·
(6)
200Ù·/5ÙÉ,
20ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
30000ØØ/100·,
Îñ»í»É ØáÛ½»Éµ³Ë ¶ÙµÐ
Krewel Meuselbach GmbH
¶»ñÙ³Ýdz
-
4422
04.08.2003
04.08.2008
²¸
´ÇáÝáñÇϳ ²¶
Bionorica AG
¶»ñÙ³Ýdz
N06AP
0553/6502
17.11.2006
17.11.2011
²¸
§²ñ³µá¦ êäÀ
Arabo JSC
º.Æ.ä.Æ.øá (àõáñɹ Ø»¹ÇëÇÝ,
²Ý·Édz-Ç Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
England)
ȳµáñ³ïáñdz ÆÝÝáï»ù
ÆÝï»ñݳëÇáÝ³É Laboratoires
Innotech International
ȳµáñ³ïáñdz ÆÝÝáï»ù
ÆÝï»ñݳëÇáÝ³É Laboratoires
Innotech International
ȳµáñ³ïáñdz ÆÝÝáï»ù
ÆÝï»ñݳëÇáÝ³É Laboratoires
Innotech International
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
г۳ëï³Ý
βêÐ
4449
²¸
º·Çåïáë
P02C A03
0980/7002
07.10.2003
07.10.2008
22.05.2007
22.05.2012
üñ³Ýëdz
P02C C01
4630
15.01.2004
15.01.2009
¸
üñ³Ýëdz
P02C C01
4628
30.01.2004
30.01.2009
¸
üñ³Ýëdz
P02C C01
4629
30.01.2004
30.01.2009
¸
º·Çåïáë
-
0044/5870
24.05.2006
24.05.2011
²¸
г۳ëï³Ý
-
5926
18.01.2006
18.01.2011
¸
ü³ñÙ³î»ù ö´À PharmaTech
CJSC
г۳ëï³Ý
5640
03.06.2005
03.06.2010
¸
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
лÙáý³ñÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³
J01F A10
1180/7186
¸
ê»ñµÇ³
J01F A10
1181/7187
19.09.2007
13.09.2012
19.09.2007
13.09.2012
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
ê»ñµÇ³ ¨
B01A B01,
5500
26.09.2005
²¸
¸
¸
101
1484
1485
1486
1487
1488
1489
1490
1491
1492
1493
1494
1495
1496
1497
30000
Hepathrombin
30000
лå³ÃñáÙµÇÝ
30000
Hepathrombin
30000
лå³ÃñáÙµÇÝ
50000
Hepathrombin
50000
heparin
Ñ»å³ñÇÝ
heparin
ùëáõù
40· å³ñÏáõ×
Hemofarm koncern A.D.
â»éÝá·áñdz
C05B A03
30000ØØ/100·,
40· å³ñÏáõ×
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
B01A B01,
C05B A03
5626
26.09.2005
26.09.2010
²¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
B01A B51,
C05B A53
6033
24.03.2006
24.03.2011
²¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
B01A B51,
C05B A53
6034
24.03.2006
24.03.2011
²¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
B01A B51,
C05B A53
6035
24.03.2006
24.03.2011
²¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
B01A B51,
C05B A53
6036
24.03.2006
24.03.2011
²¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
B05BA01
1444/7420
20.12.2007
20.12.2012
¸
èáõÙÇÝdz
A05BA03
0482/6498
¸
´»É³éáõë
B01A B01
0832/6861
èáõë³ëï³Ý
B01A B01
1111/7132
¶»ñÙ³Ýdz
B01A B01
4317
16.10.2006
16.10.2011
22.03.2007
22.03.2012
27.08.2007
27.08.2012
04.08.2003
04.08.2008
èáõë³ëï³Ý
C05B A53
1296/7264
15.10.2007
12.10.2012
²¸
èáõë³ëï³Ý
B01A B01
C05B A03
C05B A51
5327
03.02.2005
03.02.2010
20.01.2004
20.01.2009
¸
ÑáÙ»áå³Ã³ÛÇÝ
5308
Ñ»å³ñÇÝ Ý³ïñÇáõÙÇ,
¹áݹáÕ
(50000ØØ+250Ù·+
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
³É³ÝïáÇÝ,
250Ù·)/100·,
Hemofarm koncern A.D.
¹»ùëå³ÝûÝáÉ
40· å³ñÏáõ×
heparin sodium,
allantoin, dexpanthenol
лå³ÃñáÙµÇÝ
Ñ»å³ñÇÝ Ý³ïñÇáõÙÇ,
ùëáõù
(50000ØØ+300Ù·+
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
50000
³É³ÝïáÇÝ,
400Ù·)/100·,
Hemofarm koncern A.D.
Hepathrombin
¹»ùëå³ÝûÝáÉ
40· å³ñÏáõ×
50000
heparin sodium,
allantoin, dexpanthenol
лå³ÃñáÙµÇÝ Ð
Ñ»å³ñÇÝ Ý³ïñÇáõÙÇ,
ùëáõù
(65ØØ+2.233Ù·+
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hepathrombin H
åñ»¹ÝǽáÉáÝ,
30Ù·)/·,
Hemofarm koncern A.D.
åáÉǹáϳÝáÉ
20· å³ñÏáõ×
heparin sodium,
prednisolone,
polidocanol
лå³ÃñáÙµÇÝ Ð
Ñ»å³ñÇÝ Ý³ïñÇáõÙÇ,
ÙáÙÇÏÝ»ñ
120ØØ+1.675Ù·+
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hepathrombin H
åñ»¹ÝǽáÉáÝ,
30Ù·
Hemofarm koncern A.D.
åáÉǹáϳÝáÉ
(10)
heparin sodium,
prednisolone,
polidocanol
лå³ëáÉ-Ü»á
³ÙÇݳÃÃáõÝ»ñÇ
ÉáõÍáõÛÃ
80·/1000ÙÉ,
лÙáý³ñÙ ÏáÝó»ñÝ ².¸.
Hepasol-Neo
˳éÝáõñ¹
ϳÃÇɳݻñ³ñÏ-Ù³Ý 500ÙÉ ³å³Ï» ëñí³Ï
Hemofarm concern A.D.
mixture of amino acids
(1)
лå³ïáåñáï»Ïï
ëÇÉÇÙ³ñÇÝ
¹»Õ³Ñ³ï»ñ
70Ù·
´Çáý³ñÙ ê.².
Hepatoprotect
silymarin
(60/6x10/)
Biofarm S.A.
лå³ñÇÝ
Ñ»å³ñÇÝ
ÉáõÍáõÛÃ
5000ØØ/ÙÉ,
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
Heparin
heparin
Ý»ñ³ñÏÙ³Ý
5ÙÉ ëñí³Ï (5)
Belmedpreparaty RUP
лå³ñÇÝ
Ñ»å³ñÇÝ
ÉáõÍáõÛÃ
5000ØØ/1ÙÉ 5ÙÉ,
êÇÝû½ ´´À
Heparin
heparin
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (5)
Sintez Open JSC
лå³ñÇÝ Ý³ïñÇáõÙ
Ñ»å³ñÇÝ
ÉáõÍáõÛÃ
25000ØØ/5ÙÉ,
´.´ñ³áõÝ Ø»É½áõÝ·»Ý ²¶
´ñ³áõÝ
ݳïñÇáõÙi
Ý»ñ³ñÏÙ³Ý
5ÙÉ ëñí³Ï (10)
B.Braun Melsungen AG
Heparin natrium
heparin natrium
Braun
лå³ñÇÝ ùëáõù
Ñ»å³ñÇÝ,
ùëáõù
(100ØØ+0,04·+
ÜÇÅý³ñÙ ´´À
Heparin ointment
µ»Ý½áϳÛÇÝ,
0,0008·)/1·,
Nizhpharm Open JSC
µ»Ý½ÇÉÝÇÏáïÇݳï
25· å³ñÏáõ×
heparin, benzocaine,
benzylnikotinate
лå³ñÇÝ ü»ñ»ÛÝ
Ñ»å³ñÇÝ
ÉáõÍáõÛÃ
5000ØØ/ÙÉ,
§´ñÇÝó³Éáí - ²¦ ö´À
Heparin - Ferein
heparin
Ý»ñ³ñÏÙ³Ý
5ÙÉ ëñí³ÏÝ»ñ (5)
CJSC §Brinsalov - A¦
лå³ñáǹ È»ãÇí³
Ñ»å³ñÇÝáǹݻñ
ùëáõù
(100ØØ/Ù·)
È»ãÇí³ ³.ë.
Heparoid Lechiva
heparinoids
60Ù·/30·,
Lechiva a.s.
30· å³ñÏáõ×
лå»ÛÉ
¹»Õ³Ñ³ï»ñ
(50, 250)
´ÇáÉá·Çß Ð³ÛÉÙÇÃ»É Ð»ÛÉ
Hepeel
¶ÙµÐ
Biologische Heilmittel Heel
â»Ëdz
¶»ñÙ³Ýdz
26.09.2010
4413
04.02.2005
04.02.2010
¸
¸
¸
²¸
²¸
102
1498
лåïñ³É
Heptral
³¹»Ù»ÃÇáÝÇÝ
ademethionine
1499
лåïñ³É
Heptral
³¹»Ù»ÃÇáÝÇÝ
ademethionine
1500
лñå»íÇñ
Herpevir
³óÇÏÉáíÇñ
aciclovir
1501
лñå»íÇñ
Herpevir
лñå»íÇñ
Herpevir
лñó»åïÇÝ
Herceptin
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
aciclovir
ïñ³ëïáõ½áõÙ³µ
trastuzumab
1504
лùë³Éǽ
Hexalyse
1505
лùë³ë÷ñ»Û
Hexaspray
µÇÏÉáïÇÙáÉ,
Éǽá½ÇÙ,
¿ÝûùëáÉáÝ
biclotymol, lysozyme,
enoxolone
µÇÏÉáïÇÙáÉ
biclotimol
1506
лùëÇÏáÝ
Hexicon
ùÉáñÑ»ùëǹÇÝ
chlorhexidine
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
1507
лùëáñ³É
Hexoral
лùëáñ³É
Hexoral
ÐǷdz
Higia
ÐǹñáÏáñïǽáÝäúê Ü
HydrocortisonPOS N
ÐǹñáÏáñïǽáÝäúê Ü
HydrocortisonPOS N
ÐǹñáÏáñïǽáÝ
Hydrocortisone
ÐǹñáÏáñïǽáÝ
Hydrocortison
Ñ»ùë»ïǹÇÝ
hexetidine
Ñ»ùë»ïǹÇÝ
hexetidine
å»ñÙ»ÃñÇÝ
permethrin
ÑǹñáÏáñïǽáÝÇ
³ó»ï³ï
hydrocortisone acetate
óáÕ³ßÇÃ
ÐǹñáÏáñïǽáÝ
èÇËï»ñ
Hydrocortison
ÑǹñáÏáñïǽáÝÇ
³ó»ï³ï, ÉǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ
1502
1503
1508
1509
1510
1511
1512
1513
1514
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉÇáýÇÉǽ³óí³Í,
5ÙÉ ÉáõÍãáí
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ
Ýñµ³ùëáõù
ùëáõù
¹»Õ³Ñ³ï»ñ
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ 20ÙÉ
Ý»ñ³ñÏÙ³Ý çáõñ
ÉáõÍãáí
¹»Õ³Ñ³ï»ñ µ»ñ³ÝÇ
ËáéáãáõÙ
Ý»ñÍÍíáÕ
óáÕ³ßÇà ÏáÏáñ¹Ç
ÉáõÍáõÛÃ
û׳é³Ñ»ÕáõÏ
³Ïݳùëáõù
400Ù·,
ëñí³Ï/³ÙåáõÉ (5)
GmbH
²´´úîî ê.å.².
ABBOTT S.p.A.
400Ù·
(20/2x10/)
5%,
2·, 3·, 5·,10·
å³ñÏáõ×
2.5%,
15· å³ñÏáõ×
0.2·
(20)
440Ù·,
ëñí³Ï/ëñí³Ï (1)
Æï³Édz
A16A A02
0893/6893
20.04.2007
20.04.2012
¸
²´´úîî ê.å.².
ABBOTT S.p.A.
Æï³Édz
A16A A02
0894/6892
20.04.2007
20.04.2012
¸
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
èáõë³ëï³Ý
D06B B03
5324
15.02.2005
15.02.2010
²¸
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
æ»Ý»ï»ù ÆÝÏ.(ü.ÐáýÙ³Ý-ȳ
èáßÇ Ñ³Ù³ñ)
Genethech Inc.(for
F.Hoffmann-La Roche)
àõÏñ³Çݳ
J05A B01
0956/6923
¸
àõÏñ³Çݳ
J05A B01
0952/6905
²ØÜ
L01X C03
5488
03.05.2007
03.05.2012
03.05.2007
03.05.2012
25.04.2005
25.04.2010
(5Ù·+5Ù·+5Ù·)
(30)
´áõß³ñ³ è»Ïáñ¹³ïÇ BoucharaRecordati
üñ³Ýëdz
-
4967
04.10.2004
04.10.2009
²¸
750Ù·/30·,
30· óáÕ³ßÇÃÁ
60ÙÉ ßßÇÏáõÙ
0.016·
(10)
´áõß³ñ³ è»Ïáñ¹³ïÇ BoucharaRecordati
üñ³Ýëdz
-
4806
04.06.2004
04.06.2009
²¸
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
èáõë³ëï³Ý
4514
24.10.2003
24.10.2008
²¸
0.2%,
40ÙÉ ßßÇÏ
0.1%,
200ÙÉ ßßÇÏ
1%,
120· ßßÇÏ
1%,
2.5· å³ñÏáõ×
ä³ñÏ ¸»íǽ (öý³Û½»ñÇ Ñ³Ù³ñ)
Parke Davis (for Pfaizer)
ä³ñÏ ¸»íǽ (öý³Û½»ñÇ Ñ³Ù³ñ)
Parke Davis (for Pfaizer)
Ø»¹Çϳ ²¸
Medica AD
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co.KG
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co.KG
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
üñ³Ýëdz
B05C A02
D08A C02
R02A A05
A01A B12
5479
²¸
üñ³Ýëdz
A01A B12
5478
´áõÉÕ³ñdz
P03A C04
4519
¶»ñÙ³Ýdz
S01B A02,
S01C B03,
S02B A01
5885
11.05.2005
11.05.2010
11.05.2005
11.05.2010
05.11.2003
05.11.2008
07.02.2006
07.02.2011
¶»ñÙ³Ýdz
S01B A02,
S01C B03,
S02B A01
5886
07.02.2006
07.02.2011
¸
èáõë³ëï³Ý
D07A A02
1057/6850
²¸
Ȼѳëï³Ý
S01B A02
S01C B03
S02B A01
C05A H02A,
R01A D60
5482
10.07.2007
10.07.2012
27.04.2005
27.04.2010
14.12.2005
14.12.2010
¸
ÑǹñáÏáñïǽáÝÇ
³ó»ï³ï
hydrocortisone acetate
³Ïݳùëáõù
2.5%,
2.5· å³ñÏáõ×
ÑǹñáÏáñïǽáÝ
hydrocortisone
ÑǹñáÏáñïǽáÝ
hydrocortisone
ùëáõù
1%,
10· å³ñÏáõ×
0.5%,
3· å³ñÏáõ×
³Ïݳùëáõù
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý,
Ù³Ýñ³µÛáõñ»Õ³ó-
(125Ù·+25Ù·)/
5ÙÉ,
5ÙÉ ëñí³Ï (1)
ÐáõÝ·³ñdz
5728
¸
¸
²¸
²¸
¸
¸
103
Richter
hydrocortisone acetate,
lidocaine hydrochloride
1515 ÐǹñáùÉáñáÃdz½Ç ÑǹñáùÉáñáÃdz½Ç¹
¹
hydrochlorothiazide
Hydrochlorothiazide
1516
ϳÉÇáõÙ³Ï³Ý Éá½³ñï³Ý,
ÑǹñáùÉáñáÃdz½Ç¹
losartan potassium,
hydrochlorothiazide
1517
ÐÇÉ³Ï ýáñï»
¾ß»ñÇËdz ÏáÉÇ,
Hylak forte
ëïñ»åïáÏáÏ»ñ,³óǹáýÇɳÛÇÝ
ϳÃݳٳÝñ¿Ý»ñ,
Ñ»Éí»ïÇÏ
ϳÃݳٳÝñ¿Ý»ñ
Escherichia coli,
Streptoccocus faecalis,
Lactobacillus
acidophilus,
Lactobacillus halveticus
1518 ÐÇÏÙ³ Ùǹ³½áɳÙ
Ùǹ³½áɳÙ
Hikma midazolam
midazolam
1519
1520
1521
1522
1523
1524
1525
1526
1527
Ðǽ³ñ
Hyzaar
¹»Õ³Ñ³ï»ñ
0.025·
(20)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·+12.5Ù·
(14,28)
ϳÃÇÉÝ»ñ
(24.9481·+12.4741
·+ 12.4741· +
49.8960·)/100ÙÉ,
30ÙÉ,100ÙÉ ßßÇÏ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
àõÏñ³Çݳ
-
0500/5906
25.10.2006
25.10.2011
¸
Üǹ»éɳݹݻñ
C03A B03,
C03E A01
4627
31.03.2004
31.03.2009
¸
Ø»ñÏÉ» ¶ÙµÐ
Merckle GmbH
¶»ñÙ³Ýdz
-
5294
02.02.2005
02.02.2010
²¸
15Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
500Ù·
(16/2x8/)
125Ù·/5ÙÉ,
60ÙÉ ßßÇÏ
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
N05C D08
5389
22.11.2005
22.11.2010
¸
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
J01C A04
0659/6566
¸
êÉáí»Ýdz
J01C A04
1115/7106
12.01.2007
12.01.2012
12.09.2007
08.08.2012
250Ù·
(16/2x8/)
10·,30· å³ñÏáõ×
êÉáí»Ýdz
J01C A04
0569/6525
¸
Ðݹϳëï³Ý
-
4553
Øáɹáí³
C09A A02
1381/7344
Øáɹáí³
C09A A02
1382/7345
Øáɹáí³
C09A A02
1380/7343
ÐáõÝ·³ñdz
C03A A03
4929
24.11.2006
24.11.2011
24.11.2003
24.11.2008
28.11.2007
05.11.2012
28.11.2007
05.11.2012
28.11.2007
05.11.2012
10.06.2004
10.06.2009
ÐáõÝ·³ñdz
C03A A03
4930
10.06.2004
10.06.2009
¸
èáõë³ëï³Ý
D07C A01
5072
11.11.2004
11.11.2009
¸
üñ³Ýëdz
A10A B04
0352/6346
28.08.2006
28.08.2011
¸
³ÙûùëÇóÇÉÇÝ
amoxycillin
³ÙûùëÇóÇÉÇÝ
amoxicillin
ÐÇÏáÝóÇÉ
Hiconcil
ÐÇÙÏáÉÇÝ
Himcolin
ÐÇå»ñÇåñÇÉ
Hiperipril
ÐÇå»ñÇåñÇÉ
Hiperipril
ÐÇå»ñÇåñÇÉ
Hiperipril
ÐÇåáÃdz½Ç¹
Hypothiazid
³ÙûùëÇóÇÉÇÝ
amoxycillin
µáõë³Ï³Ý ÛáõÕ»ñ
herbal oils
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
ÑǹñáùÉáñáÃdz½Ç¹
hydrochlorothiazide
ÐÇåáÃdz½Ç¹
Hypothiazid
ÑǹñáùÉáñáÃdz½Ç¹
hydrochlorothiazide
¹»Õ³Ñ³ï»ñ
100Ù·
(20)
ÑǹñáÏáñïǽáÝÇ
³ó»ï³ï,
ûùëÇï»ïñ³óÇÏÉÇÝ
hydrocortisone acetate,
oxytetracycline
ÇÝëáõÉÇÝ Éǽåñá
insulin lispro
ùëáõù
(0.01·+0.03·)/ 1·,
10· å³ñÏáõ×
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
ÐÇٳɳ۳ ¸ñ³·.øá.
The Himalaya Drug Co.
ÜÛáõ îáÝ êèÈ.
New Tone SRL
ÜÛáõ îáÝ êèÈ.
New Tone SRL
ÜÛáõ îáÝ êèÈ.
New Tone SRL
ÊÇÝáÇÝ ¹»Õ³·áñÍ³Ï³Ý ¨
ùÇÙÇ³Ï³Ý ·áñͳñ³Ý øá.Èï¹
Chinoin Pharmaceutical and
Chemical Works Co.Ltd.
ÊÇÝáÇÝ ¹»Õ³·áñÍ³Ï³Ý ¨
ùÇÙÇ³Ï³Ý ·áñͳñ³Ý øá.Èï¹
Chinoin Pharmaceutical and
Chemical Works Co.Ltd.
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100ØØ/ÙÉ,
3ÙÉ ÷³Ù÷áõßïÝ»ñ
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
ÐáõÙ³Éá·
Humalog
¹»Õ³å³ïÇ×Ý»ñ
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
Ø»ñÏ Þ³ñå ¨ ¸áÑÙ ´.ì.
Merck Sharp & Dohme B.V.
ÐÇÏáÝóÇÉ
Hiconcil
ÐÇÏáÝóÇÉ
Hiconcil
1528 ÐÇûùëǽáÝ ùëáõù
Hyoxyson ointment
1529
í³Í
¹»Õ³÷áßÇ
¹»Õ³Ï³ËáõÛÃ
å³ïñ³ëï»Éáõ
¹»Õ³å³ïÇ×Ý»ñ
Ýñµ³ùëáõù
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
5Ù·
(20)
10Ù·
(20)
20Ù·
(20)
25Ù·
(20)
¸
²¸
¸
¸
¸
¸
104
1530
1531
ÐáõÙ³Éá·
Humalog
ÐáõÙáõÉÇÝ Ø3
Humulin M3
1532
ÐáõÙáõÉÇÝ Ø3
Humulin M3
1533
ÐáõÙáõÉÇÝ Ø3
Humulin M3
1534 ÐáõÙáõÉÇÝ ÜäÐ
Humulin NPH
1535 ÐáõÙáõÉÇÝ ÜäÐ
Humulin NPH
1536 ÐáõÙáõÉÇÝ ÜäÐ
Humulin NPH
1537
1538
ÐáõÙáõÉÇÝ
é»·áõɳñ
Humulin regular
ÐáõÙáõÉÇÝ
é»·áõɳñ
Humulin Regular
1539
ÐáõÙáõÉÇÝ
é»·áõɳñ
Humulin Regular
1540
ÒÏ³Ý ÛáõÕ
Oleum lecoris
1541
ÒÏ³Ý ÛáõÕ
Fish Oil
1542
(5)
ÇÝëáõÉÇÝ Éǽåñá
ÉáõÍáõÛÃ
100ØØ/ÙÉ,
insulin lispro
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï (1)
Ù³ñ¹áõ ÇÝëáõÉÇÝ
¹»Õ³Ï³ËáõÛÃ
100ØØ/ÙÉ,
30/70 (é»ÏáÙµÇݳÝï)
Ý»ñ³ñÏÙ³Ý
3ÙÉ ÷³Ù÷áõßïÝ»ñ
insulin human 30/70
(5)
(recombinant)
70% Ù³ñ¹áõ ǽáý³Ý
¹»Õ³Ï³ËáõÛÃ
100ØØ/ÙÉ,
ÇÝëáõÉÇÝ, 30%
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï
Ù³ñ¹áõ ÇÝëáõÉÇÝ
(é»ÏáÙµÇݳÝï ¸ÜÂ)
70% human insulin
isophane, 30% human
insulin (r DNA)
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
¹»Õ³Ï³ËáõÛÃ
100ØØ/ÙÉ (10ÙÉ),
ÇÝëáõÉÇÝ 30/70
10ÙÉ ëñí³Ï (1)
human recombinant
insulin 30/70
Ù³ñ¹áõ ǽáý³Ý
¹»Õ³Ï³ËáõÛÃ
100ØØ/ÙÉ,
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï
(é»ÏáÙµÇݳÝï ¸ÜÂ)
human insulin isophane
(r DNA)
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
¹»Õ³Ï³ËáõÛÃ
100ØØ/ÙÉ (10ÙÉ),
ǽáý³Ý ÇÝëáõÉÇÝ
10ÙÉ ëñí³Ï (1)
human isophane
recombinant insulin
Ù³ñ¹áõ ǽáý³Ý
¹»Õ³Ï³ËáõÛÃ
100ØØ/ÙÉ,
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
3ÙÉ ÷³Ù÷áõßïÝ»ñ
(é»ÏáÙµÇݳÝï)
(5)
insulin human isophane
(recombinant)
Ù³ñ¹áõ ÇÝëáõÉÇÝ
ÉáõÍáõÛÃ
100ØØ/ÙÉ,
(é»ÏáÙµÇݳÝï ¸ÜÂ)
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï
human insulin (r DNA)
Ù³ñ¹áõ é»·áõɳñ
ÉáõÍáõÛÃ
100ØØ/ÙÉ,
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
3ÙÉ ÷³Ù÷áõßïÝ»ñ
(é»ÏáÙµÇݳÝï)
(5)
insulin human regular
(recombinant)
Ù³ñ¹áõ é»ÏáÙµÇݳÝï
ÉáõÍáõÛÃ
100ØØ/ÙÉ (10ÙÉ),
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
10ÙÉ ëñí³Ï N1)
human recombinant
insulin
A ¨ D3 íÇï³ÙÇÝÝ»ñ,
¹»Õ³å³ïÇ×Ý»ñ
3750ØØ+375ØØ+
ÓÏ³Ý ÛáõÕ
÷³÷áõÏ Å»É³ïÇÝ»
33.740Ù·
vitamins A, D3,
(50)
cod-liver oil
ÓÏ³Ý ÛáõÕ
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
fish oil
(100)
ÒÏ³Ý ÛáõÕ D
ÓÏ³Ý ÛáõÕ, D2 íÇï³ÙÇÝ
íÇï³ÙÇÝáí
fish oil, vitamin D2
Fish oil with vitamin
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
üñ³Ýëdz
A10A
4958
14.07.2004
14.07.2009
28.08.2006
28.08.2011
¸
üñ³Ýëdz
A10A D01
0353/6344
¾ÉÇ ÈÇÉÇ ¨ øáÙå³ÝÇ
ÈÇÙÇïǹ
Eli Lilly & Company Limited
²ØÜ
A10A
0110/6010
09.06.2006
09.06.2011
¸
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
üñ³Ýëdz
A10A
4471
30.07.2003
30.07.2008
¸
¾ÉÇ ÈÇÉÇ ¨ øáÙå³ÝÇ
ÈÇÙÇïǹ
Eli Lilly & Company Limited
²ØÜ
A10A
0109/6011
09.06.2006
09.06.2011
¸
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
üñ³Ýëdz
A10A
4469
30.07.2003
30.07.2008
¸
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
üñ³Ýëdz
A10A C01
0351/6343
28.08.2006
28.08.2011
¸
¾ÉÇ ÈÇÉÇ ¨ øáÙå³ÝÇ
ÈÇÙÇïǹ
Eli Lilly & Company Limited
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
²ØÜ
A10A
0111/6009
09.06.2006
09.06.2011
¸
üñ³Ýëdz
A10A B01
0350/6345
28.08.2006
28.08.2011
¸
ÈÇÉÇ üñ³Ýë ê.².
Lilly France S.A.
üñ³Ýëdz
A10A
4470
30.07.2003
30.07.2008
¸
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
´áõÉÕ³ñdz
A11
4082
14.01.2003
14.01.2008
²¸
ÐáõÝ·³ñdz
A11CB
4768
08.06.2004
08.06.2009
²¸
èáõÙÇÝdz
C10A X06
0663/6654
12.01.2007
12.01.2012
²¸
´Çá·³É ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Biogal Pharmaceutical Works
Ltd.
(320Ù·+5ÙÏ·/
´Çáý³ñÙ ê.²
200ØØ/) (30/3x10/)
Biofarm S.A
¸
105
1543
1544
1545
1546
1547
1548
1549
1550
1551
1552
1553
D
س³Éáõë
Maalus
³ÉÛáõÙÇÝÇáõÙÇ,
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
132Ù·+275Ù·
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
Ù³·Ý»½ÇáõÙÇ
(60)
Pharmaceutical
Ñǹñûùëǹݻñ
aluminium and
magnesium hydroxides
س³Éûùë
³ÉÛáõÙÇÝÇáõÙÇ ¨ ¹»Õ³Ñ³ï»ñ ͳٻÉáõ
400Ù·+400Ù·
²í»ÝïÇë ü³ñÙ³ ê.å.².
Maalox
Ù³·Ý»½ÇáõÙÇ
(40)
Aventis Pharma S.p.A.
Ñǹñûùëǹݻñ
aluminium and
magnesium hydroxides
س³Éûùë
³ÉÛáõÙÇÝÇáõÙÇ,
¹»Õ³Ï³ËáõÛÃ
(525Ù·+600Ù·)/
ü³ñÙ³ïÇë (»ñ³åÉÇùë
Maalox
Ù³·Ý»½ÇáõÙÇ
ËÙ»Éáõ
15ÙÉ,
ɳµáñ³ïáñdzÛÇ Ñ³Ù³ñ)
Ñǹñûùëǹݻñ
15ÙÉ ÷³Ã»ÃÝ»ñ
Pharmatis for Laboratoires
aluminium and
(30), 250ÙÉ ßßÇÏ
Theraplix
magnesium hydroxides
س³Éûùë
³ÉÛáõÙÇÝÇáõÙÇ ¨
¹»Õ³Ï³ËáõÛÃ
(4·+3,5·)/100ÙÉ,
²í»ÝïÇë ü³ñÙ³ ê.å.².
Maalox
Ù³·Ý»½ÇáõÙÇ
ËÙ»Éáõ
250ÙÉ ßßÇÏ
Aventis Pharma S.p.A.
Ñǹñûùëǹݻñ
aluminium and
magnesium hydroxides
سµÃ»ñ³
éÇïáõùëÇÙ³µ
Ëï³ÝÛáõÃ
100Ù·/10ÙÉ
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
MabThera
rituximab
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (1, 2)
F.Hoffmann-La Roche Ltd.
ÉáõÍáõÛÃÇ
س·Ý»-B6
Ù³·Ý»½ÇáõÙÇ É³Ïï³ïÇ
¹»Õ³Ñ³ï»ñ
470Ù·+5Ù·
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Magne-B6
¹ÇÑǹñ³ï,
óճÝóå³ï
(50)
Sanofi Winthrop Industrie
åÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ
magnesium lactate
dihydrate, pyridoxine
hydrochloride
س·Ý»-B6
Ù³·Ý»½ÇáõÙÇ É³Ïï³ï, ÉáõÍáõÛà ËÙ»Éáõ (0.186·+0.936·+
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Magne-B6
Ù³·Ý»½ÇáõÙÇ
0.010·)/10ÙÉ,
Sanofi Winthrop Industrie
åǹáɳï,
10ÙÉ ³ÙåáõÉÝ»ñ
åÇñǹûùëÇÝÇ
(10, 20)
ÑǹñáùÉáñǹ
magnesium lactate,
magnesium pidalate,
piridoxine hydrochloride
س·Ý»½ÇáõÙÇ
Ù³·Ý»½ÇáõÙÇ ëáõÉý³ï
ÉáõÍáõÛÃ
25%,
´áñÇëáíÛ³Ý ´ä¶
ëáõÉý³ï
magnesium sulfate
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
Borisov Medical Preparations
Magnesium sulfate
(10)
Plant RUE
س·Ý»½ÇáõÙÇ
Ù³·Ý»½ÇáõÙÇ ëáõÉý³ï
ÉáõÍáõÛÃ
25% (5ÙÉ),
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
ëáõÉý³ï
magnesium sulfate
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
ýÇñÙ³ ´´À
Magnesium sulfate
(10)
Yerevan ChemicalPharmaceutical firm Open J/S
Company
س·Ý»ñáï
Ù³·Ý»½ÇáõÙÇ ûñáï³ï
¹»Õ³Ñ³ï»ñ
500Ù·
ìáÛ»ñí³· ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
Magnerot
magnesium orotat
(20/2x10/,
Woerwag Pharma GmbH & Co.
50/5x10/)
KG
س·Ý»ý³ñ B6
Ù³·Ý»½ÇáõÙÇ
¹»Õ³Ñ³ï»ñ
(500Ù· + 5Ù·)
´Çáý³ñÙ êå, ½.û.û
Magnefar B6
Ñǹñá³ëå³ñï³ï,
(60/6x10/)
Biofarm Sp z.o.o.
åÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ
magnesium
êÇñdz
A02A B01
A02A A04
5404
18.02.2005
18.02.2010
²¸
Æï³Édz
A02A
5851
14.12.2005
14.12.2010
²¸
üñ³Ýëdz
A02A
4977
04.10.2004
04.10.2009
²¸
Æï³Édz
A02A
5850
14.12.2005
14.12.2010
²¸
Þí»Ûó³ñdz
L01X X21
5231
10.01.2005
10.01.2010
¸
üñ³Ýëdz
A12C
A11H
4925
22.11.2004
22.11.2009
²¸
üñ³Ýëdz
A12C C06
A12C C08
4490
29.09.2003
29.09.2008
²¸
´»É³éáõë
B05X A05
5558
06.05.2005
06.05.2010
¸
г۳ëï³Ý
B05X A05
0708/6651
25.01.2007
25.01.2012
¸
¶»ñÙ³Ýdz
A12CC09
0853/6884
30.03.2007
30.03.2012
¸
Ȼѳëï³Ý
A10EC
0328/6298
11.08.2006
11.08.2011
²¸
106
1554
س·Ý¨Çï B6
Magnevit B6
1555
س·ÝáõÙ C
Magnum C
س·ñÇɳÝ
Magrilan
1556
1557
1558
1559
1560
hydroaspartate,
pyridoxine
hydrochloride
Ù³·Ý»½ÇáõÙÇ É³Ïï³ï
»ñÏÇÑǹñ³ï,
åÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ
magnesium lactate
dihydrate, pyridoxine
hydrochloride
-
ýÉáõûùë»ïÇÝÇ
ÑǹñáùÉáñǹ
fluoxetine hydrochloride
س¹áå³ï
ɨá¹áå³, µ»Ý½»ñ³½Ç¹
Madopar
levodopa, benserazid
س½»ñÇ ¨
ÃdzÙÇÝ, ϳÉóÇáõÙÇ
»ÕáõÝ·Ý»ñÇ Ñ³Ù³ñ
å³Ýïáûݳï, å³ñ³For Hair & Nails
³ÙÇÝᵻݽ³Û³ÃÃáõ,
ËÙáñÇãÝ»ñ, LóÇëïÇÝ, Ï»ñ³ïÇÝ
thiamine, calcium
pantothenate, para
aminobenzoic acid,
yeast, L-cystine,
Keratin
سÉáõ·»É-²ðöÆ
³ÉÛáõÙÇÝÇ,
Malugel-ARPI
Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹݻñ
aluminum and
magnesium hydroxydes
سÏÙÇñáñ
ÝÇýáõñ³ï»É
Macmiror
nifuratel
¹ñ³Å»
(0,47·+0,0052·)
(50)
´Çáý³ñÙ ê.².
Biofarm S.A.
èáõÙÇÝdz
A12CC
1342/7302
07.11.2007
05.11.2012
²¸
ѳµ»ñ
500Ù·,
(60)
20Ù·
(10, 30/3x10/)
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
Ø»¹áù»ÙÇ Èï¹
Medochemie Ltd.
²ØÜ
βêÐ
5396
²¸
ÎÇåñáë
N06A B03
1064/6942
16.03.2005
16.03.2010
16.07.2007
16.07.2012
100Ù·+25Ù·,
(100)
(60Ù·+60Ù·+
30Ù·+
130Ù·+20Ù·+
20Ù·)
(30)
ÐáýÙ³Ý-ȳ èáß Èï¹.
Hoffmann-La Roche Ltd
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
Þí»Ûó³ñdz
N04B A02
4190
¸
º·Çåïáë
A11D,
A11H
0196/6184
18.02.2003
18.02.2008
13.07.2006
13.07.2011
¹»Õ³Ñ³ï»ñ
200Ù·+200Ù·
(30)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
г۳ëï³Ý
D10A,
A02A,
A06A
4124
10.02.2003
10.02.2008
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(20)
Æï³Édz
G01A X05
5044
20.08.2004
20.08.2009
¸
Æï³Édz
G01A X05
G01A A01
5042
20.08.2004
20.08.2009
¸
Æï³Édz
G01A X05
G01A A01
5043
20.08.2004
20.08.2009
¸
êÉáí»Ýdz
S01F A03
0818/6825
¸
êÉáí»Ýdz
J01F A03
1010/6931
20.03.2007
20.03.2012
04.06.2007
04.06.2012
êÉáí»Ýdz
A11BA
1355/7316
13.11.2007
05.11.2012
²¸
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¸áå»É ü³ñÙ³ëÛáõÃÇóÇ ê.é.È.
(äáÉÇ Æݹáõëïñdz øÇÙÇϳ
ê.å.²-Ç Ñ³Ù³ñ)
Doppel Farmaceutici S.r.L. for
Poli Industria Chimica S.p.A.
1561 سÏÙÇñáñ ѳٳÉÇñ ÝÇýáõñ³ï»É, ÝÇëï³ïÇÝ
Ýñµ³ùëáõù
(10·+4000000ØØ)/ ¸áå»É ü³ñÙ³ëÛáõÃÇóÇ ê.é.È.
Macmiror complex
nifuratel, nystatine
Ñ»ßïáó³ÛÇÝ
100·,
(äáÉÇ Æݹáõëïñdz øÇÙÇϳ
30· å³ñÏáõ×
ê.å.²-Ç Ñ³Ù³ñ)
Doppel Farmaceutici S.r.L. for
Poli Industria Chimica S.p.A.
1562 سÏÙÇñáñ ѳٳÉÇñ ÝÇýáõñ³ï»É, ÝÇëï³ïÇÝ Ñ»ßïáó³ÙáÙÇÏÝ»ñ 500Ù·+200000ØØ ¸áå»É ü³ñÙ³ëÛáõÃÇóÇ ê.é.È.
Macmiror complex
nifuratel, nystatine
(6, 8, 12)
(äáÉÇ Æݹáõëïñdz øÇÙÇϳ
ê.å.²-Ç Ñ³Ù³ñ)
Doppel Farmaceutici S.r.L. for
Poli Industria Chimica S.p.A.
1563
سÏñáå»Ý
Ùǹ»Ï³ÙÇóÇÝ
¹»Õ³Ñ³ï»ñ
400Ù·
Îèβ ¹.¹., Üáíá Ù»ëïá
Macropen
midecamycin
óճÝóå³ï
(16/2x8/)
KRKA d.d., Novo mesto
1564
سÏñáå»Ý
Ùǹ»Ï³ÙÇóÇÝ
¹»Õ³÷áßÇ
175Ù·/5ÙÉ,
Îèβ ¹.¹. Üáíá Ù»ëïá
Macropen
midecamycin
ËÙ»Éáõ
115ÙÉ
KRKA d.d., Novo mesto
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
1565
سÏñáíÇï
íÇï³ÙÇÝÝ»ñ
å³ëï»ÕÝ»ñ
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
Makrovit
vitamins
KRKA d.d. Novo mesto
¸
²¸
¸
107
1566
سÝÇ·Éǹ
Maniglid
سÝÇÝÇÉ 1,75
Maninil 1,75
·Éǵ»ÝÏɳÙǹ
glibenclamide
·Éǵ»ÝÏɳÙǹ
glibenclamide
1568
سÝÇÝÇÉ 3,5
Maninil 3,5
·Éǵ»ÝÏɳÙǹ
glibenclamide
1569
سÝÇÝÇÉ 5
Maninil 5
·Éǵ»ÝÏɳÙǹ
glibenclamide
1570
سÝÇ-î»ù 10%
Manni-Tech 10%
Ù³ÝÇïáÉ
mannitol
1571
سÝÇïáÉ
Mannitol
Ù³ÝÇïáÉ
mannitol
1572
سÝïÇ
Manti
1573
Ø³ë³ ëùí³É»Ý
Masa Squalen
1574
سëïÇÉ»ùë
Mastilex
1575
سëïá¹ÇÝáÝ
Mastodinon
سëïá¹ÇÝáÝ
Mastodynon
سíÇï³ÉáÝ
Mavitalon
³ÉÛáõÙÇÝÇáõÙÇ ¨
Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹݻñ,
ëÇÙ»ÃÇÏáÝ
aluminium and
magnesium hydroxides,
simethicone
ëùí³É»Ý, ûÙ»·³-3
׳ñå³ÃÃáõÝ»ñ, A, D3,
E íÇï³ÙÇÝÝ»ñ, Ûá¹,
squalen, omega-3 fattty
acids, A, D3, E vitamins,
iodine
ó»ý³É»ùëÇÝÇ
ÙáÝáÑǹñ³ï,
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
cefalexin monohydrate,
gentamicin sulfate
-
1567
1576
1577
-
¹ÇÉïdz½»ÙÇ
ÑǹñáùÉáñǹ
diltiazem hydrochloride
1578
سñ³ëɳíÇÝ
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
Maraslavin
herbal extracts
1579 سñ¹áõ ÇÝëáõÉÇÝ
Ù³ñ¹áõ ÇÝëáõÉÇÝ
ÙÇùë 30/70 ì³Ïë»ñ³
human insulin
Human Insulin Mix
30/70 Vacsera
1580 سñ¹áõ ÇÝëáõÉÇÝ
Ù³ñ¹áõ ǽáý³Ý
Ü ì³Ïë»ñ³
ÇÝëáõÉÇÝ
Human Insulin N human isophane insulin
¹»Õ³Ñ³ï»ñ
0.005· (10, 20, 40,
§´ñÇÝó³Éáí - ²¦ ö´À
50, 100, 120, 150)
CJSC §Brinsalov - A¦
¹»Õ³Ñ³ï»ñ
1.75Ù·
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
(30, 60,120)
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
¹»Õ³Ñ³ï»ñ
3.5Ù·
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
(30, 60, 120)
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
¹»Õ³Ñ³ï»ñ
5Ù·
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
(120)
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
ÉáõÍáõÛÃ
10%, 250ÙÉ,
ü³ñÙ³ î»ù ö´À PharmaTech
ϳÃÇɳݻñ³ñÏ-Ù³Ý
400ÙÉ, 500ÙÉ
CJSC
åɳëïÇÏ ÷³Ã»Ã
ÉáõÍáõÛÃ
10%,
ÈÇÏíáñ ¸»Õ³·áñͳϳÝ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
200ÙÉ, 400ÙÉ
Ó»éݳñÏáõÃÛáõÝ
ëñí³ÏÝ»ñ
Liqvor Pharmaceuticals
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
200Ù·+200Ù·+
Úáõ-¾ë ü³ñÙ³ódz
25Ù·
ÆÝï»ñÝ»ßÝÉ ÆÝÏ.
(10, 50)
US Pharmacia International
Inc.
èáõë³ëï³Ý
A10B B01
5323
15.02.2005
15.02.2010
09.03.2004
09.03.2009
¸
¶»ñÙ³Ýdz
A10B B01
4718
¶»ñÙ³Ýdz
A10B B01
4717
09.03.2004
09.03.2009
¸
¶»ñÙ³Ýdz
A10BB01
0316/6293
08.08.2006
08.08.2011
¸
г۳ëï³Ý
B05B C01,
B05C X04
5638
09.11.2005
09.11.2010
¸
г۳ëï³Ý
B05C X04
4210
07.03.2003
07.03.2008
¸
²ØÜ
A02A B01
A02A A04
3536
02.06.2004
02.06.2009
²¸
¸
å³ïÇ×Ý»ñ
500Ù·
(100)
¶»É ö³ëÇýÇÏ ÆÝÏ.
Gel Pacific Inc.
üÇÉÇåÇÝÝ»
ñ
βêÐ
5208
05.11.2004
05.11.2009
²¸
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
(350Ù·+35Ù·)
/10ÙÉ, 10ÙÉ
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÇãáõÙ
ÆÝí»ë³
Invesa
Æëå³Ýdz
³Ý³ëݳµáõųϳÝ
0754/6221
15.02.2007
15.02.2012
¸
¹»Õ³Ñ³ï»ñ
(60)
¶»ñÙ³Ýdz
0149/6242
Ðáõݳëï³Ý
16.06.2004
16.06.2009
07.07.2006
07.07.2011
19.11.2004
19.11.2009
²¸
50ÙÉ,
100ÙÉ ßßÇÏ
60Ù·
(30)
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
ÑáÙ»áå³Ã³ÛÇÝ
C08D B01
4873
ϳÃÇÉÝ»ñ
´ÇáÝáñÇϳ ²¶
Bionorica AG
´ÇáÝáñÇϳ ²¶
Bionorica AG
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
´áõÉÕ³ñdz
µáõë³Ï³Ý
5629
²¸
º·Çåïáë
A10A
5238
27.09.2005
27.09.2010
04.11.2004
04.11.2009
º·Çåïáë
A10A
5237
04.11.2004
04.11.2009
¸
¹»Õ³Ñ³ï»ñ
Ñ»ÕáõÏ
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
100ÙÉ ßßÇÏ
êáý³ñÙ³ ´À
Sopharma JSC
(30ØØ é»·Ûáõɳñ
λÝë³ï»ËÝÇϳϳÝ
ÇÝëáõÉÇÝ+70ØØ ³ñ¹Ûáõݳµ»ñáõÃÛ³Ý »·Çåï³Ï³Ý
ǽáý³Ý
ÁÝÏ»ñáõÃÛáõÝ - ì³Ïë»ñ³
ÇÝëáõÉÇÝ)/ÙÉ, Egyptian Company for Biothec,
10ÙÉ ëñí³Ï (1)
Industries - Vacsera
100ØØ/ÙÉ,
λÝë³ï»ËÝÇϳϳÝ
10ÙÉ ëñí³Ï (1)
³ñ¹Ûáõݳµ»ñáõÃÛ³Ý »·Çåï³Ï³Ý
ÁÝÏ»ñáõÃÛáõÝ - ì³Ïë»ñ³
¶»ñÙ³Ýdz
4975
²¸
¸
¸
108
Vacsera
1582
سùëǹ»ùë
Maxidex
¹»ùë³Ù»Ã³½áÝ
dexamethasone
¹»Õ³Ï³ËáõÛóÏݳϳÃÇÉÝ»ñ
0.1%,
5ÙÉ ßßÇÏ
Egyptian Company for Biothec,
Industries - Vacsera
λÝë³ï»ËÝÇϳϳÝ
³ñ¹Ûáõݳµ»ñáõÃÛ³Ý »·Çåï³Ï³Ý
ÁÝÏ»ñáõÃÛáõÝ - ì³Ïë»ñ³
Egyptian Company for Biothec,
Industries - Vacsera
ê.².²ÉÏáÝ øáõíñ»áõñ Ü.ì.
S.A.Alcon-Couvreur N.V.
1583
سùëÇåÇÙ
Maxipime
ó»ý»åÇÙ
cefepime
1·,
ëñí³Ï (1)
´ñÇëïáÉ-سۻñë êùíǵ ê.å.È
Bristol-Myers Squibb S.p.L.
Æï³Édz
1584
سùëÇïñáÉ
Maxitrol
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ï³ËáõÛóÏݳϳÃÇÉÝ»ñ
A01A C02
C05A A09
D07A B19
H02A B02
J01D E01
´»É·Ç³
D07C B04
4895
31.05.2004
31.05.2009
¸
1585
سùëÇùáɹ
Maxicold
èáõë³ëï³Ý
N02B E51
1316/7287
30.10.2007
12.10.2012
²¸
1586
Ø»µ»ùë
Mebex
Ø»µ»ùë
Mebex
Ø»·³
Mega
¹»ùë³Ù»Ã³½áÝ,
(0.1%+3500ØØ/ÙÉ
ê.².²ÉÏáÝ øáõíñ»áõñ Ü.ì.
Ý»áÙÇóÇÝÇ ëáõÉý³ï,
(3.5Ù·/ÙÉ)+
S.A.Alcon-Couvreur N.V.
åáÉÇÙÇùëÇÝ ´
6000ØØ/ÙÉ),
ëáõÉý³ï
5ÙÉ ßßÇÏ
dexamethasone,
neomycin sulfate,
polymyxine B sulfate
å³ñ³ó»ï³ÙáÉ,
·ñ³ÝáõÉÝ»ñ
(0,75·+0,01·+
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
ý»ÝÇÉ¿ýñÇÝ,
ËÙ»Éáõ,
0,06·)/5·,
Pharmstandard-Leksredstva
³ëÏáñµÇݳÃÃáõ
ÉáõÍáõÛÃÇ
÷³Ã»ÃÇÏÝ»ñ (10)
OJSC
paracetamol,
ݳñÝçÇ, ÏÇïñáÝÇ,
phenylephrine, ascorbic
³½Ýí³Ùáñáõ
acid
ѳٻñáí
Ù»µ»Ý¹³½áÉ
¹»Õ³Ï³ËáõÛÃ
100Ù·/5ÙÉ,
êÇåɳ Èï¹.
mebendazole
30ÙÉ ßßÇÏ
Cipla Ltd.
Ù»µ»Ý¹³½áÉ
¹»Õ³Ñ³ï»ñ
100Ù·
êÇåɳ Èï¹.
mebendazole
(6x7x10)
Cipla Ltd.
å³ïÇ×Ý»ñ
500Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
åñá³ÝÃáódzÝǹÇÝå³ïÇ×Ý»ñ
(30,60)
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
Ý»ñ
New Spirit Naturals Inc.
proanthocyanidins
¹»ùë³Ù»Ã³½áÝ
³Ïݳ-/
0.1%,
º.Æ.ä.Æ.øá (àõáñɹ
dexamethasone
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
5ÙÉ ßßÇÏ
Ø»¹ÇëÇÝ/²ØÜ/-Ç Ñ³Ù³ñ,
ϳÃáóÇÏáí
E.I.P.I.Co (for World Medicine,
USA)
å³ïÇ×Ý»ñ
520Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
ý»ÝÇÉ¿ýñÇÝ
ÉáõÍáõÛÃ
1%,
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
phenylephrine
Ý»ñ³ñÏÙ³Ý
1ÙÉ ³ÙåáõÉÝ»ñ
êäÀ-Ç Ù³ëݳ×ÛáõÕ ù.ʳñÏáí
(10)
Branch of LCC §Experimental
plant GNCLS¦ c.Kharkov
å³ÝÏñ»³ïÇÝ
¹»Õ³Ñ³ï»ñ
(3500ØØ ÉÇå³½³, ´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
pancreatin
óճÝóå³ï
4200ØØ ³ÙÇɳ½³,
¶ñáõå)
250ØØ åñáû³½³), Berlin-Chemie AG (Menarini
(20, 40, 80, 100)
Group)
å³ÝÏñ»³ïÇÝ
¹»Õ³Ñ³ï»ñ
(10000ØØ
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
Ðݹϳëï³Ý
P02C A01
4258
¸
Ðݹϳëï³Ý
P02C A01
4158
Æéɳݹdz
βêÐ
5810
14.07.2003
14.07.2008
23.04.2003
23.04.2008
26.10.2005
26.10.2010
²ØÜ
βêÐ
5100
20.09.2004
20.09.2009
²¸
º·Çåïáë
S01B A01,
S02B A06,
S03B A01
5973
09.02.2006
09.02.2011
¸
Æéɳݹdz
βêÐ
5811
26.10.2005
26.10.2010
²¸
àõÏñ³Çݳ
C01C A06,
R01A A04
5875
12.01.2006
12.01.2011
¸
¶»ñÙ³Ýdz
H03B
4382
21.07.2003
21.07.2008
²¸
¶»ñÙ³Ýdz
A09A A02
0978/6966
22.05.2007
²¸
1581 سñ¹áõ ÇÝëáõÉÇÝ
è ì³Ïë»ñ³
Human Insulin R
Vacsera
1587
1588
1589
Ø»·³ åñá
Mega Pro
1590
Ø»¹»ùëáÉ
Medexol
1591
Ø»¹ÇëáÛ³
Medisoya
1592
Ø»½³ïáÝ
Mesaton
1593
Ø»½ÇÙ ýáñï»
Mezym forte
1594
Ø»½ÇÙ ýáñï»
Ù³ñ¹áõ é»·Ûáõɳñ
ÇÝëáõÉÇÝ
human regular insulin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
º·Çåïáë
A10A
5239
04.11.2004
04.11.2009
¸
´»É·Ç³
4889
31.05.2004
31.05.2009
¸
4476
23.01.2006
22.07.2008
¸
¸
²¸
109
10000
Mezym Forte 10000
1595
Ø»½Çå³Ý
Mezipan
1596
Ø»ÃÇÉáõñ³óÇÉ
Methyluracil
Ø»ÃÇÉáõñ³óÇÉ
Methyluracyl
Ø»ÃÇÉáõñ³óÇÉ
10% ùëáõù
Methyluracil
ointment 10%
Ø»ÃÇÉáõñ³óÇÉÇ
ùëáõù
Methyluracil
ointment
Ø»Ãáïñ»ùë³ï -¾´ºìº
MethotrexatEBEWE
Ø»Ãáïñ»ùë³ï-¾´ºìº
MethotrexatEBEWE
Ø»Ãáïñ»ùë³ï-¾µ»í»
MethotrexateEbewe
Ø»Ãáïñ»ùë³ï-¾µ»í»
MethotrexateEbewe
Ø»Ãáïñ»ùë³ï-¾µ»í»
MethotrexateEbewe
ػɻåëÇÝ
Melepsin
1597
1598
1599
1600
1601
1602
1603
1604
1605
pancreatin
óճÝóå³ï,
³Õ»ÉáõÛÍ
å³ÝÏñ»³ïÇÝ, óáõÉÇ
¹»Õ³Ñ³ï»ñ
É»ÕÇ,
óճÝóå³ï,
Ñ»ÙÇó»ÉÛáõÉá½
³Õ»ÉáõÛÍ (¹ñ³Å»)
pancreatin, bovine bile,
hemicellulose
Ù»ÃÇÉáõñ³óÇÉ
ÙáÙÇÏÝ»ñ
methyluracil
Ù»ÃÇÉáõñ³óÇÉ
ùëáõù
methyluracyl
Ù»ÃÇÉáõñ³óÇÉ
ùëáõù
methyluracil
0.5·,
ÜÇÅý³ñÙ ´À
(10)
Nizhpharm JSC
10%,
ÜÇÅý³ñÙ ´´À
Nizhpharm
25· å³ñÏáõ×
Open JSC
10%,
ÎǨٻ¹åñ»å³ñ³ï ´´À
15·, 30· å³ñÏáõ× ¨
Kievmedpreparat Open JSC
15·, 30·,100· ï³ñ³
èáõÙÇÝdz
A09A A02
0485/6495
16.10.2006
16.10.2011
²¸
èáõë³ëï³Ý
H03B
4322
¸
èáõë³ëï³Ý
-
5235
àõÏñ³Çݳ
H03B
4294
25.07.2003
25.07.2008
16.12.2004
16.12.2009
03.07.2003
03.07.2008
²¸
²¸
10%,
15·, 25· å³ñÏáõ×
ϳ٠³å³Ï» ï³ñ³
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´»É³éáõë
-
5014
13.12.2004
13.12.2009
²¸
Ù»Ãáïñ»ùë³ï
methotrexate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
50Ù·/5ÙÉ (5ÙÉ),
ëñí³Ï (1)
²íëïñdz
L01B A01
1453/7382
20.12.2007
20.12.2012
¸
Ù»Ãáïñ»ùë³ï
methotrexate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10Ù·/1ÙÉ (1ÙÉ),
ëñí³Ï (1)
²íëïñdz
L01B A01
1454/7383
20.12.2007
20.12.2012
¸
Ù»Ãáïñ»ùë³ï
methotrexate
¹»Õ³Ñ³ï»ñ
2.5Ù·
(50)
²íëïñdz
L01B A01
L04A X03
5113
06.12.2004
06.12.2009
¸
Ù»Ãáïñ»ùë³ï
methotrexate
¹»Õ³Ñ³ï»ñ
5Ù·
(50)
²íëïñdz
L01B A01
L04A X03
5114
06.12.2004
06.12.2009
¸
Ù»Ãáïñ»ùë³ï
methotrexate
¹»Õ³Ñ³ï»ñ
10Ù·
(50)
²íëïñdz
L01B A01
L04A X03
5115
06.12.2004
06.12.2009
¸
ϳñµ³Ù³½»åÇÝ
carbamazepine
¹»Õ³Ñ³ï»ñ
200Ù·
(50/5x10/)
º·Çåïáë
N03AF01
0383/6408
12.09.2006
12.09.2011
¸
25Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
25Ù·
(50)
(15Ù·+2Ù·+100Ù·)
(30)
¾´ºìº ü³ñÙ³ ¶»ë. Ù.µ.Ð. Üý·. ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë. Ù.µ.Ð. Üý·. ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ. Ð. Üý·. ζ
EBEWE Pharma Ges m.b.H.
Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ. Ð. Üý·. ζ
EBEWE Pharma Ges m.b.H.
Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ. Ð. Üý·. ζ
EBEWE Pharma Ges m.b.H.
Nfg.KG
꺸ÆÎà ü³ñÙ³ëÛáõÃÇù³É øá.
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²Ý·Édz)
SEDICO Pharmaceutical Co.
(for World Medicine, England)
¾¶Æê ´´À
EGIS PLC
ÐáõÝ·³ñdz
N06AA02
0847/6869
26.03.2007
26.03.2012
¸
¾¶Æê ´´À
EGIS PLC
²í»ñëÇ-è³ÃÇáÝ³É êäÀ
Aversi-Rational Ltd
ÐáõÝ·³ñdz
N06AA02
0848/6868
¸
ìñ³ëï³Ý
R03C R
1226/7142
26.03.2007
26.03.2012
25.09.2007
13.09.2012
²í»ñëÇ-è³óÇáÝ³É êäÀ
ìñ³ëï³Ý
R03C
1099/7107
08.08.2007
¸
ÇÙÇåñ³ÙÇÝ
imipramine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1607
Ø»ÉÇåñ³ÙÇÝ
Melipramin
Ø»ÉáÝ
Melon
ÇÙÇåñ³ÙÇÝ
imipramine
³ÙµñûùëáÉÇ
ÑǹñáùÉáñǹ,
ë³Éµáõï³ÙáÉÇ ëáõÉý³ï,
·áõ³Ûý»Ý»½ÇÝ
ambroxol
hydrochloride,
salbutamol sulfate,
guaifenesin
³ÙµñoùëáÉÇ
¹ñ³Å»
Ø»ÉáÝ
´Çáý³ñÙ ê.².
Biofarm S.A.
22.05.2012
ùëáõù
Ø»ÉÇåñ³ÙÇÝ
Melipramin
1609
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
Ù»ÃÇÉáõñ³óÇÉ
methyluracil
1606
1608
ÉÇå³½³+ 7500ØØ
³ÙÇɳ½³+ 375ØØ
åñáû³½³)
(10, 20)
200Ù·+25Ù·+5Ù·
(20)
¹»Õ³Ñ³ï»ñ
ûß³ñ³Ï
(15Ù·+1Ù·+50Ù·)/
¸
110
Melon
1610
Ø»ÙáåɳÝï
Memoplant
1611
Ø»Ùáñdz
Memoria
Ø»ï»áëå³½ÙÇÉ
Meteospasmyl
Ø»ïÇݹáÉ é»ï³ñ¹
Metindol retard
Ø»ïÇåñ»¹
Metypred
Ø»ïÇåñ»¹
Metypred
1612
1613
1614
1615
1616
Ø»ïáÏÉáåñ³Ùǹ
Metoclopramide
1617
ÑǹñáùÉáñǹ,
ë³Éµáõï³ÙáÉÇ ëáõÉý³ï,
·áõ³Ûý»Ý»½ÇÝ
ambroxol
hydrochloride,
salbutamol sulfate,
guaifenesin
·ÇÝÏ·á µÇÉáµ³ÛÇ ãáñ
ѳÝáõÏ
dry extract from Ginkgo
biloba
³Éí»ñÇÝ, ëÇÙ»ïÇÏáÝ
alverine, simeticone
ÇݹáÙ»ï³óÇÝ
indometacin
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
Ù»ïáÏÉáåñ³Ùǹ
metoclopramide
Ø»ïáåñáÉáÉ
Metoprolol
1618 Ø»ïáåñáÉáÉ - ÎØä
Metoprolol - KMP
1619 Ø»ïáåñáÉáÉ È»Ï
Metoprolol Lek
Ù»ïáåñáÉáÉ
metoprolol
Ù»ïáåñáÉáÉ
metoprolol
Ù»ïáåñáÉáÉÇ
ëáõÏóÇݳï
metoprolol succinate
1620
Ø»ïáåñáÉáÉ È»Ï
Metoprolol Lek
Ù»ïáåñáÉáÉÇ
ëáõÏóÇݳï
metoprolol succinate
1621
Ø»ïáåñáÉáÉ È»Ï
Metoprolol Lek
Ù»ïáåñáÉáÉÇ
ëáõÏóÇݳï
metoprolol succinate
1622
Ø»ïñá·ÇÉ
Metrogyl
Ù»ïñáÝǹ³½áÉ
metronidazole
1623
Ø»ïñá·ÇÉ
Metrogyl
Ù»ïñáÝǹ³½áÉ
metronidazole
5ÙÉ,
100ÙÉ ßßÇÏ
Aversi-Rational Ltd
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
40Ù·
(30)
¸ñ.ìÇÉÙ³ñ Þí³µ» ¶ÙµÐ ¨ øá.
Dr.Willmar Schwabe GmbH
&Co.
¶»ñÙ³Ýdz
N06B X19,
µáõë³Ï³Ý
5551
31.05.2005
31.05.2010
²¸
ϳÃÇÉÝ»ñ
20ÙÉ, 50ÙÉ,
100ÙÉ ßßÇÏ
60Ù·+300Ù· (20,
30, 40)
75Ù·
(50/2x25/)
4Ù·
(30, 100)
250Ù·+4ÙÉ,
ëñí³Ï/³ÙåáõÉ (1)
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Richard Bittner AG
سÛáÉÇ êåÇݹ»ñ ȳµáñ³ïáñdz
Mayoly Spinder Laboratoires
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
ICN Polfa Rzeszow S.A.
úñÇáÝ Îáñåáñ»ÛßÝ
Orion Corporation
úñÇáÝ Îáñåáñ»ÛßÝ
Orion Corporation
²íëïñdz
5681
Ȼѳëï³Ý
M01A B01
0455/6400
üÇÝɳݹdz
4708
üÇÝɳݹdz
D07A A01,
H02A B04
H02A B04
19.09.2005
19.09.2010
01.04.2005
01.04.2010
29.09.2006
29.09.2011
25.02.2004
25.02.2009
25.02.2004
25.02.2009
²¸
üñ³Ýëdz
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
A03A X58
´»É³éáõë
A03F A01
5125
13.12.2004
13.12.2009
¸
Ȼѳëï³Ý
C07A B02
0457/6398
¸
àõÏñ³Çݳ
C07A B02
3904
¶»ñÙ³Ýdz
C07AB02
1474/7405
29.09.2006
29.09.2011
12.02.2003
12.02.2008
20.12.2007
20.12.2012
¶»ñÙ³Ýdz
C07AB02
1475/7406
20.12.2007
20.12.2012
¸
1473/7404
20.12.2007
20.12.2012
¸
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý/
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ,
ÉáõÍãáí
¹»Õ³Ñ³ï»ñ
0.01·
´áñÇëáíÛ³Ý ´ä¶
(10, 20, 25, 30, 40, Borisov Medical Preparations
50)
Plant RUP
¹»Õ³Ñ³ï»ñ
50Ù·
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
(40/2x20/)
ICN Polfa Rzeszow S.A.
¹»Õ³Ñ³ï»ñ
0.05·
ÎǨٻ¹åñ»å³ñ³ï ´´À
(10, 20)
Kievmedpreparat Open JSC
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
95Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.
³½¹»óáõÃÛ³Ý
(30, 50, 100)
ѳٳñ)
Salutas Pharma GmbH (for Lek
d.d.)
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
190Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.³½¹»óáõÃÛ³Ý
(30, 50, 100)
Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for Lek
d.d.)
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
47.5Ù·
ê³ÉÛáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï
³½¹»óáõÃÛ³Ùµ
(30, 50, 100)
¹.¹.-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for Lek
d.d.)
¹áݹáÕ
10Ù·/·,
ÚáõÝÇù ü³ñÙ³ëÛáõÃÇù³É
Ñ»ßïáó³ÛÇÝ
30· å³ñÏáõ×
ɳµáñ³ïáñdz (æÇ.´Ç.øÇÙdzϳÝ
¨ ¹»Õ³·áñÍ³Ï³Ý Èï¹.
Ù³ëݳ×ÛáõÕ)
Unique Pharmaceutical
Laboratories (A.division of
J.B.Chemicals &
Pharmaceuticals Ltd.
¹»Õ³Ñ³ï»ñ
200Ù·
ÚáõÝÇù ý³ñÙ³ëÛáõÃÇù³É
óճÝóå³ï
(20, 500)
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
08.08.2012
¶»ñÙ³Ýdz
5401
4709
²¸
¸
¸
¸
¸
¸
Ðݹϳëï³Ý
D06B X01
G01A F01
J01X D01
P01A B01
4886
04.06.2004
04.06.2009
¸
Ðݹϳëï³Ý
A01A B17,
J01X D01,
P01A B01
4365
31.03.2004
31.03.2009
¸
111
1624
Ø»ïñá·ÇÉ
Metrogyl
Ù»ïñáÝǹ³½áÉ
metronidazole
¹áݹáÕ
1%,
30·, 50· å³ñÏáõ×
ÚáõÝÇù ý³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
Ðݹϳëï³Ý
1625
Ø»ïñá·ÇÉ
Metrogyl
Ù»ïñáÝǹ³½áÉ
metronidazole
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
400Ù·
(20, 500)
Ðݹϳëï³Ý
1626
Ø»ïñá·ÇÉ ¹»Ýï³
Metrogyl denta
¹áݹáÕ
(10Ù·+0,5Ù·)/·,
5·, 10·, 20·, 30·,
50· å³ñÏáõ×
1627
Ø»ïñáÝǹ³½áÉ
Metronidazol
Ø»ïñáÝǹ³½áÉ
Metronidazol
Ù»ïñáÝǹ³½áÉ,
ùÉáñÑ»ùëǹÇÝÇ 20%
ÉáõÍáõÛÃ
metronidazole, 20%
solution of
chlorhexidine
Ù»ïñáÝǹ³½áÉ
metronidazole
Ù»ïñáÝǹ³½áÉ
metronidazole
ÚáõÝÇù ý³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
ÚáõÝÇù ü³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
¹»Õ³Ñ³ï»ñ
250Ù·
(20)
0.25·
(20)
Ø»ïñáÝǹ³½áÉ
Metronidazol
Ø»ïñáÝǹ³½áÉ
Metronidazole
Ù»ïñáÝǹ³½áÉ
metronidazole
Ù»ïñáÝǹ³½áÉ
metronidazole
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
500Ù·
(10)
500Ù·/100ÙÉ
(0.5%),
100ÙÉ ëñí³Ï (1)
1631
Ø»ïñáÝǹ³½áÉ
Metronidazole
Ù»ïñáÝǹ³½áÉ
metronidazole
¹»Õ³Ñ³ï»ñ
1632
Ø»ïñáÝǹ³½áÉ
500Ù·
Metronidazole
500mg
Ù»ïñáÝǹ³½áÉ
metronidazole
1633
Ø»ïñáÝǹ³½áÉ
¹»Ýï³
Metronidazole
Denta
Ø»ïñáÝǹ³½áÉ
Ý.».´ñ³áõÝ
Metronidazol i.v.
Braun
Ø»ïñáÝǹ³½áÉ
ÜÇÏáÙ»¹
Metronidazole
Nycomed
Ø»ïñáÝǹ³½áÉ
ÜÇÏáÙ»¹
Metronidazole
Nycomed
Ø»ïýáñÙÇÝ È»Ï
Metformin Lek
1628
1629
1630
1634
1635
1636
1637
A01A B17,
J01X D01,
P01A B02,
D06B X01,
G01A F01
A01A B17,
J01X D01,
P01A B01
4364
31.03.2004
31.03.2009
¸
4366
31.03.2004
31.03.2009
¸
Ðݹϳëï³Ý
A01A B11
1089/7108
01.10.2007
08.08.2012
²¸
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
ü³ñÙ³åñÇÙ êèÈ
Farmaprim SRL
ê³Ý³íÇï³ ²Ïïǻݷ»½»Éß³ýï ¨ øá.
Sanavita Aktiengeaellschaft &
Co.
´áõÉÕ³ñdz
J01XD 01
1341/7300
¸
èáõë³ëï³Ý
J01X D01
0582/4951/1
06.11.2007
05.11.2012
24.11.2006
23.07.2009
Øáɹáí³
G01A F01
1315/7284
¸
¶»ñÙ³Ýdz
4384
250Ù·
(10x100)
ê³Ý³íÇï³ ²Ïïǻݷ»½»Éß³ýï ¨ øá.
Sanavita Aktiengesellschaft &
Co.
¶»ñÙ³Ýdz
4923
28.09.2004
28.09.2009
¸
¹»Õ³Ñ³ï»ñ
500Ù·
[(10+B11) /ï³ñ³/,
(20) /2x10/
µÉÇëï»ñ]
г۳ëï³Ý
0212/5709
26.07.2006
26.07.2011
¸
Ù»ïñáÝǹ³½áÉ
metronidazole
¹áݹáÕ
1%,
20· å³ñÏáõ×
ÜúÎÆ Ñ³Û³Ù»ñÇϳ·»ñٳݳϳÝ
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ êäÀ
NOKI Armenian-AmericanGerman Pharmac.J.V. Co. Ltd
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
A01A B17
J01X D01
P01A B01
D06B X01
A01A B17
D06B X01
G01A F01
J01X D01
A01A B17,
J01X D01
23.10.2007
12.10.2012
23.12.2003
23.12.2008
4205
10.02.2003
10.02.2008
¸
Ù»ïñáÝǹ³½áÉ
metronidazole
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
500Ù·/100ÙÉ,
100ÙÉ ëñí³Ï (1)
´.´ñ³áõÝ Ø»É½áõÝ·»Ý ²¶
B.Braun Melsungen AG
¶»ñÙ³Ýdz
D06B X01
G01A F01
J01X D01
S02A A13
J01X D01
4316
14.07.2003
14.07.2008
¸
Ù»ïñáÝǹ³½áÉ
metronidazole
¹»Õ³Ñ³ï»ñ
500Ù·
(20, 100)
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
Nycomed Danmark A/S
¸³Ýdz
J01X D01
P01A B01
4373
27.06.2003
27.06.2008
¸
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
Nycomed Danmark A/S
¸³Ýdz
J01X D01
4374
27.06.2003
27.06.2008
¸
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.Ç /êÉáí»Ýdz/ ѳٳñ
Salutas Pharma GmbH (for Lek
d.d., Slovenia)
¶»ñÙ³Ýdz
A10B A02
1479/7372
20.12.2007
20.12.2012
¸
Ù»ïñáÝǹ³½áÉ
metronidazole
Ù»ïýáñÙÇÝÇ
ÑǹñáùÉáñǹ
metformin
hydrochloride
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
5Ù·/ÙÉ,
ϳÃÇɳݻñ³ñÏ-Ù³Ý 20ÙÉ,100ÙÉ ³å³Ï»
ϳ٠åɳëïÇÏ ßßÇÏ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
850Ù·
(30, 120)
г۳ëï³Ý
¸
¸
112
1638
Ø»ïýáñÙÇÝ È»Ï
Metformin Lek
1639
Ø»ñǹdz 10Ù·
Meridia 10mg
Ø»ñǹdz 15Ù·
Meridia 15mg
Ø»ñϳ½áÉÇÉ
Mercasolil
Ø»ñϳ½áÉÇɼ¹áñáíÛ»
MercazolylZdorovye
Ø»ñϳóÇÝ
Merkacin
1640
1641
1642
1643
Ù»ïýáñÙÇÝÇ
ÑǹñáùÉáñǹ
metformin
hydrochloride
ëǵáõïñ³ÙÇÝ
sibutramine
ëǵáõïñ³ÙÇÝ
sibutramine
Ãdzٳ½áÉ
thiamazole
Ãdzٳ½áÉ
thiamazole
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(30, 120)
¹»Õ³å³ïÇ×Ý»ñ
10Ù·
(28, 84)
15Ù·
(7, 14)
0.005·
(50)
5Ù·
(50, 100)
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
³ÙÇϳóÇÝ
amikacin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100Ù·/2ÙÉ,
ëñí³Ï (1)
1644
Ø»ñϳóÇÝ
Merkacin
³ÙÇϳóÇÝ
amikacin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
500Ù·/2ÙÉ,
ëñí³Ï (1)
1645
Ø»ñó ëå»ódzÉ
¹ñ³Å»Ý»ñ
Merz Spezial
dragees
Ø»ó»ï³Ù
Mecetam
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
vitamins, minerals
¹ñ³Å»
(60)
åÇñ³ó»ï³Ù
piracetam
¹»Õ³å³ïÇ×Ý»ñ
400Ù·
(60)
1647
Ø»ùë³ñÇïÙ
Mexaritm
Ù»ùëÇÉ»ïÇÝ
mexiletine
¹»Õ³å³ïÇ×Ý»ñ
200Ù·
(20/2x10/)
1648
Ø»ùëǹ³Ýï
Mexidant
¿ÃÇÉÙ»ÃÇÉÑǹñûùë
ÇåÇ-ñǹÇÝÇ
ëáõÏóÇݳï
ethylmethylhydroxypiridine succinat
ÉáõÍáõÛÃ Ý/» ¨
Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
50Ù·/ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
1649
Ø»ùëǹáÉ
Mexidol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
5%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
1650
Ø»ùëǹáÉ
Mexidol
1651
Ø»ùëÇÉ
2-¿ÃÇÉ-6-Ù»ÃÇÉ-3ÑǹñûùëÇåÇñǹÇÝ
ëáõÏóÇݳï
2-ethyl-6-methyl-3hydroxypyridin
succinate
2-¿ÃÇÉ-6-Ù»ÃÇÉ-3ÑǹñûùëÇåÇñǹÇÝ
ëáõÏóÇݳï
2-ethyl-6-methyl-3hydroxypyridin
succinate
¿ÃÇÉÙ»ÃÇÉÑǹñûùë
1646
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.Ç Ñ³Ù³ñ /êÉáí»Ýdz/)
Salutas Pharma GmbH (for Lek
d.d., Slovenia)
²´´úîî ¶ÙµÐ ¨ øá. ζ
ABBOTT GmbH & Co.KG
²´´úîî ¶ÙµÐ ¨ øá. ζ
ABBOTT GmbH & Co.KG
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
º.Æ.ä.Æ.øá
(àõáñɹ Ø»¹ÇëÇÝ, ²Ý·Édz-Ç
ѳٳñ)
º.Æ.ä.Æ.øá
(àõáñɹ Ø»¹ÇëÇÝ, ²Ý·Édz-Ç
ѳٳñ)
Ø»ñó ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ³²
Merz Pharma GmbH & Co.
KGaA
¶»ñÙ³Ýdz
A10B A02
1478/7371
20.12.2007
20.12.2012
¸
¶»ñÙ³Ýdz
A08A A10
0415/5734
¸
¶»ñÙ³Ýdz
A08A A10
0416/5735
èáõë³ëï³Ý
H03B B02
5066
àõÏñ³Çݳ
H03B B02
1248/7054
19.09.2006
19.09.2011
19.09.2006
19.09.2011
11.11.2004
11.11.2009
15.10.2007
15.10.2012
º·Çåïáë
J01G B06
0636/6661
27.12.2006
27.12.2011
¸
º·Çåïáë
J01G B06
0635/6662
27.12.2006
27.12.2011
¸
¶»ñÙ³Ýdz
-
5065
01.09.2004
01.09.2009
²¸
ÚáõÝÇý³ñÙ³ (àõáñɹ
Ø»¹ÇëÇÝ) (²Ý·Édz-Ç Ñ³Ù³ñ)
Unipharma (for World
Medicine, England)
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
èáõë³ëï³ÝÇ ëñï³µ³Ý³Ï³Ý
·Çï³³ñï³¹ñ³Ï³Ý ѳٳÉÇñÇ
µÅßϳϻÝë³µ³Ý³Ï³Ý
å³ïñ³ëïáõÏÝ»ñÇ ÷áñÓ³ñ³ñ³Ï³Ý
³ñï³¹ñáõÃÛáõÝ
Russian cardiology research
and production complexexperimental plant for
biomedical products
¾É³ñ³ êäÀ (ü³ñÙ³ëáýï êäÀ-Ç
ÉÇó»Ý½Ç³Ûáí)
Ellara Ltd by license of
Pharmasoft Ltd
º·Çåïáë
N06B X03
1050/7075
02.07.2007
02.07.2012
¸
àõÏñ³Çݳ
C01B B02
0091/6069
09.06.2006
09.06.2011
¸
èáõë³ëï³Ý
N07X X
1206/7207
02.10.2007
13.09.2012
¸
èáõë³ëï³Ý
-
5234
04.04.2005
04.04.2010
¸
5233
04.04.2005
04.04.2010
¸
1165/7146
13.09.2007
¸
0.125·
ØÇñ ü³ñÙ ö´À (ü³ñÙ³ëáýï êäÀ(10, 20, 30, 40, 60)
Ç ÉÇó»Ý½Ç³Ûáí)
MIR-PHARM CJSC by license
of Pharmasoft Ltd
125Ù·
²ðöÆغ¸ ÐÒ ö´À
èáõë³ëï³Ý
г۳ëï³Ý
N07XX
¸
¸
¸
113
Mexil
1652
1653
Ø»ùëÇϳÙ
Mexicam
Ø»ùëÇϳÙ
Mexicam
1654
Ø»ý»Ý³ï
Mefenat
1655
ØdzϳÉóÇÏ
Miacalcic
1656
ÇåÇñÇ-¹ÇÝÇ
ëáõÏóÇݳï
ethylmethylhydroxypiridine succinat
Ù»ÉûùëÇϳÙ
meloxicam
Ù»ÉûùëÇϳÙ
meloxicam
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ùëáõù
(30)
ARPIMED J.V. CJ-S Co.
13.09.2012
15Ù·
(10)
15Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(6)
(0,5·+10·)/100·,
40·, 80· å³ñÏáõ×
¸»Éï³ ü³ñÙ³ ê.².º.
Delta Pharma S.A.E.
¸»Éï³ ü³ñÙ³ ê.².º.
Delta Pharma S.A.E.
º·Çåïáë
M01A C06
1170/7165
º·Çåïáë
M01A C06
1171/7166
ü³ñÙ³Ï ´´À
Farmak Open JSC
àõÏñ³Çݳ
M01A G01
13.09.2007
13.09.2012
13.09.2007
13.09.2012
¸
1062/6746
16.07.2007
16.07.2012
²¸
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100ØØ/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
Üáí³ñïÇë ü³ñÙ³ ².¶.
Novartis Pharma AG
Þí»Ûó³ñdz
-
4049
25.02.2003
25.02.2008
¸
ØǹáϳÉÙ
Mydocalm
Ù»ý»Ý³ÙÇÝ
ݳïñÇáõÙÇ, íÇÝÇÉÇÝ
mefenamic sodium,
vinilin
ë³ÕÙáÝÇ ëÇÝûïÇÏ
ϳÉóÇïáÝÇÝ
synthetic salmon
calcitonin
ÃáÉå»ñǽáÝ
tolperisone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
150Ù·
(30)
ÐáõÝ·³ñdz
M03B X04
4729
24.02.2004
24.02.2009
¸
1657
ØǹáϳÉÙ
Mydocalm
ÃáÉå»ñǽáÝ
tolperisone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(30)
ÐáõÝ·³ñdz
M03B X04
4728
24.02.2004
24.02.2009
¸
1658
ØǹáϳÉÙ
Mydocalm
ïáÉå»ñǽáÝ,
ÉǹáϳÛÇÝ
tolperisone, lidocaine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
·áñͳñ³Ý ö´À
Chemical Works Gedeon
Richter Ltd.
¶»¹»áÝ èÇËï»ñ ùÇÙdzϳÝ
·áñͳñ³Ý ö´À
Chemical Works Gedeon
Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
M03B X04
5424
01.06.2005
01.06.2010
¸
1659
ØÇÉ·³Ù³
Milgamma
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¶»ñÙ³Ýdz
A11D B03
0746/6751
15.02.2007
15.02.2012
¸
1660
ØÇÉ·³Ù³
Milgamma
(100Ù·+100Ù·),
ìáÛ»ñí³· ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
(30/2x15/, 60/4x15) Woerwag Pharma GmbH & Co.
KG
¶»ñÙ³Ýdz
A11DB01
0873/6885
30.03.2007
30.03.2012
¸
1661
ØÇɹñáݳï
Mildronat
1662
ØÇɹñáݳï
Mildronat
ÃdzÙÇÝÇ
ÑǹñáùÉáñǹ,
åÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ,
ódzÝáÏᵳɳÙÇÝ,
ÉǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ
thiamine hydrochloride,
pyridoxine
hydrochloride,
cyanocobalamine,
lidocaine hydrochloride
µ»ÝýáÃdzÙÇÝ,
åÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ
benfotiamine,
pyridoxine
hydrochloride
ïñÇÙ»ÃÇÉÑǹñ³½ÇÝ
åñáåÇáݳïÇ ¹ÇÑǹñ³ï
trimethylhydrazine
propionate dihydrate
ïñÇÙ»ÃÇÉÑǹñ³½ÇÝ
åñáåÇáݳïÇ ¹ÇÑǹñ³ï
trimethylhydrazine
propionate dihydrate
(100Ù·+2.5Ù·)/1ÙÉ
,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
(100Ù·+100Ù·+
êáÉÛáõý³ñÙ ¶ÙµÐ (ìáÛ»ñí³·
1000ÙÏ·+20Ù·)
ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ-Ç Ñ³Ù³ñ)
/2ÙÉ, 2ÙÉ
Solupharm GmbH (for
³ÙåáõÉÝ»ñ (5)
Woerwag Pharma GmbH &
Co.KG)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ûß³ñ³Ï
250Ù·/5ÙÉ,
250ÙÉ ßßÇÏ
¶ñÇݹ»ùë ´À
Grindex JSC
ȳïídz
C01EB
0433/6442
26.09.2006
26.09.2011
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10%,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
¶ñÇݹ»ùë ´À
Grindex JSC
ȳïídz
C01E B
0679/6721
17.01.2007
17.01.2012
¸
114
1663
ØÇɹñáݳï
Mildronat
ïñÇÙ»ÃÇÉÑǹñ³½ÇÝ
åñáåÇáݳïÇ ¹ÇÑǹñ³ï
trimethylhydrazine
propionate dihydrate
ÙÇÏáݳ½áÉ,
Ù»ïñáÝǹ³½áÉ
miconazole,
metronidazole
ÙÇÏáݳ½áÉÇ ÝÇïñ³ï
miconazole nitrate
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(40/4x10/)
¶ñÇݹ»ùë ´À
Grindex JSC
ȳïídz
C01E B
0678/6720
17.01.2007
17.01.2012
¸
1664
ØÇÏá åÉÛáõë
Mico Plus
ûíáõɳݻñ
(150Ù·+500Ù·)
(10)
γëå³ñ Þ³µ³ÝÇ È³µë
Kaspar Chabani Labs
êÇñdz
G01A F01
6115
06.04.2006
06.04.2011
¸
1665
ØÇÏá·»É - ÎØä
Micogel - KMP
¹áݹáÕ
2%,
15· å³ñÏáõ×
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
àõÏñ³Çݳ
3902
12.02.2003
12.02.2008
²¸
ùëáõù
(2.5Ù·+20Ù·)/1·,
15· å³ñÏáõ×
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
5659
14.12.2005
14.12.2010
¸
ØÇÏá½áñ³É
Mycosoral
ØÇÏá½áñ³É
Mycosoral
Ù³½Çåñ»¹áÝ
ÑǹñáùÉáñǹ,
ÙÇÏáݳ½áÉ
mazipredone
hydrochloride,
miconazole
Ï»ïáÏáݳ½áÉ
ketoconazole
Ï»ïáÏáݳ½áÉ
ketoconazole
D01A C02
G01A F04
J02A B01
S02A A13
D01A G01A,
J02A
1666
ØÇÏá½áÉáÝ
Mycosolon
1667
û׳é³Ñ»ÕáõÏ
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
èáõë³ëï³Ý
D01A C08
5069
²¸
èáõë³ëï³Ý
D01A C08
5070
11.11.2004
11.11.2009
11.11.2004
11.11.2009
ØÇÏá½áñ³É
Mycosoral
ØÇÏáÙ³ùë 100
Mycomax 100
ØÇÏáÙ³ùë 150
Mycomax 150
ØÇÏáÙ³ùë 50
Mycomax 50
ØÇÏáÙ³ùë ÇÝý.
Mycomax inf.
ØÇÏáݳ½áÉ
Miconazol
Ï»ïáÏáݳ½áÉ
ketoconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ÙÇÏáݳ½áÉ
miconazole
2%,
60ÙÉ ßßÇÏ
2%,
15·, 20·, 30·, 40·,
50· å³ñÏáõ×
200Ù·
(30)
100Ù·
(7)
150Ù·
(1)
50Ù·
(7,28)
200Ù·/100ÙÉ,
ëñí³Ï (1)
2%,
15· å³ñÏáõ×
èáõë³ëï³Ý
J02A B02
5068
¸
â»ËdzÛÇ
J02A C01
4506
â»Ëdz
J02A C01
4109
â»Ëdz
J02A C01
4108
â»Ëdz
J02A C01
4110
´»É³éáõë
D01A C02
0949/6874
11.11.2004
11.11.2009
10.10.2003
10.10.2008
10.04.2003
10.04.2008
10.04.2003
10.04.2008
10.04.2003
10.04.2008
03.05.2007
03.05.2012
1675
ØÇÏáë»åïÇÝ
Mykoseptin
â»Ëdz
D01A E04
4412
05.08.2003
05.08.2008
²¸
1676
ØÇÏáëÇëï
Mycosyst
ØÇÏáëÇëï
Mycosyst
ØÇÏáëÇëï
Mycosyst
ØÇÏáëÇëï
Mycosyst
ØÇÏáëåáñ
Mycospor
áõݹ»óÇÉÇݳÃÃáõ,
óÇÝÏ-áõݹ»óÇÉÇݳï
undecylinic acid, zinc
undecylinate
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
µÇýáݳ½áÉ
bifonazole
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
È»ãÇí³ ³.ë.
Lechiva a.s.
È»ãÇí³ ³.ë.
Lechiva a.s.
È»ãÇí³ ³.ë.
Lechiva a.s.
È»ãÇí³ ³.ë.
Lechiva a.s.
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
È»ãÇí³ ³.ë.
Lechiva a.s.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
λñÝ ü³ñÙ³ ê.È. (´³Û»ñ
лÉÃù»ñ ²¶-Ç
ѳٳñ/¶»ñÙ³Ýdz)
Kern Pharma S.L. (for Bayer
ÐáõÝ·³ñdz
J02A C01
5745
¸
ÐáõÝ·³ñdz
J02A C01
5744
ÐáõÝ·³ñdz
J02A C01
5743
ÐáõÝ·³ñdz
J02A C01
5658
Æëå³Ýdz
D01A C10
0439/6437
26.09.2005
26.09.2010
08.09.2005
08.09.2010
08.09.2005
08.09.2010
09.09.2005
09.09.2010
26.09.2006
26.09.2011
1668
1669
1670
1671
1672
1673
1674
1677
1678
1679
1680
ùëáõù
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Ýñµ³ùëáõù
ùëáõù
5%+20%,
30· å³ñÏáõ×
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(7)
100Ù·
(28)
150Ù·
(1,2)
200Ù·/100ÙÉ,
100ÙÉ ëñí³Ï
1%,
15· å³ñÏáõ×
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Ýñµ³ùëáõù
²¸
¸
¸
¸
¸
²¸
¸
¸
¸
²¸
115
1681
1683
ØÇÏñáë»ñ
Microser
µÇýáݳ½áÉ
bifonazole
óÇÝÏÇ áõݹ»ó»Ýá³ï,
áõݹ»ó»Ýá³ÃÃáõ
zinc undecenoate,
undecenoic acid
µ»ï³ÑÇëïÇÝ
betahistine
1684
ØÇÏñáë»ñ
Microser
1685
ØÇÝǹdzµ
Minidiab
ØÇÝÇñÇÝ
Minirin
ØÇÝÇñÇÝ
Minirin
ØÇáÉ·ÇÝ
Myolgin
1682
1686
1687
1688
ØÇÏáëåáñ
Mycospor
ØÇÏáï³
Mycota
1689
ØÇëïÇÏ
Mistik
1690
ØÇïáùë³ÝïñáÝ
Mitoxantron
1691
1692
1693
1694
1695
1696
1697
1698
ÉáõÍáõÛÃ
Ýñµ³ùëáõù
1%,
15ÙÉ ßßÇÏ
(20%+5%),
25· å³ñÏáõ×
¹»Õ³Ñ³ï»ñ
8Ù·
(50)
µ»ï³ÑÇëïÇÝ
betahistine
ϳÃÇÉÝ»ñ Ý»ñùÇÝ
ÁݹáõÝÙ³Ý
1.25%,
30ÙÉ ßßÇÏ
·ÉÇåǽǹ
glipizide
¹»ëÙáåñ»ëÇÝ
desmopressin
¹»ëÙáåñ»ëÇÝ
desmopressin
å³ñ³ó»ï³ÙáÉ,
ùÉáñ½áùë³½áÝ
paracetamol,
chlorzoxazone
-
¹»Õ³Ñ³ï»ñ
5Ù·
(30)
0.1Ù·
(30)
0.2Ù·
(30)
300Ù·+250Ù·
(10, 20)
ÙÇïáùë³ÝïñáÝ
mitoxantrone
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
å³ïÇ×Ý»ñ
260Ù·
(60)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
20Ù·/10ÙÉ,
ëñí³Ï (1)
ØÇïáùë³ÝïñáÝ
ÙÇïáùë³ÝïñáÝ
Ëï³ÝÛáõÃ
¾µ»í»
mitoxantrone
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Mitoxantron Ebewe
ÉáõÍáõÛÃÇ
ØÇïáùë³ÝïñáÝ
ÙÇïáùë³ÝïñáÝ
Ëï³ÝÛáõÃ
¾µ»í»
mitoxantrone
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Mitoxantron Ebewe
ÉáõÍáõÛÃÇ
ØÇñ³Ý¹³-1
_
ѳµ»ñ
Miranda-1
ØÇñ³Ý¹³-3
_
ѳµ»ñ
Miranda-3
ØÇùëï³ñ¹ 30
30% Ù³ñ¹áõ é»·Ûáõɳñ
¹»Õ³Ï³ËáõÛÃ
Mixtard 30
ÇÝëáõÉÇÝ, 70%
Ý»ñ³ñÏÙ³Ý
ǽáý³Ý ÇÝëáõÉÇÝ
(é»ÏáÙµÇݳÝï) 30%
Human Regular Insulin,
70% Isophane Insulin
(recombinant)
ØÇý»åñÇëïáÝ
ÙÇý»åñÇëïáÝ
¹»Õ³Ñ³ï»ñ
Mifepristone
mifepristone
Øá¹Çï»Ý ¸»åá
üÉÛáõý»Ý³½ÇÝÇ
ÉáõÍáõÛÃ
Moditen Depo
¹»Ï³Ýá³ï
Ý»ñ³ñÏÙ³Ý
fluphenazine decanoate
Øá¹Çï»Ý ¹»åá
ýÉÛáõý»Ý³½ÇÝ
ÉáõÍáõÛÃ
10Ù·/5ÙÉ,
ëñí³Ï (1)
20Ù·/10ÙÉ,
ëñí³Ï (1)
0.5·
(40)
0.5·
(90)
100ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
0,2·
(3)
25Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
25Ù·/1ÙÉ,
Healthcare AG/Germany)
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
ÂáñÝïáÝ ¨ èáë Èï¹
Thornton & Ross Ltd
¶»ñÙ³Ýdz
D01A C10
6007
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
D01AE 04
0745/6765
Æï³Édz
N07C A01
0001/5040
19.04.2006
19.04.2011
¸
Æï³Édz
N07C A01
0002/5041
19.04.2006
19.04.2011
¸
Æï³Édz
A10B B07
5561
¸
Þí»¹Ç³
H01B A02
5062
Þí»¹Ç³
H01B A02
5063
º·Çåïáë
N02B
4481
13.06.2005
13.06.2010
15.10.2004
15.10.2009
15.10.2004
15.10.2009
28.07.2003
28.07.2008
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
Ú»Éý³ ê.². ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð.Üý·.ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð.Üý·.ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
§ØÇñ³-ئ ö´À
§Mirra-M¦ CJSC
§ØÇñ³-ئ ö´À
§Mirra-M¦ CJSC
Üáíá-Üáñ¹ÇëÏ ²/ê
Novo-Nordisk A/S
Æéɳݹdz
βêÐ
5806
26.10.2005
26.10.2010
²¸
Ȼѳëï³Ý
L01D B07
0473/6461
16.10.2006
16.10.2011
¸
²íëïñdz
L01D B07
5799
01.12.2005
01.12.2010
¸
²íëïñdz
L01D B07
5800
01.12.2005
01.12.2010
¸
èáõë³ëï³Ý
βêÐ
4502
²¸
èáõë³ëï³Ý
βêÐ
4503
¸³Ýdz
A10A
5184
19.12.2003
19.12.2008
19.12.2003
19.12.2008
03.11.2004
03.11.2009
ØÇñ-ü³ñÙ³ ö´À
Mir-Pharma CJSC
´ñÇëïáÉ-سۻñë êùíǵ ê.å.È
Bristol-Myers Squibb S.p.L.
èáõë³ëï³Ý
G03XB01
1032/6921
¸
Æï³Édz
N05A B02
4280
21.06.2007
21.06.2012
23.01.2006
29.04.2008
Îèβ ¹.¹. Üáíá Ù»ëïá
êÉáí»Ýdz
N05A
0561/6533
24.11.2006
¸\Ð
ü³ñÙ³ëÛáõÃÇóÇ üáñÙ»ÝïÇ
ê.å.².
Farmaceutici Formenti S.p.A
ü³ñÙ³ëÛáõÃÇóÇ üáñÙ»ÝïÇ
ê.å.².
Farmaceutici Formenti S.p.A
ü³ñÙ³ódz Æï³Édz ê.ä.².
Pharmacia Italia S.P.A.
ü»ñÇÝ· ²´
Ferring AB
ü»ñÇÝ· ²´
Ferring AB
¶É³ùëáàõ»ÉùáÙ º·Çåïáë ê.².º.
GlaxoWellcome Egypt S.A.E.
09.03.2006
09.03.2011
15.02.2007
15.02.2012
¸
²¸
¸
¸
²¸
²¸
¸
¸
116
Moditen Depo
fluphenazine
Ý»ñ³ñÏÙ³Ý
Øá½áÉÇÝ
Mozolin
Øá½áÉÇÝ 15
Mozolin 15
ë³ÉÇóÇɳÃÃáõ
salicylic acid
ë³ÉÇóÇɳÃÃáõ
salicylic acid
ÉáõÍáõÛÃ
ÉáõÍáõÛÃ
ÏáÉáǹ³ÛÇÝ
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
10%,
10ÙÉ ßßÇÏ
15%,
10ÙÉ ßßÇÏ
1701
Øá½áÉÇÝ 20
Mozolin 20
ë³ÉÇóÇɳÃÃáõ
salicylic acid
ÉáõÍáõÛÃ
ÏáÉáǹ³ÛÇÝ
20%,
10ÙÉ ßßÇÏ
1702
ØáÝáÝÇïñáëǹ
Mononitrosid
ǽáëáñµÇ¹Ç
ÙáÝáÝÇïñ³ï
isosorbide mononitrate
¹»Õ³Ñ³ï»ñ
40Ù·
(40)
1703
ØáÝáåñÇÉ
Monopril
ØáÝáåñÇÉ
Monopril
ØáÝáõñ³É
Monural
ýá½ÇÝáåñÇÉ
fosinopril
ýá½ÇÝáåñÇÉ
fosinopril
ýáëýáÙÇóÇÝ
fosfomycin
¹»Õ³Ñ³ï»ñ
20Ù·
(28)
10Ù·
(28)
3·
(1,2)
1706
Øá뻹ÇÝ
Mosedin
Éáñ³ï³¹ÇÝ
loratadine
1707
Øá뻹ÇÝ ûß³ñ³Ï
Mosedin syrup
Éáñ³ï³¹ÇÝ
loratadine
ûß³ñ³Ï
5Ù·/5ÙÉ,
60ÙÉ ßßÇÏ
1708
ØáíÇùë
Movix
ØáíÇùë
Movix
ØáïÇÉÇáõÙ
Motilium
ØáïáñÇÏáõÙ
Motoricum
Ù»ÉûùëÇϳÙ
meloxicam
Ù»ÉûùëÇϳÙ
meloxicam
¹áÙå»ñǹáÝ
domperidone
¹áÙå»ñǹáÝ
domperidone
¹»Õ³Ñ³ï»ñ
15Ù·
(20/2x10/)
7.5Ù·
(20/2x10/)
10Ù·
(10,30)
10Ù·
(20/2x10/,
30/3x10/)
1%,
1ÙÉ ³ÙåáõÉÝ»ñ
(5, 20x5)
1699
1700
1704
1705
1709
1710
1711
1712
ØáñýÇÝÇ
ÙáñýÇÝÇ
ÑǹñáùÉáñǹ
ÑǹñáùÉáñǹ
Morphine
morphine hydrochloride
hydrochloride
1713 ØáõÉïÇ ëïñ»ÛÝ
ϳÃݳٳÝñ¿Ý»ñ
åñáµÇáïÇÏ Ñ³Ù³ÉÇñ
lactobacillus
Multi Strain Probiotic
Complex
1714
ØáõÉïÇÙ³ùë
íÇï³ÙÇÝÝ»ñ,
Multimax
ѳÝù³ÝÛáõûñ
vitamins, minerals
1715 ØáõÉïÇ-ï³µë ³ÏïÇí
Å»Ýß»ÝÇ Ñ³ÝáõÏ,
Multi-Tabs Active
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10Ù·
(10)
KRKA d.d. Novo mesto
²ñë»ÙÇ êäÀ
Arsemi Ltd.
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ êäÀ
Arsemi Agroindustrial Union
Ltd.
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ êäÀ
Arsemi Agroindustrial Union
Ltd.
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´ñÇëïáÉ-سۻñë êùíǵµ
Bristol-Myers Squibb
´ñÇëïáÉ-سۻñë êùíǵµ
Bristol-Myers Squibb
¼³ÙµáÝ ÞíÇï½»ñɳݹ Èï¹.
Zambon Switzerland Ltd.
24.11.2011
27.03.2003
27.03.2008
09.01.2006
09.01.2011
²¸
5873
09.01.2006
09.01.2011
²¸
C01D A14
0093/6103
09.06.2006
09.06.2011
¸
Æï³Édz
C09A A09
4943
¸
Æï³Édz
C09A A09
4942
Þí»Ûó³ñdz
J01X X01
5405
24.06.2004
24.06.2009
24.06.2004
24.06.2009
01.04.2005
01.04.2010
º·Çåïáë
R06A X13
0199/5882
13.07.2006
13.07.2011
²¸
º·Çåïáë
R06A X13
0198/5883
13.07.2006
13.07.2011
²¸
´áõÉÕ³ñdz
M01A C06
0914/6593
¸
´áõÉÕ³ñdz
M01A C06
0915/6592
üñ³Ýëdz
A03F A03
4870
ÎÇåñáë
A03F A03
1087/6637
26,04.2007
26.04.2012
26,04.2007
26.04.2012
08.05.2004
08.05.2009
01.10.2007
16.07.2012
¼¹áñáíÛ» ݳñá¹áõ
Zdorovye narodu
àõÏñ³Çݳ
N02A A01
0386/6426
12.09.2006
12.09.2011
¸\Ð
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
êáý³ñÙ³ ´À
Sopharma JSC
êáý³ñÙ³ ´À
Sopharma JSC
Ú³Ýë»Ý êÇɳ· ê.².
Janssen-Cilag S.A.
Ø»¹áù»ÙÇ Èï¹
Medochemie Ltd.
г۳ëï³Ý
D01A E12,
S01B C08
D01A E12,
S01B C08
4217
г۳ëï³Ý
D01A E12,
S01B C08
àõÏñ³Çݳ
г۳ëï³Ý
5872
²¸
¸
¸
¸
¸
¸
å³ïÇ×Ý»ñ
(30, 60)
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
²ØÜ
βêÐ
5099
20.09.2004
20.09.2009
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(30, 60)
ÚáõÝÇý³ñÙ ÆÝÏ.
Unipharm Inc.
²ØÜ
A11AA04
1290/7262
12.12.2007
12.10.2012
²¸
¹»Õ³Ñ³ï»ñ
(30, 60)
ü»ñáë³Ý ²/ê
Ferrosan A/S
¸³Ýdz
A11
0210/5963/1
21.07.2006
15.03.2011
²¸
117
1716
ØáõÉïÇ-ï³µë ´
ѳٳÉÇñ, Ïá¹ PT
Multi-tabs B
Complex, code PT
1717
ØáõÉïÇ-ï³µë
¿ÏáÉáçÇ
Multi-tabs Ecology
1718 ØáõÉïÇ-ï³µë ÏɳëÇÏ
Multi-tabs Classic
1719
ØáõÉïÇ-ï³µë
Ù³ÝϳϳÝ
Multi-tabs Kid
1720
ØáõÉïÇ-ï³µë
ÛáõÝÇáñ
Multi-tabs Junior
1721
ØáõÉïÇ-ï³µë
Ýáñ³ÍÇÝÝ»ñÇ
Multi-tabs Baby
1722
ØáõÉïÇ-ï³µë
å»ñÇݳï³É
(Ïá¹ RK-F)
Multi-tabs Perinatal
(code RK-F)
1723
ØáõϳÉïÇÝ
Mukaltin
1724
ØáõϳÉïÇÝ
Mucaltin
ѳÝù³ÝÛáõûñ
Ginseng extract,
vitamins, minerals
íÇï³ÙÇÝÝ»ñ
vitamins
¹»Õ³Ñ³ï»ñ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30, 90
ѳÝù³ÝÛáõûñ
óճÝóå³ï
µÉÇëï»ñÝ»ñáõÙ)
vitamins, minerals
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30, 90
ѳÝù³ÝÛáõûñ
óճÝóå³ï
µÉÇëï»ñÝ»ñáõÙ)
vitamins, minerals
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
(30
ѳÝù³ÝÛáõûñ
µÉÇëï»ñÝ»ñáõÙ)
³½Ýí³Ùáñáõ/»É³ÏÇ
ѳÙáí
vitamins, minerals with
strawberry/raspberry
flavour
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
(30
ѳÝù³ÝÛáõûñ
µÉÇëï»ñÝ»ñáõÙ)
³½Ýí³Ùáñáõ/»É³ÏÇ
ѳÙáí
vitamins, minerals with
strawberry/raspberry
flavour
A,D,C íÇï³ÙÇÝÝ»ñ
ϳÃÇÉÝ»ñ
(300ÙÏ·+10ÙÏ·+
vitamins A,D,C
35Ù·)/ÙÉ,
30ÙÉ ßßÇÏ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(50)
ѳÝù³ÝÛáõûñ
óճÝóå³ï
vitamins, minerals
ïáõÕïÇ Ñ³ÝáõÏ
Altheae extract
ïáõÕïÇ Ñ³ÝáõÏ
Althaea extract
¹»Õ³Ñ³ï»ñ
ùáݹñáÇïÇÝÇ ëáõÉý³ï
chondroitin sulfate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1726 ØáõóÇÝáõ٠ϳëϳñÇ ³×³É, ¹ÅÝÇÏ, µáɹ»³,
ѳÝáõÏáí
ϳݳ㠳ÝÇëáÝ senna,
Mucinum with
cascara, boldo, green
Cascara extract
anise
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1725
ØáõÏáë³ï
Mucosat
(100)
¹»Õ³Ñ³ï»ñ
1727
ØáùëÇóÇÝ
Moxicin
ÙáùëÇýÉûùë³óÇÝ
moxifloxacin
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
1728
ØáùëÇóÇÝ
Moxicin
ÙáùëÇýÉûùë³óÇÝ
moxifloxacin
ÉáõÍáõÛà ³ÏݳϳÃÇÉÝ»ñ
0.05·
(10)
0.05·
(10)
100Ù·/ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5, 10)
35Ù·+40Ù·+50Ù·+
30Ù·
(20)
400Ù·/÷³Ã»Ã,
100ÙÉ, 200ÙÉ,
250ÙÉ åɳëïÇÏ
÷³Ã»Ã, 200ÙÉ ëñí³Ï
0.5%,
10ÙÉ ßßÇÏ
ü»ñáë³Ý ²/ê
Ferrosan A/S
¸³Ýdz
A11
5317
10.03.2005
10.03.2010
²¸
ü»ñáë³Ý ²/ê
Ferrosan A/S
¸³Ýdz
A11
0128/6223
21.06.2006
21.06.2011
²¸
ü»ñáë³Ý ²/ê
Ferrosan A/S
¸³Ýdz
A11
0127/6222
21.06.2006
21.06.2011
²¸
ü»ñáë³Ý ²/ê
Ferrosan A.S.
¸³Ýdz
A11
0126/6221
21.06.2006
21.06.2011
²¸
ü»ñáë³Ý ²/ê
Ferrosan A.S.
¸³Ýdz
A11
0125/6220
21.06.2006
21.06.2011
²¸
ü»ñáë³Ý ²/ê
Ferrosan A/S
¸³Ýdz
A11
6025
17.03.2006
17.03.2011
²¸
ü»ñáë³Ý ²/ê
Ferrosan A/S
¸³Ýdz
A11 JC
5316
09.08.2005
09.08.2010
²¸
³ÃùÇÙý³ñÙåñ»å³ñ³ïÇ ´´À
Tatchimpharmpreparaty OJSC
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
Belmedpreparaty RUP
èáõë³ëï³Ý
5853
17.03.2006
17.03.2011
29.06.2006
29.06.2011
²¸
ÆÝÝáï»ù ÆÝï»ñݳëÇáݳÉ
ȳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
ÆÝáï»ñ³ âáõ½Ç
Innothera Chouzy for
Laboratoires Innotech
International
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
èáõë³ëï³Ý
(ÎáõñëÏ)
-
0144/6237
²¸
´»É³éáõë
H09A X02
0700/6731
25.01.2007
25.01.2012
¸
üñ³Ýëdz
µáõë³Ï³Ý
5359
26.05.2005
26.05.2010
²¸
г۳ëï³Ý
J01M
4898
15.06.2004
15.06.2009
¸
г۳ëï³Ý
J01M
4899
15.06.2004
15.06.2009
¸
118
1729 Úá¹ 5% ëåÇñï³ÛÇÝ
ÉáõÍáõÛÃ
Iodine alcoholic
solution 5%
1730
Úá¹µ³É³Ýë 100
Iodbalance 100
1731
Úá¹µ³É³Ýë 200
Iodbalance 200
1732
Úá¹¹Çó»ñÇÝ
Ioddicerin
1733 Úá¹Ç ëåÇñï³ÛÇÝ
ÉáõÍáõÛÃ 5%
Iodine alcoholic
solution 5%
1734
Úá¹áÙ³ñÇÝ
Iodomarin
Ûá¹
iodine
ÉáõÍáõÛÃ
ëåÇñï³ÛÇÝ
5%,
10ÙÉ, 15ÙÉ, 30ÙÉ
ßßÇÏ
ϳÉÇáõÙÇ Ûá¹Ç¹
potassium iodide
ϳÉÇáõÙÇ Ûá¹Ç¹
potassium iodide
Ûá¹
iodine
Ûá¹
iodine
¹»Õ³Ñ³ï»ñ
100ÙÏ·
(100)
200ÙÏ·
(100)
0.5%,
25ÙÉ ßßÇÏ
5%,
15ÙÉ, 25ÙÉ,
30ÙÉ, 1000ÙÉ
ßßÇÏ
200ÙÏ·
(50)
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛà ³ñï³ùÇÝ
ÏÇñ³éÙ³Ý
ÉáõÍáõÛÃ
ëåÇñï³ÛÇÝ
ϳÉÇáõÙÇ Ûá¹Ç¹
potassium iodide
¹»Õ³Ñ³ï»ñ
Liqvor Pharmaceuticals
²Éý³-ü³ñÙ êäÀ
Alfa Pharm Ltd.
г۳ëï³Ý
(ù.¶ÛáõÙñÇ)
D08A G03
5347
16.01.2006
16.01.2011
²¸
Ø»ñÏ Î¶³² ÜÇÏáÙ»¹Ç ѳٳñ
Merck KGaA for Nycomed
Ø»ñÏ Î¶³² ÜÇÏáÙ»¹Ç ѳٳñ
Merck KGaA for Nycomed
ü³ñÙ³Ï ´´À
Farmak JSC
¾ëÏáõɳå êäÀ
Esculap Ltd.
¶»ñÙ³Ýdz
R05C A02
5354
¸
¶»ñÙ³Ýdz
R05C A02
5355
àõÏñ³Çݳ
D08A
0640/6547
г۳ëï³Ý
D08A G03
4881
14.04.2006
04.02.2010
14.04.2006
04.02.2010
29.12.2006
29.12.2011
17.08.2004
17.08.2009
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
¶»ñÙ³Ýdz
R05C A02,
V03A B21
5705
05.09.2005
05.09.2010
¸
èáõë³ëï³Ý
4516
24.10.2003
24.10.2008
²¸
ÐÇ Ü³Ý ü»Ý· Â³Ç Æݹ³ëïñÇ ¨
øáÙ»ñó Èï¹.
He Nan Feng Tai Industry &
Comerc Ltd.
ÊÇÝáÇÝ
Chinoin
²ëï»É³ë ü³ñÙ³ ºáõñáå ´.ì.
Astellas Pharma Europe B.V.
âÇݳëï³Ý
D08A G02,
G01A X11,
R02A A15
βêÐ
5191
19.11.2004
19.11.2009
²¸
ÐáõÝ·³ñdz
N04B D01
4496
¸
Üǹ»éɳݹݻñ
J01A A02
0446/6450
29.09.2003
29.09.2008
29.09.2006
29.09.2011
¸
²¸
²¸
1735
Úá¹ûùëǹ
Iodoxid
åáíǹáÝ Ûá¹ÇÝ
povidone iodine
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
0.2·
(10)
1736
ÚáÝ· ç³Ý·
YongGang
-
ѳµ»ñ
750Ù·
(8)
1737
ÚáõÙ»ùë
Jumex
ÚáõÝǹûùë
ëáÉÛáõï³µ
Unidox Solutab
Úáùë
Jox
ë»É»·ÇÉÇÝ
selegiline
¹ûùëÇóÇÏÉÇÝ
doxycycline
¹»Õ³Ñ³ï»ñ
5Ù·
(50)
100Ù·
(10)
óáÕ³ßÇÃ
(2.55·+0.03·)/
30ÙÉ,
30ÙÉ ßßÇÏ
²Ûì²øê-âÐ ³.ë.
IVAX-CR a.s.
â»Ëdz
D08A G02,
D09A A09,
G01A X11,
4826
27.04.2004
27.04.2009
²¸
5-ÜúÎ
5-NOK
1741 ܳ½ÇÉáù 0,025%
Naziloc 0,025%
åáÉÇíǹáÝ Ûá¹,
³É³ÝïáÇÝ
polyvidone, iodine,
allantoin
ÝÇïñûùëáÉÇÝ
nitroxoline
ûùëÇٻﳽáÉÇÝ
oxymetazoline
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
óáÕ³ßÇà ùÃÇ
50Ù·
(50)
0.025%,
10ÙÉ, 15ÙÉ,
25ÙÉ, 30ÙÉ ßßÇÏ
êÉáí»Ýdz
G04A G06
5268
¸
г۳ëï³Ý
S01G A04
0714/6693
07.02.2005
07.02.2010
07.02.2007
07.02.2012
1742 ܳ½ÇÉáù 0,025%
Naziloc 0,025%
ûùëÇٻﳽáÉÇÝ
oxymetazoline
ùóϳÃÇÉÝ»ñ
0.025%,
10ÙÉ, 15ÙÉ ßßÇÏ
г۳ëï³Ý
S01G A04
0713/6694
07.02.2007
07.02.2012
²¸
1743
ܳ½ÇÉáù 0,05%
Naziloc 0,05%
ûùëÇٻﳽáÉÇÝ
oxymetazoline
ùóϳÃÇÉÝ»ñ
0.05%,
10ÙÉ, 15ÙÉ ßßÇÏ
г۳ëï³Ý
S01G A04
0712/6695
07.02.2007
07.02.2012
²¸
1744
ܳ½ÇÉáù 0,05%
Naziloc 0,05%
ûùëÇٻﳽáÉÇÝ
oxymetazoline
óáÕ³ßÇà ùÃÇ
0.05%,
10ÙÉ, 15ÙÉ,
25ÙÉ, 30ÙÉ ßßÇÏ
г۳ëï³Ý
S01G A04
0715/6692
07.02.2007
07.02.2012
²¸
1745 ܳ½ÇÉáù Ù³ÝϳϳÝ
ûùëÇٻﳽáÉÇÝ
ùóϳÃÇÉÝ»ñ
0.01%,
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ (²²Ø) êäÀ
Arsemi Agroindustrial Union
(AIU) Ltd
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ (²²Ø) êäÀ
Arsemi Agroindustrial Union
(AIU) Ltd
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ (²²Ø) êäÀ
Arsemi Agroindustrial Union
(AIU) Ltd
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ (²²Ø) êäÀ
Arsemi Agroindustrial Union
(AIU) Ltd
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
г۳ëï³Ý
S01G A04
0711/6696
07.02.2007
²¸
1738
1739
1740
¹»Õ³Ñ³ï»ñ
¸
²¸
119
0,01%
Naziloc Baby 0,01%
oxymetazoline
1746
ܳ½ÇíÇÝ
Nasivin
1747
ܳ½ÇíÇÝ
Nasivin
1748
ܳ½ÇíÇÝ
Nasivin
1749
ܳ½ÇíÇÝ
Nasivin
1750
ܳ½áÉ
Nazol
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
ûùëÇٻﳽáÉÇÝ
oxymetazoline
1751
ܳ½áÉ
Nazol
1752
ܳ½áÉ µ»µÇ
Nazol Baby
1753
ܳ½áÉ
ϳï³ñ»É³·áñÍí³Í
Nazol Advance
1754
ܳ½áÉ ³¹í³Ýë
Nazol Advance
1755
ܳ½áÉ Ïǹë
Nazol Kids
1756
ܳ½áÉ Ù³ÝϳϳÝ
Nazol Kids
1757
ܳ½áÉ
Ýáñ³ÍÇÝÝ»ñÇ
Nazol Baby
1758
ܳ½áÝ»ùë
10ÙÉ, 15ÙÉ ßßÇÏ
óáÕ³ßÇà ùÃÇ
0.05%,
10ÙÉ ßßÇÏ
ÙdzíáñáõÙ (²²Ø) êäÀ
Arsemi Agroindustrial Union
(AIU) Ltd
Ø»ñÏ Î¶³² ÜÇÏáÙ»¹Ç ѳٳñ
Merck KGaA for Nycomed
ùóϳÃÇÉÝ»ñ
0.025%,
10ÙÉ ßßÇÏ
ùóϳÃÇÉÝ»ñ
07.02.2012
¶»ñÙ³Ýdz
S01G A04
0225/6305
26.07.2006
26.07.2011
²¸
Ø»ñÏ Î¶³² ÜÇÏáÙ»¹Ç ѳٳñ
Merck KGaA for Nycomed
¶»ñÙ³Ýdz
S01G A04
0226/6304
26.07.2006
26.07.2011
²¸
0.01%,
5ÙÉ ßßÇÏ
Ø»ñÏ Î¶³² ÜÇÏáÙ»¹Ç ѳٳñ
Merck KGaA for Nycomed
¶»ñÙ³Ýdz
S01G A04
0227/6303
26.07.2006
26.07.2011
²¸
ùóϳÃÇÉÝ»ñ
0.05%,
10ÙÉ ßßÇÏ
Ø»ñÏ Î¶³² ÜÇÏáÙ»¹Ç ѳٳñ
Merck KGaA for Nycomed
¶»ñÙ³Ýdz
S01G A04
0228/6302
26.07.2006
26.07.2011
²¸
óáÕ³ßÇà ѻÕáõÏ
0.05%,
15ÙÉ, 30ÙÉ ßßÇÏ)
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
5092
08.10.2004
08.10.2009
²¸
ûùëÇٻﳽáÉÇÝ
oxymetazoline
óáÕ³ßÇÃ
0.05%,
15ÙÉ, 30ÙÉ ßßÇÏ
Æï³Édz
0495/6440
16.10.2006
16.10.2011
²¸
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ
phenylephrine
hydrochloride
ûùëÇٻﳽáÉÇÝ,
¿íϳÉÇåïáÉ, Ù»ÝÃáÉ,
ù³÷áõñ
oxymetazoline,
eucalyptol, menthol,
camphor
ûùëÇٻﳽáÉÇÝ
oxymetazoline
ùóϳÃÇÉÝ»ñ
1,25Ù·/ÙÉ,
15ÙÉ åɳëïÇÏ»
ßßÇÏ (1)
óáÕ³ßÇà ѻÕáõÏ
0.05%+0.17%+
0.17%+0.17%,
15ÙÉ, 30ÙÉ ßßÇÏ
ÆëïÇïáõïá ¸» ²Ýç»ÉÇ ê.é.É.
(ê³·Ù»É ÆÝÏ., ²ØÜ-Ç Ñ³Ù³ñ)
Istituto De Angeli S.r.l. (for
Sagmel Inc., USA)
ÆÝëïÇïáõïá ¹» ²Ýç»ÉÇ êèÈ
(ê³·Ù»É ÆÝÏ., ²ØÜ-Ç Ñ³Ù³ñ)
Instituto de Angeli S.R.L. (for
Sagmel Inc., USA)
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
S01G A04
R01A A05
R01A B07
R01A B07,
S01G A04
óáÕ³ßÇÃ
0.05%,
15ÙÉ, 30ÙÉ ßßÇÏ
óáÕ³ßÇà ùÃÇ
2,5Ù·/ÙÉ,
15ÙÉ åɳëïÇÏ»
ßßÇÏ (1)
óáÕ³ßÇà ùÃÇ
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ
phenylephrine
hydrochloride
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ,
ÝÇí»Ýáõ ÛáõÕ
phenylephrine
hydrochloride,
eucalyptol
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ
phenylephrine
hydrochloride
ÙáٻﳽáÝ
Æï³Édz
R01AA04
1465/7435
20.12.2007
20.12.2012
²¸
²ØÜ
S01G A04
R01A A05
R01A B07
5091
08.10.2004
08.10.2009
²¸
Æï³Édz
R01A B07,
S01G A04
0494/6441
16.10.2006
16.10.2011
²¸
Æï³Édz
R01AA04
1464/7434
20.12.2007
20.12.2012
²¸
0.25%+0.04%,
15ÙÉ ßßÇÏ
ÆëïÇïáõïá ¸» ²Ýç»ÉÇ ê.é.É.,
(ê³·Ù»É ÆÝÏ., ²ØÜ-Ç Ñ³Ù³ñ
Istituto De Angeli S.r.l. (for
Sagmel Inc., USA)
ÆÝëïÇïáõïá ¹» ²Ýç»ÉÇ êèÈ
(ê³·Ù»É ÆÝÏ., ²ØÜ-Ç Ñ³Ù³ñ)
Instituto de Angeli S.R.L. (for
Sagmel Inc., USA)
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
R01B A53
S01G A55
5163
10.12.2004
10.12.2009
²¸
ùóϳÃÇÉÝ»ñ
0.125%,
15ÙÉ ßßÇÏ
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
R01B A53
S01G A55
5162
10.12.2004
10.12.2009
²¸
óáÕ³ßÇà ùÃÇ
50ÙÏ·/¹»Õ³ã³÷,
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
´»É·Ç³
R01A D09
5472
09.06.2005
¸
120
Nazonex
mometasone
1759
ܳɵáõýÇÝ ë»ñµ
Nalbufin Serb
ݳɵáõýÇÝ
nalbufine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1760
ܳÉûùëáÝ
Naloxon
ݳÉûùëáÝ
naloxon
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1761
ܳÏÉáý
Naclof
ܳÏÉáý»Ý
Naklofen
ܳÏÉáý»Ý
Naklofen
ܳÏÉáý»Ý ¹áݹáÕ
Naklofen gel
ܳÏÉáý»Ý
ÙáÙÇÏÝ»ñ
Naklofen
suppositories
ܳÏÉáý»Ý
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Naklofen solution for
injection
ܳÏáÙ
Nakom
ܳ۳ïáùë
Najatox
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³Ï
diclofenac
³ÏݳϳÃÇÉÝ»ñ
1762
1763
1764
1765
1766
1767
1768
1769
ܳåñûùë»Ý
Naproxen
1770
ܳëáµ»Ï
Nasobec
1771
ܳíáµ³Ý
Navoban
1772
ܳíáåñûùëÇÝ
Navoproxin
1773 ܳïáõñ³É ÷áõß-³÷
The Natural Push-
¹»Õ³Ñ³ï»ñ
³Õ»ÉáõÛÍ
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹áݹáÕ
ÙáÙÇÏÝ»ñ
18·(120¹»Õ³ã³÷)
ßßÇÏáõÙ
20Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
0.4Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
0.1%,
5ÙÉ ßßÇÏ
50Ù·
(20/2x10/)
100Ù·
(20/2x10/)
10Ù·/1·,
60· å³ñÏáõ×
50Ù·
(10/2x5/)
Schering-Plough Labo N.V.
09.06.2010
êºð´ ê.².
SERB S.A
üñ³Ýëdz
N02A F02
0188/6200
13.07.2006
13.07.2011
¸
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ³·áñͳñ³Ý
ê²
Warsaw Pharmaceutical Works
§Polfa¦ SA
Üáí³ñïÇë úýï³ÉÙÇÏë
Novartis Ophtalmics
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
Ȼѳëï³Ý
V03AB
0541/6551
10.11.2006
10.11.2011
¸
üñ³Ýëdz
S01B C03
4024
¸
êÉáí»Ýdz
M01A B05
0814/6829
êÉáí»Ýdz
M01A B05
0813/6830
êÉáí»Ýdz
M01A B05
0817/6826
êÉáí»Ýdz
M01A B05
0815/6828
16.04.2003
16.04.2008
20.03.2007
20.03.2012
20.03.2007
20.03.2012
20.03.2007
20.03.2012
20.03.2007
20.03.2012
¸
¸
²¸
¸
¹ÇÏÉáý»Ý³Ï
diclofenac
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
75Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
êÉáí»Ýdz
M01A B05
0816/6827
20.03.2007
20.03.2012
¸
ɨá¹áå³, ϳñµÇ¹áå³
levodopa, carbidopa
ûÓÇ ÃáõÛÝ,
Ù»ÃÇÉë³ÉÇóÇɳï,
ó÷áõñ, ÝÇí»Ýáõ
ÛáõÕ
naja venom,
methylsalicylate,
camphora, eucalipt oil
ݳåñûùë»Ý
naproxen
¹»Õ³Ñ³ï»ñ
250Ù·+25Ù·
(100)
(12²Ø+4·+3·+2·)/
100·,
20· å³ñÏáõ×
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
Ø»Ïáý³ñ øÇÙdz-¹»Õ³·áñͳϳÝ
ö´À
Mekophar ChemicalPharmaceutical JSC
êÉáí»Ýdz
N04B A02
5267
¸
ìÇ»ïݳÙ
M02AC
1334/7296
07.02.2005
07.02.2010
06.11.2007
05.11.2012
¹»Õ³Ñ³ï»ñ
0.25·
(20/2x10/)
èáõë³ëï³Ý
(ÎáõñëÏ)
M01A E02
0141/6240
29.06.2006
29.06.2011
¸
óáÕ³ßÇÃ
50ÙÏ·/¹»Õ³ã³÷,
200 ¹»Õ³ã³÷
óáÕ³ßÇà ë³ñùáõÙ
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
²Ûì²øë ý³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
â»Ëdz
R01A D01
0693/6578
25.01.2007
25.01.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
5Ù·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(1, 10)
(25Ù·+50Ù·)
(20)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
Þí»Ûó³ñdz
A04A A03
4046
09.01.2003
09.01.2008
¸
¸»Éï³ ü³ñÙ³ ë.³.».
Delta Pharma S.A.E.
º·Çåïáë
-
1434/7379
20.12.2007
20.12.2012
¸
1010 Ù·
(160)
¸.ê.ü³ñÙ³ ´.ì.
D.S.Pharma
B.V.
Üǹ»éɳݹݻñ
βêÐ
4504
10.10.2003
10.10.2008
²¸
µ»ÏÉáٻó½áÝÇ
¹ÇåñáåÇáݳï
beclomethasone
dipropionate
ïñáåÇë»ïñáÝ
tropisetron
Ù»ÏÉá½ÇÝÇ
ÑǹñáùÉáñǹ,
åÇñǹoùëÇÝÇ
ÑǹñáùÉáñǹ
meclozine
hydrochloride,
pyridoxine
hydrochloride
ѳ󳽷ÇÝ»ñÇ
³ÉÛáõñÇ Ë³éÝáõñ¹,
ùëáõù
¹»Õ³Ñ³ï»ñ
ѳµ»ñ
²¸
121
Up
1774
·³ÛÉáõÏÇ Í³ÕÇÏÝ»ñ
mixed cereals flour,
hops flowers
³¹»Ýá½ÇÝÇ »éýáëý³ï
adenosine triphosphate
ܳïñÇáõÙÇ
ÉáõÍáõÛÃ
³¹»Ýá½ÇÝïñÇýáëÝ»ñ³ñÏÙ³Ý
ý³ï
Natrii
adenosintriphosphat
1775
ܳïñÇáõÙÇ
ݳïñÇáõÙÇ µÇϳñµáݳï
ÉáõÍáõÛÃ
µÇϳñµáݳï
sodium bicarbonate
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Sodium bicarbonate
1776
ܳïñÇáõÙÇ
ݳïñÇáõÙÇ µÇϳñµáݳï
ÉáõÍáõÛÃ
µÇϳñµáݳï
sodium bicarbonate
ϳÃÇɳݻñ³ñÏ-Ù³Ý
Sodium bicarbonate
1777 ܳïñÇáõÙÇ ùÉáñǹ ݳïñÇáõÙÇ ùÉáñǹ
ÉáõÍáõÛÃ
Sodium chloride
sodium chloride
Ý»ñ³ñÏÙ³Ý
1778 ܳïñÇáõÙÇ ùÉáñǹ
Sodium chloride
ݳïñÇáõÙÇ ùÉáñǹ
sodium chloride
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1779 ܳïñÇáõÙÇ ùÉáñǹ
Natrium chloridum
ݳïñÇáõÙÇ ùÉáñǹ
sodium chloride
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1780 ܳïñÇáõÙÇ ùÉáñǹ
Sodium chloride
ݳïñÇáõÙÇ ùÉáñǹ
sodium chloride
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1781 ܳïñÇáõÙÇ ùÉáñǹ
Natrium chloride
ݳïñÇáõÙÇ ùÉáñǹ
sodium chloride
1782
ݳïñÇáõÙÇ ùÉáñǹ
sodium chloride
ܳïñÇáõÙÇ
ùÉáñÇ¹Ç 0,9%
ÉáõÍáõÛÃ
Natrium chloride
0,9% solution
1783 ܳñÇÙ³ùë åÉÛáõë
Narimax plus
ɳÏïáµ³óÇÉáõë
³óǹáýÇÉáõë,
µÇýǹᵳÏï»ñÇáõÙ
µÇýǹáõÙ,
ɳÏïáµ³óÇÉáõë
é³Ùýáëáõë,
ɳÏïáµ³óÇÉáõë
µáõÉ·³ñÇÏáõë,
ɳÏïáµ³óÇÉáõë
ë³ÉÇí³ñáõë,
ëïñ»åïáÏáÏáõë
ûñÙáýÇÉáõë
Lactobacillus
Acidophilus,
Bifidobacterium
1%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
´áñÇëáíÛ³Ý ´ä¶
Borisovski Pharmaceutical
Work
´»É³éáõë
C01E B10
4587
20.02.2004
20.02.2009
¸
8,4%,
20ÙÉ, 100ÙÉ,
200ÙÉ ³å³Ï» ëñí³Ï
5%,
200ÙÉ, 400ÙÉ
³å³Ï» ëñí³Ï
0.9% (10ÙÉ),
10ÙÉ ³ÙåáõÉÝ»ñ
(10)
0.9% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
0,9% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
г۳ëï³Ý
B05C B04
1283/7251
15.10.2007
12.10.2012
¸
г۳ëï³Ý
B05C B04
1282/7250
15.10.2007
12.10.2012
¸
àõÏñ³Çݳ
B05X B01
0791/6795
13.03.2007
13.03.2012
¸
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
àõÏñ³Çݳ
B05X B01
0790/6796
13.03.2007
13.03.2012
¸
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
ýÇñÙ³ ´´À
Yerevan ChemicalPharmaceutical firm Open J/S
Company
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUE
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
г۳ëï³Ý
B05C B01
0706/6653
25.01.2007
25.01.2012
¸
´»É³éáõë
B05C B01
1088/7152
24.09.2007
13.09.2012
¸
г۳ëï³Ý
B05C B01
1016/7026
13.06.2007
13.06.2012
¸
ü³ñÙ³ï»ù ¸.Ò.
Pharmatech S.E.
г۳ëï³Ý
B05C B01
B05X A03
4349
08.04.2005
08.04.2010
¸
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd.
г۳ëï³Ý
βêÐ
6044
14.03.2006
14.03.2011
²¸
0.9% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
ÉáõÍáõÛÃ
0.9%,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
100ÙÉ, 200ÙÉ,
250ÙÉ, 500ÙÉ,
1000ÙÉ åɳëïÇÏ»
ï³ñ³, 200ÙÉ,
400ÙÉ ³å³Ï» ëñí³Ï
ÉáõÍáõÛÃ
0.9%,
Ý»ñ³ñÏÙ³Ý
100ÙÉ, 250ÙÉ,
400ÙÉ, 500ÙÉ,
1000ÙÉ, 2000ÙÉ,
3000ÙÉ åɳëïÇÏ
÷³Ã»Ã
÷áßÇ
1.5x109 áã å³Ï³ë
ÉÇáýÇÉǽ³óí³Í,
(150Ù·) ϻݹ³ÝÇ
å³ïÇ×Ý»ñáõÙ
Ù³Ýñ¿Ý»ñÇ
ÉÇáýÇÉǽ³óí³Í
÷áßÇ
å³ïÇ×Ý»ñáõÙ,
µÉÇëï»ñÝ»ñ (20,
30) ¨ åɳëïÇÏ ï³ñ³
(90)
122
1784
ܳñÇÙ³ùë ýáñï»
Narimax forte
1785
ܳñÇÝ»
Narine
1786
ܳñÇÝ»
Narine
ܳñÇÝ»
Narine
ܳñÏáï³Ý
Narcotan
ܳùëáçÇÝ
Naxogin
ܳý³-·³É
Nafa-Gal
1787
1788
1789
1790
1791
ܳý³½áÉ Ð»Ùáý³ñÙ
Nafazol - Hemofarm
1792
ܳý³½áÉÇÝü»ñ»ÛÝ
Naphazoline-Ferein
1793 ܳý³½áÉ-лÙáý³ñÙ
Nafazol-Hemofarm
Bifidum, Lact
ϳÃݳÃÃí³ÛÇÝ Ï»Ý¹³ÝÇ
Ù³Ýñ¿Ý»ñɳÏïáµ³óÇÉáõë
³óǹáýÇÉáõë,
µÇýǹᵳÏï»ñÇáõÙ
µÇýǹáõÙ, ¿ß»ñÇËdz
ÏáÉÇ Ø-17
viable lactic
ϳÃݳÃÃí³ÛÇÝ
Ù³Ýñ¿Ý»ñ
Lactobacillus
Acidophilus
--
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd.
г۳ëï³Ý
βêÐ
5988
08.02.2006
08.02.2011
²¸
÷áßÇ
ÉÇáýÇÉǽ³óí³Í
3,1x108 áã å³Ï³ë
(100Ù·) ϻݹ³ÝÇ
µ³Ïï»ñdzݻñÇ
ÉÇáýÇÉǽ³óí³Í
÷áßÇ,
µÉÇëï»ñÝ»ñáõÙ
(20, 30), åɳëïÇÏ
ï³ñ³ÛáõÙ (90)
1.5· ÷áßÇ,
÷³Ã»ÃÝ»ñ (10)
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd.
г۳ëï³Ý
βêÐ5
0758/6728
28.02.2007
28.02.2012
²¸
å³ïÇ×Ý»ñÝ»ñ
(30, 50, 90)
г۳ëï³Ý
βêÐ3
0606/6608
ѳµ»ñ
(30, 50, 90)
г۳ëï³Ý
βêÐ
0607/6607
ѳÉáóÝ
halothane
ÝÇÙáñ³½áÉ
nimorazol
ݳý³½áÉÇÝÇ
ÑǹñáùÉáñǹ
naphazoline
hydrochloride
ݳý³½áÉÇÝ
nafazoline
Ñ»ÕáõÏ
100%,
250ÙÉ ßßÇÏ
500Ù·
(6)
0.03%,
10ÙÉ ßßÇÏ
â»Ëdz
N01A B01
4414
Æï³Édz
P01A B06
5662
èáõÙÇÝdz
S01G A01
4398
14.12.2006
14.12.2011
14.12.2006
14.12.2011
05.08.2003
05.08.2008
21.07.2005
21.07.2010
16.09.2003
16.09.2008
²¸
--
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd
ìÇï³Ù³ùë-º êäÀ
Vitamax-E Ltd
È»ãÇí³ ³.ë.
Lechiva a.s.
ü³ñÙ³ódz Æï³Édz ê.å.².
Pharmacia Italia S.p.A.
ü³ñÙ³åɳÝï ´ÇᷳɻÝÇϳ
Pharmaplant Biogalenica
ùóϳÃÇÉÝ»ñ
0.1%,
10ÙÉ ßßÇÏ
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
4462
06.11.2003
06.11.2008
²¸
ݳý³½áÉÇÝ
naphazoline
ÉáõÍáõÛÃ
0.1%,
5ÙÉ, 10ÙÉ ßßÇÏ
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
èáõë³ëï³Ý
S01G A01,
R01A A08,
R01A B02
R01A B02,
S01G A01
4707
24.02.2004
24.02.2009
²¸
ݳý³½áÉÇÝ
naphazoline
ùóϳÃÇÉÝ»ñ
0.05%,
10ÙÉ ßßÇÏ
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
4461
06.11.2003
06.11.2008
²¸
0.5Ù·/ÙÉ,
5ÙÉ, 10ÙÉ ³å³Ï»
ßßÇÏ,
5ÙÉ, 10ÙÉ
åɳëïÇÏ» ßßÇÏ)
1Ù·/ÙÉ (5ÙÉ,
10ÙÉ åɳëïÇÏ»
ßßÇÏ, 5ÙÉ, 10ÙÉ
³å³Ï» ßßÇÏ
0.1%,
10ÙÉ ßßÇÏ
ü³ñÙ³Ï ´´À
Farmak Open JSC
àõÏñ³Çݳ
S01G A01
R01A A08
R01A B02
R01AA08
1459/7411
20.12.2007
20.12.2012
²¸
ü³ñÙ³Ï ´´À
Farmak Open JSC
àõÏñ³Çݳ
R01AA08
1460/7412
20.12.2007
20.12.2012
²¸
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ êäÀ
Arsemi Agroindustrial Union
Ltd
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ êäÀ
Arsemi Agroindustrial Union
Ltd
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
г۳ëï³Ý
R01A A08
0517/6542
07.11.2006
07.11.2011
²¸
г۳ëï³Ý
R01A A08
0518/6541
07.11.2006
07.11.2011
²¸
¶»ñÙ³Ýdz
C07A B12
4820
15.06.2004
15.06.2009
¸
÷áßÇ
å³ïÇ×Ý»ñáõÙ
¹»Õ³Ñ³ï»ñ
³ÏݳϳÃÇÉÝ»ñ
1794
ܳýÃǽÇÝ
Naphthizin
ݳý³½áÉÇÝ
naphazoline
ùóϳÃÇÉÝ»ñ
1795
ܳýÃǽÇÝ
Naphthizin
ݳý³½áÉÇÝ
naphazoline
ùóϳÃÇÉÝ»ñ
1796 ܳýÃǽÇÝ-²ñë»ÙÇ
Naphthyzin-Arsemi
ݳý³½áÉÇÝ
naphazoline
ùóϳÃÇÉÝ»ñ
1797 ܳýÃǽÇÝ-²ñë»ÙÇ
Naphthyzin-Arsemi
ݳý³½áÉÇÝ
naphazoline
ùóϳÃÇÉÝ»ñ
0.05%,
10ÙÉ ßßÇÏ
1798
Ý»µÇíáÉáÉ
nebivolol
¹»Õ³Ñ³ï»ñ
5Ù·
(7,14, 28)
Ü»µÇÉ»ï
Nebilet
²¸
¸
¸
²¸
123
1799
1800
Ü»·ñ³Ù
Negram
ܻɳ¹»ùë
Neladex
1801
ܻɳ¹»ùë
Neladex
1802
Ü»Ùáï³Ý
Nemotan
1803
Ü»ÛñáñáõµÇÝ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Neurorubine
solution for injection
1804
1805
1806
1807
1808
ݳÉǹÇùë³ÃÃáõ
nalidixic acid
¹»ùë³Ù»Ã³½áÝ,
Ý»áÙÇóÇÝÇ ëáõÉý³ï,
åáÉÇÙÇùëÇÝÇ B
ëáõÉý³ï
dexamethasone,
neomycin sulphate,
polymyxin B sulphate
¹»ùë³Ù»Ã³½áÝ,
Ý»áÙÇóÇÝ,
åáÉÇÙÇùëÇÝ ´
ëáõÉý³ï
dexamethasone,
neomycin, polymyxin B
sulphate
ÝÇÙá¹ÇåÇÝ
nimodipine
¹»Õ³Ñ³ï»ñ
ϳÃÇÉÝ»ñ
³ãùÇ/³Ï³ÝçÇ
³Ïݳùëáõù
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÃdzÙÇÝÇ ÝÇïñ³ï,
ÉáõÍáõÛÃ
åÇñǹûùëÇÝÇ
Ý»ñ³ñÏÙ³Ý
ÑǹñáùÉáñǹ,
ódzÝáÏᵳɳÙÇÝ
thiamine nitrate,
pyridoxine
hydrochloride,
cyanocobalamine
Ü»ÛñáñáõµÇÝ
ÃdzÙÇÝÇ ÝÇïñ³ï,
¹»Õ³Ñ³ï»ñ
ýáñï» É³Ïï³µ
åÇñǹûùëÇÝÇ
óճÝóå³ï
Neurorubine Forte
ÑǹñáùÉáñǹ,
Lactab
ódzÝáÏᵳɳÙÇÝ
thiamine nitrate,
pyridoxine
hydrochloride,
cyanocobalamine
Ü»á - Ù³Ûù»ÉáÝ
å³ñ³ó»ï³ÙáÉ,
¹»Õ³Ï³ËáõÛÃ
Neo-Michaelon
ùÉáñý»ÝÇñ³ÙÇÝÇ
ٳɻ³ï, ÷먹á¿ý»¹ñÇÝ
paracetamol,
chlorpheniramine
maleate,
pseudoephedrine
Ü»á µáñáãÇÉÇݳ C 2,4-¹ÇùÉáñᵻݽÇÉ ¹»Õ³Ñ³ï»ñ µ»ñ³ÝÇ
Neo Borocillina C ëåÇñï,³ëÏáñµÇݳÃÃáõ
ËáéáãáõÙ
2,4-dichlorobenzyl
ÉáõÍíáÕ
alcohol, ascorbic acid
Ü»á-³Ýáõ½áÉ
µÇëÙáõÃÇ ÝÇïñ³ï,
ÙáÙÇÏÝ»ñ
Neo-Anusol
óÇÝÏÇ ûùëǹ, ï³ÝÇÝ,
黽áñóÇÝ, Ûá¹,
Ù»ÃÇÉ»Ý Ï³åáõÛï
bismuth nitrate, zinc
oxyde, tanin, resorcine,
iodine, methylene blue
Ü»áÇÝï»ëïáå³Ý
ÏáÉáǹ³ÛÇÝ ³ÏïÇí³óí³Í
¹»Õ³Ñ³ï»ñ
Neo-Intestopan
³ï³åáõÉ·Çï
óճÝóå³ï
500Ù·
(56/7x8/)
(1Ù·+3,5Ù·+
6000ØØ)/ 1ÙÉ,
5ÙÉ ßßÇÏ
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
ºÆäÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
ѳٳñ)
E.I.P.I.Co. (for World Medicine)
êÉáí»Ýdz
G01M B02
0655/6570
12.01.2007
12.01.2012
22.09.2005
22.09.2010
¸
º·Çåïáë
D07C B04
5674
(1Ù·+3.5Ù·+
6000 ØØ)/1·,
3.5·, 5· å³ñÏáõ×
º.Æ.ä.Æ.øá (àõáñɹ Ø»¹ÇëÇÝ
(²ØÜ)-Ç Ñ³Ù³ñ
E.I.P.I Co (for World Medicine,
USA)
º·Çåïáë
D07C B04
0080/6188
07.06.2006
07.06.2011
¸
30Ù·
Ø»¹áù»ÙÇ Èï¹
(30/3x10/,50/5x10/,
Medochemie Ltd
100/10x10/)
100Ù·+100Ù·+
Ø»ñÏÉ» ¶ÙµÐ Ø»ý³ Èï¹-Ç
1Ù·,
ѳٳñ, Þí»Ûó³ñdz
3ÙÉ ³ÙåáõÉÝ»ñ Merckle GmbH for Mepha Ltd,
(5)
Switzerland
ÎÇåñáë
C08C A06
0209/6169
21.07.2006
21.07.2011
¸
¶»ñÙ³Ýdz
A11D BA
0627/6677
27.12.2006
27.12.2011
¸
¸
200Ù·+50Ù·+1Ù·
(20)
Ø»ý³ Èï¹.
Mepha Ltd.
Þí»Ûó³ñdz
A11D B
0626/6669
27.12.2006
27.12.2011
²¸
(125Ù·+0.75Ù·+
30Ù·)/5ÙÉ,
120ÙÉ ßßÇÏ
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
º·Çåïáë
-
0046/5867
24.05.2006
24.05.2011
²¸
1.2Ù·+70Ù·
(20)
²Éý³ ì³ë»ñÙ³Ý ê.å.².
Alfa Wassermann S.p.A.
Æï³Édz
_
4170
12.03.2003
12.03.2008
²¸
(0.075·+0.2·+
0.05·+
0.005·+0.005·+
0.003·),
(10/2x5/)
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
èáõë³ëï³Ý
C05A X02
0631/6631
27.12.2006
27.12.2011
²¸
630Ù·
(20)
ê³Ý¹á½ öñÇí³ï ÈÇÙÇﻹ
Sandoz Private Limited
Ðݹϳëï³Ý
-
5111
03.02.2005
03.02.2010
²¸
124
colloidal activated
attapulgite
¹ÇáëÙ»ÏïÇï (ëÙ»ÏïÇï
¹ÇûÏﳿ¹ñÇÏ)
diosmectite (smectite
dioctaedric)
ýáëýáÏñ»³ïÇÝ
phosphocreatine
1809
Ü»áëÙ»ÏïÇÝ
Neosmectin
1810
Ü»áïáÝ ýÉ»µá 1·
Neoton Phlebo 1g
1811
Ü»áõåá·»Ý
30ÙÉÝØ
Neupogen 30MU
ýÇÉ·ñ³ëïÇÙ
filgrastim
1812
Ü»áõñáµ»ùë
Neurobex
1813
Ü»íïáÝ
Newtone
1814
ܨñ³É·ÇÝ
Nevralgin
ÃdzÙÇÝÇ ÝÇïñ³ï,
åÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ,
ódzÝáÏᵳɳÙÇÝ
thiamine nitrate,
pyridoxine
hydrochloride,
cyanocobalamine
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
vitamins, minerals
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
acetylsalicylic acid,
paracetamol, caffeine
¹»Õ³÷áßÇ ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
ϳÃÇɳݻñ³ñÏ-Ù³Ý,
Ý»ñ³ñÏÙ³Ý çáõñ
ÉáõÍãáí
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
3·,
÷³Ã»ÃÝ»ñ (10)
ü³ñÙåñáÛ»Ïï ö´À Pharmproject
CJSC
1·,
²Éý³ ì³ë»ñÙ³Ý ê.å.².
(ëñí³Ï/ëñí³Ï
Alfa Wassermann S.p.A.
1 Ý»ñ³ñÏÙ³Ý
ѳٳϳñ·)
30ÙÉÝØ
ÐáýÙ³Ý-ȳ èáß
Hoffmann(300ÙÏ·)/0.5ÙÉ,
La Roche
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
(1,5)
15Ù·+10Ù·+
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
0.02Ù· (60)
Balkanpharma-Dupnitza AD
èáõë³ëï³Ý
-
0219/6328
26.07.2006
26.07.2011
²¸
Æï³Édz
-
5039
13.08.2004
13.08.2009
¸
Þí»Ûó³ñdz
L03A A02
4381
16.12.2003
16.12.2008
¸
´áõÉÕ³ñdz
A11D B01
0801/6848
20.03.2007
20.03.2012
²¸
¹»Õ³å³ïÇ×Ý»ñ
(30)
XL ɳµáñ³ïáñdz PVT Èï¹.
XL Laboratories PVT Ltd.
Ðݹϳëï³Ý
A11
0011/6058
12.05.2006
12.05.2011
²¸
¹»Õ³Ñ³ï»ñ
250Ù·+200Ù·+
50Ù·
(10, 20)
г۳ëï³Ý
N02B A51
4887
10.06.2004
10.06.2009
²¸
Ý»ïÇÉÙÇóÇÝ
netilmicin
Ý»ïÇÉÙÇóÇÝ
netilmycin
Ý»ñ³ñÏÙ³Ý çáõñ
water for injection
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
200Ù·/2ÙÉ,
ëñí³Ï (1)
50Ù·/2ÙÉ,
ëñí³Ï (1)
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
´»É·Ç³
J01G B07
5473
¸
´»É·Ç³
J01G B07
5474
г۳ëï³Ý
B05X A05
0707/6652
12.09.2005
12.09.2010
22.04.2005
22.04.2010
25.01.2007
25.01.2012
Æï³Édz
G01A F11
J02A B02
D01A C08
G01A F11
J02A B02
D01A C08
D01A C08
G01A F11
J02A B02
4871
08.05.2004
08.05.2009
¸
4866
08.05.2004
08.05.2009
²¸
4965
14.07.2004
14.07.2009
²¸
г۳ëï³Ý
P02D A01
0023/6121
17.05.2006
17.05.2011
¸
ÐáõÝ·³ñdz
C04A C51
1285/7254
29.10.2007
12.10.2012
²¸
1818
Üǽáñ³É
Nizoral
Ï»ïáÏáݳ½áÉ
ketoconazole
¹»Õ³Ñ³ï»ñ
200Ù·
(10,30)
§ÜúÎƦ ѳ۳ٻñÇϳ·»ñÙ³Ý³Ï³Ý Ñ³Ù³ï»Õ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ êäÀ
§NOKI¦ Armenian-AmericanGerman Pharmac. J.V.Co.Ltd.
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering Plough Labo N.V.
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering-Plough Labo N.V.
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
ýÇñÙ³ ´´À
Yerevan ChemicalPharmaceutical firm Open J/S
Company
Ú³Ýë»Ý êÇɳ· ê.å.².
Janssen-Cilag S.p.A.
1819
Üǽáñ³É
Nizoral
Ï»ïáÏáݳ½áÉ
ketoconazole
Ýñµ³ùëáõù
20Ù·/·,
15· å³ñÏáõ×
Ú³Ýë»Ý ü³ñÙ³ëÛáõÃÇù³ Ü.ì.
Janssen Pharmaceutica N.V.
´»É·Ç³
1820
Üǽáñ³É
Nizoral
Ï»ïáÏáݳ½áÉ
ketoconazole
û׳é³Ñ»ÕáõÏ
´»É·Ç³
1821
ÜÇÏÉá½³Ùǹ
Niclosamide
ÝÇÏÉá½³Ùǹ
niclosamide
1822
ÜÇÏáëå³Ý
Nikospan
ÝÇÏáïÇݳÃÃáõ,
¹ñáï³í»ñÇÝÇ
ÑǹñáùÉáñǹ
2%,
Ú³Ýë»Ý ü³ñÙ³ëÛáõÃÇù³ Ü.ì.
25ÙÉ, 60ÙÉ,
Janssen Pharmaceutica N.V.
100ÙÉ ßßÇÏ ¨ 6ÙÉ
÷³Ã»ÃÝ»ñ (6,12)
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
500Ù·,
²ðöÆغ¸ ÐÒ ö´À
åɳëïÇÏ ßßÇÏ (4),
ARPIMED J.V. CJ-S Co
µÉÇëï»ñÝ»ñ (6,10)
¹»Õ³Ñ³ï»ñ
(22Ù·+78Ù·)
ÊÇÝáÇÝ ¹»Õ³·áñÍ³Ï³Ý ¨
(50)
ùÇÙÇ³Ï³Ý ·áñͳñ³Ý øá.Èï¹
Chinoin Pharmaceutical and
1815
Ü»ïñáÙÇóÇÝ
Netromycine
1816
Ü»ïñáÙÇóÇÝ
Netromycine
1817 Ü»ñ³ñÏÙ³Ý çáõñ
Water for injection
¸
¸
125
ÜÇÏáïÇݳÃÃáõ
Nicotinic acid
ÜÇÏáñ»ï» 2Ù·
Nicorette 2mg
ÜÇÙ»Éǹ
Nimelid
nicotinic acid,
drotaverine
hydrochloride
ÝÇÏáïÇݳÃÃáõ
nicotinic acid
ÝÇÏáïÇÝ
nicotine
ÝÇÙ»ëáõÉǹ
nimesulide
1826
ÜÇÙ»ëÇÉ
Nimesil
ÝÇÙ»ëáõÉǹ
nimesulid
1827
ÜÇÙáï³ë êÇ-¸Ç
Nimotas CD
ÜÇÙáïáå
Nimotop
ÜÇÙáïáå
Nimotop
ÜÇëï³ïÇÝ
Nystatin
ÝÇÙ»ëáõÉǹ
nimesulide
ÝÇÙá¹ÇåÇÝ
nimodipin
ÝÇÙá¹ÇåÇÝ
nimodipin
ÝÇëï³ïÇÝ
nystatin
¹»Õ³Ñ³ï»ñ
ï³ñ³ÉáõÍíáÕ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ùëáõù
100Ù·
(100/10x10/)
30Ù·
(100)
10Ù·/50ÙÉ,
ëñí³Ï (1)
100000ØØ/·,
15·, 25· å³ñÏáõ×
1831
ÜÇëï³ïÇÝ
Nystatin
ÝÇëï³ïÇÝ
nystatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500000ØØ,
(10,20,30)
1832
ÜÇëï³ïÇÝ
Nystatin
ÜÇëï³ïÇÝ
Nystatin
ÝÇëï³ïÇÝ
nystatin
ÝÇëï³ïÇÝ
nystatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500000ØØ
(20,150x10)
500000ØØ
(10, 20)
ÝÇëï³ïÇÝ
nystatin
ÝÇëï³ïÇÝ
nystatin
Ñ»ßïáó³ÙáÙÇÏÝ»ñ
¹»Õ³Ñ³ï»ñ
250000Ø
(10)
500000ØØ
(20)
ÝÇëï³ïÇÝ
nystatin
·³É³Ýï³ÙÇÝ
galantamine
ùëáõù
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
100000Ø/1·,
15· å³ñÏáõ×
10Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
5Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
10Ù·
(10/1x10/,
20/2x10/)
5Ù·
(10/1x10/,
20/2x10/, 60/3x20/)
1Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
1823
1824
1825
1828
1829
1830
1833
1834
ÜÇëï³ïÇÝ
Nystatin
1835 ÜÇëï³ïÇÝ 500000
ØØ
Nystatin 500000IU
1836 ÜÇëï³ïÇÝÇ ùëáõù
Nystatin ointment
1837
ÜÇí³ÉÇÝ
Nivalin
Chemical Works Co.Ltd.
¹»Õ³Ñ³ï»ñ
ͳÙáÝ
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
1838
ÜÇí³ÉÇÝ
Nivalin
·³É³Ýï³ÙÇÝ
galantamine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1839
ÜÇí³ÉÇÝ
Nivalin
·³É³Ýï³ÙÇÝ
galantamine
¹»Õ³Ñ³ï»ñ
1840
ÜÇí³ÉÇÝ
Nivalin
·³É³Ýï³ÙÇÝ
galantamine
¹»Õ³Ñ³ï»ñ
1841
ÜÇí³ÉÇÝ
Nivalin
·³É³Ýï³ÙÇÝ
galantamine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
50Ù·
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
(50)
Pharmstandard-UfaVITA OJSC
2Ù·
ü³ñÙ³ódz ²´
(30)
Pharmacia AB
0,1·,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
÷³Ã»ÃÇÏÝ»ñ (10)
Rompharm Company SRL
100Ù·,
÷³Ã»ÃÝ»ñ (9, 15,
30)
èáõë³ëï³Ý
C10AD02
0838/6799
Þí»¹Ç³
N07B A01
4213
èáõÙÇÝdz
M01A X17
1305/7272
Æï³Édz
M01A X17
5086
06.10.2004
06.10.2009
¸
Ðݹϳëï³Ý
M01A
0778/6747
¸
¶»ñÙ³Ýdz
C08C A06
4723
¶»ñÙ³Ýdz
C08C A06
4724
´»É³éáõë
D01A A01
5015
07.03.2007
07.03.2012
06.12.2005
02.04.2009
06.12.2005
02.04.2009
13.12.2004
13.12.2009
´»É³éáõë
A07A A02
5016
13.12.2004
13.12.2009
¸
èáõÙÇÝdz
A07A A02
5604
¸
àõÏñ³Çݳ
A07A A02
1246/7056
22.07.2005
22.07.2010
15.10.2007
15.10.2012
èáõë³ëï³Ý
G01A A01
4358
¸
´áõÉÕ³ñdz
A07A A02
0373/6385
23.09.2003
23.09.2008
11.09.2006
11.09.2011
èáõë³ëï³Ý
G01A A01
4174
²¸
´áõÉÕ³ñdz
N06D A04
1001/6977
23.09.2003
23.09.2008
04.06.2007
04.06.2012
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
N06D A04
0999/6976
04.06.2007
04.06.2012
¸
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
0868/6136
30.03.2007
30.03.2012
¸
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
0867/6135
30.03.2007
30.03.2012
¸
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
0998/6974
04.06.2007
04.06.2012
¸
¶íǹáïÇ ê.å.². ɳµáñ³ïáñdz
(ػݳñÇÝÇ ·ñáõå)
Laboratori Guidotti S.p.A.
(Menarini Group)
ÆÝï³ë ý³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Intas Pharmaceuticals Ltd.
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
²ÝïǵÇáïÇÏ ê.².
Antibiotice S.A.
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
êáý³ñÙ³ ´À
Sopharma JSC
N06D A04
26.03.2007
26.03.2012
02.09.2003
02.09.2008
12.10.2007
12.10.2012
¸
²¸
¸
¸
¸
²¸
¸
¸
¸
126
1842
ÜÇí³ÉÇÝ
Nivalin
·³É³Ýï³ÙÇÝ
galantamine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1843
ÜÇïÇýáñ
Nittifor
å»ñÙ»ÃñÇÝ
permethrin
ÉáõÍáõÛÃ
1844
ÜÇïñ³½»å³Ù
Nitrazepam
ÝÇïñ³½»å³Ù
nitrazepam
¹»Õ³Ñ³ï»ñ
5Ù·
(20)
1845
ÜÇïñá
Nitro
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
1846
ÜÇïñá·ÉÇó»ñÇÝ
Nitroglycerin
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
5Ù·/ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
5Ù·/ÙÉ
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
1847
ÜÇïñá·ÉÇó»ñÇÝ
Nitroglycerin
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1848
ÜÇïñá·ÉÇó»ñÇÝ
Nitroglycerin
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
ÜÇïñá-Ù³Ï é»ï³ñ¹
Nitro-Mack Retard
1850
ÜÇïñáÙÇÝï
Nitromint
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
ÉáõÍáõÛÃ
0.1%,
10ÙÉ ³ÙåáõÉÝ»ñ
(10)
0.5Ù·,
µÉÇëï»ñ (20),
åɳëïÇÏ ï³ñ³ (40)
2.5Ù·
(30)
0.4Ù·/¹»Õ³ã³÷
8·(1%)ÉáõÍáõÛÃ
10· ßßÇÏáõÙ
6.5Ù·
(25)
0.25·/25ÙÉ,
25ÙÉ ßßÇÏ
30ÙÉ ßßÇÏ
óáÕ³óÇñ ë³ñùáí
1849
1851
ÜÇïñáÝ· ýáñï»
Nitrong forte
1852
ÜÇïñáýáõÝ·ÇÝ
Nitrofungin
1853 ÜÇïñáýáõÝ·ÇÝ Ý»á
Nitrofungin Neo
óáÕ³óÇñ
1855
ÜÇïñûùëáÉÇÝ
Nitroxoline
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
ùÉáñáÝÇïñáý»ÝáÉ
chloronitrofenol
ïñǹ»Ï³Ý³ÙÇÝÇ
áõݹ»óÇɻݳï
tridecanamine
undecylenate
ïñǹ»Ï³Ý³ÙÇÝÇ
áõݹ»óÇɻݳï
tridecanamine
undecylenate
ÝÇïñûùëáÉÇÝ
nitroxoline
1856
ÜÇïûùë 200
Nitox 200
ûùëÇï»ïñ³óÇÏÉÇÝ
oxytetracycline
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1857
ÜÇó»ñ·áÉÇÝ
Nicergoline
ÜÇý»¹ÇåÇÝ
Nifedipin
ÜÇý»¹ÇåÇÝ
Nifedipin
ÝÇó»ñ·áÉÇÝ
nicergoline
ÝÇý»¹ÇåÇÝ
nifedipine
ÝÇý»¹ÇåÇÝ
nifedipine
¹»Õ³Ñ³ï»ñ
1854 ÜÇïñáýáõÝ·ÇÝ Ý»á
Nitrofungin Neo
1858
1859
óáÕ³ßÇà ³ñï³ùÇÝ
û·ï³·áñÍÙ³Ý
2.5Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
0.5%,
60ÙÉ åɳëïÇÏ»
ßßÇÏ
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
N06D A04
1000/6975
04.06.2007
04.06.2012
¸
îºì² ¸»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý äñÇí³ï
øá. Èï¹.
TEVA Pharmaceutical Works
Private Ltd.
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
úñÇáÝ øáñåáñ»ÛßÝ
Orion Corporation
ÐáõÝ·³ñdz
P03A C04
0519/6510
10.11.2006
10.11.2011
²¸
Ȼѳëï³Ý
N05C D02
5061
24.09.2004
24.09.2009
¸\Ð
üÇÝɳݹdz
C01D A02
4427
09.09.2003
09.09.2008
¸
Æï³Édz
C01D A02
5286
16.03.2005
16.03.2010
¸
èáõë³ëï³Ý
C01D A02
5573
05.09.2005
05.09.2010
¸
ú½áÝ êäÀ
Ozon Ltd.
èáõë³ëï³Ý
C01D A02
5781
08.12.2005
08.12.2010
¸
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
êÉáí³Ïdz
C01D A02
4253
¸
ÐáõÝ·³ñdz
C01D A02
4289
19.06.2003
19.06.2008
18.06.2003
18.06.2008
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
¶³É»Ý³ ³.ë.
Galena a.s.
²Ûì²øê ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
êÉáí»Ýdz
C01SD A02
0812/6831
¸
â»Ëdz
_
4160
â»Ëdz
D01AE
0460\6366
20.03.2007
20.03.2012
26.02.2003
26.02.2008
11.10.2006
11.10.2011
¶»ÉýÇý³ñÙ³ ÆÝï»ñÝ»ÛßÝÁÉ
ê.é.É. äШî
Gelfipharma International S.r.l
for PH&T S.p.A.
ØÇÏñá·»Ý ¶²Ø
Microgen SIU
¸
²¸
²¸
ÉáõÍáõÛà ³ñï³ùÇÝ
û·ï³·áñÍÙ³Ý
25ÙÉ ßßÇÏ
²Ûì²øê ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
â»Ëdz
D01AE
0461\6365
11.10.2006
11.10.2011
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(10)
àõÏñ³Çݳ
J01X X07
0547/6503
17.11.2006
17.11.2011
¸
20%,
20ÙÉ ëñí³Ï (60),
50ÙÉ ëñí³Ï (50),
100ÙÉ ëñí³Ï (50)
5Ù·
(24,30)
10Ù·
(50,1000x10)
10Ù·
(50/5x10/)
´áñßã³·áíÛ³Ý ø¸¶
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
ÜÇï³-ü³ñÙ ö´À
Nita-Farm Closed JSC
èáõë³ëï³Ý
³Ý³ëݳµáõųϳÝ,
J01A A06
5775
27.10.2005
27.10.2010
¸
г۳ëï³Ý
C04A E02
4687
¸
سϻ¹áÝdz
C08C A05
5673
´áõÉÕ³ñdz
C08C A05
0973/6946/1
06.07.2004
06.07.2009
19.09.2005
19.09.2010
22.05.2007
20.04.2012
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
ڲβ-80
JAKA-80
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
¸
¸
127
1860
1861
ÜÛáõ ɳÛý 1000
New Life 1000
Üáµñ³ëÇï
Nobrassit
1862
Üá-¹áÉ
No-Dol
1863
Üá½»ÛÉÇÝ
Nozeylin
1864
ÜáÉÇåñ»É
Noliprel
1865
ÜáÉÇåñ»É
³ñ·ÇÝÇÝ
Noliprel arginine
1866
ÜáÉÇåñ»É ýáñï»
Noliprel forte
1867
ÜáÉÇåñ»É üáñï»
³ñ·ÇÝÇÝ
Noliprel Forte
arginine
1868
ÜáÉÇóÇÝ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
Nolicin coated
tablets
1869 ÜáËß³í»ñÇÝ §ú¼¦
NoÑshaverin §OZ¦
1870
Üá-ÙÇ·ñ³Ý
No-Migrain
1871
ÜáÝ»ëïáÝ
Noneston
Üáß-³ñ÷Ç
Nosh-Arpi
ûÙ»·³-3
å³ïÇ×Ý»ñ
omega-3
µáõë³Ï³Ý Ñ»ÕáõÏ
ÉáõÍáõÛà ËÙ»Éáõ
ѳÝáõÏ-Ýáµñ³ëÇï,
·áõ³Ûý»Ý»½ÇÝ
herbal fluid extractnobrassit, guaifenesin
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
¹»Õ³Ñ³ï»ñ
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
acetylsalicylic acid,
paracetamol, caffeine
ݳý³½áÉÇÝ,
³Ïݳ-/ ùóϳÃÇÉÝ»ñ
ùÉáñý»ÝÇñ³ÙÇÝ
naphazoline,
chlorpheniramine
å»ñÇݹáåñÇÉ,
¹»Õ³Ñ³ï»ñ
Çݹ³å³Ùǹ
perindopril, indapamide
å»ñÇݹáåñÇÉ
¹»Õ³Ñ³ï»ñ
³ñ·ÇÝÇÝ, Çݹ³å³Ùǹ
óճÝóå³ï
perindopril arginine,
indapamide
å»ñÇݹáåñÇÉ,
¹»Õ³Ñ³ï»ñ
Çݹ³å³Ùǹ
perindopril, indapamide
å»ñÇݹáåñÇÉ
¹»Õ³Ñ³ï»ñ
³ñ·ÇÝÇÝ, Çݹ³å³Ùǹ
óճÝóå³ï
perindopril arginine,
indapamide
ÝáñýÉûùë³óÇÝ
¹»Õ³Ñ³ï»ñ
norfloxacin
óճÝóå³ï
²ØÜ
βêÐ
5105
èáõë³ëï³Ý
R05C
5334
20.09.2004
20.09.2009
15.02.2005
15.02.2010
²¸
²¸
(0.3·+0.1·+0.05·)
(10, 30/3x10/)
ü³ñÙ³Ï ´´À
Farmak JSC
àõÏñ³Çݳ
N02B A51
1023/7049
13.06.2007
13.06.2012
²¸
(0.5Ù·+0.5Ù·)/
1ÙÉ,
15ÙÉ ßßÇÏ
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ, ²ØÜ-Ç Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
USA)
ê»ñíÇ» ɳµáñ³ïáñdz
Les Laboratoires Servier
º·Çåïáë
S01G A51
0042/6156
24.05.2006
24.05.2011
²¸
üñ³Ýëdz
C09A A04
4854
27.05.2004
27.05.2009
¸
ê»ñíÇ» Æݹ³ëïñÇ
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
ê»ñíÇ» ɳµáñ³ïáñdz
Les Laboratoires Servier
üñ³Ýëdz
C09B A04
1449/7384
20.12.2007
20.12.2012
¸
üñ³Ýëdz
C09A A04
4855
27.05.2004
27.05.2009
¸
ê»ñíÇ» Æݹ³ëïñÇ
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
üñ³Ýëdz
C09B A04
1450/7385
20.12.2007
20.12.2012
¸
êÉáí»Ýdz
J01M A06
0935/6879
03.05.2007
03.05.2012
¸
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
êäÀ-Ç Ù³ëݳ×ÛáõÕ ù. ʳñÏáí
Branch of LCC §Experimental
plant GNCLS¦ c. Kharkov
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
àõÏñ³Çݳ
A03A D02
0585/6137
05.12.2006
05.12.2011
¸
º·Çåïáë
N02C A72
0217/6183
26.07.2006
26.07.2011
²¸
13.01.2005
13.01.2010
20.05.2004
20.05.2009
¸
(2Ù·+0.625Ù·)
(14,30)
(2,5Ù·+0,625Ù·)
(30)
(4Ù·+1.25Ù·)
(14,30)
(5Ù·+1,25Ù·) (30)
400Ù·
(20/2x10/)
¹ñáï³í»ñÇÝ
drotaverin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2%(0.04 ·/2ÙÉ)
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(1Ù·+250Ù·+
10Ù·+ 50Ù·)
(20)
¹»Õ³Ñ³ï»ñ
50Ù·
(30)
40Ù·
(24,48,100)
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
Ðáõݳëï³Ý
N05A L01
5297
г۳ëï³Ý
A03A D02
4844
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
A03A D02
4408
25.08.2003
25.08.2008
²¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0.04·
(10,20, 30, 40, 50,
100)
2%,
2ÙÉ ³ÙåáõÉÝ»ñ
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
A03A D02
4409
25.08.2003
25.08.2008
¸
1873
Üáß-µñ³
Nos-Bra
¿ñ·áï³ÙÇÝÇ ï³ñïñ³ï,
å³ñ³ó»ï³ÙáÉ,
¹áÙå»ñǹáÝ, Ïáý»ÇÝ
ergotamine tartrate,
paracetamol,
domperidone, caffeine
ëáõÉåÇñǹ
sulpiride
¹ñáï³í»ñÇÝÇ
ÑǹñáùÉáñǹ
drotaverine
hydrochloride
¹ñáï³í»ñÇÝ
drotaverine
1874
Üáß-µñ³
Nos-Bra
¹ñáï³í»ñÇÝ
drotaverine
1872
(20, 30, 60, 80, 90, ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
120)
New Spirit Naturals Inc.
(5ÙÉ+4·)/100ÙÉ,
§´ñÇÝó³Éáí - ²¦ ö´À
50ÙÉ,
CJSC §Brinsalov - A¦
100ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
²¸
128
(5,10,25)
40Ù·
(20, 100)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
40Ù·/2ÙÉ,
³ÙåáõÉÝ»ñ (25)
¹»Õ³Ñ³ï»ñ
80Ù·
(20)
¹»Õ³Ñ³ï»ñ
500Ù·+40Ù·+8Ù·
(12)
¹»Õ³å³ïÇ×Ý»ñ
0.04·
(10,20,60)
20%,
1ÙÉ ³ÙåáõÉÝ»ñ
(12,25)
1·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(12)
3·/15ÙÉ,
15ÙÉ ³ÙåáõÉÝ»ñ
(4)
1200Ù·
(20)
800Ù·
(30)
(0,15Ù·+0,02Ù·)
(21, /3x21/)
Üá-ßå³
No-spa
1876
Üá-ßå³
No-spa
1877
Üá-ßå³ ýáñï»
No-spa forte
1878
Üá-ßå³É·ÇÝ
No-spalgin
1879
ÜááïáµñÇÉ
Nootobril
ÜááïáµñÇÉ
Nootobril
å³ñ³ó»ï³ÙáÉ,
¹ñáï³í»ñÇÝÇ
ÑǹñáùÉáñǹ,
Ïá¹»ÇÝÇ ýáëý³ï
paracetamol,
drotaverine
hydrochloride, codeine
phosphate
åÇñ³ó»ï³Ù
piracetam
åÇñ³ó»ï³Ù
piracetam
1881
ÜááïñáåÇÉ
Nootropil
åÇñ³ó»ï³Ù
piracetam
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1882
ÜááïñáåÇÉ
Nootropil
åÇñ³ó»ï³Ù
piracetam
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1880
1883 ÜááïñáåÇÉ 1200Ù·
Nootropil 1200mg
1884 ÜááïñáåÇÉ 800Ù·
Nootropil 800Ù·
1885
ÜáíÇÝ»ï
Novynette
¹ñáï³í»ñÇÝÇ
ÑǹñáùÉáñǹ
drotaverine
hydrochloride
¹ñáï³í»ñÇÝÇ
ÑǹñáùÉáñǹ
drotaverine
hydrochloride
¹ñáï³í»ñÇÝ
drotaverine
¹»Õ³Ñ³ï»ñ
1875
1886
ÜáíáϳÛÇÝ
Novocain
åÇñ³ó»ï³Ù
piracetam
åÇñ³ó»ï³Ù
piracetam
¹»½á·»ëïñ»É,
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ
desogestrel,
ethinylestradiol
åñáϳÛÇÝ
procaine
1887
ÜáíáϳÛÇÝ
Novocain
åñáϳÛÇÝ
procaine
1888
ÜáíáϳÛÇÝ-0,5%
ÉáõÍáõÛÃ
Novocain-0,5%
solution
åñáϳÛÇÝ
procaine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0.5%(2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
ÊÇÝáÇÝ ¹»Õ³·áñÍ³Ï³Ý ¨
ùÇÙÇ³Ï³Ý ·áñͳñ³Ý øá.Èï¹
Chinoin Pharmaceutical and
Chemical Works Co.Ltd.
ÊÇÝáÇÝ ¹»Õ³·áñÍ³Ï³Ý ¨
ùÇÙÇ³Ï³Ý ·áñͳñ³Ý øá.Èï¹
Chinoin Pharmaceutical and
Chemical Works Co.Ltd.
§ÊÇÝáÇݦ ¸»Õ³·áñÍ³Ï³Ý ¨
ùÇÙÇ³Ï³Ý ³ñï³¹ñ³ÝùÝ»ñÇ
·áñͳñ³Ý ´À
§Chinoin¦ Pharmaceutical and
Chemical Works Co. Ltd.
ÊÇÝáÇÝ ¹»Õ³·áñÍ³Ï³Ý ¨
ùÇÙÇ³Ï³Ý ·áñͳñ³Ý øá.Èï¹
Chinoin Pharmaceutical and
Chemical Works Co.Ltd.
ÐáõÝ·³ñdz
A03A D02
1284/7252
29.10.2007
12.10.2012
²¸
ÐáõÝ·³ñdz
A03A D02
1286/7253
29.10.2007
12.10.2012
¸
ÐáõÝ·³ñdz
A03A D02
4574
16.03.2004
16.03.2009
²¸
ÐáõÝ·³ñdz
N02B E71
4849
30.06.2004
30.06.2009
¸
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
N06B X03
4405
¸
èáõë³ëï³Ý
N06B X03
4404
25.08.2003
25.08.2008
25.08.2003
25.08.2008
Úáõ-êÇ-´Ç ê.².ü³ñÙ³ ê»Ïïáñ
UCB S.A.Pharma Sector
´»É·Ç³
N06B X03
5566
15.04.2005
15.04.2010
¸
Úáõ-êÇ-´Ç ê.².ü³ñÙ³ ê»Ïïáñ
UCB S.A.Pharma Sector
´»É·Ç³
N06B X03
5740
12.12.2005
12.12.2010
¸
Úáõ-êÇ-´Ç ê.².ü³ñÙ³ ê»Ïïáñ
UCB S.A. Pharma Sector
Úáõ-êÇ-´Ç ê.².ü³ñÙ³ ê»Ïïáñ
UCB S.A.Pharma Sector
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc
´»É·Ç³
N06B X03
5739
¸
´»É·Ç³
N06B X03
5565
ÐáõÝ·³ñdz
G03A A09
1262/7230
09.08.2005
09.08.2010
15.04.2005
15.04.2010
03.12.2007
12.10.2012
г۳ëï³Ý
C05A D05,
N01B A02
5256
25.07.2005
25.07.2010
¸
г۳ëï³Ý
C05A D05,
N01B A02
5257
25.07.2005
25.07.2010
¸
г۳ëï³Ý
N01B A02,
C05A D05
5644
09.11.2005
09.11.2010
¸
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
üÇñÙ³ ´´À
Yerevan ChemicalPharmaceutical Firm Open J/S
Company
ÉáõÍáõÛÃ
2%(2ÙÉ),
ºñ¨³ÝÇ øÇÙdz¹»Õ³·áñͳ-ϳÝ
Ý»ñ³ñÏÙ³Ý
2ÙÉ ³ÙåáõÉÝ»ñ
üÇñÙ³ ´´À
(10)
Yerevan ChemicalPharmaceutical Firm Open J/S
Company
ÉáõÍáõÛÃ
0.5%,
ü³ñÙ³ î»ù ö´À PharmaTech
ϳÃÇɳݻñ³ñÏ-Ù³Ý 100ÙÉ,200ÙÉ,250
CJSC
ÙÉ åɳëïÇÏ ÷³Ã»Ã
¸
¸
¸
129
1889
ÜáíáϳÛÇݳÙǹü»ñ»ÛÝ
NovocainamideFerein
1890
ÜáíáϳÛÇݼ¹áñáíÛ»
Novocain-Zdorovye
1891
ÜáíáϳÛÇݼ¹áñáíÛ»
Novocain-Zdorovye
1892
ÜáíáØÇùë 30
ä»ÝýÇÉ
NovoMix 30 PenFill
1893
1894
1895
1896
1897
1898
1899
1900
1901
1902
åñáϳÛÇݳÙǹ
procainamide
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10%,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
´ñÇÝó³Éáí-² ö´À
Brinsalov-A CJSC
èáõë³ëï³Ý
C01B A02
5689
19.09.2005
19.09.2010
¸
åñáϳÛÇÝ
procaine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0,5%,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
àõÏñ³Çݳ
N01B A02
1138/7109
02.10.2007
08.08.2012
¸
åñáϳÛÇÝ
procaine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2% (2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
àõÏñ³Çݳ
N 01B A02
1232/7169
15.11.2007
13.09.2012
¸
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
100²Ø/ÙÉ (3ÙÉ),
ù³ñÃñÇç (5, 10)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
Üáíá Üáñ¹ÇëÏ ²/ê
Novo Nordisk A/S
¸³Ýdz
A10AD05
1362/7323
29.11.2007
05.11.2012
¸
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
100²Ø/ÙÉ (3ÙÉ),
100²Ø/ÙÉ, 3ÙÉ
ݳ˳Éóí³Í ·ñÇã (5,
10)
1Ù·
(30,90,120)
0.5Ù·
(30,90,120)
2Ù·
(30,90,120)
(7.75·+4·)/100ÙÉ,
100ÙÉ ßßÇÏ
Üáíá Üáñ¹ÇëÏ ²/ê
Novo Nordisk A/S
¸³Ýdz
A10AD05
1364/7325
29.11.2007
05.11.2012
¸
Üáíá-Üáñ¹ÇëÏ ²/ê
Novo-Nordisk A/S
Üáíá-Üáñ¹ÇëÏ ²/ê
Novo-Nordisk A/S
Üáíá-Üáñ¹ÇëÏ ²/ê
Novo-Nordisk A/S
²Ûì²øê - êè ³.ë.
IVAX - CR a.s.
¸³Ýdz
-
5095
¸
¸³Ýdz
-
5094
¸³Ýdz
-
5096
â»Ëdz
_
4161
29.10.2004
29.10.2009
29.10.2004
29.10.2009
29.10.2004
29.10.2009
09.04.2003
26.02.2008
ÇÝëáõÉÇÝ ³ëå³ñï
(é»ÏáÙµÇݳÝï)
insulin aspart
(recombinant)
ÜáíáØÇùë 30
ÇÝëáõÉÇÝ ³ëå³ñï
üÉ»ùëö»Ý
(é»ÏáÙµÇݳÝï)
NovoMix 30
insulin aspart
FlexPen
(recombinant)
ÜáíáÝáñÙ
é»å³·ÉÇÝǹ
NovoNorm
repaglinide
ÜáíáÝáñÙ
é»å³·ÉÇÝǹ
NovoNorm
repaglinide
ÜáíáÝáñÙ
é»å³·ÉÇÝǹ
NovoNorm
repaglinide
Üáíá-å³ëÇï
Ýáíá-å³ëÇï µáõë³Ï³Ý
Novo-passit
ѳÝáõÏ,
·áõ³Ûý»Ý»½ÇÝ novopassit herbal extract,
guaifenesin
Üáíá-é³åǹ ÷»ÝýÇÉ
ÇÝëáõÉÇÝ ³ëå³ñï
Novo-Rapid Penfill
(é»ÏáÙµÇݳÝï)
insulin aspart
(recombinant)
Üáïï³
-Notta
Üáïï³
-Notta
ÜáñÏáÉáõï
Ýáñ¿ÃÇëï»ñáÝ
Norcolut
norethisterone
ÜáñÙ³ïÇÝ
ÃÇÙáÉáÉÇ Ù³É»³ï
Normatin
timolol maleate
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
²¸
100Ø/ÙÉ,
3ÙÉ ÷³Ù÷áõßïÝ»ñ
(5)
Üáíá-Üáñ¹ÇëÏ ²/ê
Novo-Nordisk A/S
¸³Ýdz
A10A
5097
16.09.2004
16.09.2009
¸
ϳÃÇÉÝ»ñ
20ÙÉ, 50ÙÉ,
100ÙÉ ßßÇÏ
(12, 48)
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Richard Bittner AG
èÇ˳ñ¹ ´ÇÃÝ»ñ ¶ÙµÐ
Richard Bittner AG
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ, ²Ý·Édz-Ç Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
England)
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ, ²Ý·Édz-Ç Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
England)
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
²íëïñdz
1052/7073
02.07.2007
02.07.2012
03.12.2007
17.02.2011
14.12.2005
14.12.2010
13.03.2007
13.03.2012
²¸
º·Çåïáë
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
G03A C01,
G03D C02
S01E D01
º·Çåïáë
S01E D01
0788/6858
13.03.2007
13.03.2012
¸
ÐáõÝ·³ñdz
C08C A01
5652
¸
ÐáõÝ·³ñdz
C08C A01
5653
êÇñdz
G03A C01
4985
22.11.2005
22.11.2010
22.11.2005
22.11.2010
17.09.2004
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
¹»Õ³Ñ³ï»ñ
³ÏݳϳÃÇÉÝ»ñ
5Ù·
(20)
0.25%,
5ÙÉ ßßÇÏ
ÜáñÙ³ïÇÝ
Normatin
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
³ÏݳϳÃÇÉÝ»ñ
0.5%,
5ÙÉ ßßÇÏ
1904
ÜáñÙá¹ÇåÇÝ
Normodipine
ÜáñÙá¹ÇåÇÝ
Normodipine
ÜáñÙáÉáõï Ü
³ÙÉá¹ÇåÇÝ
amlodipine
³ÙÉá¹ÇåÇÝ
amlodipine
Ýáñ¿ÃÇëï»ñáÝ
¹»Õ³Ñ³ï»ñ
5Ù·
(30)
10Ù·
(30)
5Ù·
1906
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1903
1905
¸
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
²íëïñdz
ÐáõÝ·³ñdz
1415/5896/1
5654
0784/6857
²¸
¸
¸
¸
¸
130
Normolute N
Üáñí³ëÏ
Norvasc
norethisterone
³ÙÉá¹ÇåÇÝÇ µ»½Çɳï
amlodipine besilate
1908
Üáñí³ëÏ
Norvasc
³ÙÉá¹ÇåÇÝÇ µ»½Çɳï
amlodipine besilate
¹»Õ³Ñ³ï»ñ
10Ù·
(14,30)
1909
Üáñí³ëÏ
Norvasc
Üáñí³ëÏ
Norvasc
Üáñí»Ï
Norvek
ÜáñíÇñ
Norvir
³ÙÉá¹ÇåÇÝÇ µ»½Çɳï
amlodipine besilate
³ÙÉá¹ÇåÇÝÇ µ»½Çɳï
amlodipine besilate
³ÙÉá¹ÇåÇÝ
amlodipine
éÇïáݳíÇñ
ritonavir
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ
5Ù·
(14,30)
10Ù·
(14,30)
5Ù·
(20,30)
100Ù· (84)
1913
Üáñïdz
Nortia
-
å³ïÇ×Ý»ñ
355Ù·
(60)
1914
ÜáñýÉûùë
Norflox
ÜáñýÉûùë³óÇݼ¹áñáíÛ»
NorfloxacinZdorovye
ÜáõïñÇÙ³ùë+
Nutrimax+
ÝáñýÉûùë³óÇÝ
norfloxacin
ÝáñýÉûùë³óÇÝ
norfloxacin
³Ïݳùëáõù
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.3%,
5· å³ñÏáõ×
0,4·
(10)
-
å³ïÇ×Ý»ñ
400Ù·
(60)
1917
Üáõñáý»Ý
Nurofen
ǵáõåñáý»Ý
ibuprofen
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(6,12,24)
1918
Üáõñáý»Ý
Nurofen
ǵáõåñáý»Ý
ibuprofen
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
200Ù·
(10)
1919
Üáõñáý»Ý
Nurofen
ǵáõåñáý»Ý
ibuprofen
¹áݹáÕ
5·/100·,
50· ³ÉÛáõÙÇÝ»
å³ñÏáõ×
ǵáõåñáý»Ý
ibuprofen
¹»Õ³Ï³ËáõÛÃ
ËÙ»Éáõ
100Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
ǵáõåñáý»Ý
ibuprofen
¹»Õ³å³ïÇ×Ý»ñ
200Ù·
(4,10)
1907
1910
1911
1912
1915
1916
1920
Üáõñáý»Ý
»ñ»Ë³Ý»ñÇ
Nurofen for children
1921 Üáõñáý»Ý áõÉïñ³Ï³å
Nurofen UltraCap
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
(20)
5Ù·
(14,30)
Pharmaceutical
лÛÝñÇË Ø³ù.ܳãý.¶ÙµÐ ¨
øá.(öý³Û½»ñ ÆÉÉ»ñÃǽ»Ý)
Heinrich Mack Nachf. GmbH &
Co. (Pfizer-Illertissen)
лÛÝñÇË Ø³ù.ܳãý.¶ÙµÐ ¨
øá.(öý³Û½»ñ ÆÉÉ»ñÃǽ»Ý)
Heinrich Mack Nachf. GmbH &
Co. (Pfizer-Illertissen)
öý³Û½»ñ ê.².
Pfizer S.A.
öý³Û½»ñ ê.².
Pfizer S.A.
¾È ê³³¹ ü³ñÙ³ëÛáõÃÇù³Éë
EL Saad Pharmaceuticals
²µµáï ȳµ. êäÀ
Abbot Lab. Ltd
¶»ñÙ³Ýdz
G03D C02
C08C A01
5192
¶»ñÙ³Ýdz
C08C A01
5193
05.10.2004
05.10.2009
¸
´»É·Ç³
C08C A01
5194
¸
´»É·Ç³
C08C A01
5195
êÇñdz
C08C A01
4782
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
Æéɳݹdz
J05A E03
1374/7336
05.10.2004
05.10.2009
05.10.2004
05.10.2009
29.03.2004
29.03.2009
20.12.2007
05.11.2012
βêÐ
5807
26.10.2005
26.10.2010
²¸
S01A X12
3990
¸
J01M A06
1139/7110
25.03.2003
25.03.2008
02.10.2007
08.08.2012
βêÐ
5823
26.10.2005
26.10.2010
²¸
M01A E01,
M02A A13
5521
15.07.2005
15.07.2010
²¸
M01A E01,
M02A A13
5520
15.07.2005
15.07.2010
²¸
M01A E01
1436/7433
20.12.2007
20.12.2012
²¸
M01A E01,
M02A A13
5523
15.07.2005
15.07.2010
²¸
M01A E01,
M02A A13
5522
15.07.2005
15.07.2010
²¸
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
êÇåɳ Èï¹
Ðݹϳëï³Ý
Cipla Ltd.
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
àõÏñ³Çݳ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
Æéɳݹdz
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
´áõïë лÉÃù»ñ
ØdzóÛ³É
ÆÝï»ñÝ»ÛßÁÝÉ
³·³íáñáõBoots Healthcare International
ÃÛáõÝ
º-ü³ñÙ³ îñ»Ýïá ê.ä.² (´áõïë
Æï³Édz
лÉÃù»ñ ÆÝï»ñÝ»ÛßÁÝÉ-Ç
ѳٳñ)
E-Pharma Trento S.P.A.(for
Boots Healthcare International)
ü³ñÙ³êÇ»é³ Ø³Ýáõý³ÏïáõñÇÝ·
Æëå³Ýdz
ê.È. (è»ùÇï ´»ÝÏǽ»ñ
лÉÃù»Ûñ ÆÝï. êäÀ-Ç Ñ³Ù³ñ,
ØdzóÛ³É Â³·³íáñáõÃÛáõÝ)
PharmaSierra Manufacturing
S.L. (for Reckitt Benckiser
HealthCare Int. Ltd., UK)
´áõïë лÉÃù»ñ
ØdzóÛ³É
ÆÝï»ñÝ»ÛßÁÝÉ
³·³íáñáõBoots Healthcare International
ÃÛáõÝ
´³ÝÝ»ñ ü³ñٳϳåë ºíñáå³ ´ì
Üǹ»éɳݹ(´áõïë лÉÃù»ñ
Ý»ñ
ÆÝï»ñÝ»ÛßÁÝÉ-Ç Ñ³Ù³ñ)
Banner Pharmacaps Europe
BV (for Boots Healthcare
17.09.2009
05.10.2004
05.10.2009
¸
¸
¸
¸
¸
131
1922 Üáõñáý»Ý äÉÛáõë
Nurofen Plus
1923
1924
1925
1926
1927
1928
1929
1930
ÜáýáõÝ·
Nofung
ÜáýáõÝ·
Nofung
ÜáýáõÝ·
Nofung
Þǽ³Ý¹ñ³ + ѳå³É³ë
Schizandra +
bilberry
ÞÇϳï³ÏÇ Ñ³ÝáõÏáí
ÙáÙÇÏÝ»ñ
Suppositories with
Belladonna extract
ÞáýÇïáÉ
Chophytol
àõÅ»Õ
ý»ñÙ»ÝïÝ»ñÇ
ѳٳÉÇñ
Power Enzyme
Complex
àõÉïáå
Ultop
àõÉïáå
Ultop
àõÉïñ³ ٻɳ¹ÇÝÇÝ
Ultra Meladinine
ǵáõåñáý»Ý, Ïá¹»ÇÝ
ibuprofen, codeine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(200Ù·+10Ù·) (12)
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
-
¹»Õ³å³ïÇ×Ý»ñ
150Ù·
(1,4)
50Ù·
(7,14)
100Ù·
(7,28)
350Ù·
(20,30)
International)
è»ùÇï ´»ÝÏǽ»ñ лÉÃù»Ûñ
ÆÝï. êäÀ
Reckitt Benckiser Health Care
Int. Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
ä³ñ³ý³ñÙ ö´À
Parapharm
CJSC
ßÇϳï³ÏÇ Ñ³ÝáõÏ
belladonnae extract
ÙáÙÇÏÝ»ñ
0.015·
(10)
ϳÝϳéÇ Ñ³ÝáõÏ
Cynara extract
-
ÉáõÍáõÛà ËÙ»Éáõ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
ѳµ»ñ
ѳµ»ñ óճÝóå³ï
1933
àõÉïñ³íÇëï-370
Ultravist -370
ûÙ»åñ³½áÉ
omeprazole
ûÙ»åñ³½áÉ
omepazole
Ù»Ãûù뽳ɻÝ
(³ÙáǹÇÝ)
methoxsalen
(ammoidin)
ÇáåñáÙǹ
iopromide
1934
àõÉïñ³íÇëï-370
Ultravist-370
ÇáåñáÙǹ
iopromide
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1935
àõÉïñ³íÇï-Ø
Ultravit-M
àõÉñ³Ý
Ulran
àõÉñ³Ý
Ulran
àõÉý³Ùǹ
Ulfamid
àõÉý³Ùǹ
Ulfamid
àõÝÇí»ñï³Ý
Univertan
íÇï³ÙÇÝÝ»ñ, »ñϳÃ
vitamins, iron
é³ÝÇïǹÇÝ
ranitidine
é³ÝÇïǹÇÝ
ranitidine
ý³ÙáïǹÇÝ
famotidine
ý³ÙáïǹÇÝ
famotidine
ëáõÉý³Ãdz½áÉ,
ùÉáñ³Ùý»ÝÇÏáÉ,
ÝÇëï³ïÇÝ, ÍÍáõÙµ,
ûß³ñ³Ï
1931
1932
1936
1937
1938
1939
1940
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ùëáõù
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
N02AA59
1435/7432
20.12.2007
20.12.2012
¸
ÐáõÝ·³ñdz
J02A C01
4869
¸
ÐáõÝ·³ñdz
J02A C01
4867
ÐáõÝ·³ñdz
J02A C01
4868
èáõë³ëï³Ý
βêÐ
5200
23.09.2004
23.09.2009
23.09.2004
23.09.2009
23.09.2004
23.09.2009
08.12.2004
08.12.2009
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
èáõë³ëï³Ý
---
1113/7000
18.09.2007
18.09.2012
²¸
20·/100ÙÉ,
120ÙÉ ßßÇÏ)
(60)
èá½³-üÇïáý³ñÙ³ ɳµáñ³ïáñdz
Rosa-Phytopharma
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
üñ³Ýëdz
-
5435
²¸
²ØÜ
βêÐ
5393
17.02.2005
17.02.2010
16.03.2005
16.03.2010
10Ù·
(14/2x7/, 28/4x7/)
40Ù·
(14/2x7/, 28/4x7/)
10Ù·
(20)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Ø»ÙýÇë øá. ü³ñÙ ¨ ø»ÙÇϳÉ
Æݹ-Ç Ñ³Ù³ñ
Memphis Co. For Pharm &
Chemical Ind.
Þ»ñÇÝ· ²¶
Schering AG
êÉáí»Ýdz
A02B
0652/6573
¸
êÉáí»Ýdz
A02B
0653/6572
º·Çåïáë
D05B A02
D05A D02
4829
12.01.2007
12.01.2012
12.01.2007
12.01.2012
19.10.2004
19.10.2009
¶»ñÙ³Ýdz
V08A B05
0190/6246
13.07.2006
13.07.2011
¸
¶»ñÙ³Ýdz
V08A B05
0189/6247
13.07.2006
13.07.2011
¸
êÇñdz
B03A E03
4386
¸
êÉáí»Ýdz
A02B A02
4603
êÉáí»Ýdz
A02B A02
4604
êÉáí»Ýdz
A02B A03
0807/6836
êÉáí»Ýdz
A02B A03
0808/6835
´áõÉÕ³ñdz
D06,
J01
0871/6315
25.02.2004
25.02.2009
12.04.2006
12.04.2011
12.04.2006
12.04.2011
20.03.2007
20.03.2012
20.03.2007
20.03.2012
30.03.2007
30.03.2012
769Ù·/ÙÉ (50ÙÉ)
/370Ù· Ûá¹ÇÝ
ѳٳñÅ»ù,
50ÙÉ ëñí³Ï (10)
769Ù·/ÙÉ (100ÙÉ)
Þ»ñÇÝ· ²¶
/370Ù· Ûá¹ÇÝ
Schering AG
ѳٳñÅ»ù,
100ÙÉ ëñí³Ï (10)
200ÙÉ ßßÇÏ
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
Pharmaceutical
150Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(20)
KRKA d.d. Novo mesto
300Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(30)
KRKA d.d. Novo mesto
40Ù·
Îèβ ¹.¹., Üáíá Ù»ëïá
(10)
KRKA d.d., Novo mesto
20Ù·
Îèβ ¹.¹., Üáíá Ù»ëïá
(20/2x10/)
KRKA d.d., Novo mesto
(130Ù·+16Ù·+
êáý³ñÙ³ ´À
2,6Ù·+
Sopharma JSC
13Ù·+13Ù·)/·,
¸
¸
²¸
²¸
¸
¸
¸
¸
¸
¸
²¸
132
1941
àõÉïñ³åñáÏï
Ultraproct
1942
àõÉïñ³åñáÏï
Ultraproct
1943
àõïñáÅ»ëï³Ý
Utrogestan
µáñ³ùë
sulfathiazole,
chloramphenicol,
nystatin, sulphur, borax
ýÉáõáÏáñïáÉáÝ 21åÇí³É³ï,
ýÉáõáÏáñïáÉáÝ 21¹»ùë³Ýá³ï, óÇÝËáϳÛÇÝ
fluocortolone 21privalate, fluocortolone
21-dexanoate,
cinchocaine
ýÉáõáÏáñïáÉáÝ 21åÇí³É³ï,
ýÉáõáÏáñïáÉáÝ 21¹»ùë³Ýá³ï, óÇÝËáϳÛÇÝ
fluocortolone 21privalate, fluocortolone
21-dexanoate,
cinchocaine
åñá·»ëï»ñáÝ
progesterone
1944
àõïñáÅ»ëï³Ý
Utrogestan
1945
àõïñáÅ»ëï³Ý
Utrogestan
1946
àõñ»·Çï
Uregyt
àõñÇÝ»ùë
Urinex
1947
1948
àõñá·ñ³ýÇÝ 60%
Urografine 60%
1949
àõñá·ñ³ýÇÝ 76%
Urografine 76%
1950
àõñáïñ³ÏïÇÝ
Urotractin
18· å³ñÏáõ×
ùëáõù
(920ÙÏ·+950ÙÏ·+
5Ù·)/·,
10·,15·, 30·,40·
å³ñÏáõ×
Þ»ñÇÝ· ê.å.².
Schering S.p.A.
Æï³Édz
S01C A04
D07B C03
4650
15.10.2004
15.10.2009
¸
ÙáÙÇÏÝ»ñ
(610ÙÏ·+630ÙÏ·+
1Ù·)/·
(10,12)
Þ»ñÇÝ· ê.å.².
Schering S.p.A.
Æï³Édz
D07B C03
H02A
N01B
4651
15.10.2004
15.10.2009
¸
¹»Õ³å³ïÇ×Ý»ñ
ËÙ»Éáõ ϳÙ
Ñ»ßïáó³ÛÇÝ
100Ù·
(30)
´»É·Ç³
G03D A04
0017/5970
12.05.2006
12.05.2011
¸
åñá·»ëï»ñáÝ
progesterone
¹»Õ³å³ïÇ×Ý»ñ
ËÙ»Éáõ ϳÙ
Ñ»ßïáó³ÛÇÝ
100Ù·
(30)
üñ³Ýëdz
G03D A04
0018/5971
12.05.2006
12.05.2011
¸
åñá·»ëï»ñáÝ
progesterone
¹»Õ³å³ïÇ×Ý»ñ
ËÙ»Éáõ ϳÙ
Ñ»ßïáó³ÛÇÝ
200Ù·
(14)
´»½ÇÝ ÆÝï»ñݳëÇáݳÉ
ɳµáñ³ïáñdzݻñ
Besins International
Laboratoires
´»½ÇÝ ÆÝï»ñݳëÇáݳÉ
ɳµáñ³ïáñdzݻñ
Besins International
Laboratoires
´»½ÇÝ ÆÝï»ñݳëÇáݳÉ
ɳµáñ³ïáñdzݻñ
Besins International
Laboratoires
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
ü³ñÏá ü³ñÙ³ëÛáõÃÇù³Éë
Pharco Pharmaceuticals
üñ³Ýëdz
G03D A04
0892/5972/1
20.04.2007
12.05.2011
¸
ÐáõÝ·³ñdz
C03C C01
6075
¸
º·Çåïáë
-
5034
23.03.2006
23.03.2011
18.09.2004
18.09.2009
Þ»ñÇÝ· ²¶
Schering AG
¶»ñÙ³Ýdz
§in vivo¦
³ËïáñáßÇã
ÙÇçáó
4418
01.08.2003
01.08.2008
¸
Þ»ñÇÝ· ²¶
Schering AG
¶»ñÙ³Ýdz
§in vivo¦
³ËïáñáßÇã
ÙÇçáó
4419
01.08.2003
01.08.2008
¸
äáÉÇý³ñÙ øá.Èï¹., ³Ûɳݹ
(ºíñá¹ñ³· ȳµáñ³ïáñdz,
´»É·Ç³ÛÇ Ñ³Ù³ñ)
Polipharm Co.Ltd., Thailand
³Ûɳݹ
G04A B03
5047
14.01.2005
14.01.2010
¸
¿ï³ÏñÇݳÃÃáõ
¹»Õ³Ñ³ï»ñ
50Ù·
etacrynic acid
(20)
¹»Õ³å³ïÇ×Ý»ñ
31Ù·+15Ù·+10Ù·+
 ¨  ÷ÇÝ»Ý, ù³Ùý»Ý,
÷³÷áõÏ, ŻɳïÇÝ»
4Ù·+4Ù·+3Ù·
µáñÝ»áÉ, ý»ÝËáÝ,
(24)
³Ý»ÃáÉ, óÇÝ»áÉ
 and  pinene,
camphene, borneol,
fenchone, anethole,
cineole
³Ùǹáïñǽá³ïÝ»ñ
ÉáõÍáõÛÃ
(0.08·+0.52·)/1ÙÉ,
ݳïñÇáõÙÇ ¨
20ÙÉ ³ÙåáõÉÝ»ñ
Ù»·ÉáõÙÇÝÇ
(10)
sodium and meglumine
amidotrizoates
³Ùǹáïñǽá³ïÝ»ñ
ÉáõÍáõÛÃ
(0.1·+0.66·)/1ÙÉ,
ݳïñÇáõÙÇ ¨
20ÙÉ ³ÙåáõÉÝ»ñ
Ù»·ÉáõÙÇÝÇ
(10)
sodium and meglumine
amidotrizoates
åÇå»Ùǹ³ÃÃáõ
¹»Õ³å³ïÇ×Ý»ñ
400Ù·
pipemidic acid
(10, 250)
¸
133
1951
àõñëáõÉ
Ursul
-
å³ïÇ×Ý»ñ
370Ù·
(60)
1952
âÇÏïáÝÇÏ
Chicktonic
íÇï³ÙÇÝÝ»ñ,
³ÙÇݳÃÃáõÝ»ñ
vitamins, aminoacids
ãÇã˳ÝÇ ÛáõÕ
hippopheae oleum
ËÙ»Éáõ ÉáõÍáõÛÃ
1É,
5É åɳëïÇÏ» ï³ñ³
(for Eurodrug Laboratories,
Belgium)
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
ÆÝí»ë³
Invesa
ÙáÙÇÏÝ»ñ
0.5·
(10)
1953 âÇã˳ÝÇ ÛáõÕáí
ÙáÙÇÏÝ»ñ
Hippopheae oleum
suppositories
1954
ä³É³ñ³ËïÇ
å³ïí³ëï³ÝÛáõà BCGM ãáñ
Tuberculosis
vaccine (BCG-M),
dry
1955
ä³ÉÇÝ
Palin
1956 ä³ÏÉÇï³ùë»É -¾µ»í»
Paclitaxel-Ebewe
BCG å³ïí³ëï³ÝÛáõÃ
BCG vaccine
åÇå»Ùǹ³ÃÃáõ
pipemidic acid
å³ÏÉÇï³ùë»É
paclitaxel
ÉÇáýÇÉǽ³ï,
0.5Ù· (20¹»Õ³ã³÷)
2ÙÉ Ý³ïñÇáõÙÇ ³ÙåáõÉ/³ÙåáõÉ (5)
ùÉáñÇ¹Ç 0.9%
ÉáõÍáõÛÃ ÉáõÍãáí
¹»Õ³å³ïÇ×Ý»ñ
200Ù·
(20)
30Ù·/5ÙÉ,
ëñí³Ï (1)
1957 ä³ÏÉÇï³ùë»É -¾µ»í»
Paclitaxel-Ebewe
å³ÏÉÇï³ùë»É
paclitaxel
1958 ä³ÏÉÇï³ùë»É -¾µ»í»
Paclitaxel-Ebewe
å³ÏÉÇï³ùë»É
paclitaxel
1959
ä³Ý³¹áÉ
Panadol
å³ñ³ó»ï³ÙáÉ
paracetamol
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1960
ä³Ý³¹áÉ ¾ùëïñ³
Panadol Extra
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
paracetamol, caffeine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(500Ù·+65Ù·)
(6,12, 24)
1961
ä³Ý³¹áÉ ¿ùëïñ³
ÉáõÍ»ÉÇ
Panadol Extra
Soluble
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
paracetamol, caffeine
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
500Ù·+65Ù·
(12,24)
1962
ä³Ý³¹áÉ ÉáõÍ»ÉÇ
Panadol Soluble
å³ñ³ó»ï³ÙáÉ
paracetamol
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
500Ù·
(12,24)
1963
ä³Ý³¹áÉ Ù³ÝϳϳÝ
å³ñ³ó»ï³ÙáÉ
ÙáÙÇÏÝ»ñ
125Ù·
210Ù·/35ÙÉ
ëñí³Ï (1)
150Ù·/25ÙÉ,
ëñí³Ï (1)
500Ù·
(6, 12, 24)
Æéɳݹdz
βêÐ
5809
26.10.2005
26.10.2010
²¸
Æëå³Ýdz
³Ý³ëݳµáõųϳÝ
0202/6256
21.07.2006
21.07.2011
¸
ÜÇÅý³ñÙ ´À
Nizhpharm SC
èáõë³ëï³Ý
-
4276
14.07.2003
14.07.2008
²¸
¶³Ù³É»³ÛÇ ³Ýí. ¾Ø¶ÐÆ äÒ
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
§Medgamal¦ branch of SI
SRIEM after Gamalei
èáõë³ëï³Ý
L03A X03
5730
26.08.2005
26.08.2010
¸
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ. Ð. Üý·. ζ
EBEWE Pharma Ges m.b.H.
Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ. Ð. Üý·. ζ
EBEWE Pharma Ges m.b.H.
Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ. Ð. Üý·. ζ
EBEWE Pharma Ges m.b.H.
Nfg.KG
¶É³ùëáêÙÇÃÎɳÛÝ ¸³Ý·³ñí³Ý
ÈÇÙÇﻹ ¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ
GlaxoSmithKline Dungarvan
Limited for GlaxoSmithKline
Consumer Healthcare
¶É³ùëáêÙÇÃÎɳÛÝ ¸³Ý·³ñí³Ý
ÈÇÙÇﻹ ¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ
GlaxoSmithKline Dungarvan
Limited for GlaxoSmithKline
Consumer Healthcare
ü³Ù³ñ ²´º (¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñ-Ç
ѳٳñ)
Famar ABE (for
GlaxoSmithKline Consumer
Healthcare)
ü³Ù³ñ ²´º (¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñ-Ç
ѳٳñ)
Famar ABE (for
GlaxoSmithKline Consumer
Healthcare)
¶É³ùëá àõ»ÉùáÙ öñá¹³ÏßÁÝ
êÉáí»Ýdz
G04A B03
5273
¸
²íëïñdz
L01C D01
4907
07.02.2005
07.02.2010
06.12.2004
06.12.2009
²íëïñdz
L01C D01
4908
06.12.2004
06.12.2009
¸
²íëïñdz
L01C D01
4944
06.12.2004
06.12.2009
¸
Æéɳݹdz
N02B E01
0027/6172
17.05.2006
17.05.2011
²¸
Æéɳݹdz
N02B E01
0029/6173
17.05.2006
17.05.2011
²¸
Ðáõݳëï³Ý
N02B E51
4165
23.09.2003
23.09.2008
²¸
Ðáõݳëï³Ý
N02B E01
4166
17.12.2003
17.12.2008
²¸
üñ³Ýëdz
N02B E01
4164
17.02.2006
²¸
¸
134
Panadol Baby
paracetamol
1964
ä³Ý³¹áÉ Ù³ÝϳϳÝ
Panadol Baby
å³ñ³ó»ï³ÙáÉ
paracetamol
1965
ä³Ý³Ý·ÇÝ
Panangin
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
(10)
¹»Õ³Ï³ËáõÛÃ
(ÉÇó»Ý½Ç³ÛÇ ë»÷³Ï³Ý³ï»ñ`
¶É³ùëá êÙÇÃÎɳÛÝ ê³Ýï»
¶ñ³Ý¹ öáõµÉÇÏ
Glaxo
Wellcome Production (licence
holder-Glaxo SmithKline Sante
Grand Public)
2.4% (120Ù·/5ÙÉ), ¶É³ùëá àõ»ÉùáÙ öñá¹³ÏßÁÝ
100ÙÉ ßßÇÏ
(¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ)
Glaxo Wellcome Production
(for GlaxoSmithKline
Consumer Healthcare)
140Ù·+158Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
(50)
Gedeon Richter Ltd.
17.02.2011
üñ³Ýëdz
Ù³·Ý»½ÇáõÙÇ ³ëå³ñï³ï,
¹»Õ³Ñ³ï»ñ
ÐáõÝ·³ñdz
ϳÉÇáõÙÇ ³ëå³ñï³ï
óճÝóå³ï
magnesium aspartate,
potassium aspartate
ä³Ý³Ý·ÇÝ
Ù³·Ý»½ÇáõÙÇ ³ëå³ñï³ï,
ÉáõÍáõÛÃ
(400Ù·+452Ù·)/
¶»¹»áÝ èÇËï»ñ Èï¹.
ÐáõÝ·³ñdz
Panangin
ϳÉÇáõÙÇ ³ëå³ñï³ï
Ý»ñ³ñÏÙ³Ý,
10ÙÉ,
Gedeon Richter Ltd.
magnesium aspartate, ϳÃÇɳݻñ³ñÏ-Ù³Ý 10ÙÉ ³ÙåáõÉÝ»ñ
potassium aspartate
(5)
ä³Ý½ÇÙ üáñï»
å³ÝÏñ»³ïÇÝ
¹»Õ³Ñ³ï»ñ
3500ØØ ÉÇå³½³,
§´ñÇÝó³Éáí-²¦ ö´À
èáõë³ëï³Ý
Panzim forte
pancreatin
óճÝóå³ï
4200ØØ ³ÙÇɳ½³,
§Brinsalov-A¦ CJSC
250ØØ åñáû³½³
(10,20,40,50,80,
100, 800)
ä³Ý½ÇÝáñÙ üáñï»ÉÇå³½, ³ÙÇɳ½,
¹»Õ³Ñ³ï»ñ
20000Ø+12000Ø+
Îèβ ¹.¹. Üáíá Ù»ëïá
êÉáí»Ýdz
Ü Panzynorm
åñáﻳ½
óճÝóå³ï
900Ø,
KRKA d.d. Novo mesto
Forte-N
lipase, amylase,
(10,30,100)
protease
ä³ÝûÝáÉ
¹»ùëå³ÝûÝáÉ
óáÕ³ßÇÃ
4,63·/100·,
ÞáíÇÝ ³ÝÏ»ñý³ñÙ ¶ÙµÐ
¶»ñÙ³Ýdz
Panthenol
dexpanthenol
÷ñ÷ñ³ÝÙ³Ý
130· ßßÇÏ
Chauvin ankerpharm GmbH
ä³ÝÇíÇï
å³ñ³ó»ï³ÙáÉ,
¹»Õ³Ñ³ï»ñ
(500Ù·+200Ù·)
ìÇï³É XD Èï¹ (àõáñɹ
¾ëïáÝdz
Panivit
³ëÏáñµÇݳÃÃáõ
¹Ûáõñ³ÉáõÛÍ
(12)
Ø»¹ÇëÇÝ, ²Ý·Édz-Ç Ñ³Ù³ñ)
paracetamol, ascorbic
Vitale-XD Ltd (for World
acid
Medicine, England)
ä³ÝÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
500Ù·+125Ù·
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
гñ³íëɳ-ídz
Panklav
ùɳíáõɳݳÃÃáõ
óճÝóå³ï
(20)
Hemofarm concern A.D.
amoxycilline, clavulanic
acid
ä³ÝÏɳí
³ÙûùëÇóÇÉÇÝ,
¹»Õ³Ñ³ï»ñ
250Ù·+125Ù·
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
гñ³íëɳ-ídz
Panklav
ùɳíáõɳݳÃÃáõ
óճÝóå³ï
(15)
Hemofarm concern A.D.
amoxycilline, clavulanic
acid
ä³ÝÏñ»³ïÇÝ
å³ÝÏñ»³ïÇÝ
¹»Õ³Ñ³ï»ñ
125Ù·
¶³É»ÝÇϳ ³.¹.
гñ³íëɳ-ídz
Pankreatin
pancreatin
óճÝóå³ï (¹ñ³Å»)
(50)
Galenika a.d.
ä³ÝÏñ»³ïÇÝ
å³ÝÏñ»³ïÇÝ
¹»Õ³Ñ³ï»ñ
4300ØØ ÉÇå³½³+ ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
èáõë³ëï³Ý
Pancreatin
pancreatin
óճÝóå³ï
3500ØØ ³ÙÇɳ½³+ Pharmstandard-Leksredstva
200ØØåñáû³½³
OJSC
(50/5x10/)
ä³ÝÏñ»³ïÇÝ
å³ÝÏñ»³ïÇÝ
¹»Õ³Ñ³ï»ñ
30Ø
ü³ñÙåñáÛ»Ïï ö´À Pharmproject èáõë³ëï³Ý
Pancreatin
pancreatin
³Õ»ÉáõÛÍ
(60)
CJSC
ä³ÝÏñ»áýɳï
å³ÝÏñ»³ïÇÝ, ¹ÇÙ»ïÇÏáÝ
¹»Õ³Ñ³ï»ñ
170Ù·+80Ù·
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶»ñÙ³Ýdz
Pankreoflat
pancreatin, dimeticone
óճÝóå³ï
(20,50,100,200)
¶ÙµÐ
Solvay Pharmaceuticals GmbH
ä³Ýïá·³ñ
ÃdzÙÇÝ
¹»Õ³å³ïÇ×Ý»ñ
60Ù·+60Ù·+
êÇÙ»ùë ²¶, Þí»Ûó³ñdz (Ø»ñó
Þí»Ûó³ñdz
N02B E01
5830
17.02.2006
17.02.2011
²¸
A12C
5655
14.12.2005
14.12.2010
¸
A12C C55
5541
01.06.2005
01.06.2010
¸
-
4766
18.03.2004
18.03.2009
²¸
-
4663
05.03.2004
05.03.2009
²¸
D03AX03
1389/7352
²¸
N02BE51
7409/6190/1
05.11.2007
05.11.2012
19.11.2007
07.06.2011
J01C R02
4463
02.10.2003
02.10.2008
¸
J01C R02
4464
02.10.2003
02.10.2008
¸
-
4578
²¸
A09A A02
0409/6354
24.11.2003
24.11.2008
19.09.2006
19.09.2011
-
0221/6323
²¸
-
4784
26.07.2006
26.07.2011
23.04.2004
23.04.2009
A11D
5348
08.02.2005
²¸
²¸
²¸
²¸
135
Pantogar
1978
ä³ÝïáÏñÇÝ
Pantocrin
1979
ä³áõ½á·»ëï
Pausogest
1980
ä³å³í»ñÇݼ¹áñáíÛ»
PapaverineZdorovye
ä³å³í»ñÇݼ¹áñáíÛ»
Papaverine Zdorovye
ä³å³í»ñÇÝÇ
ÑǹñáùÉáñǹ
Papaverine
hydrochloride
ä³å³í»ñÇÝÇ
ÑǹñáùÉáñǹ
Papaverin
hydrochloride
ÝÇïñ³ï,ϳÉóÇáõÙÇ Då³Ýïáûݳï, L-óÇëïÇÝ,
å³ñ³³ÙÇÝᵻݽá³ÃÃáõ, Ï»ñ³ïÇÝ,
µÅßÏ³Ï³Ý ËÙáñÇãÝ»ñ
thiamin nitrate, calciu
Ù³ñ³ÉÇ å³Ýï³Ý»ñÇ
ëåÇñï³ÛÇÝ (50%)
ѳÝáõÏ
alcohol (50%) extract of
maral's antlers
¿ëïñ³¹ÇáÉ,
Ýáñ¿ÃÇëï»ñáÝÇ ³ó»ï³ï
estradiol,
norethisterone acetate
å³å³í»ñÇÝÇ
ÑǹñáùÉáñǹ
papaverine
hydrochloride
å³å³í»ñÇÝÇ
ÑǹñáùÉáñǹ
papaverine
hydrochloride
å³å³í»ñÇÝÇ
ÑǹñáùÉáñǹ
papaverine
hydrochloride
å³å³í»ñÇÝÇ
ÑǹñáùÉáñǹ
papaverin
hydrochloride
1984
ä³ëÇýÇï
Passiphyt
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
ûß³ñ³Ï
100ÙÉ ßßÇÏ
1985
ä³ï»Ýï»ùë ûí³É Ü
Patentex oval N
ÝáÝûùëÇÝáÉ-9
nonoxinol-9
ûíáõɳݻñ
75Ù·
(6,12)
1986
ä³ñ³ó»ï³ÙáÉ
Paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
¹»Õ³Ñ³ï»ñ
0.5·
(10)
1987
ä³ñ³ó»ï³ÙáÉ
Paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
¹»Õ³Ñ³ï»ñ
500Ù·
(20,1000/100x10/)
1988
ä³ñ³ó»ï³ÙáÉ
Paracetamol
ä³ñ³ó»ï³ÙáÉ
Paracetamol
ä³ñ³ó»ï³ÙáÉ
Paracetamol
ä³ñ³ó»ï³ÙáÉ
Paracetamol
ä³ñ³ó»ï³ÙáÉ
Ù³ÝϳϳÝ
å³ñ³ó»ï³ÙáÉ
paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
ÉáõÍáõÛà ËÙ»Éáõ
120Ù·/5ÙÉ,
60ÙÉ ßßÇÏ
500Ù·
(20,400)
120Ù·/5ÙÉ,
125ÙÉ ßßÇÏ
500Ù·
(10,100,200)
2.4%,
100ÙÉ ßßÇÏ
1981
1982
1983
1989
1990
1991
1992
20Ù·+20Ù·+20Ù·+
100Ù·
(30,60,90)
ü³ñÙ³ëÛáõÃÇù³É ¶ÙµÐ,
¶»ñÙ³ÝdzÛÇ Ñ³Ù³ñ)
Cimex AG, Switzerland (for
Merz Pharmaceuticals GmbH,
Germany)
ѳÝáõÏ
10%,
50ÙÉ ßßÇÏ
²Û êÇ ¾Ý îáÙëÏùÇÙý³ñÙ
ICN Tomskchimpharm JSC
èáõë³ëï³Ý
-
4334
02.07.2003
02.07.2008
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2Ù·+1Ù·
(28,(3x28))
¶»¹»áÝ èÇËï»ñ ö´À
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
G03C A53,
L02A A02
4570
28.10.2003
28.10.2008
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
àõÏñ³Çݳ
A03A D01
1253/7066
15.10.2007
15.10.2012
¸
¹»Õ³Ñ³ï»ñ
10Ù·
(10)
àõÏñ³Çݳ
A03A D01
1245/7057
15.10.2007
15.10.2012
¸
ÙáÙÇÏÝ»ñ
0,02·
(10)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
èáõë³ëï³Ý
A03A D01
1295/7263
15.10.2007
12.10.2012
²¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2%(2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
´»É³éáõë
A03A D01
0948/6875
03.05.2007
03.05.2012
¸
èáõë³ëï³Ý
N05CM
0466/6490
11.10.2006
11.10.2011
²¸
¶»ñÙ³Ýdz
-
5064
01.09.2004
01.09.2009
²¸
èáõë³ëï³Ý
N02B E01
0580/1360/02.
98/1
24.11.2006
23.02.2008
²¸
Ðݹϳëï³Ý
N02B E01
0490/6482
16.10.2006
16.10.2011
²¸
г۳ëï³Ý
N02B E01
0301/6312
²¸
´áõÉÕ³ñdz
N02B E01
4306
´áõÉÕ³ñdz
N02B E01
4307
г۳ëï³Ý
N02BE01
4689
èáõë³ëï³Ý
(ÎáõñëÏ)
N02B E01
0143/6238
01.08.2006
01.08.2011
05.06.2003
05.06.2008
05.06.2003
05.06.2008
16.02.2004
16.02.2009
29.06.2006
29.06.2011
¹»Õ³Ñ³ï»ñ
ûß³ñ³Ï
¹»Õ³Ñ³ï»ñ
¹»Õ³Ï³ËáõÛÃ
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
Ø»ñó ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ³²
Merz Pharma GmbH & Co.
KGaA
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
Âñáç Ø»¹ÇÏ³É /Âñáç Ø»¹ÇϳÉ,
/¶»ñÙ³Ýdz/-Ç Ñ³Ù³ñ
Troge Medical /for Troge
Medical, Germany/
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
êáý³ñÙ³ ²¸
Sopharma AD
êáý³ñÙ³ ²¸
Sopharma AD
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
08.02.2010
²¸
²¸
²¸
²¸
136
1993
1994
1995
1996
1997
1998
Paracetamol for
children
ä³ñ³ó»ï³ÙáÉ-CлÙáý³ñÙ
Paracetamol-CHemofarm
ä³ñ³ó»ï³ÙáÉÑ»Ùáý³ñÙ
ParacetamolHemofarm
ä³ñɳ½ÇÝ
Parlazin
ä³ñɳ½ÇÝ
Parlazin
ä³ñÉá¹ÇÝ
Parlodine
ä³ñÏáÝ
Parcon
OJSC
å³ñ³ó»ï³ÙáÉ,
³ëÏáñµÇݳÃÃáõ
paracetamol, ascorbic
acid
å³ñ³ó»ï³ÙáÉ
paracetamol
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
330Ù·+200Ù·
(10)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm concern A.D.
гñ³íëɳ-ídz
N02B E51
4466
02.10.2003
02.10.2008
²¸
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
500Ù·
(20)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
N02B E01
4465
03.06.2005
03.06.2010
²¸
ó»ïÇñǽÇÝ
cetirizine
ó»ïÇñǽÇÝ
cetirizine
µñáÙáÏñÇåïÇÝ
bromocriptine
çñ³ÍÝÇ å»ñûùëǹ
hydrogen peroxide
ϳÃÇÉÝ»ñ
ÐáõÝ·³ñdz
R06A E07
6024
²¸
ÐáõÝ·³ñdz
R06A E07
6023
êÇñdz
N04B C01
4385
èáõë³ëï³Ý
S02A A06
5767
23.03.2006
23.03.2011
23.03.2006
23.03.2011
05.11.2003
05.11.2008
29.11.2005
29.11.2010
Þí»Ûó³ñdz
-
4163
07.07.2003
07.07.2008
¸
Þí»Ûó³ñdz
-
4821
18.05.2004
18.05.2009
¸
1999
ä»·³ëÇë
Pegasys
å»·ÇÝï»ñý»ñáÝ
-2-³
peginterferon -2a
å»·ÇÝï»ñý»ñáÝ ³Éý³ 2³
peginterferon alfa 2-a
2000
ä»·³ëÇë
Pegasys
2001
ä»·ÇÝïñáÝ
Pegintron
å»·ÇÝï»ñý»ñáÝ -2µ
peginterferon -2b
2002
ä»·ÇÝïñáÝ
Pegintron
å»·ÇÝï»ñý»ñáÝ -2µ
peginterferon -2b
2003
ä»·ÇÝïñáÝ
Pegintron
å»·ÇÝï»ñý»ñáÝ -2µ
peginterferon -2b
2004
ä»·ÇÝïñáÝ
Pegintron
å»·ÇÝï»ñý»ñáÝ -2µ
peginterferon -2b
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óáÕ³ßÇà ùÃÇ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ݳ˳Éóí³Í
Ý»ñ³ñÏÇãÝ»ñáõÙ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í,
ÉáõÍãáí
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í,
ÉáõÍãáí
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í,
ÉáõÍãáí
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í,
ÉáõÍãáí
10Ù·/ÙÉ,
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
20ÙÉ ßßÇÏ
Egis Pharmaceuticals Ltd.
10Ù·
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
(10,30)
Egis Pharmaceuticals Ltd.
2.5Ù·
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
(20)
Pharmaceutical
ÉáõÍáõÛÃ 1:
èáõëÇãÇ-ü³ñÙ³ êäÀ
çñ³ÍÝÇ å»ñûùëǹ
ä³ñÏÇÝý³ñÙ êäÀ-Ç å³ïí»ñáí
30% 0.1·+çáõñ Rusichi-Pharma Ltd by order of
ÙÇÝ㨠1É,
Parkinpharm Ltd.
ÉáõÍáõÛÃ 2:
µ»Ý½áÛ³ÃÃáõ0.5·+Ù³ÝÇï3.6·+ïñÇÉáÝ ´0.04·+çáõñ ÙÇÝã¨
1É, (ÉáõÍáõÛÃ 11ÙÉ, ÉáõÍáõÛÃ 229ÙÉ)
180ÙÏ·/0.5ÙÉ,
ÐáýÙ³Ý-ȳ èáß Èï¹.
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Hoffmann-La Roche Ltd
(1, 4)
135ÙÏ·/0.5ÙÉ,
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
F.Hoffmann-La Roche Ltd.
(1,4)
²¸
¸
¸
80ÙÏ·/0.5ÙÉ
ëñí³Ï/³ÙåáõÉ (1)
Þ»ñÇÝ· öɳáõ (´ñÇÝÝÇ)
øáÙ÷³ÝÇ ø³áõÝÃÇ øáÏ
Schering - Plough (Brinny)
Company Country Cork
Æéɳݹdz
-
4346
26.06.2003
26.06.2008
¸
100ÙÏ·/0.5ÙÉ
ëñí³Ï/³ÙåáõÉ (1)
Þ»ñÇÝ· öɳáõ (´ñÇÝÝÇ)
øáÙ÷³ÝÇ ø³áõÝÃÇ øáÏ
Schering - Plough (Brinny)
Company Country Cork
Æéɳݹdz
-
4347
26.06.2003
26.06.2008
¸
120ÙÏ·/0,5ÙÉ
ëñí³Ï/³ÙåáõÉ (1)
Þ»ñÇÝ· öɳáõ (´ñÇÝÝÇ)
øáÙ÷³ÝÇ ø³áõÝÃÇ øáÏ
Schering - Plough (Brinny)
Company Country Cork
Æéɳݹdz
-
4348
26.06.2003
26.06.2008
¸
50ÙÏ·/0.5ÙÉ
ëñí³Ï/³ÙåáõÉ (1)
Þ»ñÇÝ· öɳáõ (´ñÇÝÝÇ)
øáÙ÷³ÝÇ ø³áõÝÃÇ øáÏ
Schering - Plough (Brinny)
Company Country Cork
Æéɳݹdz
-
4345
26.06.2003
26.06.2008
¸
137
2005
仹ÇÉÇÝ
Pedilin
2006
ä»ÏïñáÉ
Pektrol
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
å»ñÙ»ÃñÇÝ
permethrin
ǽáëáñµÇ¹Ç
ÙáÝáÝÇïñ³ï
isosorbide mononitrate
ä»ÏïñáÉ
ǽáëáñµÇ¹Ç
Pektrol
ÙáÝáÝÇïñ³ï
isosorbide mononitrate
ä»Ý»ëï»ñ
ýÇݳëï»ñǹ
Penester
finasteride
ä»ÝÇóÇÉÇÝ ¶
µ»Ý½ÇÉå»ÝÇóÇÉÇÝ
Penicillin G
ݳïñÇáõÙÇ
benzylpenicillin sodium
ä»Ýï³É·ÇÝ-²Û-êÇå³ñ³ó»ï³ÙáÉ,
¾Ý
ٻóÙǽáÉ, Ïáý»ÇÝ,
Pentalgin-ICN
Ïá¹»ÇÝ, ý»Ýáµ³ñµÇï³É
paracetamol,
methamizole, caffeine,
codeine, phenobarbital
ä»Ýï³É·ÇÝ-Ü
Ù»ï³ÙǽáÉ,
Pentalgin-N
ݳåñáùë»Ý, Ïáý»ÇÝ,
ý»Ýáµ³ñµÇï³É, Ïá¹»ÇÝ
metamizole, naproxen,
caffeine, phenobarbital,
codeine
ä»Ýï³É·ÇÝ-ä
ٻóÙǽáÉ,
Pentalgin-P
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ,
Ïá¹»ÇÝ, ý»Ýáµ³ñµÇï³É
methamizole,
paracetamol, caffeine,
codeine, phenobarbital
ä»ÝïÇÉÇÝ »ñϳñ³ï¨
å»ÝïûùëÇýÇÉÇÝ
Ó»ñµ³½³ïٳٵ
pentoxifylline
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
Pentilin prolonged
release coated
tablets
ä»ÝïÇÉÇÝ
å»ÝïûùëÇýÇÉÇÝ
Ý»ñ³ñÏÙ³Ý
pentoxifylline
ÉáõÍáõÛÃ
Pentilin solution for
injection
ä»ÝïûùëÇýÇÉÇÝ
å»ÝïûùëÇýÇÉÇÝ
Pentoxifylline
pentoxifylline
ä»ÝïûùëÇýÇÉÇÝ
Pentoxifyllin
ä»åáÝ»Ý
Peponen
å»ÝïûùëÇýÇÉÇÝ
pentoxifylline
¹¹ÙÇ ë»ñÙÇ ÛáõÕ
pumpkin-seed oil
(oleum cucurbite pepo)
û׳é³Ñ»ÕáõÏ
Îéϳ, ¹.¹., Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
P03AC04
1357/7318
13.11.2007
05.11.2012
²¸
¹»Õ³Ñ³ï»ñ ¹³Ý¹³Õ
Ó»ñµ³½³ïٳٵ
1·/100·,
100· åɳëïÇÏ»
ßßÇÏ
60Ù·
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d.Novo mesto
êÉáí»Ýdz
C01D A14
3700
26.08.2005
26.08.2010
¸
¹»Õ³Ñ³ï»ñ ¹³Ý¹³Õ
Ó»ñµ³½³ïٳٵ
40Ù·
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d.Novo mesto
êÉáí»Ýdz
C01D A14
3699
26.08.2005
26.08.2010
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
5Ù·
(30)
1000000ØØ,
ëñí³Ï (10)
È»ãÇí³ ³.ë.
Lechiva a.s.
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
â»Ëdz
G04C B01
4103
¸
´áõÉÕ³ñdz
J01C E01
6067
10.04.2003
10.04.2008
24.03.2006
24.03.2011
0.3·+0.3·+ 0.05·+
0.008·+0.01·
(12)
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
èáõë³ëï³Ý
N02B B72
0577/4953/1
24.11.2006
23.07.2009
²¸
¹»Õ³Ñ³ï»ñ
(0.3·+0.1·+ 0.05·+
0.01·+0.008·)
(10)
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàôÒ
Belmedpreparaty RUE
´»É³éáõë
N02B B72
5704
12.07.2005
12.07.2010
¸
¹»Õ³Ñ³ï»ñ
(0.3·+0.3·+0.05·+
0.01·+0.01·)
(10)
øÇÙý³ñÙ ´À
Chimpharm JSC
Ô³½³Ë-ëï³Ý
N02B B72
0835/6618
22.03.2007
22.03.2012
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
400Ù·
(20/2x10/)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
C04A D03
0934/6880
03.05.2007
03.05.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
20Ù·/ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
C04A D03
0933/6881
03.05.2007
03.05.2012
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ
0.1·
(20, 30, 60)
´»É³éáõë
C04A D03
0800/6786
20.03.2007
20.03.2012
¸
¹»Õ³Ñ³ï»ñ
³Õ»ÉáõÛÍ
¹»Õ³å³ïÇ×Ý»ñ
0.1·
(60)
300Ù·
(100)
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàôÒ
Borisov Medical Preparations
Plant RUE
ü³ñÙåñáÛ»Ïï ö´À Pharmproject
CJSC
´Çá·³É ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Biogal Pharmaceutical Works
Ltd.
èáõë³ëï³Ý
C04AD03+
G23
G04CX
0220/6325
26.07.2006
26.07.2011
04.06.2004
04.06.2009
¸
ÐáõÝ·³ñdz
4769
¸
¸
138
2018
2019
2020
2021
2022
ä»ï»Ñ³
Peteha
ä»ñÇïáÉ
Peritol
ä»ñÇïáÉ
Peritol
ä»ñÉÇÝ·³ÝÇï
Perlinganit
ä»ñÙ»ÃñÇÝ
Permethrin
ä»ñÙ»ÃñÇÝ
Permethrin
ä»ñÙÇùëáÝ
Permixon
åñáÃÇáݳÙǹ
prothionamide
óÇåñáÑ»åï³¹ÇÝ
cyproheptadine
óÇåñáÑ»åï³¹ÇÝ
cyproheptadine
·ÉÇó»ñáÉÇ »éÝÇïñ³ï
glycerol trinitrate
å»ñÙ»ÃñÇÝ
permethrin
2023
å»ñÙ»ÃñÇÝ
permethrin
2024
ëáÕ³óáÕ ³ñÙ³í»Ýáõ
ѳÝáõÏ
extract serenoa repens
2025
ä»ñë»Ý
ϳïí³ËáïÇ Ñ³ÝáõÏ,
Persen
å³ïñÇÝçÇ Ñ³ÝáõÏ,
åÕå»Õ³ÛÇÝ ³Ý³ÝáõËÇ
ѳÝáõÏ
Valerian extract,
Melissa extract,
Peppermint extract
2026
ä»ñë»Ý ýáñï»
ϳïí³ËáïÇ Ñ³ÝáõÏ,
Persen forte
å³ïñÇÝçÇ Ñ³ÝáõÏ,
åÕå»Õ³ÛÇÝ ³Ý³ÝáõËÇ
ѳÝáõÏ
Valeriana extract,
Melissa extract,
Peppermint extract
2027
ä»ñëáϳÛÇÝ º
ÉǹáϳÛÇÝÇ
Persocaine E
ÑǹñáùÉáñǹ,
¿åÇÝ»ýñÇÝ
lidocaine hydrochloride,
epinephrine
2028
ä»ñûùëÇ·»É
çñ³ÍÝÇ å»ñûùëǹ
Peroxygel
hydrogen peroxide
2029
äÇÉáϳñåÇÝ
åÇÉáϳñåÇÝÇ
Pilocarpin
ÑǹñáùÉáñǹ
pilocarpine
hydrochloride
2030 äÇÉáϳñåÇÝ-ÉáÝ·
åÇÉáϳñåÇÝ
Pilocarpine-long
pilocarpine
2031 äÇÉáϳñåÇÝ-ü³ñÙ³Ï
åÇÉáϳñåÇÝÇ
Pilocarpin-Farmak
ÑǹñáùÉáñǹ
pilocarpine
hydrochloride
2032
äÇÉáÏÇï
I-ɳÝëáåñ³½áÉÇ
PyloKit
¹»Õ³å³ïÇ×Ý»ñ, IIïÇÝǹ³½áÉÇ
¹»Õ³Ñ³ï»ñ, IIIÏɳñÇÃñáÙÇóÇÝÇ
¹»Õ³Ñ³ï»ñ
I-lansoprazole
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ûß³ñ³Ï
250Ù· [50(10x5),
100(10x10)]
40Ù·/100ÙÉ,
100ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
4Ù·
(20)
ÉáõÍáõÛÃ
10Ù·/ÙÉ (10ÙÉ),
ϳÃÇɳݻñ³ñÏ-Ù³Ý ³ÙåáõÉÝ»ñ (10)
1%,
50· å³ñÏáõ×
5%,
50· å³ñÏáõ×
160Ù·
(30,60)
ü³ïáÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ
Fatol Arzneimittel GmbH
¾·Çë ü³ñÙ³ëÛáõÃÇù³É Èï¹.
Egis Pharmaceuticals Ltd.
¾¶Æê ´´À
EGIS PLC
ڻݳѻùë³É ü³ñÙ³ ¶ÙµÐ
(Þí³ñó ü³ñÙ³ ²¶-Ç Ñ³Ù³ñ)
Jenahexal Pharma GmbH (for
Schwarz Pharma AG)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
äÇ»é ü³µñ» Ø»¹ÇϳٻÝï
Pierre Fabre Medicament
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(50Ù·+25Ù·+ 25Ù·)
(40/4x10/)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
N05C
0084/6192
07.06.2006
07.06.2011
²¸
¹»Õ³å³ïÇ×Ý»ñ
(125Ù·+25Ù·+
25Ù·)
(20/2x10/)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
N05C
0083/6191
07.06.2006
07.06.2011
²¸
Æñ³Ý
N01B B52
4590
05.11.2003
05.11.2008
¸
Ȼѳëï³Ý
D08A X01
5368
²¸
Ȼѳëï³Ý
S01E B01
5058
10.05.2005
10.05.2010
21.10.2004
21.10.2009
èáõë³ëï³Ý
S01E B01
4755
¸
àõÏñ³Çݳ
S01E B01
5699
18.03.2004
18.03.2009
17.10.2005
17.10.2010
Ðݹϳëï³Ý
-
0360/6288
28.08.2006
28.08.2011
¸
Ýñµ³ùëáõù
Ýñµ³ùëáõù
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹áݹáÕ
³ÏݳϳÃÇÉÝ»ñ
³ÏݳϳÃÇÉÝ»ñ
³ÏݳϳÃÇÉÝ»ñ
ѳí³ù³Íáõ
(I-³Õ»ÉáõÛÍ
¹»Õ³Ñ³ï»ñ,
II-óճÝóå³ï
¹»³Ñ³ï»ñ, IIIóճÝóå³ï
¹»Õ³Ñ³ï»ñ)
(20Ù·+12.5ÙÏ·)/ÙÉ ¸³ñáõ ö³Ëß ü³ñÙ³ëÛáõÃÇù³É
1.8ÙÉ
Øý·.øá.
÷³Ù÷áõßïÝ»ñ (50) Darou Pakhsh Pharmaceutical
Mfg.Co.
3%,
15· å³ñÏáõ×
2%,
5ÙÉ ßßÇÏ (1,2)
1%,
5ÙÉ ßßÇÏ
0.1%,
5ÙÉ,10ÙÉ ßßÇÏ
(I- 30Ù·,
II-500Ù·,
III-250Ù·)
(/I-2, II-2, III-2/x7)
¶»ÙÇ
Gemi
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
ê²
Warsaw
Pharmaceutical Works §Polfa¦
SA
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
ü³ñÙ³Ï ´´À
Farmak JSC
êÇåɳ Èï¹
Cipla Ltd.
¶»ñÙ³Ýdz
J04A D01
4932
ÐáõÝ·³ñdz
R06B X02
4286
ÐáõÝ·³ñdz
R06AX02
0846/6870
¶»ñÙ³Ýdz
C01DA02
1385/7348
г۳ëï³Ý
P03A C04
4196
г۳ëï³Ý
P03A C04
5152
üñ³Ýëdz
-
0028/6143
03.07.2004
03.07.2009
21.07.2003
21.07.2008
26.03.2007
26.03.2012
05.11.2007
05.11.2012
¸
10.02.2003
10.02.2008
12.11.2004
12.11.2009
17.05.2006
17.05.2011
²¸
¸
¸
¸
²¸
¸
¸
¸
139
2033
äÇÉáïÇÙ
Pylotim
2034
äÇÏáíÇï ¸
Pikovit D
2035
äÇÏáíÇï åÉÛáõë
Pikovit Plus
2036
äÇÏáíÇï ýáñï»
Pikovit forte
2037
äÇÏáíÇï
Pikovit
äÇÏáíÇï
Pikovit
capsules, II-tinidasole
tablets, IIIclarithromycin tablets
åÇÉáϳñåÇÝ,
ÃÇÙáÉáÉ
pilocarpin, timolol
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
vitamins, minerals
íÇï³ÙÇÝÝ»ñ ¨
ѳÝù³ÝÛáõûñ
vitamins and minerals
íÇï³ÙÇÝÝ»ñ
vitamins
³ÏݳϳÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
(10Ù·+2.5Ù·)/ÙÉ,
10ÙÉ ßßÇÏ
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
èáõÙÇÝdz
S01E B51
0183/6264
13.07.2006
13.07.2011
¸
å³ëï»ÕÝ»ñ
(óճÝóå³ï
¹»Õ³Ñ³ï»ñ)
ѳµ»ñ ͳٻÉáõ
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
A11
4664
04.03.2004
04.03.2009
²¸
1.4·
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
βêÐ
6053
31.03.2006
31.03.2011
²¸
å³ëï»ÕÝ»ñ
(óճÝóå³ï
¹»Õ³Ñ³ï»ñ)
ûß³ñ³Ï
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
A11
4665
04.03.2004
04.03.2009
²¸
150ÙÉ ßßÇÏ
êÉáí»Ýdz
A11B
0557/6537
(30/3x10/)
êÉáí»Ýdz
A11A A02
0558/6536
24.11.2006
24.11.2011
24.11.2006
24.11.2011
²¸
å³ëï»ÕÝ»ñ
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
ÙáÙÇÏÝ»ñ
100Ù·
(3)
Æï³Édz
D01A A02
0444/6452
29.09.2006
29.09.2011
¸
Æï³Édz
D01A A02
0447/6453
29.09.2006
29.09.2011
¸
Üǹ»éɳݹݻñ
êÉáí»Ýdz
A07A A03
0450/6411
¸
J01M B04
0656/6569
êÉáí³Ïdz
R01A X
1184/7174
àõÏñ³Çݳ
A11
0961/5702/1
29.09.2006
29.09.2011
12.01.2007
12.01.2012
24.09.2007
13.09.2012
14.05.2007
17.10.2010
ÐáõÝ·³ñdz
D04A A10
0139/6201
ÐáõÝ·³ñdz
D04A A10
0140/6202
êÉáí»Ýdz
J04A K01
0649/6576
¶»ñÙ³Ýdz
C09BA 05
1477/7408
2039
äÇÙ³ýáõóÇÝ
Pimafucin
íÇï³ÙÇÝÝ»ñ
vitamins
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
vitamins, minerals
ݳï³ÙÇóÇÝ
natamycin
2040
äÇÙ³ýáõóÇÝ
Pimafucin
ݳï³ÙÇóÇÝ
natamycin
Ýñµ³ùëáõù
2041
äÇÙ³ýáõóÇÝ
Pimafucin
äÇÙǹ»É
Pimidel
äÇÝáëáÉ
Pinosol
äÇÝáíÇï-ü³ñÙ³Ï
Pinovit-Farmak
ݳï³ÙÇóÇÝ
natamycin
åÇå»Ùǹ³ÃÃáõ
pipemidic acid
µáõë³Ï³Ý ÛáõÕ»ñ
herbal oiles
ëá×áõ ÛáõÕ,
³Ý³ÝáõËÇ ÛáõÕ,
ÝÇí»Ýáõ ÛáõÕ, ³Éý³ÃáÏáý»ñáÉÇ ³ó»ï³ï,
ÃÇÙáÉ
pine oil, mint oil,
eucalyptus oil, alfatocopherol acetate,
thymol
åñáٻó½ÇÝ
promethazine
åñáٻó½ÇÝ
promethazine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
åÇñ³½ÇݳÙǹ
pyrazinamide
é³ÙÇåñÇÉ,
¹»Õ³Ñ³ï»ñ
2038
2042
2043
2044
2045
2046
2047
äÇåáÉý»Ý
Pipolphen
äÇåáÉý»Ý
Pipolphen
äÇñ³½ÇݳÙǹ
Pyrazinamide
2048 äÇñ³ÙÇÉ äÉÛáõë
ùóϳÃÇÉÝ»ñ
ùóϳÃÇÉÝ»ñ
¹ñ³Å»
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
²ëï»É³ë ü³ñÙ³ ê.å.². (²ëï»É³ë
ü³ñÙ³ ºáõñáå ´.ì.,
Üǹ»ñɳݹݻñ-Ç Ñ³Ù³ñ)
Astellas Pharma S.p.A. (for
Astellas Pharma Europe B.V.,
The Netherlands)
2%,
²ëï»É³ë ü³ñÙ³ ê.å.². (²ëï»É³ë
30· å³ñÏáõ×
ü³ñÙ³ ºáõñáå ´.ì.,
Üǹ»ñɳݹݻñÇ Ñ³Ù³ñ)
Astellas Pharma S.p.A. (for
Astellas Pharma Europe B.V.,
The Netherlands)
100Ù·
²ëï»É³ë ü³ñÙ³ ºáõñáå ´.ì.
(20)
Astellas Pharma Europe B.V.
200Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(20/2x10/)
KRKA d.d. Novo mesto
10ÙÉ ßßÇÏ
¼»ÝïÇí³ ³.ë.
Zentiva a.s.
(35Ù·+10Ù·+5Ù·+
ü³ñÙ³Ï ´´À
15Ù·+0,3Ù·)/ÙÉ,
Farmak JSC
10ÙÉ ßßÇÏ
25Ù·
¾¶Æê ´´À
(500/25x20/)
EGIS PLC
50Ù·/2ÙÉ,
¾¶Æê ´´À
2ÙÉ ³ÙåáõÉÝ»ñ
EGIS PLC
(10)
500Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
(100)
KRKA d.d. Novo mesto
(2,5Ù·+12,5Ù·) (20, ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.
²¸
¸
²¸
²¸
29.06.2006
29.06.2011
29.06.2006
29.06.2011
¸
12.01.2007
12.01.2012
20.12.2007
¸
¸
¸
140
Piramil Plus
äÇñ³Ýï»É
Pyrantel
äÇñ³ïñáåÇÉ
Piratropil
ÑǹñáùÉáñáÃdz½Ç¹
ramipril,
hydrocÑlorothiazide
é³ÙÇåñÇÉ,
ÑǹñáùÉáñáÃdz½Ç¹
ramipril,
hydrocÑlorothiazide
åÇñ³Ýï»É
pyrantel
åÇñ³ó»ï³Ù
piracetam
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2052
äÇñ³ó»ï³Ù
Piracetam
åÇñ³ó»ï³Ù
piracetam
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2053
äÇñ³ó»ï³Ù
Piracetam
åÇñ³ó»ï³Ù
piracetam
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2054
äÇñ³ó»ï³Ù
Piracetam
åÇñ³ó»ï³Ù
piracetam
2055
äÇñ³ó»ï³Ù
Pyracetam
åÇñ³ó»ï³Ù
pyracetam
ÉáõÍáõÛÃ Ù/Ù ¨
Ý/»
Ý»ñ³ñÏáõÙÝ»ñÇ
¹»Õ³å³ïÇ×Ý»ñ
2056
äÇñ³ó»ï³Ù
Piracetam
äÇñ³ý³ï 500Ù·
Pyrafat 500mg
åÇñ³ó»ï³Ù
piracetam
åÇñ³½ÇݳÙǹ
pyrazinamide
¹»Õ³å³ïÇ×Ý»ñ
äÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ
(B6 íÇï³ÙÇÝ)
Pyridoxine
hydrochloride
(Vitamin B6)
äÇñ᷻ݳÉ
Pyrogenal
åÇñǹûùëÇÝÇ
ÑǹñáùÉáñǹ
pyridoxine
hydrochloride
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
Ù³Ýñ¿³ÛÇÝ
ÉÇåáåáÉÇë³Ë³ñǹ-Ý»ñ
bacterial
lipopolysaccharides
Ù³Ýñ¿³ÛÇÝ
ÉÇåáåáÉÇë³Ë³ñǹ-Ý»ñ
bacterial
lipopolysaccharides
Ù³Ýñ¿³ÛÇÝ
ÉÇåáåáÉÇë³Ë³ñǹ-Ý»ñ
bacterial
lipopolysaccharides
åÇñûùëÇϳÙ
piroxicam
ÙáÙÇÏÝ»ñ
50ÙÏ·
(10)
ÉáõÍáõÛÃ Ù/Ù
Ý»ñ³ñÏÙ³Ý
50ÙÏ·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
ÉáõÍáõÛÃ Ù/Ù
Ý»ñ³ñÏÙ³Ý
100ÙÏ·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
¹»Õ³Ñ³ï»ñ
20Ù·
(20)
2049 äÇñ³ÙÇÉ åÉÛáõë
Piramil Plus
2050
2051
2057
2058
2059
2060
äÇñ᷻ݳÉ
Pyrogenal
2061
äÇñ᷻ݳÉ
Pyrogenal
2062
äÇñûùëÇϳÙ
Piroxicam
50, 100)
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ѳٳñ)
Salutas Pharma GmbH (for Lek
d.d.)
(5Ù·+25Ù·)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï ¹.¹.(20, 50, 100)
Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for Lek
d.d.)
250Ù·
äáÉý³ñÙ³ ê.².
(3)
Polpharma S.A.
200Ù·/ÙÉ (5ÙÉ), Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
Jelfa S.A.Pharmaceutical
(12)
Works
200Ù·
´áñßã³·áíÛ³Ý
(30/3x10/,
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
60/6x10/)
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
20%(5ÙÉ),
´áñÇëáíÛ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
(10,10/2x5/)
ÐàôÒ
Borisov Medical Preparations
Plant RUE
200Ù·/ÙÉ,
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
5ÙÉ ³ÙåáõÉÝ»ñ Pharmstandard-UfaVITA OJSC
(10)
0.4·,
´áñÇëáíÛ³Ý ´ä¶
(10,60)
Borisov Medical Preparations
Plant RUP
0.4·
ü³ñÙåñáÛ»Ïï ö´À Pharmproject
(60)
CJSC
500Ù·
ü³ïáÉ ²ñóݳÛÙÇÃ»É ¶ÙµÐ
[100(10x10),
Fatol Arzneimittel GmbH
1000]
5%,
ê³ÝÇï³ë ²´
1ÙÉ ³ÙåáõÉÝ»ñ
Sanitas AB
(10)
¶³Ù³É»Ç ³Ýí. ¾Ø¶ÐÆ äÒ
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
Medgamal branch of SI SRIEM
after Gamalei
¶³Ù³É»Ç ³Ýí. ¾Ø¶ÐÆ äÒ
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
Medgamal branch of SI SRIEM
after Gamalei
¶³Ù³É»Ç ³Ýí. ¾Ø¶ÐÆ äÒ
§Ø»¹·³Ù³É¦ Ù³ëݳ×ÛáõÕ
Medgamal branch of SI SRIEM
after Gamalei
î³ÉÉÇÝÇ ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
´À
Tallinn Pharmaceutical Plant
JSC
20.12.2012
¶»ñÙ³Ýdz
C09BA 05
1476/7407
20.12.2007
20.12.2012
¸
Ȼѳëï³Ý
P02C C01
0200/6203
¸
Ȼѳëï³Ý
N06B X03
5900
13.07.2006
13.07.2011
19.01.2006
19.01.2011
àõÏñ³Çݳ
N06B X03
0504/6317
25.10.2006
25.10.2011
¸
´»É³éáõë
N06B X03
0950/6873
03.05.2007
03.05.2012
¸
èáõë³ëï³Ý
N06BX03
1029/6798
21.06.2007
21.06.2012
¸
´»É³éáõë
N06B X03
5021
13.12.2004
13.12.2009
¸
èáõë³ëï³Ý
N06B x03
0218/6324
¸
¶»ñÙ³Ýdz
J04A K01
4937
26.07.2006
26.07.2011
03.07.2004
03.07.2009
ÈÇïí³
A11H A02
5489
29.03.2005
29.03.2010
¸
èáõë³ëï³Ý
L03
0783/6800
07.03.2007
07.03.2012
¸
èáõë³ëï³Ý
L03
0782/6801
07.03.2007
07.03.2012
¸
èáõë³ëï³Ý
L03
0781/6802
07.03.2007
07.03.2012
¸
¾ëïáÝdz
M01A C01
M02A A07
4987
06.11.2004
06.11.2009
¸
¸
¸
141
2063
äÇñûùëÇϳÙ
Piroxicam
äÇñûùëÇϳÙ
Piroxicam
äÇñûùëÇϳÙ
Piroxicam
åÇñûùëÇϳÙ
piroxicam
åÇñûùëÇϳÙ
piroxicam
åÇñûùëÇϳÙ
piroxicam
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(20)
20Ù·
(20)
10Ù·
(20)
2066
äÇñûùëÇϳÙ
Piroxicam
åÇñûùëÇϳÙ
piroxicam
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·
(20)
2067
äÇñûùëÇϳÙ-²ÏñÇ
Piroxicam-Akri
äÇñûùëÇϳÙ-²ÏñÇ
Piroxicam-Akri
äɳ½ÙáÉ
Plasmol
äɳÝï³·»Ý
Plantagen
åÇñûùëÇϳÙ
piroxicam
åÇñûùëÇϳÙ
piroxicam
Ù³ñ¹áõ ³ñÛ³Ý Ñ³ÝáõÏ
extract of human blood
Ýßï³ñ³ï»ñ¨ çÕ³ËáïÇ
ï»ñ¨Ý»ñÇ Ñ»ÕáõÏ
ѳÝáõÏ plantaginis
lanceolatae folium
extractum fluidum
åɳÝï³·ÉÛáõóǹ
plantaglucide
¹»Õ³å³ïÇ×Ý»ñ
0.01·
(20)
0.02·
(20)
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
12·/100·,
125· ßßÇÏ
·ñ³Ýáõɳݻñ
1·/2·,
(1) ÷³Ã»Ã (10, 30),
(2) ÷³Ã»Ã (20, 25)
ÏÉáåǹá·ñ»É
clopidogrel
ÏÉáåǹá·ñ»É
clopidogrel
åɳïÇýÇÉÇÝÇ
Ñǹñáï³ñïñ³ï
platyphylline
hydrotartrate
ÑǹñûùëÇùÉáñáùíÇÝ
hydroxychloroquine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
75Ù·
(14, 28)
75Ù· (15)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(60)
ÏÉáåǹá·ñ»ÉÇ
µÇëáõÉý³ï
clopidogrel bisulfate
³Ù³Ýï³¹ÇÝÇ ëáõÉý³ï
amantadine sulfate
³Ù³Ýï³¹ÇÝÇ ëáõÉý³ï
amantadine sulfate
¹»Õ³Ñ³ï»ñ
75Ù·
(20)
2064
2065
2068
2069
2070
2071
2072
2073
2074
2075
äɳÝï³·ÉÛáõóǹ¼¹áñáíÛ»
Plantaglucid Zdorovye
äɳíÇùë-75
Plavix-75
äɳíá·ñ»É
Plavogrel
äɳïÇýÇÉÇÝÇ
Ñǹñáï³ñïñ³ï
Platyphylline
Ñydrotartrate
äɳùí»ÝÇÉ
Plaquenil
2076
äÉáý»ùëÇÝ ²êƲ
Plofexine ASIA
2077
äÎ-Ø»ñó
PK-Merz
äÎ-Ø»ñó
ϳÃÇɳݻñ³ñÏÙ³Ý
PK-Merz infusion
äÕå»Õ³ÛÇÝ
³Ý³ÝáõËÇ
á·»ÃáõñÙ
Tinctura Menthae
Piperitae
2078
2079
2080
äáÉÇ·ÉÛáõÏÇÝ
Polyglucinum
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ûß³ñ³Ï
0,2%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
êáý³ñÙ³ ´À
Sopharma JSC
êáý³ñÙ³ ´À
Sopharma JSC
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A.Pharmaceutical
Works
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A.Pharmaceutical
Works
²ÏñÇËÇÝ ´´À
Akrikhin
Open JSC
²ÏñÇËÇÝ ´´À
Akrikhin
Open JSC
´Çáý³ñÙ ö´À Biopharm Closed
JSC
¶»ÙÇ
Gemi
´áõÉÕ³ñdz
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ê³ÝáýÇ ìÇÝÃñáå Æݹ³ëïñÇ
Sanofi Winthrop Industrie
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ê³ÝáýÇ êÇÝûɳµá Èï¹.
Sanofi Synthelabo Ltd.
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
¹»Õ³Ñ³ï»ñ
100Ù·
Ø»ñó ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ³²
óճÝóå³ï
(30,100)
Merz Pharma GmbH & KGaA
ÉáõÍáõÛÃ
200Ù·/500ÙÉ,
Ø»ñó ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ³²
ϳÃÇɳݻñ³ñÏ-Ù³Ý 500ÙÉ ëñí³Ï (2,10) Merz Pharma GmbH & KGaA
åÕå»Õ³ÛÇÝ ³Ý³ÝáõËÇ
á·»ÃáõñÙ
á·»ÃáõñÙ,
åÕå»Õ³ÛÇÝ ³Ý³ÝáõËÇ
ÛáõÕ
Tinctura Menthae,
oleum Menthae
¹»ùëïñ³Ý 70
ÉáõÍáõÛÃ
dextran 70
ϳÃÇɳݻñ³ñÏ-Ù³Ý
5860
Ȼѳëï³Ý
M01A C01,
M02A A07
M01A C01,
M02A A07
M01A C01
Ȼѳëï³Ý
M01A C01
èáõë³ëï³Ý
àõÏñ³Çݳ
M01A C01
M02A A07
M01A C01
M02A A07
-
0152/6146
Ȼѳëï³Ý
µáõë³Ï³Ý
5465
àõÏñ³Çݳ
A02X
1146/7133
04.10.2007
08.08.2012
¸
üñ³Ýëdz
B01A C04
0958/6961
¸
èáõÙÇÝdz
B01AC04
1452/7403
àõÏñ³Çݳ
A03A X12
1140/7111
14.05.2007
14.05.2012
20.12.2007
20.12.2012
02.10.2007
08.08.2012
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
êÇñdz
Po1B A02
4495
29.09.2003
29.09.2008
¸
B01A C04
0372/5504/1
11.09.2006
06.06.2010
¸
¶»ñÙ³Ýdz
N04B B01
4877
¸
¶»ñÙ³Ýdz
N04B B01
4878
08.06.2004
08.06.2009
25.06.2004
25.06.2009
´áõÉÕ³ñdz
èáõë³ëï³Ý
20.01.2006
20.01.2011
20.01.2006
20.01.2011
24.03.2006
24.03.2011
¸
6079
24.03.2006
24.03.2011
¸
4918
12.08.2004
12.08.2009
12.08.2004
12.08.2009
07.07.2006
07.07.2011
27.04.2005
27.04.2010
¸
5861
6078
4919
¸
¸
¸
¸
²¸
¸
¸
¸
10ÙÉ, 25ÙÉ,
30ÙÉ ßßÇÏ
¾ëÏáõɳå êäÀ
Esculap Ltd.
г۳ëï³Ý
-
5185
21.01.2005
21.01.2010
²¸
6%,
200ÙÉ,400ÙÉ
ëñí³Ï, 200ÙÉ,
250ÙÉ,500ÙÉ
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
г۳ëï³Ý
B05A A05
5924
18.01.2006
18.01.2011
¸
142
2081
äáÉÇ·ÉÛáõÏÇÝü³ñÙ³ï»ù
PolyglucinumPharmaTech
2082
äáÉǹ»ùë³
Polydexa
¹»ùëïñ³Ý 70,
ݳïñÇáõÙÇ ùÉáñǹ
dextran 70, sodium
chloride
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
åɳëïÇÏ ÷³Ã»Ã
(60·+9·)/1000ÙÉ,
100ÙÉ, 200ÙÉ,
250ÙÉ, 400ÙÉ,
500ÙÉ åɳëïÇÏ
÷³Ã»Ã
(1·/650000ØØ/+
1000000ØØ+
0.1·)/100ÙÉ,
10.5ÙÉ ßßÇÏ
ϳÃáóÇÏáí
ü³ñÙ³î»ù ö´À PharmaTech
CJSC
Ý»áÙÇóÇÝÇ ëáõÉý³ï,
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
´áõß³ñ³ è»Ïáñ¹³ïÇ BoucharaåáÉÇÙÇùëÇÝÇ ´
(ÉáõÍáõÛÃ)
Recordati
ëáõÉý³ï,
¹»ùë³Ù»Ã³½áÝ
neomycin sulphate,
polymyxin B sulphate,
dexamethasone
2083
äáÉǹ»ùë³
Ý»áÙÇóÇÝÇ ëáõÉý³ï,
óáÕ³ßÇà ùÃÇ
(1·/650000ØØ/+
´áõß³ñ³ è»Ïáñ¹³ïÇ Boucharaý»ÝÇÉ¿ýñÇÝáí
åáÉÇÙÇùëÇÝÇ ´
(ÉáõÍáõÛÃ)
100000ØØ+
Recordati
Polydexa with
ëáõÉý³ï,
0.025·+
Phenylephrine
¹»ùë³Ù»Ã³½áÝ,
0.250·)/100ÙÉ,
ý»ÝÇÉ¿ýñÇÝ
15ÙÉ ßßÇÏ
neomycin sulphate,
ϳÃáóÇÏáí
polymyxin B sulphate,
dexamethasone,
phenylephrine
2084
äáÉÇÄ»Ý
íÇï³ÙÇÝÝ»ñ, Å»Ýß»ÝÇ
¹»Õ³å³ïÇ×Ý»ñ
(12)
ºÆäÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
Polijen
ѳÝáõÏ, Ù»Õí³Ï³Ã,
ѳٳñ)
Ï»Ýë³ÏïÇí ÝÛáõûñ,
E.I.P.I.Co. (for World Medicine)
ѳÝù³ÝÛáõûñ
vitamins, Ginseng
extract, Royal jelly,
Bioactive components,
minerals
2085 äáÉÇÅÇݳùë íÇñ·á
Ý»áÙÇóÇÝ,
¹»Õ³å³ïÇ×Ý»ñ
35000ØØ+35000Ø ÆÝÝáï»ù ÆÝï»ñݳëÇáݳÉ
Polygynax virgo
åáÉÇÙÇùëÇÝ ´
Ñ»ßïáó³ÛÇÝ,
Ø+ 100000ØØ
ȳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
ëáõÉý³ï, ÝÇëï³ïÇÝ
÷áùñÇÏ
(6)
ÆÝáï»ñ³ âáõ½Ç
neomycine, polymyxine ³ÕçÇÏÝ»ñÇ Ñ³Ù³ñ
Innothera Chouzy for
B sulfate, nystatin
Laboratoires Innotech
International
2086
äáÉÏáñïáÉáÝ
ïñdzÙóÇÝáÉáÝ
¹»Õ³Ñ³ï»ñ
4Ù·
äáÉý³ 䳵dzÝÇó» ê.².
Polcortolon
triamcinolon
(50)
Polfa Pabianice S.A.
2087
äáÉÏáñïáÉáÝ
ïñdzÙóÇÝáÉáÝÇ
Ýñµ³ùëáõù
0.1%,
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Polcortolon
³ó»ïáÝǹ
15· å³ñÏáõ×
Jelfa S.A.Pharmaceutical
triamcinolone acetonide
Works
2088
äáÉÏáñïáÉáÝ
ïñdzÙóÇÝáÉáÝÇ
ùëáõù
0.1%,
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Polcortolon
³ó»ïáÝǹ
15· å³ñÏáõ×
Jelfa S.A.Pharmaceutical
triamcinolone acetonide
Works
2089
äáÉá¹ûùëÇÝ
¹ûùëÇóÇÏÉÇÝÇ ÑÇÏɳï ËÙ»Éáõ ÉáõÍáõÛÃ
100Ù·/ÙÉ,
ÆÝí»ë³
Pollodoxin
doxycycline hyclate
1É åɳëïÇÏ» ï³ñ³
Invesa
2090
2091
2092
2093
äáëïÇÝáñ
Postinor
äáõÙå³Ý
Pumpan
äáõÙå³Ý
Pumpan
äáõñÇ-Ý»ÃáÉ
Puri-Nethol
ɨáÝáñ·»ëïñ»É
levonorgestrel
-Ù»ñϳåïáåáõñÇÝ
mercaptopurine
¹»Õ³Ñ³ï»ñ
ϳÃÇÉÝ»ñ
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
¹»Õ³Ñ³ï»ñ
0.75Ù·
(2)
20ÙÉ, 50ÙÉ,
100ÙÉ ßßÇÏ
(12, 48)
50Ù·
(25)
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Richard Bittner AG
èÇ˳ñ¹ ´ÇÃÝ»ñ ¶ÙµÐ
Richard Bittner AG
ÐáõÙ³Ý ü³ñÙ³ ¶ÙµÐ ¶É³ùëá
àõ»ÉùáÙ ¶ÙµÐ ¨ øá.
г۳ëï³Ý
B05A A05
5639
03.06.2005
03.06.2010
¸
üñ³Ýëdz
A07A A51
S01A A03
4805
04.06.2004
04.06.2009
¸
üñ³Ýëdz
A07A A51
J01G
S01A
5202
04.10.2004
04.10.2009
¸
º·Çåïáë
A11
5678
22.09.2005
22.09.2010
²¸
üñ³Ýëdz
-
5360
23.05.2005
23.05.2010
¸
Ȼѳëï³Ý
5526
19.04.2005
19.04.2010
19.01.2006
19.01.2011
¸
5902
19.01.2006
19.01.2011
¸
0203/6257
21.07.2006
21.07.2011
¸
ÐáõÝ·³ñdz
A01A C01
H02A B08
D07A B09,
D07X B02,
H02A B08
D07A B09,
D07X B02,
H02A B08
³Ý³ëݳµáõųϳÝ,
J01A A02
G03A C03
5248
¸
²íëïñdz
-
0036/6163
²íëïñdz
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
L01B B02
1416/5895/1
30.05.2005
30.05.2010
19.05.2006
19.05.2011
03.12.2007
17.02.2011
24.02.2004
24.02.2009
Ȼѳëï³Ý
Ȼѳëï³Ý
Æëå³Ýdz
¶»ñÙ³Ýdz
5901
4685
¸
²¸
²¸
¸
143
2094
äáýáÉ
Pofol
åñáåáýáÉ
propofol
2095
äñ»·Ý³íÇï
Pregnavit
2096
äñ»¹ÝǽáÉáÝ
Prednisolon
äñ»¹ÝǽáÉáÝ
Prednisolon
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
vitamins, minerals
åñ»¹ÝǽáÉáÝ
prednisolon
Ù³½Çåñ»¹áÝ
mazipredone
2097
2098
äñ»¹ÝǽáÉáÝ
Prednisolone
äñ»¹ÝǽáÉáÝ
¹»Õ³Ñ³ï»ñ ´ä
Prednisolon Tablets
BP
äñ»¹ÝǽáÉáݸ³ñÝÇó³
PrednisolonDarnitsa
äñ»¹ÝǽáÉáÝÇ
ùëáõù
Prednisolone
ointment
äñ»¹áõÏï³É
Preductal
äñ»¹áõÏï³É Øè
Preductal MR
2104
äñ»¹áõÏï³É Øè
Preductal MR
ïñÇٻﳽǹÇÝ
trimetazidine
2105
äñ»ëï³ñÇáõÙ
Prestarium
äñ»ëï³ñÇáõÙ
Prestarium
å»ñÇݹáåñÇÉ
perindopril
å»ñÇݹáåñÇÉ
³ñ·ÇÝÇÝ
perindopril arginine
å»ñÇݹáåñÇÉ
³ñ·ÇÝÇÝ
perindopril arginine
å»ñÇݹáåñÇÉ
perindopril
å»ñÇݹáåñÇÉ ï»ñïµáõïÇɳÙÇÝ,
Çݹ³å³Ùǹ
perindopril tert-
2099
2100
2101
2102
2103
2106
2107
2108
äñ»ëï³ñÇáõÙ
Prestarium
äñ»ëï³ñÇáõÙ
Prestarium
2109 äñ»ëï³ñÇáõÙ ÏáÙµÇ
Prestarium Combi
ϳ½Ù³Ï»ñåáõÃÛ³Ý Ñ³Ù³ñ
Heuman Pharma GmbH for
Glaxo Wellcome GmbH & Co.
ÏÇà Ý/» Ý»ñ³ñÏÙ³Ý
10Ù·/ÙÉ,
¸áÝ·ÎáõÏ ü³ñÙ³ëÛáõÃÇù³É øá.,
20ÙÉ ³ÙåáõÉÝ»ñ,
Èï¹
50ÙÉ ëñí³Ï
DongKook Pharmaceutical.
(1,2,5,10,20,
Co., Ltd.
50,100)
¹»Õ³å³ïÇ×Ý»ñ
(30,60)
Ø»ñÏÉ» ¶ÙµÐ
Merckle GmbH
ùëáõù
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0,5%,
10· å³ñÏáõ×
30Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(3)
0.005·
(100)
5Ù·
(28)
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
N01AX10
1347/7308
12.11.2007
05.11.2012
¸
¶»ñÙ³Ýdz
-
5363
02.02.2005
02.02.2010
²¸
èáõë³ëï³Ý
D07A A03
1056/6851
¸
ÐáõÝ·³ñdz
H02A B19
4896
10.07.2007
10.07.2012
01.06.2005
01.06.2010
èáõë³ëï³Ý
A07E A01
C05A A04
H02A B06
5067
¸
1432/7430
11.11.2004
11.11.2009
20.12.2007
20.12.2012
àõÏñ³Çݳ
H02AB06
1263/7231
30.10.2007
12.10.2012
¸
´»É³éáõë
D07A A03
D07X A02
5017
13.12.2004
13.12.2009
¸
üñ³Ýëdz
C01D X17
4597
¸
üñ³Ýëdz
C01EB15
0836/6853
26.11.2003
26.11.2008
26.03.2007
26.03.2012
Ȼѳëï³Ý
C01EB15
1373/7335
07.11.2007
05.11.2012
¸
üñ³Ýëdz
C09A A04
4594
¸
üñ³Ýëdz
C09AA04
0880/6896
26.11.2003
26.11.2008
06.04.2007
06.04.2012
¸
åñ»¹ÝǽáÉáÝ
prednisolone
åñ»¹ÝǽáÉáÝ
prednisolone
¹»Õ³Ñ³ï»ñ
åñ»¹ÝǽáÉáÝ
prednisolone
¹»Õ³Ñ³ï»ñ
0,005·
(40)
åñ»¹ÝǽáÉáÝ
prednisolone
ùëáõù
0.5%,
10·,15· å³ñÏáõ×
ïñÇٻﳽǹÇÝ
trimetazidine
ïñÇٻﳽǹÇÝ
trimetazidine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
20Ù·
(60)
35Ù·
(60)
¹»Õ³Ñ³ï»ñ
µ³Å³Ý»ÉÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
4Ù·
(30)
5Ù·,
åɳëïÇÏ» ï³ñ³ (30)
ê»ñíÇ» ɳµáñ³ïáñdz
Les
Laboratoires Servier
ê»ñíÇ» Æݹ³ëïñÇ
ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
Industrie
²Ýý³ñÙ ê.². (ê»ñíÇ»
ȳµáñ³ïáñdz-Ç Ñ³Ù³ñ
/üñ³Ýëdz/)
Anpharm S.A. (for Les
Laboratoires Servier /France/
ê»ñíÇ» ɳµáñ³ïáñdz
Les
Laboratoires Servier
ê»ñíÇ» ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·,
åɳëïÇÏ» ï³ñ³ (30)
ê»ñíÇ» ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
üñ³Ýëdz
C09AA04
0879/6897
06.04.2007
06.04.2012
¸
¹»Õ³Ñ³ï»ñ
8Ù·
(30)
4Ù·+1.25Ù·
(30)
ê»ñíÇ» ɳµáñ³ïáñdz
Les Laboratoires Servier
ê»ñíÇ» ɳµáñ³ïáñdzݻñ
Les Laboratoires Servier
üñ³Ýëdz
C09 A04
4819
¸
üñ³Ýëdz
CO9A,
C03B
0052/6165
23.03.2004
23.03.2009
25.05.2006
25.05.2011
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
35Ù·
(60)
²ÏñÇËÇÝ ´´À
Akrikhin Open JSC
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë êäÀ
CP Pharmaceuticals Ltd.
Îáñ»³
¸³ñÝÇó³ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
ö´À
Darnitsa Pharmaceutical Firm
Closed JSC
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
¸
¸
¸
¸
144
2110
äñ»í³Ïáñ 10
Prevacore 10
butilamine, indapamide
åñ³í³ëï³ïÇÝ
pravastatine
2111
äñ»í³Ïáñ 20
Prevacore 20
2112
¹»Õ³Ñ³ï»ñ
10Ù·
(30)
åñ³í³ëï³ïÇÝ
pravastatine
¹»Õ³Ñ³ï»ñ
20Ù·
(20)
äñ»í³Ïáñ 40
Prevacore 40
åñ³í³ëï³ïÇÝ
pravastatine
¹»Õ³Ñ³ï»ñ
40Ù·
(10)
2113
äñá·»ëï»ñáÝ
Progesteron
åñá·»ëï»ñáÝ
progesteron
2114
äñá·ñ³ý
Prograf
äñá·ñ³ý
Prograf
äñá·ñ³ý
Prograf
äñá·ñ³ý
Prograf
ï³ÏñáÉÇÙáõë
tacrolimus
ï³ÏñáÉÇÙáõë
tacrolimus
ï³ÏñáÉÇÙáõë
tacrolimus
ï³ÏñáÉÇÙáõë
tacrolimus
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
¹»Õ³å³ïÇ×Ý»ñ
2118
äñá½³Ï
Prozac
2119
äñáÅ»ëïáÅ»É
Progestogel
ýÉáõûùë»ïÇÝÇ
ÑǹñáùÉáñǹ
fluoxetine hydrochloride
åñá·»ëï»ñáÝ
progesteron
2.5%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
5Ù·
(50)
0.5Ù·
(50)
1Ù·
(50)
5Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
20Ù·
(14)
2120
äñáÅ»ëïáÅ»É 1%
Progestogel 1%
2121
2115
2116
2117
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
¹áݹáÕ
1%,
80· å³ñÏáõ×
åñá·»ëï»ñáÝ
progesterone
¹áݹáÕ
1%,
80· å³ñÏáõ×
äñáÉǹ
Prolid
äñáϳݳ½áÉ
Procanazol
ÝÇÙ»ëáõÉǹ
nimesulide
ýÉáõÏáݳ½áÉ
fluconazol
¹»Õ³Ñ³ï»ñ (³ñ³·
ï³ñ³ÉáõÍíáÕ)
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
äñáϳݳ½áÉ
Procanazol
äñáϳݳ½áÉ
Procanazol
äñáÏáõÉÇÝ
Proculin
ýÉáõÏáݳ½áÉ
fluconazol
ýÉáõÏáݳ½áÉ
fluconazol
ݳý³½áÉÇÝ, µáñ³ÃÃáõ
naphazoline, boric acid
¹»Õ³å³ïÇ×Ý»ñ
2126
äñáÏïá-¶ÉÇí»ÝáÉ
Procto-Glyvenol
Ýñµ³ùëáõù
2127
äñáÏïá-¶ÉÇí»ÝáÉ
Procto-Glyvenol
ïñǵ»Ýá½Ç¹,
ÉǹáϳÛÇÝ
tribenoside, lidocaine
ïñǵ»Ýá½Ç¹,
ÉǹáϳÛÇÝ
tribenoside, lidocaine
100Ù·
(10)
2Ù·/ÙÉ,
100ÙÉ åɳëïÇÏ»
ëñí³Ï
50Ù·
(4)
150Ù·
(1)
(3Ù·+150Ù·)/
10ÙÉ,
10ÙÉ ßßÇÏ
(5%+2%)
30· å³ñÏáõ×
2122
2123
2124
2125
¹»Õ³å³ïÇ×Ý»ñ
³ÏݳϳÃÇÉÝ»ñ
ÙáÙÇÏÝ»ñ
(400Ù·+40Ù·)
(10)
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
´Çáý³ñÙ ö´À
Biopharm Closed JSC
êÇñdz
B04B B03
3981
05.05.2003
05.05.2008
¸
êÇñdz
B04B B03
3982
05.05.2003
05.05.2008
¸
êÇñdz
B04B B03
3983
05.05.2003
05.05.2008
¸
àõÏñ³Çݳ
G03D A04
0154/6082
07.07.2006
07.07.2011
¸
²ëï»É³ë ü³ñÙ³ øá. Èï¹.
Astellas Pharma Co. Ltd.
²ëï»É³ë ü³ñÙ³ øá. Èï¹.
Astellas Pharma Co. Ltd.
²ëï»É³ë ü³ñÙ³ øá. Èï¹.
Astellas Pharma Co. Ltd.
²ëï»É³ë ü³ñÙ³ øá. Èï¹.
Astellas Pharma Co. Ltd.
Æéɳݹdz
L04A A05
0479/6464
¸
Æéɳݹdz
L04A A05
0480/6463
Æéɳݹdz
L04A A05
0481/6462
Æéɳݹdz
L04A A05
0478/6465
16.10.2006
16.10.2011
16.10.2006
16.10.2011
16.10.2006
16.10.2011
16.10.2006
16.10.2011
¾ÉÇ ÈÇÉÇ ¨ øáÙå³ÝÇ Èï¹
Eli Lilly & Company Ltd
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
´»É·Ç³
N06A B03
4957
14.07.2004
14.07.2009
¸
G03DA04
0989/6807
30.05.2007
30.05.2012
¸
üñ³Ýëdz
G03D A04
0016/6110
12.05.2006
12.05.2011
¸
Ðݹϳëï³Ý
M01A X17
1193/7202
¸
Ðݹϳëï³Ý
J02A C01
1200/7195
25.09.2007
13.09.2012
25.09.2007
13.09.2012
Ðݹϳëï³Ý
J02A C01
1199/7196
¸
Ðݹϳëï³Ý
J02A C01
1198/7197
سϻ¹áÝdz
S01G A51
5480
25.09.2007
13.09.2012
25.09.2007
13.09.2012
08.04.2005
08.04.2010
Þí»Ûó³ñdz
C05A
4656
02.02.2004
02.02.2009
²¸
Þí»Ûó³ñdz
C05A
4657
02.02.2004
02.02.2009
²¸
´»½ÇÝ ÆÝï»ñݳëÇáݳÉ
´»É·Ç³ ê.².
Besins International Belgique
S.A.
´»½ÇÝ ÆÝï»ñݳëÇáݳÉ
ɳµáñ³ïáñdzݻñ
Besins International
Laboratoires
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
²ÉϳÉáǹ ²¸
Alkaloid A.D.
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis Consumer Health S.A.
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis Consumer Health S.A.
¸
¸
¸
¸
¸
²¸
145
2128
äñáÙ»¹áÉ
Promedol
ÃñÇÙ»å»ñǹÇÝ
trimeperidin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2129
äñáÙ»½
Promez
äñáÙ»ÏïÇÝ
Promectine
ûÙ»åñ³½áÉ
omeprazole
Çí»ñÙ»ÏïÇÝ
ivermectin
¹»Õ³å³ïÇ×Ý»ñ
2131
äñáÝáñ³Ý
Pronoran
åÇñǵ»¹ÇÉ
piribedil
2132
äñáå³ý»ÝáÝ
²ÉϳÉáǹ
Propafenon Alkaloid
äñáå³ý»ÝáÝ
²ÉϳÉáǹ
Propafenon Alkaloid
äñáåáýáÉ 1%
ýñ»½»ÝÇáõë
Propofol 1%
Fresenius
äñáëϳñ
Proscar
äñáëáõÉý
Prosulf
åñáå³ý»ÝáÝ
propafenone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
åñáå³ý»ÝáÝ
propafenone
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
åñáåáýáÉ
propofol
ÏÇà (¿ÙáõÉëdz)
Ý/» Ý»ñ³ñÏÙ³Ý ¨
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ýÇݳëï»ñǹ
finasteride
åñáï³ÙÇÝÇ ëáõÉý³ï
protamine sulphate
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2130
2133
2134
2135
2136
ÉáõÍáõÛà ËÙ»Éáõ
ÉáõÍáõÛÃ
2%,
1ÙÉ ³ÙåáõÉÝ»ñ
(5, 20x5)
20Ù·
(30)
1·/100ÙÉ,
1É åɳëïÇÏ» ï³ñ³
¼¹áñáíÛ» ݳñá¹áõ
Zdorovye narodu
àõÏñ³Çݳ
N02A B04
0385/6406
12.09.2006
12.09.2011
¸\Â
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
ÆÝí»ë³
Invesa
Ðݹϳëï³Ý
A02B C01
1191/7204
¸
Æëå³Ýdz
0204/6259
50Ù·
(30)
ê»ñíÇ» Æݹ³ëïñÇ É³µáñ³ïáñdz
Les Laboratoires Servier
Industrie
üñ³Ýëdz
³Ý³ëݳµáõųϳÝ,
P02C E01
C04A X13
25.09.2007
13.09.2012
21.07.2006
21.07.2011
5874
28.02.2006
28.02.2011
¸
150Ù·
(40)
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD-Skopje
سϻ¹áÝdz
C01B C03
0192/6195
13.07.2006
13.07.2011
¸
35Ù·/10ÙÉ,
10ÙÉ ³ÙåáõÉÝ»ñ
(10)
1%,
20ÙÉ ³ÙåáõÉÝ»ñ
(5), 50ÙÉ,100ÙÉ
³å³Ï» ëñí³Ï (1)
5Ù·
(14,28)
10Ù·/ÙÉ (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
2·/100ÙÉ,
20ÙÉ ßßÇÏ
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD-Skopje
سϻ¹áÝdz
C01B C03
0193/6196
13.07.2006
13.07.2011
¸
üñ»½»ÝÇáõë γµÇ ²íëïñdz
¶ÙµÐ
Fresenius Kabi Austria GmbH
²íëïñdz
N01A X10
0591/6609
05.12.2006
05.12.2011
¸
Ø»ñÏ Þ³ñå ¨ ¸áÑÙ ´.ì.
Merck Sharp & Dohme B.V.
êÇ-öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
CP Pharmaceuticals Ltd.
Üǹ»éɳݹݻñ
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
¶»ñÙ³Ýdz
G04C B01
4101
¸
V03A B14
5878
31.01.2003
31.01.2008
06.12.2005
06.12.2010
µáõë³Ï³Ý
5620
09.08.2005
09.08.2010
²¸
¶»ñÙ³Ýdz
µáõë³Ï³Ý
5621
09.08.2005
09.08.2010
²¸
Ȼѳëï³Ý
G04BX
0598/6603
14.12.2006
14.12.2011
²¸
¶»ñÙ³Ýdz
-
4830
14.04.2004
14.04.2009
¸
èáõë³ëï³Ý
µáõë³Ï³Ý
5554
13.09.2005
13.09.2010
¸
¶»ñÙ³Ýdz
µáõë³Ï³Ý
5552
31.05.2005
31.05.2010
¸
2137 äñáëå³Ý µáõë³Ï³Ý
µ³Õ»ÕÇ ãáñ³óñ³Í
ϳÃÇÉÝ»ñ
ï»ñ¨Ý»ñÇ Ñ³ÝáõÏ
Prospan Herbal
ivy (Hedera) dried leaf
Drops
extract
2138 äñáëå³Ý ѳ½³Ù³ñÇã
µ³Õ»ÕÇ ãáñ³óñ³Í
ûß³ñ³Ï
ï»ñ¨Ý»ñÇ Ñ³ÝáõÏ
Prospan Cough
ivy (Hedera) dried leaf
Syrup
extract
2139
äñáëï³ÉǽÇݳ
»ÕÇÝçÇ Ñ³ÝáõÏ
Prostalizyna
Urticae extract
ûß³ñ³Ï
7Ù·/ÙÉ,
100ÙÉ ßßÇÏ
Ù³ÍáõÏ Ý»ñùÇÝ
ÁݹáõÝÙ³Ý
100· å³ñÏáõ×
2140
äñáëï³ÙáÉ-áõÝá
Prostamol uno
¹»Õ³å³ïÇ×Ý»ñ
320Ù·
(15, 30,
60,120,180, 200)
2141
äñáëï³ÝáñÙ
Prostanorm
³ñÙ³í»Ýáõ åïáõÕÝ»ñÇ
óÝÓñ ѳÝáõÏ
extract of palma fruits
(extractum serenoa
repens)
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
ÉáõÍáõÛÃ
100ÙÉ ßßÇÏ
2142
äñáëï³åɳÝï
Prostaplant
ëáÕ³óáÕ ³ñÙ³í»Ýáõ
ѳÝáõÏ
extract from Serenoa
¹»Õ³å³ïÇ×Ý»ñ
320Ù·
(30)
¾Ý·»Éѳñ¹ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ øá. ζ
Engelhard Arzneimittel GmbH
& Co.KG
¾Ý·»Éѳñ¹ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ øá. ζ
Engelhard Arzneimittel GmbH
& Co.KG
лñµ³åáÉ, ì³ñß³í³ÛÇ
¹»Õ³µáõÛë»ñÇ ·áñͳñ³Ý
Herbapol, Warsaw Plant of
Medicinal herbs
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
ØÇÏñá·»Ý ¶²Ø-Ç Ù³ëݳ×ÛáõÕ
ìÇñÇáÝ ¶²Ø (ü³ñÙìÆȲð
¸»Õ³·áñÍ³Ï³Ý ²ñï³¹ñ³Ï³Ý
ÀÝÏ»ñáõÃÛ³Ý ÉÇó»Ý½Ç³Ûáí)
Virion SIU, the branch of
§Microgen¦ SIU (by license of
Pharm VILAR Pharmaceutical
& Industrial Company)
¸ñ.ìÇÉÙ³ñ Þí³µ» ¶ÙµÐ ¨ øá.
Dr.Willmar Schwabe GmbH
&Co.
¸
¸
146
2143
äñáíÇñáÝ-25
Proviron-25
2144 äñáï³ÙÇÝ ëáõÉý³ï
Protamine sulfate
2145
2146
2147
2148
2149
2150
2151
2152
2153
2154
2155
2156
2157
2158
2159
2160
äñáï³ñ·áÉ
Protargol
äñûùëÇÙ
Proxim
repens
Ù»ëï»ñáÉáÝ
mesterolone
åñáï³ÙÇÝÇ ëáõÉý³ï
protamine sulfate
³ñͳÃÇ åñáï»Çݳï silver
proteinate
ó»ýáõñûùëÇÙ
cefuroxim
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
25Ù·
(20,50)
50Ù·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
2%,
15ÙÉ, 30ÙÉ ßßÇÏ
750Ù·,
ëñí³Ï (1)
Þ»ñÇÝ· ²¶
Schering AG
¶³É»ÝÇϳ ³.¹.
Galenika a.d.
¾ëÏáõɳå êäÀ
Esculap Ltd
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
¹»Õ³÷áßÇ Ý/» ¨
Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
æáõÝ·ÉÇ
íÇï³ÙÇÝÝ»ñ
¹»Õ³Ñ³ï»ñ
(30,100)
ê³·Ù»É ÆÝÏ.
Jungle
vitamins
ͳٻÉáõ, ϻݹ³Ý³Ó¨
Sagmel Inc.
æáõÝ·ÉÇ µ»µÇ
A vitamin, D3 íÇï³ÙÇÝ,
ϳÃÇÉÝ»ñ
(900ØØ+400ØØ+
ê³·Ù»É ÆÝÏ.
Jungle Baby
C íÇï³ÙÇÝ,
30Ù·)/ÙÉ,
Sagmel Inc.
vitamin A, vitamin D3,
60ÙÉ ßßÇÏ
vitamin C
æáõÝ·ÉÇ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(30,60)
ê³·Ù»É ÆÝÏ.
ѳÝù³ÝÛáõûñáí
ѳÝù³ÝÛáõûñ
ͳٻÉáõ, ϻݹ³Ý³Ó¨
Sagmel Inc.
Jungle with minerals
vitamins, minerals
æáõÝ·ÉÇ ùǹë
íÇï³ÙÇÝÝ»ñ,
ûß³ñ³Ï
100ÙÉ,150ÙÉ
ê³·Ù»É ÆÝÏ.
Jungle Kids
ѳÝù³ÝÛáõûñ
ßßÇÏ
Sagmel Inc.
vitamins, minerals
æñ³ÍÝÇ å»ñûùëǹ
çñ³ÍÝÇ å»ñûùëǹ
ÉáõÍáõÛÃ
3%,
¾ëÏáõɳå êäÀ
3%
hydrogen peroxide
25ÙÉ, 30ÙÉ,
Esculap Ltd.
Hydrogen peroxide
40ÙÉ,100ÙÉ ßßÇÏ
3%
æñ³ÍÝÇ å»ñûùëǹ
çñ³ÍÝÇ å»ñûùëǹ
ÉáõÍáõÛÃ
30%,
¾ëÏáõɳå êäÀ
30%
hydrogen peroxide
25ÙÉ, 30ÙÉ,
Esculap Ltd.
Hydrogen peroxide
40ÙÉ,100ÙÉ ßßÇÏ
30%
æñ³í»ñ³Ï³Ý·ÝÇã ³Õ
³Ýçáõñ ·ÉÛáõÏá½,
¹»Õ³÷áßÇ ËÙ»Éáõ (20·+3.5·+1.5·+2.9· ê³Ý³íÇï³ ²Ïïǻݷ»ë»Éß³ýï ¨ øá.
øü, Ý»ñùÇÝ
ݳïñÇáõÙÇ ¨ ϳÉÇáõÙÇ
) ÷³Ã»ÃÝ»ñ (20) Sanavita Aktiengesellschaft &
ÁݹáõÝÙ³Ý
ùÉáñǹݻñ,
Co.
Oral Rehydration
ݳïñÇáõÙÇ óÇïñ³ï
Salts BP
anhydrous glucose,
sodium chloride,
potassium chloride,
sodium citrate
è³ÝǹÇÝ
é³ÝÇïǹÇÝ
¹»Õ³Ñ³ï»ñ
150Ù·
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Ranidin
ranitidin
óճÝóå³ï
(20)
Asia Pharmaceutical
è³ÝÇï³Ï
é³ÝÇïǹÇÝ
¹»Õ³Ñ³ï»ñ
150Ù·
²ðöÆغ¸ ÐÒ ö´À
Ranitac
ranitidine
(50)
ARPIMED J.V.CJ-S Co.
è³ÝÇïǹÇÝ
é³ÝÇïǹÇÝ
¹»Õ³Ñ³ï»ñ
150Ù·
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Ranitidin
ranitidine
óճÝóå³ï
(20,30)
Hemofarm koncern A.D.
è³ÝÇïǹÇÝ
é³ÝÇïǹÇÝÇ
¹»Õ³Ñ³ï»ñ
150Ù·
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
Ranitidin
ÑǹñáùÉáñǹ
óճÝóå³ï
(10, 20/2x10/)
ÀÝÏ»ñáõÃÛáõÝ êäÀ
ranitidine hydrochloride
Zdorovye Pharmaceutical
Company LLC
è³ÝÇïǹÇÝ
é³ÝÇïǹÇÝ
¹»Õ³Ñ³ï»ñ
150Ù·
ڲβ-80
Ranitidin
ranitidine
óճÝóå³ï
(20,1600x10)
JAKA-80
è³ÝÇïǹÇÝ
é³ÝÇïǹÇÝ
¹»Õ³Ñ³ï»ñ
0.15·
ú½áÝ êäÀ
Ranitidine
ranitidine
óճÝóå³ï
(20/2x10/)
Ozon Ltd.
è³ÝÇïǹÇÝ ²Îúê
é³ÝÇïǹÇÝÇ
¹»Õ³Ñ³ï»ñ
0.15·
êÇÝû½ ´´À
¶»ñÙ³Ýdz
G03B B01
4646
04.03.2004
04.03.2009
12.01.2007
12.01.2012
¸
ê»ñµÇ³ ¨
â»éÝá·áñdz
V03A B14
0666/6678
г۳ëï³Ý
-
0214/6130
26.07.2006
26.07.2011
25.09.2007
13.09.2012
²¸
Ðݹϳëï³Ý
J01D A06
1197/7198
²ØÜ
A11
5687
27.07.2005
27.07.2010
08.08.2005
08.08.2010
²¸
²ØÜ
A11
5715
²ØÜ
A11
5688
27.07.2005
27.07.2010
²¸
²ØÜ
A11JC
5716
08.08.2005
08.08.2010
²¸
г۳ëï³Ý
A01A B02
D08A X01
S02A A06
4883
17.08.2004
17.08.2009
²¸
г۳ëï³Ý
A01A B02
D08A X01
S02A A06
4882
17.08.2004
17.08.2009
²¸
¶»ñÙ³Ýdz
-
5603
03.08.2005
03.08.2010
¸
êÇñdz
A02B A02
4072
¸
г۳ëï³Ý
A02B A02
6054
ê»ñµÇ³ ¨
â»éÝá·áñdz
àõÏñ³Çݳ
A02B A02
5173
A02B A02
1249/7060
28.02.2003
28.02.2008
05.04.2006
05.04.2011
02.11.2004
02.11.2009
15.10.2007
15.10.2012
سϻ¹áÝdz
A02B A02
5670
¸
èáõë³ëï³Ý
A02A A02
5782
èáõë³ëï³Ý
A02B A02
1109/7042
19.09.2005
19.09.2010
08.12.2005
08.12.2010
18.09.2007
¸
¸
²¸
¸
¸
¸
¸
¸
147
Ranitidin AKOS
2161
2162
2163
2164
2165
2166
2167
2168
2169
ÑǹñáùÉáñǹ
ranitidine hydrochloride
è³áõݳïÇÝ
é³áõíáÉýdzÛÇ
Raunatin
³ÉϳÉáǹݻñ
rauwolfia alkaloids
è³åï»Ý é³åǹ
¹ÇÏÉáý»Ý³ÏÇ
Rapten Rapid
ϳÉÇáõÙ³Ï³Ý ³Õ
diclofenac potassium
軵»ïáÉ
éǵ³íÇñÇÝ
Rebetol
ribavirin
è»·áõɳùë
A, B ë»Ýá½Ç¹Ý»ñ
Regulax
(³×³ÉÇ ï»ñ¨Ý»ñ ¨
åïáõÕÝ»ñ)
A, B sennosides
(senna leaves and
fruite)
è»·áõɳùë
åÇÏáëáõÉý³ï
åÇÏáëáõÉý³ï
ݳïñÇáõÙÇ
Regulax Picosulfat
picosulfat natrium
è»·áõÉáÝ
¹»½á·»ëïñ»É,
Regulon
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ
desogestrel,
ethinylestradiol
軹³Ïï
ëǵáõïñ³ÙÇÝÇ
Redact
ÑǹñáùÉáñǹÇ
ÙáÝáÑǹñ³ï
sibutramine
hydrochloride
monohydrate
軹³Ïï
ëǵáõïñ³ÙÇÝÇ
Redact
ÑǹñáùÉáñǹÇ
ÙáÝáÑǹñ³ï
sibutramine
hydrochloride
monohydrate
è»É³ÝÇáõÙ
¹Ç³½»å³Ù
Relanium
diazepam
óճÝóå³ï
(20)
Sintez Open JSC
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.002·
(10,25,50)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(10)
¹»Õ³å³ïÇ×Ý»ñ
200Ù·
(84,140,168)
(0,71·+0,3·)
(6)
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering-Plough Labo N.V.
Îñ»í»É Øύɵ³Ë ¶ÙµÐ
Krewel Meuselbach GmbH
0.75%,
10ÙÉ, 20ÙÉ, 50ÙÉ
ßßÇÏ
(0,15Ù·+0,03Ù·)
(21, /3x21/)
¹»Õ³å³ïÇ×Ý»ñ
18.09.2012
C02A A04
0583/4335/1
24.11.2006
23.04.2009
¸
M01A B05,
M02A A15
6032
24.03.2006
24.03.2011
¸
´»É·Ç³
J05A B04
4780
¸
¶»ñÙ³Ýdz
A06AB06
1358/7319
25.05.2004
25.05.2009
29.11.2007
05.11.2012
Îñ»í»É ØáÛ½»Éµ³Ë ¶ÙµÐ
Krewel Meuselbach GmbH
¶»ñÙ³Ýdz
-
4423
04.08.2003
04.08.2008
²¸
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc
ÐáõÝ·³ñdz
G03A A09
1261/7229
03.12.2007
12.10.2012
¸
10Ù·
(20)
²êƲ ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
ASIA Pharmaceutical
Industries
êÇñdz
A08A A10
0405/6388
19.09.2006
19.09.2011
¸
¹»Õ³å³ïÇ×Ý»ñ
15Ù·
(20)
²êƲ ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
ASIA Pharmaceutical
Industries
êÇñdz
A08A A10
0406/6387
19.09.2006
19.09.2011
¸
¹»Õ³Ñ³ï»ñ
5Ù·
(20)
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
ê²
Warsaw Pharmaceutical Works
§Polfa¦ SA
¶É³ùëá àõ»ÉùáÙ öñá¹³ÏßÁÝ
Glaxo Wellcome Production
Ȼѳëï³Ý
N05B A01
5223
08.12.2004
08.12.2009
¸\Ð
Ȼѳëï³Ý
N05B A01
5031
27.08.2004
27.08.2009
¸\Ð
üñ³Ýëdz
J05AH01
1037/7009
21.06.2007
21.06.2012
¸
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
S01G A55
5089
08.10.2004
08.10.2009
²¸
Ëáñ³Ý³ñ¹ÇÏÝ»ñ
ÉáõÍáõÛÃ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2170
è»É³ÝÇáõÙ
Relanium
¹Ç³½»å³Ù
diazepam
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5,10,50)
2171
è»É»Ý½³
Relenza
½³Ý³ÙÇíÇñ
zanamivir
¹»Õ³÷áßÇ
ßÝã³éÙ³Ý
2172
è»ÉÇ»ý
Relief
ßݳÓÏ³Ý ÉÛ³ñ¹Ç ÛáõÕ,
ý»ÝÇÉ¿ýñÇÝ
shark liver oil,
phenylephrine
ÙáÙÇÏÝ»ñ
5Ù·
(1 ßÝã³éÙ³Ý
ëϳí³é³Ï³ë³ñù ¨ 5
ëϳí³é³Ï
/Ûáõñ³ù³ÝãÛáõñáõ
Ù ßÝã³éÙ³Ý
¹»Õ³÷áßáõ 4
¹»Õ³ã³÷/)
3%+0.25%
(12)
ü³ñÙëï³Ý¹³ñï-îáÙëÏùÇÙý³ñÙ ´´À èáõë³ëï³Ý
PharmstandardTomskchimpharm OJSC
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
ê»ñµÇ³ ¨
Hemofarm koncern A.D.
â»éÝá·áñdz
²¸
148
2173
è»ÉÇ»ý
Relief
2174
è»ÉÇáõÙ
Relium
ßݳÓÏ³Ý ÉÛ³ñ¹Ç ÛáõÕ,
ý»ÝÇÉ¿ýñÇÝ
shark liver oil,
phenylephrine
¹Ç³½»å³Ù
diazepam
2175
è»ÉÇáõÙ
Relium
¹Ç³½»å³Ù
diazepam
2176
è»ÉÇý
Relief
2177
è»ÉÇý ³¹í³Ýë
Relief Advance
2178
è»ÉÇý ³¹í³Ýë
Relief Advance
2179
è»ÏáñÙáÝ
Recormon
ßݳÓÏ³Ý ÉÛ³ñ¹Ç ÛáõÕ,
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ
shark liver oil,
phenylephrine
hydrochloride
µ»Ý½áϳÛÇÝ, ßݳÓϳÝ
ÉÛ³ñ¹Ç ÛáõÕ
benzocaine, shark liver
oil
ßݳÓÏ³Ý ÉÛ³ñ¹Ç ÛáõÕ,
µ»Ý½áϳÛÇÝ
shark liver oil,
benzocaine
¿åá»ïÇÝ µ»ï³
epoetin beta
2180
è»ÏáñÙáÝ
Recormon
¿åá»ïÇÝ µ»ï³
epoetin beta
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2181
è»ÏáñÙáÝ
Recormon
¾åá»ïÇÝ µ»ï³
epoetin beta
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2182
è»ÏáñÙáÝ
Recormon
¾åá»ïÇÝ µ»ï³
epoetin beta
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2183
è»ÑǹñáÝ
Rehydron
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
ÉáõÍáõÛÃÇ
2184
è»Ù»Ýë
Remens
è»Ù»Ýë
Remens
è»Ý³É·³Ý
Renalgan
·ÉÛáõÏá½Ç ³ÝÑǹñ³ï,
ݳïñÇáõÙÇ ¨ ϳÉÇáõÙÇ
ùÉáñǹݻñ,
ݳïñÇáõÙÇ óÇïñ³ï
glucose anhydrous,
sodium chloride,
potassium chloride,
sodium citrate
--
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2185
2186
Ù»ï³ÙǽáÉ,
åÇïáý»ÝáÝÇ
ùëáõù
3%+0.25%,
28,4· å³ñÏáõ×
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
S01G A55
5090
08.10.2004
08.10.2009
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5Ù·
(20)
Ȼѳëï³Ý
N05B A01
6094
12.04.2006
12.04.2011
¸\Ð
ÉáõÍáõÛÃ Ù/Ù ¨
Ý/»
Ý»ñ³ñÏáõÙÝ»ñÇ
ÙáÙÇÏÝ»ñ
10Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5,50)
/60Ù·(3%)+
5Ù·(0.25%)/
(12)
î³ñËáÙÇÝÇ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý §äáÉý³¦ ê.².
Tarchomin Pharmaceutical
Work §Polfa¦ S.A.
äáÉý³ î³ñËáÙÇÝ ê.².
Polfa Tarchomin S.A.
Ȼѳëï³Ý
N05B A01
5030
11.10.2004
11.10.2009
¸\Ð
ÆëïÇïáõïá ¸» ²Ýç»ÉÇ ê.é.É.
(ê³·Ù»É ÆÝÏ., ²ØÜ-Ç Ñ³Ù³ñ)
Instituto De Angeli S.r.l. (for
Sagmel Inc., USA)
Æï³Édz
C05A X03
0493/6492
16.10.2006
16.10.2011
²¸
ùëáõù
(200Ù·+30Ù·)/·,
28,4· å³ñÏáõ×
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
C05A D03
0705/6736
25.01.2007
25.01.2012
²¸
ÙáÙÇÏÝ»ñ
/60Ù·(3%)+
206Ù·(10,3%)/
(12)
Æï³Édz
C05A X03
0492/6493
16.10.2006
16.10.2011
²¸
¶»ñÙ³Ýdz
-
0307/6291
01.08.2006
01.08.2011
¸
¶»ñÙ³Ýdz
-
0308/6292
01.08.2006
01.08.2011
¸
¶»ñÙ³Ýdz
-
4548
16.12.2003
16.12.2008
¸
¶»ñÙ³Ýdz
-
4547
16.12.2003
16.12.2008
¸
üÇÝɳݹdz
B05
A12
4426
08.08.2003
08.08.2008
²¸
²íëïñdz
ÑáÙ»áå³Ã³ÛÇ
Ý ¹»Õ
ÑáÙ»áå³Ã³ÛÇ
Ý ¹»Õ
N02B B
5601
08.08.2005
08.08.2010
03.12.2007
17.02.2011
13.07.2006
13.07.2011
²¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ϳÃÇÉÝ»ñ
ÆëïÇïáõïá ¸» ²Ýç»ÉÇ ê.é.É.
(ê³·Ù»É ÆÝÏ., ²ØÜ-Ç Ñ³Ù³ñ)
Instituto De Angeli S.r.l. (for
Sagmel Inc., USA)
6000ØØ/0.3ÙÉ,
èáß ¸Ç³·ÝáëïÇÏë ¶ÙµÐ
ݳ˳Éóí³Í
(ü.ÐáýÙ³Ý-ȳ èáß Èï¹.-Ç
Ý»ñ³ñÏÇãÝ»ñ (6)
ѳٳñ)
Roche Diagnostics GmbH (for
F.Hoffmann-La Roche Ltd.)
10000ØØ/0.6ÙÉ,
èáß ¸Ç³·ÝáëïÇÏë ¶ÙµÐ
ݳ˳Éóí³Í
(ü.ÐáýÙ³Ý-ȳ èáß Èï¹.-Ç
Ý»ñ³ñÏÇãÝ»ñ (6)
ѳٳñ)
Roche Diagnostics GmbH (for
F.Hoffmann-La Roche Ltd.)
2000ØØ/0.3ÙÉ,
èáß ¸Ç³·ÝáëïÇÏë ¶ÙµÐ
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Roche Diagnostics GmbH
(6)
1000ØØ/0.3ÙÉ,
èáß ¸Ç³·ÝáëïÇÏë ¶ÙµÐ
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Roche Diagnostics GmbH
(6)
(10·+3.5·+2.5·+
úñÇáÝ Îáñåáñ»ÛßÝ
2.9·)/18.9·
Orion Corporation
÷³Ã»ÃÝ»ñ (20)
20ÙÉ,
50ÙÉ,100ÙÉ ßßÇÏ
(12, 48)
(2.5·+0.01·+
(0.0001·)/5ÙÉ,
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Richard Bittner AG
èÇ˳ñ¹ ´ÇÃÝ»ñ ¶ÙµÐ
Richard Bittner AG
´ÇáÉ»Ï ö´À
Biolek Closed JSC
²íëïñdz
àõÏñ³Çݳ
1417/5897/1
0175/6278
²¸
¸
149
2187
2188
2189
2190
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole, pitofenone
hydrochloride,
fenpiverin bromide
è»ÝÇï»Ï
¿Ý³É³åñÇÉÇ Ù³É»³ï
¹»Õ³Ñ³ï»ñ
Renitec
enalapril maleate
è»ÝÇï»Ï
¿Ý³É³åñÇÉÇ Ù³É»³ï
¹»Õ³Ñ³ï»ñ
Renitec
enalapril maleate
è»ÝÇï»Ï
¿Ý³É³åñÇÉÇ Ù³É»³ï
¹»Õ³Ñ³ï»ñ
Renitec
enalapril maleate
è»áåáÉÇ·ÉÛáõÏÇÝ
¹»ùëïñ³Ý
ÉáõÍáõÛÃ
Rheopolyglucin
dextran
ϳÃÇɳݻñ³ñÏ-Ù³Ý
2191 è»áåáÉÇ·ÉÛáõÏÇÝü³ñÙ³ï»ù
RheopolyglucinumPharmaTech
2192
è»áõÙ³í»Ï
Rheumavek
¹»ùëïñ³Ý 40,
ݳïñÇáõÙÇ ùÉáñǹ
dextran 40, sodium
chloride
¹ÇÏÉáý»Ý³Ï
ݳïñÇáõÙÇ
diclofenac sodium
¹ÇÏÉáý»Ý³Ï
ݳïñÇáõÙÇ
diclofenac sodium
2193 è»áõÙ³í»Ï ¹»Õ³Ñ³ï»ñ
25Ù·
Rheumavek
tabs.25mg
2194
è»åÇë³Ý
Repisan
2195
è»ï³µáÉÇÉ
ݳݹñáÉáÝÇ ¹»Ï³Ýá³ï
Retabolil
nandrolone decanoate
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
10Ù·
Ø»ñÏ Þ³ñå ¨ ¸áÑÙ ´.ì.
(7,14,28,100)
Merck Sharp & Dohme B.V.
5Ù·
Ø»ñÏ Þ³ñå ¨ ¸áÑÙ ´.ì.
(7,14,28)
Merck Sharp & Dohme B.V.
20Ù·
Ø»ñÏ Þ³ñå ¨ ¸áÑÙ ´.ì.
(7,14,28,100)
Merck Sharp & Dohme B.V.
10%,
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
200ÙÉ,400ÙÉ
Ó»éݳñÏáõÃÛáõÝ
ëñí³ÏÝ»ñ,
Liqvor Pharmaceuticals
250ÙÉ, 500ÙÉ
åɳëïÇÏ ÷³Ã»ÃÝ»ñ
ÉáõÍáõÛÃ
(100·+9·)/1000ÙÉ
ü³ñÙ³î»ù ö´À PharmaTech
ϳÃÇɳݻñ³ñÏ-Ù³Ý
100ÙÉ, 200ÙÉ,
CJSC
250ÙÉ, 400ÙÉ,
500ÙÉ åɳëïÇÏ
÷³Ã»Ã
ÉáõÍáõÛÃ
75Ù·/3ÙÉ,
ü³ñ³Ý ȳµáñ³ïáñdz ê.². Faran
Ý»ñ³ñÏÙ³Ý
3ÙÉ ³ÙåáõÉÝ»ñ
Laboratories S.A.
(5)
¹»Õ³Ñ³ï»ñ
25Ù·
ü³ñ³Ý ȳµáñ³ïáñdz ê.². Faran
(30)
Laboratories S.A.
ϳÃÇÉÝ»ñ
20ÙÉ, 50ÙÉ,
100ÙÉ ßßÇÏ
50Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(1)
10Ù·
(30)
2196
è»ï³Ý 10
Retane 10
ǽáïñ»ïÇÝáÇÝ
isotretinoin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
2197
è»ï³Ý 20
Retane 20
ǽáïñ»ïÇÝáÇÝ
isotretinoin
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
20Ù·
(30)
2198
è»ï³Ý 40
Retane 40
ǽáïñ»ïÇÝáÇÝ
isotretinoin
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
40Ù·
(30)
2199
è»ïÇÝáÉ ³ó»ï³ï
Retinol acetate
íÇï³ÙÇÝ A
vitamin A
2200
è»ùë»ïÇÝ
Rexetin
è»ùë»ïÇÝ
Rexetin
è»ýáñï³Ý
Refortan
2201
2202
2203
è»ýáñï³Ý Ü
ÉáõÍáõÛÃ
ÛáõÕ³ÛÇÝ,
¹»Õ³å³ïÇ×Ý»-ñáõÙ
å³ñûùë»ïÇÝ
¹»Õ³Ñ³ï»ñ
paroxetine
óճÝóå³ï
å³ñûùë»ïÇÝ
¹»Õ³Ñ³ï»ñ
paroxetin
óճÝóå³ï
ÑǹñûùëÇ¿ÃÇÉ ûëɳ
ÉáõÍáõÛÃ
(HES 200/0,5)
ϳÃÇɳݻñ³ñÏ-Ù³Ý
hydroxyethyl starch
(HES 200/0,5)
ÑǹñûùëÇ¿ÃÇÉ ûëɳ
ÉáõÍáõÛÃ
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
Richard Bittner AG
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
33000ØØ
(20)
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
ØÇÝëÏÇÝï»ñϳåë
Minskintercaps
30Ù·
(30)
20Ù·
(30/3x10/)
6%,
250ÙÉ, 500ÙÉ
ëñí³Ï, 500ÙÉ
åɳëïÇÏ» ï³ñ³
6%,
¶»¹»áÝ èÇËï»ñ ö´À
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc.
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
´»éÉÇÝ ø»ÙÇ ²¶ (ػݳñÇÝÇ
Üǹ»éɳݹݻñ
Üǹ»éɳݹݻñ
Üǹ»éɳݹݻñ
г۳ëï³Ý
C09A A02
4940
10.09.2004
10.09.2009
10.09.2004
10.09.2009
10.09.2004
10.09.2009
25.02.2004
25.02.2009
¸
C09A A02
4939
C09A A02
4941
B05A A05
4704
г۳ëï³Ý
B05A A05
5641
03.06.2005
03.06.2010
¸
Ðáõݳëï³Ý
M01A B05,
M02A A15,
S01B C03
M01A B05,
M02A A15,
S01B C03
4695
23.03.2004
23.03.2009
¸
4696
23.03.2004
23.03.2009
¸
²íëïñdz
-
0035/6162
²¸
ÐáõÝ·³ñdz
A14A B01
5423
19.05.2006
19.05.2011
30.05.2005
30.05.2010
êÇñdz
D10A D04
D10B A01
5509
06.06.2005
06.06.2010
¸
êÇñdz
D10A D04
D10B A01
5510
06.06.2005
06.06.2010
¸
êÇñdz
D10A D04
D10B A01
5511
06.06.2005
06.06.2010
¸
´»É³éáõë
A11C A01
0633/6648
27.12.2006
27.12.2011
¸
ÐáõÝ·³ñdz
N06A B05
4701
¸
ÐáõÝ·³ñdz
N06A B05
0725/6725
¶»ñÙ³Ýdz
-
0424/6413
15.03.2004
15.03.2009
13.02.2007
13.02.2012
26.09.2006
26.09.2011
¶»ñÙ³Ýdz
_
4096
12.03.2003
¸
Ðáõݳëï³Ý
¸
¸
¸
¸
¸
¸
150
Refortan N
hydroxyethyl starch
2204 è»ýáñï³Ý Ü åÉÛáõë ÑǹñûùëÇ¿ÃÇÉ ûëɳ
Refortan N plus
hydroxyethyl starch
2205
è»ýáñï³Ý åÉÛáõë
Refortan Plus
2206
èǵáÙáõÝÇÉ
Ribomunyl
2207
èǵûùëÇÝ
Riboxin
èǵûùëÇÝ
Riboxin
2208
2209
èÇ·»íǹáÝ
Rigevidon
2210
èÇ·»íǹáÝ 21+7
Rigevidon 21+7
2211
èÇÃÙÇá¹³ñáÝ
Rhythmiodaron
2212
èÇݳ½áÉÇÝ
Rinazoline
èÇݳ½áÉÇÝ
Rinazoline
èÇݳ½áÉÇÝ
Rinazoline
èÇÝ·»ñ
Ringer
2213
2214
2215
2216
èÇݽ³
Rinza
2217
èÇݽ³ëÇå
Rinzasip
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÑǹñûùëÇ¿ÃÇÉ ûëɳ
ÉáõÍáõÛÃ
(HES 200/0,5)
ϳÃÇɳݻñ³ñÏ-Ù³Ý
hydroxyethyl starch
(HES 200/0,5)
éǵáëáÙ³ÛÇÝ ýñ³Ïódz,
·ñ³ÝáõÉÝ»ñ
óճÝóÛÇÝ ýñ³Ïódz
ËÙ»Éáõ
ribosomal fraction,
ÉáõÍáõÛÃÇ
membrane fraction
ÇÝá½ÇÝ
¹»Õ³Ñ³ï»ñ
inosine
óճÝóå³ï
ÇÝá½ÇÝ
¹»Õ³Ñ³ï»ñ
inosine
óճÝóå³ï
250ÙÉ, 500ÙÉ
ëñí³Ï
(1,10)
10%,
250ÙÉ, 500ÙÉ
ëñí³Ï
(1,10)
10%,
500ÙÉ ëñí³Ï
(0.750Ù·+
1.125Ù·)/÷³Ã»Ã,
÷³Ã»ÃÝ»ñ (4)
0.2·
(50/5x10/)
0.2·
(6,10,30,50)
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
´»éÉÇÝ ø»ÙÇ ²¶ (ػݳñÇÝÇ
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
äÇ»é ü³µñ» Ø»¹ÇϳٻÝï
öñá¹³ÏëÇáÝ
Pierre Fabre Medicament
Production
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàõÒ
Belmedpreparaty RUP
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
12.03.2008
¶»ñÙ³Ýdz
_
4095
12.03.2003
12.03.2008
¸
¶»ñÙ³Ýdz
-
0423/6414
26.09.2006
26.09.2011
¸
üñ³Ýëdz
-
4928
18.03.2005
18.03.2010
¸
´»É³éáõë
C01EB
0831/6862
¸
´»É³éáõë
D06B B05
G01A X02
5022
22.03.2007
22.03.2012
13.12.2004
13.12.2009
ÐáõÝ·³ñdz
5602
22.06.2005
22.06.2010
¸
5250
24.05.2005
24.05.2010
¸
¸
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ,
ɨáÝáñ·»ëïñ»É
ethinylestradiol,
levonorgestrel
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ,
ɨáÝáñ·»ëïñ»É, II»ñϳÃÇ ýáõÙ³ñ³ï
ethinylestradiol,
levonorgestrel, II-iron
fumarate
³ÙÇá¹³ñáÝ
amiodarone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.15Ù·+0.03Ù·
(21,3x21)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
I-(0.03Ù·+0.15Ù·),
II-76.05
(28 /21+7/, (3x28))
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
G03A A07
G03A B03
G03F A11
G03F
G03A A07
¹»Õ³Ñ³ï»ñ
0.2·
(30/2x15/)
èáõë³ëï³Ý
C01B D01
0407/6357
19.09.2006
19.09.2011
¸
ûùëÇٻﳽáÉÇÝ
oxymetazoline
ûùëÇٻﳽáÉÇÝ
oxymetazoline
ûùëÇٻﳽáÉÇÝ
oxymetazoline
ݳïñÇáõÙÇ ùÉáñǹ,
ϳÉÇáõÙÇ ùÉáñǹ,
ϳÉóÇáõÙÇ ùÉáñǹ
sodium chloride,
potassium chloride,
calcium chloride
ùóϳÃÇÉÝ»ñ
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
ü³ñÙ³Ï ´´À
Farmak JSC
ü³ñÙ³Ï ´´À
Farmak JSC
ü³ñÙ³Ï ´´À
Farmak JSC
ü³ñÙ³î»ù ö´À
Pharma Tech CJSC
àõÏñ³Çݳ
S01G A04
5691
²¸
àõÏñ³Çݳ
S01G A04
5692
àõÏñ³Çݳ
S01G A04
5693
г۳ëï³Ý
A12B A51
5642
17.10.2005
17.10.2010
17.10.2005
17.10.2010
17.10.2005
17.10.2010
09.08.2005
09.08.2010
ÚáõÝÇù ü³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
Ðݹϳëï³Ý
N02B E71
0507/6549
07.11.2006
07.11.2011
²¸
ÚáõÝÇù ü³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz (æÇ ´Ç øÇÙdzϳÝ
¨ ¹»Õ³·áñÍ³Ï³Ý Èï¹.Ù³ëݳ×ÛáõÕ)
Ðݹϳëï³Ý
N02B E71
5768
15.02.2006
15.02.2011
²¸
0.025%,
10ÙÉ ßßÇÏ
ùóϳÃÇÉÝ»ñ
0.01%,
10ÙÉ ßßÇÏ
ùóϳÃÇÉÝ»ñ
0.05%,
10ÙÉ ßßÇÏ
ÉáõÍáõÛÃ
(8.6·+0.3·+
ϳÃÇɳݻñ³ñÏ-Ù³Ý
0.49·)/100ÙÉ,
100ÙÉ, 200ÙÉ,
250ÙÉ, 500ÙÉ,
1000ÙÉ, 2000ÙÉ,
3000ÙÉ åɳëïÇÏ
÷³Ã»Ã
¹»Õ³Ñ³ï»ñ
500Ù·+30Ù·+
10Ù·+2Ù·
(10, 20/2x10/,
100/10x10/)
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ,
ý»ÝÇÉ¿ýñÇÝ,
ùÉáñý»ÝÇñ³ÙÇÝ
paracetamol, caffeine,
phenylephrine,
chlorpheniramine
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ
ý»ÝÇñ³ÙÇÝÇ Ù³É»³ï, ËÙ»Éáõ, ݳñÝçÇ,
ý»ÝÇÉ¿ýñÇÝÇ
ÏÇïñáÝÇ Ï³Ù ë¨
(750Ù·+20Ù·+
10Ù·+ 30Ù·)/5·,
÷³Ã»ÃÝ»ñ
²¸
²¸
¸
151
ÑǹñáùÉáñǹ, Ïáý»ÇÝ Ñ³Õ³ñçÇ Ñ³Ù»ñáí
paracetamol,
pheniramine maleate,
phenylephrine
hydrochloride, caffeine
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ,
¹»Õ³Ñ³ï»ñ
ý»ÝÇÉ¿ýñÇÝ,
ùÉáñý»ÝÇñ³ÙÇÝ
paracetamol, caffeine,
phenylephrine,
chlorpheniramine
ùëÇÉáٻﳽáÉÇÝ
ùóϳÃÇÉÝ»ñ
xylometazoline
2218
èÇÝÇÏáɹ
Rinicold
2219
èÇÝùëÇÉ
Rhinxyl
2220
èÇÝùëÇÉ
Rhinxyl
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
2221
èÇë»ï
Risset
èÇë»ï
Risset
èÇë»ï
Risset
èÇë»ï
Risset
èÇëå»ñ¹³É ÏáÝëï³
Risperdal Consta
éÇëå»ñǹáÝ
risperidone
éÇëå»ñǹáÝ
risperidone
éÇëå»ñǹáÝ
risperidone
éÇëå»ñǹáÝ
risperidone
éÇëå»ñǹáÝ
risperidone
èÇëå»ñǹáÝ
Risperidon
èÇëå»ñǹáÝ
Risperidon
èÇëå»ñǹáÝ
Risperidon
èÇëåáÉ»åï
Rispolept
èÇëåáÉ»åï
Rrispolept
èÇý³ÙåÇóÇÝ
Rifampicin
èÇý³ÙåÇóÇÝ
ü»ñ»ÛÝ
Rifampicin - Ferein
éÇëå»ñǹáÝ
risperidon
éÇëå»ñǹáÝ
risperidon
éÇëå»ñǹáÝ
risperidon
éÇëå»ñǹáÝ
risperidon
éÇëå»ñǹáÝ
risperidon
éÇý³ÙåÇóÇÝ
rifampicin
éÇý³ÙåÇóÇÝ
rifampicin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ï³ËáõÛÃÇ,
»ñϳñ³ï¨
Ó»ñµ³½³ïÙ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
èÇý³ÙåÇóÇÝ
Rifampicin
2234
èÇý³ÙåÇóÇݲëï»ñdz
Rifampicin-Asteria
2235
èá·ÉÇï
Roglit
2236
èá·ÉÇï
éÇý³ÙåÇóÇÝ
rifampicin
éÇý³ÙåÇóÇÝ
rifampicin
2222
2223
2224
2225
2226
2227
2228
2229
2230
2231
2232
2233
éá½Ç·ÉÇï³½áÝ
rosiglitazone
éá½Ç·ÉÇï³½áÝ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
(5,10,25)
Unique Pharmaceutical
laboratories (a division of JB
Chemicals & Pharmaceuticals
Ltd.)
(500Ù·+30Ù·+
10Ù·+2Ù·)
(10)
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï. Èï¹.
Shreya Life Sciences Pvt. Ltd.
Ðݹϳëï³Ý
N02BE71
0345\5400
21.08.2006
21.08.2011
²¸
0.1%,
10ÙÉ ßßÇÏ
ü³ñÙ³åɳÝï ´ÇᷳɻÝÇϳ
Pharmaplant Biogalenica
èáõÙÇÝdz
4396
16.09.2003
16.09.2008
²¸
0.05%,
10ÙÉ ßßÇÏ
ü³ñÙ³åɳÝï ´ÇᷳɻÝÇϳ
Pharmaplant Biogalenica
èáõÙÇÝdz
4397
16.09.2003
16.09.2008
²¸
Êáñí³Ãdz
R01A A07
R01A B06
S01G A03
R01A A07
R01A B06
S01G A03
N05A X 08
0104/6126
¸
Êáñí³Ãdz
N05A X08
0105/6125
Êáñí³Ãdz
N05A X08
0106/6124
Êáñí³Ãdz
N05A X08
0107/6123
Þí»Ûó³ñdz
N05A X08
0024/5682
09.06.2006
09.06.2011
09.06.2006
09.06.2011
09.06.2006
09.06.2011
09.06.2006
09.06.2011
17.05.2006
17.05.2011
سϻ¹áÝdz
N05AX08
1376/7338
¸
سϻ¹áÝdz
N05AX08
1377/7339
سϻ¹áÝdz
N05AX08
1375/7337
Æï³Édz
N05A X08
4823
Æï³Édz
N05A X08
4702
èáõÙÇÝdz
J04A B02
5605
èáõë³ëï³Ý
J04A B02
4757
06.12.2007
05.11.2012
06.12.2007
05.11.2012
06.12.2007
05.11.2012
26.04.2004
26.04.2009
09.02.2004
09.02.2009
22.07.2005
22.07.2010
18.03.2004
18.03.2009
01.10.2007
13.04.2012
07.09.2005
07.09.2010
¸
30.05.2006
30.05.2011
30.05.2006
¸
4Ù·
äÉÇí³ Ðáñí³ïëϳ ¹.û.û.
(20, 60)
Pliva Hrvatska d.o.o.
3Ù·
äÉÇí³ Ðáñí³ïëϳ ¹.û.û.
(20,60)
Pliva Hrvatska d.o.o.
2Ù·
äÉÇí³ Ðáñí³ïëϳ ¹.û.û.
(20,60)
Pliva Hrvatska d.o.o.
1Ù·
äÉÇí³ Ðáñí³ïëϳ ¹.û.û.
(20,60)
Pliva Hrvatska d.o.o.
25Ù·,
êÇɳ· ²¶ (Ú³Ýë»Ý
ëñí³Ï,
ü³ñÙ³ëÛáõÃÇù³ Ü.ì., ´»É·Ç³ÛÇ
ݳ˳Éóí³Í Ý»ñ³ñÏÇã
ѳٳñ)
2ÙÉ ÉáõÍãáí, 3
Cilag AG (for Janssen
³ë»Õ
Pharmaceutica N.V., Belgium)
1Ù·
²ÉϳÉáǹ ²¸-êÏáåÛ»
(20)
Alkaloid AD-Skopje
3Ù·
²ÉϳÉáǹ ²¸-êÏáåÛ»
(20)
Alkaloid AD-Skopje
2Ù·
²ÉϳÉáǹ ²¸-êÏáåÛ»
(20)
Alkaloid AD-Skopje
4Ù·
Ú³Ýë»Ý êÇɳ· ê.å.².
(20,60)
Janssen-Cilag S.p.A.
2Ù·
Ú³Ýë»Ý êÇɳ· ê.å.².
(20,60)
Janssen-Cilag S.p.A.
300Ù·
²ÝïǵÇáïÇÏ ê.².
(10,100x10)
Antibiotice S.A.
0.15·,
§´ñÇÝó³Éáí-²¦ ö´À
³ÙåáõÉÝ»ñ (10)
§Brinsalov-A¦ CJSC
150Ù·
(20/2x10/)
300Ù·,
(100(10x10))
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàõÒ
Belmedpreparaty RUP
Îáñ»³ öñÇÙ ü³ñÙ øá.Èï¹.
Korea Prime Pharm Co.Ltd.
´»É³éáõë
J04A B02
1088/6889/1
Îáñ»³
J04A B02
5758
4Ù·
(30, 60)
2Ù·
¶»¹»áÝ èÇËï»ñ Èï¹
Gedeon Richter Ltd
¶»¹»áÝ èÇËï»ñ Èï¹
ÐáõÝ·³ñdz
A10B G02
0058/5412
ÐáõÝ·³ñdz
A10B G02
0059/5411
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
¸
152
2237
2238
2239
Roglit
èá·ÉÇï
Roglit
èáϳÉïñáÉ
Rocaltrol
rosiglitazone
éá½Ç·ÉÇï³½áÝ
rosiglitazone
ϳÉóÇïñáÉ
calcitriol
èáÙ³½áõɳÝ
Romazulan
¹»Õ³ïݳÛÇÝ »ñÇóáõÏÇ
çñ³ëåÇñï³ÛÇÝ Ñ³ÝáõÏ,
³½áõÉ»Ý
chamomille officinalis
hydraalcohol extract,
azulen
2240 èáí³ÙÇóÇÝ 1.5 ÙÇÉ
ëåÇñ³ÙÇóÇÝ
ØØ
spiramycine
Rovamycine 1.5
MIU
2241 èáí³ÙÇóÇÝ 3 ÙÇÉ
ØØ Rovamycine 3
MIU
ëåÇñ³ÙÇóÇÝ
spiramycine
2242
ó»ýïñdzùëáÝ
ceftriaxone
2243
2244
2245
2246
2247
2248
2249
2250
2251
èáó»ýÇÝ
Rocephine
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
(60)
8Ù·
(30)
0.25ÙÏ·
(30,100)
ÉáõÍáõÛÃ
(95,881·+0,037·)/
100·,
50ÙÉ, 100ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
1.5 ÙÇÉÇáÝ ØØ
(16)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
3 ÙÇÉÇáÝ ØØ
(10)
Gedeon Richter Ltd
¶»¹»áÝ èÇËï»ñ Èï¹
Gedeon Richter Ltd
è.ö.Þ»ñ»ñ ¶ÙµÐ ¨ øá. ζ
(ÐáýÙ³Ý-ȳ èáß Èï¹-Ç Ñ³Ù³ñ)
R.P.Scherer GmbH & Co.KG
(for Hoffmann-La Roche Ltd.)
´Çáý³ñÙ ê.²
Biofarm S.A.
²í»ÝïÇë ü³ñÙ³ êå»ódzÉÇï»ë
(²í»ÝïÇë ɳµáñ³ïáñdzÛÇ
ѳٳñ)
Aventis Pharma Specialites (for
Laboratoires Aventis)
²í»ÝïÇë ü³ñÙ³ êå»ódzÉÇï»ë
(²í»ÝïÇë ɳµáñ³ïáñdzÛÇ
ѳٳñ)
Aventis Pharma Specialites (for
Laboratoires Aventis)
ÐáýÙ³Ý-ȳ èáß Èï¹ HoffmannLa Roche Ltd
¹»Õ³÷áßÇ Ù/Ù
1·,
Ý»ñ³ñÏÙ³Ý,
3.5 ÙÉ ÉáõÍÇã,
3.5ÙÉ ÉáõÍãáí
ëñí³Ï/³ÙåáõÉ (1)
èáó»ýÇÝ
ó»ýïñdzùëáÝ
¹»Õ³÷áßÇ Ý/»
1·
ÐáýÙ³Ý-ȳ èáß Èï¹ HoffmannRocephine
ceftriaxone
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1,143)
La Roche Ltd
èáó»ýÇÝ
ó»ýïñdzùëáÝ
¹»Õ³÷áßÇ Ù/Ù Ý/»
250Ù·,
ü.ÐáýÙ³Ý-ȳ èáß Èï¹
Rocephin
ceftriaxone
Ý»ñ³ñÏáõÙÝ»ñÇ
ëñí³Ï (1, 143)
F. Hoffmann-La Roche Ltd.
èáõµÇï³É ýáñï»
ïáõÕïÇ ³ñÙ³ïÝ»ñÇ 6%
ûß³ñ³Ï
(25.4·+33.4·)/ 100·,
¶»ÙÇ
Rubital forte
ѳÝáõÏ, ³½Ýí³Ùáñáõ
125· ßßÇÏ
Gemi
ûß³ñ³Ï
6% extract ex radix
Althaeae, sirupus Rubi
idaei
èáõٳɳ۳
µáõë³Ï³Ý ÷áßÇÝ»ñ ¨
¹»Õ³Ñ³ï»ñ
(60)
ÐÇٳɳ۳ ¸ñ³· øá.
Rumalaya
ѳÝáõÏÝ»ñ
The Himalaya Drug Co.
herbal powders and
extracts
èáõٳɳ۳
µáõë³Ï³Ý ÷áßÇÝ»ñ ¨
Ýñµ³ùëáõù
30· å³ñÏáõ×
ÐÇٳɳ۳ ¸ñ³·.øá.
Rumalaya
ѳÝáõÏÝ»ñ
The Himalaya Drug Co.
herbal powders and
extracts
èáõÙ³ý»Ý êè
¹ÇÏÉáý»Ý³Ï
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
¶É³ùëáàõ»ÉùáÙ º·Çåïáë ê.².º.
Rheumafen SR
diclofenac
(10)
GlaxoWellcome Egypt S.A.E.
èáõï³óǹ
Ñǹñáï³ÉóÇï
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
500Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
Rutacid
hydrotalcite
(20/2x10/,
KRKA d.d. Novo mesto
60/6x10/)
èáý»ñáÝ-²
ÇÝï»ñý»ñáÝ ³Éý³-2³
ÉáõÍáõÛÃ
3ÙÇÉÇáÝ
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
Roferon-A
interferon alfa-2a
Ý»ñ³ñÏÙ³Ý
ØØ/0,5ÙÉ
F. Hoffmann-La Roche Ltd.
ݳ˳Éóí³Í Ý»ñ³ñÏÇã
(1)
èûùëÇÃñáÙÇóÇÝ
éûùëÇÃñáÙÇóÇÝ
¹»Õ³Ñ³ï»ñ
150Ù·
ȺΠü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
È»Ï Roxithromycin
roxithromycine
óճÝóå³ï
(10)
LEK Pharmaceuticals d.d.
30.05.2011
30.05.2006
30.05.2011
13.04.2004
13.04.2009
ÐáõÝ·³ñdz
A10B G02
0060/5413
¸
¶»ñÙ³Ýdz
A11C C04
4822
èáõÙÇÝdz
A01A B11
0687/6734
17.01.2007
17.01.2012
²¸
üñ³Ýëdz
J01F A02
4902
15.07.2004
15.07.2009
¸
üñ³Ýëdz
J01F A02
4901
15.07.2004
15.07.2009
¸
Þí»Ûó³ñdz
J01D A13
4026
07.01.2003
07.01.2008
¸
Þí»Ûó³ñdz
J01D A13
4025
¸
Þí»Ûó³ñdz
J01D A13
1183/7218
Ȼѳëï³Ý
µáõë³Ï³Ý
5367
07.01.2003
07.01.2008
20.09.2007
13.09.2012
23.03.2005
23.03.2010
Ðݹϳëï³Ý
-
4551
24.11.2003
24.11.2008
²¸
Ðݹϳëï³Ý
-
4552
24.11.2003
24.11.2008
²¸
º·Çåïáë
4483
0932/6882
22.08.2003
22.08.2008
03.05.2007
03.05.2012
¸
êÉáí»Ýdz
M02A A15
M01A B05
A02A D04
Þí»Ûó³ñdz
L03B B04
0133/6232
21.06.2006
21.06.2011
¸
êÉáí»Ýdz
J01F A06
4206
19.03.2003
19.03.2008
¸
¸
¸
²¸
²¸
153
Lek
èûùëÇÑ»ùë³É
Roxihexal
éûùëÇÃñáÙÇóÇÝ
roxithromycin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2253
èûùëÇÑ»ùë³É
RoxiHEXAL
éûùëÇÃñáÙÇóÇÝ
roxithromycin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2254
èûùëÇï³ë-150
Roxitas-150
ê³Éµáõï³ÙáÉ
Salbutamol
ê³Éµáõï³ÙáÉ
Salbutamol
éûùëÇÃñáÙÇóÇÝ
roxithromycin
ë³Éµáõï³ÙáÉ
salbutamol
ë³Éµáõï³ÙáÉÇ ëáõÉý³ï
salbutamol sulphate
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
óáÕ³óÇñ
2257
ê³Éµáõï³ÙáÉ
Salbutamol
ë³Éµáõï³ÙáÉÇ ëáõÉý³ï
salbutamol sulphate
¹»Õ³Ñ³ï»ñ
2258
ê³Éµáõï³ÙáÉ
Salbutamol
ë³Éµáõï³ÙáÉ
salbutamol
óáÕ³óÇñ
ßÝã³éÙ³Ý
ë³Éµáõï³ÙáÉ
salbutamol
óáÕ³óÇñ¹»Õ³Ï³ËáõÛÃ
ë³Éµáõï³ÙáÉ
salbutamol
ûß³ñ³Ï
ݳïñÇáõÙÇ ùÉáñǹ
sodium chloride
ݳïñÇáõÙÇ ùÉáñǹ
sodium chloride
óáÕ³óÇñ ùÃÇ
2252
2255
2256
2259 ê³Éµáõï³ÙáÉ ³é³Ýó
òüê-Ç
Salbutamol CFC
free
2260
ê³Éµáõï³ÙáÉ
êáý³ñÙ³
Salbutamol
Sopharma
2261
ê³ÉÇÝ
Salin
2262
ê³ÉÇÝ
Salin
2263
ê³ÉÇóÇɳÃÃáõ
Salicylic acid
ë³ÉÇóÇɳÃÃáõ
salicylic acid
2264
ê³Éïáë
Saltos
ë³Éµáõï³ÙáÉ
salbutamol
2265
ê³Ý í»Û ûÛ
San Way Tea
2266 ê³Ý¹ÇÙáõÝ Ý»áñ³É
Sandimmun Neoral
óÇÏÉáëåáñÇÝ
ciclosporine
2267 ê³Ý¹ÇÙáõÝ Ý»áñ³É
óÇÏÉáëåáñÇÝ
¹»Õ³Ñ³ï»ñ
300Ù·
(10)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
150Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
(10)
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
150Ù·
ÆÝï³ë ý³ñÙ³ëÛáõÃÇù³Éë Èï¹.
(100/10x10/)
Intas Pharmaceuticals Ltd.
100ÙÏ·/¹»Õ³ã³÷,
²ÉóÛíÇï³ÙÇÝÇ ö´À
12ÙÉ ßßÇÏ
Altajvitaminy Closed JSC
2Ù·
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
(30)
ê²
Warsaw Pharmaceutical
Works §Polfa¦ SA
4Ù·
ì³ñß³í³ÛÇ §äáÉý³¦ ¹»Õ·áñͳñ³Ý
(30)
ê²
Warsaw Pharmaceutical
Works §Polfa¦ SA
100ÙÏ·/¹»Õ³ã³÷,
¶É³ùëáêÙÇÃÎɳÛÝ
(10ÙÉ/200¹»Õ³ã÷/
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
ßÝã³éÙ³Ý
GlaxoSmithKline
ë³ñùáõÙ)
Pharmaceuticals S.A.
100ÙÏ·/¹»Õ³ã³÷,
¶É³ùëáêÙÇÃÎɳÛÝ
(200 ¹»Õ³ã³÷
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
óáÕ³óÇñ ë³ñùáõÙ)
GlaxoSmithKline
Pharmaceuticals S.A.
2Ù·/5ÙÉ,
êáý³ñÙ³ ´À
125ÙÉ ßßÇÏ
Sopharma JSC
0.65%,
44ÙÉ ßßÇÏ
6.5Ù·/ÙÉ,
30ÙÉ ßßÇÏ
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
óáÕ³ßÇà ùÃÇ
ÆÝëïÇïáõïá ¸» ²Ýç»ÉÇ ë.é.É.
(ê³·Ù»É ÆÝÏ-Ç (²ØÜ) ѳٳñ
Instituto De Angeli S.r.l. (for
Sagmel Inc., USA)
ÉáõÍáõÛÃ
3%,
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ëåÇñï³ÛÇÝ
50ÙÉ,100ÙÉ,250Ù
ÙdzíáñáõÙ ²äÀ
É ßßÇÏ
Arsemi Agroindustrial Union
Ltd.
¹»Õ³Ñ³ï»ñ
0.00723·
äáõÉÙáÙ»¹ ö´À
óճÝóå³ï »ñϳñ³ï¨
(30)
Pulmomed CJSC
³½¹»óáõÃÛ³Ý
ûÛ
2· ÷³Ã»ÃÇÏÝ»ñ
ÈÇÏ» êäÀ
(25)
League Ltd
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
è.ä. Þ»ñ»ñ ¶ÙµÐ ¨ øá. ζ
ŻɳïÇÝ», ÷³÷áõÏ
(50)
(Üáí³ñïÇë ü³ñÙ³ ²¶,
Þí»ó³ñdzÛÇ Ñ³Ù³ñ)
R. P. Sherer GmbH & Co. KG
(for Novartis Pharma AG,
Switzerland)
¹»Õ³å³ïÇ×Ý»ñ
25Ù·
è.ä. Þ»ñ»ñ ¶ÙµÐ ¨ øá. ζ
¶»ñÙ³Ýdz
J01F A06
5845
11.11.2005
11.11.2010
¸
¶»ñÙ³Ýdz
J01F A06
5855
05.12.2005
05.12.2010
¸
Ðݹϳëï³Ý
J01F A06
0776/6749
¸
èáõë³ëï³Ý
R03AC02
1128/7112
Ȼѳëï³Ý
R03A C02
5032
07.03.2007
07.03.2012
12.11.2007
08.08.2012
27.08.2004
27.08.2009
Ȼѳëï³Ý
R03A C02
5033
27.08.2004
27.08.2009
¸
Ȼѳëï³Ý
R03A C02
R03C C02
5035
25.08.2004
25.08.2009
¸
Ȼѳëï³Ý
R03A C02,
R03C C02
5964
02.02.2006
02.02.2011
¸
´áõÉÕ³ñdz
R03C C02
1205/7214
28.09.2007
13.09.2012
¸
²ØÜ
R01A X10
5756
²¸
Æï³Édz
R01A X10
1157/7178
29.09.2005
29.09.2010
13.09.2007
13.09.2012
г۳ëï³Ý
D01A E12
5965
08.02.2006
08.02.2011
²¸
èáõë³ëï³Ý
-
5054
12.08.2005
12.08.2010
¸
âÇݳëï³Ý
βêÐ
0340\6374
²¸
¶»ñÙ³Ýdz
L04AA01
0856/6812
21.08.2006
21.08.2011
30.03.2007
30.03.2012
¶»ñÙ³Ýdz
L04AA01
0854/6814
30.03.2007
¸
¸
¸
²¸
¸
154
Sandimmun Neoral
2268 ê³Ý¹ÇÙáõÝ Ý»áñ³É
Sandimmun Neoral
ciclosporine
ŻɳïÇÝ», ÷³÷áõÏ
(50)
óÇÏÉáëåáñÇÝ
ciclosporine
¹»Õ³å³ïÇ×Ý»ñ
ŻɳïÇÝ», ÷³÷áõÏ
50Ù·
(50)
0.05Ù·/1ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
0.1Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
0.1%,
10ÙÉ ßßÇÏ
2269
ê³Ý¹áëï³ïÇÝ
Sandostatin
ûÏïñ»áïǹ
octreotide
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2270
ê³Ý¹áëï³ïÇÝ
Sandostatin
ûÏïñ»áïǹ
octreotide
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2271
ê³ÝáñÇÝ
Sanorin
ݳý³½áÉÇÝ
naphazoline
2272
ê³ÝáñÇÝ
Sanorin
ݳý³½áÉÇÝ
naphazoline
ÏÇà ÝÇí»Ýáõ
ÛáõÕáí
(¿ÙáõÉëdz)
óáÕ³ßÇà ùÃÇ
2273
ê³ÝáñÇݳݳɻñ·ÇÝ
Sanorin-Analergin
2274
ê³í³ñÇùë
Savarix
2275
껵ǹÇÝ
Sebidin
2276
껹³É·ÇÝ - Ü»á
Sedalgin - Neo
2277
껹³É-Ø
Sedal-M
2278
ê»Éë»åï
CellCept
0.1%,
10ÙÉ ßßÇÏ
óáÕ³ßÇà ë³ñùáí
(2.5Ù·+50Ù·)/
10ÙÉ,
10ÙÉ ßßÇÏ
ݳý³½áÉÇÝÇ ÝÇïñ³ï, ùó-/ ³ÏݳϳÃÇÉÝ»ñ
³Ýï³½áÉÇÝÇ Ù»½Çɳï
naphazoline nitrate,
antazoline mesilate
Ñ»å³ñÇÝ,
¹áݹáÕ
(500Ø+10Ù·+
³Ý¿ëû½ÇÝ, ÓdzϳëÏÇ
50Ù·)·,
åïáõÕÝ»ñÇ Ñ³ÝáõÏ
30· å³ñÏáõ×
heparin sodium,
anesthesin, fructus
hippocastanum extract
ùÉáñÑ»ùëǹÇÝÇ
Éá½³ÝÝ»ñ
5Ù·+50Ù·
ÑǹñáùÉáñǹ,
(20)
³ëÏáñµÇݳÃÃáõ
chlorhexidine
hydrochloride, ascorbic
acid
å³ñ³ó»ï³ÙáÉ,
¹»Õ³Ñ³ï»ñ
300Ù·+150Ù·+
ٻóÙǽáÉ, Ïáý»ÇÝ,
50Ù·+10Ù·+15Ù·
Ïá¹»ÇÝ,ý»Ýáµ³ñµÇï³É
(20,100,500)
paracetamol,
methamizol, caffeine,
codeine, phenobarbital
Ù»ï³ÙǽáÉ,
¹»Õ³Ñ³ï»ñ
150Ù·+300Ù·+
å³ñ³ó»ï³ÙáÉ, Ïá¹»ÇÝÇ
10Ù·+50Ù·+15Ù·
ýáëý³ï, Ïáý»ÇÝ,
(10,20,50x10)
ý»Ýáµ³ñµÇï³É
metamizole,
paracetamol, codeine
phosphate, caffeine,
phenobarbital
Ùáý»ïÇÉÇ
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
ÙÇÏáý»Ýáɳï
(100,300)
(Üáí³ñïÇë ü³ñÙ³ ²¶,
Þí»ó³ñdzÛÇ Ñ³Ù³ñ)
R. P. Sherer GmbH & Co. KG
(for Novartis Pharma AG,
Switzerland)
è.ä. Þ»ñ»ñ ¶ÙµÐ ¨ øá. ζ
(Üáí³ñïÇë ü³ñÙ³ ²¶,
Þí»ó³ñdzÛÇ Ñ³Ù³ñ)
R. P. Sherer GmbH & Co. KG
(for Novartis Pharma AG,
Switzerland)
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
30.03.2012
¶»ñÙ³Ýdz
L04AA01
0855/6813
30.03.2007
30.03.2012
¸
Þí»Ûó³ñdz
H01C B02
4047
25.02.2003
25.02.2008
¸
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
Þí»Ûó³ñdz
H01C B02
4048
25.02.2003
25.02.2008
¸
²Ûì²øê ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
²Ûì²øë ý³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
â»Ëdz
4508
21.11.2003
21.11.2008
²¸
â»Ëdz
S01G A01
R01A A08
R01A B02
R01A A08
6012
21.03.2006
21.03.2011
²¸
â»Ëdz
S01G A51
5916
23.02.2006
23.02.2011
²¸
¶ºØÆ
GEMI
Ȼѳëï³Ý
HC05 BA53
0476/6456
16.10.2006
16.10.2011
²¸
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
Ȼѳëï³Ý
D08A C52
4910
15.06.2004
15.06.2009
²¸
´³ÉϳÝý³ñÙ³ - ¸áõåÝÇó³ ²¸
Balkanpharma - Dupnitza AD
´áõÉÕ³ñdz
N02B E71
5410
23.02.2005
23.02.2010
²¸
ØÇÉí» ü³ñÙ³ëÛáõÃÇù³É
·áñͳñ³ÝÝ»ñ
Milve Pharmaceutical Plants
´áõÉÕ³ñdz
N02B B72
5721
11.11.2005
11.11.2010
²¸
èáß ê.å.².
Roche S.p.A.
Æï³Édz
L04
4520
18.05.2004
18.05.2009
¸
155
2279
ê»Ùåñ»ùë
Semprex
2280
ê»Ý³¹»
Senade
ê»Ý³¹»ùëÇݼ¹áñáíÛ»
SenadexinZdorovye
ê»åï³Ý»ëï
³¹ñ»Ý³ÉÇÝáí
1/100000
Septanest With
Adrenaline
1/100000
ê»åïÇÉÇÝ
Septilin
2281
2282
2283
2284
2285
2286
2287
2288
mycophenolate mofetil
³ÏñÇí³ëïÇÝ
acrivastine
¹»Õ³å³ïÇ×Ý»ñ
8Ù·
(24)
àõ»ÉùáÙ ü³áõݹ»ÛßÝ Èï¹-Ç
ѳٳñ êÙÇÃÎɳÛÝ ´Çã»Ù
SmithKline Beecham for
Wellcome Foundation Ltd.
êÇåɳ Èï¹
Cipla Ltd.
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ê»åïá¹áÝï
Septodont
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
R06A X18
5287
23.12.2004
23.12.2009
¸
ë»Ýá½Ç¹Ý»ñ A, B
sennosides A,B
ë»Ýá½Ç¹Ý»ñ
sennosides
¹»Õ³Ñ³ï»ñ
13.5Ù·
(500/25x20/)
0,07·
(10, 20)
Ðݹϳëï³Ý
-
0358/6197
²¸
àõÏñ³Çݳ
A06A B06
1141/7113
28.08.2006
28.08.2011
02.10.2007
08.08.2012
³ñïÇϳÛÇÝÇ
ÑǹñáùÉáñǹ,
³¹ñ»Ý³ÉÇÝÇ ï³ñïñ³ï
articaine hydrochloride,
adrenaline tartrate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
µáõë³Ï³Ý ÷áßÇÝ»ñ ¨
ѳÝáõÏÝ»ñ
herbal powders and
extracts
ê»åïÇÉÇÝ
µáõë³Ï³Ý ÷áßÇÝ»ñ ¨
Septilin
ѳÝáõÏÝ»ñ
herbal powders and
extracts
ê»åïáÉ»ï»
µ»Ý½³ÉÏáÝÇáõÙÇ
Septolete
ùÉáñǹ, Ù»ÝÃáÉ,
ÃÇÙáÉ, åÕå»Õ³ÛÇÝ
³Ý³ÝáõËÇ »Ã»ñ³ÛáõÕ,
ÝÇí»Ýáõ »Ã»ñ³ÛáõÕ
benzalconium chloride,
menthol, thymol,
aetheroleum Menthae
piperite, aetheroleum
Eucalypti
ê»åïáÉ»ï» ¸
µ»Ý½³ÉÏáÝÇáõÙÇ
Septolete D
ùÉáñǹ, ɨáÙ»ÝÃáÉ,
ÃÇÙáÉ, åÕå»Õ³ÛÇÝ
³Ý³ÝáõËÇ »Ã»ñ³ÛáõÕ,
ÝÇí»Ýáõ »Ã»ñ³ÛáõÕ
benzalconium chloride,
levomenthol, thymol,
aetheroleum Menthae
piperite, aetheroleum
Eucalypti
ê»åïáÉ»ï» åÉÛáõë
ó»ïÇÉåÇñǹÇÝÇ
Septolete Plus
ùÉáñǹ, µ»Ý½áϳÛÇÝ
cetylpyridinium
chloride, benzocaine
ê»åïñÇÝ
ëáõÉý³Ù»Ãûùë³½áÉ,
Septrin
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
¹»Õ³Ñ³ï»ñ
(4·+1000ÙÏ·)/
100ÙÉ
//(68Ù·+0.03Ù·)/
1.7ÙÉ//,
1.7ÙÉ
÷³Ù÷áõßïÝ»ñ (50)
(60)
üñ³Ýëdz
N01B
4851
27.05.2004
27.05.2009
¸
ÐÇٳɳ۳ ¸ñ³·.øá.
The Himalaya Drug Co.
Ðݹϳëï³Ý
-
4554
24.11.2003
24.11.2008
²¸
ûß³ñ³Ï
100ÙÉ ßßÇÏ
ÐÇٳɳ۳ ¸ñ³·.øá.
The Himalaya Drug Co.
Ðݹϳëï³Ý
-
4555
24.11.2003
24.11.2008
²¸
å³ëï»ÕÝ»ñ
(1Ù·+1.2Ù·+0.6Ù·+
1Ù·+0.6Ù·)
(30/3x10/)
Îèβ ¹.¹., Üáíá Ù»ëïá
KRKA d.d., Novo mesto
êÉáí»Ýdz
R02A A20
0811/6832
20.03.2007
20.03.2012
²¸
å³ëï»ÕÝ»ñ ³é³Ýó 1Ù·+1.2Ù·+ 0.6Ù·+
ß³ù³ñÇ
1Ù·+0.6Ù·
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
R02A A16
0566/6528
24.11.2006
24.11.2011
²¸
¹»Õ³Ñ³ï»ñ
²¸
å³ëï»ÕÝ»ñ
1Ù·+5Ù·
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
D08A J03,
D09A A07
6064
05.04.2006
05.04.2011
²¸
¹»Õ³Ñ³ï»ñ
400Ù·+80Ù·
(20)
¶É³ùëáêÙÇÃÎɳÛÝ
ý³ñÙ³ëÛáõÃÇù³Éë ê.².
¶É³ùëáêÙÇÃÎɳÛÝ
(γݳ¹³)-Ç Ñ³Ù³ñ
GlaxoSmithKline (Canada) for
GlaxoSmithKline
Ȼѳëï³Ý
J01E E01
4121
12.02.2003
12.02.2008
¸
156
2289
ê»åïñÇÝ Ù³ÝϳϳÝ
¹»Õ³Ï³ËáõÛÃ
Septrin Paediatric
Suspension
ê»ïñáÝ
Setron
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimetoprim
ûݹ³Ýë»ïñáÝ
ondansetron
¹»Õ³Ï³ËáõÛÃ
240Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
2291
ê»ñ»í»Ýï
Serevent
ë³ÉÙ»ï»ñáÉ
salmeterol
óáÕ³ßÇÃ
¹»Õ³ã³÷í³Í
8Ù·/4ÙÉ,
4ÙÉ ³ÙåáõÉÝ»ñ
(5)
25ÙÏ·/1¹»Õ³ã³÷
60 ¹»Õ³ã³÷
ßÝã³éÙ³Ý ë³ñùáõÙ
2292
ê»ñ»ïǹ 125
¿íáѳɻñ
Seretide 125
Evohaler
óáÕ³óÇñ
2293
ê»ñ»ïǹ 250
¿íáѳɻñ
Seretide 250
Evohaler
2294
ê»ñ»ïǹ ¹ÇëÏáõë
Seretide diskus
2295
ê»ñ»ïǹ ¹ÇëÏáõë
Seretide diskus
2296
ê»ñÙÇáÝ
Sermion
ë³ÉÙ»ï»ñáÉ ùëÇݳýá³ï,
ýÉáõïÇϳ½áÝÇ
åñáåÇáݳï
salmeterol xinafoate,
fluticasone propionate
ë³ÉÙ»ï»ñáÉ ùëÇݳýá³ï,
ýÉáõïÇϳ½áÝÇ
åñáåÇáݳï
salmeterol xinafoate,
fluticasone propionate
ë³ÉÙ»ï»ñáÉ,
ýÉáõïÇϳ½áÝÇ
åñáåÇáݳï
salmeterol, fluticasone
propionate
ë³ÉÙ»ï»ñáÉ,
ýÉáõïÇϳ½áÝÇ
åñáåÇáݳï
salmeterol, fluticasone
propionate
ÝÇó»ñ·áÉÇÝ
nicergolin
2297
ê»ñÙÇáÝ
Sermion
ê»ñûùë³ï
Seroxat
2290
2298
2299
êdzÉÇë
Cialis
2300
êdzÉÇë
Cialis
êǵ»ñdzÝ
Syberian
2301
2302
êǹÝáý³ñÙ
Sydnopharm
ÝÇó»ñ·áÉÇÝ
nicergolin
å³ñûùë»ïÇÝÇ
ÑǹñáùÉáñǹ
paroxetine
hydrochloride
ó¹³É³ýÇÉ
tadalafil
ï³¹³É³ýÇÉ
tadalafil
¿É»áõï»ñáÏáÏÇ (÷ßáï)
³ñÙ³ïÝ»ñÇ ãáñ ѳÝáõÏ
Eleutherococcus
senticosus roots dry
extract
ÙáÉëǹáÙÇÝ
molsidomine
Pharmaceuticals S.A.
¶É³ùëáàõ»ÉùáÙ ¶ÙµÐ ¨ øá.
GlaxoWellcome GmbH & Co.
¶»ñÙ³Ýdz
J01E E01
4328
01.07.2003
01.07.2008
¸
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
Ðáñ¹³Ý³Ý
A04A A01
5884
22.11.2005
22.11.2010
¸
Ȼѳëï³Ý
R03A C12
4037
17.03.2003
17.03.2008
¸
(25ÙÏ·+125ÙÏ·)/
¹»Õ³ã³÷,
120 ¹»Õ³ã³÷
ßÝã³éÙ³Ý ë³ñùáõÙ
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
Ȼѳëï³Ý
R03A K06
5496
13.05.2005
13.05.2010
¸
óáÕ³óÇñ
(25ÙÏ·+250ÙÏ·)/
¹»Õ³ã³÷,
120 ¹»Õ³ã³÷
ßÝã³éÙ³Ý ë³ñùáõÙ
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
Ȼѳëï³Ý
R03A K06
5497
13.05.2005
13.05.2010
¸
¹»Õ³÷áßÇ
Ý»ñßÝãÙ³Ý
(50ÙÏ·+250ÙÏ·)/
¹»Õ³ã³÷,
(28 ¨ 60 ¹»Õ³ã³÷
ßÝã³éÙ³Ý
ë³ñùáõÙ)
(50ÙÏ·+100ÙÏ·)/
¹»Õ³ã³÷,
(28 ¨ 60 ¹»Õ³ã³÷
ßÝã³éÙ³Ý
ë³ñùáõÙ)
4Ù·,
ëñí³Ï/³ÙåáõÉ (4)
¶É³ùëáàõ»ÉùáÙ úå»ñ»ÛßÝ
GlaxoWellcome Operation
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
R03A K06
5225
08.12.2004
08.12.2009
¸
¶É³ùëáàõ»ÉùáÙ úå»ñ»ÛßÝ
GlaxoWellcome Operation
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
R03A K06
5226
29.11.2004
29.11.2009
¸
ü³ñÙ³ódz Æï³Édz ê.å.².
Pharmacia Italia S.p.A.
Æï³Édz
C04A E02
5351
19.01.2005
19.01.2010
¸
5Ù·
(30)
20Ù·
(30)
ü³ñÙ³ódz Æï³Édz ê.å.².
Pharmacia Italia S.p.A.
êÙÇÃÎɳÛÝ ´Çã»Ù
ü³ñÙ³ëÛáõÃÇù³Éë SmithKline
Beecham Pharmaceuticals
Æï³Édz
C04A E02
5350
¸
²Ý·Édz
N06A B05
5118
19.01.2005
19.01.2010
26.10.2004
26.10.2009
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·
(1,2,4,8)
¾ÉÇ ÈÇÉÇ ¨ øá.
Eli Lilly & Co.
-
4487
30.07.2003
30.07.2008
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·
(1, 2, 4)
100Ù·
(20 /2x10/,60
/6x10/)
ÈÇÉÇ ê.².
Lilly S.A.
´Çáý³ñÙ êå, ½.û.û
Biofarm Sp z.o.o.
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
Æëå³Ýdz
G04BE08
1353/7314
¸
Ȼѳëï³Ý
µáõë³Ï³Ý
0330/6299
07.12.2007
05.11.2012
11.08.2006
11.08.2011
¹»Õ³Ñ³ï»ñ
2Ù·
(30)
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
C01D X12
1092/7114
¹»Õ³÷áßÇ
Ý»ñßÝãÙ³Ý
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý ¨
ϳÃÇɳݻñ³ñÏ-Ù³Ý,
ÉáõÍáõÛÃÝ»ñÇ
4ÙÉ ÉáõÍãáí
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
08.08.2007
08.08.2012
¸
²¸
¸
157
2303
êÇɳ·ñ³ 100
Silagra 100
êÇɳ·ñ³ 50
Silagra 50
êÇÉϳ¹»ñÙ
Silkaderm
êÇϳåñáï»Ïï
Siccaprotect
ëÇɹ»Ý³ýÇÉÇ óÇïñ³ï
sildenafil citrate
ëÇɹ»Ý³ýÇÉÇ óÇïñ³ï
sildenafil citrate
ïñ»ïÇÝáÇÝ
tretinoin
¹»ùëå³ÝûÝáÉ
dexpanthenol
2307
êÇٳɷ»É
Simalgel
2308
êÇÙµ³Éï³
Cymbalta
êÇÙµ³Éï³
Cymbalta
êÇÙ·³É
Simgal
³ÉÛáõÙÇÝÇáõÙÇ ¨
Ù³·Ý»½ÇáõÙÇ
Ñǹñûùëǹݻñ,
ëÇÙ»ÃÇÏáÝ
aluminium, magnesium
hydroxides,
simethicone
¹áõÉoùë»ïÇÝ
duloxetine
¹áõÉûùë»ïÇÝ
duloxetine
ëÇÙí³ëï³ïÇÝ
simvastatin
2311
êÇÙ·³É
Simgal
2312
2304
2305
2306
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Ýñµ³ùëáõù
³ÏݳϳÃÇÉÝ»ñ
100Ù·
(4,10x4)
50Ù·
(4,10x4)
0.05%,
15· å³ñÏáõ×
30Ù·/ÙÉ
10ÙÉ ßßÇÏ
êÇåɳ Èï¹
Cipla Ltd.
êÇåɳ Èï¹
Cipla Ltd.
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
àõñë³ý³ñÙ ²ñóݳÛÙÇûÉ
¶ÙµÐ ¨ Îá.ζ
Ursapharm Arzneimittel GmbH
& Co. KG
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ/²ØÜ/-Ç Ñ³Ù³ñ,
E.I.P.I.Co (for World Medicine,
USA)
Ðݹϳëï³Ý
G04B E03
0364/6289
Ðݹϳëï³Ý
G04B E03
0365/6290
г۳ëï³Ý
0168/4200/1
¶»ñÙ³Ýdz
D10A D01,
L01X X14
S01G
º·Çåïáë
A02A
5977
09.02.2006
09.02.2011
²¸
Æëå³Ýdz
N06A A
0983/6943
¸
²ØÜ
-
5983
â»Ëdz
C10A A01
6013
22.05.2007
22.05.2012
08.02.2006
08.02.2011
21.03.2006
21.03.2011
â»Ëdz
C10A A01
6014
21.03.2006
21.03.2011
¸
â»Ëdz
C10A A01
6015
21.03.2006
21.03.2011
¸
Þí»Ûó³ñdz
A05B A03
0621/6674
27.12.2006
27.12.2011
²¸
0355/6337
31.08.2006
31.08.2011
31.08.2006
31.08.2011
07.07.2006
10.02.2008
28.08.2006
28.08.2011
¸
¸
²¸
¸
¹»Õ³Ï³ËáõÛÃ
ËÙ»Éáõ
(405Ù·+100Ù·+
125Ù·)/5ÙÉ,
300ÙÉ ßßÇÏ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
60Ù·
(28)
60Ù·
(14,28)
10Ù·
(28/14x2/)
ëÇÙí³ëï³ïÇÝ
simvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·
(28/14x2/)
êÇÙ·³É
Simgal
ëÇÙí³ëï³ïÇÝ
simvastatin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
40Ù·
(28/14x2/)
2313
êÇÙ»å³ñ
Simepar
¹»Õ³å³ïÇ×Ý»ñ
(40)
2314
êÇÙå³ïÇÉ
Sympathyl
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
20Ù·+75Ù·+
124,35Ù·
(40,60)
ȳµáñ³ïáñdz ÆÝÝáï»ù
ÆÝï»ñݳëÇáÝ³É Laboratoires
Innotech International
üñ³Ýëdz
-
3939
07.05.2003
07.05.2008
²¸
2315
êÇÙí³ÉÇÙÇï
Simvalimit
êÇÙí³ÉÇÙÇï
Simvalimit
êÇݳýɳÝ
Synaflan
ëÇÉÇÙ³ñÇÝ,
íÇï³ÙÇÝÝ»ñ
silimarin, vitamins
³ñ¨³·Ý¹Ç ãáñ çñ³ÛÇÝ
ѳÝáõÏ, ³Éá×Ç ãáñ
çñ³ëåÇñï³ÛÇÝ Ñ³ÝáõÏ,
Ù³·Ý»½ÇáõÙÇ ûùëǹ
Escholtzia (dry
aqueous extract),
Hawthorn blossom (dry
aqueous-alcoholic
extract), magnesium
oxide
ëÇÙí³ëï³ïÇÝ
simvastatin
ëÇÙí³ëï³ïÇÝ
simvastatin
ýÉÛáõóÇÝáÉáÝ
fluocinolone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ùëáõù
C10A A01
0075/6210
¸
ȳïídz
C10A A01
0076/6209
´»É³éáõë
D07A C04
5018
07.06.2006
07.06.2011
07.06.2006
07.06.2011
13.12.2004
13.12.2009
ùëáõù
¶ñÇݹ»ùë ´À
Grindex JSC
¶ñÇݹ»ùë ´À
Grindex JSC
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
ȳïídz
ýÉáõáóÇÝáÉáÝÇ
³ó»ïáÝǹ
fluocinolone acetonide
µáõï³ÙÇñ³ï
butamirate
20Ù·
(30 /3x10/)
10Ù·
(30 /3x10/)
0.025%,
10·,15· å³ñÏáõ× Ï³Ù
³å³Ï» ï³ñ³
0,025%,
10· å³ñÏáõ×
èáõë³ëï³Ý
D07A C04
1298/7266
15.10.2007
12.10.2012
¸
15Ù·/10ÙÉ,
200ÙÉ ßßÇÏ
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Þí»Ûó³ñdz
R05D B13
4750
15.06.2004
15.06.2009
²¸
2309
2310
2316
2317
2318
êÇݳýÉ³Ý ùëáõù
Synaflan ointment
2319
êÇÝ»Ïá¹
Sinecod
¹»Õ³å³ïÇ×Ý»ñ
ûß³ñ³Ï
ÈÇÉÇ ê.².
Lilly S.A.
¾ÉÇ ÈÇÉÇ ¨ øáÙ÷³ÝÇ Èï¹.
Eli Lilly and Company Ltd.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
Ø»ý³ Èï¹.
Mepha Ltd.
¸
¸
¸
¸
158
2320
êÇÝ»Ïá¹
Sinecod
µáõï³ÙÇñ³ï
butamirate
ϳÃÇÉÝ»ñ
5Ù·/ÙÉ,
20ÙÉ ßßÇÏ
2321
êÇÝ¿ëïñáÉ
Synestrol
Ñ»ùë¿ëïñáÉ
hexestrol
2322
êÇÝÃáÙÇóÇÝÇ
Ñ»Õáõϳùëáõù
Synthomycin
liniment
êÇÝϳåïáÝ
Synkapton
ùÉáñ³Ùý»ÝÇÏáÉ
chloramphenicol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
Ñ»Õáõϳùëáõù
2%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
10%,
25· å³ñÏáõ×
¹»Õ³Ñ³ï»ñ
óճÝóå³ï (¹ñ³Å»)
2323
Þí»Ûó³ñdz
R05D B13
4751
15.06.2004
15.06.2009
²¸
àõÏñ³Çݳ
-
0153/6083
07.07.2006
07.07.2011
¸
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
èáõë³ëï³Ý
D07A X02,
D10A F03,
J01B A01
5847
15.11.2005
15.11.2010
²¸
1Ù·+25Ù·+100Ù·
(20)
èáß ¨ гݹ»É ¶ÙµÐ س·.¹-ñ
ÂÇÉ êïñ³ÉÑáý»ñ ¶ÙµÐ-Ç
ѳٳñ
Roche & Handel GmbH for
Mag.Dr.Till Strallhofer GmbH
²íëïñdz
N02C A72
4229
18.04.2003
18.04.2008
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(30,60,120)
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
·ñáõå)
Berlin-Chemie AG (Menarini
Group)
²ëdz ý³ñÙ³ëÛáõÃÇù³É
Asia Pharmaceutical
²ëdz ý³ñÙ³ëÛáõÃÇù³É
Asia Pharmaceutical
²ëdz ý³ñÙ³ëÛáõÃÇù³É
Asia Pharmaceutical
Üáí³ñïÇë ü³ñÙ³ öñá¹³ÏßÁÝ
¶ÙµÐ
Novartis Pharma Production
GmbH
Üáí³ñïÇë ü³ñÙ³ öñá¹³ÏßÁÝ
¶ÙµÐ
Novartis Pharma Production
GmbH
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
ê»åïá¹áÝï
Septodont
¶»ñÙ³Ýdz
A10B A02
4712
20.02.2004
20.02.2009
¸
¶»ñÙ³Ýdz
A10B A02
4713
20.02.2004
20.02.2009
¸
êÇñdz
J01M A02
4069
¸
êÇñdz
J01M A02
4070
êÇñdz
J01M A02
4071
¶»ñÙ³Ýdz
M03B X02
4045
28.02.2003
28.02.2008
28.02.2003
28.02.2008
28.02.2003
28.02.2008
24.08.2005
09.01.2008
¶»ñÙ³Ýdz
M03B X02
4044
24.08.2005
09.01.2008
¸
èáõÙÇÝdz
S01X A20
0667/6610
²¸
üñ³Ýëdz
N01B B53
4853
17.01.2007
17.01.2012
14.05.2004
14.05.2009
2324
êÇáýáñ 500
Siofor 500
¿ñ·áï³ÙÇÝÇ ï³ñïñ³ï,
¹ÇÙ»ÝÑǹñÇݳï,
Ïáý»ÇÝ
ergotamine tartrate,
dimenhydrinate,
caffeine
Ù»ïýáñÙÇÝ
metformin
2325
êÇáýáñ 850
Siofor 850
Ù»ïýáñÙÇÝ
metformin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
850Ù·
(30,60,120)
2326
êÇåñá 250
Sipro 250
êÇåñá 500
Sipro 500
êÇåñá 750
Sipro 750
êÇñ¹³Éáõ¹
Sirdalud
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
ïǽ³ÝǹÇÝ
tizanidine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
250Ù·
(10)
500Ù·
(10)
750Ù·
(10)
4Ù·
(30)
2330
êÇñ¹³Éáõ¹
Sirdalud
ïǽ³ÝǹÇÝ
tizanidine
¹»Õ³Ñ³ï»ñ
2Ù·
(30)
2331
êÉ»½ÇÝ
Slezin
êϳݹáÝ»ëï 2%,
ѳïáõÏ
Scandonest 2%
special
ÑÇåñáÙ»Éá½
hypromellose
Ù»åÇí³Ï³ÛÇÝÇ
ÑǹñáùÉáñǹ,
³¹ñ»Ý³ÉÇÝÇ ï³ñïñ³ï
mepivacaine
hydrochloride,
adrenaline tartrate
Ù»åÇí³Ï³ÛÇÝÇ
ÑǹñáùÉáñǹ
mepivacaine
hydrochloride
³½»É³ÃÃáõ
azelaic acid
óÇÝÏÇ åÇñÇÃÇáÝ
zinc pyrithione
³ÏݳϳÃÇÉÝ»ñ
0,5%,
10ÙÉ ßßÇÏ
2%+1:100000,
1.8ÙÉ
÷³Ù÷áõßïÝ»ñ (50)
2327
2328
2329
2332
2333
êϳݹáÝ»ëï 3%
Scandonest 3%
2334
êÏÇÝáñ»Ý
Skinoren
êÏÇÝ-ù³å
Skin-Cap
2335
Novartis Consumer Health S.A.
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis Consumer Health S.A.
´Çáý³ñÙ ö´À
Biopharm Closed JSC
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¸
¸
¸
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
3%,
1.8ÙÉ
÷³Ù÷áõßïÝ»ñ (50)
ê»åïá¹áÝï
Septodont
üñ³Ýëdz
N01B B03,
³ï³ÙݳµáõųϳÝ
5862
02.12.2005
02.12.2010
¸
Ýñµ³ùëáõù
20%,
30· å³ñÏáõ×
1%,
150ÙÉ
Þ»ñÇÝ· ê.å.².
Schering S.p.A.
ø»ÙÇÝáí³ ÆÝï»ñݳëÇáÝ³É ê.².
Cheminova International S.A.
Æï³Édz
D10A X03
5613
²¸
Æëå³Ýdz
-
0601/6285
20.07.2005
20.07.2010
14.12.2006
14.12.2011
û׳é³Ñ»ÕáõÏ
²¸
159
2336
2337
2338
2339
2340
2341
2342
2343
2344
2345
êÏÇÝ-ù³å
Skin-Cap
êÏÇÝ-ù³å
Skin-Cap
êáÉÏá¹»ñÙ
Solcoderm
óÇÝÏÇ åÇñÇÃÇáÝ
zinc pyrithione
óÇÝÏÇ åÇñÇÃÇáÝ
zinc pyrithione
Ýñµ³ùëáõù
óáÕ³óÇñ
0.2%,
ø»ÙÇÝáí³ ÆÝï»ñݳëÇáÝ³É ê.².
50· å³ñÏáõ×
Cheminova International S.A.
0.2%,
ø»ÙÇÝáí³ ÆÝï»ñݳëÇáÝ³É ê.².
70· óáÕ³óÇñ
Cheminova International S.A.
ë³ñùáõÙ
(580.7Ù·+41.1Ù·+
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
57.4Ù·+4.5Ù·+
ICN Swizerland AG
48ÙÏ·)/ÙÉ,
0.2ÙÉ ³ÙåáõÉÝ»ñ
(1,5)
³½áï³ÃÃáõ 70%,
ÉáõÍáõÛÃ
ù³ó³Ë³ÃÃáõ 99%,
ÃñÃÝçϳÃÃáõ,
ϳÃݳÃÃáõ, åÕÝÓÇ (II)
ÝÇïñ³ïÇ »éÑǹñ³ï
nitric acid 70%, acetic
acid 99%, oxalic acid
dehydrate, lactic acid,
cooper (II) nitrate
trihydrate
êáÉÏáë»ñÇÉ
ãáñ, ëåÇï³Ïáõó³½»ñÍ
ùëáõù
2.07Ù·/·,
Solcoseryl
ïñ³Ù³ÉáõÍÇã ÑáñÃÇ
20· å³ñÏáõ×
³ñÛáõÝÇó
dried, protein-free
dialysate from calves'
blood
êáÉÏáë»ñÇÉ
ãáñ, ëåÇï³Ïáõó³½»ñÍ
ÉáõÍáõÛÃ
42.5Ù·/ÙÉ(2ÙÉ),
Solcoseryl
ïñ³Ù³ÉáõÍÇã ÑáñÃÇ
Ý»ñ³ñÏÙ³Ý
2ÙÉ ³ÙåáõÉÝ»ñ
³ñÛáõÝÇó
(25)
dried, protein-free
dialysate from calves'
blood
êáÉÏáë»ñÇÉ
ãáñ, ëåÇï³Ïáõó³½»ñÍ
ÉáõÍáõÛÃ
42.5Ù·/ÙÉ(5ÙÉ),
Solcoseryl
ïñ³Ù³ÉáõÍÇã ÑáñÃÇ
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
³ñÛáõÝÇó
(5)
dried, protein-free
dialysate from calves'
blood
êáÉÏáë»ñÇÉ
ãáñ, ëåÇï³Ïáõó³½»ñÍ
ÉáõÍáõÛÃ
42.5Ù·/ÙÉ(10ÙÉ),
Solcoseryl
ïñ³Ù³ÉáõÍÇã ÑáñÃÇ
Ý»ñ³ñÏÙ³Ý
10ÙÉ ³ÙåáõÉÝ»ñ
³ñÛáõÝÇó
(5)
dried, protein-free
dialysate from calves'
blood
êáÉÏáë»ñÇÉ
ãáñ, ëåÇï³Ïáõó³½»ñÍ
³Ïݳ¹áݹáÕ
8.3Ù·/·,
Solcoseryl
ïñ³Ù³ÉáõÍÇã ÑáñÃÇ
5· å³ñÏáõ×
³ñÛáõÝÇó
dried, protein-free
dialysate from calves'
blood
êáÉÏáë»ñÇÉ
ãáñ, ëåÇï³Ïáõó³½»ñÍ
ÉáõÍáõÛÃ
2.125·/250ÙÉ,
2000Ù· Solcoseryl ïñ³Ù³ÉáõÍÇã ÑáñÃÇ Ï³ÃÇɳݻñ³ñÏ-Ù³Ý
250ÙÉ ëñí³Ï (1)
2000mg
³ñÛáõÝÇó
dried, protein-free
dialysate from calves'
blood
êáÉÏáë»ñÇÉ ¸»Ýï³É ãáñ, ëåÇï³Ïáõó³½»ñÍ
Ù³ÍáõÏ ÏåãáõÝ
(2.125Ù·+10Ù·)/·,
Solcoseryl Dental
ïñ³Ù³ÉáõÍÇã ÑáñÃÇ
5· å³ñÏáõ×
³ñÛáõÝÇó,
åáÉǹáϳÝáÉ 600
Æëå³Ýdz
-
0602/6224
14.12.2006
14.12.2011
14.12.2006
14.12.2011
²¸
Æëå³Ýdz
-
0603/6225
Þí»Ûó³ñdz
-
4808
27.05.2004
27.05.2009
¸
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4815
27.05.2004
27.05.2009
²¸
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4812
27.05.2004
27.05.2009
¸
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4813
27.05.2004
27.05.2009
¸
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4814
27.05.2004
27.05.2009
¸
êáÉÏá ´³½»É ä.¼.
Solco Basel P.Z.
Ȼѳëï³Ý
-
4817
27.05.2004
27.05.2009
¸
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4811
27.05.2004
27.05.2009
¸
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4810
27.05.2004
27.05.2009
²¸
²¸
160
2346
2347
2348
2349
dried, protein-free
dialysate from calves'
blood, polidocanol 600
êáÉÏáë»ñÇÉ ¹áݹáÕ ãáñ, ëåÇï³Ïáõó³½»ñÍ
Solcoseryl Jelly
ïñ³Ù³ÉáõÍÇã ÑáñÃÇ
³ñÛáõÝÇó
dried, protein-free
dialysate from calves'
blood
êáÉÏáí³·ÇÝ
³½áï³ÃÃáõ 70%,
Solcovagin
ù³ó³Ë³ÃÃáõ 99%,
ÃñÃÝçϳÃÃáõ, óÇÝÏÇ
ÝÇïñ³ïÇ Ñ»ùë³Ñǹñ³ï
nitric acid 70%, acetic
acid 99%, oxalic acid
dehydrate, zinc nitrate
hexahydrate
êáÉÏáïñÇËáí³Ï
³ÏïÇí³½»ñÍ
SolcoTrichovac
ϳÃݳٳÝñ¿Ý»ñ
inactivated
microorganisms of
Lactobacillus
êáÉáõ-Ù»¹ñáÉ
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
Solu-Medrol
methylprednisolone
2350
êáÉáõ-Ù»¹ñáÉ
Solu-Medrol
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
2351
êáÉáõ-Ù»¹ñáÉ
Solu-Medrol
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
2352
êáÉáõ-Ù»¹ñáÉ
Solu-Medrol
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
2353
êáÉáõ-Ù»¹ñáÉ
Solu-Medrol
Ù»ÃÇÉåñ»¹ÝǽáÉáÝ
methylprednisolone
2354
êáÉáõï³Ý
鳹ᵻÉÇÝ,
¹áݹáÕ
4.15Ù·/·,
20· å³ñÏáõ×
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4816
27.05.2004
27.05.2009
²¸
ÉáõÍáõÛÃ
(537Ù·+20.4Ù·+
58.6Ù·+6Ù·)/ÙÉ,
0.5ÙÉ ëñí³Ï (2)
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶ (²ÛêÇ-¾Ý ü³ñÙ³ëÛáõÃÇù³É
Þí»Ûó³ñdz Èï¹-Ç Ñ³Ù³ñ)
ICN Swizerland AG (for ICN
Pharmaceutical Switzerland
Ltd.)
Þí»Ûó³ñdz
-
4807
27.05.2004
27.05.2009
¸
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶
ICN Swizerland AG
Þí»Ûó³ñdz
-
4824
27.05.2004
27.05.2009
¸
ü³ñÙ³ódz Ü.ì./ê.².
Pharmacia N.V./S.A.
´»É·Ç³
H02A B04
0374/6383
11.09.2006
11.09.2011
¸
ü³ñÙ³ódz Ü.ì./ê.².
Pharmacia N.V./S.A.
´»É·Ç³
H02A B04
0375/6382
11.09.2006
11.09.2011
¸
ü³ñÙ³ódz Ü.ì./ê.².
Pharmacia N.V./S.A.
´»É·Ç³
H02A B04
0376/6381
11.09.2006
11.09.2011
¸
ü³ñÙ³ódz Ü.ì./ê.².
Pharmacia N.V./S.A.
´»É·Ç³
H02A B04
0377/6380
11.09.2006
11.09.2011
¸
ü³ñÙ³ódz Ü.ì./ê.².
Pharmacia N.V./S.A.
´»É·Ç³
H02A B04
0378/6379
11.09.2006
11.09.2011
¸
¶³É»Ý³ ³.ë.
â»Ëdz
_
4225
09.04.2003
¸\Ð
¹»Õ³÷áßÇ Ù/Ù
ëñí³Ï/³ÙåáõÉ (1,3)
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í,
ÉáõÍãáí
¹»Õ³÷áßÇ
1000Ù·,
Ý»ñ³ñÏÙ³Ý
ëñí³Ï/ëñí³Ï (1)
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
140,4ÙÉ ÉáõÍãáí
(0,9% µ»Ý½ÇÉ
ëåÇñï)
¹»Õ³÷áßÇ
500Ù·,
Ý»ñ³ñÏÙ³Ý
ëñí³Ï/ëñí³Ï (1)
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
7,8ÙÉ ÉáõÍãáí
(0,9% µ»Ý½ÇÉ
ëåÇñï)
¹»Õ³÷áßÇ
250Ù·,
Ý»ñ³ñÏÙ³Ý
»ñÏͳí³É ëñí³Ï (1)
ÉáõÍáõÛÃÇ
ÉÇáýÇÉǽ³óí³Í
4ÙÉ ÉáõÍãáí (0,9%
µ»Ý½ÇÉ ëåÇñï)
¹»Õ³÷áßÇ
125Ù·,
Ý»ñ³ñÏÙ³Ý
»ñÏͳí³É ëñí³Ï (1)
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
2ÙÉ ÉáõÍãáí (0,9%
µ»Ý½ÇÉ ëåÇñï)
¹»Õ³÷áßÇ
40Ù·,
Ý»ñ³ñÏÙ³Ý
»ñÏͳí³É ëñí³Ï (1)
ÉáõÍáõÛÃÇ
ÉÇáýÇÉǽ³óí³Í
1ÙÉ ÉáõÍãáí (0,9%
µ»Ý½ÇÉ ëåÇñï)
ÉáõÍáõÛÃ
(0.1Ù·+1Ù·+
161
Solutan
ë³åáÝÇÝÝ»ñ, ë³ÙÇÃÇ
ÛáõÕ, ÝáíáϳÛÇÝ,
¿ý»¹ñÇÝÇ
ÑǹñáùÉáñǹ,
ݳïñÇáõÙÇ Ûá¹Ç¹,
ïáÉáõï³ÝÇ µ³É³ë³ÝÇ
ѳÝáõÏ, ¹³éÁ Ýß»Ýáõ
çáõñ
radobeline, saponines,
fennel etherolea,
procaine,ephedrine
hydrochloride,natrium
iodide,tolutan balsame
extract,water of
almond/ aqua
amygdale
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ,
Ïá¹»ÇÝÇ ýáëý³ï
paracetamol, caffeine,
codeine phosphate
0.4Ù·+
4Ù·+17.5Ù·+
100Ù·+25Ù·+
30Ù·)ÙÉ,
50ÙÉ ßßÇÏ
2355
êáÉå³¹»ÇÝ
Solpadeine
2356
êáÉå³¹»ÇÝ
Solpadeine
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ,
Ïá¹»ÇÝÇ ýáëý³ï
paracetamol, caffeine,
codeine phosphate
¹»Õ³å³ïÇ×Ý»ñ
2357
êáÉå³¹»ÇÝ
Solpadeine
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
2358
êáÉå³ýÉ»ùë
Solpaflex
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ,
Ïá¹»ÇÝÇ ýáëý³ï
paracetamol, caffeine,
codeine phosphate
ǵáõåñáý»Ý
ibuprofen
2359
êáÉí»ÝóÇ
Solvencij
êáÙÝáÉ
Somnol
êáݳå³ùë 10Ù·
Sonapax 10mg
½áåÇÏÉáÝ
zopiclone
ÃÇáñǹ³½ÇÝ
thioridazine
2362
êáݳå³ùë 25Ù·
Sonapax 25mg
ÃÇáñǹ³½ÇÝ
thioridazine
2363
êáݳï-ÎØä
Sonnat-KMP
êáñµÇý»ñ
¹áõñáõÉ»ë
½áåÇÏÉáÝ
zopiclone
»ñϳÃÇ ëáõÉý³ï,
³ëÏáñµÇݳÃÃáõ
2360
2361
2364
-
¹»Õ³Ñ³ï»ñ
Galena a.s.
(500Ù·+30Ù·+ 8Ù·) ¶É³ùëáêÙÇÃÎɳÛÝ ¸³Ý·³ñí³Ý
(6,12, 24)
ÈÇÙÇﻹ ¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ
GlaxoSmithKline Dungarvan
Limited for GlaxoSmithKline
Consumer Healthcare
(500Ù·+30Ù·+ 8Ù·) ¶É³ùëá àõ»ÉùáÙ öñá¹³ÏßÁÝ
(6,12, 24)
¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ
GlaxoWellcome Production for
GlaxoSmithKline Consumer
Healthcare
500Ù·+30Ù·+8Ù·
¶É³ùëáêÙÇÃÎɳÛÝ ¸³Ý·³ñí³Ý
(12)
Èï¹, GlaxoSmithKline
Dungarvan Ltd
¹»Õ³å³ïÇ×Ý»ñ
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
300Ù·
(6,12,24,48)
ϳÃÇÉÝ»ñ
ÑáÙ»áå³Ã³ÛÇÝ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹ñ³Å»
(¹»Õ³Ñ³ï»ñ
óճÝóå³ï )
¹ñ³Å»
(¹»Õ³Ñ³ï»ñ
óճÝóå³ï )
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
25ÙÉ ßßÇÏ
7.5Ù·
(10, 20)
10Ù·
(60)
25Ù·
(60)
0.0075·
(10)
320Ù·+60Ù·
(30, 50)
êÙÇÃÎɳÛÝ ´Çã»Ù
ü³ñÙ³ëÛáõÃÇù³Éë, ØÂ
(¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñ, Ø»Í
´ñÇï³Ýdz-Ç Ñ³Ù³ñ)
SmithKline Beecham
Pharmaceuticals, UK (for
GlaxoSmithKline Consumer
Healthcare, Great Britain)
³ÉÇáÝ-²
Talion-A
¶ñÇݹ»ùë ´À
Grindex JSC
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceutical
Works
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat OJSC
¾¶Æê ´´À
EGIS PLC
09.04.2008
Æéɳݹdz
N02B E71
0026/6171
17.05.2006
17.05.2011
²¸
üñ³Ýëdz
N02B E71
0030/6174
17.05.2006
17.05.2011
²¸
Æéɳݹdz
N02B E71
5625
06.07.2005
06.07.2010
²¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
M01A B01
M02A A13
4615
28.07.2004
16.12.2008
²¸
èáõë³ëï³Ý
0966/6988
Ȼѳëï³Ý
N05A C02
5980
14.05.2007
14.05.2012
15.02.2007
15.02.2012
14.02.2006
14.02.2011
²¸
ȳïídz
ÑáÙ»áå³Ã³ÛÇÝ
N05C F01
Ȼѳëï³Ý
N05A C02
5981
14.02.2006
14.02.2011
¸
àõÏñ³Çݳ
N05C F01
4620
¸\Ð
ÐáõÝ·³ñdz
B03A A07
0924/6972
29.03.2004
29.03.2009
26,04.2007
26.04.2012
0729/6782
¸\Ð
¸
¸
162
Sorbifer Durules
2365
2366
2367
êáõµñ»ëïÇÝ
Subrestine
êáõµñ»ëïÇÝ
Subrestine
ferrous sulfate, ascorbic
acid
ùÉáñáåÇñ³ÙÇÝ
chloropyramine
ùÉáñáåÇñ³ÙÇÝ
chloropyramine
êáõÉÇݹ»ùë
Sulindex
ëáõÉÇݹ³Ï
sulindac
¹»Õ³Ñ³ï»ñ
ëáõÉý³¹ÇÙ»ÃûùëÇÝ
sulfadimethoxine
¹»Õ³Ñ³ï»ñ
0.5·
(10)
ëáõÉý³ë³É³½ÇÝ
sulfasalazine
ëáõÉý³ë³É³½ÇÝ
sulfasalazine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
³Õ»ÉáõÛÍ
³ÏݳϳÃÇÉÝ»ñ
2368 êáõÉý³¹ÇÙ»ÃûùëÇ
Ý Sulfadimethoxine
2369
êáõÉý³ë³É³½ÇÝ
Sulfasalazin
2370 êáõÉý³ë³É³½ÇÝ-ºÜ
Sulfasalazine-EN
2371
êáõÉý³óÇÉ
ݳïñÇáõÙ
Sulfacyl-sodium
êáõÉý³óÇÉ-ü³ñÙ³Ï
Sulfacil-Farmak
êáõÉýáϳÙýáϳÛÇݸ³ñÝÇó³
SulfocamphocainDarnitsa
êáõÏñ³Éý³ï
Sucralfat
êáõÏñ³Éý³ï - ÎØä
Sucralfate - KMP
êáõÙ³½Ç¹
Sumazid
êáõٳٻ¹
Sumamed
êáõٳٻ¹
Sumamed
êáõٳٻ¹
Sumamed
êáõٳٻ¹
Sumamed
ëáõÉý³ó»ï³Ùǹ
sulfacetamide
ëáõÉýáϳÙýáñ³ÃÃáõ,
åñáϳÛÇÝ
sulfocamphoric acid,
procaine
ëáõÏñ³Éý³ï
sucralfat
ëáõÏñ³Éý³ï
sucralfate
³½ÇÃñáÙÇóÇÝ
azithromycin
³½ÇÃñáÙÇóÇÝ
azithromycin
³½ÇÃñáÙÇóÇÝ
azithromycin
³½ÇÃñáÙÇóÇÝ
azithromycin
³½ÇÃñáÙÇóÇÝ
azithromycin
2381
êáõٳٻ¹
Sumamed
³½ÇÃñáÙÇóÇÝ
azithromycin
2382
êáõٳٻ¹ ýáñï»
Sumamed forte
³½ÇÃñáÙÇóÇÝ
azithromycin
2383
êáõÙ³ñáÙ
Sumarom
³½ÇÃñáÙÇóÇÝ
azithromycin
2372
2373
2374
2375
2376
2377
2378
2379
2380
ëáõÉý³ó»ï³Ùǹ
sulfacetamide
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
³ÏݳϳÃÇÉÝ»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
25Ù·
(10,20,30,40,50)
20Ù·/ÙÉ (1ÙÉ),
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
200Ù·
(20)
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
´ñÇÝó³Éáí - ² ö´À Brinsalov A CJSC
èáõë³ëï³Ý
500Ù·
(50/5x10/)
500Ù·
(50)
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
30%,
5ÙÉ ³å³Ï» ßßÇÏ
30%,
5ÙÉ,10ÙÉ ßßÇÏ
10%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
500Ù·
(100)
¹»Õ³Ñ³ï»ñ
0,5·
(10,50)
¹»Õ³å³ïÇ×Ý»ñ
0.25·
(6,10,12,20)
¹»Õ³Ñ³ï»ñ
500Ù·
óճÝóå³ï
(3)
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(6)
¹»Õ³Ñ³ï»ñ
125Ù·
óճÝóå³ï
(6)
¹»Õ³÷áßÇ ËÙ»Éáõ
100Ù·/5ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
(400Ù· ¹»Õ³÷áßÇ
20ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ)
¹»Õ³÷áßÇ
500Ù·,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (5)
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ ËÙ»Éáõ
200Ù·/5ÙÉ,
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ 15ÙÉ,
30ÙÉ, 37.5ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
250Ù· (6)
4756
èáõë³ëï³Ý
D04A A09,
R06A C03
R06A C03
18.03.2004
18.03.2009
25.01.2006
25.01.2011
²¸
êÇñdz
M01A B02
3985
05.05.2003
05.05.2008
¸
èáõë³ëï³Ý
(ÎáõñëÏ)
J01E D01
0142/6239
29.06.2006
29.06.2011
¸
êÉáí»Ýdz
A07E C01
0564/6530
¸
êÉáí»Ýdz
A07E C01
0138/6117
24.11.2006
24.11.2011
29.06.2006
29.06.2011
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàõÒ
Belmedpreparaty RUP
´»É³éáõë
S01A B04
1021/7010
13.06.2007
13.06.2012
¸
ü³ñÙ³Ï ´´À
Farmak JSC
§¸³ñÝÇó³¦ ¹»Õ³·áñÍ³Ï³Ý ýÇñÙ³
´À
Pharmaceutical Firm
§Darnitsa¦ JSC
Ø»¹Çϳ ²¸
Medica AD
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
§´ñÇÝó³Éáí-²¦ ö´À
§Brinsalov-A¦ CJSC
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
äÉÇí³ ¹.¹.
Pliva d.d.
äÉÇí³ ¹.¹.
Pliva d.d.
àõÏñ³Çݳ
S01A B04
5696
²¸
àõÏñ³Çݳ
C01E
6084
19.08.2005
19.08.2010
27.03.2006
27.03.2011
´áõÉÕ³ñdz
A02B X02
4111
²¸
àõÏñ³Çݳ
A02B X02
4029
èáõë³ëï³Ý
J01F A10
4761
Êáñí³Ãdz
J01F A10
0629/6485
Êáñí³Ãdz
J01F A10
0764/6439
Êáñí³Ãdz
J01F A10
5321
Êáñí³Ãdz
J01F A10
5320
13.02.2003
13.02.2008
12.02.2003
12.02.2008
29.03.2004
29.03.2009
27.12.2006
27.12.2011
28.02.2007
28.02.2012
21.03.2005
21.03.2010
25.03.2005
25.03.2010
äÉÇí³ Ðñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
Êáñí³Ãdz
J01FA10
0769/5993/1
28.02.2007
20.03.2011
¸
äÉÇí³ Ðáñí³ïëϳ ¹.û.û.
Pliva Hrvatska d.o.o.
Êáñí³Ãdz
J01F A10
0103/6127
09.06.2006
09.06.2011
¸
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
èáõÙÇÝdz
J01F A10
1451/7375
20.12.2007
20.12.2012
¸
5942
¸
¸
¸
²¸
¸
¸
¸
¸
¸
163
2384
êáõåɳ½ÇÝ
Suplasyn
ÑdzÉáõñáݳï
ݳïñÇáõÙÇ
hyaluronate sodium
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
20Ù·/2ÙÉ
(ݳ˳Éóí³Í
Ý»ñ³ñÏÇã 1)
2385
êáõåñ³ëïÇÝ
Suprastin
êáõåñ³ëïÇÝ
Suprastin
ùÉáñáåÇñ³ÙÇÝ
chloropyramine
ùÉáñáåÇñ³ÙÇÝ
chloropyramine
¹»Õ³Ñ³ï»ñ
25Ù·
(20)
20Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
100ÙÉ ßßÇÏ
2386
2387 êáõåñÇÙ³-µñáÝËá
Suprima-Broncho
2388
êáõåñÇÙ³-Éáñ
Suprima-Lor
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
Æéɳݹdz
M09A X01
5206
10.01.2005
10.01.2010
¸
ÐáõÝ·³ñdz
R06A C03
6073
²¸
ÐáõÝ·³ñdz
R06A C03
6107
23.03.2006
23.03.2011
13.04.2006
13.04.2011
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï.Èï¹.
Shreya Life Sciences Pvt.Ltd.
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï.Èï¹.
Shreya Life Sciences Pvt.Ltd.
Ðݹϳëï³Ý
-
5645
²¸
Ðݹϳëï³Ý
-
5647
06.03.2006
06.03.2011
06.03.2006
06.03.2011
¸
êáõëï³Ï ýáñï»
Sustac forte
êáõñ·³ÙÇÝ 100
Surgamine 100
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
³ÙÇÉ Ù»ï³Ïñ»½áÉ,
2,4-¹ÇùÉáñᵻݽÇÉ
ëåÇñï amyl
metacresol,
2,4-dichlorobenzyl
alcohol
ù³÷áõñ, Ù»ÝÃáÉ,
ÝÇí»Ýáõ ÛáõÕ,
ÃÇÙáÉ, µ¨»ÏݳÛáõÕ
camphor, menthol,
eucalyptus oil, thymol,
terpentine oil
ÝÇïñá·ÉÇó»ñÇÝ
nitroglycerin
Ãdzåñáý»Ý³ÃÃáõ
tiaprofenic acid
2392
êáõñ·³ÙÇÝ 300
Surgamine 300
Ãdzåñáý»Ý³ÃÃáõ
tiaprofenic acid
¹»Õ³Ñ³ï»ñ
300Ù·
(30)
2393
êáý³Ù»ï
Sophamet
êáý³Ù»ï
Sophamet
êå³½·³Ý
Spasgan
Ù»ïýáñÙÇÝ
metformin
Ù»ïýáñÙÇÝ
metformin
Ù»ï³ÙǽáÉ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole, pitofenone
hydrochloride,
fenpiverine bromide
Ù»ï³ÙǽáÉ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole, pitofenone
hydrochloride,
fenpiverine bromide
Ù»ï³ÙǽáÉ
ݳïñÇáõÙÇ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole sodium,
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
850Ù·
(30)
500Ù·
(50)
(500Ù·+2Ù·+
0.02Ù·)/ÙÉ
5ÙÉ ³ÙåáõÉÝ»ñ
(5, 25)
¹»Õ³Ñ³ï»ñ
0.5·+5Ù·+0.1Ù·
(10x10)
ìáÏ˳ñ¹ Èï¹
Wockhardt Ltd.
Ðݹϳëï³Ý
N02B B72
4509
03.10.2003
03.10.2008
²¸
¹»Õ³Ñ³ï»ñ
(500Ù·+5Ù·+0,1Ù·)
(20/2x10/)
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´áõÉÕ³ñdz
A03D C
0985/6993/1
22.05.2007
14.05.2012
²¸
2389 êáõåñÇÙ³-åÉÛáõë
Suprima-Plus
2390
2391
2394
2395
2396
êå³½·³Ý
Spasgan
2397
ê峽ٳɷáÝ
Spasmalgon
ûß³ñ³Ï
´ÇáÝÇß Â»áñ³Ý (´ÇáÝÇß
ü³ñÙ³ ¶ñáõåÇ Ù³ëݳ×ÛáõÕ)
Bioniche Teoran (division of
Bioniche Pharma Group)
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
Éá½³ÝÝ»ñ
0.6Ù·+1.2Ù·
(16)
²¸
ùëáõù
(7·+6·+3·+
1.5·+2·)/
100·,
20· åɳëïÇÏ ï³ñ³
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï.Èï¹.
Shreya Life Sciences Pvt.Ltd.
Ðݹϳëï³Ý
-
5646
06.03.2006
06.03.2011
²¸
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
6.4Ù·
(25)
100Ù·
(30)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
êáý³ñÙ³ ´À
Sopharma JSC
êáý³ñÙ³ ´À
Sopharma JSC
ìáÏ˳ñ¹ Èï¹
Wockhardt Ltd.
êÉáí»Ýdz
C01D A02
0563/6531
¸
êÇñdz
M01A E11
5507
24.11.2006
24.11.2011
23.08.2005
23.08.2010
êÇñdz
M01A E11
5508
07.03.2006
07.03.2011
¸
´áõÉÕ³ñdz
A01B A02
1311/7280
¸
´áõÉÕ³ñdz
A01B A02
1312/7279
Ðݹϳëï³Ý
N02B B72
4626
16.10.2007
12.10.2012
16.10.2007
12.10.2012
16.01.2004
16.01.2009
¸
¸
¸
164
2398
ê峽ٳɷáÝ
Spasmalgon
2399
ê峽ٳɷáÝ
Spasmalgon
2400
êå³½ÙÇÉ-Ø
Spasmil-M
2401
êå³½ÙáÉ
Spasmol
2402
êå³½Ùáí»ñ³É·ÇÝ
Ý»á
Spasmoveralgin
Neo
pitofenon
hydrochloride,
fenpiverin bromide
Ù»ï³ÙǽáÉ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole, pitofenone
hydrochloride,
fenpiverine bromide
Ù»ï³ÙǽáÉ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole, pitofenone
hydrochloride,
fenpiverine bromide
Ù»ï³ÙǽáÉ,
åÇïáý»ÝáÝÇ
ÑǹñáùÉáñǹ,
ý»ÝåÇí»ñÇÝÇ µñáÙǹ
metamizole, pitofenone
hydrochloride,
fenpiverine bromide
¹ñáï³í»ñÇÝ
drotaverin
åñáåÇý»Ý³½áÝ,
ý»Ýáµ³ñµÇï³É,
å³å³í»ñÇÝÇ
ÑǹñáùÉáñǹ,
Ïá¹»ÇÝÇ
¹ÇÑǹñá·»Ýýáëý³ï,
¿ý»¹ñÇÝ, ³ïñáåÇÝ
propifenazon,
phenobarbital,
papaverini
hydrochloride, codeine
dihydrogenphosphoricu
m, ephedrine, atropine
2403
êåÇñá½ÇÝ
ó»ýáï³ùëÇÙÇ
Spirosine
ݳïñÇáõÙ³Ï³Ý ³Õ
cefotaxime sodium
2404 êåÇñï µÅßÏ³Ï³Ý 70%
¿Ã³ÝáÉ
Alcohol Medical
ethanol
70%
2405 êåÇñï µÅßÏ³Ï³Ý 70%
Alcohol Medical
70%
¿Ã³ÝáÉ
ethanol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
(2.5·+10Ù·+
0.1Ù·)/
5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(10)
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
N02B B52
0031/5755
19.05.2006
19.05.2011
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
(1·+4Ù·+0,04Ù·)/
2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
N02B B52
0201/5754
21.07.2006
21.07.2011
¸
¹»Õ³Ñ³ï»ñ
500Ù·+5.25Ù·+
0.1Ù·
(10,20,50x20)
ØÇÉí» ü³ñÙ³ëÛáõÃÇù³É
·áñͳñ³ÝÝ»ñ
Milve Pharmaceutical Plants
´áõÉÕ³ñdz
N02B B52
5722
11.11.2005
11.11.2010
²¸
¹»Õ³Ñ³ï»ñ
0.04·
(20, 100)
èáõë³ëï³Ý
-
0574/4391/1
24.11.2006
14.08.2008
²¸
¹»Õ³Ñ³ï»ñ
(0.15·+0.02·+
0.03·+
0.01534·+0.005·+
0.0005·)
(10)
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïdz
N02A,
N03A
4254
19.06.2003
19.06.2008
¸
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
1·
ëñí³Ï (6)
ü³ñ³Ý ȳµáñ³ïáñdz ê.². Faran
Laboratories S.A.
Ðáõݳëï³Ý
J01D A10
4699
23.03.2004
23.03.2009
¸
ÉáõÍáõÛÃ
70%,
25ÙÉ, 30ÙÉ,
50ÙÉ, 100ÙÉ,
250ÙÉ, 750ÙÉ
ßßÇÏ ¨ 1000ÙÉ
ßÇß
ÑÇí³Ý¹³Ýáó³ÛÇÝ
70%,
50ÙÉ, 100ÙÉ,
250ÙÉ ßßÇÏ,
(÷³Ã»Ã³íá-ñáõÙÁ
1000ÙÉ
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
ÙdzíáñáõÙ êäÀ
Arsemi Agroindustrial Union
Ltd
г۳ëï³Ý
D08A X08
0516/6543
07.11.2006
07.11.2011
²¸
ÈǽÇÝ ´´À
Lizin Open JSC
г۳ëï³Ý
V03A B16,
V03A Z01
5772
16.09.2005
16.09.2010
²¸
ÉáõÍáõÛÃ
165
ÑÇí³Ý¹³Ýáó³ÛÇÝ)
90%,
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
25ÙÉ, 30ÙÉ,
ÙdzíáñáõÙ êäÀ
50ÙÉ, 100ÙÉ,
Arsemi Agroindustrial Union
250ÙÉ, 750ÙÉ
Ltd
ßßÇÏ ¨ 1000ÙÉ
ßÇß
ÑÇí³Ý¹³Ýáó³ÛÇÝ
2407 êåÇñï µÅßÏ³Ï³Ý 96%
¿Ã³ÝáÉ
ÉáõÍáõÛÃ
96%,
г·»Ý³ë êäÀ
Alcohol Medical
ethanol
50ÙÉ, 100ÙÉ,
Hagenas Ltd
96%
250ÙÉ, 1000ÙÉ
ßßÇÏ
2408 êåÇñï µÅßÏ³Ï³Ý 96%
¿Ã³ÝáÉ
ÉáõÍáõÛÃ
96%,
ÈǽÇÝ ´´À
Alcohol Medical
ethanol
50ÙÉ,100ÙÉ,
Lizin Open JSC
96%
250ÙÉ ßßÇÏ,
(÷³Ã»Ã³íá-ñáõÙÁ
1000ÙÉ
ÑÇí³Ý¹³Ýáó³ÛÇÝ)
2409 êåÇñï µÅßÏ³Ï³Ý 96%
¾Ã³ÝáÉ
ÉáõÍáõÛÃ
96%
²ñë»ÙÇ ³·ñá³ñ¹Ûáõݳµ»ñ³-ϳÝ
Alcohol Medical
ethanol
(25ÙÉ, 30ÙÉ,
ÙdzíáñáõÙ êäÀ
96%
50ÙÉ, 100ÙÉ,
Arsemi Agroindustrial Union
250ÙÉ, 750ÙÉ
Ltd
åɳëïÇÏ Ï³Ù ³å³Ï»
ßßÇÏ ¨ 1000ÙÉ
ÑÇí³Ý¹³Ýáó³ÛÇÝ
÷³Ã»Ã³íáñáõÙ)
2410
êåñ»·³É
¿ë¹»å³É»ÃñÇÝ
ÉáõÍáõÛÃ
(0.663·+5.305·)/
ȳµáñ³ïáñdz ü³ñÙÇÅÇ»Ý êβî
Spregal
(¿ëµÇáÉ),
(óáÕ³óÇñ) ³ñï³ùÇÝ
100·,
Laboratoires Pharmygiene
÷Çå»ñáÝÇɵáõïûùëǹ
ÏÇñ³éÙ³Ý
152·/145ÙÉ
SCAT
esdepallethrine (esbiol),
óáÕ³óÇñ ï³ñ³ÛáõÙ
piperonyl butoxide
2411
êåñ»Û ÷³ùë
÷Çñ»ïñáõÙÇ Ñ³ÝáõÏ
óáÕ³óÇñ ³ñï³ùÇÝ (3.63·+7.27·)/ 100·, ȳµáñ³ïáñdz ü³ñÙÇÅÇ»Ý êβî
Spray Pax
25%,
ÏÇñ³éÙ³Ý
8· óáÕ³óÇñ
Laboratoires Pharmygiene
÷Çå»ñáÝÇɵáõïûùëǹ
ï³ñ³ÛáõÙ
SCAT
25% pirethrum extract,
piperonylbutoxide
2412
êí»ÉïýáñÙ+
å³ïÇ×Ý»ñ
405Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
Sveltform
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
2413
êﳵǽáÉ
ÑǹñûùëÇ¿ÃÇÉ ûëɳ
ÉáõÍáõÛÃ
6%,
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
Stabisol
(HES 450/0,7)
ϳÃÇɳݻñ³ñÏ-Ù³Ý
500ÙÉ ëñí³Ï
¶ñáõå)
hydroxyethyl starch
Berlin-Chemie AG (Menarini
(HES 450/0,7)
Group)
2414
êïáÙ³Éûùë
³ÉÛáõÙÇÝÇáõÙÇ,
¹»Õ³Ñ³ï»ñ
400Ù·+400Ù·
²ðöÆغ¸ ÐÒ ö´À ARPIMED
Stomalox
Ù³·Ý»½ÇáõÙÇ
(6,10,24,30,48)
J.V. CJ-S Co.
Ñǹñûùëǹݻñ
aluminium and
magnesium hydroxides
2415
êïáÙ³Éûùë
³ÉÛáõÙÇÝÇáõÙÇ,
¹»Õ³Ï³ËáõÛÃ
(525Ù·+600Ù·)/ ²ðöÆغ¸ ÐÒ ö´À
ARPIMED
Stomalox
Ù³·Ý»½ÇáõÙÇ
ËÙ»Éáõ
15ÙÉ,
J.V. CJ-S Co.
Ñǹñûùëǹݻñ
120ÙÉ, 250ÙÉ
aluminium and
ßßÇÏ
magnesium hydroxydes
2416
êïáå³ñïñá½
·ÉÛáõÏá½³ÙÇÝ
¹»Õ³÷áßÇ Ý»ñùÇÝ
1500Ù·,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
2406 êåÇñï µÅßÏ³Ï³Ý 90%
Alcohol Medical
90%
¿Ã³ÝáÉ
ethanol
ÉáõÍáõÛÃ
г۳ëï³Ý
D08A X08
0515/6544
07.11.2006
07.11.2011
²¸
г۳ëï³Ý
V03A Z01
1288/7256
12.10.2007
12.10.2012
²¸
г۳ëï³Ý
V03A B16,
V03A Z01
5771
16.09.2005
16.09.2010
²¸
г۳ëï³Ý
V03A B16,
V03A Z01
0164/6161/1
07.07.2006
25.05.2011
²¸
üñ³Ýëdz
-
0135/6140
29.06.2006
29.06.2011
²¸
üñ³Ýëdz
-
0134/6187
29.06.2006
29.06.2011
²¸
Æéɳݹdz
βêÐ
5821
26.10.2005
26.10.2010
²¸
¶»ñÙ³Ýdz
-
0425/6412
26.09.2006
26.09.2011
¸
г۳ëï³Ý
A02A
5149
12.11.2004
12.11.2009
²¸
г۳ëï³Ý
A02A
5148
30.12.2004
30.12.2009
²¸
èáõÙÇÝdz
M01A X05
0669/6520
17.01.2007
²¸
166
Stopartroz
2417
êïáå³ñïñá½ ýáñï»
Stopartroz forte
2418
êïáåïáõëÇÝ
Stoptussin
2419
êïáåïáõëÇÝ ýÇïá
Stoptussin Fito
2420
êïáõ·»ñáÝ
Stugeron
êïñ»åëÇÉë
Strepsils
2421
2422
êïñ»åëÇÉë C
íÇï³ÙÇÝáí
Strepsils with
vitamin C
2423
êïñ»åëÇÉë ³é³Ýó
ß³ù³ñÇ
Strepsils sugar free
2424 êïñ»åëÇÉë Ù»ÕñÇ
¨ ÏÇïñáÝÇ
Strepsils Honey and
Lemon
2425
êïñ»åëÇÉë
Ù»ÝÃáÉÇ ¨
ÝÇí»Ýáõ
Strepsils Menthol
and Eucalyptus
2426 êïñ»åëÇÉë åÉÛáõë
Strepsils Plus
2427 êïñ»åëÇÉë åÉÛáõë
Strepsils Plus
glucosamine
ÁݹáõÝÙ³Ý
÷³Ã»ÃÝ»ñ
Rompharm Company SRL
ÉáõÍáõÛÃÝÇ
(5, 10, 20)
·ÉÛáõÏá½³ÙÇÝÇ
¹»Õ³÷áßÇ Ý»ñùÇÝ (850Ù·+250Ù·), êɳídz ü³ñÙ êèÈ Slavia Pharm
ëáõÉý³ï, ùáݹñáÇïÇÝÇ
ÁݹáõÝÙ³Ý
(10,20)
SRL
ëáõÉý³ï
ÉáõÍáõÛÃÇ
glucosamine sulfate,
chondroitin sulfate
µáõï³ÙÇñ³ï,
ϳÃÇÉÝ»ñ
(4Ù·+100Ù·)/1ÙÉ,
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
·áõ³Ûý»Ý»½ÇÝ
10ÙÉ ßßÇÏ
ë.é.û.
butamirate, guaifenesin
IVAX Pharmaceuticals s.r.o.
ëáíáñ³Ï³Ý áõñóÇ,
ûß³ñ³Ï
(4.1666·+ 4.1666·+
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
·»ïݳï³ñ³Í áõñóÇ,
4.1666·),
ë.é.û.
çÕ³ËáïÇ Ñ»ÕáõÏ
100ÙÉ ßßÇÏ
IVAX Pharmaceuticals s.r.o.
ѳÝáõÏÝ»ñ
Thymi, Serpylli,
Plantaginis fluid
extracts
óÇݳñǽÇÝ
¹»Õ³Ñ³ï»ñ
25Ù·
¶»¹»áÝ èÇËï»ñ Èï¹.
cinnarizine
(50)
Gedeon Richter Ltd.
³ÙÇÉÙ»ï³Ïñ»½áÉ,
Éá½³ÝÝ»ñ
(0.6Ù·+1.2Ù·)
´áõïë лÉÃù»ñ
2,4-¹ÇùÉáñᵻݽÇÉ
(24)
ÆÝï»ñÝ»ÛßÁÝÉ
ëåÇñï
Boots Healthcare International
amylmetacresol,
2,4-dichlorobenzyl
alcohol
³ÙÇÉÙ»ï³Ïñ»½áÉ,
Éá½³ÝÝ»ñ
(0.6Ù·+1.2Ù·+
´áõïë лÉÃù»ñ
2,4-¹ÇùÉáñᵻݽÇÉ
100Ù·) (24)
ÆÝï»ñÝ»ÛßÁÝÉ
ëåÇñï, ³ëÏáñµÇݳÃÃáõ
Boots Healthcare International
amylmetacresol,
2,4-dichlorobenzyl
alcohol, ascorbic acid
³ÙÇÉÙ»ï³Ïñ»½áÉ,
Éá½³ÝÝ»ñ
(0.6Ù·+1.2Ù·)
´áõïë лÉÃù»ñ
2,4-¹ÇùÉáñᵻݽÇÉ
(16,24)
ÆÝï»ñÝ»ÛßÁÝÉ
ëåÇñï
Boots Healthcare International
amylmetacresol,
2,4-dichlorobenzyl
alcohol
³ÙÇÉÙ»ï³Ïñ»½áÉ,
Éá½³ÝÝ»ñ
(0.6Ù·+1.2Ù·)
´áõïë лÉÃù»ñ
2,4-¹ÇùÉáñᵻݽÇÉ
(8,24)
ÆÝï»ñÝ»ÛßÁÝÉ
ëåÇñï
Boots Healthcare International
amylmetacresol,
2,4-dichlorobenzyl
alcohol
³ÙÇÉÙ»ï³Ïñ»½áÉ,
Éá½³ÝÝ»ñ
(0.6Ù·+1.2Ù·+8Ù·)
´áõïë лÉÃù»ñ
2,4-¹ÇùÉáñᵻݽÇÉ
(24)
ÆÝï»ñÝ»ÛßÁÝÉ
ëåÇñï, ɨáÙ»ÝÃáÉ
Boots Healthcare International
amylmetacresol,
2,4-dichlorobenzyl
alcohol, levomenthol
³ÙÇÉÙ»ï³Ïñ»½áÉ,
Éá½³ÝÝ»ñ
(0.6Ù·+1.2Ù·+
´áõïë лÉÃù»ñ
2,4-¹ÇùÉáñᵻݽÇÉ
10Ù·)
ÆÝï»ñÝ»ÛßÁÝÉ
ëåÇñï, ÉǹáϳÛÇÝ
(12,16)
Boots Healthcare International
amylmetacresol,
³ÙÇÉÙ»ï³Ïñ»½áÉ,
óáÕ³ßÇÃ
(0.29Ù·+0.58Ù·+
´áõïë лÉÃù»ñ
2,4-¹ÇùÉáñᵻݽÇÉ
0.78Ù·)/¹»Õ³ã³÷,
ÆÝï»ñÝ»ÛßÁÝÉ
17.01.2012
èáõÙÇÝdz
M01A X05
0670/6636
17.01.2007
17.01.2012
²¸
â»Ëdz
R05FB02
5463
10.05.2005
10.05.2010
²¸
â»Ëdz
µáõë³Ï³Ý
5464
10.05.2005
10.05.2010
²¸
ÐáõÝ·³ñdz
N07C A02
5421
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
-
5513
01.06.2005
01.06.2010
15.07.2005
15.07.2010
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
-
5514
15.07.2005
15.07.2010
²¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
-
5516
15.07.2005
15.07.2010
²¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
-
5515
15.07.2005
15.07.2010
²¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
-
5517
15.07.2005
15.07.2010
²¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
N01B B52
5518
15.07.2005
15.07.2010
²¸
ØdzóÛ³É
³·³íáñáõ-
N01B B52
5519
15.07.2005
15.07.2010
²¸
²¸
167
2428
êïñ»åïáÏÇݳ½
Streptokinase
ëåÇñï, ÉǹáϳÛÇÝ
amylmetacresol,
2,4-dichlorobenzyl
alcohol, lidocaine
ëïñ»åïáÏÇݳ½
streptokinase
2429
êïñ»åïáÏÇݳ½
Streptokinase
ëïñ»åïáÏÇݳ½
streptokinase
2430
êïñ»åïáÙÇóÇÝ
Streptomycin
2431 êïñ»åïáÙÇóÇÝ-ÎØä
Streptomycin-KMP
ëïñ»åïáÙÇóÇÝÇ
ëáõÉý³ï
streptomycin sulphate
ëïñ»åïáÙÇóÇÝ
streptomycin
2432 êïñ»åïáÙÇóÇÝ-ÎØä
Streptomycin-KMP
ëïñ»åïáÙÇóÇÝ
streptomycin
2433
êïñ»ë³Ù
Stresam
2434
êïñÇùë
Strix
êïñáõÏïáõÙ
Structum
2435
¿ïÇýûùëÇÝÇ
ÑǹñáùÉáñǹ
etifoxine hydrochloride
-
20ÙÉ/70¹»Õ³ã³÷/
ßßÇÏáõÙ
Boots Healthcare International
ÃÛáõÝ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
1500000 ØØ,
ëñí³Ï (1)
´»ÉÙ»¹åñ»å³ñ³ïÇ ´´À
Belmedpreparaty Open JSC
´»É³éáõë
B01A D01
4976
21.07.2004
21.07.2009
¸
750000ØØ,
ëñí³Ï (1)
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàõÒ
Belmedpreparaty RUP
´»É³éáõë
B01A D01
6081
21.03.2006
21.03.2011
¸
1·,
ëñí³Ï (1, 50)
²ÝïǵÇáïÇÏ ê.².
Antibiotice
S.A.
èáõÙÇÝdz
J01G A01
4354
16.07.2003
16.07.2008
¸
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
1·,
ëñí³Ï (10,40)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
àõÏñ³Çݳ
J01G A01
0402/6423
19.09.2006
19.09.2011
¸
0.5·
ëñí³Ï (10, 40)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat JSC
àõÏñ³Çݳ
J01G A01
0592/6491
05.12.2006
05.12.2011
¸
50Ù·
(60)
´ÇáÏá¹»ùë
Biocodex
üñ³Ýëdz
N05BX03
1258/7226
12.11.2007
12.10.2012
¸
454Ù·
(30)
500Ù·
(60)
ü»ñáë³Ý ²/ê
Ferrosan A/S
äÇ»é ü³µñ» Ø»¹ÇϳٻÝï
öñá¹³ÏëÇáÝ
Pierre Fabre Medicament
Production
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
¸³Ýdz
βêÐ
5136
²¸
üñ³Ýëdz
M09A X02
4927
24.01.2005
24.01.2010
18.03.2005
18.03.2010
àõÏñ³Çݳ
C01A C01
1121/7022
01.10.2007
01.10.2012
¸
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
àõÏñ³Çݳ
C01A C
5312
10.11.2005
10.11.2010
¸
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
êäÀ-Ç Ù³ëݳ×ÛáõÕ ù.ʳñÏáí
Branch of LCC §Experimental
plant GNCLS¦ c.Kharkov
äáÉý³ 䳵dzÝÇó» ê.².
Polfa Pabianice S.A.
´³Û»ñ лÉÃù»ñ ²¶, Þí³ñó ü³ñÙ³
²¶, ¶»ñÙ³Ýdz-Ç Ñ³Ù³ñ
Bayer Healthcare AG for
Schwarz Pharma AG, Germany
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹.,Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
ÞÇ»½Ç ê.².
Chiesi S.A.
àõÏñ³Çݳ
-
5877
12.01.2006
12.01.2011
¸
Ȼѳëï³Ý
5525
1339/7341
19.04.2005
19.04.2010
05.11.2007
05.11.2012
¸
¶»ñÙ³Ýdz
D08A E02
G01A X03
C01EA01
êÉáí»Ýdz
C10A A01
1006/6935
¸
êÉáí»Ýdz
C10A A01
6063
êÉáí»Ýdz
C01A A01
1005/6936
üñ³Ýëdz
N04B,
N06B
4321
04.06.2007
04.06.2012
05.04.2006
05.04.2011
04.06.2007
04.06.2012
28.07.2003
28.07.2008
ѳµ»ñ
2436
êïñáý³ÝÃÇÝ Î
Strophanthin K
ݳïñÇáõٳϳÝ
ùáݹñáÇïÇÝÇ ëáõÉý³ï
sodium chondroitine
sulfate
ëïñáý³ÝÃÇÝ
strophanthin
2437
êïñáý³ÝÃÇÝ Î
Strophanthin K
ëïñáý³ÝÃÇÝ Î
strophanthinum K
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2438
êïñáý³ÝïÇÝ-¶
Strophantin-G
áõ³µ³ÛÇÝ
ouabain
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2439
ì³·áÃÇÉ
Vagothyl
ì³½³åñáëï³Ý
Vasaprostan
åáÉÇÏñ»½áõÉ»Ý
policresulen
³Éåñáëï³¹ÇÉ
alprostadil
ÉáõÍáõÛÃ
2440
2441
2442
2443
2444
ì³½ÇÉÇå
Vasilip
ì³½ÇÉÇå
Vasilip
ì³½ÇÉÇå
Vasilip
ì³½áµñ³É
Vasobral
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ÉÇáýÇÉǽ³ï
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃ
å³ïñ³ëï»Éáõ
ëÇÙí³ëï³ïÇÝ
¹»Õ³Ñ³ï»ñ
simvastatine
óճÝóå³ï
ëÇÙí³ëï³ïÇÝ
¹»Õ³Ñ³ï»ñ
simvastatin
óճÝóå³ï
ëÇÙí³ëï³ïÇÝ
¹»Õ³Ñ³ï»ñ
simvastatine
óճÝóå³ï
¹ÇÑǹñá¿ñ·áÏñÇåïÇÝ, ÉáõÍáõÛà ËÙ»Éáõ
Ïáý»ÇÝ
0,25Ù·/ÙÉ
(0,025%), 1ÙÉ
³ÙåáõÉÝ»ñ (10)
0.025%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
0.025%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
36%,
50· ßßÇÏ
20ÙÏ·,
³ÙåáõÉÝ»ñ (10)
10Ù·
(28/4x7/)
40Ù·
(14,28)
20Ù·
(28/4x7/)
(50Ù·+500Ù·)/
50ÙÉ,
¸
¸
¸
¸
¸
168
2445
2446
2447
2448
2449
2450
2451
ì³½áϳñ¹ÇÝ
Vasocardin
ì³½áåñ»Ý
Vasopren
ì³½áåñ»Ý
Vasopren
ì³½áåñ»Ý
Vasopren
ì³½áåñÇÉ 10Ù·
Vasopril 10 mg
ì³½áåñÇÉ 5Ù·
Vasopril 5 mg
ì³É¹Çëå»ñï
Valdispert
2452
ì³ÉǹáÉ
Validol
2453
ì³ÉǹáÉü³ñÙëï³Ý¹³ñï
ValidolPharmstandard
2454
ì³ÉÇáõÙ
Valium
2455
ì³ÉÇáõÙ
Valium
ì³ÉáÏáñ¹ÇÝ
Valocordin
2456
2457
ì³ÉóÇï
Valcyt
2458
ì³Ù»É³Ý
Vamelan
2459
ì³Ý·³íÇï
Vangavit
dihydroergocryptine,
caffeine
Ù»ïáåñáÉáÉ
metoprolol
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
¿Ý³É³åñÇÉÇ Ù³É»³ï
enalapril maleate
ϳïí³ËáïÇ Ñ³ÝáõÏ
valerian extract
Ù»ÝÃáÉ,
ǽáí³É»ñdzݳÃÃíÇ
Ù»ÃÇÉ ¿ëûñ
menthol, methyl ether
isovaleric acid
Ù»ÝÃáÉ,
ǽáí³É»ñdzݳÃÃíÇ
Ù»ÃÇÉ ¿ëûñ
menthol, methyl ether
isovaleric acid
¹Ç³½»å³Ù
diazepam
¹Ç³½»å³Ù
diazepam
ý»Ýáµ³ñµÇï³É,
¿ÃÇɵñáÙǽáí³É»ñ³ÃÃáõ, åÕå»Õ³ÛÇÝ
³Ý³ÝáõËÇ ÛáõÕ,
·³ÛÉáõÏÇ ÛáõÕ
phenobarbital,
ethylbromisovaleriat,
oleum Menthae
piperitae, oleum Humuli
í³É·³ÝóÇÏÉáíÇñ
valganciclovir
50ÙÉ ßßÇÏ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(ß³ù³ñáí)
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
(50)
10Ù·
(28)
5Ù·
(28)
20Ù·
(28)
10Ù·
(10x20)
5Ù·
(10x20)
125Ù·
(25,50,100)
100Ù·(0.1·)
(20)
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êáý³ñÙ³ ´À
Sopharma JSC
êáý³ñÙ³ ´À
Sopharma JSC
êáý³ñÙ³ ´À
Sopharma JSC
êÇåɳ Èï¹
Cipla Ltd
êÇåɳ Èï¹
Cipla Ltd
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶ÙµÐ
Solvay Pharmaceuticals GmbH
ØÇÝëÏÇÝï»ñϳåë
Minskintercaps
êÉáí³Ïdz
C07A B02
4249
19.06.2003
19.06.2008
20.07.2005
20.07.2010
20.07.2005
20.07.2010
20.07.2005
20.07.2010
13.03.2003
13.03.2008
13.03.2003
13.03.2008
09.10.2003
30.07.2008
¸
´áõÉÕ³ñdz
C09A A02
5437
´áõÉÕ³ñdz
D09A A02
5438
´áõÉÕ³ñdz
C09A A02
5436
Ðݹϳëï³Ý
C09A A02
4062
Ðݹϳëï³Ý
C09A A02
4061
¶»ñÙ³Ýdz
N05C M09
4302
´»É³éáõë
C01E X
1083/6739
21.08.2007
21.08.2012
²¸
¸
¸
¸
¸
¸
²¸
¹»Õ³Ñ³ï»ñ
»Ýóɻ½í³ÛÇÝ
0.06·
(6,10)
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
èáõë³ëï³Ý
(ÎáõñëÏ)
-
0146/6235
29.06.2006
29.06.2011
²¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
10Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
5Ù·
(25)
(2·+2·+0.14·+0.02·
)/100·,
20ÙÉ, 50ÙÉ ßßÇÏ
èáß
Roche
üñ³Ýëdz
N05B A01
4189
16.04.2003
16.04.2008
¸\Ð
ÐáýÙ³Ý-ȳ èáß Èï¹.
Hoffmann-La Roche Ltd.
Îñ»í»É Øύɵ³Ë ¶ÙµÐ
Krewel Meuselbach GmbH
Þí»Ûó³ñdz
N05B A01
4188
¸\Ð
¶»ñÙ³Ýdz
N05A A02
1186/7185
16.04.2003
16.04.2008
24.09.2007
13.09.2012
γݳ¹³
J05AB14
5313
31.01.2005
31.01.2010
¸
Ȼѳëï³Ý
N05CM
0734/6764
15.02.2007
15.02.2012
²¸
´áõÉÕ³ñdz
βêÐ
4214
01.04.2003
01.04.2008
²¸
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
450Ù·
(60)
ä³Ã»áÝ ÆÝÏ., γݳ¹³ (ü.ÐáýÙ³Ýȳ èáß Èï¹. Þí»Ûó³ñdzÛÇ
³ñïáݳ·ñáí) Patheon Inc.,
Canada (under license of
F.Hoffmann-La Roche Ltd.,
Switzerland)
ϳïí³ËáïÇ, åÕå»Õ³ÛÇÝ
¹»Õ³å³ïÇ×Ý»ñ
125Ù·+25Ù·+ 25Ù·
öÇ-öÇ-¾ý гëÏá-È»Ï ê.².
³Ý³ÝáõËÇ, å³ïñÇÝçÇ ÷³÷áõÏ, ŻɳïÇÝ»
(30/2x15/)
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
ãáñ ѳÝáõÏÝ»ñ
²Ý·Édz)
Valeriana, Peppermint,
P.P.F. Hasco-Lek S.A. (for
Melissa dry extracts
World Medicine, England)
Chlorella
ѳµ»ñ
400Ù·
Ø»¹Çϳ ²¸
ÙÇÏñáçñÇÙáõéÝ»ñÇ
(30,60)
Medica AD
ãáñ³óí³Í Ï»Ýë³µ³Ý³Ï³Ý
²¸
169
2460
ì³ÝÏáÙÇóÇÝ îºì²
Vancomycin TEVA
½³Ý·í³Í
dried biomass of
seaweed Chlorella
í³ÝÏáÙÇóÇÝ
vancomycin
2461
ì³ÝÏáÙÇóÇÝ îºì²
Vancomycin TEVA
2462
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
500Ù·,
ëñí³Ï (1)
í³ÝÏáÙÇóÇÝ
vancomycin
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
1000Ù·,
ëñí³Ï (1)
ì³ÝÏáï»ùë
Vancotex
í³ÝÏáÙÇóÇÝ
vancomycin
2463
ì³ÝÏáï»ùë
Vancotex
í³ÝÏáÙÇóÇÝ
vancomycin
2464
ì³ñý³Ýï
Warfant
ì³ñý³Ýï
Warfant
ì³ñý³Ýï
Warfant
ì»·³ 100 ²ëdz
Vega 100 ASIA
ì»·³ñ³ 100
Vegarra 100
í³ñý³ñÇÝ
warfarin
í³ñý³ñÇÝ
warfarin
í³ñý³ñÇÝ
warfarin
ëÇɹ»Ý³ýÇÉÇ óÇïñ³ï
syldenafil citrate
ëÇɹ»Ý³ýÇÉ
sildenafil
¹»Õ³÷áßÇ Ý/»
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ Ý/»
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
2469
ì»·³ñ³ 50
Vegarra 50
2470
ì»·³ñ÷Ç
Vegarpi
컽Çϳñ
Vesicare
컽Çϳñ
Vesicare
ì»ÉµáõïñÇÝ êè
Welbutrin SR
2465
2466
2467
2468
2471
2472
2473
2474
ì»Ý½³
Vensa
ÐáõÝ·³ñdz
J01X A01
5378
17.02.2005
17.02.2010
¸
ÐáõÝ·³ñdz
J01X A01
5379
17.02.2005
17.02.2010
¸
500Ù·,
ëñí³Ï (1)
îºì² ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ»ë Èï¹. ÐáõÙ³Ý
ê»ñáõÙ öñ»¹³ÏßÁÝ Áݹ
Ø»¹ÇëÇÝ Ø³Ýáõý³ÏïáõñÇÝ·
øá.Èï¹.
TEVA
Pharmaceutical Industries Ltd,
Human Serum Production and
Medicine Manufacturing
Co.Ltd.
îºì² ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ»ë Èï¹. ÐáõÙ³Ý
ê»ñáõÙ öñ»¹³ÏßÁÝ Áݹ
Ø»¹ÇëÇÝ Ø³Ýáõý³ÏïáõñÇÝ·
øá.Èï¹.
TEVA Pharmaceutical
Industries Ltd, Human Serum
Production and Medicine
Manufacturing Co.Ltd.
ü³ñÙ³ï»ùë Æï³Édz ê.é.È.
Pharmatex Italia S.r.l.
Æï³Édz
J01X A01
0829/6843
22.03.2007
22.03.2012
¸
1000Ù·,
ëñí³Ï (1)
ü³ñÙ³ï»ùë Æï³Édz ê.é.È.
Pharmatex Italia S.r.l.
Æï³Édz
J01X A01
0828/6844
22.03.2007
22.03.2012
¸
B01A A03
4086
¸
B01A A03
4085
B01A A03
4084
G04B E04
0021/4431/1
G04BE03
1335/7297
14.03.2003
14.03.2008
14.03.2003
14.03.2008
14.03.2003
14.03.2008
12.05.2006
05.11.2008
05.11.2007
05.11.2012
G04BE03
1336/7298
05.11.2007
05.11.2012
¸
G03BE
0590/6561
¸
G04B D08
0417/6394
G04B D08
0418/6393
_
4035
05.12.2006
05.12.2011
26.09.2006
26.09.2011
26.09.2006
26.09.2011
01.04.2003
01.04.2008
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
1051/7072
02.07.2007
02.07.2012
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5Ù·
(100)
3Ù·
(100)
1Ù·
(100)
100Ù·
(4)
100Ù·
(4)
ëÇɹ»Ý³ýÇÉ
sildenafil
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(4)
ëÇɹ»Ý³ýÇÉ
sildenafil
ëáÉÇý»Ý³óÇÝ
solifenacine
ëáÉÇý»Ý³óÇÝ
solifenacine
µáõåñáåÇáÝÇ
ÑǹñáùÉáñǹ
bupropion
hydrochloride
--
¹»Õ³Ñ³ï»ñ
50Ù·
(4, 10, 12)
10Ù·
(10, 30)
5Ù·
(10, 30)
150Ù·
(30,60)
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
Ó»ñµ³½³ïÙ³Ý
ϳÃÇÉÝ»ñ
20ÙÉ, 50ÙÉ,
100ÙÉ ßßÇÏ
²ÝïÇ·»Ý ü³ñÙ³ëÛáõÃÇù³Éë Èï¹ Æéɳݹdz
Antigen Pharmaceuticals Ltd.
²ÝïÇ·»Ý ü³ñÙ³ëÛáõÃÇù³Éë Èï¹ Æéɳݹdz
Antigen Pharmaceuticals Ltd.
²ÝïÇ·»Ý ü³ñÙ³ëÛáõÃÇù³Éë Èï¹ Æéɳݹdz
Antigen Pharmaceuticals Ltd.
²ëdz ü³ñÙ³ëÛáõÃÇù³É
êÇñdz
Asia Pharmaceutical
²Èü²-²É»ååá ü³ñÙ³ëÛáõÃÇù³É
êÇñdz
Æݹ³ëïñdz½
ALPHA-Aleppo Pharmaceutical
Industries
²Èü²-²É»ååá ü³ñÙ³ëÛáõÃÇù³É
êÇñdz
Æݹ³ëïñdz½
ALPHA-Aleppo Pharmaceutical
Industries
²ðöÆغ¸ ÐÒ ö´À
г۳ëï³Ý
ARPIMED J.V. CJ-S Co
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Üǹ»éɳݹYamanouchi Europe B.V.
Ý»ñ
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Üǹ»éɳݹYamanouchi Europe B.V.
Ý»ñ
¶É³ùëáêÙÇÃÎɳÛÝ
Ȼѳëï³Ý
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
èÇ˳ñ¹ ´ÇÃÝ»ñ ²¶
²íëïñdz
Richard Bittner AG
¸
¸
¸
¸
¸
¸
¸
170
2475
2478
ì»ÝáÑ»å³ÝáÉ
Venohepanol
2479
ì»ÝáñáõïÇÝáÉ
Venorutinol
í»Ýɳý³ùëÇÝ
venlafaxine
í»Ýɳý³ùëÇÝ
venlafaxine
¹ÇáëÙÇÝ,
Ñ»ëå»ñǹÇÝ,
³ëÏáñµÇݳÃÃáõ
diosmin, hesperidin,
ascorbic acid
ïñáùë»ñáõïÇÝ,
Ñ»å³ñÇÝ Ý³ïñÇáõÙÇ,
¹»ùëå³ÝûÝáÉ
troxerutin, heparin
sodium, dexpanthenol
ïñáùë»ñáõïÇÝ
troxerutin
2480
ì»ÝáñáõïÇÝáÉ
Venorutinol
ïñáùë»ñáõïÇÝ
troxerutin
¹áݹáÕ
2481
ì»ÝáñáõïáÝ
Venoruton
¹áݹáÕ
2482
ì»ÝáñáõïáÝ
Venoruton
2483
ì»Ýï»ñ
Venter
ì»ë»É ¹áõ» ¾ü
Vessel Due F
éáõïá½Ç¹Ý»ñ (û-(µ»ï³ÑǹñûùëÇ¿ÃÇÉ))
rutosides (o-(betahydroxyethyl))
û-(µ»ï³ÑǹñûùëÇ¿ÃÇÉ)
éáõïá½Ç¹Ý»ñ
o-(beta-hydroxyethyl)
rutosides
ëáõÏñ³Éý³ï
sucralfate
ëáõÉá¹»ùëǹ
sulodexide
ì»ë»É ¹áõ» ¾ü
Vessel Due F
ì»ëïǵá 16Ù·
Vestibo 16mg
ì»ëïǵá 8Ù·
Vestibo 8mg
ì»ñ³å³ÙÇÉ
Verapamil
ì»ñ³å³ÙÇÉ
Verapamil
ì»ñ³å³ÙÇÉ ²ÉϳÉáǹ
Verapamil Alkaloid
ì»ñ³å³ÙÇÉ ²ÉϳÉáǹ
Verapamil Alkaloid
ì»ñ³ï³ñ¹ 180
Veratard 180
ëáõÉá¹»ùëǹ
sulodexide
µ»ï³ÑÇëïÇÝ
betahistine
µ»ï³ÑÇëïÇÝ
betahistine
í»ñ³å³ÙÇÉ
verapamil
í»ñ³å³ÙÇÉ
verapamil
í»ñ³å³ÙÇÉ
verapamil
í»ñ³å³ÙÇÉ
verapamil
í»ñ³å³ÙÇÉ
verapamil
2476
2477
2484
2485
2486
2487
2488
2489
2490
2491
2492
ì»Ýɳùëáñ
Venlaxor
ì»Ýɳùëáñ
Venlaxor
ì»Ýá¹ÇáÉ
Venodiol
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹áݹáÕ
¹»Õ³å³ïÇ×Ý»ñ
75Ù·
(30 /3x10/)
37.5Ù·
(30 /3x10/)
450Ù·+
50Ù·+100Ù·,
(30/3x10/)
¶ñÇݹ»ùë ´À
Grindex JSC
¶ñÇݹ»ùë ´À
Grindex JSC
꺸ÆÎà ü³ñÙ³ëÛáõÃÇù³É øá.
(àõáñɹ Ø»¹ÇëÇÝÇ Ñ³Ù³ñ,
²Ý·Édz)
SEDICO Pharmaceutical Co.
(for World Medicine, England)
(2·+0,2499·/30000
´áñßã³·áíÛ³Ý
ØØ/+3·)/100·,
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
40· å³ñÏáõ×
ö´À Borshchahivskiy
Chemical-Pharmaceutical Plant
CJSC
300Ù·
´áñßã³·áíÛ³Ý
(20)
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
2%,
´áñßã³·áíÛ³Ý
40· å³ñÏáõ×
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À Borshchahivskiy
Chemical-Pharmaceutical Plant
CJSC
20Ù·/·,
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
40· å³ñÏáõ×
ê.².
Novartis Consumer Health S.A.
ȳïídz
N06A X16
0077/6208
07.06.2006
07.06.2011
07.06.2006
07.06.2011
17.01.2007
17.01.2012
¸
ȳïídz
N06A X16
0078/6207
º·Çåïáë
C05C A53
0677/6719
àõÏñ³Çݳ
C05C A54
5838
27.12.2005
27.12.2010
²¸
àõÏñ³Çݳ
C05C A04
0096/5990
09.06.2006
09.06.2011
²¸
àõÏñ³Çݳ
C05C A04
5837
27.12.2005
27.12.2010
²¸
Þí»Ûó³ñdz
C05C A51
4654
02.02.2004
02.02.2009
²¸
¸
¸
¹»Õ³å³ïÇ×Ý»ñ
300Ù·
(50)
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis Consumer Health S.A.
Þí»Ûó³ñdz
C05C A51
4655
15.03.2004
15.03.2009
¸
¹»Õ³Ñ³ï»ñ
1·
(50)
600ÈØ/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
250ÈØ
(50)
16Ù·
(30/3x10/)
8Ù·
(30/3x10/)
40Ù·
(30,1000x15)
80Ù·
(50,1000x10)
80Ù·
(30/2x15/)
40Ù·
(30/2x15/)
180Ù·
(30/3x10/)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
²Éý³ ì³ë»ñÙ³Ý ê.å.².
Alfa Wassermann S.p.A.
êÉáí»Ýdz
A02BX02
1356/7317
¸
Æï³Édz
B01A B11
5037
13.11.2007
05.11.2012
13.08.2004
13.08.2009
²Éý³ ì³ë»ñÙ³Ý ê.å.².
Alfa Wassermann S.p.A.
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
ڲβ-80
JAKA-80
ڲβ-80
JAKA-80
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD-Skopje
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD-Skopje
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Æï³Édz
B01A B11
5038
¸
´áõÉÕ³ñdz
N07C A01
0803/6846
´áõÉÕ³ñdz
N07C A01
0802/6847
سϻ¹áÝdz
C08D A01
5666
سϻ¹áÝdz
C08D A01
5667
سϻ¹áÝdz
C08D A01
0684/6615
سϻ¹áÝdz
C08D A01
0683/6616
àõÏñ³Çݳ
C08D A01
0772/6697
13.08.2004
13.08.2009
20.03.2007
20.03.2012
20.03.2007
20.03.2012
19.09.2005
19.09.2010
19.09.2005
19.09.2010
17.01.2007
17.01.2012
17.01.2007
17.01.2012
07.03.2007
07.03.2012
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ, ŻɳïÇÝ»
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
»ñϳñ³ï¨
¸
¸
¸
¸
¸
¸
¸
¸
171
Ó»ñµ³½³ïٳٵ
2493
2494
2495
2496
2497
2498
2499
2500
2501
2502
2503
2504
2505
2506
2507
2508
2509
ì»ñÙáùë
Vermox
ì»ñá·³Éǹ ºè 240Ù·
Verogalid ER
240mg
ì»ñáßåÇñáÝ
Verospiron
ì»ñáßåÇñáÝ
Verospiron
ìdz·ñ³
Viagra
ìdz·ñ³
Viagra
ìdz·ñ³
Viagra
ìÇï³ÙÇÝ E
Vitamin E
ìǵñ³ÙÇóÇÝ
Vibramycin
ìǵñáóÇÉ
Vibrocil
Ù»µ»Ý¹³½áÉ
mebendazole
í»ñ³å³ÙÇÉ
verapamil
ëåÇñáÝáɳÏïáÝ
spironolacton
ëåÇñáÝáɳÏïáÝ
spironolacton
ëÇɹ»Ý³ýÇÉ
sildenafil
ëÇɹ»Ý³ýÇÉ
sildenafil
ëÇɹ»Ý³ýÇÉ
sildenafil
ÃáÏáý»ñáÉÇ ³ó»ï³ï
tocopherol acetate
¹ûùëÇóÇÏÉÇÝ
doxycycline
¹ÇÙ»ÃÇݹ»Ý,
ý»ÝÇÉ¿ýñÇÝ
dimethindene,
phenylephrine
ìǵñáóÇÉ
¹ÇÙ»ÃÇݹ»Ý,
Vibrocil
ý»ÝÇÉ¿ýñÇÝ
dimethindene,
phenylephrine
ìǵñáóÇÉ
¹ÇÙ»ÃÇݹ»Ý,
Vibrocil
ý»ÝÇÉ¿ýñÇÝ
dimethindene,
phenylephrine
ìǽÇÝ
ï»ïñǽáÉÇÝ
Visine
tetrisoline
ìǽáåïÇÝ
ï»ïñǽáÉÇÝ
Vizoptin
tetrizoline
ìÇÉåñ³ý»Ý
çá½³ÙÇóÇÝ
Wilprafen
josamycin
ìÇϳëáÉ
ٻݳ¹ÇáÝÇ Ý³ïñÇáõÙ
Vikasol
µÇëáõÉýÇï
menadione sodium
bisulfite
ìÇݵɳëïÇÝ-èÇËï»ñ
íÇݵɳëïÇÝ
Vinblastin-Richter
vinblastine
2510
ìÇݻɵÇÝ
Vinelbine
íÇÝáñ»ÉµÇÝ
vinorelbine
2511
ìÇݻɵÇÝ
Vinelbine
íÇÝáñ»ÉµÇÝ
vinorelbine
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï, ¹³Ý¹³Õ
Ó»ñµ³½³ïٳٵ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹áݹáÕ ùÃÇ
100Ù·
(6)
240Ù·
(10,30)
50Ù·
(30)
25Ù·
(20)
50Ù·
(1, 4,8,12)
100Ù·
(1,4,8,12)
25Ù·
(1,4,8,12)
200ØØ
(30,100)
100Ù·
(10)
0.025%+0.25%,
12· å³ñÏáõ×
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
²Ûì²øë ü³ñÙ³ëÛáõÃÇù³Éë
ë.é.û.
IVAX Pharmaceuticals s.r.o.
¶»¹»áÝ èÇËï»ñ ö´À
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
öý³Û½»ñ ä¶Ø
Pfizer PGM
öý³Û½»ñ ä¶Ø
Pfizer PGM
öý³Û½»ñ ä¶Ø
Pfizer PGM
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
öý³Û½»ñ ê.².
Pfizer S.A.
Üáí³ñïÇë øáÝëáõÙ»ñ лÉà ê²
Novartis Consumer Health SA
ÐáõÝ·³ñdz
P02C A01
5803
â»Ëdz
C08D A01
6016
ÐáõÝ·³ñdz
C03D A01
5203
ÐáõÝ·³ñdz
C03D A01
5241
üñ³Ýëdz
G04B E03
4737
üñ³Ýëdz
G04B E03
4738
üñ³Ýëdz
G04B E03
4865
²ØÜ
A11HA03
0703/6738
´»É·Ç³
J01A A02
4734
Þí»Ûó³ñdz
R06A
4445
14.12.2005
14.12.2010
21.03.2006
21.03.2011
¸
04.10.2004
04.10.2009
01.06.2005
01.06.2010
25.03.2004
25.03.2009
25.03.2004
25.03.2009
01.06.2004
01.06.2009
25.01.2007
25.01.2012
25.03.2004
25.03.2009
19.08.2003
19.08.2008
¸
¸
¸
¸
¸
¸
²¸
¸
²¸
óáÕ³ßÇà ùÃÇ
0.025%+0.25%, Üáí³ñïÇë øáÝëáõÙ»ñ лÉà ê²
10ÙÉ åɳëïÇÏ ßßÇÏ Novartis Consumer Health SA
Þí»Ûó³ñdz
R06A
4447
19.08.2003
19.08.2008
²¸
ùóϳÃÇÉÝ»ñ
(0.25Ù·+2.5Ù·)/ÙÉ, Üáí³ñïÇë øáÝëáõÙ»ñ лÉà ê²
15· ßßÇÏ
Novartis Consumer Health SA
Þí»Ûó³ñdz
R06A
4446
19.08.2003
19.08.2008
²¸
γݳ¹³
4796
0959/6938
Æï³Édz
J01F A07
5836
èáõë³ëï³Ý
(ÎáõñëÏ)
B02BA02
1028/6666
23.04.2004
23.04.2009
14.05.2007
14.05.2012
22.11.2005
22.11.2010
21.06.2007
21.06.2012
²¸
èáõÙÇÝdz
R01A A06,
S01G A02
S01G A02
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
L01CA01
5547
01.06.2005
01.06.2010
¸
¸²´àõð ü³ñÙ³ Èï¹
DABUR Pharma Ltd
Ðݹϳëï³Ý
L01C A04
0431/6386
26.09.2006
26.09.2011
¸
¸²´àõð ü³ñÙ³ Èï¹
DABUR Pharma Ltd
Ðݹϳëï³Ý
L01C A04
0313/6085
01.08.2006
01.08.2011
¸
³ÏݳϳÃÇÉÝ»ñ
³ÏݳϳÃÇÉÝ»ñÉáõÍáõÛÃ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
0.05%
(15ÙÉ ßßÇÏ)
0,05%
15ÙÉ ßßÇÏ
500Ù·
(10)
0,015·
(10, 20)
¹»Õ³÷áßÇ
5Ù·,
ÉÇáýÇÉǽ³óí³Í, ëñí³Ï/³ÙåáõÉ (10)
5ÙÉ Ý³ïñÇáõÙÇ
ùÉáñÇ¹Ç 0.9%
ÉáõÍáõÛÃ ÉáõÍãáí
Ëï³ÝÛáõÃ
10Ù·/1ÙÉ,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
1ÙÉ ëñí³Ï (1)
ÉáõÍáõÛÃÇ
Ëï³ÝÛáõÃ
50Ù·/5ÙÉ,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
5ÙÉ ëñí³Ï (1)
öý³Û½»ñ γݳ¹³ ÆÝÏ.
Pfizer Canada Inc.
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
Ú³Ù³ÝáõãÇ ü³ñÙ³ ê.å.².
Yamanouchi Pharma S.p.A.
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
²¸
¸
¸
172
2512
ìÇÝ»ùë
Vinex
-
ÉáõÍáõÛÃÇ
å³ïÇ×Ý»ñ
2513 ìÇÝÏñÇëïÇÝ-èÇËï»ñ
Vincristin-Richter
íÇÝÏñÇëïÇÝ
vincristin
2514 ìÇÝáñ»ÉµÇÝ-¾µ»í»
Vinorelbine-Ebewe
íÇÝáñ»ÉµÇÝ
vinorelbine
2515
ìÇÝåáó»ïÇÝ
Vinpocetin
ìÇÝåáó»ïÇÝ
Vinpocetin
íÇÝåáó»ïÇÝ
vinpocetine
íÇÝåáó»ïÇÝ
vinpocetine
2517
ìÇÝåáó»ïÇÝ
Vinpocetin
íÇÝåáó»ïÇÝ
vinpocetine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2518
ìÇÝåáó»ïÇÝ
Vinpocetin
íÇÝåáó»ïÇÝ
vinpocetin
¹»Õ³Ñ³ï»ñ
2516
2519 ìÇÝåáó»ïÇÝ øáí»ùë
íÇÝåáó»ïÇÝ
5Ù·
vinpocetine
Vinpocetin Covex
5mg
2520
ìÇáë»åï
Ûá¹áùÉáñûùëÇùÇÝáÉ
Viosept
ÇÝ, ïñÇå»É»Ý³ÙÇÝÇ
ÑǹñáùÉáñǹ,
¹áÙÇý»Ý µñáÙǹ
iodochloroxychinolin,
tripelennamine
hydrochloride,
domiphen bromide
2521
ìÇåñáë³É §´¦
ÇÅÇ ÃáõÛÝ,
Viprosal §B¦
ë³ÉÇóÇɳÃÃáõ,
ù³÷áõñ, µ¨»ÏݳÛáõÕ Ï³Ù
»Õ¨ÝÇÇ »Ã»ñ³ÛáõÕ
viper poison, salicylic
acid, camphorae,
turpentine or fir oil
(oleum Abies)
2522
ìÇåñáë³É ´
ÇÅÇ ÃáõÛÝ, ù³÷áõñ,
Viprosal B
µ¨»ÏݳÛáõÕ,
ë³ÉÇóÇɳÃÃáõ
viperae venom,
camphor, turpentine oil,
salicylic acid
2523 ìÇï³-µ³É³Ýë 2000
Vita-Balance 2000
2524
ìÇï³Ù³ùë
íÇï³ÙÇÝÝ»ñ,
Vitamax
ѳÝù³ÝÛáõûñ
vitamins, minerals
250Ù·
(30)
¹»Õ³÷áßÇ
1Ù·,
ÉÇáýÇÉǽ³óí³Í, ëñí³Ï/³ÙåáõÉ (10)
10ÙÉ Ý³ïñÇáõÙÇ
ùÉáñÇ¹Ç 0.9%
ÉáõÍáõÛÃ ÉáõÍãáí
Ëï³ÝÛáõÃ
10Ù·/1ÙÉ,
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (1)
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
5Ù·
(50/2x25/)
¹»Õ³Ñ³ï»ñ
0.005·
(10,50)
¹»Õ³Ñ³ï»ñ
0.5%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
5Ù·
(20/2x10/,
30/3x10/, 50/5x10/)
5Ù·
(50)
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
Æéɳݹdz
βêÐ
5805
26.10.2005
26.10.2010
²¸
ÐáõÝ·³ñdz
L01CA02
5546
01.06.2005
01.06.2010
¸
²íëïñdz
L01C A04
0063/6099
02.06.2006
02.06.2011
¸
ÐáõÝ·³ñdz
N06B X18
0723/6727
¸
´»É³éáõë
N06B X18
4999
13.02.2007
13.02.2012
13.12.2004
13.12.2009
´»É³éáõë
N06B X18
5000
13.12.2004
13.12.2009
¸
èáõë³ëï³Ý
N06B X18
0170/6276
07.07.2006
07.07.2011
¸
øáí»ùë ê.².
Covex S.A.
Æëå³Ýdz
N06B X18
5773
07.10.2005
07.10.2010
¸
¾´ºìº ü³ñÙ³ ¶»ë. Ù.µ.Ð. Üý·. ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc.
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
ü³ñÙåñáÛ»Ïï ö´À Pharmproject
CJSC
¸
ùëáõù
(20Ù·+20Ù·+
0.5Ù·)/1·,
15· å³ñÏáõ×
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A.Pharmaceutical
Works
Ȼѳëï³Ý
D04A,
A01A
5903
19.01.2006
19.01.2011
¸
ùëáõù
(0.05زØ+10Ù·+
30Ù·+ 30Ù·)/·,
15·, 25·, 30·
å³ñÏáõ× Ï³Ù ³å³Ï»
ï³ñ³
¾ëÏáõɳå êäÀ
Esculap Ltd.
г۳ëï³Ý
-
4571
29.10.2003
29.10.2008
²¸
ùëáõù
(0.05ØØ+30Ù·+
30Ù·+
10Ù·)/1·,
30·,50· å³ñÏáõ×
î³ÉÇÝÇ ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
´À
Tallinn Pharmaceutical Works
A.S.
¾ëïáÝdz
-
0098/6213
09.06.2006
09.06.2011
²¸
ѳµ»ñ
(80)
²ØÜ
βêÐ
5392
(5,15)
º·Çåïáë
A11
5342
16.03.2005
16.03.2010
25.01.2005
25.01.2010
²¸
¹»Õ³å³ïÇ×Ý»ñ
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
New Spirit Naturals Inc.
¶É³ùëáêÙÇÃÎɳÛÝ ê.².º.
GlaxoSmithKline S.A.E.
²¸
173
2525
2526
2527
2528
ìÇï³ÙÇÝ A
Vitamin A
ìÇï³ÙÇÝ A
Vitamin A
ìÇï³ÙÇÝ A
Vitamin A
ìÇï³ÙÇÝ A+D3
Vitamin A+D3
2529 ìÇï³ÙÇÝ B h³Ù³ÉÇñ
Vitamin B complex
2530 ìÇï³ÙÇÝ B ѳٳÉÇñ
Vitamin B Complex
2531 ìÇï³ÙÇÝ B ѳٳÉÇñ
Vitamin B complex
2532 ìÇï³ÙÇÝ B ѳٳÉÇñ
Vitamin B complex
2533
ìÇï³ÙÇÝ C
Vitamin C
2534 ìÇï³ÙÇÝ C 200Ù·
Vitamin C 200mg
2535 ìÇï³ÙÇÝ D3 ´.ú.Ü.
Vitamin D3 B.O.N.
2536
2537
2538
2539
ìÇï³ÙÇÝ E
Vitamin E
ìÇï³ÙÇÝ E 100 êÉáí³Ïáý³ñÙ³
Vitamin E 100
Slovakofarma
ìÇï³ÙÇÝ E 200 êÉáí³Ïáý³ñÙ³
Vitamin E 200
Slovakofarma
ìÇï³ÙÇÝ E 400 êÉáí³Ïáý³ñÙ³
Vitamin E 400
Slovakofarma
é»ïÇÝáÉ
retinol
é»ïÇÝáÉ
retinol
é»ïÇÝáÉ
retinol
é»ïÇÝáÉÇ å³ÉÙÇï³ï,
ËáɻϳÉóÇý»ñáÉ
retinol palmitate,
cholecalciferol
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
¹»Õ³å³ïÇ×Ý»ñ
ŻɳïÇÝ»
ÉáõÍáõÛÃ
ËÙ»Éáõ, çñ³ÛÇÝ
(ϳÃÇÉÝ»ñ)
50000ØØ
(40,80)
2500ØØ
(50,100)
8000ØØ
(100)
(20000ØØ+
10000ØØ)/ÙÉ
10ÙÉ ßßÇÏ
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
Ø»¹³Ý³ ü³ñÙ³ î»ñåáÉ ¶ñáõå
ѳٳï»Õ µ³ÅÝ»ïÇñ³Ï³Ý
ÁÝÏ»ñáõÃÛáõÝ
MEDANA PHARMA TERPOL
GROUP, JOINT STOCK
COMPANY
²ðöÆغ¸ Ð/Ò ö´À
ARPIMED J.V. CJ-S Co
íÇï³ÙÇÝÝ»ñ B1, B2,
ÉáõÍáõÛÃ Ù/Ù
(10Ù·+4Ù·+4Ù·+
B6, ¹»ùëå³ÝûÝáÉ,
Ý»ñ³ñÏÙ³Ý
6Ù·+
ÝÇÏáïÇݳÙǹ
40Ù·)/2ÙÉ
B1, B2, B6 vitamins,
³ÙåáõÉÝ»ñ
dexpanthenol,
(10/2x5/)
nicotinamide
B1, B2, B6, PP
¹»Õ³Ñ³ï»ñ
5Ù·+2Ù·+2Ù·+
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
íÇï³ÙÇÝÝ»ñ
óճÝóå³ï
20Ù·
Pharmaceutical
vitamins B1, B2, B6, PP
(20,50)
ÃdzÙÇÝ, éǵáýɳíÇÝ,
¹»Õ³Ñ³ï»ñ
(20)
êáý³ñÙ³ ´À
åÇñǹûùëÇÝ,
óճÝóå³ï
Sopharma JSC
ÝÇÏáïÇݳÙǹ
thiamine, riboflavine,
pyridoxine,
nicotinamide
ÃdzÙÇÝ, éǵáýɳíÇÝ,
ÉáõÍáõÛÃ
(10Ù·+2Ù·+10Ù·+
êáý³ñÙ³ ´À
åÇñǹûùëÇÝ,
Ý»ñ³ñÏÙ³Ý
100Ù·)/2ÙÉ,
Sopharma JSC
ÝÇÏáïÇݳÙǹ
2ÙÉ ³ÙåáõÉÝ»ñ
thiamine, riboflavin,
(10)
pyridoxine,
nicotinamide
³ëÏáñµÇݳÃÃáõ
¹»Õ³Ñ³ï»ñ
500Ù·
²ðöÆغ¸ Ð/Ò ö´À
ascorbic acid
(20)
ARPIMED J.V. CJ-S Co
³ëÏáñµÇݳÃÃáõ
¹»Õ³Ñ³ï»ñ
200Ù·
êÇÏáÙ»¹ ê.².
ascorbic acid
(20)
Sicomed S.A.
ËáɻϳÉóÇý»ñáÉ
ÉáõÍáõÛà ËÙ»Éáõ 200000ØØ/ÙÉ
´áõß³ñ³ è»Ïáñ¹³ïÇ/ü³ñÙ³
cholecalciferol
ϳ٠Ù/Ù Ý»ñ³ñÏÙ³Ý
(5Ù·/ÙÉ)
ÈÇíñáÝ
1ÙÉ ³ÙåáõÉÝ»ñ
Bouchara-Recordati/Pharma
(1,10)
Livron
å³ïÇ×Ý»ñ ÷³÷áõÏ
400ØØ
ÜÛáõ êåÇñÇï Ü»Ûãñɽ ÆÝÏ.
ŻɳïÇÝ»
(90)
New Spirit Naturals Inc.
ÃáÏáý»ñáÉÇ ³ó»ï³ï
¹»Õ³å³ïÇ×Ý»ñ
100Ù·,
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
tocopherol acetas
(10,20,30)
Slovakofarma a.s., Hlohovec
´áõÉÕ³ñdz
²ØÜ (âÇϳ·á)
D10A D02,
A11C A01
D10A D02,
A11C A01
A11C A01
14.01.2003
14.01.2008
24.01.2003
24.01.2008
08.08.2006
08.08.2011
18.11.2004
18.11.2009
²¸
0319/6363
Ȼѳëï³Ý
A11C
5157
г۳ëï³Ý
A11B A
0975/6978
22.05.2007
22.05.2012
¸
êÇñdz
A11
4073
05.11.2003
05.11.2008
²¸
´áõÉÕ³ñdz
A11E X
0920/6701
26,04.2007
26.04.2012
²¸
´áõÉÕ³ñdz
A11D
5753
20.03.2006
20.03.2011
¸
г۳ëï³Ý
A11G A01
0861/6909
²¸
èáõÙÇÝdz
A11G A01
3949
üñ³Ýëdz
-
5211
30.03.2007
30.03.2012
06.03.2003
06.03.2008
16.12.2004
16.12.2009
²ØÜ
βêÐ
5394
²¸
êÉáí³Ïdz
A11H A03
4241
16.03.2005
16.03.2010
22.07.2003
22.07.2008
´áõÉÕ³ñdz
4079
4080
²¸
²¸
¸
²¸
¸
²¸
ÃáÏáý»ñáÉÇ ³ó»ï³ï
tocopherol acetas
¹»Õ³å³ïÇ×Ý»ñ
200Ù·,
(10,20,30)
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïdz
A11H A03
4242
22.07.2003
22.07.2008
²¸
ÃáÏáý»ñáÉÇ ³ó»ï³ï
tocopherol acetas
¹»Õ³å³ïÇ×Ý»ñ
400Ù·,
(30)
êÉáí³Ïáý³ñÙ³ ³.ë.,ÐÉáÑáí»ó
Slovakofarma a.s., Hlohovec
êÉáí³Ïdz
A11H A03
4243
22.07.2003
22.07.2008
²¸
174
2540
ìÇï³ÙÇÝ C
Vitamin C
ìÇï³ÙÇÝ C
Vitamin C
ìÇï³ÙÇÝ C
Vitamin C
ìÇï³ÙÇÝ C
Vitamin C
³ëÏáñµÇݳÃÃáõ
ascorbic acid
³ëÏáñµÇݳÃÃáõ
ascorbic acid
³ëÏáñµÇݳÃÃáõ
ascorbic acid
³ëÏáñµÇݳÃÃáõ
ascorbic acid
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
1000Ù·
(20)
250Ù·
(20)
250Ù·
(10,20,100)
1000Ù·
(10)
2544
ìÇï³ÙÇÝ C
Vitamin C
³ëÏáñµÇݳÃÃáõ
ascorbic acid
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(25)
2545
ìÇï³åñáëï
Vitaprost
2541
2542
2543
2546
2547
2548
2549
2550
2551
2552
ë³Ùåñáëï (óÉÇ Ï³Ù
ÙáÙÇÏÝ»ñ
óÉÇÏÇ ß³Ï³Ý³Ï³·»ÕÓÇ
ãáñ ѳÝáõÏ)
samprost (dry extract of
calf prostate)
ìÇïñáõÙ µ»ÛµÇ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
Vitrum Baby
ѳÝù³ÝÛáõûñ
vitamins, minerals
ìÇïñáõÙ ÛáõÝÇáñ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
Vitrum Junior
ѳÝù³ÝÛáõûñ
vitamins, minerals
ìÇïñáõÙ åñ»Ý³ï³É
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
ýáñï»
ѳÝù³ÝÛáõûñ
óճÝóå³ï
Vitrum prenatal forte
vitamins, minerals
ìÇïñáõÙ íÇÅÝ
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
Vitrum Vision
ѳÝù³ÝÛáõûñ
óճÝóå³ï
vitamins, minerals
ìÇïñáõÙ ûëï»áÙ³·
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
Vitrum osteomag
ѳÝù³ÝÛáõûñ
óճÝóå³ï
vitamins, minerals
ìÇñ³½áÉ
éǵ³íÇñÇÝ
Ëï³ÝÛáõÃ
Virazole
ribavirin
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
ìÇñ³ó»åï
Viracept
ìÇñáÉ»ùë ³Ïݳùëáõù
Virolex eye ointment
ìÇñáÉ»ùë
Virolex
ìÇñáÉ»ùë
Virolex
ìÇñáÉ»ùë
Virolex
Ý»ÉýÇݳíÇñ
nelfinavir
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
aciclovir
³óÇÏÉáíÇñ
aciclovir
2557 ìÇñáõ-Ù»ñó ë»ñáÉ
Viru-Merz serol
ïñáÙ³Ýï³¹ÇÝ
tromantadine
2558
ó»ýﳽǹÇÙ
2553
2554
2555
2556
ìÇó»ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
³Ïݳùëáõù
Ýñµ³ùëáõù
¹»Õ³Ñ³ï»ñ
¹»Õ³÷áßÇ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹áݹáÕ
¹»Õ³÷áßÇ
0.05·
(10)
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
ê»ñµÇ³ ¨
Hemofarm koncern A.D.
â»éÝá·áñdz
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
ê»ñµÇ³ ¨
Hemofarm koncern A.D.
â»éÝá·áñdz
²ðöÆغ¸ ÐÒ ö´À ARPIMED
г۳ëï³Ý
J.V. CJ-S Co.
²ëdz ü³ñÙ³ëÛáõÃÇù³É
êÇñdz
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
¶É³ùëáêÙÇÃÎɳÛÝ
Ȼѳëï³Ý
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
ÜÇÅý³ñÙ ´´À
èáõë³ëï³Ý
Nizhpharm Open JSC
A11G A01
0533/6435
10.11.2006
10.11.2011
10.11.2006
10.11.2011
12.07.2004
12.07.2009
23.08.2005
23.08.2010
²¸
A11G A01
0534/6434
A11G A01
4922
A11G A01
5503
A11G A01
5059
25.08.2004
25.08.2009
²¸
G04BX
0630/6630
27.12.2006
27.12.2011
¸
²¸
²¸
²¸
(30, 60)
ÚáõÝÇý³ñÙ ÆÝÏ.
Unipharm Inc.
²ØÜ
A11AA04
1292/7260
12.12.2007
12.10.2012
²¸
(30,60)
ÚáõÝÇý³ñÙ ÆÝÏ.
Unipharm Inc.
²ØÜ
A11AA04
1359/7320
29.11.2007
05.11.2012
²¸
(30, 60)
ÚáõÝÇý³ñÙ ÆÝÏ.
Unipharm Inc.
²ØÜ
A11AA04
1293/7259
12.12.2007
12.10.2012
²¸
(60)
ÚáõÝÇý³ñÙ ÆÝÏ.
Unipharm Inc.
²ØÜ
A11AA04
1291/7261
12.12.2007
12.10.2012
²¸
(30, 60)
ÚáõÝÇý³ñÙ ÆÝÏ.
Unipharm Inc.
²ØÜ
A11AA03
1294/7258
12.12.2007
12.10.2012
²¸
100Ù·/ÙÉ,
12ÙÉ ëñí³Ï (5)
²Û-êÇ-¾Ý Þí»Ûó³ñdz ²¶ (²ÛêÇ-¾Ý ü³ñÙ³ëÛáõÃÇù³Éë
Þí»Ûó³ñdz Èï¹-Ç Ñ³Ù³ñ)
ICN Switzerland AG (for ICN
Pharmaceutical Switzerland
Ltd.)
èáß ü³ñÙ³ ê²
Roche Farma SA
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Þí»Ûó³ñdz
J05A B04
5135
24.11.2004
24.11.2009
¸
Æëå³Ýdz
J05A E04
0132/6231
¸
êÉáí»Ýdz
S01A D03
0827/6816
êÉáí»Ýdz
D06B B03
0571/6523
êÉáí»Ýdz
J05A B01
0570/6524
êÉáí»Ýdz
J05A B01
0572/6522
21.06.2006
21.06.2011
20.03.2007
20.03.2012
24.11.2006
24.11.2011
24.11.2006
24.11.2011
24.11.2006
24.11.2011
Ø»ñó ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ³²
Merz Pharma GmbH & KGaA
¶»ñÙ³Ýdz
D06B B02
J05A C03
4876
08.06.2004
08.06.2009
²¸
²´úÈÙ»¹ êäÀ
èáõë³ëï³Ý
J01D A11
4608
20.01.2004
¸
250Ù·
(270, 300)
30Ù·/1·,
4.5· å³ñÏáõ×
50Ù·/1·,
5· å³ñÏáõ×
200Ù·
(20)
250Ù·,
ëñí³Ï (5)
1%,
2·,5·,10· ¨ 20·
å³ñÏáõ×
1·,
¸
²¸
¸
¸
175
2561
ìáÉï³ñ»Ý 25
Voltaren 25
ceftazidime
¿Ý½ÇÙÝ»ñ
enzymes
¹ÇÏÉáý»Ý³Ï
ݳïñÇáõÙÇ
diclofenac sodium
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
diclofenac sodium
2562
ìáÉï³ñ»Ý 50
Voltaren 50
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
diclofenac sodium
ÙáÙÇÏÝ»ñ
50Ù·
(10)
2563
ìáÉï³ñ»Ý ³ÏïÇ
Voltaren akti
ϳÉÇáõÙ³Ï³Ý ¹ÇÏÉáý»Ý³Ï
diclofenac potassium
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
12.5·
(10,20)
¹ÇÏÉáý»Ý³Ï
diclofenac
¹ÇÏÉáý»Ý³ÏÇ
¹Ç¾ÃÇɳÙÇÝ
diclofenac diethylamin
¹»Õ³Ñ³ï»ñ
ï³ñ³ÉáõÍíáÕ
¹áݹáÕ
50Ù·
(20)
1%,
50· å³ñÏáõ×
¹áݹáÕ
1%,
20·, 50· å³ñÏáõ×
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
25Ù·
(30)
Üáí³ñïÇë ü³ñÙ³ ê.².ê (Üáí³ñïÇë
ü³ñÙ³ ²¶, Þí»Ûó³ñdzÛÇ Ñ³Ù³ñ)
Novartis Pharma S.A.S. (for
Novartis Pharma AG,
Switzerland)
Üáí³ñïÇë ü³ñÙ³ ê.².ê (Üáí³ñïÇë
ü³ñÙ³ ²¶, Þí»Ûó³ñdzÛÇ Ñ³Ù³ñ)
Novartis Pharma S.A.S. (for
Novartis Pharma AG,
Switzerland)
Üáí³ñïÇë ü³ñÙ³ëÛáõÃÇù³ ê.².,
Æëå³Ýdz (Üáí³ñïÇë
øáÝëáõÙ»ñ лÉÃ,
Þí»Ûó³ñdzÛÇ Ñ³Ù³ñ)
Novartis Pharmaceutica S.A.,
Spain (for Novartis Consumer
Health, Switzerland)
Üáí³ñïÇë ü³ñÙ³ ¶ÙµÐ
Novartis Pharma GmbH
Üáí³ñïÇë ü³ñÙ³ äñá¹áõÏïÇáÝë
¶ÙµÐ (Üáí³ñïÇë øáÝëÛáõÙ»ñ
лÉà ê»ñíÇ뻽 ê.².-Ç Ñ³Ù³ñ,
Þí»Ûó³ñdzÛ)
Novartis Pharma Produktions
GmbH for Novartis Consumer
Health Servises S.A.,
Switzerland
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis
Consumer Health S.A.
Üáí³ñïÇë ü³ñÙ³ ê.å.².
Novartis Pharma S.p.A.
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
50Ù·
(20)
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
Ñ»ßïáó³ÛÇÝ
2559
2560
Vicef
ìᵻݽÇÙ
Wobenzym
ìáÉï³ñ»Ý
Voltaren
2564
ìáÉï³ñ»Ý ¸
Voltaren D
2565 ìáÉï³ñ»Ý ¾ÙáõÉ·»É
Voltaren EmulGel
2566 ìáÉï³ñ»Ý ¿ÙáõÉ·»É
Voltaren Emulgel
2567
2568
2569
2570
2571
¹ÇÏÉáý»Ý³ÏÇ
¹Ç¿ÃÇɳÙÇÝ
diclofenac diethylamine
ìáÉï³ñ»Ý é³åǹ 25Ù·
¹ÇÏÉáý»Ý³ÏÇ
Voltaren Rapid
ϳÉÇáõÙ³Ï³Ý ³Õ
25mg
diclofenac potassium
ìáÉï³ñ»Ý é³åǹ 50Ù·
¹ÇÏÉáý»Ý³ÏÇ
Voltaren Rapid
ϳÉÇáõÙ³Ï³Ý ³Õ
50mg
diclofenac potassium
ìáÉï³ñ»Ý êè
¹ÇÏÉáý»Ý³Ï
Voltaren SR
ݳïñÇáõÙÇ
diclofenac sodium
ìáϳ¹ÇÝ
åáíǹáÝ Ûá¹ÇÝ
Wokadine
povidone iodine
ìáëáõÉÇÝ-30/70
Wosulin-30/70
30% Ù³ñ¹áõ é»·áõɳñ
ÇÝëáõÉÇÝ, 70%
ǽáý³Ý ÇÝëáõÉÇÝ
(é»ÏáÙµÇݳÝï)
30% Regular Insulin
Human, 70% Isophane
Insulin (recimbinant)
Ý»ñ³ñÏÙ³Ý
¹ñ³Å»
ëñí³Ï (1)
(40,200,800)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
75Ù·/3ÙÉ,
³ÙåáõÉÝ»ñ (5)
ÙáÙÇÏÝ»ñ
25Ù·
(10)
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
ABOLmed Ltd
ØáõÏáë ü³ñÙ³
MuCos
Pharma
Üáí³ñïÇë ü³ñÙ³ ²¶
Novartis Pharma AG
20.01.2009
21.08.2003
21.08.2008
20.06.2003
20.06.2008
¶»ñÙ³Ýdz
-
4545
Þí»Ûó³ñdz
M01A B05
M02A A15
4337
üñ³Ýëdz
M01AB05
0860/6808
30.03.2007
30.03.2012
¸
üñ³Ýëdz
M01AB05
0857/6809
30.03.2007
30.03.2012
¸
Æëå³Ýdz
M01A B05
M02A A15
4383
19.08.2003
19.08.2008
²¸
¶»ñÙ³Ýdz
M01A B05
M02A A15
M02A A15
4341
26.06.2003
26.06.2008
01.10.2007
31.10.2012
¸
¶»ñÙ³Ýdz
1328/6585
¸
¸
²¸
Þí»Ûó³ñdz
M01A B05
S01B C03
4832
15.06.2004
15.06.2009
²¸
Æï³Édz
M01A B05
M02A A15
4343
20.06.2003
20.06.2008
¸
Üáí³ñïÇë ü³ñÙ³ ê.å.².
Novartis Pharma S.p.A.
Æï³Édz
M01A B05
M02A A15
4344
20.06.2003
20.06.2008
¸
75Ù·
(20)
Üáí³ñïÇë ü³ñÙ³ ê.å.².
Novartis Pharma S.p.A.
Æï³Édz
M01A B05
M02A A15
4342
26.06.2003
26.06.2008
¸
200Ù·,
14 ¹»Õ³Ñ³ï
Ý»ñ¹ñáõÏáí
40ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
ìáÏ˳ñ¹ Èï¹.
Wockhardt Ltd.
Ðݹϳëï³Ý
G01A X11
4625
26.11.2004
26.11.2009
²¸
ìáÏѳñ¹ Èï¹
Wockhardt Ltd
Ðݹϳëï³Ý
A10A D01
0089/6217
07.06.2006
07.06.2011
¸
176
2572
ìáëáõÉÇÝ-50/50
Wosulin-50/50
2573
ìáëáõÉÇÝ-Ü
Wosulin-N
2574
ìáëáõÉÇÝ-Ü
Wosulin-N
2575
ìáëáõÉÇÝ-è
Wosulin-R
2576
ìáëáõÉÇÝ-è
Wosulin-R
2577
ìáõÉÝáõ½³Ý
Vulnusan
2578
ìáõñ¹áÝ
Vurdon
2579
ìáõñ¹áÝ
Vurdon
2580
ìáõñ¹áÝ
Vurdon
ìáõñ¹áÝ
Vurdon
ìáõñ¹áÝ
Vurdon
2581
2582
2583
2584
ìáõñ¹áÝ
Vurdon
ìáõñ¹áÝ
Vurdon
2585
ìý»Ý¹
Vfend
2586
ìý»Ý¹
50% Ù³ñ¹áõ é»·áõɳñ
¹»Õ³Ï³ËáõÛÃ
ÇÝëáõÉÇÝ, 50%
Ý»ñ³ñÏÙ³Ý
ǽáý³Ý ÇÝëáõÉÇÝ
(é»ÏáÙµÇݳÝï)
50% Human Regular
Insulin 50% Isophane
Insulin (recombinant)
Ù³ñ¹áõ ǽáý³Ý
¹»Õ³Ï³ËáõÛÃ
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
(é»ÏáÙµÇݳÝï)
Isophan Insulin Human
(recombinant)
Ù³ñ¹áõ ǽáý³Ý
¹»Õ³Ï³ËáõÛÃ
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
(é»ÏáÙµÇݳÝï)
Isophan Insulin Human
(recombinant)
Ù³ñ¹áõ é»·áõɳñ
ÉáõÍáõÛÃ
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
(é»ÏáÙµÇݳÝï)
Regular Insulin Human
(recûmbinant)
Ù³ñ¹áõ é»·áõɳñ
ÉáõÍáõÛÃ
ÇÝëáõÉÇÝ
Ý»ñ³ñÏÙ³Ý
(é»ÏáÙµÇݳÝï)
Regular Insulin Human
(recombinant)
ϳÛáõݳóí³Í ÙáËñ³çáõñ
ùëáõù
êáÉÇÉáõ·
stabilized lye Solilug
¹ÇÏÉáý»Ý³Ï
¹»Õ³Ñ³ï»ñ
ݳïñÇáõÙÇ
óճÝóå³ï
diclofenac sodium
³Õ»ÉáõÛÍ
¹ÇÏÉáý»Ý³Ï
ÉáõÍáõÛÃ
ݳïñÇáõÙÇ
Ý»ñ³ñÏÙ³Ý
diclofenac sodium
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ÙáÙÇÏÝ»ñ
diclofenac sodium
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
ÙáÙÇÏÝ»ñ
diclofenac sodium
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
¹»Õ³Ñ³ï»ñ
diclofenac sodium
óճÝóå³ï ¹³Ý¹³Õ
Ó»ñµ³½³ïٳٵ
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
¹»Õ³Ñ³ï»ñ
diclofenac sodium
óճÝóå³ï
¹Ç¿ÃÇɳÙáÝÇáõÙ
¹áݹáÕ
¹ÇÏÉáý»Ý³Ï
diclofenac
diethylammonium
íáñÇÏáݳ½áÉ
¹»Õ³Ñ³ï»ñ
voriconazole
óճÝóå³ï
íáñÇÏáݳ½áÉ
¹»Õ³Ñ³ï»ñ
40ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
ìáÏѳñ¹ Èï¹
Wockhardt Ltd
Ðݹϳëï³Ý
A10A D01
0090/6218
07.06.2006
07.06.2011
¸
100ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
ìáÏѳñ¹ Èï¹
Wockhardt Ltd
Ðݹϳëï³Ý
A10A C01
0122/6249
21.06.2006
21.06.2011
¸
40ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
ìáÏѳñ¹ Èï¹
Wockhardt Ltd
Ðݹϳëï³Ý
A10A C01
0088/6216
07.06.2006
07.06.2011
¸
100ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
ìáÏѳñ¹ Èï¹
Wockhardt Ltd
Ðݹϳëï³Ý
A10A B01
0121/6248
21.06.2006
21.06.2011
¸
40ØØ/ÙÉ,
10ÙÉ ëñí³Ï (1)
ìáÏѳñ¹ Èï¹
Wockhardt Ltd
Ðݹϳëï³Ý
A10A B01
0087/6215
07.06.2006
07.06.2011
¸
12·/100·,
45· å³ñÏáõ×
êáý³ñÙ³ ²¸
Sopharma AD
´áõÉÕ³ñdz
D03AX
1369/7331
13.11.2007
05.11.2012
¸
25Ù·
(30,100)
лÉ÷ ê.².
Help S.A.
Ðáõݳëï³Ý
M01A B05
M02A A15
4222
20.03.2003
20.03.2008
¸
75Ù·/3ÙÉ,
3ÙÉ ³ÙåáõÉÝ»ñ
(5)
100Ù·
(10)
50Ù·
(10)
100Ù·
(10)
лÉ÷ ê.².
Help S.A.
Ðáõݳëï³Ý
M01A B05
M02A A15
4223
20.03.2003
20.03.2008
¸
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
Ðáõݳëï³Ý
M01A B05
M02A A15
M01A B05
M02A A15
M01A B05
M02A A15
4968
11.10.2004
11.10.2009
11.10.2004
11.10.2009
11.10.2004
11.10.2009
¸
50Ù·
(20)
1%,
25· å³ñÏáõ×
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
Ðáõݳëï³Ý
4971
11.10.2004
11.10.2009
11.10.2004
11.10.2009
¸
Ðáõݳëï³Ý
M01A B05
M02A A15
M01A B05
M02A A15
S01B C03
50Ù·
(2,10,14,20,28,
30,50, 56,100)
лÛÝñÇË Ø³ù. ܳãý. ¶ÙµÐ ¨
øá. ζ
(öý³ÛÕ»ñ ¶ñáõå)
Heinrich Mack Nachf. GmbH &
Co. KG ((Pfizer Group)
лÛÝñÇË Ø³ù. ܳãý. ¶ÙµÐ ¨
¶»ñÙ³Ýdz
_
4179
19.03.2003
19.03.2008
¸
¶»ñÙ³Ýdz
_
4180
19.03.2003
¸
200Ù·
Ðáõݳëï³Ý
Ðáõݳëï³Ý
4969
4970
4972
¸
¸
²¸
177
Vfend
voriconazole
óճÝóå³ï
(2, 10, 14, 20,
28,30,50, 56,100)
2587
ìý»Ý¹
Vfend
íáñÇÏáݳ½áÉ
voriconazole
200Ù·,
ëñí³Ï (1)
2588
î³µ»ùë
Tabex
î³½»å³Ù
Tazepam
óÇïǽÇÝ
cytisine
ûùë³½»å³Ù
oxazepam
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
î³ÉÇïáÝ
Talliton
î³ÉÇïáÝ
Talliton
î³ÉÇïáÝ
Talliton
î³ÙÇý»Ý 10
Tamifen 10
î³ÙÇý»Ý 20
Tamifen 20
î³ÙûùëÇý»Ý §¾´ºìº¦
Tamoxifen
§EBEWE¦
î³ÙûùëÇý»Ý §¾´ºìº¦
Tamoxifen
§EBEWE¦
î³ÙûùëÇý»Ý
¹»Õ³Ñ³ï»ñ ´ä 10Ù·
Tamoxifen Tablets
BP 10mg
î³ÙûùëÇý»Ý
¹»Õ³Ñ³ï»ñ ´ä 20Ù·
Tamoxifen Tablets
BP 20mg
î³Ý³Ï³Ý
Tanakan
ϳñí»¹ÇÉáÉ
carvedilol
ϳñí»¹ÇÉáÉ
carvedilol
ϳñí»¹ÇÉáÉ
carvedilol
ï³ÙûùëÇý»Ý
tamoxifen
ï³ÙûùëÇý»Ý
tamoxifen
ï³ÙûùëÇý»Ý
tamoxifen
¹»Õ³Ñ³ï»ñ
6.25Ù·
(14,28)
12.5Ù·
(14,28)
25Ù·
(14,28)
10Ù·
(30)
20Ù·
(100)
10Ù·
(30)
ï³ÙûùëÇý»Ý
tamoxifen
¹»Õ³Ñ³ï»ñ
20Ù·
(30)
ï³ÙûùëÇý»ÝÇ óÇïñ³ï
tamoxifen citrate
¹»Õ³Ñ³ï»ñ
ï³ÙûùëÇý»ÝÇ óÇïñ³ï
tamoxifen citrate
2589
2590
2591
2592
2593
2594
2595
2596
2597
2598
2599
øá. ζ
(öý³ÛÕ»ñ ¶ñáõå)
Heinrich Mack Nachf. GmbH &
Co. KG ((Pfizer Group)
öý³Û½»ñ ê.².
Pfizer S.A.
19.03.2008
üñ³Ýëdz
_
4273
02.04.2003
02.04.2008
¸
´áõÉÕ³ñdz
N07BA00
1368/7330
²¸
Ȼѳëï³Ý
N05B A04
6097
13.11.2007
05.11.2012
12.04.2006
12.04.2011
ÐáõÝ·³ñdz
C07A G02
6020
ÐáõÝ·³ñdz
C07A G02
6021
ÐáõÝ·³ñdz
C07A G02
6022
ÎÇåñáë
L02B A01
4512
ÎÇåñáë
L02B A01
4513
²íëïñdz
L02B A01
4566
²íëïñdz
L02B A01
10Ù·
(30)
êáý³ñÙ³ ´À
Sopharma JSC
î³ñËáÙÇÝÇ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý §äáÉý³¦ ê.².
Tarchomin Pharmaceutical
Work §Polfa¦ S.A.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
¾·Çë ü³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Egis Pharmaceuticals Ltd.
Ø»¹áù»ÙÇ Èï¹.
Medochemie Ltd.
Ø»¹áù»ÙÇ Èï¹.
Medochemie Ltd.
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð.Üý·.ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð.Üý·.ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹
CP Pharmaceuticals Ltd.
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
¹»Õ³Ñ³ï»ñ
20Ù·
(30)
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹
CP Pharmaceuticals Ltd.
ÉáõÍáõÛà ËÙ»Éáõ
40Ù·/ÙÉ,
30ÙÉ, 60ÙÉ,
90ÙÉ,100ÙÉ ßßÇÏ
40Ù·
(30,60,90)
¹áݹáÕ
5%,
50· å³ñÏáõ×
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
1,5Ù·
(100)
10Ù·
(50)
2600
î³Ý³Ï³Ý
Tanakan
2601
î³ÝïáõÙ
Tantum
·ÇÝÏ·á µÇÉáµ³ÛÇ
ѳÝáõÏ
extract ginkgo biloba
·ÇÝÏ·á µÇÉáµ³ÛÇ
ѳÝáõÏ
extract ginkgo biloba
µ»Ý½Ç¹³ÙÇÝ
benzydamine
2602
î³ÝïáõÙ ì»ñ¹»
Tantum Verde
µ»Ý½Ç¹³ÙÇÝ
benzydamine
óáÕ³ßÇÃ
µ»ñ³ÝÇ
0,15%
2603
î³ÝïáõÙ ì»ñ¹»
Tantum Verde
µ»Ý½Ç¹³ÙÇÝ
benzydamine
ÉáõÍáõÛÃ
0,15%,
60ÙÉ, 120ÙÉ,
150ÙÉ, 1000ÙÉ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¸\Ð
23.03.2006
23.03.2011
23.03.2006
23.03.2011
23.03.2006
23.03.2011
05.10.2004
05.10.2009
05.10.2004
05.10.2009
28.10.2003
28.10.2008
¸
4567
28.10.2003
28.10.2008
¸
L02B A
1431/7387
20.12.2007
20.12.2012
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
L02B A
1430/7386
20.12.2007
20.12.2012
¸
´áýáõñ Æåë»Ý ÆݹáõëïñÇ
Beaufour Ipsen Industrie
üñ³Ýëdz
N06B X19
4227
06.03.2003
06.03.2008
¸
´áýáõñ Æåë»Ý ÆݹáõëïñÇ
Beaufour Ipsen Industrie
üñ³Ýëdz
N06B X19
4228
06.03.2003
06.03.2008
¸
²Ýç»ÉÇÝÇ üñ³Ýã»ëÏá ê.å.². ².ò.è.².ü.
Angelini Francesco S.p.A. A.C.R.A.F.
²Ýç»ÉÇÝÇ üñ³Ýã»ëÏá ¾Û-êDzé-¾Û-¾ý ê.å.².
Angelini Francesco -A.C.R. A.F
.S.p.A.
²Ýç»ÉÇÝÇ üñ³Ýã»ëÏá ¾Û-êDzé-¾Û-¾ý ê.å.².
Angelini Francesco -A.C.R. A.F
Æï³Édz
M01A X07,
M02A A05
0003/5127
19.04.2006
19.04.2011
²¸
Æï³Édz
A01A D02
1331/5049/1
31.10.2007
13.08.2009
²¸
Æï³Édz
A01A D02
1332/5048/1
31.10.2007
16.09.2009
²¸
¸
¸
¸
¸
¸
178
2604
î³ÝïáõÙ í»ñ¹»
Tantum Verde
µ»Ý½Ç¹³ÙÇÝ
benzydamine
Éá½³ÝÝ»ñ
ßßÇÏ
3Ù·
(20,30)
2605
î³áõýáÝ
Taufon
ï³áõñÇÝ
taurine
ÉáõÍáõÛÃ
(³ÏݳϳÃÇÉÝ»ñ)
4%,
10ÙÉ ßßÇÏ
î³áõýáÝ-ü³ñÙ³Ï
Taufon-Farmak
2607 î³áõýáÝ-ý³ñÙ³ï»ù
Taufon-PharmaTech
2608
î³í³ÝÇÏ
Tavanic
ï³áõñÇÝ
taurine
ï³áõñÇÝ
taurin
ɨáýÉûùë³óÇÝ
levofloxacin
³ÏݳϳÃÇÉÝ»ñ
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
4%,
5ÙÉ, 10ÙÉ ßßÇÏ
4%,
5ÙÉ, 10ÙÉ ßßÇÏ
5Ù·/ÙÉ,
100ÙÉ ëñí³Ï
2609
î³í³ÝÇÏ
Tavanic
ɨáýÉûùë³óÇÝ
levofloxacin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(5, 7,10)
2610
î³í³ÝÇÏ
Tavanic
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(5,7)
2611
î³í»·ÇÉ
Tavegyl
ɨáýÉûùë³óÇÝÇ
Ñ»ÙÇÑǹñ³ï
levofloxacin
hemihydrate
ÏɻٳëïÇÝ
clemastine
2612
î³í»·ÇÉ
Tavegyl
ÏɻٳëïÇÝ
clemastine
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2613
î³í»·ÇÉ
Tavegyl
ÏɻٳëïÇÝ
clemastine
¹»Õ³Ñ³ï»ñ
2614
î³í»·ÇÉ
Tavegyl
î³ñÇý»ñǹ
Tariferid
î³ñó»í³
Tarceva
ÏɻٳëïÇÝ
clemastine
ûýÉûùë³óÇÝ
ofloxacin
¿ñÉáïÇÝǵ
erlotinib
¹»Õ³Ñ³ï»ñ
2606
2615
2616
³ÏݳϳÃÇÉÝ»ñ
ûß³ñ³Ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
.S.p.A.
²Ýç»ÉÇÝÇ üñ³Ýã»ëÏá ê.å.².,
².Î.è.².ü. (÷³Ã»Ã³íáñáõÙÁª ¸Çß
²¶, Þí»Ûó³ñdz ²Ç-¾ë-êÇ
ü³ñÙ³ëÛáõÃÇù³Éë, ²íëïñdz)
Angelini Francesco S.p.A.,
A.C.R.A.F., packed by Disch
AG for CSC Pharmaceutical,
Austria
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
ü³ñÙ³Ï ´´À
Farmak JSC
ü³ñÙ³î»ù ö´À
PharmaTech CJSC
ÐÛáËëï سñÇáÝ èáõë»É
(²í»ÝïÇë ü³ñÙ³ ¶ÙµÐ)
Hoechst Marion Rousel
(Aventis Pharma GmbH)
ÐÛáËëï Ù³ñÇáÝ èáõë»É
(²í»ÝïÇë ü³ñÙ³ ¶ÙµÐ)
Hoechst Marion Rousel
(Aventis Pharma GmbH)
²í»ÝïÇë ÆÝï»ñÏáÝïÇÝ»Ýï³É
Aventis Intercontinental
0.67Ù·/5ÙÉ,
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
60ÙÉ,100ÙÉ ßßÇÏ (Þí»Ûó³ñdz) ϳ½Ù³Ï»ñåáõÃÛ³Ý
ѳٳñ Üáí³ñïÇë
¾Ýï»ñåñ³Û½Çë öñÇí³ï
ÈÇÙÇﻹ (Ðݹϳëï³Ý)
Novartis Enterprises Private
Limited (India) for Novartis
Consumer Health (Switzerland)
1Ù·/ÙÉ,
Üáí³ñïÇë ü³ñÙ³ ²¶
2ÙÉ ³ÙåáõÉÝ»ñ
Novartis Pharma AG
(5)
1Ù·
ü³Ù³ñ Æï³Édz ê.å.² (Üáí³ñïÇë
(20/2x10/)
øáÝëÛáõÙ»ñ лÉà ê»ñíÇ뻽
ê.².-Ç Ñ³Ù³ñ, Þí»ó³ñdzÛ)
Famar Italia S.p.A. for Novartis
Consumer Health Servises
S.A., Switzerland
1Ù·
Üáí³ñïÇë ü³ñÙ³ ²¶
(20)
Novartis Pharma AG
0.2·
§´ñÇÝó³Éáí-²¦ ö´À
(10,20)
§Brinsalov-A¦ CJSC
150Ù·
Þí³ñó ü³ñÙ³ سÝáõý³ÏïáõñÇÝ·
(30)
ÆÝÏ (ü.ÐáýÙ³Ý-ȳ èáß
Èï¹.ÉÇó»Ý½Ç³Ûáí)
Made under licence from
F.Hoffmann-La Roche Ltd. By
Schwarz Pharma
Æï³Édz
G02C C03
M01A X07
M02A A05
5050
03.09.2004
03.09.2009
²¸
г۳ëï³Ý
S
5207
13.12.2004
13.12.2009
¸
àõÏñ³Çݳ
S01X A
5694
¸
г۳ëï³Ý
S01A
0993/6622
¶»ñÙ³Ýdz
J01M A12
0497/6487
19.08.2005
19.08.2010
30.05.2007
30.05.2012
25.10.2006
25.10.2011
¶»ñÙ³Ýdz
J01M A12
0498/6486
25.10.2006
25.10.2011
¸
üñ³Ýëdz
J01M A12
0392/6347
12.09.2006
12.09.2011
¸
Ðݹϳëï³Ý
D04A A14,
R06A A04
4638
16.02.2004
16.02.2009
²¸
Þí»Ûó³ñdz
D04A A14
R06A A04
4872
15.06.2004
15.06.2009
¸
Æï³Édz
R06A A04
1327/6586
31.10.2007
31.10.2012
²¸
Þí»Ûó³ñdz
4448
²ØÜ
-
5665
19.09.2003
19.09.2008
29.03.2004
29.03.2009
12.07.2005
12.07.2010
²¸
èáõë³ëï³Ý
D04A A14
R06A A04
J01F A01
4763
¸
¸
¸
¸
179
2617
î»·ñ»ïáÉ 200
Tegretol 200
ϳñµ³Ù³½»åÇÝ
carbamazepine
¹»Õ³Ñ³ï»ñ
200Ù·
(50)
2618
î»Ùå³É·ÇÝ
Tempalgin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(500Ù·+20Ù·)
(20)
2619
î»Ùå³Ý·ÇÝáÉ
Tempanginol
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(500Ù·+20Ù·)
(10)
2620
î»ÝáñÇÏ
Tenoric
¹»Õ³Ñ³ï»ñ
50Ù·+12.5Ù·,
(28, (10X10))
2621
î»Ýáùë
Tenox
î»Ýáùë
Tenox
î»í»ï»Ý
Teveten
î»í»ï»Ý åÉÛáõë
Teveten plus
Ù»ï³ÙǽáÉ,
ïñdzó»ïá³ÙÇÝ 4ïáÉáõ»ÝëáõÉýáݳï
metamizole,
triacetoamine 4toluensulfonate
Ù»ï³ÙǽáÉ
ݳïñÇáõÙÇ ³Õ,
»é³ó»ïáݳÙÇÝ 4ÃáÉáõ»ÝëáõÉýáݳï
metamizole sodium,
triacetonamine 4toluensulfonate
³ï»ÝáÉáÉ,
ùÉáñóÉǹáÝ
atenolol,
chlorthalidone
³ÙÉá¹ÇåÇÝ
amlodipine
³ÙÉá¹ÇåÇÝ
amlodipine
¿åñáë³ñï³Ý
eprosartan
¿åñáë³ñï³Ý,
ÑǹñáùÉáñáÃdz½Ç¹
eprosartan,
hydrochlorothiazide
¹ÇëáõÉýÇñ³Ù
disulfiram
Manufacturing Inc.
Üáí³ñïÇë ü³ñÙ³ ê.å.² (Üáí³ñïÇë
ü³ñÙ³ ²¶, Þí»Ûó³ñdzÛÇ Ñ³Ù³ñ)
Novartis Pharma S.p.A. (for
Novartis Pharma AG,
Switzerland)
êáý³ñÙ³ ´À
Sopharma JSC
¹»Õ³Ñ³ï»ñ
10Ù·
(30,90)
5Ù·
(30,90)
600Ù·
(14,28,56)
600Ù·+12.5Ù·
(14,28,64)
¹»Õ³Ñ³ï»ñ
0.15·
(30/3x10/)
³ÏݳϳÃÇÉÝ»ñ
1%,
10ÙÉ ßßÇÏ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
¹»Õ³å³ïÇ×Ý»ñ
20ÙÉ, 50ÙÉ,
100ÙÉ ëñí³Ï
2622
2623
2624
2625
î»ïáõñ³Ù
Teturam
2626
î»ïñ³Ï³ÛÇÝ
Tetracaine
2627
î»ïñ³íÇï
Tetravit
2628
î»ïñ³óÇÏÉÇÝ
Tetracycline
î»ïñ³óÇÏÉÇÝ
Tetracycline
î»ïñ³óÇÏÉÇÝ
Tetracycline
ï»ïñ³Ï³ÛÇÝÇ
ÑǹñáùÉáñǹ
tetracaine
hydrochloride
A, D3, E, F
íÇï³ÙÇÝÝ»ñ
vitamins A, D3, E, F
ï»ïñ³óÇÏÉÇÝ
tetracycline
ï»ïñ³óÇÏÉÇÝ
tetracycline
ï»ïñ³óÇÏÉÇÝ
tetracycline
î»ïñ³óÇÏÉÇÝ
Tetracycline
î»ïñ³óÇÏÉÇÝÇ
ï»ïñ³óÇÏÉÇÝ
tetracycline
ï»ïñ³óÇÏÉÇÝ
2629
2630
2631
2632
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ùëáõù
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ùëáõù
250Ù·
(20)
3%,
15· å³ñÏáõ×
250Ù·
(10,20)
100Ù·
(20/2x10/)
3%,
Æï³Édz
N03AX01
0859/6811
30.03.2007
30.03.2012
¸
´áõÉÕ³ñdz
N02B B72
1310/7281
16.10.2007
12.10.2012
¸
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´áõÉÕ³ñdz
N02B B72
1019/7013
13.06.2007
13.06.2012
²¸
Æåϳ ȳµáñ³ïáñdz Èï¹.
Ipca Laboratories Ltd.
Ðݹϳëï³Ý
C07D B01
3820
04.08.2003
04.08.2008
¸
Îèβ ¹.¹.,Üáíá Ù»ëïá
êÉáí»Ýdz
KRKA d.d. Novo mesto
Îèβ ¹.¹.,Üáíá Ù»ëïá
êÉáí»Ýdz
KRKA d.d. Novo mesto
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì. Üǹ»éɳݹSolvay Pharmaceuticals B.V.
Ý»ñ
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶»ñÙ³Ýdz
¶ÙµÐ
Solvay Pharmaceuticals GmbH
C08C A01
6091
¸
C08C A01
6090
-
4301
-
4911
12.04.2006
12.04.2011
12.04.2006
12.04.2011
10.06.2003
10.06.2008
21.06.2004
21.06.2009
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
èáõë³ëï³Ý
V03A A01
0408/6355
19.09.2006
19.09.2011
¸
г۳ëï³Ý
S01H A03
1017/7027
13.06.2007
13.06.2012
¸
ÜÇï³-ü³ñÙ ö´À
Nita-Farm Closed JSC
èáõë³ëï³Ý
³Ý³ëݳµáõųϳÝ
0751/6722
15.02.2007
15.02.2012
¸
èáõÙÇÝdz
A01A B13
J01A A07
D06A A04
4535
¸
г۳ëï³Ý
A01A B13,
J01A A07
4692
04.11.2003
04.11.2008
16.05.2005
16.05.2010
16.02.2004
16.02.2009
´»É³éáõë
J01AA07
0887/6891
г۳ëï³Ý
D06A A04
5187
ºíñáý³ñÙ ê.².
Europharm
S.A.
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
§ÜúÎƦ ѳ۳ٻñÇϳ·»ñٳݳϳÝ
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ êäÀ
§NOKI¦ Armenian-AmericanGerman Pharmac. J.V.Co.Ltd.
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàõÒ
Belmedpreparaty RUP
¾ëÏáõɳå êäÀ
èáõë³ëï³Ý
5532
13.04.2007
13.04.2012
21.01.2005
¸
¸
¸
²¸
¸
¸
²¸
180
2633
2634
2635
2636
2637
2638
2639
2640
2641
2642
2643
ùëáõù
Tetracycline
ointment
î»ïñ³óÇÏÉÇÝÇ
ùëáõù
Tetracycline
ointment
î»ñ³ýÉÛáõ
Teraflu
tetracycline
ï»ïñ³óÇÏÉÇÝ
tetracycline
³Ïݳùëáõù
15·, 30· å³ñÏáõ×
ϳ٠³å³Ï» ï³ñ³
Esculap Ltd.
1%,
3·,7·,10· å³ñÏáõ×
³ÃùÇÙý³ñÙåñ»å³ñ³ïÇ ´´À
Tatchimpharmpre-paraty
OJSC
ä³Ã»áÝ àõÇÃµÇ ÆÝÏ.,
(Üáí³ñïÇë øáÝëáõÙ»ñ лÉÃ-Ç
ѳٳñ)
Patheon Whitby Inc., (for
Novartis Consumer Health)
ý»ÝÇñ³ÙÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ
20Ù·+10Ù·+
ý»ÝÇÉ¿ýñÇÝ,
ÉáõÍáõÛÃÇ
325Ù·+50Ù·
å³ñ³ó»ï³ÙáÉ,
÷³Ã»ÃÝ»ñ
³ëÏáñµÇݳÃÃáõ
(6,8,10,12)
pheniramine,
phenylephrine,
paracetamole, ascorbic
acid
î»ñ³ýÉÛáõ ¿ùëïñ³
ý»ÝÇñ³ÙÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ 20Ù·+10Ù·+ 650Ù·
ä³Ã»áÝ àõÇÃµÇ ÆÝÏ.,
Teraflu Extra
ý»ÝÇÉ¿ýñÇÝ,
ÉáõÍáõÛÃÇ
÷³Ã»ÃÝ»ñ
(Üáí³ñïÇë øáÝëáõÙ»ñ лÉÃ-Ç
å³ñ³ó»ï³ÙáÉ
(6,8,10,12)
ѳٳñ)
pheniramine,
Patheon Whitby Inc., (for
phenylephrine,
Novartis Consumer Health)
paracetamole
î»ñµÇ½ÇÉ
ï»ñµÇݳýÇÝ
¹»Õ³Ñ³ï»ñ
250Ù·
¶»¹»áÝ èÇËï»ñ ´´À
Terbisil
terbinafine
(14, 28/2x14/)
Gedeon Richter Plc.
î»ñµÇ½ÇÉ
ï»ñµÇݳýÇÝ
Ýñµ³ùëáõù
1%,
¶»¹»áÝ èÇËï»ñ ´´À
Terbisil
terbinafine
15· å³ñÏáõ×
Gedeon Richter Plc.
î»ñÅÇݳÝ
ï»ñÝǹ³½áÉ,
¹»Õ³Ñ³ï»ñ
0.2·+0.1·/
´áõß³ñ³ è»Ïáñ¹³ïÇ BoucharaTergynan
Ý»áÙÇóÇÝ, ÝÇëï³ïÇÝ,
Ñ»ßïáó³ÛÇÝ
65000ØØ/+
Recordati
åñ»¹ÝǽáÉáÝ
100000ØØ+ 0.003·
ternidazole, neomycine,
(6,10)
nystatine, prednizolone
îdzÝßÇ §ÈÛ³Ý Ú³Ý¦
å³ïÇ×Ý»ñ
0.45·
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
/·»Õ»óϳóÝáÕ/
(80)
Tianjin Tianshi Co.Ltd.
å³ïÇ×Ý»ñ
Tianshi Beauty
Capsules
îdzÝßÇ §Î»Ýë³Ï³Ý¦
å³ïÇ×Ý»ñ
0.8·
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
(§ì»Ûϳݦ) ÷³÷áõÏ
(80)
Tianjin Tianshi Co.Ltd.
å³ïÇ×Ý»ñ
Tianshi Vitality
Softgel Capsules
îdzÝßÇ §ê³Ý ¶³á
å³ïÇ×Ý»ñ
0.45·
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
¸³Ý¦ (ÂñÇßáÙá
(30)
Tianjin Tianshi Co.Ltd.
³ÝßÇÝáÝ
È»Ûßáõ³) å³ïÇ×Ý»ñ
Tianshi Trishomo
Tanshinone Laisure
Capsules
îdzÝßÇ ³ñ¹Ûáõݳí»ï
å³ïÇ×Ý»ñ
0.4·
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
å³ïÇ×Ý»ñ
(150)
Tianjin Tianshi Co.Ltd.
Tianshi Benefical
Capsules
îdzÝßÇ ËÇïá½³Ý
å³ïÇ×Ý»ñ
0.315·
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
å³ïÇ×Ý»ñ
(100)
Tianjin Tianshi Co.Ltd.
Tianshi Chitosan
Capsules
21.01.2010
èáõë³ëï³Ý
S01A A09
S02A A08
5189
19.11.2004
19.11.2009
¸
γݳ¹³
N02B E71
4473
19.08.2003
19.08.2008
²¸
γݳ¹³
N02B E71
4472
19.08.2003
19.08.2008
²¸
ÐáõÝ·³ñdz
D01B A02
0726/6655
¸
ÐáõÝ·³ñdz
D01A E15
0727/6656
üñ³Ýëdz
A07A
D06A
R02B
4931
13.02.2007
13.02.2012
13.02.2007
13.02.2012
07.06.2004
07.06.2009
âÇݳëï³Ý
βêÐ
4681
03.12.2003
03.12.2008
²¸
âÇݳëï³Ý
βêÐ
4675
03.12.2003
03.12.2008
²¸
âÇݳëï³Ý
βêÐ
4682
03.12.2003
03.12.2008
²¸
âÇݳëï³Ý
βêÐ
4679
03.12.2003
03.12.2008
²¸
âÇݳëï³Ý
βêÐ
4678
03.12.2003
03.12.2008
²¸
²¸
¸
181
2644 îdzÝßÇ Ï³ÉóÇáõÙÇ
µ³ñÓñ å³ñáõݳÏáõÃÛ³Ùµ Ù³ÝϳϳÝ
ëÝݹ³ñ³ñ ÷áßÇ
Tianshi Nutrient
High Calcium
Powder
2645 îdzÝßÇ Ï³ÉóÇáõÙÇ
µ³ñÓñ å³ñáõݳÏáõÃÛ³Ùµ ëÝݹ³ñ³ñ
÷áßÇ
Tianshi Nutrient
High Calcium
Powder
2646 îdzÝßÇ Ï³ÉóÇáõÙÇ
ͳٻÉáõ ѳµ»ñ
Tianshi Calcium
Chewable Tablets
2647 îdzÝßÇ Ï³ÉóÇáõÙÇ
áõÕ»Õ³ËóÝÇã
å³ïÇ×Ý»ñ
Tianshi High
Calcium Braintonic
Capsules
2648 îdzÝßÇ Ïáñ¹Çó»åëÇ
ÙÇó»ÉÇáõÙÇ
å³ïÇ×Ý»ñ
Tianshi Cordiceps
Mycelium Capsules
2649
îdzÝßÇ ÏñÏݳÏÇ
ó»ÉÛáõÉὠѳµ»ñ
Tianshi Double
Cellulose Tablets
2650
îdzÝßÇ
ѳϳÉÇåǹ³ÛÇÝ
ûÛ
Tianshi Tea
Antilipemic
2651
îdzÝßÇ
ÝÇѳñ»óÝáÕ Ã»Û
Tianshi Slimming
Tea
2652
îdzÝßÇ óÇÝÏÇ
ÁÝïÇñ ѳí»ÉáõÙ
Tianshi Zinci Cream
Supplement
2653
îǽ»ñóÇÝ
Tisercin
2654
îǽÇÝ
Tyzine
2655
îǽÇÝ
Tyzine
2656
îÇÝǹ³½áÉ
Tinidazol
2657
îÇÝǹ³½áÉ
-
÷áßÇ
10·
÷³Ã»ÃÇÏÝ»ñ (10)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4700
30.12.2003
30.12.2008
²¸
-
÷áßÇ
10·
÷³Ã»ÃÇÏÝ»ñ (10)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4671
03.12.2003
03.12.2008
²¸
-
ѳµ»ñ
1.2·
(60)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4673
03.12.2003
03.12.2008
²¸
-
å³ïÇ×Ý»ñ
0.4·
(18)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4672
03.12.2003
03.12.2008
²¸
-
å³ïÇ×Ý»ñ
0.5·
(100)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4680
03.12.2003
03.12.2008
²¸
-
ѳµ»ñ
1·
(70)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá. Èï¹.
Tianjin Tianshi Co. Ltd.
âÇݳëï³Ý
βêÐ
4676
03.12.2003
03.12.2008
²¸
-
µáõë³÷áßÇ
1.5·
÷³Ã»ÃÇÏÝ»ñ (40)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4677
03.12.2003
03.12.2008
²¸
-
µáõë³÷áßÇ
1.5·
÷³Ã»ÃÇÏÝ»ñ (40)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4683
03.12.2003
03.12.2008
²¸
-
å³ïÇ×Ý»ñ
0.27·
(60)
îÛ³Ýó½ÇÝ îÛ³ÝßÇ øá.Èï¹.
Tianjin Tianshi Co.Ltd.
âÇݳëï³Ý
βêÐ
4674
03.12.2003
03.12.2008
²¸
ɨáÙ»åñáÙ³½ÇÝ
levomepromazine
ï»ïñǽáÉÇÝ
tetryzoline
ï»ïñǽáÉÇÝ
tetryzoline
ïÇÝǹ³½áÉ
tinidazole
ïÇÝǹ³½áÉ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ùóϳÃÇÉÝ»ñ
25Ù·
(50)
0.05%,
10ÙÉ ßßÇÏ
0.1%,
10ÙÉ ßßÇÏ
500Ù·
(4)
500Ù·
¾¶Æê ´´À
EGIS PLC
öý³Û½»ñ ¶ÙµÐ
Pfizer GmbH
öý³Û½»ñ ¶ÙµÐ
Pfizer GmbH
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupniza AD
äáÉý³ñÙ³ ê.².
ÐáõÝ·³ñdz
N05A A02
0979/6981
¸\Ð
¶»ñÙ³Ýdz
4736
´áõÉÕ³ñdz
R01A A06
S01G A02
R01A A06
S01G A02
J01X D02
0618/6645
Ȼѳëï³Ý
J01X D02
0064/6157
22.05.2007
22.05.2012
30.07.2004
30.07.2009
30.07.2004
30.07.2009
18.12.2006
18.12.2011
02.06.2006
ùóϳÃÇÉÝ»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
¶»ñÙ³Ýdz
4735
²¸
²¸
¸
¸
182
2658
2659
2660
2661
2662
2663
2664
2665
2666
Tinidazole
îÇÝǹ³½áÉ-²ÏñÇ
Tinidazole-Akri
îÇÝǹ³½áÉ-²ëï»ñdz
Tinidazole-Asteria
îÇïáõë
Titus
îáÏáý³ñÙ
Tocopharm
îáݽÇÉáïñ»Ý
Tonsilotren
îáå³Ù³ùë
Topamax
îáå³Ù³ùë
Topamax
îáåá·»É
Topogel
îáï±Ð»Ù³
Tot±Hema
2667
îáñ³¹áÉ
Toradol
2668
îáñ³¹áÉ
Toradol
2669
îáñ³¹áÉ
Toradol
2670
îáñ³¹áÉ
Toradol
2671
îáõÉÇÝ
Tullin
2672
îáõÉÇå
Tulip
2673
îáõÉÇå
Tulip
2674
îáõÉÇå
Tulip
2675 îáõÛ³ ÏáÙå (Ù»¹ÝÇ
íë³¹ÝÇÏ)
Thuja comp (mednij
tinidazole
ïÇÝǹ³½áÉ
tinidazole
ïÇÝǹ³½áÉ
tinidazole
Éáñ³½»å³Ù
lorazepam
ÃáÏáý»ñáÉ
tocopherol
-
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ Å»É³ïÇÝ»
¹»Õ³Ñ³ï»ñ
ïáåÇñ³Ù³ï
¹»Õ³Ñ³ï»ñ
topiramate
óճÝóå³ï
ïáåÇñ³Ù³ï
¹»Õ³Ñ³ï»ñ
topiramate
óճÝóå³ï
Ï»ïáåñáý»Ý
¹áݹáÕ
ketoprofen
»ñϳÃÇ, ٳݷ³ÝÇ,
ÉáõÍáõÛà ËÙ»Éáõ
åÕÝÓÇ ·ÉÛáõÏáݳïÝ»ñ
ferrous, manganes,
copper gluconates
Ï»ïáñáɳÏÇ ïñáÙ»ï³ÙáÉ ÉáõÍáõÛà Ù/Ù,
ketorolac trometamol
Ý/»
Ý»ñ³ñÏáõÙÝ»ñÇ
(4,16)
0.5·
(4)
500Ù·
(100)
1Ù·
(20)
0.1·
(40,80)
(60)
25Ù·
(28,60)
100Ù·
(28,60)
2.5%,
40· å³ñÏáõ×
(50Ù·+1.33Ù·+
0.7Ù·)/
10ÙÉ,
³ÙåáõÉÝ»ñ (20)
30Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
Ï»ïáñáɳÏÇ ïñáÙ»ï³ÙáÉ
ketorolacum
trometamolum
Ï»ïáñáɳÏÇ ïñáÙ»ï³ÙáÉ
ketorolacum
trometamolum
Ï»ïáñáɳÏÇ ïñáÙ»ï³ÙáÉ
ketorolac trometamol
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
10Ù·
(20)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»ùëïñáÙ»Ãáñý³Ý,
·áõ³Ûý»Ý»½ÇÝ,
÷먹á¿ý»¹ñÇÝ,
å³ñ³ó»ï³ÙáÉ
dextromethorphane,
guifenesin,
pseudoephedrine,
paracetamol
³ïáñí³ëï³ïÇÝ
atorvastatin
³ïáñí³ëï³ïÇÝ
atorvastatin
³ïáñí³ëï³ïÇÝ
atorvastatin
-
¹»Õ³å³ïÇ×Ý»ñ
÷³÷áõÏ, ŻɳïÇÝ»
30Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
10Ù·/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
10Ù·+100Ù·+
30Ù·+ 250Ù·
(20, 250, 500)
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ϳÃÇÉÝ»ñ
ÑáÙ»áå³Ã³ÛÇÝ
10Ù·
(30, 60, 90)
20Ù·
(30, 60, 90)
40Ù·
(30, 60, 90)
25ÙÉ ßßÇÏ
Polpharma S.A.
²ÏñÇËÇÝ ´´À
Akrikhin
èáõë³ëï³Ý
Open JSC
ÐáõáÝë øá. Èï¹.
Îáñ»³
Huons Co.Ltd
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Ðáõݳëï³Ý
Help S.A. Pharmaceuticals
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
´áõÉÕ³ñdz
Balkanpharma-Troyan AD
¶»ñÙ³Ý³Ï³Ý ÐáÙ»áå³Ã³ÛÇÝ
¶»ñÙ³Ýdz
ØÇáõÃÛáõÝ (¶ÐØ)
Deutsche Homoopathie Union
(DHU)
Ú³Ýë»Ý-êÇɳ· ü³ñÙ³ëÛáõÃÇù³ äáñïáõ·³-Édz
Janssen-Cilag Farmaceutica
Ú³Ýë»Ý-êÇɳ· ü³ñÙ³ëÛáõÃÇù³ äáñïáõ·³-Édz
Janssen-Cilag Farmaceutica
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
´áõÉÕ³ñdz
Balkanpharma-Troyan AD
ȳµáñ³ïáñdz ÆÝÝáï»ù
üñ³Ýëdz
ÆÝï»ñݳëÇáÝ³É Laboratoires
Innotech International
êºÜºøêÆ ê²ê (ü. ÐáýÙ³Ý È³
èáß Èï¹. (Þí»Ûó³ñdz)-Ç Ñ³Ù³ñ)
CENEXI SAS (for F.
Hoffmann-La Roche Ltd.Switzerland)
èáß ü³ñÙ³ ê.².
Roche
Pharma S.A.
J01X D02
P01A B02
J01X D02,
P01A B02
N05B A06
4920
A11H A03
4083
ÑáÙ»áå³Ã³ÛÇÝ ¹»Õ
5217
N03A X11
4599
N03A X11
4600
M02A A10
0160/6272
5486
5298
4637
02.06.2011
12.08.2004
12.08.2009
26.05.2005
26.05.2010
13.01.2005
13.01.2010
03.03.2003
03.03.2008
13.12.2004
13.12.2009
19.12.2003
19.12.2008
19.12.2003
19.12.2008
07.07.2006
07.07.2011
15.01.2004
15.01.2009
¸
¸
¸\Ð
²¸
²¸
¸
¸
²¸
¸
üñ³Ýëdz
M01A B15
1182/7219
20.09.2007
13.09.2012
¸
Æëå³Ýdz
M01A B15
4562
15.12.2003
15.12.2008
¸
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
Hoffmann-La Roche Ltd
Þí»Ûó³ñdz
M01A B15
4563
15.12.2003
15.12.2008
¸
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
F.Hoffmann-La Roche Ltd.
Þí»Ûó³ñdz
M01A B15,
S01B C05
4850
13.04.2004
13.04.2009
¸
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia Pharmaceutical
êÇñdz
R05D
R01B A52
4984
04.10.2004
04.10.2009
¸
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
³ÉÇáÝ-²
Talion-A
êÉáí»Ýdz
C10A A05
1044/7051
¸
êÉáí»Ýdz
C10A A05
1045/7052
êÉáí»Ýdz
C10A A05
1047/6996
èáõë³ëï³Ý
ÑáÙ»áå³Ã³ÛÇÝ
0965/6987
02.07.2007
02.07.2012
02.07.2007
02.07.2012
02.07.2007
02.07.2012
14.05.2007
14.05.2012
¸
¸
²¸
183
2676
2677
vsadnik)
îáõëÇÝ
Tussin
îáõëÇÝ åÉÛáõë
Tussin Plus
·áõ³Ûý»Ý»½ÇÝ
guaifenesin
·áõ³Ûý»Ý»½ÇÝ,
¹»ùëïñáÙ»Ãáñý³ÝÇ
ÑǹñáµñáÙǹ
guaifenesin,
dextromethorphan
hydrobromide
¹»ùëïñáÙ»Ãáñý³Ý,
ûùëáٻٳ½ÇÝ,
ݳïñÇáõÙÇ µ»Ý½á³ï
dextromethorphane,
oxomemazine, sodium
benzoate
³ïñ³ÏáõñÇáõÙÇ
µ»½Çɳï
atracurium besilate
ûß³ñ³Ï
100Ù·/5ÙÉ,
118ÙÉ ßßÇÏ
(100Ù·+10Ù·)/5ÙÉ,
118ÙÉ ßßÇÏ
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
²ØÜ
R05C A03
0748/6760
²ØÜ
R05CA03
0881/6888
ûß³ñ³Ï
(10Ù·+1.5Ù·+
60Ù·)/ 5ÙÉ,
100ÙÉ ßßÇÏ
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Æݹ³ëïñÇ
Asia Pharmaceutical Industries
êÇñdz
R05D,
R06A
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
10Ù·/ÙÉ (2,5ÙÉ),
³ÙåáõÉÝ»ñ (5)
Æï³Édz
5%,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
50Ù·/1ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
100Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
50Ù·
(20)
100Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
50Ù·/1ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
100Ù·/ÙÉ,
10ÙÉ ßßÇÏ
5% (2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(5,10)
100Ù·/2ÙÉ,
³ÙåáõÉÝ»ñ (5)
¶É³ùëá êÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
Glaxo SmithKline
Pharmaceuticals S.A.
´ÇáÉ»Ï ö´À
Biolek CJSC
ûß³ñ³Ï
2678
îáùëÇÉ-²ëdz
Toxil-Asia
2679
îñ³ÏñÇáõÙ
Tracrium
2680
îñ³Ù³¹áÉ
Tramadol
ïñ³Ù³¹áÉ
tramadol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2681
îñ³Ù³¹áÉ
Tramadol
ïñ³Ù³¹áÉ
tramadol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2682
îñ³Ù³¹áÉ
Tramadol
ïñ³Ù³¹áÉ
tramadol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2683
îñ³Ù³¹áÉ
Tramadol
îñ³Ù³¹áÉ
Tramadol
ïñ³Ù³¹áÉ
tramadol
ïñ³Ù³¹áÉ
tramadol
¹»Õ³å³ïÇ×Ý»ñ
2685
îñ³Ù³¹áÉ
Tramadol
ïñ³Ù³¹áÉ
tramadol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2686
îñ³Ù³¹áÉ
Tramadol
îñ³Ù³¹áÉ - Ø
Tramadol - M
ïñ³Ù³¹áÉ
tramadol
ïñ³Ù³¹áÉ
tramadol
ÉáõÍáõÛà ËÙ»Éáõ
ïñ³Ù³¹áÉÇ
ÑǹñáùÉáñǹ
tramadol hydrochloride
ïñ³Ù³¹áÉÇ
ÑǹñáùÉáñǹ
tramadol hydrochloride
ïñ³Ù³¹áÉ
tramadol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2684
2687
2688 îñ³Ù³¹áÉ ²ÉϳÉáǹ
Tramadol Alkaloid
2689 îñ³Ù³¹áÉ ²ÉϳÉáǹ
Tramadol Alkaloid
2690
îñ³Ù³¹áÉ
¹»Õ³å³ïÇ×Ý»ñ
Tramadol capsules
2691
îñ³Ù³¹áÉÇ
ïñ³Ù³¹áÉÇ
ÑǹñáùÉáñǹ 50Ù·
ÑǹñáùÉáñǹ
¹»Õ³å³ïÇ×Ý»ñ
tramadol hydrochloride
Tramadol
Hydrochloride
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
15.02.2007
15.02.2012
06.04.2007
06.04.2012
²¸
5502
23.08.2005
23.08.2010
²¸
M03AC04
1379/7342
05.11.2007
05.11.2012
¸
àõÏñ³Çݳ
N02A X02
0523/6512
10.11.2006
10.11.2011
¸\Ð
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
N02A X02
0540/6251
10.11.2006
10.11.2011
¸\Ð
лÙáý³ñÙ ÙdzíáñáõÙ ¸.¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
N02A X02
0539/6250
10.11.2006
10.11.2011
¸\Ð
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
ê»ñµÇ³ ¨
â»éÝá·áñdz
êÉáí»Ýdz
N02A X02
6037
¸\Ð
N02A X02
0809/6834
24.03.2006
24.03.2011
20.03.2007
20.03.2012
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
N02A X02
1004/6999
04.06.2007
04.06.2012
¸\Ð
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
¼¹áñáíÛ» ܳñá¹áõ
Zdorovya narodu
êÉáí»Ýdz
N02F X02
1009/6932
¸\Ð
àõÏñ³Çݳ
N02A X02
4215
04.06.2007
04.06.2012
31.03.2003
31.03.2008
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD-Skopje
سϻ¹áÝdz
N02A X02
1116/7115
11.10.2007
08.08.2012
¸\Ð
²¸
¸\Ð
¸\Ð
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(20)
²ÉϳÉáǹ ²¸-êÏáåÛ»
Alkaloid AD-Skopje
سϻ¹áÝdz
N02A X02
1117/7116
17.09.2007
08.08.2012
¸\Ð
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(20/2x10/)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
N02A X02
0810/6833
20.03.2007
20.03.2012
¸\Ð
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(10,60,100)
ÜÇã æ»Ý»ñÇÏë Èï¹
ϳ½Ù³Ï»ñåáõÃÛ³Ý Ñ³Ù³ñ â³Ý»É
Ø»¹Çϳ ÈÇÙÇﻹ
Chanelle Medical Limited for
Niche Generics Limited
Æéɳݹdz
N02A X02
4612
21.01.2004
21.01.2009
¸\Ð
184
Capsules 50mg
îñ³Ù³É
Tramal
ïñ³Ù³¹áÉ
tramadol
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(20)
2693
îñ³ÝùíÇÝ
Tranquine
¹Ç³½»å³Ù
diazepam
¹»Õ³Ñ³ï»ñ
2694
îñ³ÝùíÇÝ
Tranquine
¹Ç³½»å³Ù
diazepam
¹»Õ³Ñ³ï»ñ
2695
îñ³ÝùíÇÝ
Tranquine
¹Ç³½»å³Ù
diazepam
¹»Õ³Ñ³ï»ñ
2696
îñ³íÇëÇÉ
Travisil
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
ûß³ñ³Ï
10Ù·,
(20/2x10/,
100/10x10/)
5Ù·,
(20/2x10/,
100/10x10/)
2Ù·
(20/2x10/,
100/10x10/)
100ÙÉ ßßÇÏ
2697
îñ³íÇëÇÉ
Travisil
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
2698
îñ³íá·»Ý
Travogen
îñ³íáÏáñï
Travocort
îñ»Ýå»Ýï³É
Trenpental
îñ»Ýå»Ýï³É
Trenpental
ǽáÏáݳ½áÉÇ ÝÇïñ³ï
isoconazole nitrate
ǽáÏáݳ½áÉÇ ÝÇïñ³ï,
¹ÇýÉáõÏáñïáÉáÝÇ
í³É»ñ³ï
isoconazole nitrate,
diflucortolone valerate
å»ÝïûùëÇýÇÉÇÝ
pentoxifylline
å»ÝïûùëÇýÇÉÇÝ
pentoxifilline
Éá½³ÝÝ»ñ
³Ý³ÝáõËÇ,
ÏÇïñáÝÇ Ï³Ù
ٳݹ³ñÇÝÇ
ѳٻñáí
Ýñµ³ùëáõù
îñ»Ýï³É
Trental
îñ»Ýï³É
Trental
å»ÝïûùëÇýÇÉÇÝ
pentoxifylline
å»ÝïûùëÇýÇÉÇÝ
pentoxifylline
îñ»Ýï³É 400
Trental 400
îñdzÝáÉ
Trianol
2692
2699
2700
2701
2702
2703
2704
2706
îñÇËáµñáÉ
Trichobrol
å»ÝïûùëÇýÇÉÇÝ
pentoxifylline
³ýñÇÏÛ³Ý åÇ·»áõÙÇ
ѳÝáõÏ
extract of Pygeum
Africanum
Ù»ïñáÝǹ³½áÉ
metronidazole
2707
îñÇËáåáÉ
Trichopol
Ù»ïñáÝǹ³½áÉ
metronidazole
2705
´ÅßϳϻÝë³µ³Ý³Ï³Ý
å³ïñ³ëïáõÏÝ»ñÇ ÷áñÓ³ñ³ñ³Ï³Ý
³ñï³¹ñáõÃÛáõÝ-èáõë³ëï³ÝÇ
ëñï³µ³Ý³Ï³Ý ·Çï³³ñï³¹ñ³Ï³Ý
ѳٳÉÇñ
Experimental production of
biomedical preparationscientific and productive
cardiological complex of Russia
¸ñ. ²µÇ¹Ç ý³ñÙ³ëÛáõÃÇù³É
ȳµë.
Dr. Abidi Pharmaceutical Labs.
¸ñ. ²µÇ¹Ç ý³ñÙ³ëÛáõÃÇù³É
ȳµë.
Dr. Abidi Pharmaceutical Labs.
¸ñ. ²µÇ¹Ç ý³ñÙ³ëÛáõÃÇù³É
ȳµë.
Dr. Abidi Pharmaceutical Labs.
öÉ»ÃÇùá ü³ñÙ³ëÛáõÃÇù³Éë
Èï¹
Plethico Pharmaceuticals Ltd
öÉ»ÃÇùá ü³ñÙ³ëÛáõÃÇù³Éë
Èï¹
Plethico Pharmaceuticals Ltd
èáõë³ëï³Ý
N02A X02
0509/6494
07.11.2006
07.11.2011
¸\Ð
Æñ³Ý
N05B A01
0550/6540
17.11.2006
17.11.2011
¸\Ð
Æñ³Ý
N05B A01
0551/6539
17.11.2006
17.11.2011
¸\Ð
Æñ³Ý
N05B A01
0552/6538
17.11.2006
17.11.2011
¸\Ð
Ðݹϳëï³Ý
HR05
0780/6758
07.03.2007
07.03.2012
²¸
Ðݹϳëï³Ý
HR05
0779/6759
07.03.2007
07.03.2012
²¸
1·/10Ù·,
20· å³ñÏáõ×
(10Ù·+1Ù·)/1·,
15· å³ñÏáõ×
Þ»ñÇÝ· ê.å.².
Schering S.p.A.
Þ»ñÇÝ· ê.å.².
Schering S.p.A.
Æï³Édz
D01A C05
1124/7117
¸
Æï³Édz
D01A C05,
G01A F07
5612
24.10.2007
08.08.2012
20.07.2005
20.07.2010
0.1·
(20,30,60)
2% (5ÙÉ),
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
100Ù·
(60)
100Ù·/5ÙÉ,
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
400Ù·
(20/2x10/)
25Ù·
(30)
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
èáõë³ëï³Ý
C04A D03
4406
¸
èáõë³ëï³Ý
C04A D03
5333
25.08.2003
25.08.2008
03.02.2005
03.02.2010
²í»ÝïÇë ü³ñÙ³ ÈÇÙÇﻹ
Aventis Pharma Limited
²í»ÝïÇë ü³ñÙ³ Èï¹
Aventis Pharma Ltd.
Ðݹϳëï³Ý
C04A D03
4861
¸
Ðݹϳëï³Ý
C04A D03
0391/6351
26.04.2004
26.04.2009
12.09.2006
12.09.2011
²í»ÝïÇë ü³ñÙ³ ÈÇÙÇﻹ
Aventis Pharma Limited
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
Ðݹϳëï³Ý
C04A D03
0496/6428
¸
êÉáí»Ýdz
G04C X01
5281
25.10.2006
25.10.2011
07.02.2005
07.02.2010
¹»Õ³Ñ³ï»ñ
0.25·
(20)
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
4407
25.08.2003
25.08.2008
¸
¹»Õ³Ñ³ï»ñ
250Ù·
(20/2x10/)
äáÉý³ñÙ³ ê.².
Polpharma S.A.
Ȼѳëï³Ý
A01A B17
J01X D01
P01A B01
A01A B17,
J01X D01,
0066/6141
02.06.2006
02.06.2011
¸
Ýñµ³ùëáõù
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Ëï³ÝÛáõà Ý/»
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
(16)
¸
¸
¸
¸
185
2708
îñÇËáåáÉ
Trichopol
2709 îñÇٻﳽǹÇÝ Øè
ê»ñíÇ»
Trimetazidine MR
Servier
2710
îñÇáëáÝ
Trioson
2711
îñÇáíÇï
Triovit
Ù»ïñáÝǹ³½áÉ
metronidazole
ïñÇٻﳽǹÇÝ
trimetazidine
-
¹»Õ³Ñ³ï»ñ
Ñ»ßïáó³ÛÇÝ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
ѳµ»ñ
µ»ï³Ï³ñáïÇÝ, ë»É»Ý,
³Éý³-ÃáÏáý»ñáÉÇ
³ó»ï³ï, ³ëÏáñµÇݳÃÃáõ
betacarotine, selen,
alpha-tocopherol
acetate, ascorbic acid
¿ÃÇÝÇÉ¿ëïñ³¹ÇáÉ,
ɨáÝáñ·»ëïñ»É
ethinylestradiol,
levonorgestrel
¹»Õ³å³ïÇ×Ý»ñ
äáÉý³ñÙ³ ê.².
Polpharma S.A.
ê»ñíÇ» ȳµáñ³ïáñdz
Les Laboratoires Servier
Ȼѳëï³Ý
P01A B01
G01A F01
5087
üñ³Ýëdz
C01E B15
3858
350Ù·,
(20,30)
(10Ù·+50ÙÏ·+
40Ù·+100Ù·)
(30/3x10/)
ä³ñ³ý³ñÙ ö´À
Parapharm
CJSC
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d., Novo mesto
èáõë³ëï³Ý
βêÐ
5201
êÉáí»Ýdz
A11A A03
1008/6933
I-(0,03Ù·+0,05Ù·)
II-(0,04Ù·+0,075Ù·)
III(0,03Ù·+0,125Ù·)
(21, 3x21)
356Ù·
(20)
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
C03A A07,
G03F B09,
G03A B03,
G03F A11
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
àõÏñ³Çݳ
08.09.2005
08.09.2010
¸
N05C M50
1217/7153
24.10.2007
13.09.2012
²¸
²ØÜ
A11A A04
1155/7209
13.09.2007
13.09.2012
²¸
àõÏñ³Çݳ
N05A B06
1142/7118
02.10.2007
08.08.2012
¸\Ð
г۳ëï³Ý
N05A B06
5150
12.11.2004
12.11.2009
¸\Ð
àõÏñ³Çݳ
C05C A04
3910
²¸
´áõÉÕ³ñdz
C05CA04
0866/6508
12.02.2003
12.02.2008
30.03.2007
30.03.2012
11.09.2006
11.09.2011
26.07.2006
26.07.2011
20.01.2006
20.01.2011
²¸
îñÇí³ÉáõÙ»Ý
Trivalumen
ïñÇí³ÉáõÙ»Ý (µáõë³Ï³Ý
ѳÝáõÏÝ»ñ)
trivalumen (herbal
extracts)
¹»Õ³å³ïÇ×Ý»ñ
2714
îñÇ-ìÇ äÉÛáõë
Tri-V Plus
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(30)
2715
îñÇýó½Çݼ¹áñáíÛ»
TriphthazineZdorovye
îñÇýï³½ÇÝ
Triftazine
íÇï³ÙÇÝÝ»ñ,
ѳÝù³ÝÛáõûñ
vitamins, minerals
ïñÇýÉáõáå»ñ³½ÇÝ
trifluoperazine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
5Ù·
(50)
ïñÇýÉáõáå»ñ³½ÇÝÇ
ÑǹñáùÉáñǹ
trifluoperazine
hydrochloride
ïñáùë»ñáõïÇÝ
troxerutin
ïñáùë»éáõïÇÝ
troxerutin
¹»Õ³Ñ³ï»ñ
5Ù·
(24,48)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
¹áݹáÕ
2%,
30·,40· å³ñÏáõ×
300Ù·
(50)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
êáý³ñÙ³ ´À
Sopharma JSC
300Ù·
(50/5x10/)
2%,
40· å³ñÏáõ×
2%,
40· å³ñÏáõ×
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
êáý³ñÙ³ ´À
Sopharma JSC
´áõÉÕ³ñdz
C05C A04
0381/6405
´áõÉÕ³ñdz
C05C A04
0222/6297
´áõÉÕ³ñdz
C05C A04
5859
2718
2719
2720
2721
2722
2723
ò»¹³ùë
¹»Õ³å³ïÇ×Ý»ñ
¸\Ð
5661
2713
îñáùë»·»É - ÎØä
Troxegel - KMP
îñáùë»éáõïÇÝ
êáý³ñÙ³
Troxerutin
Sopharma
îñáùë»í³½ÇÝ
Troxevasin
îñáùë»í³½ÇÝ
Troxevasin
îñáùë»ñáõïÇÝ
êáý³ñÙ³
Troxerutin
Sopharma
ò»µñÇÉǽÇÝ
Cebrilysin
¸
²¸
îñÇ-è»·áÉ
Tri-Regol
2717
02.11.2004
02.11.2009
12.02.2003
12.02.2008
08.12.2004
08.12.2009
04.06.2007
04.06.2012
2712
2716
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(10)
35Ù·
(60)
²¸
¸
ïñáùë»éáõïÇÝ
troxerutin
ïñáùë»éáõïÇÝ
troxerutin
ïñáùë»ñáõïÇÝ
troxerutin
¹»Õ³å³ïÇ×Ý»ñ
Ëáßáñ »Õç»ñ³íáñÝ»ñÇ
·ÉËáõÕ»ÕÇ
ÑǹñáÉǽ³ï
cattle brain hydrolyzate
ó»ýïǵáõï»Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
-
4804
03.11.2004
03.11.2009
¸
¹»Õ³Ï³ËáõÛÃ
36Ù·/ÙÉ,
êÆüÆ ê.å.². (Þ»ñÇÝ· öɳáõÇ
Æï³Édz
J01D D14
5477
22.04.2005
¸
¹áݹáÕ
¹áݹáÕ
²¸
²¸
186
Cedax
ceftibuten
2724
ò»¹³ùë
Cedax
ó»ýïǵáõï»Ý
ceftibuten
2725
ò»É»ëïá¹»ñÙ-ì
Celestoderm-V
2726
2727
2728
2729
2730
2731
2732
2733
2734
2735
2736
¹»Õ³å³ïÇ×Ý»ñ
30ÙÉ ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
400Ù·
(5)
ѳٳñ)
SIFI S.p.A. (for ScheringPlough)
êÆüÆ ê.å.²., (Þ»ñÇÝ· öɳáõÇ
ѳٳñ)
SIFI S.p.A.for Schering Plough
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Schering-Plough Labo N.V.
µ»ï³Ù»Ã³½áÝÇ 17Ýñµ³ùëáõù
0.1%,
í³É»ñ³ï
15·, 30· å³ñÏáõ×
betamethasone 17valerate
ò»É»ëïá¹»ñÙ-ì
µ»ï³Ù»Ã³½áÝÇ 17ùëáõù
0.1%,
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
Celestoderm-V
í³É»ñ³ï
15·, 30· å³ñÏáõ×
Schering-Plough Labo N.V.
betamethasone 17valerate
ò»É»ëïá¹»ñÙ-ì
µ»ï³Ù»Ã³½áÝÇ 17Ýñµ³ùëáõù
(1Ù·+1000ØØ)/·,
Þ»ñÇÝ· öɳáõ ȳµá Ü.ì.
·³ñ³ÙÇóÇÝáí
í³É»ñ³ï, ·»Ýï³ÙÇóÇÝÇ
15·, 30· å³ñÏáõ×
Schering-Plough Labo N.V.
Celestoderm-V with
ëáõÉý³ï
Garamycin
betamethasone 17valerate, gentamicin
sulphate
ò»É»ëïá¹»ñÙ-ì
µ»ï³Ù»Ã³½áÝÇ 17ùëáõù
(1Ù·+1000ØØ)/·,
Þ»ñÇÝ·-öɳáõ ȳµá Ü.ì.
·³ñ³ÙÇóÇÝáí
í³É»ñ³ï, ·»Ýï³ÙÇóÇÝÇ
15·, 30· å³ñÏáõ×
Schering Plough Labo N.V.
Celestoderm-V with
ëáõÉý³ï
Garamycin
betamethasone 17valerate, gentamicine
sulphate
ò»ïÇñǽÇÝ
ó»ïÇñǽÇÝÇ
¹»Õ³Ñ³ï»ñ
10Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
Ñ»ùë³É Cetirizin
¹ÇÑǹñáùÉáñǹ
óճÝóå³ï
(7,20)
²¶-Ç Ñ³Ù³ñ)
Hexal
cetirizine
Salutas Pharma GmbH (for
dihydrochloride
Hexal AG)
ò»ïÇñǽÇÝ
ó»ïÇñǽÇÝÇ
ÉáõÍáõÛà ËÙ»Éáõ
1Ù·/ÙÉ,
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
Ñ»ùë³É Cetirizin
¹ÇÑǹñáùÉáñǹ
75ÙÉ ßßÇÏ
²¶-Ç Ñ³Ù³ñ)
Hexal
cetirizine
Salutas Pharma GmbH (for
dihydrochloride
Hexal AG)
ò»ïÇñÇݳùë
ó»ïÇñǽÇÝ
¹»Õ³Ñ³ï»ñ
10Ù·
²Ïï³íÇë Ñ.ý.
Cetirinax
cetirizine
óճÝóå³ï
(10)
Actavis h.f.
ò»ïñáïǹ
ó»ïñáñ»ÉÇùëÇ ³ó»ï³ï
¹»Õ³÷áßÇ
0.25Ù·,
´³ùëï»ñ úÝÏáÉáçÇ ¶ÙµÐ
Cetrotide
cetrorelix acetate
Ý»ñ³ñÏÙ³Ý
ëñí³Ï, Ý»ñ³ñÏÇã
Baxter Oncology GmbH
ÉáõÍáõÛÃÇ,
1ÙÉ ÉáõÍãáí,
1ÙÉ ÉáõÍãáí
ò»ïñáïǹ
ó»ïñáñ»ÉÇùëÇ ³ó»ï³ï
¹»Õ³÷áßÇ
3Ù·,
´³ùëï»ñ úÝÏáÉáçÇ ¶ÙµÐ
Cetrotide
cetrorelix acetate
Ý»ñ³ñÏÙ³Ý
ëñí³Ï, Ý»ñ³ñÏÇã
Baxter Oncology GmbH
ÉáõÍáõÛÃÇ,
3ÙÉ ÉáõÍãáí,
3ÙÉ ÉáõÍãáí
2 ³ë»Õ, 2 ëåÇñïáí
Ý»ñÍÍí³Í µ³ñÓÇÏ (1)
ò»ñ»µñáÉǽ³ï
Ëáßáñ »Õç»ñ³íáñÝ»ñÇ
ÉáõÍáõÛÃ
1ÙÉ ³ÙåáõÉÝ»ñ
ØÇÏñá·»Ý ¶²Ø
Cerebrolysate
·ÉËáõÕ»ÕÇ
Ý»ñ³ñÏÙ³Ý
(10)
Microgen SIU
ÑǹñáÉǽ³ï
cattle brain hydrolysate
ò»ñ»µñáÉǽ³ï
Ëáßáñ »Õçñ³íáñÝ»ñÇ
ÉáõÍáõÛÃ
1ÙÉ ³ÙåáõÉÝ»ñ
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàõÒ
Cerebrolysate
ϳ٠Ëá½Ç ·ÉËáõÕ»ÕÇ
Ý»ñ³ñÏÙ³Ý
(10)
Belmedpreparaty RUP
ÑǹñáÉǽ³ï
cattle or porcine brain
hydrolysate
ò»ñ»µñáÉǽÇÝ
å»åïǹݻñ Ëá½Ç
ÉáõÍáõÛÃ
215,2Ù·/ÙÉ (5ÙÉ), ¾´ºìº ü³ñÙ³ ¶»ë. Ù.µ.Ð. Üý·. ζ
22.04.2010
Æï³Édz
J01D D14
5476
02.09.2005
02.09.2010
¸
´»É·Ç³
D07A C01
D07X C01
H02A B01
R01A D06
D07A C01
D07X C01
H02A B01
R01A D06
D07C C01
4836
21.06.2004
21.06.2009
²¸
4837
21.06.2004
21.06.2009
²¸
4838
16.06.2004
16.06.2009
¸
´»É·Ç³
D07C C01
S01C A05
4993
04.08.2004
04.08.2009
¸
¶»ñÙ³Ýdz
R06A E07
5589
19.05.2005
19.05.2010
¸
¶»ñÙ³Ýdz
R06A E07
5590
19.05.2005
19.05.2010
¸
Æëɳݹdz
R06A E07
5719
¸
¶»ñÙ³Ýdz
H01C C02
5562
07.09.2005
07.09.2010
18.05.2005
18.05.2010
¶»ñÙ³Ýdz
H01C C02
5563
18.05.2005
18.05.2010
¸
èáõë³ëï³Ý
-
5574
05.09.2005
05.09.2010
¸
´»É³éáõë
-
5741
23.02.2006
23.02.2011
¸
²íëïñdz
N06BX
1456/7401
20.12.2007
¸
´»É·Ç³
´»É·Ç³
¸
187
Cerebrolysin
2737
ò»ñ»µñáÉǽÇÝ
Cerebrolysin
2738
ò»ñ»µñáÉǽÇÝ
Cerebrolysin
2739
ò»ñáõ·É³Ý
Ceruglan
·ÉËáõÕ»ÕÇó
porcine brain peptides
å»åïǹݻñ Ëá½Ç
·ÉËáõÕ»ÕÇó
porcine brain peptides
å»åïǹݻñ Ëá½Ç
·ÉËáõÕ»ÕÇó
porcine brain peptides
Ù»ïáÏÉáåñ³Ùǹ
metoclopramide
2740
ò»ñáõϳÉ
Cerucal
ò»ñáõϳÉ
Cerucal
Ù»ïáÏÉáåñ³Ùǹ
metoclopramide
Ù»ïáÏÉáåñ³Ùǹ
metoclopramide
2742
ò»ý³½áÉÇÝ
Cefazolin
2743
ò»ý³½áÉÇÝ
Cefazolin
ó»ý³½áÉÇÝ
ݳïñÇáõÙÇ
cefazolin sodium
ó»ý³½áÉÇÝ
cefazolin
2741
2744
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
20.12.2012
²íëïñdz
N06BX
1455/7400
20.12.2007
20.12.2012
¸
²íëïñdz
N06BX
1457/7402
20.12.2007
20.12.2012
¸
èáõë³ëï³Ý
A03F A01
4583
29.10.2003
29.10.2008
¸
¶»ñÙ³Ýdz
A03F A01
1053/7076
¸
Êáñí³Ãdz
A03F A01
0108/6122
10.07.2007
10.07.2012
09.06.2006
09.06.2011
´áõÉÕ³ñdz
J01D B04
6066
24.03.2006
24.03.2011
¸
1·,
ëñí³Ï (10)
1·,
ëñí³Ï (1)
´»ÉÙ»¹åñ»å³ñ³ïÇ ´´À
Belmedpreparaty Open JSC
´»É³éáõë
J01D B04
5397
06.04.2005
06.04.2010
¸
0.5·,
ëñí³Ï (10)
Îáñ»³ öñÇÙ ü³ñÙ øá. Èï¹.
Korea Prime Pharm.Co.Ltd.
Îáñ»³
J01D A04
4739
13.03.2004
13.03.2009
¸
ó»ý³½áÉÇÝ
cefazolin
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
1·,
ëñí³Ï (10)
Îáñ»³ öñÇÙ ü³ñÙ øá. Èï¹.
Korea Prime Pharm.Co.Ltd.
Îáñ»³
J01D A04
4740
13.03.2004
13.03.2009
¸
ó»ý³½áÉÇÝ
cefazolin
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
1·,
ëñí³Ï (40, 50, 100)
Üáíáý³ñÙ³ äÉÛáõë
Novopharma Plus
àõ½µ»Ïëï³Ý
S01D A04
1179/7191
19.09.2007
13.09.2012
¸
1·,
ëñí³Ï (1)
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
²íëïñdz
J01D A04
0911/6949
26,04.2007
26.04.2012
¸
1·,
ëñí³Ï (1)
лÉ÷ ê.².
Help S.A.
Ðáõݳëï³Ý
J01D A04
4220
20.03.2003
20.03.2008
¸
1·,
ëñí³Ï (10)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
àõÏñ³Çݳ
J01D B04
0009/6100
02.05.2006
02.05.2011
¸
250Ù·
(16)
500Ù·
(16)
250Ù·/5ÙÉ,
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
·ñ³ÝáõÉÝ»ñ
250Ù·
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ê»ñµÇ³ ¨
â»éÝá·áñdz
ê»ñµÇ³ ¨
â»éÝá·áñdz
ê»ñµÇ³ ¨
â»éÝá·áñdz
C05B A53
5498
¸
C05B A53
5499
J01D A01
6019
23.05.2005
23.05.2010
23.05.2005
23.05.2010
28.02.2006
28.02.2011
´áñßã³·áíÛ³Ý ùÇÙdz¹»Õ³·áñͳ-
àõÏñ³Çݳ
J01D B01
0097/6068
09.06.2006
¸
2748 ò»ý³½áÉÇÝ/лÉ÷
Cefazolin/Help
ó»ý³½áÉÇÝ
cefazolin
2749
ò»ý³½áÉÇÝ-ÎØä
Cefazolin-KMP
ó»ý³½áÉÇÝ
cefazolin
2750
ò»ý³É»ÏëÇÝ
Cefaleksin
ò»ý³É»ÏëÇÝ
Cefaleksin
ò»ý³É»ÏëÇÝ
Cefaleksin
ó»ý³É»ùëÇÝ
cefalexin
ó»ý³É»ùëÇÝ
cefalexin
ó»ý³É»ùëÇÝ
cefalexin
ò»ý³É»ùëÇÝ
ó»ý³É»ùëÇÝ
2753
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
EBEWE Pharma
Ges.m.b.H.Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë. Ù.µ.Ð. Üý·. ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
¾´ºìº ü³ñÙ³ ¶»ë. Ù.µ.Ð. Üý·. ζ
EBEWE Pharma
Ges.m.b.H.Nfg.KG
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ó»ý³½áÉÇÝ
cefazolin
2752
¹»Õ³Ñ³ï»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
215,2Ù·/ÙÉ (1ÙÉ),
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
215,2Ù·/ÙÉ
(10ÙÉ), 10ÙÉ
³ÙåáõÉÝ»ñ (5)
0.5% (10Ù·/2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
10Ù·
(50)
10Ù·/2ÙÉ,
³ÙåáõÉÝ»ñ (10)
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
AWD pharma GmbH & Co. KG
äÉÇí³ Ðáñí³ïëϳ ¹.û.û. ((²ì¸ ý³ñÙ³
¶ÙµÐ ¨ øá. ζ, ¶»ñÙ³ÝdzÛÇ
ѳٳñ)
Pliva Hrvatska d.o.o.(for AWD
Pharma GmbH & Co. KG,
Germany)
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
ò»ý³½áÉÇÝ ²ëï»ñdz 0,5·
Cefazolin - Asteria
0,5g
2745
ò»ý³½áÉÇÝ ²ëï»ñdz 1·
Cefazolin - Asteria
1g
2746
ò»ý³½áÉÇÝ
ݳïñÇáõÙ
Cefazolin sodium
2747 ò»ý³½áÉÇÝ ê³Ý¹á½
Cefazolin Sandoz
2751
Ý»ñ³ñÏÙ³Ý
ó»ý³½áÉÇÝ
cefazoline
ÉáõÍáõÛÃ Ý/» ¨
Ý/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
¹»Õ³å³ïÇ×Ý»ñ
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³å³ïÇ×Ý»ñ
¸
¸
¸
188
Cefalexin
cefalexin
2754
ò»ý³É»ùëÇÝ
Cefalexin
ó»ý³É»ùëÇÝ
cefalexin
2755
ò»ý³É»ùëÇÝ
Cefalexin
ó»ý³É»ùëÇÝ
cefalexin
2756
ò»ý³É»ùëÇÝ
Cefalexin
ó»ý³É»ùëÇÝ
cefalexin
2757
ò»ý³É»ùëÇÝ
Cephalexin
ó»ý³É»ùëÇÝ
cefalexin
2758
ò»ý³Ù»¹
Cefamed
ó»ýïñdzùëáÝ
ceftriaxone
2759
ò»ý³Ù»¹
Cefamed
ó»ýïñdzùëáÝ
ceftriaxone
2760
ò»ý³Ù»½ÇÝ
Cefamezin
ó»ý³½áÉÇÝ
cefazolin
2761
ò»ý³ùëÇÙ
Cefaxim
ó»ýáï³ùëÇÙ
cefotaxime
2762
ò»ý»½áÉ
Cefezol
ó»ý³½áÉÇÝ
cefazolin
2763
ò»ý»ÏáÝ ¸
Cefecon D
ò»ý»ÏáÝ ¸
Cefecon D
ò»ý»ÏáÝ ¸
Cefecon D
ò»ý»ÏáÝ Ü
Cefecon N
å³ñ³ó»ï³ÙáÉ
paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
ݳåñûùë»Ý, Ïáý»ÇÝ,
ë³ÉÇóÇɳÙǹ
naproxen, caffeine,
salicylamide
2764
2765
2766
(20/2x10/)
¹»Õ³÷áßÇ ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
Ï³Ý ·áñͳñ³Ý ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
¾ëÏáõɳå êäÀ
Esculap Ltd
250Ù·/5ÙÉ,
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ
¹»Õ³å³ïÇ×Ý»ñ
250Ù·,
¾ëÏáõɳå êäÀ
µÉÇëï»ñ ¨ åɳëïÇÏ
Esculap Ltd
ï³ñ³
(10,16,20)
¹»Õ³å³ïÇ×Ý»ñ
500Ù·,
¾ëÏáõɳå êäÀ
µÉÇëï»ñ ¨ åɳëïÇÏ
Esculap Ltd
ï³ñ³
(10,16,20)
¹»Õ³÷áßÇ ËÙ»Éáõ
250Ù·/5ÙÉ,
²ñ³µ ¸ñ³· øáÙå³ÝÇ
¹»Õ³Ï³ËáõÛÃÇ
30· ¹»Õ³÷áßÇ
The Arab Drug Company
ßßÇÏáõÙ 60ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ ¨ 50·
¹»Õ³÷áßÇ
ßßÇÏáõÙ 100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ
¹»Õ³÷áßÇ
0.5·,
ºÆäÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
Ý»ñ³ñÏÙ³Ý
ëñí³Ï/³ÙåáõÉ (1)
ѳٳñ)
ÉáõÍáõÛÃÇ, 2ÙÉ
E.I.P.I.Co. (for World Medicine)
ÉǹáϳÛÇÝÇ 1%
ÉáõÍáõÛÃ ÉáõÍãáí
¹»Õ³÷áßÇ
1·,
ºÆäÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
Ý»ñ³ñÏÙ³Ý
ëñí³Ï/³ÙåáõÉ (1)
ѳٳñ)
ÉáõÍáõÛÃÇ,
E.I.P.I.Co. (for World Medicine)
3.5ÙÉ
ÉǹáϳÛÇÝÇ 1%
ÉáõÍáõÛÃ ÉáõÍãáí
¹»Õ³÷áßÇ
1000Ù·,
Îèβ ¹.¹. Üáíá Ù»ëïá
Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
KRKA d.d. Novo mesto
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ Ý/» ¨
1·,
Ü»ÛßÁÝÁÉ øáÙå³ÝÇ ýáñ
Ù/Ù Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
ü³ñÙ³ëÛáõÃÇù³É Æݹ³ëïñÇ
National Company for
Pharmaceutical Industry
¹»Õ³÷áßÇ Ù/Ù ¨
1·,
§´ñÇÝó³Éáí-²¦ ö´À
Ý/» Ý»ñ³ñÏÙ³Ý
ëñí³Ï (1)
CJSC §Brinsalov-A¦
ÉáõÍáõÛÃÇ
ÙáÙÇÏÝ»ñ
0.05·
ÜÇÅý³ñÙ ´´À
(10/2x5/)
Nizhpharm Open JSC
ÙáÙÇÏÝ»ñ
0.1·
ÜÇÅý³ñÙ ´´À
(10/2x5/)
Nizhpharm Open JSC
ÙáÙÇÏÝ»ñ
0.25·
ÜÇÅý³ñÙ ´´À
(10/2x5/)
Nizhpharm Open JSC
ÙáÙÇÏÝ»ñ
0.075·+0.05·+ 0.6·
ÜÇÅý³ñÙ ´À
(10)
Nizhpharm JSC
09.06.2011
г۳ëï³Ý
J01D B01
0370/6286
11.09.2006
11.09.2011
¸
г۳ëï³Ý
J01D B01
0039/5958
24.05.2006
24.05.2011
¸
г۳ëï³Ý
J01D B01
0040/5959
24.05.2006
24.05.2011
¸
º·Çåïáë
J01D A01
4720
19.10.2004
19.10.2009
¸
º·Çåïáë
J01D D04
5675
22.09.2005
22.09.2010
¸
º·Çåïáë
J01D D04
5676
22.09.2005
22.09.2010
¸
êÉáí»Ýdz
J01D A04
0562/6532
24.11.2006
24.11.2011
¸
êÇñdz
J01D A10
3969
05.05.2003
05.05.2008
¸
èáõë³ëï³Ý
J01D A04
4410
25.08.2003
25.08.2008
¸
èáõë³ëï³Ý
N02B E01
1095/7119
²¸
èáõë³ëï³Ý
E02B E01
1096/7120
èáõë³ëï³Ý
N02B E01
1097/7121
èáõë³ëï³Ý
G02C
4360
08.08.2007
08.08.2012
08.08.2007
08.08.2012
08.08.2007
08.08.2012
23.06.2003
23.06.2008
²¸
²¸
²¸
189
2767
ò»ý½Ç¹
Cefzid
ó»ýﳽǹÇÙ
ceftazidime
2768
ò»ýÇùëÇÙ
Cefixime
ò»ýÇùëÇÙ
Cefixime
ò»ýáµÇ¹
Cefobid
ò»ýáå»ñ³µáÉ
Cefoperabol
ò»ýáï³ùëÇÙ
Cefotaxim
ó»ýÇùëÇÙ
cefixime
ó»ýÇùëÇÙ
cefixime
ó»ýáå»ñ³½áÝ
cefoperazone
ó»ýáå»ñ³½áÝ
cefoperasone
ó»ýáï³ùëÇÙ
cefotaxime
1·,
ëñí³Ï (1)
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
Ðݹϳëï³Ý
J01D A11
1196/7199
25.09.2007
13.09.2012
¸
J01D D08
0303/6308
¸
г۳ëï³Ý
J01D D08
0304/6307
Æï³Édz
J01D D12
6055
èáõë³ëï³Ý
J01D A32
4607
´»É³éáõë
J01D D01
0947/6898
01.08.2006
01.08.2011
01.08.2006
01.08.2011
31.03.2006
31.03.2011
20.01.2004
20.01.2009
03.05.2007
03.05.2012
ó»ýáï³ùëÇÙ
cefotaxime
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
1·,
ëñí³Ï (270)
´»É³éáõë
J01D D01
0946/6899
03.05.2007
03.05.2012
¸
ò»ýáï³ùëÇÙ
Cefotaxime
ó»ýáï³ùëÇÙ
cefotaxime
1·,
ëñí³Ï (1)
èáõÙÇÝdz
J01D A13
0981/6944
22.05.2007
22.05.2012
¸
2775
ò»ýáï³ùëÇÙ È»Ï
Cefotaxim Lek
ó»ýáï³ùëÇÙ
cefotaxim
êÉáí»Ýdz
J01D D01
1046/7053
02.07.2007
02.07.2012
¸
2776
ò»ýáñ³Ý 1·
Ceforan 1 g
ò»ýáñï
Cefort
ó»ýáï³ùëÇÙ
cefotaxime
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
öý³Û½»ñ Æï³Édz ê.é.É.
Pfizer Italia S.r.l.
²´úÈÙ»¹ êäÀ
ABOLmed Ltd
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
²ÝïǵÇáïÇÏ ê.² .
Antibiotice S.A.
г۳ëï³Ý
¹»Õ³÷áßÇ Ù/Ù, Ý/»
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
400Ù·
(10)
200Ù·
(10)
1·,
ëñí³Ï (1)
1·,
ëñí³Ï (1)
0.5·,
ëñí³Ï (270)
2773
ò»ýáï³ùëÇÙ
Cefotaxim
2774
Ðݹϳëï³Ý
J01D A10
4415
¸
èáõÙÇÝdz
J01D D04
5750
10.10.2003
10.10.2008
23.12.2005
23.12.2010
ò»ýáõñ³µáÉ
Cefurabol
2779
ò»ýáõñûùëÇÙ²ëï»ñdz
Cefuroxim-Asteria
2780 ò»ýﳽǹÇÙ - ÎØä
Ceftazidim - KMP
2781
ò»ýïñdzùëáÝ
Ceftriaxone
ó»ýáõñûùëÇÙ
cefuroxim
ó»ýáõñûùëÇÙ
cefuroxime
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
²´úÈÙ»¹ êäÀ
ABOLmed Ltd
Îáñ»³ öñÇÙ ü³ñÙ øá. Èï¹.,
Korea Prime Pharm Co.Ltd.
èáõë³ëï³Ý
J01D A06
4606
¸
Îáñ»³
J01D C02
5555
20.01.2004
20.01.2009
14.07.2005
14.07.2010
ó»ýﳽǹÇÙ
ceftazidim
ó»ýïñdzùëáÝ
ceftriaxon
1·,
ëñí³Ï (1,10)
1000Ù·,
ëñí³Ï (10,12)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
àõÏñ³Çݳ
J01D A11
4030
¸
г۳ëï³Ý
J01D D04
0300/6310
12.02.2003
12.02.2008
01.08.2006
01.08.2011
2782
ò»ýïñdzùëáÝ
Ceftriaxone
ó»ýïñdzùëáÝ
ceftriaxon
500Ù·,
ëñí³Ï (10,12)
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
г۳ëï³Ý
J01D D04
0302/6309
01.08.2006
01.08.2011
¸
2783
ò»ýïñdzùëáÝ
Ceftriaxone
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ Ù/Ù, Ý/»
Ý»ñ³ñÏÙ³Ý ¨
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÝ»ñÇ
¹»Õ³÷áßÇ Ù/Ù, Ý/»
Ý»ñ³ñÏÙ³Ý ¨
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÝ»ñÇ
¹»Õ³÷áßÇ Ý/» ¨
Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
1·,
ëñí³Ï (270)
´»É³éáõë
J01D A13
0941/6904
03.05.2007
03.05.2012
¸
2784
ò»ýïñdzùëáÝ
ó»ýïñdzùëáÝ
¹»Õ³÷áßÇ
0.5·,
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
´áñÇëáíÛ³Ý ´ä¶
´»É³éáõë
J01D D04
5024
13.12.2004
¸
2769
2770
2771
2772
2777
2778
¹»Õ³÷áßÇ Ý/» ¨
Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
1·,
ëñí³Ï
(1)
1·,
ëñí³Ï (1)
1·
ëñí³Ï (1,20) ¨
ÑÇí³Ý¹³Ýáó³ÛÇÝ
(50)
0.75·,
ëñí³Ï (1)
0.75·,
ëñí³Ï (10)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
ìáÏ˳ñ¹ Èï¹.
Wockhardt
Ltd.
²ÝïǵÇáïÇÏ ê.².
Antibiotice S.A.
¸
¸
¸
¸
¸
¸
¸
190
Ceftriaxone
ceftriaxone
Ý»ñ³ñÏÙ³Ý
ò»ýïñdzùëáÝ
Ceftriaxone
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
2786 ò»ýïñdzùëáÝ - ÎØä
Ceftriaxon - KMP
ó»ýïñdzùëáÝ
ceftriaxon
2787 ò»ýïñdzùëáÝ - ÎØä
Ceftriaxon - KMP
ó»ýïñdzùëáÝ
ceftriaxon
2788
ò»ýïñdzùëáÝ ²ëï»ñdz
Ceftriaxone - Asteria
ó»ýïñdzùëáÝ
ceftriaxone
2789
ò»ýïñdzùëáÝ ²ëï»ñdz
Ceftriaxone - Asteria
ó»ýïñdzùëáÝ
ceftriaxone
2790 ò»ýïñdzùëáÝ ´ø¸¶
Ceftriaxon BChPhP
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ Ý/»
Ý»ñ³ñÏÙ³Ý,
20ÙÉ Ý»ñ³ñÏÙ³Ý
çáõñ ÉáõÍãáí
¹»Õ³÷áßÇ Ù/Ù
Ý»ñ³ñÏÙ³Ý,
5ÙÉ ÉǹáϳÛÇÝÇ
1% ÉáõÍáõÛÃ
ÉáõÍãáí
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
2791 ò»ýïñdzùëáÝ äñáï»ù
Ceftriaxone Protech
ó»ýïñdzùëáÝ
ceftriaxone
2792
2785
ò»ýïñdzùëáݲëï»ñdz
Ceftriaxone-Asteria
2793
ò»ýïñdzùëáݲëï»ñdz
Ceftriaxone-Asteria
2794
ò»ýïñÇýÇÝ 1·
Ceftrifin 1 g
2795 òdzÝáÏᵳɳÙÇÝ
Cyanocobalamin
2796
2797
òÇ·³ä³Ý
CigaPan
òÇÏÉá¹ÇÝáÝ
Cyclodynon
2798
òÇÏÉá¹ÇÝáÝ
Cyclodynon
2799
òÇÏÉá¹áÉ
Cyclodolum
2800
òÇÏÉá¹áÉ
Cyclodol
ëñí³Ï
(1,50,100,270)
1·,
ëñí³Ï (1,
50,100,270)
1·,
ëñí³Ï (1)
Borisov Medical Preparations
Plant RUP
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
0.5·
ëñí³Ï (1)
13.12.2009
´»É³éáõë
J01D D04
5025
13.12.2004
13.12.2009
¸
àõÏñ³Çݳ
J01D A13
3905
12.02.2003
12.02.2008
¸
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
àõÏñ³Çݳ
J01D A13
3906
12.02.2003
12.02.2008
¸
1·,
ëñí³Ï/³ÙåáõÉ (1)
Îáñ»³ öñÇÙ ü³ñÙ øá.Èï¹.
Korea Prime Pharm Co.Ltd.
Îáñ»³
J01D D04
5556
22.06.2005
22.06.2010
¸
1·,
ëñí³Ï/³ÙåáõÉ (1)
Îáñ»³ öñÇÙ ü³ñÙ øá.Èï¹.
Korea Prime Pharm Co.Ltd.
Îáñ»³
J01D D04
5557
22.06.2005
22.06.2010
¸
1000Ù·,
ëñí³Ï (5)
àõÏñ³Çݳ
J01D A06
0972/5840/1
22.05.2007
27.12.2010
¸
Ðݹϳëï³Ý
J01D A13
1195/7200
25.09.2007
13.09.2012
¸
1·,
ëñí³Ï (1)
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ Ý/» ¨
Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
1·,
ëñí³Ï (1,10)
Îáñ»³ öñÇÙ ü³ñÙ øá.Èï¹.
Korea Prime Pharm.Co.Ltd.
Îáñ»³
J01D A13
4296
09.06.2003
09.06.2008
¸
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
0.5·,
ëñí³Ï (1,10)
Îáñ»³ öñÇÙ ü³ñÙ øá.Èï¹.
Korea Prime Pharm.Co.Ltd.
Îáñ»³
J01D A13
4295
09.06.2003
09.06.2008
¸
ó»ýïñdzùëáÝ
ceftriaxone
ódzÝáÏᵳɳÙÇÝ
cyanocobalamin
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
Ðݹϳëï³Ý
J01D
4416
¸
àõÏñ³Çݳ
B03BA01
0890/6864
10.10.2003
10.10.2008
13.04.2007
13.04.2012
èáõë³ëï³Ý
βêÐ
5402
²¸
¶»ñÙ³Ýdz
G02C X
0940/6964
16.02.2005
16.02.2010
03.05.2007
03.05.2012
´ÇáÝáñÇϳ ²¶
Bionorica AG
¶»ñÙ³Ýdz
G02C X
0939/6965
03.05.2007
03.05.2012
²¸
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
г۳ëï³Ý
N04A A01
4848
21.04.2004
21.04.2009
¸\Ð
î³ÉÉÇÝÇ ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
´À
¾ëïáÝdz
N04A A01
4874
07.05.2004
07.05.2009
¸\Ð
1·,
ëñí³Ï (1)
0.05%
(500ÙÏ·/ÙÉ), 1ÙÉ
³ÙåáõÉÝ»ñ (10)
ѳµ»ñ
400Ù·
(30)
³µñ³Ñ³Ù³Í³éÇ
ϳÃÇÉÝ»ñ Ý»ñùÇÝ
0.24·
åïáõÕÝ»ñÇ ãáñ ѳÝáõÏ
ÁݹáõÝÙ³Ý
(8,3-12,5:1)/100·,
Agnus castus dry
50ÙÉ ßßÇÏ
extract
³µñ³Ñ³Ù³Í³éÇ
¹»Õ³Ñ³ï»ñ
4Ù·
åïáõÕÝ»ñÇ ãáñ ѳÝáõÏ
óճÝóå³ï
(8.3-12.5:1)
Agnus castus dry
(30)
extract
ïñÇÑ»ùëÇý»ÝǹÇÉÇ
¹»Õ³Ñ³ï»ñ
2Ù·
ÑǹñáùÉáñǹ
(10,24,48,100)
trihexyphenidyl
hydrocloride
ïñÇÑ»ùëÇý»ÝǹÇÉ
¹»Õ³Ñ³ï»ñ
0.002·
trihexyphenidyl
(50)
ìáÏ˳ñ¹ Èï¹.
Wockhardt
Ltd.
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
äÉ³Ý»ï³ ¼¹áñáíÛ³-2000
Planeta Zdorov'ya-2000
´ÇáÝáñÇϳ ²¶
Bionorica AG
¸
²¸
191
2801
2802
2803
òÇÏÉá¹áÉ
Cyclodol
òÇÏÉá¹áÉ-²Ø
Cyclodol-AM
òÇÏÉáë»ñÇÝ
Cycloserine
2804
òÇÏÉáëåáñÇÝ
Ñ»ùë³É
Cyclosporin Hexal
2805
òÇÏÉáý»ñáÝ
Cycloferon
2806
òÇÏÉáý»ñáÝ
Cycloferon
2807
òÇÏÉáýáëý³Ý-ÎØä
CyclophosphanKMP
òÇݳñǽÇÝ
Cinnarizin
òÇݳñǽÇÝ
Cinnarizin
òÇÝÏÇ 10% ùëáõù
Zinc 10% ointment
òÇÝÏáõݹ³Ý
Zincundanum
2808
ïñÇÑ»ùëÇý»ÝǹÇÉ
trihexyphenidyl
ïñÇÑ»ùëÇý»ÝǹÇÉ
trihexyphenidyl
óÇÏÉáë»ñÇÝ
cycloserine
N04A A01
4825
Ðáõݳëï³Ý
J04A B01
0462\6403
¶»ñÙ³Ýdz
L04A A01
5595
12.07.2005
12.07.2010
¸
¸\Ð
¸
èáõë³ëï³Ý
L03AA
1207/7194
29.11.2007
13.09.2012
¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
³Õ»ÉáõÛÍ
0.15Ù·
(10,50)
§äáÉÇë³Ý ¶î¸ü¦ êäÀ
STPF §Polysan¦ Ltd
èáõë³ëï³Ý
-
5145
26.05.2005
26.05.2010
¸
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
0.2·,
ëñí³Ï (1, 40)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat Open JSC
àõÏñ³Çݳ
L01AA01
1287/7255
12.12.2007
12.10.2012
¸
25Ù·
(50, 50/5x10/)
25Ù·
(50)
10%,
25· ï³ñ³, å³ñÏáõ×
(10·+10·+10·)/
100·,
15· ï³ñ³ ϳ٠å³ñÏáõ×
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
êáý³ñÙ³ ´À
Sopharma JSC
¾ëÏáõɳå êäÀ
Esculap Ltd.
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
´áõÉÕ³ñdz
N07CA02
0875/6919
¸
´áõÉÕ³ñdz
N07C A02
0918/6707
г۳ëï³Ý
-
5633
àõÏñ³Çݳ
D01A E04
1122/7023
06.04.2007
06.04.2012
26,04.2007
26.04.2012
12.01.2006
12.01.2011
01.10.2007
01.10.2012
¹»Õ³å³ïÇ×Ý»ñ
(25Ù·+400Ù·)
(60)
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
èáõÙÇÝdz
N07C
1159/7206
13.09.2007
13.09.2012
¸
ÉáõÍáõÛÃ Ý/»
Ý»ñ³ñÏÙ³Ý
2Ù·/1ÙÉ,
100ÙÉ åɳëïÇÏ
ëñí³Ï
250Ù·
(100/10x10/)
500Ù·
(100/10x10/)
200Ù·/100ÙÉ,
100ÙÉ ëñí³Ï (1)
750Ù·
(10, 20/2x10/)
100Ù·/10ÙÉ,
10ÙÉ ³ÙåáõÉÝ»ñ
(5)
250Ù·
(10)
êÇåɳ Èï¹.
Cipla Ltd.
Ðݹϳëï³Ý
J01M A02
3988
07.02.2003
07.02.2008
¸
êÇåɳ Èï¹
Cipla Ltd.
êÇåɳ Èï¹
Cipla Ltd.
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Ðݹϳëï³Ý
J01M A02
0362/6359
¸
Ðݹϳëï³Ý
J01M A02
0363/6358
êÉáí»Ýdz
J01M A02
0651/6574
êÉáí»Ýdz
J01M A02
0650/6575
êÉáí»Ýdz
S01M A02
0826/6817
31.08.2006
31.08.2011
31.08.2006
31.08.2011
12.01.2007
12.01.2012
12.01.2007
12.01.2012
20.03.2007
20.03.2012
êÉáí»Ýdz
S01M A02
0825/6818
20.03.2007
20.03.2012
¸
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
òÇåñÇÝáÉ
Ciprinol
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
2819
àõÏñ³Çݳ
äáÉÇë³Ý êäÀ
Polysan Ltd
òÇåÉûùë-250
Ciplox-250
òÇåÉûùë-500
Ciplox-500
òÇåñÇÝáÉ
Ciprinol
òÇåñÇÝáÉ
Ciprinol
òÇåñÇÝáÉ
Ciprinol
2818
¸\Ð
125Ù·/ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
2814
2817
26.09.2006
26.09.2011
29.03.2004
29.03.2009
11.10.2006
11.10.2011
ÉáõÍáõÛÃ Ù/Ù ¨
Ý/»
Ý»ñ³ñÏáõÙÝ»ñÇ
òÇåÉûùë
Ciplox
2816
0434/6449
³ÏñǹáÝù³ó³Ë³ÃÃáõ,
N-Ù»ÃÇÉ ·ÉÛáõϳÙÇÝ
acridonacetic acid,
N-methyl glucamin
³ÏñǹáÝù³ó³Ë³ÃÃáõ,
N-Ù»ÃÇÉ ·ÉÛáõϳÙÇÝ
acridonacetic acid,
N-methyl glucamin
óÇÏÉáýáëý³Ùǹ
cyclophosphamide
2813
2815
N04A A01
100Ù·/ÙÉ,
50ÙÉ ßßÇÏ
òÇÝáïñáåÇÉ
Cinnotropil
2811
¹»Õ³å³ïÇ×Ý»ñ
ȳïídz
ÉáõÍáõÛà ËÙ»Éáõ
2812
2810
¹»Õ³Ñ³ï»ñ
2Ù·
(50)
0.002·
(40)
250Ù·
(100)
óÇÏÉáëåáñÇÝ
cyclosporin
óÇݳñǽÇÝ
cinnarizine
óÇݳñǽÇÝ
cinnarizine
óÇÝÏÇ ûùëǹ
zinc oxide
áõݹ»óÇɻݳÃÃáõ,
óÇÝÏÇ áõݹ»óÇɻݳï,
ë³ÉÇóÇɳÃÃíÇ ³ÝÇÉǹ
undecylenic acid, zinc
undecylenat, salicylic
acid anilid
óÇݳñǽÇÝ,
åÇñ³ó»ï³Ù
cinnarizine, piracetam
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
2809
¹»Õ³Ñ³ï»ñ
Tallinn Pharmaceutical plant
JSC
¶ñÇݹ»ùë ´À
Grindex JSC
´áñßã³·áíÛ³Ý ø¸¶
Borshagovsky Ch.Ph.P.
ì³ÛÝ»ùë ê.². (¾ÉÇ ÈÇÉÇ
/²ñ¨»Éù/-Ç Ñ³Ù³ñ)
Vianex S.A. (for Eli Lilly /East/)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ
Salutas Pharma GmbH
¹»Õ³Ñ³ï»ñ
ùëáõù
ùëáõù
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
¸
²¸
²¸
¸
¸
¸
¸
192
2820 òÇåñÇÝáÉ 500Ù·
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
Ciprinol 500mg film
coated tablets
2821
òÇåñáµ³Û
Ciprobay
2822
òÇåñáµ³Û
Ciprobay
2823
òÇåñáµ³Û
Ciprobay
2824
òÇåñá-Ãñá
Cipro-Tro
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(10)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
S01M A02
0824/6819
20.03.2007
20.03.2012
¸
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(10)
200Ù·/100ÙÉ,
100ÙÉ ëñí³Ï
250Ù·
(10)
500Ù·
(10)
¶»ñÙ³Ýdz
J01M A02
5920
¸
¶»ñÙ³Ýdz
J01M A02
5921
¶»ñÙ³Ýdz
J01M A02
5919
Ðݹϳëï³Ý
J01M A02
0486/6478
02.03.2006
02.03.2011
02.03.2006
02.03.2011
02.03.2006
02.03.2011
16.10.2006
16.10.2011
2825 òÇåñá-Ãñá 250Ù·
Cipro-Tro 250mg
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(10,100)
Ðݹϳëï³Ý
J01M A02
0634/6649
27.12.2006
27.12.2011
¸
2826
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
´³Û»ñ лÉÃù»ñ ²¶
Bayer HealthCare AG
îñáç Ø»¹ÇÏ³É /îñáç Ø»¹ÇϳÉ,
/¶»ñÙ³Ýdz/-Ç Ñ³Ù³ñ
Troge Medical /for Troge
Medical, Germany/
Âñáç Ø»¹ÇϳÉ
(Âñáç Ø»¹ÇϳÉ, ¶»ñÙ³ÝdzÛÇ
ѳٳñ)
ü³ñÙ³ î»ù ö´À PharmaTech
CJSC
г۳ëï³Ý
J01M A02
5637
09.11.2005
09.11.2010
¸
г۳ëï³Ý
S01AX13
0994/6624
¸
àõÏñ³Çݳ
S01A X13
5703
èáõÙÇÝdz
S01A X13
0187/6270
30.05.2007
30.05.2012
19.08.2005
19.08.2010
13.07.2006
13.07.2011
èáõë³ëï³Ý
J01M A02
5783
¸
г۳ëï³Ý
J01M A02
6071
08.12.2005
08.12.2010
23.03.2006
23.03.2011
òÇåñá-î»ù
Cipro-Tech
2827
òÇåñá-ï»ù
Cipro-Tech
2828
òÇåñáý³ñÙ
Ciprofarm
2829 òÇåñáýÉûùë³óÇÝ
Ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacine
óÇåñáýÉûùë³óÇÝ
ciprofloxacine
óÇåñáýÉûùë³óÇÝ
ciprofloxacine
2830 òÇåñáýÉûùë³óÇÝ
Ciprofloxacin
2831 òÇåñáýÉûùë³óÇÝ
Ciprofloxacin
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
óÇåñáýÉûùë³óÇÝÇ
ÑǹñáùÉáñǹ
ciprofloxacine
hydrochloride
óÇåñáýÉûùë³óÇÝÇ
ÑǹñáùÉáñǹ
ciprofloxacine
hydrochloride
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
2832 òÇåñáýÉûùë³óÇÝ
Ciprofloxacin
2833 òÇåñáýÉûùë³óÇÝ ²ÉϳÉáǹ
Ciprofloxacin Alkaloid
2834 òÇåñáýÉûùë³óÇݲëï»ñdz 250Ù·
¹»Õ³Ñ³ï»ñ
CiprofloxacinAsteria 250mg
tablets
2835 òÇåñáýÉûùë³óÇݲëï»ñdz 500Ù·
¹»Õ³Ñ³ï»ñ
CiprofloxacinAsteria 500mg
tablets
2836
òÇåý³ëï 500
ÉáõÍáõÛÃ
0.2%,
ϳÃÇɳݻñ³ñÏ-Ù³Ý 100ÙÉ,200ÙÉ,500
ÙÉ åɳëïÇÏ ÷³Ã»Ã
³ÏݳϳÃÇÉÝ»ñ
0.3%,
ü³ñÙ³î»ù ö´À
5ÙÉ, 10ÙÉ ßßÇÏ
PharmaTech CJSC
³Ïݳ-/
0.3%,
ü³ñÙ³Ï ´´À
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
5ÙÉ, 10ÙÉ ßßÇÏ
Farmak JSC
³Ïݳ/³Ï³Ýç³0.3%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
ϳÃÇÉÝ»ñ
5ÙÉ ßßÇÏ
Rompharm Company SRL
(ÉáõÍáõÛÃ)
¹»Õ³Ñ³ï»ñ
0.25·
ú½áÝ êäÀ
óճÝóå³ï
(10)
Ozon Ltd.
ÉáõÍáõÛÃ
0.2%,
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
200ÙÉ åɳëïÇÏ
Ó»éݳñÏáõÃÛáõÝ ö´À
÷³Ã»Ã
Liqvor Pharmaceuticals CJSC
¸
¸
¸
¸
¸
¸
³ÏݳϳÃÇÉÝ»ñ
0.3%,
10ÙÉ åɳëïÇÏ ßßÇÏ
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
г۳ëï³Ý
S01A X13
6072
23.03.2006
23.03.2011
¸
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
100Ù·/10ÙÉ,
10ÙÉ ³ÙåáõÉÝ»ñ
(5)
²ÉϳÉáǹ ²¸
Alkaloid A.D.
سϻ¹áÝdz
J01M A02
5481
08.04.2005
08.04.2010
¸
óÇåñáýÉûùë³óÇÝ
ciprofloxacine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(100)
Îáñ»³ öñÇÙ ü³ñÙ øá. Èï¹
Korea Prime Pharm Co.Ltd.
Îáñ»³
J01M A02
4741
16.06.2004
16.06.2009
¸
óÇåñáýÉûùë³óÇÝ
ciprofloxacine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(100)
Îáñ»³ öñÇÙ ü³ñÙ øá.Èï¹.
Korea Prime Pharm.Co.Ltd.
Îáñ»³
J01M A02
4742
21.05.2004
21.05.2009
¸
óÇåñáýÉûùë³óÇÝ
¹»Õ³Ñ³ï»ñ
500Ù·
XL ɳµáñ³ïáñdz PVT Èï¹.
Ðݹϳëï³Ý
-
0015/5884
12.05.2006
¸
193
Cipfast 500
2837 òÇëåɳïÇÝ §¾´ºìº¦
Cisplatin §EBEWE¦
ciprofloxacin
óÇëåɳïÇÝ
cisplatin
2838
òÇëåɳïÇÝ È»Ï
Cisplatin Lek
óÇëåɳïÇÝ
cisplatin
2839
òÇëåɳïÇÝ È»Ï
Cisplatin Lek
óÇëåɳïÇÝ
cisplatin
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
10Ù·/20ÙÉ,
20ÙÉ ëñí³Ï
2840
òÇëï»Ý³É
Cystenal
ϳÃÇÉÝ»ñ
(0.14·+1.475·+
2.8·+1.475·+
0.0093·)/10ÙÉ,
(10ÙÉ ßßÇÏ)
2841
òÇëïáÝ
Cystone
òÇëïáýÇï
Cystofit
òÇï³Ñ»ùë³É
Citahexal
Ù³·Ý»½ÇáõÙÇ
ë³ÉÇóÇɳï, ³ÝÇëÇ,
ÝÇí»Ýáõ, ë³ÙÇÃÇ
»Ã»ñ³ÛáõÕ»ñ, ïáñáÝÇ
á·»ÃáõñÙ
magnesii salicylas,
Anisi etheroleum,
Eucalypti etheroleum,
Foeniculi etheroleum,
Rubiac tinctorum
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
-
¹»Õ³Ñ³ï»ñ
óÇï³Éáåñ³Ù
citalopram
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
223Ù·
(100)
330Ù·
(30,40)
10Ù·
(20,100)
2842
2843
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
Ëï³ÝÛáõÃ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÇ
ѳµ»ñ
2844
òÇï³Ñ»ùë³É
Citahexal
óÇï³Éáåñ³Ù
citalopram
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2845
òÇï³Ñ»ùë³É
Citahexal
óÇï³Éáåñ³Ù
citalopram
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2846
òÇﻳÉ
Cyteal
ÉáõÍáõÛÃ
÷ñ÷ñ³·áÛ³óÝáÕ
2847
òÇïá½³ñ
Cytosar
Ñ»ùë³ÙǹÇÝ,
ùÉáñÑ»ùëǹÇÝ 20%
ÉáõÍáõÛÃ,
ùÉáñáÏñ»½áÉ
hexamidine,
chlorhexidine solutin
20%, chlorocresol
óÇï³ñ³µÇÝ
cytarabin
2848
òÇïá½³ñ
Cytosar
óÇï³ñ³µÇÝ
cytarabin
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
ÉÇáýÇÉǽ³óí³Í,
10ÙÉ ÉáõÍãáí
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ,
(10)
50Ù·/100ÙÉ,
ëñí³Ï (1)
50Ù·/100ÙÉ,
100ÙÉ ëñí³Ï
XL Laboratories PVT Ltd.
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·. ζ
EBEWE Pharma Ges.m.b.H.
Nfg. KG
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï
ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.,
êÉáí»ÝdzÛÇ Ñ³Ù³ñ)
Salutas Pharma GmbH for Lek
Pharmaceuticals d.d., Slovenia
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (È»Ï
ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.,
êÉáí»ÝdzÛÇ Ñ³Ù³ñ)
Salutas Pharma GmbH for Lek
Pharmaceuticals d.d., Slovenia
¶³É»Ý³ ³.ë.
Galena a.s.
ÐÇÙ³É³Û ¸ñ³· øá.
Himalaya Drug Co
ä³ñ³ý³ñÙ ö´À
Parapharm
CJSC
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
20Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
(20,100)
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
40Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
(20,100)
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
(100Ù·+0.5ÙÉ+300
äÇ»é ü³µñ» Ø»¹ÇϳٻÝï
Ù·)/100ÙÉ,
öñá¹³ÏëÇáÝ
250ÙÉ ßßÇÏ
Pierre Fabre Medicament
Production
12.05.2011
21.06.2004
21.06.2009
²íëïñdz
L01X A01
4906
¶»ñÙ³Ýdz
L01X A01
1094/7123
08.08.2007
08.08.2012
¸
¶»ñÙ³Ýdz
L01X A01
1093/7122
08.08.2007
08.08.2012
¸
â»Ëdz
-
4827
27.04.2004
27.04.2009
²¸
1176/7188
13.09.2007
13.09.2012
08.12.2004
08.12.2009
12.01.2007
12.01.2012
¸
Ðݹϳëï³Ý
¸
èáõë³ëï³Ý
βêÐ
5198
²¸
¶»ñÙ³Ýdz
N06A B04
0643/5591
¶»ñÙ³Ýdz
N06A B04
5592
28.06.2005
28.06.2010
¸
¶»ñÙ³Ýdz
N06A B04
5593
28.06.2005
28.06.2010
¸
üñ³Ýëdz
D08A C52
4926
18.03.2005
18.03.2010
²¸
¸
500Ù·,
ëñí³Ï/³ÙåáõÉ (1+1)
ü³ñÙ³ódz Æï³Édz ê.å.².
Pharmacia Italia S.p.A.
Æï³Édz
L01B C01
5834
10.11.2005
10.11.2010
¸
100Ù·,
ëñí³Ï/³ÙåáõÉ (1+1)
ü³ñÙ³ódz Æï³Édz ê.å.².
Pharmacia Italia S.p.A.
Æï³Édz
L01B C01
5833
10.11.2005
10.11.2010
¸
194
2849
òÇïá½³ñ
Cytosar
óÇï³ñ³µÇÝ
cytarabin
2850
òÇïñ³ÙáÝ- ä
Citramon-P
2851
òÇïñ³ÙáÝ-ä
Citramon-P
2852
òÇïñ³å³ñ
Citrapar
2853
ò-üÉûùë 500
C-FLOX 500
ö³Ý³ïáõë
Panatus
ö³Ý³ïáõë
Panatus
ö³Ý³ïáõë ýáñï»
Panatus forte
ö³Ý³ïáõë ýáñï»
Panatus forte
ö³ëÇɳï
Passilat
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
acetylsalicylic acid,
paracetamol, caffeine
³ó»ïÇÉë³ÉÇódzÃÃáõ,
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ
acetylsalicylic acid,
paracetamol, caffeine
³ó»ïÇÉë³ÉÇóÇɳÃÃáõ,
Ïáý»ÇÝ, å³ñ³ó»ï³ÙáÉ
acetylsalicylic acid,
caffeine, paracetamol
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
µáõï³ÙÇñ³ï
butamirate
µáõï³ÙÇñ³ï
butamirate
µáõï³ÙÇñ³ï
butamirate
µáõï³ÙÇñ³ï
butamirate
-
2854
2855
2856
2857
2858
2859
ö³ñ³ åÉÛáõë
Para Plus
2860
ö³ùë+
Pax+
2861
öÇÉ»ùë
Pilex
2862
öÇÉ»ùë
Pilex
2863
öÉ»áëï³ï
Pleostat
2864
öñÇáñÇùë
Priorix
ÉÇáýÇÉǽ³óí³Í,
5ÙÉ ÉáõÍãáí
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
1·
ëñí³Ï (1)
ü³ñÙ³ódz Æï³Édz
ê.å.².(öý³Û½»ñ ·ñáõåÇ
ÁÝÏ»ñáõÃÛáõÝ)
Pharmacia Italia S.p.A.(Pfizer
Group Company)
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
Æï³Édz
L01B C01
6043
31.03.2006
31.03.2011
¸
èáõë³ëï³Ý
N02BA71
1401/7364
05.11.2007
05.11.2012
²¸
¹»Õ³Ñ³ï»ñ
(240Ù·+180Ù·+
30Ù·) (10)
¹»Õ³Ñ³ï»ñ
(240Ù·+180Ù·+
30Ù·) (10)
øÇÙý³ñÙ ´À
Chimpharm JSC
Ô³½³Ë-ëï³Ý
N02BA71
1383/7346
22.11.2007
05.11.2012
²¸
¹»Õ³å³ïÇ×Ý»ñ
0.24·+0.03·+ 0.18·
(10,20)
§´ñÇÝó³Éáí-²¦ ö´À
CJSC §Brinsalov-A¦
èáõë³ëï³Ý
N02B A71
4558
02.10.2003
02.10.2008
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ûß³ñ³Ï
500Ù·
(100/10x10/)
20Ù·
(10)
4Ù·/5ÙÉ,
200ÙÉ ßßÇÏ
7.5Ù·/5ÙÉ,
200ÙÉ ßßÇÏ
50Ù·
(10)
320Ù·
(60)
ÆÝï³ë ý³ñÙ³ëÛáõÃÇù³Éë Èï¹.
Intas Pharmaceuticals Ltd.
Îèβ ¹.¹.Üáíá Ù»ëïá
KRKA d.d.Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d.Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d.Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d.Novo mesto
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
ȳµáñ³ïáñdz ü³ñÙÇÅÇ»Ý êβî
Laboratoires Pharmygiene
SCAT
Ðݹϳëï³Ý
D01B
0777/6748
¸
êÉáí»Ýdz
R05D B13
4092
êÉáí»Ýdz
R05D B13
4090
êÉáí»Ýdz
R05D B13
4091
êÉáí»Ýdz
R05D B13
4093
Æéɳݹdz
βêÐ
5808
07.03.2007
07.03.2012
24.03.2005
24.03.2010
25.12.2003
25.12.2008
25.12.2003
25.12.2008
25.12.2003
25.12.2008
26.10.2005
26.10.2010
üñ³Ýëdz
P03A
0136/6000
29.06.2006
29.06.2011
²¸
Æéɳݹdz
βêÐ
5822
26.10.2005
26.10.2010
²¸
Ðݹϳëï³Ý
-
4549
24.11.2003
24.11.2008
²¸
Ðݹϳëï³Ý
-
4550
24.11.2003
24.11.2008
²¸
êÉáí»Ýdz
M05B
3708
20.11.2003
20.11.2008
¸
´»É·Ç³
J07B J51
5156
17.11.2004
17.11.2009
¸
ûß³ñ³Ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
å³ïÇ×Ý»ñ
å»ñÙ»ÃñÇÝ,
óáÕ³óÇñ ³ñï³ùÇÝ
(0.58·+0.29·+
ٳɳÃÇáÝ,
û·ï³·áñÍÙ³Ý
3.32·)/ 116·,
åÇå»ñáÝÇɵáõïûùëǹ
116·/125ÙÉ
permethrin, malathion,
óáÕ³óÇñ ï³ñ³ÛáõÙ
piperonylbutoxide
å³ïÇ×Ý»ñ
405Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
µáõë³Ï³Ý ÷áßÇÝ»ñ ¨
¹»Õ³Ñ³ï»ñ
(100)
ÐÇٳɳ۳ ¸ñ³·.øá.
ѳÝáõÏÝ»ñ
The Himalaya Drug Co.
herbal powders and
extracts
µáõë³Ï³Ý ÷áßÇÝ»ñ ¨
ùëáõù
30· å³ñÏáõ×
ÐÇٳɳ۳ ¸ñ³·.øá.
ѳÝáõÏÝ»ñ
The Himalaya Drug Co.
herbal powders and
extracts
¿ïǹñáݳïÇ
¹»Õ³Ñ³ï»ñ
400Ù·
Îèβ ¹.¹. Üáíá Ù»ëïá
»ñÏݳïñÇáõÙ³Ï³Ý ³Õ
(14,56)
KRKA d.d. Novo mesto
etidronate disodium
ϳñÙñáõÏÇ, ϳñÙñ³ËïÇ,
å³ïí³ëï³ÝÛáõÃ
1 ¹»Õ³ã³÷ (0.5ÙÉ),
¶É³ùëáêÙÇÃÎɳÛÝ
ѳñ³Ï³Ýç³ÛÇÝ
ÉÇáýÇÉǽ³óí³Í,
ëñí³Ï/³ÙåáõÉ (1),
´ÇáÉá·ÇϳÉë ë.³.
²¸
²¸
²¸
²¸
²¸
195
2865
2866
2867
ø³Ã»ç»É
ÉǹáϳÛÇÝáí
Cathejell with
lidocaine
ø³ÉåáÉ
Calpol
ø³ÉåáÉ
Calpol
·»ÕÓ³µáñµÇ
ÉáõÍãáí
10 ¹»Õ³ã³÷
å³ïí³ëï³ÝÛáõà vaccine
ëñí³Ï/³ÙåáõÉ (50)
against
measles,rubella,
mumps
ÉǹáϳÛÇÝ,
¹áݹáÕ (çñ³ÉáõÛÍ)
2%+0.05%,
ùÉáñÑ»ùëǹÇÝ
12.5· ͳÉù³íáñ
lidocaine, chlorhexidine
Ý»ñ³ñÏÇã (1,25)
å³ñ³ó»ï³ÙáÉ
paracetamol
å³ñ³ó»ï³ÙáÉ
paracetamol
¹»Õ³Ï³ËáõÛÃ
ÙáÙÇÏÝ»ñ
2868
»ùíáÕ ù³çí³ñ¹Ç
ù³çí³ñ¹Ç Ëáï, ù³çí³ñ¹Ç
á·»ÃáõñÙ
á·»ÃáõñÙ
Ïá×Õ³ñÙ³ïÝ»ñáí
Paeoniae Anomalae
³ñÙ³ïÝ»ñÁ
tincture
paeoniae herba,
paeoniae radix and
rhizoma
2869
ø³÷áõñÇ ÛáõÕ
ù³÷áõñ
ÉáõÍáõÛÃ
Camphor oil
camphora
ÛáõÕ³ÛÇÝ
2870
øɳíáÙ»¹
³ÙûùëÇóÇÉÇÝ,
¹»Õ³÷áßÇ ËÙ»Éáõ
Clavomed
ùɳíáõɳݳÃÃáõ
¹»Õ³Ï³ËáõÛÃÇ
amoxicilline, clavulanic
acid
2871
øɳíáÙ»¹
Clavomed
³ÙûùëÇóÇÉÇÝ,
ùɳíáõɳݳÃÃáõ
amoxicilline, clavulanic
acid
¹»Õ³÷áßÇ
¹»Õ³Ï³ËáõÛÃÇ
2872
øɳñÇë»Ýë
Clarisens
Éáñ³ï³¹ÇÝ
loratadine
ûß³ñ³Ï
2873
2874
2875
2876
2877
2878
øɻݵáõï»ñáÉ
ùɻݵáõï»ñáÉ
Clenbuterol
clenbuterol
øÉáñ³Ùý»ÝÇÏáÉÇ
ùÉáñ³Ùý»ÝÇÏáÉ
ݳïñÇáõÙ ëáõÏóÇݳï ëáõÏóÇݳï ݳïñÇáõÙÇ
Chloramphenicol
chloramphenicol
sodium succinate
sodium succinate
øÉáñùÇݳɹÇÝ
ùÉáñùíÇݳɹáÉ
Chlorchinaldin
chlorquinaldol
øÉáý³½áÉÇÝ
ùÉáÝǹÇÝ
Chlophazolin
clonidine
øáɹñ»ùë
å³ñ³ó»ï³ÙáÉ, Ïáý»ÇÝ,
Coldrex
ý»ÝÇÉ¿ýñÇÝ, ï»ñåÇÝ
Ñǹñ³ï, ³ëÏáñµÇݳÃÃáõ
paracetamol, caffeine,
phenylephrine, terpin
hydrate, ascorbic acid
øáɹñ»ùë µñáÝËá
·áõ³Ûý»Ý»½ÇÝ,
ûß³ñ³Ï
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
Éá½³ÝÝ»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
ûß³ñ³Ï
Glaxo SmithKline Biologicals
s.a.
ØáÝï³íÇï ¶»ë.Ù.µ.Ð Montavit
Ges.m.b.H
²íëïñdz
N01B B52,
D08A C52
5538
03.11.2005
03.11.2010
¸
¶»ñÙ³Ýdz
N02B E01
4120
²¸
Ȼѳëï³Ý
N02B E01
5060
24.01.2003
24.01.2008
25.08.2004
25.08.2009
èáõë³ëï³Ý
N05CM
1214/7135/1
25.12.2007
13.09.2012
²¸
¾ëÏáõɳå êäÀ
Esculap Ltd.
꺸ÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
ѳٳñ, ²Ý·Édz)
SEDICO Pharmaceutical Co.
(for World Medicine, England)
г۳ëï³Ý
C01E B02
5634
²¸
º·Çåïáë
J01C R02
0123/6227
12.01.2006
12.01.2011
21.06.2006
21.06.2011
꺸ÆÎú (àõáñɹ Ø»¹ÇëÇÝÇ
ѳٳñ, ²Ý·Çɳ)
SEDICO Pharmaceutical Co.
(for World Medicine, England)
º·Çåïáë
J01C R02
0124/6228
21.06.2006
21.06.2011
¸
ü³ñÙëï³Ý¹³ñï-È»Ïëñ»¹ëïí³ ´´À
Pharmstandard-Leksredstva
OJSC
´³ÉϳÝý³ñÙ³-îñáÛ³Ý ²¸
Balkanpharma-Troyan AD
²ÝïǵÇáïÇÏ ê.².
Antibiotice
S.A.
èáõë³ëï³Ý
R06A X13
0410/6356
19.09.2006
19.09.2011
²¸
´áõÉÕ³ñdz
R03C C13
0900/6940
¸
èáõÙÇÝdz
J01B A01
4357
20.04.2007
20.04.2012
16.07.2003
16.07.2008
Ȼѳëï³Ý
R02A A11
0454/6399
²¸
´áõÉÕ³ñdz
5630
Æéɳݹdz
C02A C01,
N02C X02
N02B E71
0025/6170
29.09.2006
29.09.2011
27.09.2005
27.09.2010
17.05.2006
17.05.2011
ØdzóÛ³É
R05C A03
4613
16.12.2003
²¸
120Ù·/5ÙÉ,
70ÙÉ ßßÇÏ
125Ù·
(10)
¶É³ùëá àõ»ÉùáÙ ¶ÙµÐ ¨ øá.
Glaxo Wellcome GmbH & Co.
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê.².
GlaxoSmithKline
Pharmaceuticals S.A.
(50·+50·)/1ÙÉ,
²ÉóÛíÇï³ÙÇÝÇ ö´À
25ÙÉ, 100ÙÉ ßßÇÏ
Altajvitaminy Closed JSC
10%,
30ÙÉ ßßÇÏ
312.5Ù· (250Ù·+
62.5Ù·)/5ÙÉ,
80ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ ³å³Ï»
ßßÇÏáõÙ
156.25Ù·
(125Ù·+31.25
Ù·)/5ÙÉ, 80ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³÷áßÇ ³å³Ï»
ßßÇÏáõÙ
1Ù·/ÙÉ,
100ÙÉ ßßÇÏ
0.001Ù·/ÙÉ,
100ÙÉ ßßÇÏ
1·,
ëñí³Ï (1, 50)
2Ù·
(20)
0.15Ù·
(50)
(500Ù·+25Ù·+
5Ù·+ 20Ù·+30Ù·)
(6,12,24)
100Ù·+3·+1.35·)/
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
ICN Polfa Rzeszow S.A.
êáý³ñÙ³ ´À Sopharma JSC
¶É³ùëáêÙÇÃÎɳÛÝ ¸³Ý·³ñí³Ý
ÈÇÙÇﻹ ¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ
GlaxoSmithKline Dungarvan
Limited for GlaxoSmithKline
Consumer Healthcare
è³ýïáÝ É³µáñ³ïáñdz ÉÇÙÇﻹ
²¸
¸
¸
¸
²¸
196
Coldrex Broncho
Ñ»ÕáõÏ ·ÉÛáõÏá½,
Ùñ·³ÑÛáõÃ
guaifenesin, liquid
glucose, treacle
5ÙÉ,
100ÙÉ,160ÙÉ
ßßÇÏ
(¶É³ùëáêÙÇÃÎɳÛÝ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ)
WraftonLaboratories Limited
(for GlaxoSmithKline
Consumer Healthcare)
2879 øáɹñ»ùë ÑáÃñ»Ù
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ ËÙ»Éáõ
600Ù·+40Ù·+
¶É³ùëáêÙÇÃÎɳÛÝ
Ù»ÕñÇ ¨ ÏÇïñáÝÇ
³ëÏáñµÇݳÃÃáõ,
ÉáõÍáõÛÃÇ
10Ù·, ÷³Ã»ÃÝ»ñ
øáÝëáõÙ»ñ лÉÃù»ñ
Coldrex Hotrem
ý»ÝÇÉ»ýñÇÝ
(5,10)
GlaxoSmithKline Consumer
Honey and Lemon paracetamol, ascorbic
Healthcare
acid, phenylephrine
2880 øáɹñ»ùë Ðáïè»Ù
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ ËÙ»Éáõ
(600Ù·+10Ù·+
¶É³ùëá êÙÇÃÎɳÛÝ
Ù»Õñ ¨ ÏÇïñáÝ
ý»ÝÇÉ¿ýñÇÝÇ
ÉáõÍáõÛÃÇ
40Ù·)/6·,
øáÝëÛáõÙ»ñ лÉà ø»Ûñ
Coldrex HotRem
ÑǹñáùÉáñǹ,
6· ÷³Ã»ÃÝ»ñ
GlaxoSmithKline Consumer
honey & lemon
³ëÏáñµÇݳÃÃáõ
(5, 10)
HealthCare
paracetamol,
phenylephrine
hydrochloride, ascorbic
acid
2881 øáɹñ»ùë Ñáïñ»Ù
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ ËÙ»Éáõ 750Ù·+60Ù·+10Ù·
êÙÇÃÎɳÛÝ ´Çã»Ù ê.².
ÏÇïñáÝÇ
³ëÏáñµÇݳÃÃáõ,
ÉáõÍáõÛÃÇ
(5,10,50)
(¶É³ùëáêÙÇÃÎɳÛÝ
Coldrex HotRem
ý»ÝÇÉ¿ýñÇÝÇ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ)
Lemon
ÑǹñáùÉáñǹ
SmithKline Beecham S.A.(for
paracetamol, ascorbic
GlaxoSmithKline Consumer
acid, phenylephrine
Healthcare)
hydrochloride
2882 øáɹñ»ùë Ñáïñ»Ù
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ ËÙ»Éáõ 750Ù·+60Ù·+10Ù·
êÙÇÃÎɳÛÝ ´Çã»Ù ê.².
ë¨ Ñ³Õ³ñçÇ
³ëÏáñµÇݳÃÃáõ,
ÉáõÍáõÛÃÇ
(5,10,50)
(¶É³ùëáêÙÇÃÎɳÛÝ
Coldrex HotRem
ý»ÝÇÉ¿ýñÇÝÇ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ)
Blackcurrant
ÑǹñáùÉáñǹ
SmithKline Beecham S.A.(for
paracetamol, ascorbic
GlaxoSmithKline Consumer
acid, phenylephrine
Healthcare)
hydrochloride
2883 øáɹñ»ùë Ù³ùë·ñÇå
å³ñ³ó»ï³ÙáÉ,
¹»Õ³÷áßÇ ËÙ»Éáõ 1000Ù·+40Ù·+
êÙÇÃÎɳÛÝ ´Çã»Ù ê.².
ÏÇïñáÝ
³ëÏáñµÇݳÃÃáõ,
ÉáõÍáõÛÃÇ
10Ù·, ÷³Ã»ÃÝ»ñ
SmithKline Beecham S.A.
Coldrex MaxGrip
ý»ÝÇÉ¿ýñÇÝÇ
(5,10)
Lemon
ÑǹñáùÉáñǹ
paracetamol, ascorbic
acid, phenylephrine
hydrochloride
2884
øáɹñ»ùë ݳÛï
å³ñ³ó»ï³ÙáÉ,
ûß³ñ³Ï
(1000Ù·+20Ù·+
è³ýïáÝ É³µáñ³ïáñdz ÉÇÙÇﻹ
Coldrex Nite
åñáٻó½ÇÝÇ
15Ù·)/20ÙÉ,
(¶É³ùëáêÙÇÃÎɳÛÝ
ÑǹñáùÉáñǹ,
100ÙÉ,160ÙÉ
øáÝëáõÙ»ñ лÉÃù»ñÇ Ñ³Ù³ñ)
¹»ùëïñáÙ»Ãáñý³ÝÇ
ßßÇÏ
Wrafton Laboratories Limited
ÑǹñáùÉáñǹ
(for GlaxoSmithKline
paracetamol,
Consumer Healthcare)
promethazine
hydrochloride,
dextromethorphan
hydrochloride
2885
øáÙåÉÇíÇï
íÇï³ÙÇÝÝ»ñ,
¹»Õ³Ñ³ï»ñ
(60)
ü³ñÙëï³Ý¹³ñï-àõý³ìÆî² ´´À
Complivit
ѳÝù³ÝÛáõûñ
óճÝóå³ï
Pharmstandard-UfaVITA OJSC
vitamins, minerals
2886
øáݹñáÇïÇÝ
ùáݹñáïÇÝÇ ëáõÉý³ï
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
´»ÉÙ»¹åñ»å³ñ³ïÇ ÐàõÒ
ëáõÉý³ï
chondroitin sulfate
(10, 20/2x10/,
Belmedpreparaty RUP
Chondroitin sulfate
30/3x10/)
³·³íáñáõÃÛáõÝ
16.12.2008
Æëå³Ýdz
N02B E71
4168
25.02.2003
25.02.2008
²¸
Æëå³Ýdz
N02B E51
1439/7429
20.12.2007
20.12.2012
²¸
Æëå³Ýdz
N02B E51
5831
17.02.2006
17.02.2011
²¸
Æëå³Ýdz
N02B E51
5832
17.02.2006
17.02.2011
²¸
Æëå³Ýdz
N02B E71
4781
15.04.2004
15.04.2009
²¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
N02B E71
4614
16.12.2003
16.12.2008
²¸
èáõë³ëï³Ý
A11AA04
0837/6845
26.03.2007
26.03.2012
²¸
´»É³éáõë
M09A X02
0752/6785
15.02.2007
15.02.2012
²¸
197
2887
øáݹñûùëǹ
Chondroxid
ùáݹñáÇïÇÝÇ ëáõÉý³ï
chondroitin sulfate
ùëáõù
2888
øáõå»ñë
Cupers
-
å³ïÇ×Ý»ñ
2889
øë»Éá¹³
Xeloda
øë»ÝÇϳÉ
Xenical
øë»ýáϳ٠è³åǹ
Xefocam Rapid
øëÇÉáٻﳽáÉÇÝ
Xylometazolin
øëÇÉáٻﳽáÉÇÝ
Xylometazolin
øëÇÉá-ݳ½³É
Xylo-Nazal
øëÇÉá-ݳ½³É
Xylo-Nazal
øëÇÙ»ÉÇÝ
Xymelin
ϳå»óÇï³µÇÝ
capecitabine
ûñÉÇëï³ï
orlistat
ÉáñÝûùëÇϳÙ
lornoxicam
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
¹»Õ³Ñ³ï»ñ
2897
øëÇÙ»ÉÇÝ
Xymelin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
óáÕ³ßÇà ùÃÇ
0.5Ù·/ÙÉ,
15ÙÉ ßßÇÏ
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
Nycomed Danmark A/S
¸³Ýdz
2898
øëÇÙ»ÉÇÝ
Xymelin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
1Ù·/ÙÉ,
10ÙÉ ßßÇÏ
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
Nycomed Danmark A/S
¸³Ýdz
2899
øëÇÙ»ÉÇÝ
Xymelin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
óáÕ³ßÇà ùÃÇ
1Ù·/ÙÉ,
15ÙÉ ßßÇÏ
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
Nycomed Danmark A/S
¸³Ýdz
2900
øí³¹ñáåñÇÉ
Quadropril
øí³Ù³ï»É
Quamatel
øí³Ù³ï»É
Quamatel
øí³Ù³ï»É
Quamatel
ëåÇñ³åñÇÉ
spirapril
ý³ÙáïǹÇÝ
famotidine
ý³ÙáïǹÇÝ
famotidine
ý³ÙáïǹÇÝ
famotidine
¹»Õ³Ñ³ï»ñ
6Ù·
(30)
20Ù·
(28)
40Ù·
(14)
20Ù·,
ëñí³Ï/³ÙåáõÉ (5)
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
AWD pharma GmbH & Co.KG
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
øí³Ù³ï»É ÙÇÝÇ
Quamatel Mini
øíÇݳùë
Qiunax
ý³ÙáïǹÇÝ
famotidine
³½³å»Ýï³ó»ÝÇ
åáÉÇëáõÉýáݳï
azapentacene
polysulfonate
ùñáÙá·ÉÇϳï
ݳïñÇáõÙÇ
sodium cromoglicate
10Ù·
(10)
0.15Ù·/ÙÉ,
15ÙÉ ßßÇÏ
³ÏݳϳÃÇÉÝ»ñ
2%,
10ÙÉ ßßÇÏ
óáÕ³ßÇà ùÃÇ
20Ù·/ÙÉ,
2890
2891
2892
2893
2894
2895
2896
2901
2902
2903
2904
2905
2906
øñáÙáÑ»ùë³É
Cromohexal
2907
øñáÙáÑ»ùë³É
ùñáÙá·ÉÇϳï
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ùóϳÃÇÉÝ»ñ
ùóϳÃÇÉÝ»ñ
ùóϳÃÇÉÝ»ñ
ùóϳÃÇÉÝ»ñ
ùóϳÃÇÉÝ»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý,
ÉÇáýÇÉǽ³óí³Í,
ÉáõÍãáí
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ÉáõÍáõÛóÏݳϳÃÇÉÝ»ñ
5%,
ÜÇÅý³ñÙ ´À
30·,50· å³ñÏáõ× Ï³Ù
Nizhpharm JSC
ï³ñ³
355Ù·
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
(60)
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
500Ù·
ü.ÐáýÙ³Ý-ȳ èáß Èï¹.
(120)
F.Hoffmann-La Roche Ltd.
120Ù·
èáß ê.å.².(ê»çñ³ï)
(21,42,84)
Roche S.p.A.(Segrate)
8Ù·
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ².å.ê.
(6)
Nycomed Danmark ApS
0.05%
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
ICN Polfa Rzeszow S.A.
0.1%,
²Û-êÇ-¿Ý äáÉý³ Ä»ßáõí ê.².
10ÙÉ ßßÇÏ
ICN Polfa Rzeszow S.A.
0,1%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
10ÙÉ ßßÇÏ
Rompharm Company SRL
0,05%,
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
10ÙÉ ßßÇÏ
Rompharm Company SRL
0.5Ù·/ÙÉ,
ÜÇÏáÙ»¹ ¸³ÝÙ³ñÏ ²/ê
10ÙÉ ßßÇÏ
Nycomed Danmark A/S
èáõë³ëï³Ý
M09A X02
4515
26.01.2004
26.01.2009
²¸
Æéɳݹdz
βêÐ
5814
26.10.2005
26.10.2010
²¸
Þí»Ûó³ñdz
L01B C06
5319
¸
Æï³Édz
-
4666
¸³Ýdz
-
0414/6378
Ȼѳëï³Ý
R01A A07
0456/6401
Ȼѳëï³Ý
R01A A07
0459/6336
èáõÙÇÝdz
R01A A07
0672/6713
èáõÙÇÝdz
R01A A07
0673/6712
¸³Ýdz
4377
¶»ñÙ³Ýdz
R01A A07
R01A B06
S01G A03
R01A A07
R01A B06
S01G A03
R01A A07
R01A B06
S01G A03
R01A A07
R01A B06
S01G A03
C09A A11
21.02.2005
21.02.2010
13.04.2004
13.04.2009
26.09.2006
26.09.2011
29.09.2006
29.09.2011
29.09.2006
29.09.2011
17.01.2007
17.01.2012
17.01.2007
17.01.2012
27.06.2003
27.06.2008
ÐáõÝ·³ñdz
A02B A03
5243
ÐáõÝ·³ñdz
A02B A03
5244
ÐáõÝ·³ñdz
A02B A03
5245
¶»¹»áÝ èÇËï»ñ ´´À
Gedeon Richter Plc.
ê.².²ÉÏáÝ øáõíñ»áõñ Ü.ì.
S.A.Alcon-Couvreur N.V.
ÐáõÝ·³ñdz
A02B A03
0724/6726
´»É·Ç³
-
4890
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
¶»ñÙ³Ýdz
S01G
S01G X51
¶»ñÙ³Ýdz
S
¸
¸
²¸
²¸
²¸
²¸
²¸
4379
27.06.2003
27.06.2008
²¸
4378
27.06.2003
27.06.2008
²¸
4380
27.06.2003
27.06.2008
²¸
5081
12.10.2004
12.10.2009
30.05.2005
30.05.2010
30.05.2005
30.05.2010
30.05.2005
30.05.2010
¸
13.02.2007
13.02.2012
31.05.2004
31.05.2009
¸
5132
15.10.2004
15.10.2009
²¸
5219
29.12.2004
²¸
¸
¸
¸
¸
198
Cromohexal
ݳïñÇáõÙÇ
sodium chromoglicate
(ÉáõÍáõÛÃ)
15ÙÉ ßßÇÏ
2908
øñáÙíÇï³É+
Chromvital+
-
å³ïÇ×Ý»ñ
410Ù·
(60)
2909
úµ½Ç¹³Ý
Obsidan
2910
2911
2912
2913
2914
2915
2916
2917
2918
2919
2920
2921
2922
åñáåñ³ÝáÉáÉÇ
¹»Õ³Ñ³ï»ñ
ÑǹñáùÉáñǹ
propranolol
hydrochloride
ú¹»ëïáÝ
ÑÇÙ»ÏñáÙáÝ
¹»Õ³Ñ³ï»ñ
Odeston
hymecromon
úÉÇ·áíÇï
íÇï³ÙÇÝÝ»ñ
¹»Õ³Ñ³ï»ñ
Oligovit
vitamins
óճÝóå³ï (¹ñ³Å»)
úÉÇϳñ¹ 40 é»ï³ñ¹
ǽáëáñµÇ¹-5¹»Õ³å³ïÇ×Ý»ñ
Olicard 40 retard
ÙáÝáÝÇïñ³ï
é»ï³ñ¹
isosorbide-5mononitrate
úÉÇϳñ¹ 60 é»ï³ñ¹
ǽáëáñµÇ¹-5¹»Õ³å³ïÇ×Ý»ñ
Olicard 60 retard
ÙáÝáÝÇïñ³ï
é»ï³ñ¹
isosorbide-5mononitrate
úÉý»Ý ¹áݹáÕ
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
¹áݹáÕ
Olfen Gel
diclofenac sodium
úÉý»Ý-100 é»Ïïáϳåë ¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
¹»Õ³å³ïÇ×Ý»ñ
Olfen-100
diclofenac sodium
áõÕÇÕ ³ÕÇù³ÛÇÝ
Rectocaps
úÉý»Ý-100 êè
¹»åáϳåë
Olfen-100 SR
Depocaps
úÉý»Ý-50 ɳÏï³µ
Olfen-50 Lactab
úÉý»Ý-75
Olfen-75
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
diclofenac sodium
¹»Õ³å³ïÇ×Ý»ñ
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ
¹»Õ³Ñ³ï»ñ
diclofenac sodium
óճÝóå³ï
¹ÇÏÉáý»Ý³Ï ݳïñÇáõÙÇ,
ÉáõÍáõÛÃ
ÉǹáϳÛÇÝÇ
Ý»ñ³ñÏÙ³Ý
ÑǹñáùÉáñǹ
diclofenac sodium,
lidocaine hydrochloride
úÏáõïÇÙ
ÃÇÙáÉáÉ
³ÏݳϳÃÇÉÝ»ñ
Ocutim
timolol
úÏáõïÇÙ
ÃÇÙáÉáÉ
³ÏݳϳÃÇÉÝ»ñ
Ocutim
timolol
úÓÇ (·Ûáõñ½³, ¿ý³,
ÓÇáõ ³ñÛ³Ý
ßÇ×áõÏ
Ïáµñ³)
µ³½Ù³í³É»Ýï Ù³ùñí³Í,
»ÝóٳßϳÛÇÝ ¨
ѳϳÃáõݳÛÇÝ
Ëï³óí³Í Ñ»ÕáõÏ ßÇ×áõÏ
Ý/»
ßÇ×áõÏ
a polyvalent, purified,
Ý»ñ³ñÏáõÙÝ»ñÇ
Snake Antivenom
concentrated Snake
Serum (Gyurza, Efa, Venom Antisera from
Cobra)
the serum of horses
úÓÇ ßÇ×áõϳÛÇÝ
ûÓ»ñÇ ÃáõÛÝÁ
åɳ½Ù³
µ³½Ù³í³É»Ýï
㻽áù³óÝáÕ
ÉÇáýÇÉǽ³óí³Í,
ѳϳÃáõÛÝ
ѳϳÃáõÛÝ-ßÇ×áõÏ
ÉáõÍÇãáí
SII Polyvalent
venom of iSnake
40Ù·
(60)
200Ù·
(50)
(30)
40Ù·
(20)
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
ÜáõïñÇý³ñÙ³ Èï¹ (²ñÏáý³ñÙ³
ÁÝÏ»ñáõÃÛ³Ý ëïáñ³µ³Å³ÝáõÙ)
Nutripharma Ltd (the company
of ARCOPHARMA Group)
²Éý³ñÙ³ ÆêÆê ¶ÙµÐ ¨ øá.ζ.
Alpharma ISIS GmbH & Co.KG
29.12.2009
Æéɳݹdz
βêÐ
5820
26.10.2005
26.10.2010
²¸
¶»ñÙ³Ýdz
C07A A05
4743
05.02.2004
05.02.2009
¸
A05A X02
5524
¸
-
4579
C01D A14
3947
19.04.2005
19.04.2010
24.11.2003
24.11.2008
11.02.2003
11.02.2008
äáÉý³ 䳵dzÝÇó» ê.².
Ȼѳëï³Ý
Polfa Pabianice S.A.
¶³É»ÝÇϳ ³.¹.
гñ³íëɳ-ídz
Galenika a.d.
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶»ñÙ³Ýdz
¶ÙµÐ
Solvay Pharmaceuticals GmbH
²¸
¸
60Ù·
(20,25)
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶ÙµÐ
Solvay Pharmaceuticals GmbH
¶»ñÙ³Ýdz
C01D A14
3948
11.06.2003
11.06.2008
¸
1%,
20· å³ñÏáõ×
100Ù·
(5)
Ø»ý³ Èï¹.
Mepha Ltd.
è. ä. Þ»ñ»ñ ¶ÙµÐ /Ø»ý³ Èï¹ Ç Ñ³Ù³ñ, Þí»Ûó³ñdz/
R.P. Scherer GmbH for Mepha
Ltd., Switzerland
Ø»ý³ Èï¹.
Mepha Ltd.
Þí»Ûó³ñdz
M02A A15
0625/6670
²¸
¶»ñÙ³Ýdz
M01A B05
0620/6675
27.12.2006
27.12.2011
27.12.2006
27.12.2011
Þí»Ûó³ñdz
M01A B15
0624/6671
27.12.2006
27.12.2011
¸
50Ù·
Ø»ý³ Èï¹.
(20)
Mepha Ltd.
(75Ù·+20Ù·)/2ÙÉ,
Ø»ñÏÉ» ¶ÙµÐ Ø»ý³ Èï¹-Ç
2ÙÉ ³ÙåáõÉÝ»ñ
ѳٳñ, Þí»Ûó³ñdz
(5)
Merckle GmbH for Mepha Ltd,
Switzerland
Þí»Ûó³ñdz
M01A B15
0623/6672
¸
¶»ñÙ³Ýdz
M01A B05
0628/6676
27.12.2006
27.12.2011
27.12.2006
27.12.2011
Ðݹϳëï³Ý
S01E D01
4182
¸
Ðݹϳëï³Ý
S01E D01
4181
àõ½µ»Ïëï³Ý
J06A A
1072/7047
23.06.2003
23.06.2008
23.06.2003
23.06.2008
25.07.2007
25.07.2012
Ðݹϳëï³Ý
-
5341
31.01.2005
31.01.2010
¸
100Ù·
(10)
0.5%,
5ÙÉ ßßÇÏ
0.25%,
5ÙÉ ßßÇÏ
1 ¹»Õ³ã³÷,
³ÙåáõÉ (1)
êÇåɳ Èï¹
Cipla Ltd.
êÇåɳ Èï¹
Cipla Ltd.
àõ½µÇáý³ñÙ ´´À
Uzbiopharm OJSC
ÉÇáýÇÉǽ³óí³Í Ðݹϳëï³ÝÇ ê»ñáõÙ ÆÝëïÇïáõï
åɳ½Ù³,10ÙÉ
Èï¹
Ý»ñ³ñÏÙ³Ý çáõñ,
Serum Institute of India Ltd.
ëñí³Ï/³ÙåáõÉ (1,10)
¸
¸
¸
¸
199
AntiSnake Venom
Serum
2923
úÙ³Ïáñ
Omacor
neutralizing antisera
¹»Õ³å³ïÇ×Ý»ñ
1000Ù·
(28,100,280)
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶ÙµÐ
Solvay Pharmaceuticals GmbH
¶»ñÙ³Ýdz
B04A
4783
07.07.2004
23.04.2009
¸
úÙ³ùë-20
Omax-20
úÙ»åñ³½áÉ
Omeprazole
ûÙ»·³-3׳ñå³ÃÃáõÝ»ñÇ ¿ÃÇÉ
¿ëûñ 90
omega-3-acid ethyl
esters 90
ûÙ»åñ³½áÉ
omeprazole
ûÙ»åñ³½áÉ
omeprazole
¹»Õ³å³ïÇ×Ý»ñ
20Ù·
(30)
0.02·
(30/3x10/)
Ðݹϳëï³Ý
A02B C01
5288
¸
´»É³éáõë
A02B C01
0793/6793
11.04.2005
11.04.2010
20.03.2007
20.03.2012
2926
úÙ»åñ³½áÉ
Omeprazol
ûÙ»åñ³½áÉ
omeprazole
¹»Õ³å³ïÇ×Ý»ñ
³Õ»ÉáõÛÍ
´ÇáÙ»¹Çϳñ
Biomedicare
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´áõÉÕ³ñdz
A02B C01
0610/6617/1
14.12.2006
05.12.2011
¸
2927
úÙ»åñ³½áÉ
Omeprazole
úÙ»åñ³½áÉ
Omeprazole
ûÙ»åñ³½áÉ
omeprazole
ûÙ»åñ³½áÉ
omeprazole
¹»Õ³å³ïÇ×Ý»ñ
г۳ëï³Ý
A02B C01
0909/6939
¸
г۳ëï³Ý
A02B C01
0213/5707
20.04.2007
20.04.2012
26.07.2006
26.07.2011
úÙ»åñ³½áÉ ÎØä
Omeprazol-KMP
úÙ»ë³Ý 20
Omesan 20
úÙ»ñ³Ý
Omeran
ûÙ»åñ³½áÉ
omeprazole
ûÙ»åñ³½áÉ
omeprazole
ûÙ»åñ³½áÉ
omeprazole
¹»Õ³å³ïÇ×Ý»ñ
àõÏñ³Çݳ
A02B C01
4292
¸
Ðݹϳëï³Ý
A01B C01
0957/6952
èáõÙÇÝdz
A02B C01
4792
03.07.2003
03.07.2008
14.05.2007
14.05.2012
08.12.2004
08.12.2009
úÙ»ý»½
Omefez
úÙÇïáùë
Omitox
úÙݳ¹ñ»Ý 250
Omnadren 250
ûÙ»åñ³½áÉ
omeprazole
ûÙ»åñ³½áÉ
omeprazole
ûëïáëï»ñáÝÇ
åñáåÇáݳï,
ûëïáëï»ñáÝÇ
ý»ÝÇÉåñáåÇáݳï,
ûëïáëï»ñáÝÇ
ǽáϳåñáݳï,
ûëïáëï»ñáÝÇ ¹»Ï³Ýá³ï
testosterone
propionate,
testosterone
phenylpropionate,
testosterone
isocaproate,
testosterone decanoate
óÙëáõÉá½ÇÝÇ
ÑǹñáùÉáñǹ
tamsulosin
hydrochloride
óÙëáõÉá½ÇÝÇ
¹»Õ³å³ïÇ×Ý»ñ
èáõë³ëï³Ý
A02B C01
5329
¸
Ðݹϳëï³Ý
A02BC01
0346\5399
Ȼѳëï³Ý
C03B A03
5994
15.02.2005
15.02.2010
21.08.2006
21.08.2011
06.03.2006
06.03.2011
2924
2925
2928
2929
2930
2931
2932
2933
2934
2935
úÙÝÇÏ
Omnic
2936
úÙÝÇÏ úβê
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
20Ù·,
(14/2x7/, 28/4x7/,
30/3x10/)
20Ù·
(20/2x10/)
20Ù·
[(14) /ï³ñ³/,
(20) /2x10/
µÉÇëï»ñ]
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
ÜúÎÆ Ñ³Û³Ù»ñÇϳ·»ñٳݳϳÝ
ѳٳï»Õ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ êäÀ
NOKI Armenian-AmericanGerman Pharmac.J.V. Co. Ltd
0.02·
ÎǨٻ¹åñ»å³ñ³ï ´´À
(10)
Kievmedpreparat Open JSC
20Ù·
èáõë³Ý ü³ñÙ³ Èï¹.
(100/10x10/)
Rusan Pharma Ltd.
20Ù·
ºíñáý³ñÙ ê.².
(20)
¶É³ùëáêÙÇÃÎɳÛÝÇ Ñ³Ù³ñ
Europharm S.A. for
GlaxoSmithKline
0.02·
§´ñÇÝó³Éáí - ²¦ö´À
(10,20,30)
CJSC §Brinsalov - A¦
20Ù·
Þñ»Û³ ȳÛý ê³ÛÝëÇë äíï. Èï¹.
(30)
Shreya Life Sciences Pvt. Ltd.
(30Ù·+60Ù·+60Ù·+ Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
100Ù·)/ÙÉ,
Jelfa S.A.Pharmaceutical
1ÙÉ ³ÙåáõÉÝ»ñ
Works
(5)
¸
¸
¸
¸
¸
¸
¹»Õ³å³ïÇ×Ý»ñ
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
0.4Ù·
(10,30)
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
Üǹ»éɳݹݻñ
G04C A02
5742
05.09.2005
05.09.2010
¸
¹»Õ³Ñ³ï»ñ
0.4Ù·
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Üǹ»éɳݹ-
G04C A02
5835
22.11.2005
¸
200
Omnic OCAS
ÑǹñáùÉáñǹ
óճÝóå³ï, ¹³Ý¹³Õ
(30)
tamsulosin
Ó»ñµ³½³ïٳٵ
hydrochloride
ÙáñýÇÝÇ, ݳñÏáïÇÝÇ,
ÉáõÍáõÛÃ
(11.5Ù·+5.4Ù·+
å³å³í»ñÇÝÇ, Ïá¹»ÇÝÇ
Ý»ñ³ñÏÙ³Ý
0.72Ù·+1.44Ù·)/ÙÉ
ÑǹñáùÉáñǹݻñ
-2%,
morphine, narcotine,
1ÙÉ ³ÙåáõÉÝ»ñ
papaverine, codeine
(5, 20x5)
hydrochlorides
ûݹ³Ýë»ïñáÝ
ÉáõÍáõÛÃ
2Ù·/ÙÉ (2ÙÉ),
ondansetron
Ý»ñ³ñÏÙ³Ý
2ÙÉ ³ÙåáõÉÝ»ñ
(5)
Yamanouchi Europe B.V.
Ý»ñ
22.11.2010
¼¹áñáíÛ» ݳñá¹áõ
Zdorovye narodu
àõÏñ³Çݳ
N02A A51
0384/6407
12.09.2006
12.09.2011
¸\Ð
àõÏñ³Çݳ
A04A A01
0773/6744
07.03.2007
07.03.2012
¸
àõÏñ³Çݳ
A04AA01
0863/6762
30.03.2007
30.03.2012
¸
àõÏñ³Çݳ
A04AA01
0862/6763
30.03.2007
30.03.2012
¸
àõÏñ³Çݳ
A04A A01
0774/6743
07.03.2007
07.03.2012
¸
Ðݹϳëï³Ý
J01D A32
1194/7201
25.09.2007
13.09.2012
¸
2937
úÙÝáåáÝ
Omnopon
2938
úݹ³Ýë»ïñáÝ
Ondansetron
2939
úݹ³Ýë»ïñáÝ
Ondansetron
ûݹ³Ýë»ïñáÝ
ondansetron
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
4Ù·
(10)
2940
úݹ³Ýë»ïñáÝ
Ondansetron
ûݹ³Ýë»ïñáÝ
ondansetron
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
8Ù·
(10)
2941
úݹ³Ýë»ïñáÝ
Ondansetron
ûݹ³Ýë»ïñáÝ
ondansetron
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2Ù·/ÙÉ (4ÙÉ),
4ÙÉ ³ÙåáõÉÝ»ñ
(5)
2942
úå»ñ³½
Operaz
ó»ýáå»ñ³½áÝ
cefoperazone
1·,
ëñí³Ï (1)
2943
úå»ñÇÉ
Operil
0,05%,
10ÙÉ ßßÇÏ
È»Ï ý³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
R01A A05
1201/7179
02.10.2007
13.09.2012
²¸
2944
úå»ñÇÉ
Operil
ùóϳÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
0,05%,
10ÙÉ ßßÇÏ
È»Ï ý³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
R01A A05
1202/7180
02.10.2007
13.09.2012
²¸
2945
úå»ñÇÉ ä
Operil P
óáÕ³ßÇà ùÃÇ
(ÉáõÍáõÛÃ)
0,025%,
10ÙÉ ßßÇÏ
È»Ï ý³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
R01A A05
1203/7181
02.10.2007
13.09.2012
²¸
2946
úå»ñÇÉ ä
Operil P
ùóϳÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
0,025%,
10ÙÉ ßßÇÏ
È»Ï ý³ñÙ³ëÛáõÃÇù³Éë ¹.¹
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
R01A A05
1204/7182
02.10.2007
13.09.2012
²¸
2947
úë³ñµáÝ
Osarbon
úëɳ¹»ùë
OslaDex
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
ûùëÇٻﳽáÉÇÝÇ
ÑǹñáùÉáñǹ
oxymetazoline
hydrochloride
³ó»ï³ñëáÉ
acetarsol
ÑǹñûùëÇ¿ÃÇÉ ûëɳ
hydroxyethyl starch
¹»Õ³÷áßÇ Ý/» ¨
Ù/Ù
Ý»ñ³ñÏáõÙÝ»ñÇ
óáÕ³ßÇà ùÃÇ
(ÉáõÍáõÛÃ)
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalParmaceutical Plant CJSC
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
´áñßã³·áíÛ³Ý
ùÇÙdz¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
ö´À
Borshchahivskiy ChemicalPharmaceutical Plant CJSC
äñáï»ù ´ÇáëÇëï»Ùë äíï. Èï¹.
Protech Biosystems Pvt. Ltd.
èáõë³ëï³Ý
G01A B01
1098/7124
¸
г۳ëï³Ý
B05A A07
0744/6797
08.08.2007
08.08.2012
15.02.2007
15.02.2012
úêØú-³¹³É³ï
OSMO-Adalat
ÝÇý»¹ÇåÇÝ
nifedipine
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ ö´À
Liqvor Pharmaceuticals CJSC
´³Û»ñ лÉÃù»ñ ²¶ Bayer
HealhCare AG
¶»ñÙ³Ýdz
C08C A05
5769
28.10.2005
28.10.2010
¸
2948
2949
Ñ»ßïáó³0.25·
ÙáÙÇÏÝ»ñ
(10/2x5/)
ÉáõÍáõÛÃ
6%,
ϳÃÇɳݻñ³ñÏ-Ù³Ý 500ÙÉ åɳëïÇÏ ï³ñ³
¹»Õ³Ñ³ï»ñ
óճÝóå³ï,
30Ù·
(28)
¸
201
2950
úêØú-²¹³É³ï
OSMO-Adalat
ÝÇý»¹ÇåÇÝ
nifedipine
2951
úëå³Ùûùë
Ospamox
³ÙûùëÇóÇÉÇÝ
amoxicillin
2952
úëå³Ùûùë
Ospamox
³ÙûùëÇóÇÉÇÝ
amoxicillin
2953
úëå³Ùûùë
Ospamox
³ÙûùëÇóÇÉÇÝ
amoxicillin
2954
úëå³Ùûùë
Ospamox
úëï³ÉáÝ
Ostalon
³ÙûùëÇóÇÉÇÝ
amoxicillin
³É»Ý¹ñáݳÃÃáõ
alendronic acid
2955
2956
2957
2958
2959
2960
2961
úëï»á·»ÝáÝ
Osteogenon
úïǽáÉ
Otizol
úïÇϳÇÝ
Oticaine
úïÇå³ùë
Otipax
úïÇñ»É³ùë
Otirelax
úïáñ³É·ÇÝ
Otoralgin
2962
úïáý³
Otofa
2963
úïñÇíÇÝ
Otrivin
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
60Ù·
óճÝóå³ï,
(28)
»ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
¹»Õ³÷áßÇ ËÙ»Éáõ
500Ù·/5ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
(¹»Õ³÷áßÇ 60ÙÉ,
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ)
¹»Õ³÷áßÇ ËÙ»Éáõ
250Ù·/5ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
(¹»Õ³÷áßÇ 60ÙÉ,
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ)
¹»Õ³÷áßÇ ËÙ»Éáõ
125Ù·/5ÙÉ;
¹»Õ³Ï³ËáõÛÃÇ
(¹»Õ³÷áßÇ 60ÙÉ,
100ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
ѳٳñ)
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(100x10)
¹»Õ³Ñ³ï»ñ
70Ù·
óճÝóå³ï
(4)
ûë»ÇÝ-Ñǹñûùëdzå³ïÇï
¹»Õ³Ñ³ï»ñ
ossein-hydroxyapatite
³ÝïÇåÇñÇÝ,
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
µ»Ý½áϳÛÇÝ,
(ÉáõÍáõÛÃ)
ý»ÝÇÉ¿ýñÇÝÇ
ÑǹñáùÉáñǹ
antipyrine, benzocaine,
phenylephrine
hydrochloride
ý»Ý³½áÝ, ÉǹáϳÛÇÝ Ï³ÃÇÉÝ»ñ ³Ï³ÝçÇ
phenazone, lidocaine
ý»Ý³½áÝ, ÉǹáϳÛÇÝ
ÉáõÍáõÛÃphenazone, lidocaine
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
ü»Ý³½áÝ, ÉǹáϳÛÇÝ
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
phenazone, lidocaine
(ÉáõÍáõÛÃ)
ý»Ý³½áÝ,
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
ÝÇïñáýáõñ³½áÝ,
ÉǹáϳÛÇÝ
phenazone,
nitrofurazone, lidocaine
éÇý³ÙÇóÇÝ
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
rifamycin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
óáÕ³ßÇà ùÃÇ
830Ù·
(40)
(50Ù·+50Ù·+
1.25Ù·)/ÙÉ,
15ÙÉ ßßÇÏ
´³Û»ñ лÉÃù»ñ ²¶ Bayer
HealthCare AG
¶»ñÙ³Ýdz
C08C A05
5852
05.12.2005
05.12.2010
¸
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
²íëïñdz
J01CA04
0341\6175
21.08.2006
21.08.2011
¸
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
²íëïñdz
J01CA04
0342/6176
21.08.2006
21.08.2011
¸
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
²íëïñdz
J01CA04
0343\6177
21.08.2006
21.08.2011
¸
ê³Ý¹á½ ¶ÙµÐ
Sandoz GmbH
¶ñá¹½ÇÝëÏÇ ¹»Õ³·áñͳϳÝ
·áñͳñ³Ý äáÉý³ êäÀ (¶»¹»áÝ
èÇËï»ñ ´´À ÐáõÝ·³ñdzÛÇ
ѳٳñ
Grodzinsk pharmaceutical
Works Polfa Co. Ltd for
Gedeon Richter Plc. Hungary
èáµ³ý³ñÙ Èï¹. Robapharm Ltd.
²íëïñdz
J01CA04
0344\6178
¸
Ȼѳëï³Ý
M05B A04
1189/6783/1
21.08.2006
21.08.2011
03.10.2007
13.02.2012
Þí»Ûó³ñdz
M05BX
4966
¸
²ØÜ
A01A A30
1080/7125
18.03.2005
18.03.2010
08.08.2007
08.08.2012
г۳ëï³Ý
N02B B71
4433
üñ³Ýëdz
S02DA30
1210/7151
èáõÙÇÝdz
S02D A30
0668/6635
г۳ëï³Ý
N02B B71
4434
üñ³Ýëdz
J04A B03
S02A A12
S01A A16
R01A A07
S01G A03
ê³·Ù»É ÆÝÏ.
Sagmel Inc.
4%+1%,
²ðöÆغ¸ ÐÒ ö´À ARPIMED
15· ßßÇÏ
J.V. CJ-S Co.
(0,64·+0,16·)/16·,
´ÇáÏá¹»ùë
16· ßßÇÏ
Biocodex
(4%+1%),
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
15ÙÉ ßßÇÏ
Rompharm Company SRL
7%+0.2%+2.5%, ²ðöÆغ¸ ÐÒ ö´À
ARPIMED
5·,15· ßßÇÏ
J.V. CJ-S Co.
2.6· (2000000ØØ)/ ´áõß³ñ³ è»Ïáñ¹³ïÇ Bouchara
100ÙÉ,
Recordati
10ÙÉ ßßÇÏ
0,1%,
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
10ÙÉ ßßÇÏ
ê.².
Þí»Ûó³ñdz
¸
²¸
08.10.2003
08.10.2008
12.11.2007
13.09.2012
17.01.2007
17.01.2012
06.09.2005
08.10.2008
²¸
4546
17.11.2003
17.11.2008
¸
4748
15.06.2004
15.06.2009
²¸
²¸
²¸
¸
202
2964
úïñÇíÇÝ
Otrivin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ÉáõÍáõÛÃ ùÃÇ
(ϳÃÇÉÝ»ñ)
0.05%,
10ÙÉ ßßÇÏ
2965
úïñÇíÇÝ Ù»ÝÃáÉ
Otrivin Menthol
ùëÇÉáٻó½áÉÇÝ
xylomethazoline
óáÕ³ßÇà ùÃÇ,
¹»Õ³ã³÷í³Í
0.1%,
10ÙÉ ßßÇÏ
2966
úñ³Ïáõñ ¹áݹáÕ
Oracure Gel
¹áݹáÕ
(2·+100Ù·)/100·
15· å³ñÏáõ×
2967
úñÉáµÇÝ
Orlobin
úñáݳ½áÉ
Oronazol
úñáõÝ·³É
Orungal
úñáõÝ·³ÙÇÝ
Orungamin
úñïáý»Ý-¼î
Ortofen-ZT
ÉǹáϳÛÇÝÇ
ÑǹñáùÉáñǹ,
ó»ïÇÉåÇñǹÇÝÇ
ùÉáñǹ
lidocaine hydrochloride,
cetylpyridine chloride
³ÙÇϳóÇÝ
amikacin
Ï»ïáÏáݳ½áÉ
ketoconazole
Çïñ³Ïáݳ½áÉ
itraconazole
Çïñ³Ïáݳ½áÉ
itraconazole
¹ÇÏÉáý»Ý³Ï
diclofenac
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³Ñ³ï»ñ
500Ù·/2ÙÉ,
ëñí³Ï (1)
200Ù·
(20)
100Ù·
(14,28)
0.1·
(10/2x5/,15/3x5/)
0,025·
(30)
2972
úñïáý»ñ
Ortofer
¹ÇÏÉáý»Ý³Ï
diclofenac
ÉáõÍáõÛÃ Ù/Ù
Ý»ñ³ñÏÙ³Ý
2973
úñïáý»ñ
Ortofer
¹ÇÏÉáý»Ý³Ï
diclofenac
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
2974
úùëǵñ³É
Oxybral
úùëÇÏáñï
Oxycort
2968
2969
2970
2971
íÇÝϳÙÇÝ
vincamine
2975
ûùëÇï»ïñ³óÇÏÉÇÝÇ
ÑǹñáùÉáñǹ,
ÑǹñáÏáñïǽáÝÇ
³ó»ï³ï
oxytetracycline
hydrochloride,
hydrocortisone acetate
2976 úùëÇåñá·»ëï»-ñáÝÇ ûùëÇåñá·»ëï»ñáÝÇ
ϳåñáݳï
ϳåñáݳï
Oxyprogesterone
oxyprogesterone
caproate
caproate
2977
úùëÇï³Ý
ûùë³ÉÇåɳïÇÝ
Oxitan
oxaliplatin
2978
úùëÇï³Ý
Oxitan
ûùë³ÉÇåɳïÇÝ
oxaliplatin
2979
úùëÇïáóÇÝ
ûùëÇïáóÇÝ
Novartis Consumer Health S.A.
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis Consumer Health S.A.
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê²
Novartis Consumer Health S.A.
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
Þí»Ûó³ñdz
R01A A07
S01G A03
4749
15.06.2004
15.06.2009
²¸
Þí»Ûó³ñdz
-
0100/5936
09.06.2006
09.06.2011
²¸
º·Çåïáë
N01B B52
0117/6041
15.06.2006
15.06.2011
²¸
Ðáõݳëï³Ý
J01G B06
5302
¸
êÉáí»Ýdz
J02A B02
5575
Æï³Édz
J02A C02
4912
èáõë³ëï³Ý
J02A C02
5791
àõÏñ³Çݳ
M01A B05
1143/7126
13.01.2005
13.01.2010
10.06.2005
10.06.2010
24.05.2004
24.05.2009
08.12.2005
08.12.2010
02.10.2007
08.08.2012
2.5% (3ÙÉ),
3ÙÉ ³ÙåáõÉÝ»ñ
(5,10)
0.025·
§´ñÇÝó³Éáí - ²¦ ö´À CJSC
(10,15,20,30,40,
§Brinsalov - A¦
45,
50,60,75,80,100,
150,200)
30Ù·
¶É³ùëáàõ»ÉùáÙ º·Çåïáë ê.².º.
(10,20,60)
GlaxoWellcome Egypt S.A.E.
(30Ù·+10Ù·)/1·, Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
10· å³ñÏáõ×
Jelfa S.A. Pharmaceutical
Works
èáõë³ëï³Ý
M01A B05
M02A A15
5339
03.02.2005
03.02.2010
¸
èáõë³ëï³Ý
M01A B05
M02A A15
5338
15.02.2005
15.02.2010
¸
º·Çåïáë
C04A X07
4482
¸
Ȼѳëï³Ý
D06A A03,
J01A A56
5978
05.02.2004
28.07.2008
14.02.2006
14.02.2011
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
12.5%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
´Çáý³ñÙ³ ö´À Biopharm Closed
JSC
àõÏñ³Çݳ
-
0151/6204
07.07.2006
07.07.2011
¸
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³÷áßÇ
ÉÇáýÇÉǽ³óí³Í,
Ý»ñ³ñÏÙ³Ý
ÉáõÍáõÛÃÇ
ÉáõÍáõÛÃ
50Ù·,
ëñí³Ï (1)
¸²´àõð ü³ñÙ³ Èï¹
DABUR Pharma Ltd
Ðݹϳëï³Ý
L01XA03
0990/6990
30.05.2007
30.05.2012
¸
100Ù·,
ëñí³Ï (1)
¸²´àõð ü³ñÙ³ Èï¹
DABUR Pharma Ltd
Ðݹϳëï³Ý
L01XA03
0991/6991
30.05.2007
30.05.2012
¸
5 ØØ/ÙÉ,
¶ñÇݹ»ùë ´À
ȳïídz
H01B B02
0074/6211
07.06.2006
¸
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³å³ïÇ×Ý»ñ
ùëáõù
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Ú³Ýë»Ý êÇɳ· ê.å.².
Janssen-Cilag S.p.A.
ú½áÝ êäÀ
Ozon Ltd.
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
§´ñÇÝó³Éáí - ²¦ ö´À
CJSC §Brinsalov - A¦
¸
¸
¸
¸
¸
203
Oxytocin
oxytocine
Ý»ñ³ñÏÙ³Ý
2980
úùëÇïáóÇÝ
Oxytocin
ûùëÇïáóÇÝ
oxytocin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2981
úùëÇïáóÇÝ
Oxytocin
ûùëÇïáóÇÝ
oxytocin
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2982 úùëáÉÇÝÇ ùëáõù
Oxolin ointment
2983
úýÉáÑ»ùë³É
Oflohexal
ûùëáÉÇÝ
oxolin
ûýÉûùë³óÇÝ
ofloxacin
ùëáõù
2984
úýÉáÑ»ùë³É
Oflohexal
ûýÉûùë³óÇÝ
ofloxacin
2985
úýÉáï³ë
Oflotas
úýÉáóÇÝ 200
Oflocine 200
úýÉáóÇÝ 400
Oflocine 400
úýÉáùë
Oflox
úýÉûùë³óÇÝ
Ofloxacin
úýÉûùë³óÇÝ
Ofloxacin
ûýÉûùë³óÇÝ
ofloxacin
ûýÉûùë³óÇÝ
ofloxacine
ûýÉáùë³óÇÝ
ofloxacine
ûýÉáùë³óÇÝ
ofloxacin
ûýÉûùë³óÇÝ
ofloxacin
ûýÉûùë³óÇÝ
ofloxacin
úýÉûùë³óÇÝ
Ofloxacin
ûýÉûùë³óÇÝ
ofloxacin
2986
2987
2988
2989
2990
2991
2992 úýÉûùë³óÇÝ - ÎØä
Ofloxacin - KMP
2993
úýÉûùëÇÝ
Ofloxin
2994
úýÉûùëÇÝ 200
Ofloxin 200
2995 úýÉûùëÇÝ ÇÝý.
Ofloxin inf.
2996
úýï³·»É
Oftagel
2997
2998
2999
úýï³Ý
¹»ùë³Ù»Ã³½áÝ
Oftan
Dexamethasone
úýï³Ý ÃÇÙáÉáÉ
Oftan Timolol
úýï³Ý ÃÇÙáÉáÉ
Oftan Timolol
ûýÉûùë³óÇÝ
ofloxacin
ûýÉûùë³óÇÝ
ofloxacine
ûýÉûùë³óÇÝ
ofloxacine
ûýÉûùë³óÇÝ
ofloxacine
ϳñµáÙ»ñ 974P
carbomer 974P
¹»ùë³Ù»Ã³½áÝÇ
ݳïñÇáõÙÇ ýáëý³ï
dexamethasone sodium
phosphate
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
ÃÇÙáÉáÉÇ Ù³É»³ï
timolol maleate
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
5ØØ/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
5ØØ/ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
0.25%,
10· å³ñÏáõ×
200Ù·
(10)
Grindex JSC
´ÇáÉ»Ï ö´À
Biolek CJSC
àõÏñ³Çݳ
H01B B02
0522/6513
10.11.2006
10.11.2011
¸
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ÐáõÝ·³ñdz
H01B B02
5247
01.06.2005
01.06.2010
¸
èáõë³ëï³Ý
G04A
4518
²¸
¶»ñÙ³Ýdz
J01M A01
5582
24.10.2003
24.10.2008
30.05.2005
30.05.2010
¶»ñÙ³Ýdz
J01M A01
5583
30.05.2005
30.05.2010
¸
Ðݹϳëï³Ý
J01M A01
0442/6415
¸
êÇñdz
J01M A01
5265
êÇñdz
J01M A01
5264
Ðݹϳëï³Ý
S01A X11
4098
èáõë³ëï³Ý
J01M A01
5790
г۳ëï³Ý
J01A X11
6047
29.09.2006
29.09.2011
30.03.2005
30.03.2010
31.01.2005
31.01.2010
29.01.2003
29.01.2008
08.12.2005
08.12.2010
16.03.2006
16.03.2011
г۳ëï³Ý
J01M A01
6048
16.03.2006
16.03.2011
¸
àõÏñ³Çݳ
J01M A01
4027
¸
â»Ëdz
J01M A01
1091/7043
â»Ëdz
J01M A01
4106
â»Ëdz
J01M A01
4107
¶»ñÙ³Ýdz
-
5534
12.02.2003
12.02.2008
07.09.2007
07.09.2012
10.04.2003
10.04.2008
10.04.2003
10.04.2008
05.08.2005
05.08.2010
üÇÝɳݹdz
S01B A01,
S01C B01,
S02B A06
4271
15.07.2003
15.07.2008
¸
üÇÝɳݹdz
S01E
4265
¸
üÇÝɳݹdz
S01E
4266
15.07.2003
15.07.2008
15.07.2003
15.07.2008
ÜÇÅý³ñÙ ´À
Nizhpharm JSC
¹»Õ³Ñ³ï»ñ
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
óճÝóå³ï
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
¹»Õ³Ñ³ï»ñ
400Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
óճÝóå³ï
(10)
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
¹»Õ³Ñ³ï»ñ
200Ù·
ÆÝï³ë ý³ñÙ³ëÛáõÃÇù³Éë Èï¹.
(10)
Intas Pharmaceuticals Ltd.
¹»Õ³Ñ³ï»ñ
200Ù·
γëå³ñ Þ³µ³ÝÇ É³µë.
óճÝóå³ï
(10)
Kaspar Chabani Labs.
¹»Õ³Ñ³ï»ñ
400Ù·
γëå³ñ Þ³µ³ÝÇ É³µë
óճÝóå³ï
(10)
Kaspar Chabani Labs.
³ÏݳϳÃÇÉÝ»ñ
0.3%
êÇåɳ Èï¹.
5ÙÉ ßßÇÏ
Cipla Ltd.
¹»Õ³Ñ³ï»ñ
200Ù·
ú½áÝ êäÀ
óճÝóå³ï
(10)
Ozon Ltd.
³ÏݳϳÃÇÉÝ»ñ
0.3%,
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
5ÙÉ åɳëïÇÏ ßßÇÏ
Ó»éݳñÏáõÃÛáõÝ ö´À
ϳÃáóÇÏáí
Liqvor Pharmaceuticals CJSC
ÉáõÍáõÛÃ
0.2%,
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
ϳÃÇɳݻñ³ñÏ-Ù³Ý
100ÙÉ åɳëïÇÏ
Ó»éݳñÏáõÃÛáõÝ ö´À
÷³Ã»Ã
Liqvor Pharmaceuticals CJSC
¹»Õ³Ñ³ï»ñ
0.2·
ÎǨٻ¹åñ»å³ñ³ï ´´À
(10)
Kievmedpreparat Open JSC
¹»Õ³Ñ³ï»ñ
400Ù·
¼»ÝïÇí³ ³.ë.
óճÝóå³ï
(10)
Zentiva a.s.
¹»Õ³Ñ³ï»ñ
200Ù·
È»ãÇí³ ³.ë.
óճÝóå³ï
(10,14,28)
Lechiva a.s.
ÉáõÍáõÛÃ
200Ù·/100ÙÉ,
È»ãÇí³ ³.ë.
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ëñí³Ï (1)
Lechiva a.s.
³Ïݳ¹áݹáÕ
2.5Ù·/·,
àõñë³ý³ñÙ³ ²ñóݳÛÙÇûÉ
10· ßßÇÏ
¶ÙµÐ (ê³Ýï»ÝÇ Ñ³Ù³ñ)
Ursapharma Arzneimittel
GmbH (for Santen)
³ÏݳϳÃÇÉÝ»ñ
0.1%(1Ù·/ÙÉ),
ê³Ýï»Ý ´À
5ÙÉ ëñí³Ï
§Santen Oy¦
³ÏݳϳÃÇÉÝ»ñ
³ÏݳϳÃÇÉÝ»ñ
0.25% (2.5Ù·/ÙÉ),
5ÙÉ ëñí³Ï
0.5% (5Ù·/ÙÉ),
5ÙÉ ëñí³Ï
07.06.2011
ê³Ýï»Ý ´À
§Santen Oy¦
ê³Ýï»Ý ´À
§Santen Oy¦
¸
¸
¸
¸
¸
¸
¸
¸
¸
²¸
¸
204
3000
3001
úýï³Ý ǹáõ
Oftan Idu
úýï³Ý ϳï³ùñáÙ
Oftan Catachrom
3002 úýï³Ý åÇÉáϳñåÇÝ
Oftan Pilocarpin
3003
3004
3005
3006
3007
3008
3009
3010
3011
3012
3013
3014
úýï³ùíÇùë
Oftaquix
5-üïáñáõñ³óÇɾµ»í»
5-Fluorouracil Ebewe
5-üïáñáõñ³óÇɾµ»í»
5-Fluorouracil Ebewe
ü³½ÇÅÇÝ
Fasigyn
ü³½ÇÅÇÝ
Fasigyn
ü³ÉÇÙÇÝï
Falimint
ü³Ùáë³Ý 20Ù·
Famosan 20mg
ü³Ùáë³Ý 40Ù·
Famosan 40mg
ü³ÙáïǹÇÝ
Famotidine
ü³ÙáïǹÇÝ
Famotidine
ü³ÙáïǹÇÝ
Famotidine
ü³ÙáïǹÇÝ
Famotidin
3015
ü³ÙáïǹÇÝ
Famotidin
3016 ü³ÙáïǹÇÝ-²ëï»ñdz
Famotidine-Asteria
3017 ü³ÙáïǹÇÝ-²ëï»ñdz
Famotidine-Asteria
ǹûùëáõñǹÇÝ
idoxuridine
óÇïáùñáÙ ò,
³¹»Ýá½ÇÝ,
ÝÇÏáïÇݳÙǹ
cytochrome C,
adenosine,
nicotinamide
åÇÉáϳñåÇÝÇ
ÑǹñáùÉáñǹ
pilocarpine
hydrochloride
ɨáýÉûùë³óÇÝ
levofloxacin
ýïáñáõñ³óÇÉ
fluorouracil
³ÏݳϳÃÇÉÝ»ñ
0.1% (1Ù·/ÙÉ),
10ÙÉ ëñí³Ï
(0.675Ù·+2Ù·+
20Ù·)/ÙÉ,
10ÙÉ ëñí³Ï
ê³Ýï»Ý ´À
§Santen Oy¦
ê³Ýï»Ý ´À
§Santen Oy¦
üÇÝɳݹdz
S01A D01
4264
üÇÝɳݹdz
S
4270
³ÏݳϳÃÇÉÝ»ñ
1% (10Ù·/ÙÉ),
10ÙÉ ëñí³Ï
ê³Ýï»Ý ´À
§Santen Oy¦
üÇÝɳݹdz
S01E B01
³ÏݳϳÃÇÉÝ»ñ
5Ù·/ÙÉ,
5ÙÉ ßßÇÏ
500Ù·/10ÙÉ,
ëñí³Ï (1),
10ÙÉ ³ÙåáõÉÝ»ñ
(5)
250Ù·/5ÙÉ,
ëñí³Ï (1),
5ÙÉ ³ÙåáõÉÝ»ñ
(5)
500Ù·
(4)
500Ù·
(4)
25Ù·
(20)
ê³Ýï»Ý ´À
Santen Oy
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·.ζ
EBEWE Pharma Ges.m.b.H.
Nfg.KG
üÇÝɳݹdz
³ÏݳϳÃÇÉÝ»ñ
Ëï³ÝÛáõÃ
Ý»ñ³ñÏÙ³Ý ¨
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÝ»ñÇ
ýïáñáõñ³óÇÉ
Ëï³ÝÛáõÃ
fluorouracil
Ý»ñ³ñÏÙ³Ý ¨
ϳÃÇɳݻñ³ñÏ-Ù³Ý
ÉáõÍáõÛÃÝ»ñÇ
ïÇÝǹ³½áÉ
¹»Õ³Ñ³ï»ñ
tinidazole
óճÝóå³ï
ïÇÝǹ³½áÉ
¹»Õ³Ñ³ï»ñ
tinidazole
óճÝóå³ï
³ó»ïÇɳÙÇÝáÝÇïñáåñá
¹ñ³Å»
åûùëǵ»Ý½»Ý
acetylaminonitropropox
ybenzene
ý³ÙáïǹÇÝ
¹»Õ³Ñ³ï»ñ
famotidine
óճÝóå³ï
ý³ÙáïǹÇÝ
¹»Õ³Ñ³ï»ñ
famotidine
óճÝóå³ï
ý³ÙáïǹÇÝ
¹»Õ³Ñ³ï»ñ
famotidine
óճÝóå³ï
ý³ÙáïǹÇÝ
¹»Õ³Ñ³ï»ñ
famotidine
óճÝóå³ï
20Ù·
(20)
40Ù·
(10)
20Ù·
(30)
0.02·
(20/2x10/)
ý³ÙáïǹÇÝ
famotidine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.04·
(20/2x10/)
ý³ÙáïǹÇÝ
famotidin
ý³ÙáïǹÇÝ
famotidin
ý³ÙáïǹÇÝ
famotidine
ý³ÙáïǹÇÝ
famotidine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
20Ù·
(20,30)
40Ù·
(20,30)
20Ù·
(100)
40Ù·
(100)
¹»Õ³Ñ³ï»ñ
15.07.2003
15.07.2008
15.07.2003
15.07.2008
¸
4272
15.07.2003
15.07.2008
¸
J01M A12
6046
¸
²íëïñdz
L01B C02
4565
14.03.2006
14.03.2011
03.02.2005
03.02.2010
¾´ºìº ü³ñÙ³ ¶»ë.Ù.µ.Ð. Üý·.ζ
EBEWE Pharma Ges.m.b.H.
Nfg.KG
²íëïñdz
L01B C02
4564
03.02.2005
03.02.2010
¸
öý³Û½»ñ ê.².
Pfizer S.A.
öý³Û½»ñ ä¶Ø
Pfizer PGM
´»éÉÇÝ-ø»ÙÇ ²¶ (ػݳñÇÝÇ
¶ñáõå)
Berlin-Chemie AG (Menarini
Group)
äðà. غ¸. êÇ ¿ë äñ³Ñ³ ³.ë.
PRO.MED.CS Praha a.s.
äðà. غ¸. êÇ ¿ë äñ³Ñ³ ³.ë.
PRO.MED.CS Praha a.s.
Ø»¹Çϳ ²¸
Medica AD
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
лÙáý³ñÙ ÙdzíáñáõÙ ².¸.
Hemofarm koncern A.D.
ÐáõáÝë øá.Èï¹
Huons Co.Ltd.
ÐáõáÝë øá.Èï¹
Huons Co.Ltd.
´»É·Ç³
J01X D02
4799
¸
üñ³Ýëdz
5761
¶»ñÙ³Ýdz
J01X D02 ,
P01A B02
-
13.05.2004
13.05.2009
07.10.2005
07.10.2010
30.09.2003
30.09.2008
â»Ëdz
A02B A03
0368/6282
â»Ëdz
A02B A03
0366/6283
´áõÉÕ³ñdz
A02B A03
4362
´»É³éáõë
A02B A03
0799/6787
´»É³éáõë
A02B A03
ê»ñµÇ³,
â»éÝá·áñdz
ê»ñµÇ³,
â»éÝá·áñdz
Îáñ»³
Îáñ»³
4489
¸
¸
¸
²¸
31.08.2006
31.08.2011
31.08.2006
31.08.2011
14.08.2003
14.08.2008
20.03.2007
20.03.2012
¸
0798/6788
20.03.2007
20.03.2012
¸
A02B A03
5171
¸
A02B A03
5172
A02B A03
5484
A02B A03
5485
01.10.2004
01.10.2009
01.10.2004
01.10.2009
10.06.2005
10.06.2010
10.06.2005
10.06.2010
¸
¸
¸
¸
¸
¸
205
3018
ü³ëïáõÙ ·»É
Fastum Gel
Ï»ïáåñáý»Ý
ketoprofen
¹áݹáÕ
3019
ü¨³ñÇÝ 100
Fevarin 100
ü¨³ñÇÝ 50
Fevarin 50
ü³ñÇÝ·áë»åï
Faringosept
ü³ñÇÝ·áë»åï
ÏÇïñáÝÇ Ñ³Ùáí
Faringosept with
lemon taste
ü³ñÙ³¹»ùë
Farmadex
ýÉÛáõíûùë³ÙÇÝ
fluvoxamine
ýÉÛáõíûùë³ÙÇÝ
fluvoxamine
³Ùµ³½áÝ
ambazone
³Ùµ³½áÝ
ambazone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Éá½³ÝÝ»ñ
¹»ùë³Ù»Ã³½áÝ
dexamethasone
³ÏݳϳÃÇÉÝ»ñ
0.1%,
5ÙÉ,10ÙÉ ßßÇÏ
ü³ñÙ³Ï ´´À
Farmak JSC
àõÏñ³Çݳ
3024
ü³ñÙ³½áÉÇÝ
Farmazolin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
0.1%,
5ÙÉ, 10ÙÉ ßßÇÏ
ü³ñÙ³Ï ´´À
Farmak JSC
àõÏñ³Çݳ
3025
ü³ñÙ³½áÉÇÝ
Farmazolin
ùëÇÉáٻﳽáÉÇÝ
xylometazoline
ùóϳÃÇÉÝ»ñ
0.05%,
5ÙÉ, 10ÙÉ ßßÇÏ
ü³ñÙ³Ï ´´À
Farmak JSC
àõÏñ³Çݳ
3026
ü³ñÙ³ï»ùë
Pharmatex
µ»Ý½³ÉÏáÝÇáõÙÇ
ùÉáñÇ¹Ç 50%
ÉáõÍáõÛÃ
benzalkonium chloride
50% solution
Ýñµ³ùëáõù
Ñ»ßïáó³ÛÇÝ,
ÙdzÝí³·
¹»Õ³ã³÷áõÙ
1.2%,
4.5· ÙdzÝí³·
¹»Õ³ã³÷-å³ñÏáõ× (6)
3027
ü»µñáýǹ
Febrofid
Ï»ïáåñáý»Ý
ketoprofen
¹áݹáÕ
2,5%,
30·, 50· å³ñÏáõ×
3028
ü»½³Ù
Phezam
¹»Õ³å³ïÇ×Ý»ñ
(400Ù·+25Ù·)
(60/6x10/)
3029
ü»ÉáÑ»ùë³É
Felohexal
åÇñ³ó»ï³Ù,
óÇݳñǽÇÝ
piracetam, cinnarizin
ý»Éá¹ÇåÇÝ
felodipine
ÆÝÝáï»ù ÆÝï»ñݳëÇáݳÉ
ȳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
ÆÝáï»ñ³ âáõ½Ç
Innothera Chouzy for
Laboratoires Innotech
International
Ø»¹³Ý³ ü³ñÙ³ î»ñåáÉ ¶ñáõå ´À
Medana Pharma Terpol Group
JSC
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
5Ù·
(20)
3030
ü»ÉáÑ»ùë³É
Felohexal
ý»Éá¹ÇåÇÝ
felodipine
3031
ü»ÙǽáÉ
Femizol
3032
ü»ÙáëïáÝ 1/10
Femoston 1/10
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
3033
ü»Ý³½»å³Ù
å³ñ³ó»ï³ÙáÉ, å³Ù³µñáÙ,
åÇñÇɳÙÇÝÇ Ù³É»³ï
paracetamol,
pamabrom, pyrilamine
maleate
I-¿ëïñ³¹ÇáÉ,
II-¿ëïñ³¹ÇáÉ +
¹Ç¹ñá·»ëï»ñáÝ
I-estradiol, II-estradiol+
dydrogesterone
ý»Ý³½»å³Ù
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
ϳñ·³íáñíáÕ
Ó»ñµ³½³ïٳٵ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
3020
3021
3022
3023
Éá½³ÝÝ»ñ
¹»Õ³Ñ³ï»ñ
2.5%,
².ػݳñÇÝÇ Ø³Ýáõý³ÏïáõñÇÝ·
Æï³Édz
20·, 30·, 50·, 100·
ÈáçÇëïÇÏ Áݹ ë»ñíǽ êèÈ
å³ñÏáõ×
A. Menarini Manufacturing
Logistics and Services SRL
100Ù·
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì. Üǹ»ñɳݹݻ
(15)
Solvay Pharmaceuticals B. V.
ñ
50Ù·
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì. Üǹ»ñɳݹݻ
(15)
Solvay Pharmaceuticals B. V.
ñ
10Ù·,
»ñ³ådz ê.².
èáõÙÇÝdz
(20)
Terapia S.A.
10Ù·,
»ñ³ådz ê.².
èáõÙÇÝdz
(20)
Terapia S.A.
M01A E03,
M02A A10
1112/5622/1
18.09.2007
22.06.2010
²¸
N06A B08
0526/6506
¸
N06A B08
0525/6505
R02A A01
4323
R02A A01
4324
10.11.2006
10.11.2011
10.11.2006
10.11.2011
16.07.2003
16.07.2008
16.07.2003
16.07.2008
5695
19.08.2005
19.08.2010
¸
5700
19.08.2005
19.08.2010
²¸
5701
17.10.2005
17.10.2010
²¸
üñ³Ýëdz
S01B A01,
S01C B01,
S02B A06,
S03B A01
R01A A07,
R01A B06,
S01G A03
R01A A07,
R01A B06,
S01G A03
-
5358
23.05.2005
23.05.2010
²¸
Ȼѳëï³Ý
M02AA10
1212/7190
19.10.2007
13.10.2012
²¸
´áõÉÕ³ñdz
N06B X
0970/6995
14.05.2007
14.05.2012
¸
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
10Ù·
ê³Éáõï³ë ü³ñÙ³ ¶ÙµÐ (лùë³É
(20)
²¶-Ç Ñ³Ù³ñ)
Salutas Pharma GmbH (for
Hexal AG)
(500Ù·+25Ù·+15Ù·
ê³·Ù»É ÆÝÏ.
) (24)
Sagmel Inc.
¶»ñÙ³Ýdz
C08C A02
5748
07.09.2005
07.09.2010
¸
¶»ñÙ³Ýdz
C08C A02
5749
07.09.2005
07.09.2010
¸
²ØÜ
N02B E51
0747/6761
15.02.2007
15.02.2012
²¸
I-1Ù·, II-(1Ù·+10Ù·) êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë ´.ì.
((14+14),
Solvay Pharmaceuticals B.V.
3x(14+14))
Üǹ»éɳݹݻñ
G03C A53
4034
13.03.2003
13.03.2008
¸
èáõë³ëï³Ý
N05B X
0926/6916
26,04.2007
¸\Ð
1Ù·
²ÏñÇËÇÝ ´´À
¸
²¸
²¸
206
3034
3035
3036
3037
3038
3039
3040
3041
Phenazepam
ü»Ý³½»å³Ù
Phenazepam
ü»ÝÇÉÇÝ
Phenylin
ü»ÝÇëïÇÉ
Fenistil
ü»ÝÇëïÇÉ
Fenistil
ü»ÝÇëïÇÉ 24
Fenistil 24
ü»Ýáµ³ñµÇï³É
Phenobarbital
ü»Ýï³ÝÇÉ
Fentanyl
phenazepam
ý»Ý³½»å³Ù
phenazepam
ý»ÝÇݹÇáÝ
phenindione
¹»Õ³Ñ³ï»ñ
¹»¹³Ñ³ï»ñ
¹ÇÙ»ÃÇݹ»ÝÇ Ù³É»³ï
¹áݹáÕ
dimethindene maleate
¹ÇÙ»ÃÇݹ»ÝÇ Ù³É»³ï ÉáõÍáõÛà ËÙ»Éáõ
dimethindene maleate
(ϳÃÇÉÝ»ñ)
¹ÇÙ»ÃÇݹ»ÝÇ Ù³É»³ï
¹»Õ³å³ïÇ×Ý»ñ
dimethindene maleate
»ñϳñ³ï¨
³½¹»óáõÃÛ³Ý
ý»Ýáµ³ñµÇï³É
¹»Õ³Ñ³ï»ñ
phenobarbital
ý»Ýï³ÝÇÉ
ÉáõÍáõÛÃ
fentanyl
Ý»ñ³ñÏÙ³Ý
(50/5x10/)
1Ù·
(24, 48)
0,03·
(20)
0.1%,
30· å³ñÏáõ×
0.1%,
20ÙÉ ßßÇÏ
4Ù·
(10)
100Ù·
(24,48,100)
0.005%,
2ÙÉ ³ÙåáõÉÝ»ñ
(20x5)
0.25·
(10,20,24,30)
Akrikhin Open JSC
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
Üáí³ñïÇë øáÝëáõÙ»ñ лÉà ê²
Novartis Consumer Health SA
Üáí³ñïÇë øáÝëáõÙ»ñ лÉà ê²
Novartis Consumer Health SA
Üáí³ñïÇë øáÝëÛáõÙ»ñ лÉÃ
ê.².
Novartis Consumer Health SA
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
¼¹áñáíÛ» ݳñá¹áõ
Zdorovye narodu
ü»ÝûùëÇÙ»ÃÇÉ- ý»ÝûùëÇÙ»ÃÇÉå»ÝÇó
¹»Õ³Ñ³ï»ñ
ÎǨٻ¹åñ»å³ñ³ï ´´À
å»ÝÇóÇÉÇÝ-ÎØä
Ç-ÉÇÝ
Kievmedpreparat OJSC
Phenoxymethylpeni phenoxymethylpenicillicilli-num-KMP
num
3042
ü»ëï³É
å³ÝÏñ»³ïÇÝ,
¹»Õ³Ñ³ï»ñ
192Ù·+50Ù·+25Ù·
²í»ÝïÇë ü³ñÙ³ Èï¹
Festal
Ñ»ÙÇó»ÉÛáõÉá½,
óճÝóå³ï
(100/10x10/)
Aventis Pharma Ltd.
É»Õáõ µ³Õ³¹ñ³Ù³ë»ñ ³Õ»ÉáõÛÍ (¹ñ³Å»)
pancreatin,
hemicellulose, bile
component
3043
ü»ñ»ëï³É
å³ÝÏñ»³ïÇÝ (³ÙÇɳ½
¹»Õ³Ñ³ï»ñ
/0.192·-0.210·/+
§´ñÇÝó³Éáí - ²¦ ö´À
Pherestal
4500ØØ, ÉÇå³½
óճÝóå³ï
0.05·+0.025·
CJSC §Brinsalov - A¦
6000ØØ, åñáﻳ½
(10,20,30,50,60,80,
300ØØ),
100)
Ñ»ÙÇó»ÉÛáõÉá½,
É»Õáõ µ³Õ³¹ñ³Ù³ë»ñ
pancreatin (amylase
4500 IU, lipase 6000
IU, protease 300 IU),
hemicellulose, bile
component
3044
ü»ñáåÉ»Ïï
»ñϳÃÇ ëáõÉý³ïÇ
¹»Õ³Ñ³ï»ñ
(50Ù·+30Ù·)
´áñßã³·áíÛ³Ý ùÇÙdz¹»Õ³·áñͳFeroplect
Ñ»åï³Ñǹñ³ï,
óճÝóå³ï
(50)
Ï³Ý ·áñͳñ³Ý ö´À
³ëÏáñµÇݳÃÃáõ
Borshchahivskiy Chemicalferrous sulfate
Pharmaceutical Plant CJSC
heptahydrate, ascorbic
acid
3045
ü»ñáåÉ»ùë
»ñϳÃÇ ëáõÉý³ï,
¹ñ³Å»
50Ù·+30Ù·
îºì² ¸»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý äñÇí³ï
Ferroplex
³ëÏáñµÇݳÃÃáõ
(100)
øá. Èï¹.
ferrous sulphate,
TEVA Pharmaceutical Works
ascorbic acid
Private Ltd.
3046
ü»ñáõ٠ȺÎ
»ñϳÃÇ (III)
ûß³ñ³Ï
50Ù·/5ÙÉ,
È»Ï ¹.¹
Ferrum LEK
ÑǹñûùëÇ¹Ç ¨
100ÙÉ ßßÇÏ
Lek d.d.
åáÉÇÙ³Éïá½Ç
ѳٳÉÇñ
iron (III) hydroxide with
г۳ëï³Ý
N05B
0224/6329
àõÏñ³Çݳ
B01A A02
1144/7127
Þí»Ûó³ñdz
R06A
4443
Þí»Ûó³ñdz
R06A
4442
Þí»Ûó³ñdz
D04A A13
R06A B03
4831
г۳ëï³Ý
N03A A02
4982
àõÏñ³Çݳ
N02A B03
0387/6373
àõÏñ³Çݳ
J01C E02
Ðݹϳëï³Ý
26.04.2012
26.07.2006
26.07.2011
02.10.2007
08.08.2012
¸\Ð
¸
19.08.2003
19.08.2008
19.08.2003
19.08.2008
16.08.2004
16.08.2009
²¸
12.07.2004
12.07.2009
12.09.2006
12.09.2011
¸\Ð
4622
29.03.2004
29.03.2009
¸
A09A A03
0388/6348
12.09.2006
12.09.2011
²¸
èáõë³ëï³Ý
-
5335
15.02.2005
15.02.2010
²¸
àõÏñ³Çݳ
B03A E10
1218/7154
24.10.2007
03.09.2012
¸
ÐáõÝ·³ñdz
B03A A07
0520/6509
10.11.2006
10.11.2011
¸
êÉáí»Ýdz
B03A B05
1277/7245
22.10.2007
12.10.2012
¸
²¸
²¸
¸\Ð
207
3047
ü»ñáõ٠ȺÎ
Ferrum LEK
3048
ü»ñáõÙ È»Ï
Ferrum Lek
3049
ü»ñá-üáÉ·³Ù³
Ferro-Folgamma
3050
3051
3052
3053
polymaltose complex
»ñϳÃÇ (III)
¹»Õ³Ñ³ï»ñ ͳٻÉáõ
ÑǹñûùëÇ¹Ç ¨
åáÉÇÙ³Éïá½Ç
ѳٳÉÇñ
iron (III) hydroxide with
polymaltose complex
»ñϳÃÇ (III) Ñǹñûùëǹ ÉáõÍáõÛà Ù/Ù
iron (III) hydroxide
Ý»ñ³ñÏÙ³Ý
»ñϳÃÇ ëáõÉý³ï,
ýáɳÃÃáõ,
ódzÝáÏᵳɳÙÇÝ,
³ëÏáñµÇݳÃÃáõ
ferrous sulphate, folic
acid, cyanocobalamine,
ascorbic acid
ü»ñí»ùë Ù³ÝϳϳÝ,
å³ñ³ó»ï³ÙáÉ,
ß³ù³ñáí
³ëÏáñµÇݳÃÃáõ,
Fervex for Children ý»ÝÇñ³ÙÇÝÇ Ù³É»³ï
with sugar
paracetamol, ascorbic
acid, pheniramine
maleate
ü»ñí»ùë
å³ñ³ó»ï³ÙáÉ,
ٻͻñÇ,³é³Ýó
³ëÏáñµÇݳÃÃáõ,
ß³ù³ñÇ
ý»ÝÇñ³ÙÇÝÇ Ù³É»³ï
Fervex Adults
paracetamol, ascorbic
without sugar
acid, pheniramine
maleate
ü»ñí»ùë ٻͻñÇ,
å³ñ³ó»ï³ÙáÉ,
ß³ù³ñáí
³ëÏáñµÇݳÃÃáõ,
Fervex Adults with
ý»ÝÇñ³ÙÇÝÇ Ù³É»³ï
sugar
paracetamol, ascorbic
acid, pheniramine
maleate
üǽÇáï»Ý½
ÙûùëáÝǹÇÝ
Physiotens
moxonidine
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
(30)
È»Ï ¹.¹
Lek d.d.
êÉáí»Ýdz
B03A B05
1278/7246
22.10.2007
12.10.2012
¸
100Ù·/2ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5,50)
(100Ù·+5Ù·+
10ÙÏ·+ 100Ù·)
(20/2x10/,
50/5x10/)
È»Ï ü³ñÙ³ëÛáõÃÇù³Éë ¹.¹.
Lek Pharmaceuticals d.d.
êÉáí»Ýdz
B03A B04
5280
07.02.2005
07.02.2010
¸
ìáÛ»ñí³· ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
Woerwag Pharma GmbH &
Co.KG
¶»ñÙ³Ýdz
B03AE01
0872/6886
30.03.2007
30.03.2012
¸
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
ÉáõÍáõÛÃÇ
280Ù·+100Ù·+
10Ù· (6,8,12,16)
´ñÇëïáÉ-سۻñë êùíǵ
Bristol-Myers Squibb
üñ³Ýëdz
N02B E51
4577
23.01.2006
01.10.2008
²¸
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
ÉáõÍáõÛÃÇ
500Ù·+200Ù·+
25Ù· (6,8,10,12)
´ñÇëïáÉ-سۻñë êùíǵ
Bristol-Myers Squibb
üñ³Ýëdz
N02B E51
4576
23.01.2006
01.10.2008
²¸
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
ÉáõÍáõÛÃÇ
500Ù·+200Ù·+
25Ù· (6,8,10,12)
´ñÇëïáÉ-سۻñë êùíǵ
Bristol-Myers Squibb
üñ³Ýëdz
N02B E51
4575
23.01.2006
01.10.2008
²¸
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
0.4Ù·
(14,28,98)
êáÉí»Û ü³ñÙ³ëÛáõÃÇù³Éë
¶ÙµÐ
Solvay Pharmaceuticals GmbH
Ø»¹áý³ñÙ, Ðݹϳëï³Ý (üÇÉÏá
ü³ñÙ³ÛÇ Ñ³Ù³ñ, ¶»ñÙ³Ýdz)
Medopharm, India (for Philco
Pharma, Germany)
Ø»¹áý³ñÙ, Ðݹϳëï³Ý (üÇÉÏá
ü³ñÙ³ÛÇ Ñ³Ù³ñ, ¶»ñÙ³Ýdz)
Medopharm, India (for Philco
Pharma, Germany)
Ø»¹áý³ñÙ, Ðݹϳëï³Ý (üÇÉÏá
ü³ñÙ³ÛÇ Ñ³Ù³ñ, ¶»ñÙ³Ýdz)
Medopharm, India (for Philco
Pharma, Germany)
Ø»¹áý³ñÙ, Ðݹϳëï³Ý (üÇÉÏá
ü³ñÙ³ÛÇ Ñ³Ù³ñ, ¶»ñÙ³Ýdz)
Medopharm, India (for Philco
Pharma, Germany)
Ø»¹áý³ñÙ³ üÇÉÏá ü³ñÙ³
¶»ñÙ³Ýdz
C02A C05
3862
19.01.2004
19.01.2009
¸
Ðݹϳëï³Ý
J01C A01
5165
30.11.2004
30.11.2009
¸
Ðݹϳëï³Ý
J01C A01
5166
30.11.2004
30.11.2009
¸
Ðݹϳëï³Ý
J01C A04
5168
30.11.2004
30.11.2009
¸
Ðݹϳëï³Ý
J01C A04
5169
30.11.2004
30.11.2009
¸
Ðݹϳëï³Ý
J01G B03
4224
18.04.2003
¸
3054
üÇÉÏá-³ÙåÇ 250
Philco-Ampi 250
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(100x10)
3055
üÇÉÏá-³ÙåÇ 500
Philco-Ampi 500
³ÙåÇóÇÉÇÝ
ampicillin
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(100x10)
3056 üÇÉÏá-³ÙûùëÇ 250
Philco-Amoxi 250
³ÙûùëÇóÇÉÇÝ
amoxycillin
¹»Õ³å³ïÇ×Ý»ñ
250Ù·
(100x10)
3057 üÇÉÏá-³ÙûùëÇ 500
Philco-Amoxi 500
³ÙûùëÇóÇÉÇÝ
amoxycillin
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(100x10)
·»Ýï³ÙÇóÇÝÇ ëáõÉý³ï
ÉáõÍáõÛÃ
80Ù·/2ÙÉ,
3058
üÇÉÏá-·»Ýï³ 80
208
Philco-Genta 80
gentamycin sulphate
Ý»ñ³ñÏÙ³Ý
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
3059
üÇÉÏá-·ÇÝ·Ïá 40
Philco-Gingko 40
·ÇÝ·Ïá µÇÉáµ³ ѳÝáõÏ
gingko biloba extract
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
40 Ù·
(50)
3060
üÇÉÏá-¹ûùëÇ 100
Philco-Doxy 100
¹ûùëÇóÇÏÉÇÝÇ ÑÇÏɳï
doxycycline hyclate
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
100Ù·
(120)
3061
üÇÉÏá-ϳñµ³ 200
Philco-Carba 200
ϳñµ³Ù³½»åÇÝ
carbamazepine
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
200Ù·
(100x10)
3062
üÇÉÏá-ϳåïá 25
Philco-Capto 25
ϳåïáåñÇÉ
captopril
¹»Õ³Ñ³ï»ñ
25Ù·
(100x10)
3063
üÇÉÏá-ÏáïñÇ 480
Philco-Cotri 480
¹»Õ³Ñ³ï»ñ
400Ù·+80Ù·
(100x10)
3064
üÇÉÏá-Ù»åñ³ 20
Philco-Mepra 20
ëáõÉý³Ù»Ãûùë³½áÉ,
ïñÇÙ»ÃáåñÇÙ
sulfamethoxazole,
trimethoprim
ûÙ»åñ³½áÉ
omeprazole
¹»Õ³å³ïÇ×Ý»ñ
³Õ»ÉáõÛÍ
20Ù·
(20,120)
3065
üÇÉÏá-å³ñ³
Philco-Para
å³ñ³ó»ï³ÙáÉ
paracetamol
¹»Õ³Ñ³ï»ñ
500Ù·
(10x100)
3066
üÇÉÏá-ó»ý³ 500
Philco-Cefa 500
ó»ý³É»ùëÇÝ
cefalexin
¹»Õ³å³ïÇ×Ý»ñ
500Ù·
(120)
3067 üÇÉÏá-ó»ýïñdzùëáÝ
1·
Philco-Ceftriaxone
1g
3068 üÇÉÏá-óÇåñá 250
Pilco-Cipro 250
ó»ýïñdzùëáÝ
ceftriaxone
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
1·,
ëñí³Ï (1,25)
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(120)
3069 üÇÉÏá-óÇåñá 500
Pilco-Cipro 500
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(120)
3070
üÇÉá½³Ï
Philozac
ýÉáõûùë»ïÇÝ
fluoxetine
¹»Õ³å³ïÇ×Ý»ñ
10Ù·
(10)
3071
üÇÉá½³Ï
Philozac
ýÉáõûùë»ïÇÝ
fluoxetine
¹»Õ³å³ïÇ×Ý»ñ
20Ù·
(10)
3072
üÇÝÉ»åëÇÝ
Finlepsin
üÇÝÉ»åëÇÝ 200
é»ï³ñ¹
ϳñµ³Ù³½»åÇÝ
carbamazepine
ϳñµ³Ù³½»åÇÝ
carbamazepine
¹»Õ³Ñ³ï»ñ
200Ù·
(50)
200Ù·
(50,100,200)
3073
¹»Õ³Ñ³ï»ñ ¹³Ý¹³Õ
Ó»ñµ³½³ïٳٵ
(¶»ñÙ³Ýdz)-Ç Ñ³Ù³ñ
Medopharm for Philco Pharma
(Germany)
Ø»¹áý³ñÙ üÇÉÏá ü³ñÙ³
(¶»ñÙ³Ýdz-Ç) ѳٳñ
Medopharm for Philco Pharma
(Germany)
Ø»¹áý³ñÙ
(üÇÉÏá ü³ñÙ³, ¶»ñÙ³Ýdz
ýÇñÙ³ÛÇ Ñ³Ù³ñ)
Ø»¹áý³ñÙ, Ðݹϳëï³Ý (üÇÉÏá
ü³ñÙ³ÛÇ Ñ³Ù³ñ, ¶»ñÙ³Ýdz)
Medopharm, India (for Philco
Pharma, Germany)
Ø»¹áý³ñÙ
(üÇÉÏá ü³ñÙ³, ¶»ñÙ³Ýdz
ýÇñÙ³ÛÇ Ñ³Ù³ñ)
Medopharm
Ø»¹áý³ñÙ
(üÇÉÏá ü³ñÙ³, ¶»ñÙ³Ýdz
ýÇñÙ³ÛÇ Ñ³Ù³ñ)
Medopharm
Ø»¹áý³ñÙ
(üÇÉÏá ü³ñÙ³, ¶»ñÙ³Ýdz
ýÇñÙ³ÛÇ Ñ³Ù³ñ)
Ø»¹áý³ñÙ
(üÇÉÏá ü³ñÙ³, ¶»ñÙ³Ýdz
ýÇñÙ³ÛÇ Ñ³Ù³ñ)
Ø»¹áý³ñÙ
(üÇÉÏá ü³ñÙ³, ¶»ñÙ³Ýdz
ýÇñÙ³ÛÇ Ñ³Ù³ñ)
Ø»¹áý³ñÙ
(üÇÉÏá ü³ñÙ³, ¶»ñÙ³Ýdz
ýÇñÙ³ÛÇ Ñ³Ù³ñ)
Medopharm
Ø»¹áý³ñÙ üÇÉÏá ü³ñÙ³
(¶»ñÙ³Ýdz-Ç) ѳٳñ
Medopharm for Philco Pharma
(Germany)
Ø»¹áý³ñÙ üÇÉÏá ü³ñÙ³
(¶»ñÙ³Ýdz-Ç) ѳٳñ
Medopharm for Philco Pharma
(Germany)
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá. ζ
AWD pharma GmbH & Co. KG
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
AWD pharma GmbH & Co.KG
18.04.2008
Ðݹϳëï³Ý
-
4297
03.03.2004
03.03.2009
²¸
Ðݹϳëï³Ý
J01A A02
5935
02.02.2006
02.02.2011
¸
Ðݹϳëï³Ý
N03A F01
5167
30.11.2004
30.11.2009
¸
Ðݹϳëï³Ý
C09A A01
5955
07.02.2006
07.02.2011
¸
Ðݹϳëï³Ý
J01E E01
5954
07.02.2006
07.02.2011
¸
Ðݹϳëï³Ý
A02B C01
5933
02.02.2006
02.02.2011
¸
Ðݹϳëï³Ý
N02B E01
5932
02.02.2006
02.02.2011
²¸
Ðݹϳëï³Ý
J01D B01
5934
02.02.2006
02.02.2011
¸
Ðݹϳëï³Ý
C09A A01
5956
07.02.2006
07.02.2011
¸
Ðݹϳëï³Ý
J01M A02
4298
25.06.2003
25.06.2008
¸
Ðݹϳëï³Ý
J01M A02
4299
25.06.2003
25.06.2008
¸
º·Çåïáë
N06A B03
0194/6280
13.07.2006
13.07.2011
¸
º·Çåïáë
N06A B03
0195/6279
13.07.2006
13.07.2011
¸
¶»ñÙ³Ýdz
N03AF01
1337/7299
¸
¶»ñÙ³Ýdz
N03A F01
5079
05.11.2007
05.11.2012
12.10.2004
12.10.2009
¸
209
Finlepsin 200 retard
üÇÝÉ»åëÇÝ 400
é»ï³ñ¹
Finlepsin 400 retard
3075
üÇÝáåïÇÝ
Finoptin
3074
3076
ϳñµ³Ù³½»åÇÝ
carbamazepine
¹»Õ³Ñ³ï»ñ ¹³Ý¹³Õ
Ó»ñµ³½³ïٳٵ
400Ù·
(50,100,200)
²ì¸ ü³ñÙ³ ¶ÙµÐ ¨ øá.ζ
AWD pharma GmbH & Co.KG
¶»ñÙ³Ýdz
N03A F01
5080
12.10.2004
12.10.2009
¸
í»ñ³å³ÙÇÉ
verapamil
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2.5Ù·/ÙÉ,
2ÙÉ ³ÙåáõÉÝ»ñ
(5,25)
40Ù·
(30,100)
80Ù·
(30,100)
100· å³ñÏáõ×
úñÇáÝ Îáñåáñ»ÛßÝ
Orion Corporation
üÇÝɳݹdz
C08D A01
4903
29.06.2004
29.06.2009
¸
úñÇáÝ øáñåáñ»ÛßÝ
Orion Corporation
úñÇáÝ øáñåáñ»ÛßÝ
Orion Corporation
ü³ñÙ³Ï ´´À
Farmak JSC
üÇÝɳݹdz
C08D A01
4424
¸
üÇÝɳݹdz
C08D A01
4425
àõÏñ³Çݳ
G04BC
1400/7363
09.09.2003
09.09.2008
09.09.2003
09.09.2008
13.11.2007
05.11.2012
лñµ³åáÉ, ì³ñß³í³ÛÇ
¹»Õ³µáõÛë»ñÇ ·áñͳñ³Ý
Herbapol, Warsaw Plant of
Medicinal herbs
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
γï³ñÇÝ»Ýë» ê/² ɳµáñ³ïáñdz
Laboratorio Catarinense S/A
Ȼѳëï³Ý
G04BC
0599/6602
14.12.2006
14.12.2011
¸
àõÏñ³Çݳ
µáõë³Ï³Ý
3376
04.02.2004
04.02.2009
¸
´ñ³½ÇÉdz
µáõë³Ï³Ý
5137
30.08.2005
30.08.2010
¸
üÇÝáåïÇÝ
Finoptin
üÇÝáåïÇÝ
Finoptin
üÇïáÉǽÇÝ
äÉÛáõë
Phytolysin Plus
üÇïáÉǽÇÝ
Fitolizyn
í»ñ³å³ÙÇÉ
verapamil
í»ñ³å³ÙÇÉ
verapamil
µáõë³Ï³Ý ѳÝáõÏ
herbal extracts
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
Ù³ÍáõÏ Ý»ñùÇÝ
ÁݹáõÝÙ³Ý
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
Ù³ÍáõÏ Ý»ñùÇÝ
ÁݹáõÝÙ³Ý
100· å³ñÏáõ×
3080
üÇïáÉÇï
Phytolytum
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
(50,100)
3081
üÇïáϳÉÙ
Phytocalm
ÉáõÍáõÛÃ
(0.375ÙÉ+0.3ÙÉ+
0.55ÙÉ+0.4ÙÉ+
0.6ÙÉ)/10ÙÉ,
150ÙÉ ßßÇÏ
3082
üÇïáϳÉÙ
Phytocalm
¹»Õ³å³ïÇ×Ý»ñ
67Ù·+54Ù·+99Ù·+
72Ù·+108Ù·)
(20)
γï³ñÇÝ»Ýë» ê/² ɳµáñ³ïáñdz
Laboratorio Catarinense S/A
´ñ³½ÇÉdz
µáõë³Ï³Ý
5138
30.08.2005
30.08.2010
¸
3083
üÇïáíÇï
Fitovit
ϳïí³ËáïÇ, ã³ñã³ñ³Í³ÕÏÇ,
»ñÇóáõÏÇ, ³Éá×Ç,
µáõë³Í³éÇ Ñ»ÕáõÏ
ѳÝáõÏÝ»ñ
extractum fluidum ex
Valerianae, Passiflorae,
Chamomillae, Crataegi,
Erythrinae
ϳïí³ËáïÇ, ã³ñã³ñ³Í³ÕÏÇ,
»ñÇóáõÏÇ, ³Éá×Ç,
µáõë³Í³éÇ Ñ»ÕáõÏ
ѳÝáõÏÝ»ñ
extractum siccum ex
Valerianae, Passiflorae,
Chamomillae, Crataegi,
Erythrinae
µáõë³Ï³Ý ѳÝáõÏÝ»ñ
herbal extracts
¹»Õ³å³ïÇ×Ý»ñ
(30,100)
Ðݹϳëï³Ý
-
4369
31.03.2004
31.03.2009
²¸
3084
üÇïáíÇï³É
Fitovital
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
300Ù·
(20)
´ñ³½ÇÉdz
µáõë³Ï³Ý
5139
30.08.2005
30.08.2010
²¸
3085
üɳ¹³½áÉ
Fladazole
ͳÏáïÏ»Ý ëñáÑáõݹÇ
ãáñ ѳÝáõÏ
extractum siccum ex
Hypericum perforatum
ë»ÏÝǹ³½áÉ
secnidazole
ÚáõÝÇù ý³ñÙ³ëÛáõÃÇù³É
ɳµáñ³ïáñdz
Unique Pharmaceutical
Laboratories
γï³ñÇÝ»Ýë» ê/² ɳµáñ³ïáñdz
Laboratorio Catarinense S/A
¹»Õ³Ñ³ï»ñ
500Ù·
(4)
º·Çåïáë
P01A B07
0116/6160
15.06.2006
15.06.2011
¸
3086
üɳ½áÉ
Flazol
Ù»ïñáÝǹ³½áÉ
metronidazole
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
250Ù·
(20)
²ÙáõÝ ý³ñÙ³ëÛáõÃÇù³É
øáÙ÷³ÝÇ
Amoun Pharmaceutical
Company
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia
Pharmaceutical
êÇñdz
4387
05.11.2003
05.11.2008
¸
3087
üɳ½áÉ ýáñï
Flazol Fort
Ù»ïñáÝǹ³½áÉ
metronidazole
¹»Õ³Ï³ËáõÛÃ
ËÙ»Éáõ
200Ù·/5ÙÉ,
100ÙÉ ßßÇÏ
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Asia Pharmaceutical
êÇñdz
A01A B17
J01X D01
P01A B01
A01A B17
J01X D01
4388
05.11.2003
05.11.2008
¸
3077
3078
3079
¸
²¸
210
3088
üɳ½áÉ üáñï
Flazol Fort
3089
üɳÙÇÝ
Flamin
3090 üɳÙÇÝ-¼¹áñáíÛ»
Flamin-Zdorovye
Ù»ïñáÝǹ³½áÉ
metronidazole
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
500Ù·
(20)
ýɳÙÇÝ
flamin
ýɳÙÇÝ
flamin
¹»Õ³Ñ³ï»ñ
50Ù·
(30)
50Ù·
(30)
²ëdz ü³ñÙ³ëÛáõÃÇù³É
Pharmaceutical
Asia
4389
05.11.2003
05.11.2008
¸
àõÏñ³Çݳ
P01A B01
A01A B17
J01X D01
P01A B01
A05A X10
1187/7159
²¸
àõÏñ³Çݳ
A05A X10
1236/7173
24.09.2007
13.09.2012
15.11.2007
19.11.2012
êÇñdz
3091
üÉ»µá¹Ç³ 600Ù·
Phlebodia 600mg
¹ÇáëÙÇÝ
diosmin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
600Ù·
(15, 30)
3092
üÉ»ÙáÏɳí
ëáÉÛáõï³µ
Flemoclav Solutab
¹»Õ³Ñ³ï»ñ (³ñ³·
ï³ññ³ÉáõÍíáÕ)
(125Ù·+ 31.25 Ù·)
(15 /3x5/, 20 /4x5/)
3093
üÉ»ÙáÏɳí
ëáÉÛáõï³µ
Flemoclav Solutab
¹»Õ³Ñ³ï»ñ (³ñ³·
ï³ññ³ÉáõÍíáÕ)
(250Ù·+62.5 Ù·)
(15 /3x5/, 20/4x5/ )
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
Üǹ»éɳݹݻñ
J01C R02
0449/6230
29.09.2006
29.09.2011
¸
3094
üÉ»ÙáÏɳí
ëáÉÛáõï³µ
Flemoclav Solutab
¹»Õ³Ñ³ï»ñ (³ñ³·
ï³ññ³ÉáõÍíáÕ)
(500Ù·+125Ù·)
(15/3x5/,20/4x5/)
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
Üǹ»éɳݹݻñ
J01C R02
0419/6392
26.09.2006
26.09.2011
¸
3095
üÉ»ÙûùëÇÝ
ëáÉÛáõï³µ
Flemoxin Solutab
üÉ»ÙûùëÇÝ
ëáÉÛáõï³µ
Flemoxin Solutab
üÉ»ÙûùëÇÝ
ëáÉÛáõï³µ
Flemoxin Solutab
üÉÇùëáݳ½
Flixonase
³ÙûùëÇóÇÉÇÝ,
ùɳíáõɳݳÃÃáõ
amoxicillin, clavulanic
acid
³ÙûùëÇóÇÉÇÝ,
ùɳíáõɳݳÃÃáõ
amoxicillin, clavulanic
acid
³ÙûùëÇóÇÉÇÝ,
ùɳíáõɳݳÃÃáõ
amoxicillin, clavulanic
acid
³ÙûùëÇóÇÉÇÝ
amoxycillin
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ÆÝáï»ñ³ âáõ½Ç ÆÝÝáï»Ï
ÆÝï»ñݳëÇáݳÉ
ȳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
Innothera Chouzy for
Laboratoires Innotech
International
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
¹»Õ³Ñ³ï»ñ
500Ù·
(20/4x5/)
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
Üǹ»éɳݹݻñ
J01C A04
0420/6391
26.09.2006
26.09.2011
¸
³ÙûùëÇóÇÉÇÝ
amoxycillin
¹»Õ³Ñ³ï»ñ
250Ù·
(20/4x5/)
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
Üǹ»éɳݹݻñ
J01C A04
0421/6390
26.09.2006
26.09.2011
¸
³ÙûùëÇóÇÉÇÝ
amoxycillin
¹»Õ³Ñ³ï»ñ
125Ù·
(20/4x5/)
Ú³Ù³ÝáõãÇ ºáõñáå ´.ì.
Yamanouchi Europe B.V.
Üǹ»éɳݹݻñ
J01C A04
0422/6389
26.09.2006
26.09.2011
¸
ýÉáõïÇϳ½áÝ
fluticasone
¹»Õ³Ï³ËáõÛÃ
çñ³ÛÇÝ, ùÃÇ
0.05%,
50ÙÏ·/¹»Õ³ã³÷,
120 ¹»Õ³ã³÷
óáÕ³ßÇà ë³ñùáõÙ
Æëå³Ýdz
R01A D08
4116
03.03.2003
03.03.2008
²¸
ïñÇåëÇÝ, µñáٻɳÛÝ,
éáõïá½Ç¹.3H2O
tripsin, bromelain,
rutosid.3H2O
µ»ï³Ù»Ã³½áÝÇ
¹ÇåñáåÇáݳï,
µ»ï³Ù»Ã³½áÝÇ
»ñÏݳïñÇáõÙ³Ï³Ý ýáëý³ï
betamethasone
dipropionate,
betamethasone
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¶»ñÙ³Ýdz
B06A
4544
21.08.2003
21.08.2008
²¸
êÉáí»Ýdz
H02A B01
0657/6568
12.01.2007
12.01.2012
¸
3096
3097
3098
3099
üÉ᷻ݽÇÙ
Phlogenzym
3100
üÉáëï»ñáÝ
Flosteron
¹»Õ³Ñ³ï»ñ
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
¶É³ùëáàõ»ÉùáÙ ê²
¶É³ùëáêÙÇÃÎɳÛÝ
ü³ñÙ³ëÛáõÃÇù³Éë ê²
(Ȼѳëï³Ý)-Ç Ñ³Ù³ñ
GlaxoWellcome SA for
GlaxoSmithKline
Pharmaceuticals SA (Poland)
48Ù·+90Ù·+ 100Ù· ØáõÏáë ü³ñÙ³
MuCos
(40,100,200,800)
Pharma
7Ù·(5Ù·+2Ù·)/
1ÙÉ,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
²¸
üñ³Ýëdz
C05C A03
0596/6598
14.12.2006
14.12.2011
¸
Üǹ»éɳݹݻñ
J01C R02
0448/6229
29.09.2006
29.09.2011
¸
211
üÉáñ³Ý
Floran
üÉáõ¹Çëáýï
Fludisoft
disodium phosphate
ǽáýÉáõñ³Ý
isoflurane
¹»ùëïñáÙ»Ãáñý³Ý
dextromethorphane
3103
üÉáõ¹Çï»Ï
Fluditec
3104
3101
ÉáõÍáõÛÃ
ßÝã³éÙ³Ý
ÉáõÍáõÛà ËÙ»Éáõ
100%,
100ÙÉ ßßÇÏ
0.15%,
150ÙÉ ßßÇÏ
ϳñµáóÇëï»ÇÝ
carbocisteine
ûß³ñ³Ï
Ýáñ³ÍÇÝÝ»ñÇ ¨
»ñ»Ë³Ý»ñÇ
2%,
125ÙÉ ßßÇÏ
üÉáõ¹Çï»Ï
Fluditec
ϳñµáóÇëï»ÇÝ
carbocisteine
ûß³ñ³Ï ٻͻñÇ
5%,
125ÙÉ ßßÇÏ
3105
üÉáõ½³Ù»¹
Fluzamed
ýÉáõÏáݳ½áÉ
fluconazole
¹»Õ³å³ïÇ×
150Ù·
(1)
3106
üÉáõ½áÉ
Fluzole
üÉáõÇÙáõóÇÉ
Fluimucil
üÉáõϳݹ
Flucand
üÉáõϳݹ
Flucand
üÉáõϳݹ
Flucand
üÉáõÏá½áÉ
Flucozol
üÉáõÏá½áÉ
Flucozol
üÉáõÏáݳ½áÉ
Fluconazole
üÉáõÏáݳ½áɲëï»ñdz
Fluconazole-Asteria
üÉáõÏáݳ½áɲëï»ñdz
Fluconazole-Asteria
üÉáõÏáݳ½áɼ¹áñáíÛ»
FluconazolZdorovye
üÉáõÏáݳ½áɼ¹áñáíÛ»
Fluconazol-
ýÉáõÏáݳ½áÉ
fluconazole
³ó»ïÇÉóÇëï»ÇÝ
acetylcysteine
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõÏáݳ½áÉ
fluconazole
¹»Õ³å³ïÇ×Ý»ñ
0.15·
(1,4,7,10)
600Ù·
(10,20)
2Ù·/ÙÉ,
100ÙÉ ëñí³Ï (1)
50Ù·
(7)
150Ù·
(1)
150Ù·
(10)
50Ù·
(10)
50Ù·
(10)
50Ù·,
(100(10x10))
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
ÆÝÝáï»ù ÆÝï»ñݳëÇáݳÉ
ȳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
ÆÝáï»ñ³ âáõ½Ç
Innothera Chouzy for
Laboratoires Innotech
International
ÆÝÝáï»ù ÆÝï»ñݳëÇáݳÉ
ȳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
ÆÝáï»ñ³ âáõ½Ç
Innothera Chouzy for
Laboratoires Innotech
International
ÆÝÝáï»ù ÆÝï»ñݳëÇáݳÉ
ȳµáñ³ïáñdzÛÇ Ñ³Ù³ñ
ÆÝáï»ñ³ âáõ½Ç
Innothera Chouzy for
Laboratoires Innotech
International
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ/²ØÜ/-Ç Ñ³Ù³ñ,
E.I.P.I.Co (for World Medicine,
USA)
§´ñÇÝó³Éáí - ²¦ ö´À
§Brinsalov - A¦ CJSC
¼³ÙµáÝ ÞíÇï½»ñɳݹ Èï¹.
Zambon Switzerland Ltd.
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇϳÉë
Hikma Pharmaceuticals
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇù³Éë
Hikma Pharmaceuticals
ÐÇÏÙ³ ü³ñÙ³ëÛáõÃÇù³Éë
Hikma Pharmaceuticals
γëå³ñ Þ³µ³ÝÇ É³µë.
Kaspar Chabani Labs
γëå³ñ Þ³µ³ÝÇ É³µë.
Kaspar Chabani Labs
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co.
Îáñ»³ öñÇÙ ü³ñÙ øá. Èï¹.
Korea Prime Pharm Co.Ltd.
3102
3107
3108
3109
3110
3111
3112
3113
3114
3115
3116
3117
¹»Õ³Ñ³ï»ñ
¹Ûáõñ³ÉáõÛÍ
ÉáõÍáõÛÃ Ý/»
ϳÃÇɳݻñ³ñÏ-Ù³Ý
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³å³ïÇ×Ý»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³å³ïÇ×Ý»ñ
Ðáñ¹³Ý³Ý
N01A B06
5143
14.12.2004
14.12.2009
28.10.2004
28.10.2009
¸
üñ³Ýëdz
R05D A09
5112
üñ³Ýëdz
R05C B03
5362
23.05.2005
23.05.2010
²¸
üñ³Ýëdz
R05C B03
5361
23.05.2005
23.05.2010
²¸
º·Çåïáë
J02A C01
5976
09.02.2006
09.02.2011
¸
èáõë³ëï³Ý
J02A C01
5328
¸
Þí»Ûó³ñdz
R05C B01
5406
Ðáñ¹³Ý³Ý
J02A C01
5383
Ðáñ¹³Ý³Ý
J02A C01
5381
Ðáñ¹³Ý³Ý
J02A C01
5382
êÇñdz
J02A C01
5263
êÇñdz
J02A C01
5262
г۳ëï³Ý
J02A C01
4197
Îáñ»³
J02A C01
5759
25.03.2005
25.03.2010
01.04.2005
01.04.2010
22.11.2005
22.11.2010
11.01.2006
11.01.2011
11.01.2006
11.01.2011
09.02.2005
09.02.2010
09.02.2005
09.02.2010
10.02.2003
10.02.2008
29.08.2005
29.08.2010
¸
²¸
¸
¸
¸
¸
¸
¸
¸
ýÉáõÏáݳ½áÉ
fluconazole
¹»Õ³å³ïÇ×Ý»ñ
150Ù·
(100(10x10))
Îáñ»³ öñÇÙ ü³ñÙ øá.Èï¹.
Korea Prime Pharm Co.Ltd.
Îáñ»³
J02A C01
5760
05.09.2005
05.09.2010
¸
ýÉáõÏáݳ½áÉ
fluconazole
¹»Õ³å³ïÇ×Ý»ñ
150Ù·
(1,2)
àõÏñ³Çݳ
J02A C01
1145/7128
02.10.2007
08.08.2012
¸
ýÉáõÏáݳ½áÉ
fluconazole
¹»Õ³å³ïÇ×Ý»ñ
100Ù·
(10)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
àõÏñ³Çݳ
J02A C01
1244/7067
15.10.2007
15.10.2012
¸
212
3118
3119
3120
3121
3122
3123
3124
3125
3126
Zdorovye
üÉáõÏáݳ½áɼ¹áñáíÛ»
FluconazolZdorovye
üÉáõáóÇÝáÉáÝ
Fluocinolone
üÉáõï³Ùǹ
Flutamide
üÉáõóÇݳñ
Flucinar
ýÉáõÏáݳ½áÉ
fluconazole
ýÉáõáóÇÝáÉáÝ
fluocinolone
ýÉáõï³Ùǹ
flutamide
ýÉáõáóÇÝáÉáÝÇ
³ó»ïáÝǹ fluocinolone
acetonide
üÉáõóÇݳñ
ýÉáõáóÇÝáÉáÝÇ
Flucinar
³ó»ïáÝǹ fluocinolone
acetonide
üÉáõóÇݳñ Ü
ýÉáõáóÇÝáÉáÝÇ
Flucinar N
³ó»ïáÝǹ, Ý»áÙÇóÇÝ
fluocinolone acetonide,
neomycine
üÉáõûùë»ïÇÝ ÎØä
ýÉáõûùë»ïÇÝ
Fluoxetinum - KMP
fluoxetine
üÉûùë³¹»ùë
óÇåñáýÉûùë³óÇÝ,
Floxadex
¹»ùë³Ù»Ã³½áÝ
ciprofloxacin,
dexamethasone
üÉûùëÇÙ»¹
óÇåñáýÉûùë³óÇÝ
Floximed
ciprofloxacin
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(10)
ùëáõù
0.025%,
15· å³ñÏáõ×
250Ù·
(84)
0.025%,
15· å³ñÏáõ×
¹»Õ³Ñ³ï»ñ
ùëáõù
¸
г۳ëï³Ý
D07A C04
0619/6632
¸
üÇÝɳݹdz
L02B B01
3935
Ȼѳëï³Ý
D07A C04
5779
18.12.2006
18.12.2011
16.01.2003
16.01.2008
14.12.2005
14.12.2010
Ȼѳëï³Ý
D07A C04
5778
14.12.2005
14.12.2010
¸
Ȼѳëï³Ý
D07A C04
5780
14.12.2005
14.12.2010
¸
10.03.2004
10.03.2009
02.04.2004
02.04.2009
¸
¸
¸
¹»Õ³å³ïÇ×Ý»ñ
0.02·
(10)
(3.5Ù·+1Ù·)/1ÙÉ,
(10ÙÉ ßßÇÏ)
ÎǨٻ¹åñ»å³ñ³ï ´´À
Kievmedpreparat OJSC
ÈÇÏíáñ ¹»Õ³·áñͳϳÝ
Ó»éݳñÏáõÃÛáõÝ
Liqvor Pharmaceuticals
àõÏñ³Çݳ
N06A B03
4621
г۳ëï³Ý
J01A A02,
S01A X13
4752
³ÏݳϳÃÇÉÝ»ñ
0.3%,
5ÙÉ ßßÇÏ
ϳÃáóÇÏáí
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ/²ØÜ/-Ç Ñ³Ù³ñ,
E.I.P.I.Co (for World Medicine,
USA)
º.Æ.ä.Æ.øá (àõáñɹ
Ø»¹ÇëÇÝ, ²Ý·Édz-Ç Ñ³Ù³ñ)
E.I.P.I Co (for World Medicine,
England)
´ñÇëïáÉ-سۻñë êùíǵµ
Bristol-Myers Squibb
º·Çåïáë
S01A X13
5974
09.02.2006
09.02.2011
¸
º·Çåïáë
S01A X13
0785/6854
13.03.2007
13.03.2012
¸
Æï³Édz
C09A A09,
C03A A03
5529
16.05.2005
16.05.2010
¸
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
²ðöÆغ¸ ÐÒ ö´À ARPIMED
J.V. CJ-S Co.
êÇ öÇ ü³ñÙ³ëÛáõÃÇù³Éë Èï¹
CP Pharmaceuticals Ltd.
´»É³éáõë
B03B B01
5004
13.12.2004
13.12.2009
¸
г۳ëï³Ý
-
4803
¸
ØdzóÛ³É
³·³íáñáõÃÛáõÝ
B03B B01
1082/7129
20.05.2004
20.05.2009
08.08.2007
08.08.2012
àõÏñ³Çݳ
G03C A07
1250/7061
15.10.2007
15.10.2012
¸
üñ³Ýëdz
A02A B03
0445/6451
29.09.2006
29.09.2011
²¸
³ãùÇ, ³Ï³ÝçÇ
¹»Õ³Ï³ËáõÛÃ
0.3%,
5· å³ñÏáõ×
3128
üá½Ç¹ 20
Fozide 20
¹»Õ³Ñ³ï»ñ
20Ù·+12,5Ù·
(10,14,20,28)
3129
üáɳÃÃáõ
Folic acid
ýá½ÇÝáåñÇÉ
ݳïñÇáõÙÇ,
ÑǹñáùÉáñáÃdz½Ç¹
fosinopril sodium,
hydrochlorothiazide
ýáɳÃÃáõ
folic acid
¹»Õ³Ñ³ï»ñ
0.001·
(50)
¹»Õ³Ñ³ï»ñ
1Ù·
(24,48)
5Ù·
(28)
üáëý³ÉÛáõ·»É
Phosphalugel
15.10.2007
15.10.2012
(0.25Ù·+5Ù·)/·,
15· å³ñÏáõ×
³Ïݳùëáõù
3133
1243/7068
ùëáõù
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
ýáɳÃÃáõ
folic acid
ýáɳÃÃáõ
folic acid
J02A C01
0.025%,
15· å³ñÏáõ×
üÉûùëÇÙ»¹
Floximed
üáɳÃÃáõ
Folic acid
3131
üáɳÃÃáõ
¹»Õ³Ñ³ï»ñ ´ä 5Ù·
Folic Acid Tablets
BP 5mg
3132
üáÉÇÏáõÉÇݼ¹áñáíÛ»
Folliculin-Zdorovye
àõÏñ³Çݳ
¹áݹáÕ
3127
3130
Company LLC
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
²ðöÆغ¸ ÐÒ ö´À
ARPIMED J.V. CJ-S Co
úñÇáÝ Îáñåáñ»ßÁÝ
Orion Corporation
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceuticals
Works
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceuticals
Works
Ú»Éý³ ê.². ¹»Õ³·áñÍ³Ï³Ý ·áñͳñ³Ý
Jelfa S.A. Pharmaceuticals
Works
¹»Õ³Ñ³ï»ñ
¿ëïñÇáÉ
estriol
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý,
ÛáõÕ³ÛÇÝ
0,1%,
1ÙÉ ³ÙåáõÉÝ»ñ
(10)
³ÉÛáõÙÇÝÇáõÙÇ
ýáëý³ï
aluminium phosphate
¹áݹáÕ Ý»ñùÇÝ
ÁݹáõÝÙ³Ý
16·,
÷³Ã»ÃÝ»ñ (20)
¼¹áñáíÛ» ¸»Õ³·áñͳϳÝ
ÀÝÏ»ñáõÃÛáõÝ êäÀ
Zdorovye Pharmaceutical
Company LLC
ü³ñÙ³ïÇë (²ëï»É³ë ü³ñÙ³
ºáõñáå ´.ì., Üǹ»ñɳݹݻñ-Ç
ѳٳñ)
Pharmatis (for Astellas Pharma
¸
¸
213
3134
üáëýáµÇáÝ
Fosfobion
³¹»Ýá½ÇÝÇ »éýáëý³ï
adenosine triphosphate
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
3135
üáïÇÉ
Fotil
³ÏݳϳÃÇÉÝ»ñ
3136
üáïÇÉ ýáñï»
Fotil forte
3137
üáñɳùë
Forlax
üáñÙǹñáÝ
Formidron
üáñëï»á
Forsteo
åÇÉáϳñåÇÝÇ
ÑǹñáùÉáñǹ,
ÃÇÙáÉáÉÇ Ù³É»³ï
pilocarpine
hydrochloride, timolol
maleate
åÇÉáϳñåÇÝÇ
ÑǹñáùÉáñǹ,
ÃÇÙáÉáÉÇ Ù³É»³ï
pilocarpine
hydrochloride, timolol
maleate
Ù³Ïñá·áÉ 4000
macrogol 4000
ýáñÙ³ÉÇÝ
formalin
ï»ñÇå³ñ³ïǹ
teriparatide
3140
üáñ﻽³
Forteza
Ù³Ïñá·áÉ 4000
makrogol 4000
3141
üáñï»ñ³
Forterra
üáñïáõÙ
Fortum
üáñïáõÙ
Fortum
üáñïñ³Ýë
Fortrans
óÇåñáýÉûùë³óÇÝ
ciprofloxacin
ó»ýﳽǹÇÙ
ceftazidime
ó»ýﳽǹÇÙ
ceftazidime
Ù³Ïñá·áÉ 4000
macrogol 4000
3145
üáõ³ñÇùë
2007/2008
Fluarix 2007/2008
·ñÇåÇ ³ÏïÇí³½»ñÍ
×»Õùí³Í å³ïí³ëï³ÝÛáõÃ
inactivated split
influenza vaccine
¹»Õ³Ï³ËáõÛÃ
Ý»ñ³ñÏÙ³Ý
3146
üáõÏáñóÇÝ
Fucorcin
ÉáõÍáõÛÃ
3147
üáõÝ·³½áÉ
Fungazol
ý»ÝáÉ, 黽áñóÇÝ,
µáñ³ÃÃáõ
phenol, resorcin, boric
acid
ÙÇÏáݳ½áÉÇ ÝÇïñ³ï
miconazole nitrate
3148
üáõÝ·Çù»ñ-150
¹»Õ³å³ïÇ×Ý»ñ
ýÉáõÏáݳ½áÉ
fluconazole
3138
3139
3142
3143
3144
1%,
1ÙÉ ³ÙåáõÉÝ»ñ
(5)
(20Ù·+6.84Ù·)/ÙÉ,
5ÙÉ ëñí³Ï
Europe B.V., The Netherlands)
êÇÏáÙ»¹ ê.².
Sicomed S.A.
èáõÙÇÝdz
C01E B10
4230
27.06.2003
27.06.2008
¸
ê³Ýï»Ý ´À
§Santen Oy¦
üÇÝɳݹdz
S01E B51
4267
15.07.2003
15.07.2008
¸
³ÏݳϳÃÇÉÝ»ñ
(40Ù·+6.84Ù·)/ÙÉ,
5ÙÉ ëñí³Ï
ê³Ýï»Ý ´À
§Santen Oy¦
üÇÝɳݹdz
S01E B51
4268
15.07.2003
15.07.2008
¸
¹»Õ³÷áßÇ ËÙ»Éáõ
ÉáõÍáõÛÃÇ
ÉáõÍáõÛÃ
10·,
÷³Ã»ÃÝ»ñ (20)
10%,
30ÙÉ ßßÇÏ
20ÙÏ·/80ÙÏÉ,
3ÙÉ/28¹»Õ³ã³÷/
ݳ˳Éóí³Í ·ñÇãÝ»ñ³ñÏÇã
10·,
÷³Ã»ÃÝ»ñ (10)
´áýáõñ Æåë»Ý ÆݹáõëïñÇ
Beaufour Ipsen Industrie
¾ëÏáõɳå êäÀ
Esculap Ltd.
ÈÇÉÇ üñ³Ýë ê.².ê.
Lilly France S.A.S.
üñ³Ýëdz
A06A D65
0369/6313
²¸
г۳ëï³Ý
-
5635
üñ³Ýëdz
-
0463\6404
11.09.2006
11.09.2011
12.01.2006
12.01.2011
11.10.2006
11.10.2011
èáÙý³ñÙ øáÙ÷³ÝÇ êèÈ
Rompharm Company SRL
èáõÙÇÝdz
A06AD15
1390/7353
05.11.2007
05.11.2012
²¸
500Ù·
(10)
500Ù·
ëñí³Ï (1)
1·
ëñí³Ï (1)
64·,
÷³Ã»ÃÇÏÝ»ñ (4)
лÉ÷ ê.². ü³ñÙ³ëÛáõÃÇù³Éë
Help S.A. Pharmaceuticals
¶É³ùëáêÙÇÃÎɳÛÝ ê.å.².
GlaxoSmithKline S.p.A.
¶É³ùëáêÙÇÃÎɳÛÝ ê.å.².
GlaxoSmithKline S.p.A.
´áýáñ Æåë»Ý ÆݹáõëïñÇ
/´áýáõñ Æåë»Ý
ÆÝï»ñݳëÇáݳÉÇ Ñ³Ù³ñ/
Beaufour Ipsen Industrie for
Beaufour Ipsen International
¶É³ùëáêÙÇÃÎɳÛÝ
´ÇáÉáçÇϳÉë ê.².
GlaxoSmithKline Biologicals
S.A.
Ðáõݳëï³Ý
J01M A02
5295
¸
Æï³Édz
J01D A11
4067
Æï³Édz
J01D A11
4068
üñ³Ýëdz
A06A D
4660
13.01.2005
13.01.2010
24.01.2003
24.01.2008
24.01.2003
24.01.2008
04.03.2004
04.03.2009
¶»ñÙ³Ýdz
-
1321/5119/3
31.10.2007
06.10.2009
¸
²ñë»ÙÇ êäÀ
Arsemi Ltd.
г۳ëï³Ý
D08A
D10A
4218
27.03.2003
27.03.2008
²¸
ü³ñٳϳñ Èï¹
Pharmacare Ltd
Æëñ³Û»É
1409
15.01.2003
15.01.2008
²¸
´ÇáÙ»¹Çù»Ûñ äìî Èï¹.
Biomedicare PVT Ltd.
Ðݹϳëï³Ý
D01A C02
G01A F04
J02A B01
S02A A13
J02A C01
5962
28.03.2006
28.03.2011
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ Ý»ñùÇÝ
ÁݹáõÝÙ³Ý
ÉáõÍáõÛÃÇ
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ
Ý»ñ³ñÏÙ³Ý
¹»Õ³÷áßÇ ËÙ»Éáõ
ÉáõÍáõÛÃÇ
Ýñµ³ùëáõù
¹»Õ³å³ïÇ×Ý»ñ
15ÙÏ·
ѻٳ·ÉÛáõïÇÝÇÝ
Ûáõñ³ù³ÝãÛáõñ
»ñ³ß˳íáñí³Í
ßï³ÙÇó, 0,5ÙÉ
ݳ˳Éóí³Í
Ý»ñ³ñÏÇãÝ»ñ (1)
3.9·+7.8·+
0.8Ù·/100ÙÉ,
10ÙÉ, 250ÙÉ
30ÙÉ ßßÇÏ
2%,
15· å³ñÏáõ×
150Ù·
(1)
²¸
¸
¸
¸
¸
214
Fungicare-150
capsules
üáõÝ·Çù»ñ-50
¹»Õ³å³ïÇ×Ý»ñ
Fungicare-50
capsules
üáõÝ·áÉáÝ
Fungolon
üáõÝ·áï»ñµÇÝ
Fungoterbin
üáõÝ·áï»ñµÇÝ
Fungoterbin
üáõñ³·ÇÝ
Furagin
üáõñ³¹áÝÇÝ
Furadonin
ýÉáõÏáݳ½áÉ
fluconazole
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(4,10x4)
´ÇáÙ»¹Çù»Ûñ äìî Èï¹.
Biomedicare PVT Ltd.
Ðݹϳëï³Ý
J02A C01
5961
28.03.2006
28.03.2011
¸
ýÉáõÏáݳ½áÉ
fluconazole
ï»ñµÇݳýÇÝ
terbinafine
ï»ñµÇݳýÇÝ
terbinafine
ýáõñ³½Ç¹ÇÝ
furazidin
ÝÇïñáýáõñ³ÝïáÇÝ
nitrofurantoin
¹»Õ³å³ïÇ×Ý»ñ
50Ù·
(4,8)
0.25·
(10, 14)
1%,
15· å³ñÏáõ×
50Ù·
(30)
0.05·
(10)
´áõÉÕ³ñdz
J02A C01
4753
¸
èáõë³ëï³Ý
D01B A02
0588/6458
èáõë³ëï³Ý
5533
àõÏñ³Çݳ
D01AE15,
D01BA02
J01X E03
1123/7024
´»É³éáõë
J01X E01
0942/6903
03.06.2004
03.06.2009
05.12.2006
05.12.2011
16.05.2005
16.05.2010
01.10.2007
01.10.2012
03.05.2007
03.05.2012
3155
üáõñ³½áÉǹáÝ
Furazolidon
ýáõñ³½áÉǹáÝ
furazolidone
¹»Õ³Ñ³ï»ñ
50Ù·
(10)
´»É³éáõë
G01A X06
0943/6902
03.05.2007
03.05.2012
¸
3156
üáõñ³É·ÇÝ
Furalgin
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
(7·+2.5·+0.2·+
90.3·)/100·,
5· ßßÇÏ
г۳ëï³Ý
S01H
4645
11.11.2005
20.01.2009
²¸
3157
üáõñ³óÇÉÇÝÇ
ùëáõù Furacilin
ointment
üáõñ³óÇÉÇÝÇ
ùëáõù Furacillin
ointment
üáõñáë»Ùǹ
Furosemid
üáõñáë»Ùǹ
Furosemid
üáõñáë»Ùǹ
Furosemid
³ÝïÇåÇñÇÝ, ¹ÇϳÛÇÝ
(ï»ïñ³Ï³ÛÇÝ),
ýáõñ³óÇÉÇÝ,
·ÉÇó»ñÇÝ antipyrin,
dicain (tetracaine),
furacilin, glycerin
ÝÇïñáýáõñ³É
nitrofural
´³ÉϳÝý³ñÙ³-è³½·ñ³¹ ²¸
Balkanpharma-Razgrad AD
ÜÇÅý³ñÙ ´´À
Nizhpharm OJSC
ÜÇÅý³ñÙ ´´À
Nizhpharm Open JSC
¶³ÉÇãý³ñÙ ´À
Galichpharm JSC
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
¾ëÏáõɳå êäÀ
Esculap Ltd.
ùëáõù
0,2%,
25· å³ñÏáõ×
ê³ÝÇï³ë ´À
Sanitas JSC
ÈÇïí³
D08A F01,
D09A A03
5680
30.11.2005
30.11.2010
²¸
ÝÇïñáýáõñ³É
nitrofural
ùëáõù
D08A F01
D09A A03
5020
13.12.2004
13.12.2009
²¸
¹»Õ³Ñ³ï»ñ
´áõÉÕ³ñdz
C03C A01
0921/6700
´áõÉÕ³ñdz
C03C A01
0969/6994
´»É³éáõë
C03C A01
0945/6900
26,04.2007
26.04.2012
14.05.2007
14.05.2012
03.05.2007
03.05.2012
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
´áñÇëáíÛ³Ý ´ä¶ Borisov
Medical Preparations Plant
RUP
êáý³ñÙ³ ´À
Sopharma JSC
´³ÉϳÝý³ñÙ³-¸áõåÝÇó³ ²¸
Balkanpharma-Dupnitza AD
´áñÇëáíÛ³Ý
µáõÅå³ïñ³ëïáõÏÝ»ñÇ ·áñͳñ³Ý
ÐàõÒ
Borisov Medical Preparations
Plant RUE
¶ÜòÈê ÷áñÓ³ñ³ñ³Ï³Ý ·áñͳñ³Ý
êäÀ-Ç Ù³ëݳ×ÛáõÕ
Branch of LCC '' Experimental
plant GNCLS''
´áñÇëáíÛ³Ý ´ä¶
Borisov Medical Preparations
Plant RUP
êáý³ñÙ³ ´À
Sopharma JSC
´»É³éáõë
ýáõñáë»Ùǹ
furosemide
ýáõñáë»Ùǹ
furosemide
ýáõñáë»Ùǹ
furosemide
0.2%,
15·, 25· å³ñÏáõ×
ϳ٠³å³Ï» ï³ñ³
40Ù·
(20)
40Ù·
(50)
1%,
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
àõÏñ³Çݳ
C03C A01
1492/7393
20.12.2007
20.12.2012
¸
´»É³éáõë
C03C A01
5023
13.12.2004
13.12.2009
¸
´áõÉÕ³ñdz
S01A,
S02A,
S01H
5858
20.01.2006
20.01.2011
²¸
3149
3150
3151
3152
3153
3154
3158
3159
3160
3161
¹»Õ³Ñ³ï»ñ
Ýñµ³ùëáõù
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
¹»Õ³Ñ³ï»ñ
3162
üáõñáë»Ùǹ
Furosemid
ýáõñáë»Ùǹ
furosemide
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
0,01·/ÙÉ (2ÙÉ),
2ÙÉ ³ÙåáõÉÝ»ñ
(10)
3163
üáõñáë»Ùǹ
Furosemide
ýáõñáë»Ùǹ
furosemide
¹»Õ³Ñ³ï»ñ
3164
üáõñáï³É·ÇÝ
Furotalgin
ÝÇïñáýáõñ³É,
ï»ïñ³Ï³ÛÇÝÇ
ÑǹñáùÉáñǹ,
³Ï³Ýç³Ï³ÃÇÉÝ»ñ
(ÉáõÍáõÛÃ)
0.04·
(10,
20,25,30,40,50)
(2.5Ù·+31.25Ù·+
87.5Ù·)/ÙÉ,
5ÙÉ ßßÇÏ
¸
²¸
¸
¸
¸
¸
215
3165
3166
3167
3168
3169
3170
3171
3172
üïáñ³ýáõñ
Ftorafur
üïáñáÏáñï
Ftorocort
üñ³ùëÇå³ñÇÝ
2850ØØ(²ÝïÇ
Æøê³)
Fraxiparine 2850 IU
(Anti Xa)
üñ³ùëÇå³ñÇÝ
3800ØØ (²ÝïÇ
Æøê³)
Fraxiparine 3800 IU
(Anti Xa)
üñ³ùëÇå³ñÇÝ
5700ØØ (²ÝïÇ
Æøê³)
Fraxiparine 5700 IU
(Anti Xa)
üñ³ùëÇå³ñÇÝ
7600ØØ(²ÝïÇ
Æøê³)
Fraxiparine 7600 IU
(Anti Xa)
üñ³ùëÇå³ñÇÝ
9500ØØ(²ÝïÇ
Æøê³)
Fraxiparine 9500 IU
(Anti Xa)
üñǹ»ñÙ pH-µ³É³Ýë
Freederm pHBalance
3173
üñǹ»ñÙ ÓÛáõÃ
Freederm Tar
3174
üñǹ»ñÙ òÇÝÏ
Freederm Zinc
ý»Ý³½áÝ
nitrofural, tetracaine
hydrochloride,
phenazone
ï»·³ýáõñ
tegafur
ïñdzÙóÇÝáÉáÝÇ
³ó»ïáÝǹ
triamcinolone acetonide
ݳ¹ñáå³ñÇÝ Ï³ÉóÇáõÙ
nadroparin calcium
¹»Õ³å³ïÇ×Ý»ñ
ùëáõù
400Ù·
(100)
0.1%,
15· å³ñÏáõ×
¶ñÇݹ»ùë ´À
Grindex JSC
¶»¹»áÝ èÇËï»ñ Èï¹.
Gedeon Richter Ltd.
ȳïídz
L01B C03
0696/6638
ÐáõÝ·³ñdz
D07A B09
5249
25.01.2007
25.01.2012
30.05.2005
30.05.2010
¸
¸
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
2850ØØ/0.3ÙÉ,
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Sanofi Winthrop Industrie
(2,10)
üñ³Ýëdz
B01A B06
4539
09.03.2004
09.03.2009
¸
ݳ¹ñáå³ñÇÝ Ï³ÉóÇáõÙ
nadroparin calcium
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
3800ØØ/0.4ÙÉ,
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Sanofi Winthrop Industrie
(2,10)
üñ³Ýëdz
B01A B06
4540
09.03.2004
09.03.2009
¸
ݳ¹ñáå³ñÇÝ Ï³ÉóÇáõÙ
nadroparin calcium
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
5700ØØ/0.6ÙÉ,
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Sanofi Winthrop Industrie
(2,10)
üñ³Ýëdz
B01A B06
4541
09.03.2004
09.03.2009
¸
ݳ¹ñáå³ñÇÝ Ï³ÉóÇáõÙ
nadroparin calcium
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
7600ØØ/0.8ÙÉ,
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Sanofi Winthrop Industrie
(2,10)
üñ³Ýëdz
B01A B06
4542
09.03.2004
09.03.2009
¸
ݳ¹ñáå³ñÇÝ Ï³ÉóÇáõÙ
nadroparin calcium
ÉáõÍáõÛÃ
Ý»ñ³ñÏÙ³Ý
9500ØØ/1ÙÉ,
ê³ÝáýÇ ìÇÝÃñáå ÆݹáõëïñÇ
Éóí³Í Ý»ñ³ñÏÇãÝ»ñ
Sanofi Winthrop Industrie
(2,10)
üñ³Ýëdz
B01A B06
4543
09.03.2004
09.03.2009
¸
ïñǿóÝáɳÙÇÝ
ɳáõñÇÉ ëáõÉý³ï,
åáÉÇ¿ÃÇÉ»Ý ·ÉÇÏáÉ8-¹Çëﻳñ³ï,
ÙáÝá¿Ã³ÝáɳÙÇÝ
ÏáϳÙǹ,
¹Ç¿Ã³ÝáɳÙÇÝ ÏáϳÙǹ
triethanolamine lauryl
sulfate polyet
é³ýÇݳóí³Í ³Í˳ÓÛáõÃ
0.5%, ïñǿóÝáɳÙÇÝ
ɳáõñÇÉ ëáõÉý³ï,
åáÉÇ¿ÃÇÉ»Ý ·ÉÇÏáÉ8-¹Çëﻳñ³ï,
ÙáÝá¿Ã³ÝáɳÙÇÝ
ÏáϳÙǹ,
¹Ç¿Ã³ÝáɳÙÇÝ ÏáϳÙǹ
refined coal tar 0.5%,
triethanolamine la
óÇÝÏ åÇñÇÃÇáÝ 2%,
ïñǿóÝáɳÙÇÝ
û׳é³Ñ»ÕáõÏ
150ÙÉ ßßÇÏ
Þ»ñÇÝ· öɳáõ ü³ñÙ³ ȹ³
Achering Plough Farma Lda
äáñïáõ·³-Édz
-
5927
23.01.2006
23.01.2011
²¸
û׳é³Ñ»ÕáõÏ
150ÙÉ ßßÇÏ
Þ»ñÇÝ· öɳáõ ü³ñÙ³ ȹ³
Achering Plough Farma Lda
äáñïáõ·³-Édz
-
5928
23.01.2006
23.01.2011
²¸
û׳é³Ñ»ÕáõÏ
150ÙÉ ßßÇÏ
Þ»ñÇÝ· öɳáõ ü³ñÙ³ ȹ³
Achering Plough Farma Lda
äáñïáõ·³-Édz
-
5929
23.01.2006
23.01.2011
²¸
216
3175
3176
3177
3178
üñáÙÇÉǹ
Fromilid
üñáÙÇÉǹ
Fromilid
üñáÙÇÉǹ
Fromilid
ɳáõñÇÉ ëáõÉý³ï,
åáÉÇ¿ÃÇÉ»Ý ·ÉÇÏáÉ8-¹Çëﻳñ³ï,
ÙáÝá¿Ã³ÝáɳÙÇÝ
ÏáϳÙǹ,
¹Ç¿Ã³ÝáɳÙÇÝ ÏáϳÙǹ
zinc pyrithione 2%,
triethanolamine lauryl
sulfate polyethylene
glycole-8-distearate,
monoethanolamine
cocamide,
diethanolamine
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
üñáÙÇÉǹ áõÝá
Fromilid Uno
ÏɳñÇÃñáÙÇóÇÝ
clarithromycin
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
¹»Õ³Ñ³ï»ñ
óճÝóå³ï
·ñ³ÝáõÉÝ»ñ
ËÙ»Éáõ
¹»Õ³Ï³ËáõÛÃÇ
¹»Õ³Ñ³ï»ñ »ñϳñ³ï¨
Ó»ñµ³½³ïٳٵ
250Ù·,
(14)
500Ù·,
(14)
125Ù·/5ÙÉ,
(60ÙÉ
¹»Õ³Ï³ËáõÛÃÇ
·ñ³ÝáõÉÝ»ñ)
500Ù·
(5,7,14/2x7/)
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
Îèβ ¹.¹.Üáíá Ù»ëïá
KRKA d.d.Novo mesto
êÉáí»Ýdz
J01F A09
4440
êÉáí»Ýdz
J01F A09
4441
êÉáí»Ýdz
J01F A09
4089
Îèβ ¹.¹. Üáíá Ù»ëïá
KRKA d.d. Novo mesto
êÉáí»Ýdz
J01F A09
0648/6577
16.07.2003
16.07.2008
16.07.2003
16.07.2008
24.03.2005
24.03.2010
¸
12.01.2007
12.01.2012
¸
¸
¸
217